date generated: 2024-03-10

Background

Mitch performs unidimensional and multidimensional gene set enrichment analysis. The concept behind this dates to work by Cox and Mann (https://doi.org/10.1186/1471-2105-13-S16-S12). This implementation is suited to R based workflows of multi-omics datasets. This software was developed by Antony Kaspi and Mark Ziemann. Learn more about Mitch at the website: https://github.com/markziemann/Mitch

Input profiles

Here is the first few lines of the input profile.

The profiling data being passed to mitch
x
A1BG -0.2987185
A1BG-AS1 -0.4355672
A1CF -0.0075548
A2M 0.2520922
A2M-AS1 -0.8309598
A2ML1 0.0785158

Here are some metrics about the input data profile:

Profiling data metrics
Profile metrics
num_genesets 7647
num_genes_in_profile 23030
duplicated_genes_present 0
num_profile_genes_in_sets 16920
num_profile_genes_not_in_sets 6110

Here is a plot of the input profiles. Note the dynamic ranges.

Here is the contour plot of the profile including all detected genes.

Input genesets

Here are some metrics about the gene sets used:

GMT file of genesets:
Gene set metrics
Gene sets metrics
num_genesets 7647
num_genesets_excluded 2082
num_genesets_included 5565

Differential pathway expression


Interactive enrichment scatterplot

Significance is calculated by -log10(p-value). All points shown are FDR<0.05.

Significance is calculated by -log10(p-value). Top N sets shown irrespective of FDR.

Results table

Top N= 50 gene sets

## Warning in kable_styling(., "hover", full_width = FALSE): Please specify format
## in kable. kableExtra can customize either HTML or LaTeX outputs. See
## https://haozhu233.github.io/kableExtra/ for details.
set setSize pANOVA s.dist p.adjustANOVA
DISRUPTION OF PLASMA MEMBRANE INTEGRITY IN ANOTHER ORGANISM 6 1.01e-04 0.917 0.01370
DISRUPTION OF CELLULAR ANATOMICAL STRUCTURE IN ANOTHER ORGANISM 10 3.66e-06 0.845 0.00101
LOBAR BRONCHUS EPITHELIUM DEVELOPMENT 5 2.36e-03 -0.785 0.10800
NEGATIVE REGULATION OF SEROTONIN SECRETION 5 3.08e-03 0.764 0.13000
MODULATION OF MICROTUBULE CYTOSKELETON INVOLVED IN CEREBRAL CORTEX RADIAL GLIA GUIDED MIGRATION 5 3.86e-03 -0.746 0.14500
REGULATION OF T CELL EXTRAVASATION 5 7.36e-03 0.692 0.20000
GALACTOSE CATABOLIC PROCESS 5 8.45e-03 -0.680 0.21600
INDUCTION OF BACTERIAL AGGLUTINATION 6 4.09e-03 0.677 0.15100
REGULATION OF SUPEROXIDE DISMUTASE ACTIVITY 7 2.12e-03 -0.671 0.10400
CELLULAR RESPONSE TO SODIUM ARSENITE 5 9.42e-03 -0.670 0.22800
POSITIVE REGULATION OF RAC PROTEIN SIGNAL TRANSDUCTION 5 1.09e-02 0.658 0.24400
LOBAR BRONCHUS DEVELOPMENT 6 5.60e-03 -0.653 0.17400
PROXIMAL DISTAL PATTERN FORMATION INVOLVED IN NEPHRON DEVELOPMENT 5 1.15e-02 -0.653 0.25000
REGULATION OF LONG CHAIN FATTY ACID IMPORT ACROSS PLASMA MEMBRANE 6 5.72e-03 -0.651 0.17400
POSITIVE REGULATION OF PROTEOGLYCAN BIOSYNTHETIC PROCESS 5 1.17e-02 -0.651 0.25100
DNA METHYLATION ON CYTOSINE 6 5.87e-03 -0.649 0.17700
MODULATION BY VIRUS OF HOST PROCESS 7 3.21e-03 -0.643 0.13000
FC RECEPTOR MEDIATED INHIBITORY SIGNALING PATHWAY 5 1.31e-02 0.641 0.26900
NEGATIVE REGULATION OF PHOSPHOLIPID METABOLIC PROCESS 7 3.42e-03 -0.639 0.13400
REGULATION OF MIDBRAIN DOPAMINERGIC NEURON DIFFERENTIATION 5 1.49e-02 -0.629 0.28700
LEUKOTRIENE B4 METABOLIC PROCESS 5 1.57e-02 0.624 0.29500
C 5 METHYLATION OF CYTOSINE 5 1.62e-02 -0.621 0.29700
GLOSSOPHARYNGEAL NERVE DEVELOPMENT 5 1.71e-02 -0.616 0.30000
PYRIMIDINE NUCLEOSIDE BIOSYNTHETIC PROCESS 5 1.73e-02 -0.615 0.30100
CELL MOTILITY INVOLVED IN CEREBRAL CORTEX RADIAL GLIA GUIDED MIGRATION 8 2.71e-03 -0.612 0.12000
NEGATIVE REGULATION OF ATP METABOLIC PROCESS 7 5.13e-03 -0.611 0.16800
RETINAL CELL APOPTOTIC PROCESS 7 5.14e-03 -0.611 0.16800
POSITIVE REGULATION OF PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY 6 9.88e-03 -0.608 0.23200
EXOCYST LOCALIZATION 5 1.94e-02 -0.603 0.32300
CARDIOLIPIN BIOSYNTHETIC PROCESS 7 5.75e-03 -0.603 0.17400
REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY ENDOTHELIN 6 1.09e-02 -0.600 0.24400
REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS INVOLVED IN CHOLESTEROL TRANSPORT 6 1.10e-02 -0.599 0.24500
NEGATIVE REGULATION OF T CELL MIGRATION 6 1.20e-02 0.592 0.25300
REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE ACTIVITY 8 3.73e-03 -0.592 0.14100
KETONE BODY BIOSYNTHETIC PROCESS 6 1.30e-02 -0.585 0.26800
AMELOBLAST DIFFERENTIATION 5 2.34e-02 0.585 0.35800
NADH OXIDATION 6 1.32e-02 -0.584 0.27100
REGULATION OF SEROTONIN SECRETION 7 7.47e-03 0.584 0.20000
POSITIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION OF STAT PROTEIN 14 1.61e-04 0.582 0.01800
MAINTENANCE OF PROTEIN LOCATION IN MITOCHONDRION 5 2.58e-02 -0.576 0.36500
REGULATION OF PHOSPHATIDYLCHOLINE BIOSYNTHETIC PROCESS 5 2.63e-02 -0.574 0.36500
5 PHOSPHORIBOSE 1 DIPHOSPHATE METABOLIC PROCESS 6 1.51e-02 0.573 0.29000
LIPID HYDROXYLATION 7 8.76e-03 0.572 0.22000
REGULATION OF PHOSPHOLIPID CATABOLIC PROCESS 7 8.98e-03 -0.570 0.22200
RESPONSE TO OZONE 5 2.87e-02 -0.565 0.37300
NEGATIVE REGULATION OF ATP BIOSYNTHETIC PROCESS 5 2.87e-02 -0.565 0.37300
LONG CHAIN FATTY ACID IMPORT ACROSS PLASMA MEMBRANE 10 2.00e-03 -0.564 0.10200
ENDOCANNABINOID SIGNALING PATHWAY 5 3.05e-02 -0.559 0.38500
REGULATION OF FAS SIGNALING PATHWAY 6 1.79e-02 -0.558 0.30800
FATTY ACID OMEGA OXIDATION 5 3.31e-02 0.550 0.39900


Results (complete table)


Click HERE to show results for all gene sets

Complete results
set setSize pANOVA s.dist p.adjustANOVA
DISRUPTION OF PLASMA MEMBRANE INTEGRITY IN ANOTHER ORGANISM 6 1.01e-04 9.17e-01 1.37e-02
DISRUPTION OF CELLULAR ANATOMICAL STRUCTURE IN ANOTHER ORGANISM 10 3.66e-06 8.45e-01 1.01e-03
LOBAR BRONCHUS EPITHELIUM DEVELOPMENT 5 2.36e-03 -7.85e-01 1.08e-01
NEGATIVE REGULATION OF SEROTONIN SECRETION 5 3.08e-03 7.64e-01 1.30e-01
MODULATION OF MICROTUBULE CYTOSKELETON INVOLVED IN CEREBRAL CORTEX RADIAL GLIA GUIDED MIGRATION 5 3.86e-03 -7.46e-01 1.45e-01
REGULATION OF T CELL EXTRAVASATION 5 7.36e-03 6.92e-01 2.00e-01
GALACTOSE CATABOLIC PROCESS 5 8.45e-03 -6.80e-01 2.16e-01
INDUCTION OF BACTERIAL AGGLUTINATION 6 4.09e-03 6.77e-01 1.51e-01
REGULATION OF SUPEROXIDE DISMUTASE ACTIVITY 7 2.12e-03 -6.71e-01 1.04e-01
CELLULAR RESPONSE TO SODIUM ARSENITE 5 9.42e-03 -6.70e-01 2.28e-01
POSITIVE REGULATION OF RAC PROTEIN SIGNAL TRANSDUCTION 5 1.09e-02 6.58e-01 2.44e-01
LOBAR BRONCHUS DEVELOPMENT 6 5.60e-03 -6.53e-01 1.74e-01
PROXIMAL DISTAL PATTERN FORMATION INVOLVED IN NEPHRON DEVELOPMENT 5 1.15e-02 -6.53e-01 2.50e-01
REGULATION OF LONG CHAIN FATTY ACID IMPORT ACROSS PLASMA MEMBRANE 6 5.72e-03 -6.51e-01 1.74e-01
POSITIVE REGULATION OF PROTEOGLYCAN BIOSYNTHETIC PROCESS 5 1.17e-02 -6.51e-01 2.51e-01
DNA METHYLATION ON CYTOSINE 6 5.87e-03 -6.49e-01 1.77e-01
MODULATION BY VIRUS OF HOST PROCESS 7 3.21e-03 -6.43e-01 1.30e-01
FC RECEPTOR MEDIATED INHIBITORY SIGNALING PATHWAY 5 1.31e-02 6.41e-01 2.69e-01
NEGATIVE REGULATION OF PHOSPHOLIPID METABOLIC PROCESS 7 3.42e-03 -6.39e-01 1.34e-01
REGULATION OF MIDBRAIN DOPAMINERGIC NEURON DIFFERENTIATION 5 1.49e-02 -6.29e-01 2.87e-01
LEUKOTRIENE B4 METABOLIC PROCESS 5 1.57e-02 6.24e-01 2.95e-01
C 5 METHYLATION OF CYTOSINE 5 1.62e-02 -6.21e-01 2.97e-01
GLOSSOPHARYNGEAL NERVE DEVELOPMENT 5 1.71e-02 -6.16e-01 3.00e-01
PYRIMIDINE NUCLEOSIDE BIOSYNTHETIC PROCESS 5 1.73e-02 -6.15e-01 3.01e-01
CELL MOTILITY INVOLVED IN CEREBRAL CORTEX RADIAL GLIA GUIDED MIGRATION 8 2.71e-03 -6.12e-01 1.20e-01
NEGATIVE REGULATION OF ATP METABOLIC PROCESS 7 5.13e-03 -6.11e-01 1.68e-01
RETINAL CELL APOPTOTIC PROCESS 7 5.14e-03 -6.11e-01 1.68e-01
POSITIVE REGULATION OF PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY 6 9.88e-03 -6.08e-01 2.32e-01
EXOCYST LOCALIZATION 5 1.94e-02 -6.03e-01 3.23e-01
CARDIOLIPIN BIOSYNTHETIC PROCESS 7 5.75e-03 -6.03e-01 1.74e-01
REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY ENDOTHELIN 6 1.09e-02 -6.00e-01 2.44e-01
REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS INVOLVED IN CHOLESTEROL TRANSPORT 6 1.10e-02 -5.99e-01 2.45e-01
NEGATIVE REGULATION OF T CELL MIGRATION 6 1.20e-02 5.92e-01 2.53e-01
REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE ACTIVITY 8 3.73e-03 -5.92e-01 1.41e-01
KETONE BODY BIOSYNTHETIC PROCESS 6 1.30e-02 -5.85e-01 2.68e-01
AMELOBLAST DIFFERENTIATION 5 2.34e-02 5.85e-01 3.58e-01
NADH OXIDATION 6 1.32e-02 -5.84e-01 2.71e-01
REGULATION OF SEROTONIN SECRETION 7 7.47e-03 5.84e-01 2.00e-01
POSITIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION OF STAT PROTEIN 14 1.61e-04 5.82e-01 1.80e-02
MAINTENANCE OF PROTEIN LOCATION IN MITOCHONDRION 5 2.58e-02 -5.76e-01 3.65e-01
REGULATION OF PHOSPHATIDYLCHOLINE BIOSYNTHETIC PROCESS 5 2.63e-02 -5.74e-01 3.65e-01
5 PHOSPHORIBOSE 1 DIPHOSPHATE METABOLIC PROCESS 6 1.51e-02 5.73e-01 2.90e-01
LIPID HYDROXYLATION 7 8.76e-03 5.72e-01 2.20e-01
REGULATION OF PHOSPHOLIPID CATABOLIC PROCESS 7 8.98e-03 -5.70e-01 2.22e-01
RESPONSE TO OZONE 5 2.87e-02 -5.65e-01 3.73e-01
NEGATIVE REGULATION OF ATP BIOSYNTHETIC PROCESS 5 2.87e-02 -5.65e-01 3.73e-01
LONG CHAIN FATTY ACID IMPORT ACROSS PLASMA MEMBRANE 10 2.00e-03 -5.64e-01 1.02e-01
ENDOCANNABINOID SIGNALING PATHWAY 5 3.05e-02 -5.59e-01 3.85e-01
REGULATION OF FAS SIGNALING PATHWAY 6 1.79e-02 -5.58e-01 3.08e-01
FATTY ACID OMEGA OXIDATION 5 3.31e-02 5.50e-01 3.99e-01
NEGATIVE REGULATION OF PROTEIN TARGETING TO MITOCHONDRION 5 3.38e-02 5.48e-01 4.03e-01
NADPH OXIDATION 5 3.53e-02 -5.43e-01 4.03e-01
IRON ION IMPORT ACROSS PLASMA MEMBRANE 5 3.54e-02 5.43e-01 4.03e-01
GROWTH INVOLVED IN HEART MORPHOGENESIS 5 3.58e-02 -5.42e-01 4.04e-01
INDOLE CONTAINING COMPOUND BIOSYNTHETIC PROCESS 5 3.60e-02 5.42e-01 4.04e-01
GAP JUNCTION MEDIATED INTERCELLULAR TRANSPORT 6 2.17e-02 5.41e-01 3.44e-01
NEGATIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT VIA HIGH VOLTAGE GATED CALCIUM CHANNEL 5 3.70e-02 -5.39e-01 4.10e-01
OSTEOCLAST FUSION 6 2.27e-02 -5.37e-01 3.53e-01
SPINAL CORD OLIGODENDROCYTE CELL DIFFERENTIATION 5 3.77e-02 5.37e-01 4.12e-01
AUTOPHAGOSOME LYSOSOME FUSION 9 5.61e-03 -5.33e-01 1.74e-01
RESPONSE TO NEMATODE 7 1.47e-02 5.33e-01 2.85e-01
SERINE PHOSPHORYLATION OF STAT PROTEIN 18 9.80e-05 5.30e-01 1.36e-02
REGULATION OF I KAPPAB PHOSPHORYLATION 8 9.86e-03 -5.27e-01 2.32e-01
PARAXIAL MESODERM FORMATION 7 1.58e-02 5.27e-01 2.95e-01
REGULATION OF ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN 6 2.55e-02 -5.26e-01 3.65e-01
NORADRENERGIC NEURON DEVELOPMENT 5 4.17e-02 5.26e-01 4.31e-01
REGULATION OF OVARIAN FOLLICLE DEVELOPMENT 6 2.60e-02 -5.25e-01 3.65e-01
MAST CELL DIFFERENTIATION 6 2.62e-02 -5.24e-01 3.65e-01
LONG CHAIN FATTY ACID CATABOLIC PROCESS 9 6.53e-03 5.24e-01 1.90e-01
POSITIVE REGULATION OF DOPAMINERGIC NEURON DIFFERENTIATION 5 4.49e-02 -5.18e-01 4.45e-01
MAINTENANCE OF ANIMAL ORGAN IDENTITY 5 4.50e-02 5.18e-01 4.45e-01
POSITIVE REGULATION OF BLOOD VESSEL REMODELING 6 2.81e-02 -5.18e-01 3.73e-01
NEGATIVE REGULATION OF ANTIGEN PROCESSING AND PRESENTATION 8 1.13e-02 -5.17e-01 2.49e-01
RETROGRADE NEURONAL DENSE CORE VESICLE TRANSPORT 5 4.67e-02 -5.14e-01 4.52e-01
REGULATION OF NATURAL KILLER CELL CHEMOTAXIS 8 1.21e-02 5.12e-01 2.55e-01
SOMATOSTATIN RECEPTOR SIGNALING PATHWAY 5 4.83e-02 -5.10e-01 4.58e-01
CHORIONIC TROPHOBLAST CELL PROLIFERATION 5 4.84e-02 -5.10e-01 4.58e-01
INTERLEUKIN 11 MEDIATED SIGNALING PATHWAY 6 3.09e-02 -5.09e-01 3.85e-01
PH REDUCTION 6 3.19e-02 -5.06e-01 3.90e-01
PROSTATIC BUD FORMATION 9 8.71e-03 5.05e-01 2.20e-01
ERBB2 EGFR SIGNALING PATHWAY 8 1.40e-02 -5.01e-01 2.79e-01
POSITIVE REGULATION OF LYMPHOCYTE ANERGY 5 5.27e-02 5.00e-01 4.75e-01
REGULATION OF MEMBRANE REPOLARIZATION DURING CARDIAC MUSCLE CELL ACTION POTENTIAL 7 2.28e-02 -4.97e-01 3.53e-01
NEURAL FOLD FORMATION 7 2.29e-02 4.96e-01 3.55e-01
CEREBELLAR PURKINJE CELL GRANULE CELL PRECURSOR CELL SIGNALING INVOLVED IN REGULATION OF GRANULE CELL PRECURSOR CELL PROLIFERATION 5 5.51e-02 4.95e-01 4.85e-01
NEGATIVE REGULATION OF MEIOTIC CELL CYCLE PHASE TRANSITION 5 5.58e-02 -4.94e-01 4.88e-01
REGULATION OF PLASMA CELL DIFFERENTIATION 5 5.59e-02 -4.94e-01 4.88e-01
SEROTONIN SECRETION 10 7.12e-03 4.91e-01 1.97e-01
REGULATION OF LONG CHAIN FATTY ACID IMPORT INTO CELL 8 1.64e-02 -4.90e-01 2.97e-01
REGULATION OF RETINAL GANGLION CELL AXON GUIDANCE 6 3.79e-02 4.89e-01 4.13e-01
MESENCHYME MIGRATION 5 5.83e-02 -4.89e-01 4.97e-01
NEGATIVE REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM 10 7.44e-03 4.89e-01 2.00e-01
REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL DEDIFFERENTIATION 6 3.83e-02 -4.88e-01 4.15e-01
FORMATE METABOLIC PROCESS 6 3.89e-02 -4.87e-01 4.16e-01
RECEPTOR MEDIATED ENDOCYTOSIS INVOLVED IN CHOLESTEROL TRANSPORT 8 1.72e-02 -4.86e-01 3.00e-01
SEMICIRCULAR CANAL MORPHOGENESIS 7 2.63e-02 4.85e-01 3.65e-01
POSITIVE REGULATION OF HIGH DENSITY LIPOPROTEIN PARTICLE CLEARANCE 7 2.66e-02 -4.84e-01 3.67e-01
REGULATION OF DENDRITIC CELL ANTIGEN PROCESSING AND PRESENTATION 10 8.31e-03 -4.82e-01 2.13e-01
HEPOXILIN METABOLIC PROCESS 9 1.25e-02 -4.81e-01 2.61e-01
REGULATION OF ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE OR POLYSACCHARIDE ANTIGEN VIA MHC CLASS II 5 6.35e-02 -4.79e-01 5.16e-01
RESPONSE TO SODIUM ARSENITE 6 4.24e-02 -4.79e-01 4.33e-01
POSITIVE REGULATION OF ANTIBACTERIAL PEPTIDE PRODUCTION 5 6.52e-02 -4.76e-01 5.24e-01
MOTOR NEURON MIGRATION 13 3.10e-03 4.74e-01 1.30e-01
REGULATION OF PROSTATIC BUD FORMATION 6 4.56e-02 4.71e-01 4.48e-01
NEGATIVE REGULATION OF ACUTE INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS 5 6.93e-02 4.69e-01 5.33e-01
BRAINSTEM DEVELOPMENT 8 2.22e-02 4.67e-01 3.49e-01
REGULATION OF PHOSPHATIDYLCHOLINE METABOLIC PROCESS 10 1.07e-02 -4.66e-01 2.42e-01
NATURAL KILLER CELL CHEMOTAXIS 10 1.07e-02 4.66e-01 2.42e-01
SENSORY PERCEPTION OF SMELL 360 4.49e-52 4.65e-01 3.42e-48
OLFACTORY BULB INTERNEURON DIFFERENTIATION 13 3.79e-03 4.64e-01 1.43e-01
HEPARAN SULFATE PROTEOGLYCAN CATABOLIC PROCESS 9 1.63e-02 -4.62e-01 2.97e-01
GMP SALVAGE 5 7.41e-02 4.61e-01 5.48e-01
MONOTERPENOID METABOLIC PROCESS 6 5.05e-02 4.61e-01 4.68e-01
QUINOLINATE METABOLIC PROCESS 5 7.52e-02 -4.60e-01 5.51e-01
COP9 SIGNALOSOME ASSEMBLY 5 7.57e-02 4.59e-01 5.51e-01
PROTEIN LOCALIZATION TO BASOLATERAL PLASMA MEMBRANE 8 2.50e-02 4.58e-01 3.65e-01
HYPOXIA INDUCIBLE FACTOR 1ALPHA SIGNALING PATHWAY 7 3.62e-02 4.57e-01 4.06e-01
POSITIVE REGULATION OF TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY 13 4.32e-03 -4.57e-01 1.55e-01
APOLIPOPROTEIN A I MEDIATED SIGNALING PATHWAY 7 3.64e-02 -4.57e-01 4.07e-01
GERM CELL MIGRATION 8 2.57e-02 4.55e-01 3.65e-01
AXON CHOICE POINT RECOGNITION 7 3.74e-02 4.54e-01 4.12e-01
POSITIVE REGULATION OF T HELPER 2 CELL CYTOKINE PRODUCTION 9 1.84e-02 -4.54e-01 3.12e-01
POSITIVE REGULATION OF NEURON PROJECTION REGENERATION 13 4.63e-03 -4.54e-01 1.62e-01
NEGATIVE REGULATION OF SYNCYTIUM FORMATION BY PLASMA MEMBRANE FUSION 5 7.91e-02 4.54e-01 5.59e-01
RESPONSE TO INDOLE 3 METHANOL 6 5.53e-02 -4.52e-01 4.86e-01
ALKALOID METABOLIC PROCESS 7 3.87e-02 4.51e-01 4.16e-01
PROPIONATE METABOLIC PROCESS 5 8.13e-02 -4.50e-01 5.64e-01
REGULATION OF GLOMERULUS DEVELOPMENT 6 5.75e-02 4.48e-01 4.96e-01
POSITIVE REGULATION OF HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION 6 5.86e-02 4.46e-01 4.97e-01
PHOSPHATIDYLETHANOLAMINE ACYL CHAIN REMODELING 11 1.06e-02 -4.45e-01 2.42e-01
MONOCYTE AGGREGATION 5 8.51e-02 4.45e-01 5.74e-01
RESPONSE TO HYDROSTATIC PRESSURE 7 4.19e-02 -4.44e-01 4.31e-01
PURINE NUCLEOSIDE DIPHOSPHATE CATABOLIC PROCESS 5 8.70e-02 -4.42e-01 5.79e-01
REGULATION OF ANTIGEN PROCESSING AND PRESENTATION 19 8.54e-04 -4.42e-01 5.71e-02
REGULATION OF VERY LOW DENSITY LIPOPROTEIN PARTICLE REMODELING 6 6.09e-02 -4.42e-01 5.08e-01
TRIGLYCERIDE RICH LIPOPROTEIN PARTICLE CLEARANCE 7 4.37e-02 -4.40e-01 4.38e-01
POSITIVE REGULATION OF METALLOPEPTIDASE ACTIVITY 10 1.59e-02 -4.40e-01 2.96e-01
NEGATIVE REGULATION OF FIBROBLAST GROWTH FACTOR PRODUCTION 5 8.88e-02 -4.39e-01 5.82e-01
T CELL ACTIVATION VIA T CELL RECEPTOR CONTACT WITH ANTIGEN BOUND TO MHC MOLECULE ON ANTIGEN PRESENTING CELL 10 1.64e-02 -4.38e-01 2.97e-01
NEGATIVE REGULATION OF RIG I SIGNALING PATHWAY 8 3.22e-02 -4.37e-01 3.93e-01
NEGATIVE REGULATION OF T HELPER 2 CELL DIFFERENTIATION 5 9.15e-02 4.36e-01 5.87e-01
CHITIN METABOLIC PROCESS 6 6.48e-02 4.35e-01 5.22e-01
POSITIVE REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE 13 6.69e-03 -4.34e-01 1.93e-01
POSITIVE REGULATION OF BASEMENT MEMBRANE ASSEMBLY INVOLVED IN EMBRYONIC BODY MORPHOGENESIS 5 9.27e-02 -4.34e-01 5.89e-01
HIGH DENSITY LIPOPROTEIN PARTICLE ASSEMBLY 13 7.05e-03 -4.32e-01 1.97e-01
ADENYLATE CYCLASE INHIBITING G PROTEIN COUPLED GLUTAMATE RECEPTOR SIGNALING PATHWAY 9 2.50e-02 4.32e-01 3.65e-01
EPOXYGENASE P450 PATHWAY 18 1.58e-03 4.30e-01 8.86e-02
VITAMIN B6 METABOLIC PROCESS 5 9.64e-02 -4.29e-01 5.96e-01
IMMUNE RESPONSE INHIBITING CELL SURFACE RECEPTOR SIGNALING PATHWAY 9 2.57e-02 4.29e-01 3.65e-01
NITRIC OXIDE TRANSPORT 5 9.69e-02 -4.29e-01 5.96e-01
MYCOTOXIN METABOLIC PROCESS 6 6.99e-02 4.27e-01 5.35e-01
PLATELET DEGRANULATION 7 5.07e-02 4.26e-01 4.69e-01
POSITIVE REGULATION OF GLOMERULUS DEVELOPMENT 5 9.88e-02 4.26e-01 6.01e-01
POSITIVE REGULATION OF ANTIGEN PROCESSING AND PRESENTATION 9 2.70e-02 -4.26e-01 3.68e-01
DIACYLGLYCEROL CATABOLIC PROCESS 5 9.99e-02 -4.25e-01 6.02e-01
OVIDUCT DEVELOPMENT 5 1.00e-01 4.25e-01 6.02e-01
REGULATION OF COLLAGEN FIBRIL ORGANIZATION 8 3.77e-02 -4.24e-01 4.12e-01
PHOSPHATIDYLGLYCEROL BIOSYNTHETIC PROCESS 9 2.78e-02 -4.23e-01 3.73e-01
POSITIVE REGULATION OF WOUND HEALING SPREADING OF EPIDERMAL CELLS 5 1.01e-01 -4.23e-01 6.04e-01
OLFACTORY BULB INTERNEURON DEVELOPMENT 8 3.91e-02 4.21e-01 4.17e-01
REGULATION OF VERY LOW DENSITY LIPOPROTEIN PARTICLE CLEARANCE 5 1.03e-01 -4.21e-01 6.07e-01
ANTIBACTERIAL PEPTIDE PRODUCTION 9 2.89e-02 -4.21e-01 3.73e-01
PURINE NUCLEOBASE BIOSYNTHETIC PROCESS 11 1.59e-02 4.20e-01 2.95e-01
AMP CATABOLIC PROCESS 5 1.04e-01 -4.20e-01 6.08e-01
HIGH DENSITY LIPOPROTEIN PARTICLE CLEARANCE 18 2.08e-03 -4.19e-01 1.04e-01
POSITIVE REGULATION OF I KAPPAB PHOSPHORYLATION 6 7.57e-02 -4.19e-01 5.51e-01
NEGATIVE REGULATION OF NON CANONICAL WNT SIGNALING PATHWAY 6 7.58e-02 -4.19e-01 5.51e-01
DETECTION OF LIPOPOLYSACCHARIDE 5 1.05e-01 -4.18e-01 6.09e-01
POSITIVE REGULATION OF FIBROBLAST MIGRATION 15 5.14e-03 -4.17e-01 1.68e-01
MITOCHONDRIAL TRANSLATIONAL ELONGATION 5 1.07e-01 -4.17e-01 6.11e-01
REGULATION OF PLATELET DERIVED GROWTH FACTOR RECEPTOR ALPHA SIGNALING PATHWAY 5 1.07e-01 4.16e-01 6.11e-01
FAS SIGNALING PATHWAY 8 4.15e-02 -4.16e-01 4.30e-01
RESPONSE TO SORBITOL 6 7.76e-02 -4.16e-01 5.55e-01
LEUKOTRIENE D4 METABOLIC PROCESS 8 4.21e-02 -4.15e-01 4.32e-01
L HISTIDINE TRANSMEMBRANE TRANSPORT 5 1.08e-01 -4.15e-01 6.14e-01
ATRIOVENTRICULAR VALVE FORMATION 8 4.32e-02 -4.13e-01 4.36e-01
RETINAL BIPOLAR NEURON DIFFERENTIATION 8 4.37e-02 -4.12e-01 4.38e-01
NUCLEAR MIGRATION ALONG MICROTUBULE 5 1.12e-01 -4.11e-01 6.21e-01
PSEUDOPODIUM ORGANIZATION 16 4.46e-03 -4.11e-01 1.58e-01
NEGATIVE REGULATION OF NUCLEOTIDE BIOSYNTHETIC PROCESS 6 8.28e-02 -4.09e-01 5.70e-01
POSITIVE REGULATION OF MICROTUBULE NUCLEATION 8 4.53e-02 -4.09e-01 4.47e-01
NEGATIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL APOPTOTIC PROCESS 7 6.22e-02 -4.07e-01 5.12e-01
NEGATIVE REGULATION OF DENDRITIC CELL DIFFERENTIATION 5 1.15e-01 -4.07e-01 6.30e-01
CENP A CONTAINING CHROMATIN ASSEMBLY 10 2.59e-02 4.07e-01 3.65e-01
MANNOSE METABOLIC PROCESS 9 3.48e-02 -4.06e-01 4.03e-01
LUTEINIZING HORMONE SECRETION 10 2.61e-02 4.06e-01 3.65e-01
POSITIVE REGULATION OF AXON GUIDANCE 5 1.16e-01 4.06e-01 6.30e-01
CORPUS CALLOSUM MORPHOGENESIS 6 8.52e-02 -4.06e-01 5.75e-01
SENSORY PERCEPTION OF CHEMICAL STIMULUS 435 8.07e-48 4.05e-01 2.05e-44
NEGATIVE REGULATION OF FEEDING BEHAVIOR 6 8.62e-02 4.04e-01 5.77e-01
PROTEIN LIPID COMPLEX ASSEMBLY 30 1.26e-04 -4.04e-01 1.59e-02
ENDOCARDIAL CUSHION TO MESENCHYMAL TRANSITION 6 8.65e-02 -4.04e-01 5.77e-01
NEGATIVE REGULATION OF PLASMINOGEN ACTIVATION 8 4.81e-02 -4.03e-01 4.58e-01
LIPID IMPORT INTO CELL 20 1.82e-03 -4.03e-01 9.78e-02
PHOSPHATIDYLCHOLINE BIOSYNTHETIC PROCESS 29 1.76e-04 -4.02e-01 1.89e-02
PROTEIN LOCALIZATION TO PHAGOPHORE ASSEMBLY SITE 16 5.44e-03 -4.01e-01 1.72e-01
POSITIVE REGULATION OF NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN CONTAINING SIGNALING PATHWAY 7 6.62e-02 -4.01e-01 5.26e-01
FOREBRAIN NEUROBLAST DIVISION 5 1.21e-01 4.01e-01 6.34e-01
OMEGA HYDROXYLASE P450 PATHWAY 11 2.16e-02 4.00e-01 3.43e-01
DETECTION OF STIMULUS INVOLVED IN SENSORY PERCEPTION 451 3.78e-48 3.99e-01 1.44e-44
NEGATIVE REGULATION OF NUCLEOTIDE METABOLIC PROCESS 11 2.22e-02 -3.98e-01 3.49e-01
CELLULAR RESPONSE TO OXIDISED LOW DENSITY LIPOPROTEIN PARTICLE STIMULUS 14 9.94e-03 -3.98e-01 2.33e-01
PROLINE IMPORT ACROSS PLASMA MEMBRANE 5 1.23e-01 3.98e-01 6.44e-01
POSITIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR 7 6.89e-02 3.97e-01 5.33e-01
REGULATION OF BINDING OF SPERM TO ZONA PELLUCIDA 5 1.25e-01 -3.97e-01 6.46e-01
REGULATION OF ENDOSOME TO PLASMA MEMBRANE PROTEIN TRANSPORT 5 1.25e-01 3.96e-01 6.47e-01
POSITIVE REGULATION OF LIPOPROTEIN PARTICLE CLEARANCE 11 2.30e-02 -3.96e-01 3.55e-01
POSITIVE REGULATION OF SYNAPTIC VESICLE FUSION TO PRESYNAPTIC ACTIVE ZONE MEMBRANE 6 9.33e-02 3.96e-01 5.90e-01
MITRAL VALVE DEVELOPMENT 13 1.35e-02 -3.96e-01 2.74e-01
DNA LIGATION INVOLVED IN DNA REPAIR 5 1.27e-01 -3.94e-01 6.48e-01
AXON MIDLINE CHOICE POINT RECOGNITION 5 1.27e-01 3.94e-01 6.48e-01
GALACTOSE METABOLIC PROCESS 9 4.07e-02 -3.94e-01 4.25e-01
POSITIVE REGULATION OF DENDRITIC CELL ANTIGEN PROCESSING AND PRESENTATION 7 7.11e-02 -3.94e-01 5.39e-01
METANEPHRIC TUBULE MORPHOGENESIS 11 2.37e-02 -3.94e-01 3.58e-01
REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY VASOPRESSIN 5 1.28e-01 -3.94e-01 6.48e-01
NEGATIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY 12 1.84e-02 -3.93e-01 3.13e-01
REGULATION OF T CIRCLE FORMATION 5 1.29e-01 -3.92e-01 6.48e-01
SYNAPTIC SIGNALING VIA NEUROPEPTIDE 6 9.66e-02 3.92e-01 5.96e-01
VOLUNTARY SKELETAL MUSCLE CONTRACTION 5 1.30e-01 -3.91e-01 6.50e-01
REGULATION OF MITOCHONDRIAL ATP SYNTHESIS COUPLED ELECTRON TRANSPORT 7 7.33e-02 3.91e-01 5.45e-01
ACTIN FILAMENT SEVERING 16 6.80e-03 -3.91e-01 1.94e-01
INTERCELLULAR TRANSPORT 10 3.27e-02 3.90e-01 3.97e-01
REGULATION OF ANTIBACTERIAL PEPTIDE PRODUCTION 7 7.40e-02 -3.90e-01 5.48e-01
GROWTH HORMONE RECEPTOR SIGNALING PATHWAY VIA JAK STAT 10 3.28e-02 -3.90e-01 3.98e-01
NEGATIVE REGULATION OF CHEMOKINE C C MOTIF LIGAND 5 PRODUCTION 5 1.32e-01 -3.88e-01 6.56e-01
EPOXIDE METABOLIC PROCESS 5 1.33e-01 -3.88e-01 6.56e-01
POSITIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE 7 7.58e-02 -3.88e-01 5.51e-01
NEGATIVE REGULATION OF SYNAPSE ASSEMBLY 8 5.80e-02 3.87e-01 4.97e-01
TRANSFERRIN TRANSPORT 10 3.49e-02 -3.85e-01 4.03e-01
POSITIVE REGULATION OF TYPE 2 IMMUNE RESPONSE 18 4.69e-03 -3.85e-01 1.62e-01
METHYLGLYOXAL METABOLIC PROCESS 6 1.03e-01 -3.85e-01 6.07e-01
TRIGLYCERIDE RICH LIPOPROTEIN PARTICLE REMODELING 12 2.11e-02 -3.84e-01 3.42e-01
ERK5 CASCADE 5 1.37e-01 3.84e-01 6.61e-01
NEGATIVE REGULATION OF INTERLEUKIN 6 MEDIATED SIGNALING PATHWAY 9 4.71e-02 -3.82e-01 4.53e-01
SKELETAL MUSCLE FIBER DIFFERENTIATION 8 6.12e-02 3.82e-01 5.08e-01
TRANSCRIPTION INITIATION AT RNA POLYMERASE III PROMOTER 8 6.14e-02 -3.82e-01 5.08e-01
SPLICEOSOMAL CONFORMATIONAL CHANGES TO GENERATE CATALYTIC CONFORMATION 5 1.39e-01 -3.82e-01 6.65e-01
INTRACELLULAR DISTRIBUTION OF MITOCHONDRIA 7 8.01e-02 -3.82e-01 5.60e-01
PROTEIN SIALYLATION 5 1.39e-01 -3.82e-01 6.65e-01
PATTERN SPECIFICATION INVOLVED IN KIDNEY DEVELOPMENT 8 6.19e-02 -3.81e-01 5.11e-01
MALE MATING BEHAVIOR 6 1.06e-01 3.81e-01 6.11e-01
POSITIVE REGULATION OF TOLL LIKE RECEPTOR 9 SIGNALING PATHWAY 6 1.07e-01 -3.80e-01 6.11e-01
PARAXIAL MESODERM MORPHOGENESIS 10 3.76e-02 3.80e-01 4.12e-01
REGULATION OF INTEGRIN BIOSYNTHETIC PROCESS 5 1.43e-01 3.78e-01 6.69e-01
MONOACYLGLYCEROL CATABOLIC PROCESS 7 8.32e-02 -3.78e-01 5.70e-01
POSITIVE REGULATION OF PSEUDOPODIUM ASSEMBLY 12 2.37e-02 -3.77e-01 3.58e-01
HEART VALVE FORMATION 15 1.15e-02 -3.77e-01 2.50e-01
DEOXYRIBONUCLEOSIDE DIPHOSPHATE METABOLIC PROCESS 5 1.45e-01 -3.76e-01 6.74e-01
POSITIVE REGULATION OF AMYLOID BETA CLEARANCE 8 6.58e-02 -3.76e-01 5.24e-01
CARNITINE TRANSPORT 9 5.10e-02 -3.76e-01 4.69e-01
UBIQUITIN INDEPENDENT PROTEIN CATABOLIC PROCESS VIA THE MULTIVESICULAR BODY SORTING PATHWAY 5 1.46e-01 -3.75e-01 6.74e-01
NORADRENERGIC NEURON DIFFERENTIATION 11 3.11e-02 3.75e-01 3.85e-01
RENAL WATER ABSORPTION 6 1.12e-01 -3.75e-01 6.21e-01
XENOPHAGY 14 1.52e-02 -3.75e-01 2.90e-01
NEGATIVE REGULATION OF CELLULAR RESPONSE TO OXIDATIVE STRESS 8 6.67e-02 -3.74e-01 5.28e-01
PROTEOGLYCAN CATABOLIC PROCESS 11 3.17e-02 -3.74e-01 3.89e-01
CD8 POSITIVE ALPHA BETA T CELL PROLIFERATION 9 5.26e-02 -3.73e-01 4.75e-01
CELLULAR RESPONSE TO INDOLE 3 METHANOL 5 1.48e-01 -3.73e-01 6.76e-01
MITOTIC SISTER CHROMATID COHESION CENTROMERIC 5 1.49e-01 3.73e-01 6.76e-01
LYMPHOCYTE ANERGY 8 6.84e-02 3.72e-01 5.32e-01
OVULATION FROM OVARIAN FOLLICLE 8 6.85e-02 3.72e-01 5.32e-01
NEGATIVE REGULATION OF FATTY ACID TRANSPORT 7 8.86e-02 -3.72e-01 5.82e-01
MAMMALIAN OOGENESIS STAGE 12 2.58e-02 -3.72e-01 3.65e-01
KETONE BODY METABOLIC PROCESS 10 4.19e-02 -3.72e-01 4.31e-01
LYSINE METABOLIC PROCESS 8 6.90e-02 3.71e-01 5.33e-01
METANEPHRIC NEPHRON TUBULE MORPHOGENESIS 8 6.97e-02 -3.70e-01 5.35e-01
DEFENSE RESPONSE TO FUNGUS 53 3.09e-06 3.70e-01 9.43e-04
REGULATION OF PRESYNAPTIC MEMBRANE POTENTIAL 29 5.62e-04 3.70e-01 4.12e-02
VESICLE TETHERING TO GOLGI 5 1.52e-01 3.70e-01 6.79e-01
REGULATION OF RAB PROTEIN SIGNAL TRANSDUCTION 7 9.03e-02 -3.70e-01 5.85e-01
CADMIUM ION TRANSMEMBRANE TRANSPORT 6 1.17e-01 -3.69e-01 6.30e-01
REGULATION OF LUTEINIZING HORMONE SECRETION 6 1.17e-01 3.69e-01 6.30e-01
PURINE RIBONUCLEOSIDE SALVAGE 7 9.11e-02 3.69e-01 5.86e-01
LATERAL SPROUTING FROM AN EPITHELIUM 11 3.42e-02 3.69e-01 4.03e-01
NEGATIVE REGULATION OF TYPE 2 IMMUNE RESPONSE 15 1.37e-02 3.68e-01 2.76e-01
NEGATIVE REGULATION OF ADENYLATE CYCLASE ACTIVATING ADRENERGIC RECEPTOR SIGNALING PATHWAY 6 1.19e-01 -3.68e-01 6.32e-01
NEGATIVE REGULATION OF GLYCOLYTIC PROCESS 18 6.96e-03 -3.67e-01 1.97e-01
REGULATION OF WOUND HEALING SPREADING OF EPIDERMAL CELLS 9 5.63e-02 -3.67e-01 4.90e-01
REGULATION OF MODIFICATION OF POSTSYNAPTIC ACTIN CYTOSKELETON 5 1.55e-01 -3.67e-01 6.79e-01
BASEMENT MEMBRANE ASSEMBLY 9 5.66e-02 -3.67e-01 4.91e-01
CELLULAR HYPOTONIC RESPONSE 11 3.52e-02 -3.67e-01 4.03e-01
POSITIVE REGULATION OF CELL PROLIFERATION INVOLVED IN HEART MORPHOGENESIS 5 1.56e-01 3.67e-01 6.79e-01
POSITIVE REGULATION OF PINOCYTOSIS 7 9.39e-02 -3.66e-01 5.92e-01
NEGATIVE REGULATION OF EXTRACELLULAR MATRIX DISASSEMBLY 5 1.57e-01 3.65e-01 6.79e-01
PARTURITION 15 1.44e-02 -3.65e-01 2.82e-01
OXIDATIVE DEMETHYLATION 14 1.82e-02 3.64e-01 3.11e-01
TRACHEA CARTILAGE DEVELOPMENT 7 9.50e-02 -3.64e-01 5.94e-01
POSITIVE REGULATION OF APOPTOTIC PROCESS INVOLVED IN MORPHOGENESIS 5 1.59e-01 -3.64e-01 6.79e-01
RESPONSE TO LUTEINIZING HORMONE 7 9.57e-02 -3.64e-01 5.96e-01
REGULATION OF PROTEIN OLIGOMERIZATION 5 1.60e-01 3.63e-01 6.80e-01
ESTABLISHMENT OR MAINTENANCE OF CYTOSKELETON POLARITY 7 9.64e-02 -3.63e-01 5.96e-01
NEGATIVE REGULATION OF METALLOENDOPEPTIDASE ACTIVITY 9 6.00e-02 -3.62e-01 5.04e-01
MEDIUM CHAIN FATTY ACID BIOSYNTHETIC PROCESS 6 1.25e-01 -3.61e-01 6.48e-01
PLASMA CELL DIFFERENTIATION 9 6.09e-02 -3.61e-01 5.08e-01
GLYCERALDEHYDE 3 PHOSPHATE METABOLIC PROCESS 6 1.27e-01 -3.60e-01 6.48e-01
NEGATIVE REGULATION OF RECEPTOR BINDING 12 3.10e-02 -3.60e-01 3.85e-01
POSITIVE REGULATION OF IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE 7 9.95e-02 -3.60e-01 6.02e-01
MAMMARY GLAND FORMATION 7 1.00e-01 3.59e-01 6.02e-01
POSITIVE REGULATION OF NEUTROPHIL ACTIVATION 6 1.29e-01 -3.58e-01 6.48e-01
REGULATION OF RETROGRADE PROTEIN TRANSPORT ER TO CYTOSOL 13 2.56e-02 3.58e-01 3.65e-01
PRIMARY AMINO COMPOUND BIOSYNTHETIC PROCESS 6 1.30e-01 3.57e-01 6.50e-01
REGULATION OF METALLOENDOPEPTIDASE ACTIVITY 16 1.36e-02 -3.56e-01 2.74e-01
MELANOCYTE PROLIFERATION 5 1.68e-01 3.56e-01 6.87e-01
PROTEIN C LINKED GLYCOSYLATION 6 1.32e-01 3.55e-01 6.55e-01
LEUKOTRIENE TRANSPORT 7 1.04e-01 -3.55e-01 6.07e-01
REGULATION OF SYNAPTIC VESICLE CLUSTERING 6 1.32e-01 -3.55e-01 6.56e-01
REGULATION OF FEMALE RECEPTIVITY 7 1.04e-01 -3.55e-01 6.07e-01
BONE TRABECULA MORPHOGENESIS 13 2.69e-02 -3.54e-01 3.68e-01
ADENOSINE METABOLIC PROCESS 10 5.25e-02 -3.54e-01 4.75e-01
CEREBRAL CORTEX TANGENTIAL MIGRATION 6 1.34e-01 3.54e-01 6.58e-01
UBIQUITIN DEPENDENT ENDOCYTOSIS 8 8.37e-02 -3.53e-01 5.70e-01
NEGATIVE REGULATION OF MACROPHAGE CYTOKINE PRODUCTION 12 3.41e-02 -3.53e-01 4.03e-01
POSITIVE REGULATION OF RECEPTOR CLUSTERING 6 1.35e-01 -3.53e-01 6.59e-01
CAVEOLIN MEDIATED ENDOCYTOSIS 11 4.29e-02 -3.53e-01 4.35e-01
APOPTOTIC PROCESS INVOLVED IN HEART MORPHOGENESIS 7 1.06e-01 3.52e-01 6.11e-01
POSITIVE REGULATION OF FERTILIZATION 5 1.72e-01 3.52e-01 6.90e-01
DETECTION OF MOLECULE OF BACTERIAL ORIGIN 13 2.79e-02 -3.52e-01 3.73e-01
NEGATIVE REGULATION OF BROWN FAT CELL DIFFERENTIATION 5 1.73e-01 -3.52e-01 6.90e-01
POSITIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL DIFFERENTIATION 13 2.80e-02 -3.52e-01 3.73e-01
METANEPHRIC PROXIMAL TUBULE DEVELOPMENT 5 1.73e-01 -3.52e-01 6.90e-01
REGULATION OF HEART RATE BY CHEMICAL SIGNAL 7 1.07e-01 -3.52e-01 6.11e-01
REGULATION OF APOPTOTIC PROCESS IN BONE MARROW CELL 5 1.74e-01 3.51e-01 6.92e-01
PHOSPHOLIPID EFFLUX 14 2.34e-02 -3.50e-01 3.58e-01
RESPONSE TO CORTICOSTERONE 14 2.37e-02 3.49e-01 3.58e-01
POSITIVE REGULATION OF METALLOENDOPEPTIDASE ACTIVITY 7 1.10e-01 -3.49e-01 6.17e-01
NEGATIVE REGULATION OF GENE EXPRESSION VIA CPG ISLAND METHYLATION 7 1.10e-01 -3.49e-01 6.17e-01
RETINAL BLOOD VESSEL MORPHOGENESIS 6 1.39e-01 -3.49e-01 6.65e-01
POSITIVE REGULATION OF MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION INVOLVED IN APOPTOTIC SIGNALING PATHWAY 12 3.71e-02 -3.48e-01 4.10e-01
PYRIMIDINE CONTAINING COMPOUND SALVAGE 7 1.13e-01 -3.46e-01 6.25e-01
RRNA 5 END PROCESSING 5 1.80e-01 -3.46e-01 7.01e-01
POSITIVE REGULATION OF DOPAMINE SECRETION 6 1.42e-01 3.46e-01 6.69e-01
DNA REPLICATION DEPENDENT CHROMATIN ASSEMBLY 6 1.43e-01 3.46e-01 6.69e-01
PANCREATIC JUICE SECRETION 11 4.72e-02 -3.46e-01 4.53e-01
RESPONSE TO TYPE III INTERFERON 12 3.82e-02 -3.46e-01 4.15e-01
REGULATION OF COMPLEMENT ACTIVATION CLASSICAL PATHWAY 9 7.28e-02 -3.45e-01 5.43e-01
POSITIVE REGULATION OF MYELOID CELL APOPTOTIC PROCESS 10 5.87e-02 3.45e-01 4.97e-01
REGULATION OF PHOSPHOLIPID BIOSYNTHETIC PROCESS 17 1.37e-02 -3.45e-01 2.76e-01
MEIOTIC CELL CYCLE CHECKPOINT SIGNALING 8 9.10e-02 -3.45e-01 5.86e-01
CELLULAR RESPONSE TO IRON ION 9 7.37e-02 -3.44e-01 5.48e-01
GLUTATHIONE TRANSPORT 9 7.40e-02 -3.44e-01 5.48e-01
NEGATIVE REGULATION OF T CELL MEDIATED CYTOTOXICITY 9 7.46e-02 3.43e-01 5.49e-01
RNA GUANINE N7 METHYLATION 6 1.46e-01 3.43e-01 6.74e-01
POSITIVE REGULATION OF UTERINE SMOOTH MUSCLE CONTRACTION 7 1.16e-01 -3.43e-01 6.30e-01
NEGATIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE I 12 3.97e-02 -3.43e-01 4.19e-01
NEGATIVE REGULATION OF PROSTAGLANDIN BIOSYNTHETIC PROCESS 5 1.84e-01 3.43e-01 7.07e-01
NEGATIVE REGULATION OF PHOSPHOLIPASE ACTIVITY 7 1.18e-01 3.42e-01 6.30e-01
LIPOXIN METABOLIC PROCESS 5 1.86e-01 -3.42e-01 7.08e-01
REGULATION OF HIPPOCAMPAL NEURON APOPTOTIC PROCESS 5 1.87e-01 -3.41e-01 7.08e-01
MEMBRANOUS SEPTUM MORPHOGENESIS 8 9.54e-02 3.40e-01 5.96e-01
PHENYLPROPANOID METABOLIC PROCESS 7 1.19e-01 3.40e-01 6.32e-01
AORTA SMOOTH MUSCLE TISSUE MORPHOGENESIS 6 1.49e-01 -3.40e-01 6.76e-01
SEMICIRCULAR CANAL DEVELOPMENT 9 7.73e-02 3.40e-01 5.54e-01
L ASCORBIC ACID METABOLIC PROCESS 10 6.33e-02 -3.39e-01 5.15e-01
RESPONSE TO MUSCLE INACTIVITY 9 7.86e-02 -3.39e-01 5.58e-01
NUCLEOBASE CONTAINING SMALL MOLECULE INTERCONVERSION 8 9.77e-02 -3.38e-01 5.97e-01
VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2 SIGNALING PATHWAY 6 1.52e-01 -3.38e-01 6.79e-01
REGULATION OF PHOSPHOLIPID METABOLIC PROCESS 34 6.47e-04 -3.38e-01 4.61e-02
POSITIVE REGULATION OF MICROGLIAL CELL ACTIVATION 10 6.44e-02 3.38e-01 5.20e-01
OTOLITH MORPHOGENESIS 5 1.91e-01 -3.38e-01 7.14e-01
LIPID DROPLET FORMATION 14 2.89e-02 -3.37e-01 3.73e-01
VERY LOW DENSITY LIPOPROTEIN PARTICLE ASSEMBLY 12 4.31e-02 -3.37e-01 4.36e-01
NEGATIVE REGULATION OF LYMPHOCYTE MIGRATION 15 2.41e-02 3.36e-01 3.60e-01
NEGATIVE REGULATION OF HIPPO SIGNALING 13 3.58e-02 -3.36e-01 4.04e-01
PENTOSE PHOSPHATE SHUNT NON OXIDATIVE BRANCH 6 1.54e-01 -3.36e-01 6.79e-01
POSITIVE REGULATION OF DENDRITIC CELL DIFFERENTIATION 6 1.54e-01 -3.36e-01 6.79e-01
ANTIGEN PROCESSING AND PRESENTATION ENDOGENOUS LIPID ANTIGEN VIA MHC CLASS IB 5 1.93e-01 3.36e-01 7.16e-01
PHOSPHATIDYLSERINE EXPOSURE ON APOPTOTIC CELL SURFACE 9 8.10e-02 3.36e-01 5.63e-01
PLASMA MEMBRANE TO ENDOSOME TRANSPORT 8 1.00e-01 -3.36e-01 6.02e-01
REVERSIBLE DIFFERENTIATION 12 4.42e-02 -3.35e-01 4.42e-01
LEUKOTRIENE CATABOLIC PROCESS 6 1.55e-01 3.35e-01 6.79e-01
NEGATIVE REGULATION OF PLATELET ACTIVATION 17 1.68e-02 -3.35e-01 2.98e-01
AMP SALVAGE 5 1.95e-01 3.35e-01 7.19e-01
HYPEROSMOTIC SALINITY RESPONSE 10 6.79e-02 -3.33e-01 5.32e-01
MULTI PASS TRANSMEMBRANE PROTEIN INSERTION INTO ER MEMBRANE 8 1.03e-01 -3.33e-01 6.07e-01
DIADENOSINE POLYPHOSPHATE CATABOLIC PROCESS 6 1.58e-01 3.33e-01 6.79e-01
NEUROBLAST DIFFERENTIATION 8 1.03e-01 3.33e-01 6.07e-01
NEGATIVE REGULATION OF STEROID HORMONE BIOSYNTHETIC PROCESS 6 1.60e-01 3.31e-01 6.80e-01
POSITIVE REGULATION OF LAMELLIPODIUM MORPHOGENESIS 7 1.29e-01 -3.31e-01 6.48e-01
HEMIDESMOSOME ASSEMBLY 6 1.61e-01 -3.31e-01 6.81e-01
POSITIVE REGULATION OF CHEMOKINE C X C MOTIF LIGAND 2 PRODUCTION 11 5.76e-02 -3.31e-01 4.96e-01
SPHINGOMYELIN CATABOLIC PROCESS 8 1.06e-01 -3.30e-01 6.11e-01
FAT SOLUBLE VITAMIN CATABOLIC PROCESS 11 5.86e-02 3.29e-01 4.97e-01
N ACYLPHOSPHATIDYLETHANOLAMINE METABOLIC PROCESS 9 8.71e-02 -3.29e-01 5.79e-01
HISTONE METHYLATION 38 4.45e-04 -3.29e-01 3.85e-02
POSITIVE REGULATION OF CHOLESTEROL BIOSYNTHETIC PROCESS 10 7.17e-02 -3.29e-01 5.42e-01
SEMAPHORIN PLEXIN SIGNALING PATHWAY INVOLVED IN NEURON PROJECTION GUIDANCE 16 2.27e-02 -3.29e-01 3.53e-01
CELLULAR LIPID BIOSYNTHETIC PROCESS 12 4.89e-02 -3.28e-01 4.61e-01
NEGATIVE REGULATION OF UBIQUITIN PROTEIN LIGASE ACTIVITY 9 8.82e-02 3.28e-01 5.81e-01
MEIOTIC SPINDLE ASSEMBLY 12 4.90e-02 3.28e-01 4.61e-01
REGULATION OF METALLOPEPTIDASE ACTIVITY 24 5.42e-03 -3.28e-01 1.72e-01
REGULATION OF CAVEOLIN MEDIATED ENDOCYTOSIS 6 1.65e-01 -3.28e-01 6.83e-01
RESPONSE TO SYMBIONT 6 1.65e-01 -3.28e-01 6.83e-01
INTRACELLULAR GLUTAMATE HOMEOSTASIS 5 2.05e-01 3.28e-01 7.29e-01
ATP TRANSPORT 18 1.61e-02 -3.28e-01 2.97e-01
PROTEIN LOCALIZATION TO CILIARY TRANSITION ZONE 8 1.10e-01 -3.26e-01 6.17e-01
POSITIVE REGULATION OF EXECUTION PHASE OF APOPTOSIS 8 1.10e-01 -3.26e-01 6.17e-01
POSITIVE REGULATION OF PHOSPHOLIPID TRANSLOCATION 5 2.06e-01 3.26e-01 7.29e-01
NEGATIVE REGULATION OF GLUCOCORTICOID METABOLIC PROCESS 5 2.07e-01 3.26e-01 7.29e-01
NEGATIVE REGULATION OF PROTEIN TARGETING TO MEMBRANE 6 1.67e-01 -3.26e-01 6.86e-01
REGULATION OF INOSITOL 1 4 5 TRISPHOSPHATE SENSITIVE CALCIUM RELEASE CHANNEL ACTIVITY 5 2.07e-01 -3.26e-01 7.29e-01
POSITIVE REGULATION OF DNA DAMAGE CHECKPOINT 5 2.07e-01 -3.26e-01 7.29e-01
POSITIVE REGULATION OF DNA CATABOLIC PROCESS 5 2.08e-01 -3.25e-01 7.29e-01
RESPONSE TO PHEROMONE 7 1.36e-01 3.25e-01 6.60e-01
REGULATION OF MONOATOMIC ANION TRANSMEMBRANE TRANSPORT 8 1.11e-01 3.25e-01 6.20e-01
PURINE NUCLEOSIDE DIPHOSPHATE BIOSYNTHETIC PROCESS 6 1.68e-01 -3.25e-01 6.87e-01
ERBB3 SIGNALING PATHWAY 5 2.08e-01 -3.25e-01 7.29e-01
CARDIAC VASCULAR SMOOTH MUSCLE CELL DIFFERENTIATION 10 7.57e-02 -3.24e-01 5.51e-01
REGULATION OF MEMBRANE REPOLARIZATION DURING VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL 5 2.09e-01 -3.24e-01 7.30e-01
SEGMENT SPECIFICATION 17 2.07e-02 -3.24e-01 3.37e-01
PLATELET DERIVED GROWTH FACTOR RECEPTOR BETA SIGNALING PATHWAY 14 3.57e-02 -3.24e-01 4.04e-01
REGULATION OF INTERLEUKIN 6 MEDIATED SIGNALING PATHWAY 12 5.19e-02 -3.24e-01 4.74e-01
NEGATIVE REGULATION OF GLUTAMATE SECRETION 6 1.70e-01 3.24e-01 6.87e-01
CHONDROCYTE DEVELOPMENT INVOLVED IN ENDOCHONDRAL BONE MORPHOGENESIS 8 1.13e-01 -3.23e-01 6.25e-01
POSITIVE REGULATION OF CARDIAC MUSCLE CONTRACTION 9 9.40e-02 3.22e-01 5.92e-01
REGULATION OF METAPHASE PLATE CONGRESSION 13 4.44e-02 -3.22e-01 4.43e-01
DENTINOGENESIS 6 1.72e-01 -3.22e-01 6.90e-01
INTERLEUKIN 3 MEDIATED SIGNALING PATHWAY 6 1.72e-01 -3.22e-01 6.90e-01
REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO HYDROGEN PEROXIDE 6 1.73e-01 -3.21e-01 6.90e-01
POLYKETIDE METABOLIC PROCESS 10 7.94e-02 3.20e-01 5.59e-01
POSITIVE REGULATION OF MONOCYTE DIFFERENTIATION 10 7.95e-02 -3.20e-01 5.59e-01
KILLING BY HOST OF SYMBIONT CELLS 27 4.00e-03 3.20e-01 1.49e-01
INTRACELLULAR TRIGLYCERIDE HOMEOSTASIS 8 1.17e-01 3.20e-01 6.30e-01
NEGATIVE REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY 25 5.67e-03 -3.20e-01 1.74e-01
REGULATION OF NK T CELL PROLIFERATION 7 1.44e-01 -3.19e-01 6.71e-01
ESTABLISHMENT OF SISTER CHROMATID COHESION 11 6.69e-02 3.19e-01 5.28e-01
B CELL LINEAGE COMMITMENT 6 1.76e-01 -3.19e-01 6.94e-01
FOREBRAIN VENTRICULAR ZONE PROGENITOR CELL DIVISION 5 2.18e-01 3.18e-01 7.36e-01
PROSTHETIC GROUP METABOLIC PROCESS 6 1.77e-01 3.18e-01 6.97e-01
REGULATION OF POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR ACTIVITY 5 2.18e-01 -3.18e-01 7.37e-01
REGULATION OF ENDODERMAL CELL DIFFERENTIATION 7 1.46e-01 -3.17e-01 6.74e-01
CRD MEDIATED MRNA STABILIZATION 11 6.86e-02 3.17e-01 5.32e-01
HIGH DENSITY LIPOPROTEIN PARTICLE REMODELING 16 2.82e-02 -3.17e-01 3.73e-01
DNA PROTECTION 6 1.79e-01 -3.17e-01 6.99e-01
RESPONSE TO YEAST 7 1.47e-01 3.17e-01 6.75e-01
CYCLIC GMP AMP TRANSMEMBRANE IMPORT ACROSS PLASMA MEMBRANE 6 1.80e-01 -3.16e-01 7.00e-01
DIPHOSPHOINOSITOL POLYPHOSPHATE METABOLIC PROCESS 5 2.21e-01 3.16e-01 7.40e-01
REGULATION OF IRON ION TRANSMEMBRANE TRANSPORT 5 2.21e-01 3.16e-01 7.40e-01
UTP BIOSYNTHETIC PROCESS 10 8.36e-02 -3.16e-01 5.70e-01
AUTOCRINE SIGNALING 7 1.48e-01 3.16e-01 6.75e-01
REGULATION OF SMOOTH MUSCLE CELL CHEMOTAXIS 7 1.48e-01 3.16e-01 6.75e-01
CYTOSOLIC RIBOSOME ASSEMBLY 5 2.22e-01 3.16e-01 7.40e-01
SEPTUM PRIMUM DEVELOPMENT 5 2.22e-01 -3.16e-01 7.40e-01
POSITIVE REGULATION OF GONADOTROPIN SECRETION 7 1.49e-01 3.15e-01 6.76e-01
POSITIVE REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY 5 2.22e-01 -3.15e-01 7.41e-01
POSITIVE REGULATION OF TELOMERASE RNA LOCALIZATION TO CAJAL BODY 15 3.47e-02 3.15e-01 4.03e-01
ATRIAL CARDIAC MUSCLE TISSUE MORPHOGENESIS 6 1.82e-01 3.15e-01 7.01e-01
METANEPHRIC TUBULE FORMATION 6 1.82e-01 -3.15e-01 7.01e-01
POSITIVE REGULATION OF PHOSPHOLIPID METABOLIC PROCESS 13 5.01e-02 -3.14e-01 4.66e-01
LIPID TRANSPORT ACROSS BLOOD BRAIN BARRIER 6 1.83e-01 -3.14e-01 7.04e-01
PROTEASOME ASSEMBLY 12 6.01e-02 3.13e-01 5.04e-01
RESPONSE TO LIPOTEICHOIC ACID 10 8.63e-02 -3.13e-01 5.77e-01
LIPID GLYCOSYLATION 12 6.04e-02 -3.13e-01 5.05e-01
GLYCINE BIOSYNTHETIC PROCESS 7 1.52e-01 3.13e-01 6.79e-01
PHOSPHATIDYLGLYCEROL ACYL CHAIN REMODELING 9 1.04e-01 -3.13e-01 6.07e-01
ETHER METABOLIC PROCESS 26 5.76e-03 -3.13e-01 1.74e-01
FOREBRAIN MORPHOGENESIS 13 5.09e-02 3.13e-01 4.69e-01
PYRIMIDINE DEOXYRIBONUCLEOSIDE METABOLIC PROCESS 5 2.26e-01 -3.13e-01 7.44e-01
REGULATION OF POSTSYNAPTIC CYTOSOLIC CALCIUM ION CONCENTRATION 10 8.71e-02 3.12e-01 5.79e-01
NEGATIVE REGULATION OF B CELL APOPTOTIC PROCESS 16 3.07e-02 -3.12e-01 3.85e-01
REGULATION OF T CELL ACTIVATION VIA T CELL RECEPTOR CONTACT WITH ANTIGEN BOUND TO MHC MOLECULE ON ANTIGEN PRESENTING CELL 6 1.86e-01 -3.12e-01 7.08e-01
NATURAL KILLER CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE 27 5.03e-03 3.12e-01 1.66e-01
NEGATIVE REGULATION OF G0 TO G1 TRANSITION 7 1.53e-01 -3.12e-01 6.79e-01
REGULATION OF VASCULOGENESIS 16 3.11e-02 -3.11e-01 3.85e-01
DORSAL VENTRAL AXIS SPECIFICATION 12 6.26e-02 -3.10e-01 5.12e-01
DENSE CORE GRANULE EXOCYTOSIS 10 8.94e-02 3.10e-01 5.83e-01
OLIGOPEPTIDE IMPORT ACROSS PLASMA MEMBRANE 5 2.30e-01 -3.10e-01 7.46e-01
ENDOTHELIAL CELL FATE COMMITMENT 8 1.29e-01 3.10e-01 6.48e-01
CHEMOKINE C X C MOTIF LIGAND 2 PRODUCTION 20 1.66e-02 -3.09e-01 2.98e-01
REGULATION OF CHRONIC INFLAMMATORY RESPONSE 10 9.05e-02 -3.09e-01 5.85e-01
CAMP BIOSYNTHETIC PROCESS 10 9.06e-02 -3.09e-01 5.85e-01
LEUKOTRIENE D4 BIOSYNTHETIC PROCESS 6 1.90e-01 -3.09e-01 7.13e-01
POSITIVE REGULATION OF DNA LIGATION 5 2.32e-01 3.09e-01 7.49e-01
REGULATION OF GASTRULATION 16 3.26e-02 -3.09e-01 3.96e-01
POSITIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE 31 2.97e-03 -3.08e-01 1.27e-01
PROGESTERONE BIOSYNTHETIC PROCESS 6 1.92e-01 -3.08e-01 7.15e-01
G QUADRUPLEX DNA UNWINDING 7 1.59e-01 3.08e-01 6.79e-01
REGULATION OF NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN CONTAINING 2 SIGNALING PATHWAY 10 9.22e-02 -3.08e-01 5.88e-01
2 OXOGLUTARATE METABOLIC PROCESS 15 3.93e-02 -3.07e-01 4.18e-01
B 1 B CELL DIFFERENTIATION 5 2.34e-01 -3.07e-01 7.52e-01
MACROPHAGE INFLAMMATORY PROTEIN 1 ALPHA PRODUCTION 6 1.93e-01 -3.07e-01 7.16e-01
PROXIMAL TUBULE DEVELOPMENT 10 9.27e-02 -3.07e-01 5.89e-01
APOPTOTIC PROCESS INVOLVED IN BLOOD VESSEL MORPHOGENESIS 5 2.34e-01 -3.07e-01 7.52e-01
PHENOTYPIC SWITCHING 17 2.84e-02 -3.07e-01 3.73e-01
POSITIVE REGULATION OF CALCIUM ION IMPORT ACROSS PLASMA MEMBRANE 11 7.81e-02 3.07e-01 5.57e-01
FRUCTOSE METABOLIC PROCESS 14 4.69e-02 -3.07e-01 4.52e-01
REGULATION OF SYNAPTIC VESICLE MEMBRANE ORGANIZATION 12 6.58e-02 3.07e-01 5.24e-01
POSITIVE REGULATION OF EPITHELIAL CELL PROLIFERATION INVOLVED IN WOUND HEALING 10 9.46e-02 3.05e-01 5.92e-01
EQUILIBRIOCEPTION 7 1.62e-01 3.05e-01 6.81e-01
UTP METABOLIC PROCESS 12 6.73e-02 -3.05e-01 5.30e-01
REVERSE CHOLESTEROL TRANSPORT 20 1.82e-02 -3.05e-01 3.11e-01
ERBB2 SIGNALING PATHWAY 18 2.51e-02 -3.05e-01 3.65e-01
REGULATION OF MEMBRANE REPOLARIZATION DURING ACTION POTENTIAL 10 9.50e-02 -3.05e-01 5.94e-01
DELAMINATION 7 1.63e-01 -3.05e-01 6.81e-01
NEUROTRANSMITTER CATABOLIC PROCESS 10 9.52e-02 3.05e-01 5.94e-01
MUSCLE CELL FATE COMMITMENT 20 1.84e-02 3.05e-01 3.12e-01
VESICLE MEDIATED CHOLESTEROL TRANSPORT 9 1.14e-01 -3.05e-01 6.25e-01
HIPPOCAMPAL NEURON APOPTOTIC PROCESS 7 1.63e-01 -3.04e-01 6.81e-01
REGULATION OF TOLL LIKE RECEPTOR 3 SIGNALING PATHWAY 12 6.79e-02 -3.04e-01 5.32e-01
VERY LOW DENSITY LIPOPROTEIN PARTICLE CLEARANCE 7 1.63e-01 -3.04e-01 6.81e-01
SEROTONIN METABOLIC PROCESS 11 8.09e-02 3.04e-01 5.62e-01
REGULATION OF BLOOD VESSEL REMODELING 12 6.84e-02 -3.04e-01 5.32e-01
PROTEIN SULFATION 6 1.98e-01 -3.03e-01 7.23e-01
GUANINE NUCLEOTIDE TRANSPORT 9 1.16e-01 -3.03e-01 6.30e-01
DETECTION OF STIMULUS 574 2.05e-35 3.03e-01 3.92e-32
MATERNAL PROCESS INVOLVED IN PARTURITION 6 2.00e-01 -3.02e-01 7.25e-01
POSITIVE REGULATION OF MITOPHAGY 8 1.39e-01 -3.02e-01 6.65e-01
CHOLINE TRANSPORT 9 1.18e-01 -3.01e-01 6.30e-01
POSITIVE REGULATION OF FEVER GENERATION 7 1.68e-01 3.01e-01 6.87e-01
FRUCTOSE 6 PHOSPHATE METABOLIC PROCESS 11 8.38e-02 -3.01e-01 5.70e-01
RNA POLYMERASE I PREINITIATION COMPLEX ASSEMBLY 8 1.40e-01 -3.01e-01 6.68e-01
NEGATIVE REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS 5 2.44e-01 3.01e-01 7.63e-01
NEGATIVE REGULATION OF STRIATED MUSCLE CELL APOPTOTIC PROCESS 33 2.79e-03 -3.01e-01 1.21e-01
SYNOVIOCYTE PROLIFERATION 5 2.44e-01 -3.01e-01 7.63e-01
POSITIVE REGULATION OF CHOLESTEROL STORAGE 8 1.41e-01 -3.00e-01 6.69e-01
REGULATION OF SALIVA SECRETION 7 1.69e-01 3.00e-01 6.87e-01
URINARY BLADDER SMOOTH MUSCLE CONTRACTION 7 1.70e-01 -3.00e-01 6.87e-01
NUCLEAR MIGRATION 25 9.60e-03 -2.99e-01 2.30e-01
TRNA 5 END PROCESSING 16 3.84e-02 2.99e-01 4.15e-01
NEGATIVE REGULATION OF LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL 13 6.25e-02 -2.98e-01 5.12e-01
NEGATIVE REGULATION OF HUMORAL IMMUNE RESPONSE MEDIATED BY CIRCULATING IMMUNOGLOBULIN 10 1.02e-01 -2.98e-01 6.06e-01
POSITIVE REGULATION OF MUCUS SECRETION 5 2.48e-01 -2.98e-01 7.64e-01
TYROSINE CATABOLIC PROCESS 6 2.06e-01 -2.98e-01 7.29e-01
RENAL WATER TRANSPORT 9 1.22e-01 -2.98e-01 6.37e-01
DISRUPTION OF ANATOMICAL STRUCTURE IN ANOTHER ORGANISM 97 3.93e-07 2.98e-01 1.87e-04
AMACRINE CELL DIFFERENTIATION 12 7.40e-02 2.98e-01 5.48e-01
ADP BIOSYNTHETIC PROCESS 5 2.49e-01 -2.98e-01 7.65e-01
PROTECTION FROM NATURAL KILLER CELL MEDIATED CYTOTOXICITY 6 2.08e-01 -2.97e-01 7.29e-01
CARDIAC SEPTUM CELL DIFFERENTIATION 5 2.51e-01 2.96e-01 7.67e-01
NEGATIVE REGULATION OF CHRONIC INFLAMMATORY RESPONSE 5 2.52e-01 -2.96e-01 7.68e-01
NEGATIVE REGULATION OF MUSCLE CELL APOPTOTIC PROCESS 50 2.91e-04 -2.96e-01 2.78e-02
BRONCHUS DEVELOPMENT 11 8.92e-02 -2.96e-01 5.83e-01
REGULATION OF HISTAMINE SECRETION BY MAST CELL 6 2.10e-01 -2.96e-01 7.30e-01
STOMACH DEVELOPMENT 5 2.52e-01 2.96e-01 7.68e-01
REGULATION OF FIBROBLAST MIGRATION 39 1.42e-03 -2.95e-01 8.04e-02
SPINDLE ASSEMBLY INVOLVED IN FEMALE MEIOSIS 9 1.25e-01 2.95e-01 6.48e-01
REGULATION OF PRESYNAPTIC CYTOSOLIC CALCIUM ION CONCENTRATION 15 4.79e-02 2.95e-01 4.56e-01
EMBRYONIC DIGESTIVE TRACT MORPHOGENESIS 17 3.52e-02 2.95e-01 4.03e-01
HEPARAN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS POLYSACCHARIDE CHAIN BIOSYNTHETIC PROCESS 8 1.49e-01 -2.95e-01 6.76e-01
INSULIN PROCESSING 8 1.49e-01 2.95e-01 6.76e-01
GLYCEROL ETHER METABOLIC PROCESS 21 1.94e-02 -2.95e-01 3.23e-01
REGULATION OF ADENYLATE CYCLASE ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY 14 5.65e-02 -2.94e-01 4.91e-01
DENDRITIC CELL ANTIGEN PROCESSING AND PRESENTATION 13 6.62e-02 -2.94e-01 5.26e-01
MICROGLIAL CELL PROLIFERATION 9 1.27e-01 -2.94e-01 6.48e-01
RESPONSE TO SALT STRESS 24 1.28e-02 -2.93e-01 2.65e-01
REGULATION OF HISTONE METHYLATION 19 2.72e-02 -2.93e-01 3.69e-01
NEGATIVE REGULATION OF HEMATOPOIETIC STEM CELL DIFFERENTIATION 5 2.58e-01 2.92e-01 7.71e-01
MONOACYLGLYCEROL METABOLIC PROCESS 14 5.83e-02 -2.92e-01 4.97e-01
MULTINUCLEAR OSTEOCLAST DIFFERENTIATION 8 1.52e-01 -2.92e-01 6.79e-01
HISTONE H3 K4 METHYLATION 20 2.37e-02 -2.92e-01 3.58e-01
DNA REPLICATION SYNTHESIS OF RNA PRIMER 7 1.82e-01 2.92e-01 7.01e-01
REGULATION OF INTRACELLULAR LIPID TRANSPORT 10 1.11e-01 -2.91e-01 6.18e-01
ALDITOL BIOSYNTHETIC PROCESS 5 2.59e-01 -2.91e-01 7.72e-01
REGULATION OF SKELETAL MUSCLE ADAPTATION 14 5.92e-02 -2.91e-01 5.01e-01
REGULATION OF LYMPHANGIOGENESIS 6 2.17e-01 2.91e-01 7.36e-01
OLIGODENDROCYTE PROGENITOR PROLIFERATION 8 1.55e-01 2.90e-01 6.79e-01
POSITIVE REGULATION OF NATURAL KILLER CELL CHEMOTAXIS 5 2.61e-01 2.90e-01 7.72e-01
MIRNA MEDIATED GENE SILENCING BY MRNA DESTABILIZATION 64 5.93e-05 -2.90e-01 9.82e-03
NEGATIVE REGULATION OF SKELETAL MUSCLE CELL DIFFERENTIATION 5 2.61e-01 2.90e-01 7.72e-01
ADIPONECTIN ACTIVATED SIGNALING PATHWAY 7 1.84e-01 -2.90e-01 7.06e-01
NEGATIVE REGULATION OF PROTEIN EXPORT FROM NUCLEUS 6 2.19e-01 -2.90e-01 7.37e-01
RIBONUCLEOSIDE DIPHOSPHATE CATABOLIC PROCESS 8 1.56e-01 -2.90e-01 6.79e-01
PYRUVATE FAMILY AMINO ACID METABOLIC PROCESS 5 2.62e-01 -2.89e-01 7.74e-01
ADP TRANSPORT 11 9.66e-02 -2.89e-01 5.96e-01
POSITIVE REGULATION OF VESICLE FUSION 11 9.68e-02 2.89e-01 5.96e-01
POSITIVE REGULATION OF ACTION POTENTIAL 8 1.57e-01 -2.89e-01 6.79e-01
ERROR PRONE TRANSLESION SYNTHESIS 11 9.68e-02 2.89e-01 5.96e-01
RESPONSE TO LECTIN 22 1.89e-02 2.89e-01 3.18e-01
POSITIVE REGULATION OF T HELPER 17 CELL DIFFERENTIATION 8 1.57e-01 -2.89e-01 6.79e-01
NEGATIVE REGULATION OF SYNAPTIC TRANSMISSION GLUTAMATERGIC 8 1.57e-01 2.89e-01 6.79e-01
POSITIVE REGULATION OF DOPAMINE RECEPTOR SIGNALING PATHWAY 5 2.63e-01 2.89e-01 7.74e-01
RIBONUCLEOSIDE DIPHOSPHATE BIOSYNTHETIC PROCESS 9 1.34e-01 -2.89e-01 6.58e-01
POSITIVE REGULATION OF LOW DENSITY LIPOPROTEIN RECEPTOR ACTIVITY 5 2.64e-01 2.89e-01 7.74e-01
ECTODERMAL PLACODE DEVELOPMENT 14 6.17e-02 2.88e-01 5.10e-01
GLUTATHIONE TRANSMEMBRANE TRANSPORT 7 1.86e-01 -2.88e-01 7.08e-01
STRAND INVASION 6 2.21e-01 2.88e-01 7.40e-01
POSITIVE REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR 16 4.60e-02 2.88e-01 4.48e-01
CELLULAR RESPONSE TO HISTAMINE 7 1.87e-01 2.88e-01 7.08e-01
PARAXIAL MESODERM DEVELOPMENT 18 3.45e-02 2.88e-01 4.03e-01
NEGATIVE REGULATION OF NEUTROPHIL ACTIVATION 5 2.65e-01 -2.88e-01 7.75e-01
REGULATION OF MAMMARY GLAND EPITHELIAL CELL PROLIFERATION 15 5.38e-02 -2.88e-01 4.80e-01
CELLULAR RESPONSE TO SALT STRESS 14 6.25e-02 -2.87e-01 5.12e-01
ESTABLISHMENT OF MITOTIC SISTER CHROMATID COHESION 7 1.88e-01 2.87e-01 7.09e-01
POSITIVE REGULATION OF BLOOD BRAIN BARRIER PERMEABILITY 5 2.66e-01 -2.87e-01 7.76e-01
HEXOSE CATABOLIC PROCESS 44 1.00e-03 -2.87e-01 6.31e-02
GOLGI VESICLE FUSION TO TARGET MEMBRANE 5 2.67e-01 -2.87e-01 7.77e-01
NEGATIVE REGULATION OF ASTROCYTE ACTIVATION 5 2.67e-01 -2.87e-01 7.77e-01
CELL CELL JUNCTION MAINTENANCE 18 3.53e-02 -2.87e-01 4.03e-01
NEGATIVE REGULATION OF PLATELET AGGREGATION 10 1.17e-01 -2.86e-01 6.30e-01
POSITIVE REGULATION OF TOLERANCE INDUCTION 12 8.61e-02 2.86e-01 5.77e-01
NEGATIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL PROLIFERATION INVOLVED IN SPROUTING ANGIOGENESIS 26 1.16e-02 -2.86e-01 2.50e-01
ESTABLISHMENT OF MEIOTIC SPINDLE LOCALIZATION 6 2.25e-01 -2.86e-01 7.42e-01
COPI COATED VESICLE BUDDING 6 2.25e-01 -2.86e-01 7.42e-01
MICROTUBULE ANCHORING AT MICROTUBULE ORGANIZING CENTER 14 6.42e-02 -2.86e-01 5.19e-01
CYCLIC NUCLEOTIDE TRANSPORT 9 1.38e-01 -2.86e-01 6.63e-01
NEGATIVE REGULATION OF SMOOTH MUSCLE CELL APOPTOTIC PROCESS 14 6.45e-02 -2.85e-01 5.21e-01
POSITIVE REGULATION OF MACROPHAGE DIFFERENTIATION 16 4.84e-02 -2.85e-01 4.58e-01
APOPTOTIC CHROMOSOME CONDENSATION 6 2.27e-01 -2.85e-01 7.44e-01
ISOPRENOID TRANSPORT 5 2.70e-01 -2.85e-01 7.79e-01
NUCLEOSIDE DIPHOSPHATE BIOSYNTHETIC PROCESS 13 7.54e-02 -2.85e-01 5.51e-01
PROTEIN N LINKED GLYCOSYLATION VIA ASPARAGINE 24 1.58e-02 2.85e-01 2.95e-01
GLUCOSE IMPORT IN RESPONSE TO INSULIN STIMULUS 6 2.27e-01 -2.85e-01 7.44e-01
POSITIVE REGULATION OF LONG TERM NEURONAL SYNAPTIC PLASTICITY 6 2.28e-01 -2.84e-01 7.44e-01
REGULATION OF NEUTROPHIL ACTIVATION 14 6.55e-02 -2.84e-01 5.24e-01
POSITIVE REGULATION OF PROTEIN DEUBIQUITINATION 5 2.71e-01 -2.84e-01 7.79e-01
GALACTOLIPID BIOSYNTHETIC PROCESS 6 2.28e-01 -2.84e-01 7.45e-01
IMMUNOGLOBULIN V D J RECOMBINATION 8 1.65e-01 -2.84e-01 6.84e-01
COMPLEMENT RECEPTOR MEDIATED SIGNALING PATHWAY 12 8.92e-02 2.83e-01 5.83e-01
NEGATIVE REGULATION OF AUTOPHAGY OF MITOCHONDRION 7 1.94e-01 -2.83e-01 7.18e-01
MEIOTIC ATTACHMENT OF TELOMERE TO NUCLEAR ENVELOPE 5 2.73e-01 -2.83e-01 7.80e-01
POSITIVE REGULATION OF PROTEIN LOCALIZATION TO SYNAPSE 6 2.30e-01 -2.83e-01 7.46e-01
FATTY ACID TRANSMEMBRANE TRANSPORT 20 2.84e-02 -2.83e-01 3.73e-01
MEIOTIC CHROMOSOME SEPARATION 8 1.66e-01 -2.83e-01 6.85e-01
PERICARDIUM MORPHOGENESIS 8 1.66e-01 2.83e-01 6.85e-01
RRNA PSEUDOURIDINE SYNTHESIS 8 1.67e-01 2.82e-01 6.85e-01
REGULATION OF SKELETAL MUSCLE CONTRACTION BY CALCIUM ION SIGNALING 7 1.96e-01 -2.82e-01 7.20e-01
SEMAPHORIN PLEXIN SIGNALING PATHWAY 44 1.20e-03 -2.82e-01 7.28e-02
REGULATION OF PENTOSE PHOSPHATE SHUNT 7 1.96e-01 -2.82e-01 7.20e-01
POSITIVE REGULATION OF APOPTOTIC PROCESS INVOLVED IN DEVELOPMENT 6 2.32e-01 -2.82e-01 7.49e-01
CITRATE METABOLIC PROCESS 5 2.75e-01 -2.82e-01 7.81e-01
B CELL PROLIFERATION INVOLVED IN IMMUNE RESPONSE 6 2.32e-01 -2.82e-01 7.49e-01
G PROTEIN COUPLED PURINERGIC NUCLEOTIDE RECEPTOR SIGNALING PATHWAY 12 9.10e-02 -2.82e-01 5.86e-01
CHROMOSOME ATTACHMENT TO THE NUCLEAR ENVELOPE 7 1.97e-01 -2.82e-01 7.21e-01
REGULATION OF POLYAMINE TRANSMEMBRANE TRANSPORT 5 2.76e-01 -2.81e-01 7.83e-01
CELLULAR RESPONSE TO STEROL DEPLETION 16 5.14e-02 -2.81e-01 4.71e-01
POSITIVE REGULATION OF ANOIKIS 6 2.33e-01 -2.81e-01 7.50e-01
REGULATION OF METANEPHROS DEVELOPMENT 6 2.33e-01 2.81e-01 7.50e-01
REGULATION OF RHODOPSIN MEDIATED SIGNALING PATHWAY 10 1.24e-01 -2.81e-01 6.45e-01
NEGATIVE REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY 35 4.04e-03 -2.81e-01 1.50e-01
HEPARIN BIOSYNTHETIC PROCESS 11 1.07e-01 -2.81e-01 6.11e-01
HAIR FOLLICLE PLACODE FORMATION 5 2.77e-01 2.81e-01 7.85e-01
POSITIVE REGULATION OF KILLING OF CELLS OF ANOTHER ORGANISM 8 1.70e-01 2.80e-01 6.87e-01
ANTERIOR POSTERIOR AXON GUIDANCE 7 1.99e-01 2.80e-01 7.25e-01
L LYSINE TRANSPORT 8 1.71e-01 -2.80e-01 6.87e-01
GANGLIOSIDE BIOSYNTHETIC PROCESS VIA LACTOSYLCERAMIDE 6 2.35e-01 -2.80e-01 7.54e-01
PYRIMIDINE RIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS 18 4.00e-02 -2.80e-01 4.21e-01
NEGATIVE REGULATION OF ENDOPLASMIC RETICULUM CALCIUM ION CONCENTRATION 8 1.72e-01 -2.79e-01 6.90e-01
CELL DIFFERENTIATION INVOLVED IN EMBRYONIC PLACENTA DEVELOPMENT 24 1.81e-02 -2.79e-01 3.11e-01
REGULATION OF HUMORAL IMMUNE RESPONSE MEDIATED BY CIRCULATING IMMUNOGLOBULIN 17 4.68e-02 -2.78e-01 4.52e-01
RHODOPSIN MEDIATED SIGNALING PATHWAY 14 7.12e-02 -2.78e-01 5.39e-01
NEGATIVE REGULATION OF CELL PROLIFERATION INVOLVED IN KIDNEY DEVELOPMENT 6 2.38e-01 -2.78e-01 7.56e-01
GRANULOCYTE COLONY STIMULATING FACTOR PRODUCTION 5 2.81e-01 2.78e-01 7.89e-01
REGULATION OF HIGH DENSITY LIPOPROTEIN PARTICLE CLEARANCE 11 1.10e-01 -2.78e-01 6.17e-01
INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO HYDROGEN PEROXIDE 9 1.48e-01 -2.78e-01 6.76e-01
RETINA VASCULATURE MORPHOGENESIS IN CAMERA TYPE EYE 10 1.28e-01 -2.78e-01 6.48e-01
REGULATION OF MAST CELL CHEMOTAXIS 8 1.74e-01 -2.78e-01 6.90e-01
INTERLEUKIN 4 MEDIATED SIGNALING PATHWAY 10 1.28e-01 -2.78e-01 6.48e-01
CENTRAL NERVOUS SYSTEM MYELIN MAINTENANCE 5 2.82e-01 -2.78e-01 7.90e-01
MICROGLIAL CELL MEDIATED CYTOTOXICITY 5 2.82e-01 2.78e-01 7.90e-01
POSITIVE REGULATION OF CHOLESTEROL METABOLIC PROCESS 15 6.27e-02 -2.78e-01 5.12e-01
POSITIVE REGULATION OF DEFENSE RESPONSE TO BACTERIUM 14 7.22e-02 -2.78e-01 5.42e-01
NEGATIVE REGULATION OF MEMBRANE DEPOLARIZATION 7 2.04e-01 -2.77e-01 7.29e-01
ZYMOGEN INHIBITION 8 1.75e-01 2.77e-01 6.92e-01
G1 TO G0 TRANSITION 19 3.65e-02 -2.77e-01 4.08e-01
POSITIVE REGULATION OF INTERLEUKIN 13 PRODUCTION 14 7.27e-02 -2.77e-01 5.43e-01
FRUCTOSE 2 6 BISPHOSPHATE METABOLIC PROCESS 5 2.83e-01 -2.77e-01 7.91e-01
CELLULAR RESPONSE TO PROGESTERONE STIMULUS 7 2.04e-01 -2.77e-01 7.29e-01
RESPONSE TO INACTIVITY 12 9.68e-02 -2.77e-01 5.96e-01
B CELL APOPTOTIC PROCESS 27 1.28e-02 -2.77e-01 2.65e-01
NEGATIVE REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY 22 2.49e-02 -2.76e-01 3.65e-01
ZINC ION IMPORT INTO ORGANELLE 9 1.51e-01 2.76e-01 6.79e-01
POSITIVE REGULATION OF T CELL DIFFERENTIATION IN THYMUS 11 1.13e-01 2.76e-01 6.25e-01
T CELL ANTIGEN PROCESSING AND PRESENTATION 5 2.85e-01 -2.76e-01 7.93e-01
FIBROBLAST MIGRATION 53 5.16e-04 -2.76e-01 3.95e-02
PLATELET DERIVED GROWTH FACTOR RECEPTOR ALPHA SIGNALING PATHWAY 7 2.07e-01 2.76e-01 7.29e-01
REGULATION OF PINOCYTOSIS 12 9.85e-02 -2.75e-01 6.00e-01
T CELL CHEMOTAXIS 26 1.51e-02 2.75e-01 2.89e-01
GLUTATHIONE CATABOLIC PROCESS 7 2.07e-01 -2.75e-01 7.29e-01
INNATE IMMUNE RESPONSE IN MUCOSA 27 1.33e-02 2.75e-01 2.72e-01
MEMBRANE REPOLARIZATION DURING ATRIAL CARDIAC MUSCLE CELL ACTION POTENTIAL 7 2.08e-01 -2.75e-01 7.29e-01
ACTIN POLYMERIZATION DEPENDENT CELL MOTILITY 7 2.08e-01 2.75e-01 7.29e-01
REPLICATION BORN DOUBLE STRAND BREAK REPAIR VIA SISTER CHROMATID EXCHANGE 7 2.08e-01 2.75e-01 7.29e-01
POST TRANSLATIONAL PROTEIN TARGETING TO MEMBRANE TRANSLOCATION 8 1.79e-01 2.75e-01 6.99e-01
AXONAL TRANSPORT OF MITOCHONDRION 18 4.40e-02 2.74e-01 4.40e-01
PITUITARY GLAND DEVELOPMENT 42 2.14e-03 2.74e-01 1.05e-01
REGULATION OF NEURON PROJECTION REGENERATION 32 7.40e-03 -2.74e-01 2.00e-01
RESPONSE TO FUNGUS 64 1.54e-04 2.74e-01 1.75e-02
NEGATIVE REGULATION OF MEMBRANE PERMEABILITY 21 3.00e-02 -2.73e-01 3.83e-01
NEGATIVE REGULATION OF LIPOPROTEIN PARTICLE CLEARANCE 21 3.00e-02 -2.73e-01 3.83e-01
REGULATION OF CALCIUM ION IMPORT ACROSS PLASMA MEMBRANE 16 5.83e-02 2.73e-01 4.97e-01
NEGATIVE REGULATION OF TELOMERASE ACTIVITY 10 1.35e-01 -2.73e-01 6.59e-01
MEIOTIC CELL CYCLE PROCESS INVOLVED IN OOCYTE MATURATION 6 2.46e-01 -2.73e-01 7.64e-01
NEGATIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRION 7 2.11e-01 2.73e-01 7.32e-01
DCMP CATABOLIC PROCESS 6 2.47e-01 2.73e-01 7.64e-01
TOLL SIGNALING PATHWAY 11 1.17e-01 -2.73e-01 6.30e-01
POSITIVE REGULATION OF TOLL LIKE RECEPTOR 3 SIGNALING PATHWAY 8 1.81e-01 -2.73e-01 7.01e-01
REGULATION OF VESICLE FUSION 24 2.06e-02 2.73e-01 3.37e-01
REACTIVE GLIOSIS 6 2.47e-01 -2.73e-01 7.64e-01
FOLLICLE STIMULATING HORMONE SECRETION 8 1.82e-01 2.73e-01 7.01e-01
NEGATIVE REGULATION OF LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY 14 7.74e-02 2.73e-01 5.55e-01
POSITIVE REGULATION OF RESPIRATORY BURST 7 2.12e-01 2.73e-01 7.32e-01
REGULATION OF MICROVILLUS LENGTH 7 2.12e-01 -2.72e-01 7.32e-01
L ASPARTATE IMPORT ACROSS PLASMA MEMBRANE 6 2.48e-01 2.72e-01 7.64e-01
GROWTH PLATE CARTILAGE CHONDROCYTE DEVELOPMENT 5 2.92e-01 -2.72e-01 7.99e-01
REGULATION OF TESTOSTERONE BIOSYNTHETIC PROCESS 7 2.12e-01 2.72e-01 7.32e-01
NEGATIVE REGULATION OF IMMUNOGLOBULIN PRODUCTION 12 1.03e-01 2.72e-01 6.07e-01
PODOSOME ASSEMBLY 20 3.52e-02 -2.72e-01 4.03e-01
LEUCINE IMPORT ACROSS PLASMA MEMBRANE 5 2.92e-01 -2.72e-01 8.00e-01
MRNA 3 SPLICE SITE RECOGNITION 6 2.49e-01 -2.72e-01 7.65e-01
PYRIMIDINE RIBONUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS 15 6.83e-02 -2.72e-01 5.32e-01
RESPONSE TO BILE ACID 7 2.13e-01 -2.72e-01 7.33e-01
REGULATION OF HYDROGEN PEROXIDE MEDIATED PROGRAMMED CELL DEATH 14 7.86e-02 -2.72e-01 5.58e-01
NEGATIVE REGULATION OF CELL VOLUME 5 2.93e-01 -2.71e-01 8.01e-01
REGULATION OF LYMPHOCYTE CHEMOTAXIS 25 1.89e-02 2.71e-01 3.18e-01
PROLINE TRANSMEMBRANE TRANSPORT 12 1.04e-01 2.71e-01 6.07e-01
REGULATION OF GLOMERULAR FILTRATION 8 1.84e-01 -2.71e-01 7.06e-01
CEREBRAL CORTEX REGIONALIZATION 7 2.14e-01 -2.71e-01 7.33e-01
NEGATIVE REGULATION OF ADENYLATE CYCLASE ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY 11 1.20e-01 -2.71e-01 6.33e-01
CEREBELLAR GRANULAR LAYER FORMATION 7 2.15e-01 2.71e-01 7.33e-01
TYPE III INTERFERON PRODUCTION 5 2.94e-01 2.71e-01 8.02e-01
REGULATION OF ENDOSOME ORGANIZATION 5 2.95e-01 -2.70e-01 8.03e-01
RETINAL GANGLION CELL AXON GUIDANCE 23 2.48e-02 2.70e-01 3.65e-01
ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN VIA MHC CLASS IB 18 4.72e-02 -2.70e-01 4.53e-01
MITOCHONDRIAL ATP TRANSMEMBRANE TRANSPORT 7 2.16e-01 -2.70e-01 7.33e-01
INTERLEUKIN 2 MEDIATED SIGNALING PATHWAY 9 1.61e-01 -2.70e-01 6.81e-01
ETHER BIOSYNTHETIC PROCESS 12 1.05e-01 -2.70e-01 6.09e-01
POSITIVE REGULATION OF TOOTH MINERALIZATION 8 1.87e-01 -2.70e-01 7.08e-01
NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN CONTAINING 1 SIGNALING PATHWAY 8 1.87e-01 -2.69e-01 7.08e-01
DESMOSOME ORGANIZATION 10 1.40e-01 -2.69e-01 6.68e-01
NEGATIVE REGULATION OF CELL MATURATION 8 1.87e-01 -2.69e-01 7.09e-01
NEGATIVE REGULATION OF TRIGLYCERIDE CATABOLIC PROCESS 5 2.98e-01 2.69e-01 8.04e-01
PHOTOTRANSDUCTION 45 1.81e-03 -2.69e-01 9.78e-02
REGULATION OF BLOOD VOLUME BY RENIN ANGIOTENSIN 8 1.88e-01 2.69e-01 7.10e-01
REGULATION OF TRANSFORMING GROWTH FACTOR BETA ACTIVATION 10 1.42e-01 -2.68e-01 6.69e-01
CELLULAR RESPONSE TO LUTEINIZING HORMONE STIMULUS 5 2.99e-01 -2.68e-01 8.05e-01
REGULATION OF URINE VOLUME 21 3.33e-02 -2.68e-01 4.00e-01
MITOCHONDRIAL RNA MODIFICATION 10 1.42e-01 2.68e-01 6.69e-01
RESPONSE TO CORTISOL 6 2.55e-01 -2.68e-01 7.70e-01
REGULATION OF SYNAPTIC VESICLE TRANSPORT 5 3.00e-01 2.68e-01 8.06e-01
INTRACELLULAR STEROL TRANSPORT 35 6.09e-03 -2.68e-01 1.81e-01
NEGATIVE REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING 14 8.28e-02 -2.68e-01 5.70e-01
ADENYLATE CYCLASE ACTIVATING DOPAMINE RECEPTOR SIGNALING PATHWAY 9 1.64e-01 -2.68e-01 6.83e-01
POSITIVE REGULATION OF PROTEIN CATABOLIC PROCESS IN THE VACUOLE 6 2.56e-01 -2.68e-01 7.70e-01
HISTONE DEACETYLATION 23 2.64e-02 -2.67e-01 3.66e-01
REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL DIFFERENTIATION 25 2.07e-02 -2.67e-01 3.38e-01
DENDRITE ARBORIZATION 10 1.44e-01 2.67e-01 6.70e-01
POSITIVE REGULATION OF ENDOCYTIC RECYCLING 8 1.91e-01 -2.67e-01 7.14e-01
GTP BIOSYNTHETIC PROCESS 11 1.26e-01 -2.67e-01 6.48e-01
CGMP CATABOLIC PROCESS 5 3.02e-01 2.67e-01 8.07e-01
SYMPATHETIC GANGLION DEVELOPMENT 9 1.67e-01 2.66e-01 6.85e-01
CELLULAR RESPONSE TO HYPEROXIA 5 3.03e-01 2.66e-01 8.07e-01
TELOMERIC LOOP DISASSEMBLY 9 1.67e-01 -2.66e-01 6.86e-01
POSITIVE REGULATION OF TRIGLYCERIDE LIPASE ACTIVITY 9 1.67e-01 -2.66e-01 6.86e-01
EMBRYONIC PROCESS INVOLVED IN FEMALE PREGNANCY 7 2.23e-01 2.66e-01 7.41e-01
REGULATION OF MACROPHAGE PROLIFERATION 7 2.23e-01 -2.66e-01 7.41e-01
MACROPHAGE PROLIFERATION 13 9.72e-02 -2.66e-01 5.97e-01
CELL DIFFERENTIATION IN HINDBRAIN 23 2.75e-02 2.66e-01 3.71e-01
CARBOHYDRATE PHOSPHORYLATION 23 2.77e-02 -2.65e-01 3.73e-01
NEUROBLAST MIGRATION 6 2.61e-01 2.65e-01 7.72e-01
NEGATIVE REGULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY 24 2.47e-02 -2.65e-01 3.65e-01
SCHWANN CELL PROLIFERATION 11 1.28e-01 -2.65e-01 6.48e-01
REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY 58 4.92e-04 -2.65e-01 3.91e-02
REGULATION OF INNER EAR AUDITORY RECEPTOR CELL DIFFERENTIATION 9 1.69e-01 -2.64e-01 6.87e-01
FERMENTATION 5 3.06e-01 -2.64e-01 8.11e-01
NEGATIVE REGULATION OF MYOTUBE DIFFERENTIATION 17 5.92e-02 -2.64e-01 5.01e-01
REGULATION OF TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY 31 1.09e-02 -2.64e-01 2.44e-01
ANTEROGRADE DENDRITIC TRANSPORT OF NEUROTRANSMITTER RECEPTOR COMPLEX 5 3.07e-01 -2.64e-01 8.11e-01
I KAPPAB PHOSPHORYLATION 17 5.96e-02 -2.64e-01 5.02e-01
IONOTROPIC GLUTAMATE RECEPTOR SIGNALING PATHWAY 24 2.53e-02 2.64e-01 3.65e-01
REGULATION OF ADIPONECTIN SECRETION 7 2.27e-01 -2.64e-01 7.44e-01
EOSINOPHIL DIFFERENTIATION 7 2.27e-01 2.64e-01 7.44e-01
REGULATION OF LIPOPROTEIN PARTICLE CLEARANCE 36 6.21e-03 -2.63e-01 1.83e-01
REGULATION OF RELAXATION OF CARDIAC MUSCLE 6 2.64e-01 2.63e-01 7.74e-01
LYSOSOMAL MICROAUTOPHAGY 13 1.00e-01 -2.63e-01 6.02e-01
PURINE NUCLEOBASE METABOLIC PROCESS 21 3.68e-02 2.63e-01 4.09e-01
POSITIVE REGULATION OF THE FORCE OF HEART CONTRACTION 5 3.08e-01 2.63e-01 8.11e-01
NEGATIVE REGULATION OF RESPIRATORY BURST INVOLVED IN INFLAMMATORY RESPONSE 5 3.09e-01 2.63e-01 8.11e-01
NEGATIVE REGULATION OF LIPID TRANSPORT 48 1.66e-03 -2.62e-01 9.25e-02
ASTRAL MICROTUBULE ORGANIZATION 10 1.51e-01 -2.62e-01 6.79e-01
RESPONSE TO AMMONIUM ION 6 2.66e-01 2.62e-01 7.76e-01
SUBSTRATE DEPENDENT CELL MIGRATION CELL EXTENSION 9 1.73e-01 2.62e-01 6.90e-01
NEGATIVE REGULATION OF OSTEOCLAST DEVELOPMENT 5 3.10e-01 2.62e-01 8.13e-01
NEGATIVE REGULATION OF STEROL TRANSPORT 31 1.16e-02 -2.62e-01 2.50e-01
POSITIVE REGULATION OF VASCULOGENESIS 12 1.17e-01 -2.62e-01 6.30e-01
ANTIFUNGAL HUMORAL RESPONSE 5 3.11e-01 2.62e-01 8.13e-01
REGULATION OF HEMOGLOBIN BIOSYNTHETIC PROCESS 8 2.00e-01 -2.61e-01 7.26e-01
LATE NUCLEOPHAGY 8 2.01e-01 -2.61e-01 7.27e-01
ESTABLISHMENT OF SKIN BARRIER 33 9.40e-03 -2.61e-01 2.28e-01
POSITIVE REGULATION OF INTERLEUKIN 23 PRODUCTION 7 2.32e-01 2.61e-01 7.49e-01
TONGUE MORPHOGENESIS 10 1.53e-01 2.61e-01 6.79e-01
LOW DENSITY LIPOPROTEIN RECEPTOR PARTICLE METABOLIC PROCESS 6 2.69e-01 -2.61e-01 7.78e-01
PHOTOTRANSDUCTION VISIBLE LIGHT 20 4.37e-02 -2.60e-01 4.38e-01
GOLGI VESICLE BUDDING 10 1.54e-01 -2.60e-01 6.79e-01
MEMBRANE RAFT LOCALIZATION 8 2.02e-01 -2.60e-01 7.29e-01
NON LYTIC VIRAL RELEASE 14 9.19e-02 -2.60e-01 5.88e-01
REGULATION OF PHOSPHOLIPASE A2 ACTIVITY 9 1.77e-01 2.60e-01 6.97e-01
GOLGI DISASSEMBLY 6 2.71e-01 2.60e-01 7.79e-01
REGULATION OF AXON DIAMETER 5 3.15e-01 2.60e-01 8.17e-01
POSITIVE REGULATION OF CYTOPLASMIC TRANSLATION 15 8.18e-02 2.60e-01 5.65e-01
INTERLEUKIN 17A MEDIATED SIGNALING PATHWAY 6 2.71e-01 2.59e-01 7.79e-01
CARNITINE TRANSMEMBRANE TRANSPORT 7 2.35e-01 -2.59e-01 7.54e-01
PYRIMIDINE RIBONUCLEOSIDE DIPHOSPHATE METABOLIC PROCESS 7 2.35e-01 -2.59e-01 7.54e-01
DORSAL AORTA DEVELOPMENT 10 1.56e-01 -2.59e-01 6.79e-01
REGULATION OF SKELETAL MUSCLE CELL DIFFERENTIATION 20 4.49e-02 2.59e-01 4.45e-01
CELL CELL JUNCTION DISASSEMBLY 5 3.16e-01 2.59e-01 8.19e-01
POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR INTERNALIZATION 24 2.83e-02 -2.59e-01 3.73e-01
FUCOSE CATABOLIC PROCESS 9 1.79e-01 -2.58e-01 7.00e-01
REGULATION OF CONNECTIVE TISSUE REPLACEMENT 15 8.32e-02 2.58e-01 5.70e-01
NEGATIVE REGULATION OF INTERLEUKIN 1 ALPHA PRODUCTION 5 3.17e-01 -2.58e-01 8.20e-01
SKELETAL MUSCLE CONTRACTION 44 3.08e-03 -2.58e-01 1.30e-01
NEGATIVE REGULATION OF B CELL RECEPTOR SIGNALING PATHWAY 7 2.38e-01 2.58e-01 7.56e-01
VITAMIN D BIOSYNTHETIC PROCESS 10 1.58e-01 2.58e-01 6.79e-01
LACTATE METABOLIC PROCESS 18 5.85e-02 -2.58e-01 4.97e-01
NEGATIVE REGULATION OF ADIPOSE TISSUE DEVELOPMENT 5 3.19e-01 2.57e-01 8.21e-01
GLUCOSAMINE CONTAINING COMPOUND CATABOLIC PROCESS 9 1.81e-01 2.57e-01 7.01e-01
MESANGIAL CELL DEVELOPMENT 6 2.75e-01 -2.57e-01 7.82e-01
TRANSFORMING GROWTH FACTOR BETA2 PRODUCTION 9 1.82e-01 2.57e-01 7.01e-01
SPERMIDINE TRANSPORT 5 3.20e-01 -2.57e-01 8.21e-01
RHOMBOMERE DEVELOPMENT 8 2.08e-01 -2.57e-01 7.29e-01
NUCLEOBASE BIOSYNTHETIC PROCESS 19 5.27e-02 2.57e-01 4.75e-01
UTERINE SMOOTH MUSCLE CONTRACTION 9 1.83e-01 -2.56e-01 7.03e-01
DETECTION OF MUSCLE STRETCH 7 2.40e-01 2.56e-01 7.59e-01
ALDEHYDE CATABOLIC PROCESS 14 9.69e-02 -2.56e-01 5.96e-01
SENSORY PERCEPTION OF UMAMI TASTE 7 2.41e-01 -2.56e-01 7.59e-01
CALCIUM ION IMPORT INTO SARCOPLASMIC RETICULUM 5 3.21e-01 2.56e-01 8.23e-01
SYNAPTIC VESICLE CYTOSKELETAL TRANSPORT 18 6.01e-02 2.56e-01 5.04e-01
REGULATION OF T CELL COSTIMULATION 5 3.22e-01 2.56e-01 8.23e-01
RESPONSE TO INTERLEUKIN 4 35 8.93e-03 -2.55e-01 2.22e-01
RESPONSE TO GRAM POSITIVE BACTERIUM 5 3.23e-01 -2.55e-01 8.23e-01
ENDOTHELIN RECEPTOR SIGNALING PATHWAY 10 1.63e-01 -2.55e-01 6.81e-01
POSITIVE REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY 61 5.82e-04 -2.55e-01 4.22e-02
CYTOPLASMIC SEQUESTERING OF PROTEIN 22 3.88e-02 -2.54e-01 4.16e-01
EXTRACELLULAR MATRIX CELL SIGNALING 5 3.25e-01 -2.54e-01 8.25e-01
NEGATIVE REGULATION OF CENTRIOLE REPLICATION 7 2.44e-01 -2.54e-01 7.63e-01
LEUCINE METABOLIC PROCESS 8 2.13e-01 -2.54e-01 7.32e-01
IMMUNE RESPONSE INHIBITING SIGNAL TRANSDUCTION 11 1.45e-01 2.54e-01 6.73e-01
FUSED ANTRUM STAGE 6 2.82e-01 -2.54e-01 7.90e-01
EXCITATORY CHEMICAL SYNAPTIC TRANSMISSION 12 1.28e-01 2.54e-01 6.48e-01
REGULATION OF SECONDARY HEART FIELD CARDIOBLAST PROLIFERATION 9 1.88e-01 2.53e-01 7.10e-01
RAB PROTEIN SIGNAL TRANSDUCTION 21 4.47e-02 -2.53e-01 4.44e-01
COMPARTMENT PATTERN SPECIFICATION 5 3.28e-01 -2.53e-01 8.29e-01
CANONICAL WNT SIGNALING PATHWAY INVOLVED IN OSTEOBLAST DIFFERENTIATION 7 2.47e-01 2.53e-01 7.64e-01
HISTONE H3 K9 METHYLATION 6 2.84e-01 -2.53e-01 7.91e-01
SKELETAL MUSCLE SATELLITE CELL DIFFERENTIATION 9 1.89e-01 2.53e-01 7.11e-01
REGULATION OF OPSONIZATION 11 1.47e-01 -2.53e-01 6.75e-01
NUCLEOSIDE DIPHOSPHATE CATABOLIC PROCESS 12 1.30e-01 -2.53e-01 6.50e-01
CELL SUBSTRATE JUNCTION DISASSEMBLY 8 2.17e-01 -2.52e-01 7.35e-01
PYRIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS 31 1.51e-02 -2.52e-01 2.89e-01
CELLULAR RESPONSE TO GLUCAGON STIMULUS 11 1.48e-01 2.52e-01 6.75e-01
NEGATIVE REGULATION OF CELLULAR RESPONSE TO HYPOXIA 11 1.48e-01 2.52e-01 6.75e-01
RESPONSE TO THYROGLOBULIN TRIIODOTHYRONINE 5 3.29e-01 -2.52e-01 8.30e-01
PYRIMIDINE NUCLEOSIDE DIPHOSPHATE BIOSYNTHETIC PROCESS 6 2.85e-01 -2.52e-01 7.93e-01
LEUCINE CATABOLIC PROCESS 6 2.86e-01 -2.52e-01 7.94e-01
MONOSACCHARIDE CATABOLIC PROCESS 52 1.69e-03 -2.52e-01 9.34e-02
PROTEIN LOCALIZATION TO PHOTORECEPTOR OUTER SEGMENT 7 2.49e-01 -2.52e-01 7.65e-01
EMBRYONIC NEUROCRANIUM MORPHOGENESIS 9 1.91e-01 -2.51e-01 7.14e-01
NEGATIVE REGULATION OF SYNAPTIC TRANSMISSION GABAERGIC 6 2.86e-01 2.51e-01 7.94e-01
DGMP METABOLIC PROCESS 5 3.30e-01 -2.51e-01 8.31e-01
NEGATIVE REGULATION OF HEMATOPOIETIC STEM CELL PROLIFERATION 5 3.30e-01 2.51e-01 8.31e-01
POSITIVE REGULATION OF CAMP DEPENDENT PROTEIN KINASE ACTIVITY 5 3.31e-01 2.51e-01 8.31e-01
MRNA PSEUDOURIDINE SYNTHESIS 9 1.93e-01 2.51e-01 7.16e-01
BUD ELONGATION INVOLVED IN LUNG BRANCHING 7 2.51e-01 2.51e-01 7.67e-01
NEGATIVE REGULATION OF SECONDARY METABOLITE BIOSYNTHETIC PROCESS 5 3.32e-01 2.51e-01 8.31e-01
DEOXYRIBONUCLEOSIDE METABOLIC PROCESS 11 1.50e-01 -2.50e-01 6.79e-01
TRANSFORMING GROWTH FACTOR BETA ACTIVATION 13 1.18e-01 -2.50e-01 6.30e-01
POSITIVE REGULATION OF GASTRULATION 6 2.88e-01 -2.50e-01 7.97e-01
REGULATION OF GLIAL CELL APOPTOTIC PROCESS 10 1.71e-01 -2.50e-01 6.88e-01
POSITIVE REGULATION OF HUMORAL IMMUNE RESPONSE MEDIATED BY CIRCULATING IMMUNOGLOBULIN 7 2.52e-01 -2.50e-01 7.68e-01
NEGATIVE REGULATION OF INTERLEUKIN 21 PRODUCTION 5 3.33e-01 -2.50e-01 8.31e-01
TRNA 5 LEADER REMOVAL 13 1.19e-01 2.50e-01 6.32e-01
PROTEIN LOCALIZATION TO AXON 9 1.95e-01 2.49e-01 7.19e-01
NUCLEUS LOCALIZATION 33 1.33e-02 -2.49e-01 2.71e-01
GLYCINE IMPORT ACROSS PLASMA MEMBRANE 5 3.35e-01 -2.49e-01 8.31e-01
MIDGUT DEVELOPMENT 11 1.53e-01 2.49e-01 6.79e-01
POSITIVE REGULATION OF SULFUR METABOLIC PROCESS 5 3.35e-01 -2.49e-01 8.31e-01
CORNIFIED ENVELOPE ASSEMBLY 6 2.91e-01 -2.49e-01 7.99e-01
NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE 12 1.36e-01 2.49e-01 6.60e-01
EPIBOLY 39 7.19e-03 -2.49e-01 1.98e-01
REGULATION OF ATTACHMENT OF MITOTIC SPINDLE MICROTUBULES TO KINETOCHORE 8 2.24e-01 -2.49e-01 7.41e-01
REGULATION OF LUNG BLOOD PRESSURE 5 3.36e-01 2.48e-01 8.31e-01
REGULATION OF GLUTAMINE FAMILY AMINO ACID METABOLIC PROCESS 8 2.24e-01 -2.48e-01 7.41e-01
POSITIVE REGULATION OF VASCULAR WOUND HEALING 5 3.36e-01 -2.48e-01 8.31e-01
TELOMERE TETHERING AT NUCLEAR PERIPHERY 6 2.93e-01 -2.48e-01 8.01e-01
POSITIVE REGULATION OF HEMOGLOBIN BIOSYNTHETIC PROCESS 6 2.94e-01 -2.48e-01 8.02e-01
REGULATION OF RIG I SIGNALING PATHWAY 20 5.52e-02 -2.48e-01 4.86e-01
PHOSPHATIDYLCHOLINE METABOLIC PROCESS 76 1.90e-04 -2.48e-01 1.99e-02
POSITIVE REGULATION OF GOLGI TO PLASMA MEMBRANE PROTEIN TRANSPORT 5 3.38e-01 -2.48e-01 8.33e-01
POSITIVE REGULATION OF STRESS FIBER ASSEMBLY 51 2.26e-03 -2.47e-01 1.08e-01
HISTAMINE METABOLIC PROCESS 6 2.95e-01 -2.47e-01 8.02e-01
MAINTENANCE OF PROTEIN LOCATION IN NUCLEUS 23 4.05e-02 -2.47e-01 4.24e-01
SOMITE SPECIFICATION 5 3.40e-01 -2.47e-01 8.35e-01
REGULATION OF NEURON MATURATION 8 2.28e-01 -2.46e-01 7.44e-01
PYRIMIDINE NUCLEOSIDE DIPHOSPHATE METABOLIC PROCESS 9 2.01e-01 -2.46e-01 7.27e-01
FATTY ACID ELONGATION SATURATED FATTY ACID 7 2.59e-01 2.46e-01 7.72e-01
MEMBRANE DISASSEMBLY 11 1.57e-01 -2.46e-01 6.79e-01
COENZYME A BIOSYNTHETIC PROCESS 11 1.58e-01 -2.46e-01 6.79e-01
REGULATION OF TOLERANCE INDUCTION 20 5.71e-02 2.46e-01 4.94e-01
POSITIVE REGULATION OF MAST CELL CHEMOTAXIS 6 2.97e-01 -2.46e-01 8.04e-01
PROTEIN LOCALIZATION TO CELL CELL JUNCTION 22 4.60e-02 -2.46e-01 4.48e-01
WNT PROTEIN SECRETION 6 2.97e-01 -2.46e-01 8.04e-01
HYDROGEN SULFIDE METABOLIC PROCESS 6 2.98e-01 -2.46e-01 8.04e-01
AMYLOID BETA CLEARANCE BY CELLULAR CATABOLIC PROCESS 8 2.29e-01 -2.45e-01 7.46e-01
SEQUESTERING OF METAL ION 11 1.59e-01 2.45e-01 6.79e-01
REGULATION OF ACUTE INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS 15 9.99e-02 2.45e-01 6.02e-01
TRANSITION BETWEEN FAST AND SLOW FIBER 9 2.03e-01 -2.45e-01 7.29e-01
GMP BIOSYNTHETIC PROCESS 14 1.12e-01 2.45e-01 6.23e-01
PROTEIN IMPORT INTO PEROXISOME MEMBRANE 6 2.98e-01 2.45e-01 8.05e-01
AGGRESSIVE BEHAVIOR 7 2.62e-01 2.45e-01 7.73e-01
POSITIVE REGULATION OF ERBB SIGNALING PATHWAY 29 2.25e-02 -2.45e-01 3.52e-01
CELLULAR RESPONSE TO COCAINE 8 2.31e-01 -2.44e-01 7.49e-01
TOLL LIKE RECEPTOR 3 SIGNALING PATHWAY 26 3.11e-02 -2.44e-01 3.85e-01
NEGATIVE REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION 16 9.07e-02 -2.44e-01 5.85e-01
SULFUR AMINO ACID TRANSPORT 12 1.43e-01 -2.44e-01 6.70e-01
RETINAL CELL PROGRAMMED CELL DEATH 6 3.01e-01 -2.44e-01 8.07e-01
ADENYLATE CYCLASE INHIBITING SEROTONIN RECEPTOR SIGNALING PATHWAY 7 2.64e-01 2.44e-01 7.74e-01
CEREBROSPINAL FLUID CIRCULATION 15 1.02e-01 2.44e-01 6.06e-01
EOSINOPHIL MIGRATION 30 2.10e-02 2.43e-01 3.41e-01
REGULATION OF RNA POLYMERASE II REGULATORY REGION SEQUENCE SPECIFIC DNA BINDING 9 2.06e-01 -2.43e-01 7.29e-01
MITOCHONDRIAL ELECTRON TRANSPORT CYTOCHROME C TO OXYGEN 20 5.97e-02 2.43e-01 5.02e-01
ACTIN FILAMENT BUNDLE ORGANIZATION 166 6.44e-08 -2.43e-01 3.51e-05
TETRAHYDROFOLATE BIOSYNTHETIC PROCESS 5 3.47e-01 2.43e-01 8.37e-01
ORNITHINE TRANSPORT 7 2.66e-01 -2.43e-01 7.76e-01
NEGATIVE REGULATION OF LOW DENSITY LIPOPROTEIN PARTICLE CLEARANCE 15 1.04e-01 -2.43e-01 6.07e-01
FUCOSYLATION 17 8.32e-02 -2.43e-01 5.70e-01
SYMPATHETIC NERVOUS SYSTEM DEVELOPMENT 22 4.88e-02 2.43e-01 4.61e-01
REGULATION OF ER TO GOLGI VESICLE MEDIATED TRANSPORT 10 1.85e-01 2.42e-01 7.07e-01
CARDIAC FIBROBLAST CELL DIFFERENTIATION 5 3.49e-01 -2.42e-01 8.40e-01
DIADENOSINE POLYPHOSPHATE METABOLIC PROCESS 8 2.36e-01 2.42e-01 7.54e-01
NON CANONICAL WNT SIGNALING PATHWAY VIA JNK CASCADE 6 3.05e-01 2.42e-01 8.10e-01
POSITIVE REGULATION OF AUTOPHAGY OF MITOCHONDRION 15 1.05e-01 -2.42e-01 6.09e-01
CD4 POSITIVE CD25 POSITIVE ALPHA BETA REGULATORY T CELL DIFFERENTIATION 10 1.86e-01 2.42e-01 7.08e-01
POSITIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEOLUS 6 3.06e-01 -2.41e-01 8.11e-01
TOOTH ERUPTION 5 3.50e-01 -2.41e-01 8.41e-01
DEDIFFERENTIATION 12 1.48e-01 -2.41e-01 6.75e-01
LAMELLIPODIUM MORPHOGENESIS 18 7.68e-02 -2.41e-01 5.53e-01
POSITIVE REGULATION OF GLUCONEOGENESIS 21 5.62e-02 -2.41e-01 4.90e-01
NEGATIVE REGULATION OF FIBRINOLYSIS 13 1.33e-01 -2.40e-01 6.58e-01
POSITIVE REGULATION OF SPHINGOLIPID BIOSYNTHETIC PROCESS 6 3.08e-01 -2.40e-01 8.11e-01
DENDRITIC CELL CYTOKINE PRODUCTION 19 6.99e-02 -2.40e-01 5.35e-01
ANTIMICROBIAL HUMORAL RESPONSE 121 5.06e-06 2.40e-01 1.28e-03
REGULATION OF HEART MORPHOGENESIS 10 1.89e-01 2.40e-01 7.11e-01
REGULATION OF MITOPHAGY 16 9.69e-02 -2.40e-01 5.96e-01
MYELOID DENDRITIC CELL CYTOKINE PRODUCTION 8 2.40e-01 -2.40e-01 7.59e-01
CELLULAR RESPONSE TO PROSTAGLANDIN E STIMULUS 16 9.72e-02 -2.39e-01 5.97e-01
MORPHOGENESIS OF AN EPITHELIAL BUD 15 1.08e-01 2.39e-01 6.15e-01
ENDOPLASMIC RETICULUM PLASMA MEMBRANE TETHERING 6 3.11e-01 -2.39e-01 8.13e-01
ANTIVIRAL INNATE IMMUNE RESPONSE 48 4.16e-03 -2.39e-01 1.52e-01
RIG I SIGNALING PATHWAY 28 2.86e-02 -2.39e-01 3.73e-01
SHORT CHAIN FATTY ACID METABOLIC PROCESS 16 9.82e-02 -2.39e-01 5.99e-01
GLUCOSE 6 PHOSPHATE METABOLIC PROCESS 29 2.60e-02 -2.39e-01 3.65e-01
REGULATION OF ACROSOME REACTION 17 8.88e-02 2.38e-01 5.82e-01
OXALOACETATE METABOLIC PROCESS 9 2.16e-01 -2.38e-01 7.33e-01
NEGATIVE REGULATION OF FILOPODIUM ASSEMBLY 5 3.56e-01 -2.38e-01 8.44e-01
INTERLEUKIN 27 MEDIATED SIGNALING PATHWAY 7 2.75e-01 -2.38e-01 7.82e-01
POSITIVE REGULATION OF PHOSPHATASE ACTIVITY 28 2.93e-02 2.38e-01 3.78e-01
NEGATIVE REGULATION OF VITAMIN METABOLIC PROCESS 7 2.76e-01 2.38e-01 7.83e-01
RIBOFLAVIN TRANSPORT 6 3.13e-01 2.38e-01 8.15e-01
GLYCINE METABOLIC PROCESS 16 9.98e-02 2.38e-01 6.02e-01
PLATELET ACTIVATING FACTOR METABOLIC PROCESS 8 2.44e-01 -2.38e-01 7.63e-01
VACUOLE FUSION 12 1.54e-01 -2.38e-01 6.79e-01
VESICLE FUSION WITH GOLGI APPARATUS 9 2.17e-01 2.38e-01 7.36e-01
REGULATION OF B CELL APOPTOTIC PROCESS 21 5.96e-02 -2.37e-01 5.02e-01
NEURON PROJECTION REGENERATION 57 1.93e-03 -2.37e-01 9.93e-02
DERMATAN SULFATE BIOSYNTHETIC PROCESS 5 3.58e-01 -2.37e-01 8.45e-01
POSITIVE REGULATION OF CELL PROLIFERATION IN BONE MARROW 6 3.14e-01 2.37e-01 8.16e-01
ARTICULAR CARTILAGE DEVELOPMENT 6 3.14e-01 -2.37e-01 8.17e-01
MORPHOGENESIS OF AN EPITHELIAL FOLD 24 4.43e-02 2.37e-01 4.42e-01
DIACYLGLYCEROL METABOLIC PROCESS 27 3.30e-02 -2.37e-01 3.98e-01
CELLULAR RESPONSE TO TEMPERATURE STIMULUS 5 3.59e-01 -2.37e-01 8.46e-01
CARBON CATABOLITE REGULATION OF TRANSCRIPTION 8 2.46e-01 -2.37e-01 7.64e-01
NEGATIVE REGULATION OF CELL ADHESION MOLECULE PRODUCTION 13 1.39e-01 -2.37e-01 6.65e-01
RESPONSE TO PLATELET DERIVED GROWTH FACTOR 23 4.93e-02 -2.37e-01 4.63e-01
RETROGRADE VESICLE MEDIATED TRANSPORT GOLGI TO ENDOPLASMIC RETICULUM 52 3.16e-03 -2.37e-01 1.30e-01
REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY 106 2.56e-05 -2.37e-01 4.64e-03
OXYGEN METABOLIC PROCESS 6 3.16e-01 -2.37e-01 8.19e-01
POSITIVE REGULATION OF TRIGLYCERIDE CATABOLIC PROCESS 8 2.47e-01 -2.36e-01 7.64e-01
REGULATION OF TRANSCRIPTION OF NUCLEOLAR LARGE RRNA BY RNA POLYMERASE I 15 1.13e-01 -2.36e-01 6.25e-01
POSITIVE REGULATION OF PROTEIN TARGETING TO MEMBRANE 27 3.37e-02 -2.36e-01 4.03e-01
REGULATION OF PLATELET DERIVED GROWTH FACTOR RECEPTOR BETA SIGNALING PATHWAY 8 2.48e-01 -2.36e-01 7.64e-01
PLASMA MEMBRANE TUBULATION 19 7.50e-02 -2.36e-01 5.51e-01
CDP DIACYLGLYCEROL BIOSYNTHETIC PROCESS 12 1.57e-01 -2.36e-01 6.79e-01
MICROTUBULE ANCHORING 24 4.56e-02 -2.36e-01 4.48e-01
PLASMA MEMBRANE REPAIR 28 3.10e-02 -2.35e-01 3.85e-01
ESTABLISHMENT OF GOLGI LOCALIZATION 8 2.49e-01 -2.35e-01 7.65e-01
NUCLEOLAR CHROMATIN ORGANIZATION 11 1.77e-01 -2.35e-01 6.96e-01
POSITIVE REGULATION OF TRANSCRIPTION BY GLUCOSE 7 2.81e-01 -2.35e-01 7.89e-01
TRICUSPID VALVE MORPHOGENESIS 5 3.63e-01 -2.35e-01 8.47e-01
NEGATIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL DIFFERENTIATION 13 1.43e-01 -2.35e-01 6.69e-01
POSITIVE REGULATION OF HAIR FOLLICLE DEVELOPMENT 12 1.59e-01 -2.35e-01 6.80e-01
URATE TRANSPORT 11 1.78e-01 2.34e-01 6.98e-01
PEPTIDE MODIFICATION 6 3.20e-01 2.34e-01 8.22e-01
NOTCH RECEPTOR PROCESSING 9 2.24e-01 -2.34e-01 7.41e-01
REGULATION OF PROTEIN TARGETING TO MEMBRANE 33 2.02e-02 -2.34e-01 3.32e-01
INTRACELLULAR OXYGEN HOMEOSTASIS 8 2.53e-01 2.34e-01 7.68e-01
NEGATIVE REGULATION OF PHOTORECEPTOR CELL DIFFERENTIATION 6 3.22e-01 -2.33e-01 8.23e-01
CARDIOBLAST PROLIFERATION 11 1.80e-01 2.33e-01 7.01e-01
NEGATIVE REGULATION OF CALCIUM ION IMPORT ACROSS PLASMA MEMBRANE 8 2.53e-01 2.33e-01 7.68e-01
GLYCOLYTIC PROCESS THROUGH GLUCOSE 6 PHOSPHATE 20 7.08e-02 -2.33e-01 5.37e-01
POSITIVE REGULATION OF OXIDATIVE STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY 8 2.53e-01 2.33e-01 7.69e-01
ESTABLISHMENT OF BLOOD RETINAL BARRIER 5 3.68e-01 -2.33e-01 8.48e-01
RESPONSE TO REDOX STATE 14 1.32e-01 -2.33e-01 6.55e-01
MEDIUM CHAIN FATTY ACID CATABOLIC PROCESS 5 3.68e-01 -2.32e-01 8.48e-01
GLYCOLYTIC PROCESS THROUGH FRUCTOSE 6 PHOSPHATE 24 4.90e-02 -2.32e-01 4.61e-01
SHORT CHAIN FATTY ACID CATABOLIC PROCESS 7 2.88e-01 -2.32e-01 7.97e-01
MESANGIAL CELL DIFFERENTIATION 7 2.88e-01 -2.32e-01 7.97e-01
MESENCHYMAL STEM CELL PROLIFERATION 11 1.83e-01 2.32e-01 7.03e-01
ACTIVATION OF TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE ACTIVITY 6 3.25e-01 2.32e-01 8.25e-01
POSITIVE REGULATION OF CYTOPLASMIC MRNA PROCESSING BODY ASSEMBLY 6 3.25e-01 2.32e-01 8.25e-01
REGULATION OF CORE PROMOTER BINDING 5 3.69e-01 2.32e-01 8.48e-01
TRNA THREONYLCARBAMOYLADENOSINE MODIFICATION 5 3.69e-01 2.32e-01 8.48e-01
NEGATIVE REGULATION OF PROTEIN POLYUBIQUITINATION 8 2.56e-01 -2.32e-01 7.70e-01
POSITIVE REGULATION OF MONOCYTE CHEMOTAXIS 21 6.57e-02 2.32e-01 5.24e-01
PHOTOPERIODISM 28 3.38e-02 -2.32e-01 4.03e-01
NEGATIVE REGULATION OF FIBROBLAST MIGRATION 11 1.83e-01 -2.32e-01 7.04e-01
REGULATION OF POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR INTERNALIZATION 16 1.08e-01 -2.32e-01 6.15e-01
RENAL RESPONSE TO BLOOD FLOW INVOLVED IN CIRCULATORY RENIN ANGIOTENSIN REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE 6 3.26e-01 2.31e-01 8.27e-01
CALCIUM INDEPENDENT CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES 23 5.48e-02 -2.31e-01 4.84e-01
EOSINOPHIL ACTIVATION 8 2.58e-01 2.31e-01 7.71e-01
MONOCYTE ACTIVATION 12 1.66e-01 -2.31e-01 6.84e-01
ACTIVATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY 14 1.35e-01 -2.31e-01 6.59e-01
CRANIAL GANGLION DEVELOPMENT 5 3.71e-01 2.31e-01 8.48e-01
STRESS FIBER ASSEMBLY 111 2.65e-05 -2.31e-01 4.70e-03
NEGATIVE REGULATION OF CHEMOKINE MEDIATED SIGNALING PATHWAY 7 2.90e-01 2.31e-01 7.99e-01
REGULATION OF FEAR RESPONSE 10 2.06e-01 -2.31e-01 7.29e-01
VASCULAR ASSOCIATED SMOOTH MUSCLE CELL APOPTOTIC PROCESS 18 9.05e-02 -2.30e-01 5.85e-01
THYROID HORMONE MEDIATED SIGNALING PATHWAY 8 2.59e-01 -2.30e-01 7.72e-01
REGULATION OF TOLL LIKE RECEPTOR 9 SIGNALING PATHWAY 10 2.07e-01 -2.30e-01 7.29e-01
REGULATION OF FEMALE GONAD DEVELOPMENT 7 2.92e-01 -2.30e-01 7.99e-01
PYRIDINE NUCLEOTIDE BIOSYNTHETIC PROCESS 28 3.51e-02 -2.30e-01 4.03e-01
REGULATION OF ATRIAL CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION 8 2.60e-01 -2.30e-01 7.72e-01
BONE TRABECULA FORMATION 10 2.08e-01 -2.30e-01 7.29e-01
HYPOTONIC RESPONSE 13 1.52e-01 -2.30e-01 6.79e-01
REGULATION OF MICROTUBULE NUCLEATION 19 8.31e-02 -2.30e-01 5.70e-01
TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE PHOSPHATASE SIGNALING PATHWAY 6 3.30e-01 -2.30e-01 8.31e-01
OLIGOPEPTIDE TRANSMEMBRANE TRANSPORT 9 2.33e-01 -2.30e-01 7.50e-01
POSITIVE REGULATION OF ENAMEL MINERALIZATION 5 3.74e-01 -2.30e-01 8.50e-01
POSITIVE REGULATION OF PODOSOME ASSEMBLY 11 1.88e-01 -2.29e-01 7.09e-01
ATRIOVENTRICULAR CANAL DEVELOPMENT 13 1.53e-01 2.29e-01 6.79e-01
RESPONSE TO INTERLEUKIN 2 11 1.88e-01 -2.29e-01 7.10e-01
REGULATION OF CHLORIDE TRANSPORT 7 2.94e-01 2.29e-01 8.02e-01
ADHERENS JUNCTION ASSEMBLY 13 1.53e-01 -2.29e-01 6.79e-01
REGULATION OF AUTOPHAGY OF MITOCHONDRION 40 1.23e-02 -2.29e-01 2.58e-01
POSITIVE REGULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY 8 2.63e-01 -2.28e-01 7.74e-01
REGULATION OF CD4 POSITIVE CD25 POSITIVE ALPHA BETA REGULATORY T CELL DIFFERENTIATION 7 2.95e-01 2.28e-01 8.03e-01
TONIC SMOOTH MUSCLE CONTRACTION 11 1.90e-01 -2.28e-01 7.12e-01
INTERLEUKIN 21 PRODUCTION 7 2.96e-01 -2.28e-01 8.04e-01
REGULATION OF NUCLEOTIDE EXCISION REPAIR 28 3.67e-02 -2.28e-01 4.09e-01
NEUROTRANSMITTER RECEPTOR TRANSPORT ENDOSOME TO POSTSYNAPTIC MEMBRANE 11 1.90e-01 2.28e-01 7.13e-01
THALAMUS DEVELOPMENT 13 1.55e-01 2.28e-01 6.79e-01
VITAMIN TRANSMEMBRANE TRANSPORT 21 7.05e-02 -2.28e-01 5.37e-01
EMBRYONIC DIGESTIVE TRACT DEVELOPMENT 33 2.36e-02 2.28e-01 3.58e-01
FAT SOLUBLE VITAMIN BIOSYNTHETIC PROCESS 13 1.55e-01 2.28e-01 6.79e-01
LYMPHOCYTE CHEMOTAXIS 61 2.12e-03 2.27e-01 1.04e-01
REGULATION OF STORE OPERATED CALCIUM ENTRY 16 1.16e-01 -2.27e-01 6.30e-01
METANEPHRIC COLLECTING DUCT DEVELOPMENT 10 2.14e-01 -2.27e-01 7.33e-01
POSITIVE REGULATION OF URINE VOLUME 13 1.57e-01 -2.27e-01 6.79e-01
OTIC VESICLE MORPHOGENESIS 10 2.14e-01 2.27e-01 7.33e-01
REGULATION OF SYNAPSE PRUNING 6 3.36e-01 2.27e-01 8.31e-01
CELLULAR RESPONSE TO AMMONIUM ION 5 3.80e-01 2.27e-01 8.51e-01
POSITIVE REGULATION OF AUTOPHAGOSOME ASSEMBLY 19 8.72e-02 -2.27e-01 5.79e-01
SULFUR COMPOUND CATABOLIC PROCESS 37 1.71e-02 -2.27e-01 3.00e-01
UTERUS DEVELOPMENT 23 6.00e-02 2.27e-01 5.04e-01
PHAGOSOME ACIDIFICATION 7 3.00e-01 -2.26e-01 8.06e-01
GLUCOSE CATABOLIC PROCESS 27 4.18e-02 -2.26e-01 4.31e-01
POSITIVE REGULATION OF GRANULOCYTE DIFFERENTIATION 9 2.40e-01 2.26e-01 7.59e-01
POSITIVE REGULATION OF GROWTH HORMONE SECRETION 9 2.40e-01 2.26e-01 7.59e-01
ANTIMICROBIAL HUMORAL IMMUNE RESPONSE MEDIATED BY ANTIMICROBIAL PEPTIDE 81 4.29e-04 2.26e-01 3.76e-02
POSITIVE REGULATION OF GLYCOGEN METABOLIC PROCESS 17 1.06e-01 -2.26e-01 6.11e-01
REGULATION OF CELLULAR AMINO ACID METABOLIC PROCESS 13 1.58e-01 -2.26e-01 6.79e-01
BASIC AMINO ACID TRANSPORT 22 6.69e-02 -2.26e-01 5.28e-01
REGULATION OF MICROTUBULE BINDING 7 3.01e-01 -2.26e-01 8.07e-01
REGULATION OF TRANSLATIONAL FIDELITY 18 9.75e-02 -2.26e-01 5.97e-01
NECROPTOTIC SIGNALING PATHWAY 8 2.70e-01 -2.25e-01 7.79e-01
NEURON CELL CELL ADHESION 16 1.19e-01 2.25e-01 6.32e-01
NEGATIVE REGULATION OF INTERLEUKIN 1 MEDIATED SIGNALING PATHWAY 7 3.02e-01 -2.25e-01 8.07e-01
POSITIVE REGULATION OF PYROPTOSIS 5 3.83e-01 -2.25e-01 8.54e-01
CELL DIFFERENTIATION INVOLVED IN PHENOTYPIC SWITCHING 5 3.83e-01 -2.25e-01 8.54e-01
NEGATIVE REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS 44 9.82e-03 -2.25e-01 2.32e-01
HEPATOCYTE APOPTOTIC PROCESS 21 7.43e-02 -2.25e-01 5.49e-01
POSITIVE REGULATION OF LONG TERM SYNAPTIC DEPRESSION 7 3.03e-01 2.25e-01 8.08e-01
REGULATION OF SNRNA TRANSCRIPTION BY RNA POLYMERASE II 5 3.84e-01 2.25e-01 8.54e-01
POSITIVE REGULATION BY SYMBIONT OF ENTRY INTO HOST 14 1.46e-01 -2.24e-01 6.74e-01
ATRIAL CARDIAC MUSCLE TISSUE DEVELOPMENT 22 6.84e-02 2.24e-01 5.32e-01
MEGAKARYOCYTE DEVELOPMENT 23 6.26e-02 -2.24e-01 5.12e-01
POSITIVE REGULATION OF NON CANONICAL NF KAPPAB SIGNAL TRANSDUCTION 68 1.38e-03 -2.24e-01 7.98e-02
NEGATIVE REGULATION OF INTERFERON BETA PRODUCTION 15 1.33e-01 -2.24e-01 6.56e-01
REGULATION OF MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION INVOLVED IN APOPTOTIC SIGNALING PATHWAY 25 5.24e-02 -2.24e-01 4.75e-01
REGULATION OF ER ASSOCIATED UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS 9 2.45e-01 2.24e-01 7.63e-01
POSITIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION 52 5.22e-03 -2.24e-01 1.68e-01
NEGATIVE REGULATION OF AMINE METABOLIC PROCESS 6 3.42e-01 -2.24e-01 8.36e-01
CEREBELLAR GRANULAR LAYER MORPHOGENESIS 9 2.45e-01 2.24e-01 7.63e-01
REGULATION OF GLYCOGEN STARCH SYNTHASE ACTIVITY 6 3.43e-01 2.24e-01 8.36e-01
MACROMOLECULE DEPALMITOYLATION 11 1.99e-01 -2.24e-01 7.25e-01
POSITIVE REGULATION OF STORE OPERATED CALCIUM CHANNEL ACTIVITY 5 3.87e-01 -2.24e-01 8.55e-01
NEGATIVE REGULATION OF CHEMOKINE C X C MOTIF LIGAND 2 PRODUCTION 6 3.43e-01 -2.24e-01 8.36e-01
POSITIVE REGULATION OF BONE RESORPTION 18 1.01e-01 -2.23e-01 6.04e-01
POSITIVE REGULATION OF KIDNEY DEVELOPMENT 10 2.22e-01 2.23e-01 7.40e-01
PEPTIDYL PROLINE HYDROXYLATION TO 4 HYDROXY L PROLINE 8 2.74e-01 -2.23e-01 7.81e-01
MAMMARY GLAND INVOLUTION 8 2.75e-01 -2.23e-01 7.81e-01
POSITIVE REGULATION OF CARDIAC EPITHELIAL TO MESENCHYMAL TRANSITION 9 2.47e-01 -2.23e-01 7.64e-01
CERAMIDE 1 PHOSPHATE TRANSPORT 7 3.07e-01 2.23e-01 8.11e-01
NEURONAL DENSE CORE VESICLE EXOCYTOSIS 7 3.08e-01 2.23e-01 8.11e-01
REGULATION OF PLASMINOGEN ACTIVATION 18 1.02e-01 -2.23e-01 6.05e-01
GAMMA AMINOBUTYRIC ACID SIGNALING PATHWAY 29 3.80e-02 2.23e-01 4.14e-01
POSITIVE REGULATION OF FEAR RESPONSE 7 3.08e-01 -2.22e-01 8.11e-01
GLYCOSYLCERAMIDE BIOSYNTHETIC PROCESS 8 2.76e-01 -2.22e-01 7.83e-01
POSITIVE REGULATION OF LIPID CATABOLIC PROCESS 27 4.56e-02 -2.22e-01 4.48e-01
3 UTR MEDIATED MRNA STABILIZATION 21 7.80e-02 -2.22e-01 5.57e-01
PROTEIN MATURATION BY 4FE 4S CLUSTER TRANSFER 7 3.09e-01 2.22e-01 8.12e-01
CHORIO ALLANTOIC FUSION 7 3.09e-01 2.22e-01 8.12e-01
PROTEIN LIPID COMPLEX ORGANIZATION 54 4.81e-03 -2.22e-01 1.63e-01
BEHAVIORAL RESPONSE TO PAIN 19 9.42e-02 -2.22e-01 5.92e-01
SIALYLATION 8 2.78e-01 -2.22e-01 7.85e-01
ATF6 MEDIATED UNFOLDED PROTEIN RESPONSE 9 2.50e-01 -2.22e-01 7.65e-01
HEPARIN METABOLIC PROCESS 17 1.14e-01 -2.22e-01 6.25e-01
DEVELOPMENT OF SECONDARY SEXUAL CHARACTERISTICS 9 2.50e-01 -2.21e-01 7.67e-01
UMP CATABOLIC PROCESS 5 3.92e-01 2.21e-01 8.57e-01
LIPOXYGENASE PATHWAY 11 2.04e-01 -2.21e-01 7.29e-01
TRNA TRANSPORT 6 3.49e-01 2.21e-01 8.40e-01
POSITIVE REGULATION OF LYMPHOCYTE CHEMOTAXIS 19 9.56e-02 2.21e-01 5.96e-01
HETEROPHILIC CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES 53 5.48e-03 2.21e-01 1.73e-01
NEGATIVE REGULATION OF ASTROCYTE DIFFERENTIATION 16 1.27e-01 -2.20e-01 6.48e-01
HYALURONAN BIOSYNTHETIC PROCESS 14 1.54e-01 -2.20e-01 6.79e-01
PLASMA LIPOPROTEIN PARTICLE CLEARANCE 55 4.73e-03 -2.20e-01 1.62e-01
REGULATION OF MONOCYTE DIFFERENTIATION 20 8.83e-02 -2.20e-01 5.81e-01
METANEPHRIC PART OF URETERIC BUD DEVELOPMENT 6 3.50e-01 2.20e-01 8.41e-01
REGULATION OF CHOLESTEROL BIOSYNTHETIC PROCESS 26 5.21e-02 -2.20e-01 4.74e-01
REGULATION OF TRANSLATIONAL ELONGATION 12 1.87e-01 2.20e-01 7.08e-01
REGULATION OF BRANCHING MORPHOGENESIS OF A NERVE 6 3.51e-01 -2.20e-01 8.41e-01
AMINOACYL TRNA METABOLISM INVOLVED IN TRANSLATIONAL FIDELITY 13 1.70e-01 -2.20e-01 6.87e-01
NERVOUS SYSTEM PROCESS INVOLVED IN REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE 14 1.55e-01 2.20e-01 6.79e-01
CILIARY NEUROTROPHIC FACTOR MEDIATED SIGNALING PATHWAY 5 3.95e-01 -2.20e-01 8.59e-01
NEGATIVE REGULATION OF SOMATIC STEM CELL POPULATION MAINTENANCE 5 3.95e-01 -2.19e-01 8.59e-01
POSITIVE REGULATION OF TRANSFORMING GROWTH FACTOR BETA PRODUCTION 23 6.85e-02 -2.19e-01 5.32e-01
NEGATIVE REGULATION OF MEIOTIC NUCLEAR DIVISION 9 2.54e-01 2.19e-01 7.69e-01
NEGATIVE REGULATION OF CENTROSOME DUPLICATION 12 1.88e-01 -2.19e-01 7.10e-01
SENSORY PERCEPTION 876 2.39e-28 2.19e-01 3.65e-25
HOST MEDIATED REGULATION OF INTESTINAL MICROBIOTA COMPOSITION 8 2.83e-01 -2.19e-01 7.90e-01
PSEUDOURIDINE SYNTHESIS 18 1.07e-01 2.19e-01 6.11e-01
REGULATION OF CHONDROCYTE DEVELOPMENT 6 3.53e-01 -2.19e-01 8.42e-01
DEFENSE RESPONSE TO GRAM NEGATIVE BACTERIUM 85 4.78e-04 2.19e-01 3.91e-02
GLYCOPROTEIN CATABOLIC PROCESS 35 2.49e-02 -2.19e-01 3.65e-01
POSITIVE REGULATION OF T CELL TOLERANCE INDUCTION 9 2.55e-01 2.19e-01 7.70e-01
NEGATIVE REGULATION OF RETINOIC ACID RECEPTOR SIGNALING PATHWAY 9 2.56e-01 2.19e-01 7.70e-01
TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY 56 4.62e-03 -2.19e-01 1.62e-01
NEGATIVE REGULATION OF B CELL DIFFERENTIATION 6 3.54e-01 -2.19e-01 8.43e-01
CLEARANCE OF FOREIGN INTRACELLULAR NUCLEIC ACIDS 6 3.54e-01 -2.18e-01 8.43e-01
HINDGUT DEVELOPMENT 8 2.85e-01 2.18e-01 7.93e-01
PEROXISOME FISSION 9 2.57e-01 -2.18e-01 7.71e-01
REGULATION OF XENOPHAGY 9 2.57e-01 -2.18e-01 7.71e-01
PHOSPHATIDYLCHOLINE ACYL CHAIN REMODELING 14 1.58e-01 -2.18e-01 6.79e-01
REGULATION OF ARTERY MORPHOGENESIS 11 2.11e-01 -2.18e-01 7.32e-01
AMINOGLYCOSIDE ANTIBIOTIC METABOLIC PROCESS 10 2.33e-01 2.18e-01 7.50e-01
NEGATIVE REGULATION OF SYNAPSE ORGANIZATION 11 2.11e-01 2.18e-01 7.32e-01
NEGATIVE REGULATION OF T CELL CYTOKINE PRODUCTION 11 2.11e-01 2.18e-01 7.32e-01
NEGATIVE REGULATION OF TRANSMISSION OF NERVE IMPULSE 6 3.56e-01 -2.18e-01 8.44e-01
REGULATION OF EXECUTION PHASE OF APOPTOSIS 17 1.20e-01 -2.18e-01 6.34e-01
NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN CONTAINING 2 SIGNALING PATHWAY 19 1.01e-01 -2.17e-01 6.03e-01
POSITIVE REGULATION OF DNA DEMETHYLATION 9 2.59e-01 2.17e-01 7.72e-01
ENDONUCLEOLYTIC CLEAVAGE IN 5 ETS OF TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA 8 2.87e-01 -2.17e-01 7.96e-01
REGULATION OF HISTONE H3 K4 METHYLATION 13 1.75e-01 -2.17e-01 6.92e-01
KINETOCHORE ORGANIZATION 20 9.26e-02 2.17e-01 5.89e-01
POSITIVE REGULATION OF GLUCOSE METABOLIC PROCESS 45 1.17e-02 -2.17e-01 2.51e-01
NEGATIVE REGULATION OF MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION INVOLVED IN APOPTOTIC SIGNALING PATHWAY 13 1.75e-01 -2.17e-01 6.93e-01
REGULATION OF MUCUS SECRETION 8 2.88e-01 -2.17e-01 7.97e-01
SATELLITE CELL ACTIVATION INVOLVED IN SKELETAL MUSCLE REGENERATION 5 4.01e-01 -2.17e-01 8.63e-01
REGULATION OF GLYCOLYTIC PROCESS 52 6.85e-03 -2.17e-01 1.95e-01
C X C CHEMOKINE RECEPTOR CXCR4 SIGNALING PATHWAY 5 4.02e-01 2.17e-01 8.63e-01
LOOP OF HENLE DEVELOPMENT 12 1.94e-01 -2.16e-01 7.18e-01
NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO OSMOTIC STRESS 5 4.02e-01 -2.16e-01 8.63e-01
NEUROTRANSMITTER LOADING INTO SYNAPTIC VESICLE 7 3.22e-01 2.16e-01 8.23e-01
SNRNA TRANSCRIPTION BY RNA POLYMERASE III 8 2.90e-01 -2.16e-01 7.99e-01
PURINE NUCLEOSIDE TRANSMEMBRANE TRANSPORT 5 4.03e-01 2.16e-01 8.63e-01
RESPONSE TO VITAMIN E 8 2.90e-01 -2.16e-01 7.99e-01
REGULATION OF INTESTINAL LIPID ABSORPTION 10 2.37e-01 -2.16e-01 7.56e-01
HYPERSENSITIVITY 12 1.95e-01 2.16e-01 7.19e-01
OXYGEN TRANSPORT 15 1.48e-01 2.16e-01 6.75e-01
MEMBRANE DEPOLARIZATION DURING SA NODE CELL ACTION POTENTIAL 5 4.04e-01 2.16e-01 8.63e-01
REGULATION OF CYTOPLASMIC MRNA PROCESSING BODY ASSEMBLY 8 2.91e-01 2.16e-01 7.99e-01
DE NOVO NAD BIOSYNTHETIC PROCESS 8 2.91e-01 -2.16e-01 7.99e-01
AZOLE TRANSMEMBRANE TRANSPORT 14 1.63e-01 -2.15e-01 6.81e-01
NLS BEARING PROTEIN IMPORT INTO NUCLEUS 19 1.04e-01 2.15e-01 6.08e-01
FATTY ACID BETA OXIDATION USING ACYL COA OXIDASE 12 1.97e-01 -2.15e-01 7.21e-01
MUCUS SECRETION 18 1.14e-01 -2.15e-01 6.25e-01
POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO TELOMERE 10 2.39e-01 2.15e-01 7.57e-01
HISTIDINE CATABOLIC PROCESS 8 2.92e-01 -2.15e-01 8.00e-01
T CELL TOLERANCE INDUCTION 15 1.49e-01 2.15e-01 6.77e-01
PHOSPHOLIPASE C ACTIVATING DOPAMINE RECEPTOR SIGNALING PATHWAY 9 2.64e-01 -2.15e-01 7.74e-01
CHONDROBLAST DIFFERENTIATION 5 4.05e-01 -2.15e-01 8.63e-01
PROTEIN LOCALIZATION TO ADHERENS JUNCTION 6 3.62e-01 -2.15e-01 8.46e-01
ESTABLISHMENT OF BLOOD BRAIN BARRIER 16 1.37e-01 -2.15e-01 6.61e-01
CELL PROLIFERATION IN HINDBRAIN 16 1.37e-01 2.15e-01 6.61e-01
POSITIVE REGULATION OF PHOSPHOLIPID BIOSYNTHETIC PROCESS 10 2.40e-01 -2.15e-01 7.59e-01
SPHINGOLIPID TRANSLOCATION 5 4.07e-01 -2.14e-01 8.63e-01
NEGATIVE REGULATION OF LONG TERM SYNAPTIC POTENTIATION 13 1.81e-01 -2.14e-01 7.01e-01
ACETYL COA BIOSYNTHETIC PROCESS FROM PYRUVATE 11 2.19e-01 2.14e-01 7.37e-01
GROWTH HORMONE SECRETION 14 1.66e-01 2.14e-01 6.84e-01
ACTIN FILAMENT DEPOLYMERIZATION 58 4.85e-03 -2.14e-01 1.63e-01
REGULATION OF MITOCHONDRIAL ELECTRON TRANSPORT NADH TO UBIQUINONE 6 3.64e-01 2.14e-01 8.48e-01
RNA DECAPPING 19 1.07e-01 2.14e-01 6.11e-01
GLIAL CELL APOPTOTIC PROCESS 15 1.52e-01 -2.14e-01 6.79e-01
RESPONSE TO STEROL DEPLETION 18 1.17e-01 -2.13e-01 6.30e-01
THYMOCYTE MIGRATION 7 3.29e-01 -2.13e-01 8.30e-01
MAINTENANCE OF PROTEIN LOCALIZATION IN ORGANELLE 41 1.82e-02 -2.13e-01 3.11e-01
SEROTONIN RECEPTOR SIGNALING PATHWAY 28 5.10e-02 2.13e-01 4.69e-01
NEGATIVE REGULATION OF ERYTHROCYTE DIFFERENTIATION 8 2.97e-01 -2.13e-01 8.04e-01
NEGATIVE REGULATION OF CALCIUM ION IMPORT 10 2.44e-01 2.13e-01 7.63e-01
GONADOTROPIN SECRETION 17 1.29e-01 2.13e-01 6.48e-01
ASTROCYTE ACTIVATION 25 6.56e-02 -2.13e-01 5.24e-01
NEURAL CREST CELL FATE COMMITMENT 6 3.67e-01 -2.12e-01 8.48e-01
REGULATION OF NADP METABOLIC PROCESS 9 2.70e-01 -2.12e-01 7.79e-01
REGULATION OF DENDRITIC CELL DIFFERENTIATION 14 1.69e-01 -2.12e-01 6.87e-01
REGULATION OF NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN CONTAINING SIGNALING PATHWAY 15 1.55e-01 -2.12e-01 6.79e-01
RESPONSE TO INTERLEUKIN 15 12 2.04e-01 -2.12e-01 7.29e-01
MICROGLIAL CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE 5 4.12e-01 -2.12e-01 8.65e-01
MESENCHYMAL CELL APOPTOTIC PROCESS 16 1.42e-01 2.12e-01 6.69e-01
SKIN MORPHOGENESIS 13 1.87e-01 -2.11e-01 7.08e-01
PROLINE METABOLIC PROCESS 10 2.48e-01 -2.11e-01 7.64e-01
REGULATION OF CENTROMERE COMPLEX ASSEMBLY 6 3.71e-01 -2.11e-01 8.48e-01
GENERAL ADAPTATION SYNDROME 6 3.71e-01 2.11e-01 8.48e-01
PERISTALSIS 12 2.06e-01 2.11e-01 7.29e-01
REGULATION OF NEUTROPHIL DEGRANULATION 8 3.02e-01 -2.11e-01 8.07e-01
POSITIVE REGULATION OF ATTACHMENT OF SPINDLE MICROTUBULES TO KINETOCHORE 11 2.27e-01 -2.10e-01 7.44e-01
SODIUM INDEPENDENT ORGANIC ANION TRANSPORT 15 1.59e-01 2.10e-01 6.79e-01
REGULATION OF CARDIAC MUSCLE CELL MEMBRANE POTENTIAL 7 3.36e-01 -2.10e-01 8.31e-01
CELLULAR RESPONSE TO ELECTRICAL STIMULUS 13 1.90e-01 -2.10e-01 7.12e-01
REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY 19 1.13e-01 -2.10e-01 6.25e-01
NEURAL PLATE ANTERIOR POSTERIOR REGIONALIZATION 5 4.16e-01 -2.10e-01 8.67e-01
RESPONSE TO COBALT ION 10 2.51e-01 -2.10e-01 7.67e-01
AIM2 INFLAMMASOME COMPLEX ASSEMBLY 5 4.17e-01 2.10e-01 8.68e-01
CELLULAR RESPONSE TO ESTROGEN STIMULUS 19 1.14e-01 -2.10e-01 6.25e-01
REGULATION OF LIPID KINASE ACTIVITY 38 2.55e-02 -2.09e-01 3.65e-01
CYSTEINE METABOLIC PROCESS 11 2.29e-01 -2.09e-01 7.46e-01
PYRIMIDINE NUCLEOBASE CATABOLIC PROCESS 8 3.05e-01 2.09e-01 8.10e-01
REGULATION OF RENAL SODIUM EXCRETION 8 3.05e-01 2.09e-01 8.10e-01
REGULATION OF CARBOHYDRATE CATABOLIC PROCESS 63 4.06e-03 -2.09e-01 1.50e-01
MEMBRANE TO MEMBRANE DOCKING 5 4.18e-01 2.09e-01 8.68e-01
NEURON NEURON SYNAPTIC TRANSMISSION 6 3.75e-01 -2.09e-01 8.50e-01
REGULATION OF DOPAMINERGIC NEURON DIFFERENTIATION 12 2.10e-01 -2.09e-01 7.30e-01
HYDROGEN PEROXIDE BIOSYNTHETIC PROCESS 16 1.48e-01 2.09e-01 6.75e-01
REGULATION OF COA TRANSFERASE ACTIVITY 10 2.53e-01 -2.09e-01 7.68e-01
INTERNEURON MIGRATION 15 1.62e-01 2.09e-01 6.81e-01
NEGATIVE REGULATION OF MONONUCLEAR CELL MIGRATION 24 7.68e-02 2.09e-01 5.53e-01
REGULATION OF VITAMIN METABOLIC PROCESS 12 2.12e-01 2.08e-01 7.32e-01
NEGATIVE REGULATION OF MACROAUTOPHAGY 32 4.14e-02 -2.08e-01 4.30e-01
OTIC VESICLE FORMATION 8 3.08e-01 2.08e-01 8.11e-01
REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY 44 1.69e-02 -2.08e-01 3.00e-01
NUCLEOSIDE MONOPHOSPHATE PHOSPHORYLATION 11 2.32e-01 -2.08e-01 7.49e-01
POSITIVE REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR 29 5.26e-02 2.08e-01 4.75e-01
POSITIVE REGULATION OF SISTER CHROMATID COHESION 9 2.80e-01 2.08e-01 7.87e-01
NEGATIVE REGULATION OF LIPID LOCALIZATION 66 3.52e-03 -2.08e-01 1.35e-01
FOLATE TRANSMEMBRANE TRANSPORT 5 4.22e-01 -2.07e-01 8.72e-01
AMELOGENESIS 25 7.25e-02 -2.07e-01 5.43e-01
REGULATION OF PRE MIRNA PROCESSING 6 3.79e-01 2.07e-01 8.51e-01
BARBED END ACTIN FILAMENT CAPPING 25 7.27e-02 -2.07e-01 5.43e-01
PLATELET MORPHOGENESIS 24 7.87e-02 -2.07e-01 5.58e-01
REGULATION OF CELL FATE SPECIFICATION 26 6.75e-02 -2.07e-01 5.30e-01
RELAXATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE 6 3.80e-01 2.07e-01 8.51e-01
METHYLGUANOSINE CAP DECAPPING 16 1.52e-01 2.07e-01 6.79e-01
REGULATION OF MESODERM DEVELOPMENT 7 3.43e-01 2.07e-01 8.36e-01
NEGATIVE REGULATION OF INCLUSION BODY ASSEMBLY 12 2.15e-01 -2.07e-01 7.33e-01
DERMATAN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS 8 3.11e-01 -2.07e-01 8.13e-01
NEUTROPHIL EXTRAVASATION 13 1.97e-01 2.07e-01 7.21e-01
POSITIVE REGULATION OF EXTRACELLULAR MATRIX DISASSEMBLY 8 3.11e-01 -2.07e-01 8.13e-01
MACROPHAGE ACTIVATION INVOLVED IN IMMUNE RESPONSE 19 1.19e-01 -2.07e-01 6.32e-01
NEGATIVE REGULATION OF CELLULAR RESPIRATION 10 2.58e-01 -2.07e-01 7.71e-01
ACUTE INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS 24 8.02e-02 2.06e-01 5.60e-01
MONOACYLGLYCEROL BIOSYNTHETIC PROCESS 7 3.45e-01 -2.06e-01 8.37e-01
REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO HYPOXIA 10 2.59e-01 2.06e-01 7.72e-01
REGULATION OF SKELETAL MUSCLE CONTRACTION 16 1.53e-01 -2.06e-01 6.79e-01
MACROPINOCYTOSIS 10 2.59e-01 -2.06e-01 7.72e-01
ENTRAINMENT OF CIRCADIAN CLOCK 30 5.07e-02 -2.06e-01 4.69e-01
NEGATIVE REGULATION OF APOPTOTIC PROCESS INVOLVED IN DEVELOPMENT 6 3.83e-01 2.06e-01 8.54e-01
RETINAL METABOLIC PROCESS 18 1.31e-01 -2.06e-01 6.53e-01
SERINE TRANSPORT 10 2.60e-01 2.06e-01 7.72e-01
MEIOTIC SPINDLE ORGANIZATION 19 1.21e-01 2.06e-01 6.35e-01
POSITIVE REGULATION OF LEUKOCYTE DEGRANULATION 23 8.79e-02 -2.06e-01 5.80e-01
CELLULAR RESPONSE TO GROWTH HORMONE STIMULUS 25 7.52e-02 -2.06e-01 5.51e-01
NEGATIVE REGULATION OF TUBULIN DEACETYLATION 6 3.83e-01 2.05e-01 8.54e-01
CELL MIGRATION INVOLVED IN METANEPHROS DEVELOPMENT 5 4.26e-01 -2.05e-01 8.73e-01
EPITHELIAL CELL CELL ADHESION 15 1.68e-01 -2.05e-01 6.87e-01
NEGATIVE REGULATION OF INFLAMMASOME MEDIATED SIGNALING PATHWAY 15 1.69e-01 -2.05e-01 6.87e-01
NEURAL PLATE REGIONALIZATION 6 3.84e-01 -2.05e-01 8.54e-01
MAMMARY GLAND EPITHELIAL CELL PROLIFERATION 26 7.02e-02 -2.05e-01 5.36e-01
POSITIVE REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS 33 4.14e-02 -2.05e-01 4.30e-01
IMP SALVAGE 5 4.27e-01 2.05e-01 8.74e-01
NEGATIVE REGULATION OF HOMOTYPIC CELL CELL ADHESION 12 2.19e-01 -2.05e-01 7.37e-01
MRNA 3 END PROCESSING BY STEM LOOP BINDING AND CLEAVAGE 6 3.85e-01 2.05e-01 8.55e-01
SULFUR AMINO ACID CATABOLIC PROCESS 10 2.62e-01 -2.05e-01 7.73e-01
ADENYLATE CYCLASE INHIBITING G PROTEIN COUPLED ACETYLCHOLINE RECEPTOR SIGNALING PATHWAY 8 3.16e-01 2.05e-01 8.19e-01
SA NODE CELL TO ATRIAL CARDIAC MUSCLE CELL SIGNALING 9 2.88e-01 2.05e-01 7.97e-01
REGULATION OF CILIUM BEAT FREQUENCY INVOLVED IN CILIARY MOTILITY 9 2.88e-01 -2.05e-01 7.97e-01
NAD METABOLIC PROCESS 42 2.17e-02 -2.05e-01 3.44e-01
POSITIVE REGULATION OF ENDOTHELIAL CELL MATRIX ADHESION VIA FIBRONECTIN 5 4.28e-01 -2.05e-01 8.74e-01
RESPONSE TO CHEMOKINE 97 4.97e-04 2.05e-01 3.91e-02
POSITIVE REGULATION OF HYDROGEN PEROXIDE METABOLIC PROCESS 6 3.86e-01 2.05e-01 8.55e-01
REGULATION OF SYNAPSE STRUCTURAL PLASTICITY 8 3.17e-01 2.04e-01 8.20e-01
RETROTRANSPOSON SILENCING BY HETEROCHROMATIN FORMATION 15 1.70e-01 2.04e-01 6.87e-01
PROTEIN TRANSPORT TO VACUOLE INVOLVED IN UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS VIA THE MULTIVESICULAR BODY SORTING PATHWAY 15 1.70e-01 -2.04e-01 6.87e-01
MACROPHAGE FUSION 6 3.86e-01 -2.04e-01 8.55e-01
CALCITONIN FAMILY RECEPTOR SIGNALING PATHWAY 8 3.17e-01 2.04e-01 8.20e-01
PERICYTE CELL DIFFERENTIATION 11 2.41e-01 -2.04e-01 7.59e-01
ISOLEUCINE TRANSPORT 5 4.29e-01 -2.04e-01 8.74e-01
REGULATION OF BRANCHING INVOLVED IN PROSTATE GLAND MORPHOGENESIS 5 4.29e-01 2.04e-01 8.74e-01
SHORT TERM MEMORY 11 2.42e-01 2.04e-01 7.61e-01
GLYCOLYTIC PROCESS 89 8.87e-04 -2.04e-01 5.83e-02
REGULATION OF BASEMENT MEMBRANE ORGANIZATION 11 2.42e-01 -2.04e-01 7.62e-01
MITOCHONDRIAL ELECTRON TRANSPORT SUCCINATE TO UBIQUINONE 5 4.31e-01 -2.04e-01 8.74e-01
EPIDERMAL CELL FATE SPECIFICATION 5 4.31e-01 -2.03e-01 8.74e-01
ENAMEL MINERALIZATION 20 1.15e-01 -2.03e-01 6.29e-01
REGULATION OF LIPID TRANSPORTER ACTIVITY 6 3.88e-01 2.03e-01 8.56e-01
POLYPRENOL METABOLIC PROCESS 24 8.46e-02 2.03e-01 5.72e-01
VITAMIN D3 METABOLIC PROCESS 6 3.88e-01 2.03e-01 8.56e-01
REGULATION OF T HELPER 17 CELL LINEAGE COMMITMENT 7 3.52e-01 2.03e-01 8.41e-01
CONNECTIVE TISSUE REPLACEMENT 21 1.07e-01 2.03e-01 6.11e-01
G PROTEIN COUPLED GLUTAMATE RECEPTOR SIGNALING PATHWAY 14 1.89e-01 2.03e-01 7.11e-01
REGULATION OF PHOSPHATIDYLINOSITOL BIOSYNTHETIC PROCESS 5 4.32e-01 -2.03e-01 8.74e-01
PIGMENT CATABOLIC PROCESS 11 2.44e-01 -2.03e-01 7.63e-01
REGULATION OF ACTOMYOSIN STRUCTURE ORGANIZATION 104 3.57e-04 -2.03e-01 3.24e-02
REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CONTRACTION 10 2.67e-01 -2.03e-01 7.77e-01
INTRACELLULAR MONOATOMIC ANION HOMEOSTASIS 10 2.68e-01 2.02e-01 7.77e-01
ISOTYPE SWITCHING TO IGG ISOTYPES 16 1.61e-01 2.02e-01 6.81e-01
REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY CIRCULATORY RENIN ANGIOTENSIN 17 1.49e-01 2.02e-01 6.76e-01
POSITIVE REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION 36 3.60e-02 -2.02e-01 4.04e-01
RESPONSE TO PEPTIDOGLYCAN 13 2.07e-01 -2.02e-01 7.29e-01
L ALANINE TRANSMEMBRANE TRANSPORT 5 4.35e-01 2.02e-01 8.74e-01
REGULATION OF PROTEIN COMPLEX STABILITY 14 1.91e-01 -2.02e-01 7.14e-01
POSITIVE REGULATION OF MESENCHYMAL STEM CELL PROLIFERATION 7 3.56e-01 2.01e-01 8.44e-01
REGULATION OF NEUTROPHIL MEDIATED CYTOTOXICITY 5 4.36e-01 2.01e-01 8.74e-01
SINOATRIAL NODE DEVELOPMENT 12 2.27e-01 2.01e-01 7.44e-01
REGULATION OF CELL COMMUNICATION BY ELECTRICAL COUPLING 16 1.64e-01 2.01e-01 6.82e-01
POSITIVE REGULATION OF RYANODINE SENSITIVE CALCIUM RELEASE CHANNEL ACTIVITY 8 3.25e-01 2.01e-01 8.25e-01
CARDIAC MUSCLE MYOBLAST PROLIFERATION 7 3.58e-01 2.01e-01 8.45e-01
ERBB SIGNALING PATHWAY 124 1.12e-04 -2.01e-01 1.48e-02
L ALANINE TRANSPORT 11 2.49e-01 2.01e-01 7.65e-01
KERATINIZATION 78 2.17e-03 2.01e-01 1.06e-01
ACTIN MYOSIN FILAMENT SLIDING 16 1.65e-01 -2.00e-01 6.84e-01
REGULATION OF PROTEIN LOCALIZATION TO CENTROSOME 12 2.30e-01 -2.00e-01 7.46e-01
MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION 36 3.76e-02 -2.00e-01 4.12e-01
NEGATIVE REGULATION OF CATECHOLAMINE SECRETION 13 2.12e-01 2.00e-01 7.32e-01
MAINTENANCE OF GASTROINTESTINAL EPITHELIUM 24 8.99e-02 -2.00e-01 5.85e-01
POSITIVE REGULATION OF HISTONE METHYLATION 16 1.66e-01 -2.00e-01 6.85e-01
CEREBELLAR GRANULAR LAYER DEVELOPMENT 13 2.12e-01 2.00e-01 7.32e-01
PYRIDINE CONTAINING COMPOUND METABOLIC PROCESS 86 1.37e-03 -2.00e-01 7.95e-02
ARF PROTEIN SIGNAL TRANSDUCTION 22 1.05e-01 -1.99e-01 6.09e-01
RETINA VASCULATURE DEVELOPMENT IN CAMERA TYPE EYE 19 1.32e-01 -1.99e-01 6.56e-01
CARDIOLIPIN METABOLIC PROCESS 15 1.81e-01 -1.99e-01 7.01e-01
PHOSPHOLIPID CATABOLIC PROCESS 55 1.05e-02 -1.99e-01 2.42e-01
REGULATION OF LAMELLIPODIUM MORPHOGENESIS 11 2.53e-01 -1.99e-01 7.68e-01
POSITIVE REGULATION OF MAST CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE 14 1.97e-01 -1.99e-01 7.21e-01
SUBSTRATE INDEPENDENT TELENCEPHALIC TANGENTIAL MIGRATION 11 2.53e-01 1.99e-01 7.68e-01
IMP BIOSYNTHETIC PROCESS 11 2.53e-01 1.99e-01 7.68e-01
CHROMOSOME MOVEMENT TOWARDS SPINDLE POLE 7 3.62e-01 1.99e-01 8.46e-01
REGULATION OF GONADOTROPIN SECRETION 11 2.54e-01 1.99e-01 7.69e-01
NEGATIVE REGULATION OF METALLOPEPTIDASE ACTIVITY 14 1.98e-01 -1.99e-01 7.24e-01
CALMODULIN DEPENDENT KINASE SIGNALING PATHWAY 11 2.54e-01 1.98e-01 7.69e-01
INTESTINAL EPITHELIAL STRUCTURE MAINTENANCE 8 3.31e-01 -1.98e-01 8.31e-01
PURINE DEOXYRIBONUCLEOTIDE BIOSYNTHETIC PROCESS 5 4.42e-01 -1.98e-01 8.78e-01
POSITIVE REGULATION OF ER ASSOCIATED UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS 7 3.64e-01 1.98e-01 8.47e-01
NEGATIVE REGULATION OF LIPASE ACTIVITY 16 1.70e-01 1.98e-01 6.87e-01
NEGATIVE REGULATION OF SPROUTING ANGIOGENESIS 28 6.96e-02 -1.98e-01 5.35e-01
RIBOSOME DISASSEMBLY 13 2.16e-01 1.98e-01 7.35e-01
POSITIVE REGULATION OF INTERLEUKIN 5 PRODUCTION 10 2.79e-01 -1.98e-01 7.85e-01
POSITIVE REGULATION OF STEROID METABOLIC PROCESS 27 7.53e-02 -1.98e-01 5.51e-01
FATTY ACID BETA OXIDATION USING ACYL COA DEHYDROGENASE 12 2.36e-01 -1.98e-01 7.54e-01
DIET INDUCED THERMOGENESIS 13 2.17e-01 -1.98e-01 7.36e-01
PYRIMIDINE NUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS 19 1.36e-01 -1.97e-01 6.60e-01
REGULATION OF PODOSOME ASSEMBLY 14 2.02e-01 -1.97e-01 7.28e-01
POSITIVE REGULATION OF MELANOCYTE DIFFERENTIATION 5 4.45e-01 1.97e-01 8.79e-01
SEQUESTERING OF BMP IN EXTRACELLULAR MATRIX 5 4.45e-01 -1.97e-01 8.79e-01
COPPER ION TRANSMEMBRANE TRANSPORT 8 3.35e-01 -1.97e-01 8.31e-01
REGULATION OF SKELETAL MUSCLE FIBER DEVELOPMENT 11 2.58e-01 1.97e-01 7.71e-01
L PHENYLALANINE METABOLIC PROCESS 8 3.35e-01 -1.97e-01 8.31e-01
PYRIMIDINE NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS 24 9.51e-02 -1.97e-01 5.94e-01
ADP METABOLIC PROCESS 8 3.35e-01 -1.97e-01 8.31e-01
NEGATIVE REGULATION OF ACUTE INFLAMMATORY RESPONSE 12 2.38e-01 1.97e-01 7.56e-01
SPONTANEOUS NEUROTRANSMITTER SECRETION 8 3.35e-01 1.97e-01 8.31e-01
SMOOTH MUSCLE CELL MATRIX ADHESION 6 4.04e-01 -1.97e-01 8.63e-01
STRIATED MUSCLE CELL APOPTOTIC PROCESS 58 9.56e-03 -1.97e-01 2.29e-01
NEGATIVE REGULATION OF ACTIN FILAMENT DEPOLYMERIZATION 44 2.41e-02 -1.97e-01 3.60e-01
POSITIVE REGULATION OF LEUKOCYTE TETHERING OR ROLLING 13 2.20e-01 1.97e-01 7.38e-01
REGULATION OF PRO B CELL DIFFERENTIATION 8 3.36e-01 -1.96e-01 8.31e-01
FUCOSE METABOLIC PROCESS 16 1.74e-01 -1.96e-01 6.90e-01
CELL SURFACE PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY 71 4.20e-03 -1.96e-01 1.52e-01
L SERINE TRANSPORT 8 3.36e-01 1.96e-01 8.31e-01
INTRACELLULAR SPHINGOLIPID HOMEOSTASIS 5 4.47e-01 -1.96e-01 8.79e-01
WYBUTOSINE METABOLIC PROCESS 6 4.05e-01 1.96e-01 8.63e-01
CORTISOL SECRETION 5 4.48e-01 -1.96e-01 8.80e-01
DETECTION OF TEMPERATURE STIMULUS INVOLVED IN SENSORY PERCEPTION OF PAIN 17 1.62e-01 -1.96e-01 6.81e-01
NEGATIVE REGULATION OF MONOCYTE CHEMOTAXIS 6 4.06e-01 -1.96e-01 8.63e-01
CELL FATE COMMITMENT INVOLVED IN PATTERN SPECIFICATION 11 2.61e-01 1.96e-01 7.72e-01
UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS VIA THE MULTIVESICULAR BODY SORTING PATHWAY 36 4.21e-02 -1.96e-01 4.32e-01
CELLULAR RESPONSE TO PROSTAGLANDIN STIMULUS 21 1.21e-01 -1.96e-01 6.34e-01
ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN VIA MHC CLASS I 37 3.94e-02 -1.96e-01 4.19e-01
REGULATION OF SERINE TYPE PEPTIDASE ACTIVITY 7 3.70e-01 1.96e-01 8.48e-01
SPERM EJACULATION 5 4.49e-01 -1.95e-01 8.80e-01
DEVELOPMENT OF SECONDARY FEMALE SEXUAL CHARACTERISTICS 6 4.07e-01 -1.95e-01 8.63e-01
DNA STRAND RESECTION INVOLVED IN REPLICATION FORK PROCESSING 8 3.39e-01 1.95e-01 8.34e-01
NEGATIVE REGULATION OF VITAMIN D BIOSYNTHETIC PROCESS 5 4.50e-01 1.95e-01 8.81e-01
ESTABLISHMENT OF SERTOLI CELL BARRIER 5 4.50e-01 -1.95e-01 8.81e-01
WOUND HEALING SPREADING OF EPIDERMAL CELLS 22 1.13e-01 -1.95e-01 6.25e-01
BLOOD VESSEL ENDOTHELIAL CELL PROLIFERATION INVOLVED IN SPROUTING ANGIOGENESIS 55 1.23e-02 -1.95e-01 2.58e-01
POSITIVE REGULATION OF CD8 POSITIVE ALPHA BETA T CELL ACTIVATION 9 3.11e-01 -1.95e-01 8.13e-01
RESPONSE TO STIMULUS INVOLVED IN REGULATION OF MUSCLE ADAPTATION 13 2.23e-01 -1.95e-01 7.41e-01
GLYOXYLATE METABOLIC PROCESS 8 3.39e-01 -1.95e-01 8.35e-01
ENDOSOME TO LYSOSOME TRANSPORT VIA MULTIVESICULAR BODY SORTING PATHWAY 17 1.64e-01 -1.95e-01 6.82e-01
CMP METABOLIC PROCESS 8 3.40e-01 -1.95e-01 8.35e-01
PROLINE TRANSPORT 13 2.24e-01 1.95e-01 7.41e-01
NEGATIVE REGULATION OF SCHWANN CELL PROLIFERATION 8 3.41e-01 -1.94e-01 8.35e-01
REGULATION OF KILLING OF CELLS OF ANOTHER ORGANISM 11 2.64e-01 1.94e-01 7.74e-01
GASTRIC MOTILITY 5 4.52e-01 -1.94e-01 8.81e-01
SULFATION 19 1.43e-01 -1.94e-01 6.69e-01
POSITIVE REGULATION OF CONNECTIVE TISSUE REPLACEMENT 12 2.44e-01 1.94e-01 7.63e-01
POSITIVE REGULATION OF INOSITOL TRISPHOSPHATE BIOSYNTHETIC PROCESS 5 4.52e-01 -1.94e-01 8.81e-01
NUCLEOPHAGY 19 1.43e-01 -1.94e-01 6.69e-01
TRYPTOPHAN CATABOLIC PROCESS 9 3.13e-01 -1.94e-01 8.15e-01
PROTEIN SIDE CHAIN DEGLUTAMYLATION 5 4.53e-01 1.94e-01 8.81e-01
PRIMARY AMINO COMPOUND METABOLIC PROCESS 14 2.09e-01 1.94e-01 7.30e-01
POSITIVE REGULATION OF T HELPER 17 TYPE IMMUNE RESPONSE 16 1.80e-01 -1.94e-01 7.01e-01
REGULATION OF MYELOID DENDRITIC CELL ACTIVATION 5 4.53e-01 -1.94e-01 8.81e-01
REGULATION OF MACROPHAGE DIFFERENTIATION 25 9.42e-02 -1.93e-01 5.92e-01
POSITIVE REGULATION OF GLYCOPROTEIN METABOLIC PROCESS 26 8.79e-02 -1.93e-01 5.80e-01
PEPTIDYL SERINE AUTOPHOSPHORYLATION 8 3.44e-01 -1.93e-01 8.36e-01
REGULATION OF TRAIL ACTIVATED APOPTOTIC SIGNALING PATHWAY 6 4.12e-01 -1.93e-01 8.65e-01
PIRNA PROCESSING 24 1.01e-01 1.93e-01 6.04e-01
ANTIBACTERIAL HUMORAL RESPONSE 61 9.09e-03 1.93e-01 2.24e-01
RESPONSE TO GROWTH HORMONE 37 4.21e-02 -1.93e-01 4.32e-01
BRANCHING INVOLVED IN LABYRINTHINE LAYER MORPHOGENESIS 13 2.28e-01 -1.93e-01 7.45e-01
OUTER MITOCHONDRIAL MEMBRANE ORGANIZATION 15 1.96e-01 1.93e-01 7.20e-01
RESPONSE TO WATER 13 2.29e-01 -1.93e-01 7.45e-01
REGULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY 38 3.97e-02 -1.93e-01 4.19e-01
DORSAL AORTA MORPHOGENESIS 8 3.45e-01 -1.93e-01 8.37e-01
REGULATION OF DNA METHYLATION DEPENDENT HETEROCHROMATIN FORMATION 18 1.57e-01 1.93e-01 6.79e-01
TRANSCYTOSIS 20 1.36e-01 -1.93e-01 6.60e-01
MESENCHYMAL CELL PROLIFERATION INVOLVED IN LUNG DEVELOPMENT 6 4.14e-01 1.93e-01 8.66e-01
REGULATION OF MEMBRANE DEPOLARIZATION DURING CARDIAC MUSCLE CELL ACTION POTENTIAL 5 4.56e-01 1.92e-01 8.84e-01
MUCOCILIARY CLEARANCE 8 3.46e-01 1.92e-01 8.37e-01
NEGATIVE REGULATION OF SMOOTH MUSCLE CONTRACTION 13 2.30e-01 1.92e-01 7.46e-01
NEGATIVE REGULATION OF FAT CELL PROLIFERATION 5 4.57e-01 -1.92e-01 8.84e-01
REGULATION OF GLUCOCORTICOID SECRETION 10 2.92e-01 -1.92e-01 8.00e-01
REGULATION OF SYNAPTIC VESICLE PRIMING 7 3.79e-01 -1.92e-01 8.51e-01
REGULATION OF FOCAL ADHESION DISASSEMBLY 6 4.15e-01 -1.92e-01 8.67e-01
COMMON BILE DUCT DEVELOPMENT 5 4.57e-01 -1.92e-01 8.84e-01
VITAMIN CATABOLIC PROCESS 14 2.14e-01 1.92e-01 7.33e-01
REGULATION OF LOW DENSITY LIPOPROTEIN PARTICLE CLEARANCE 22 1.19e-01 -1.92e-01 6.32e-01
ERROR FREE TRANSLESION SYNTHESIS 5 4.57e-01 -1.92e-01 8.84e-01
PYRIMIDINE DIMER REPAIR 9 3.19e-01 1.92e-01 8.21e-01
REGULATION OF RESPONSE TO OSMOTIC STRESS 16 1.84e-01 -1.92e-01 7.06e-01
REGULATION OF BRANCHING INVOLVED IN URETERIC BUD MORPHOGENESIS 21 1.29e-01 1.92e-01 6.48e-01
NEGATIVE REGULATION OF CYCLIN DEPENDENT PROTEIN SERINE THREONINE KINASE ACTIVITY 24 1.04e-01 1.91e-01 6.08e-01
REGULATION OF PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR SIGNALING PATHWAY 15 1.99e-01 1.91e-01 7.25e-01
EARLY ENDOSOME TO RECYCLING ENDOSOME TRANSPORT 6 4.17e-01 -1.91e-01 8.68e-01
SEROTONIN TRANSPORT 22 1.21e-01 1.91e-01 6.34e-01
CYTOPLASMIC SEQUESTERING OF TRANSCRIPTION FACTOR 14 2.16e-01 -1.91e-01 7.33e-01
ANTRAL OVARIAN FOLLICLE GROWTH 11 2.72e-01 -1.91e-01 7.80e-01
ADHERENS JUNCTION MAINTENANCE 7 3.82e-01 -1.91e-01 8.53e-01
REGULATION OF HIPPO SIGNALING 26 9.21e-02 -1.91e-01 5.88e-01
ISOPENTENYL DIPHOSPHATE BIOSYNTHETIC PROCESS 5 4.60e-01 -1.91e-01 8.88e-01
REGULATION OF PHOSPHOLIPASE C ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY 6 4.19e-01 -1.91e-01 8.69e-01
CELLULAR MODIFIED AMINO ACID CATABOLIC PROCESS 22 1.22e-01 -1.91e-01 6.37e-01
NEURAL CREST CELL MIGRATION INVOLVED IN AUTONOMIC NERVOUS SYSTEM DEVELOPMENT 6 4.19e-01 1.91e-01 8.69e-01
CUT CATABOLIC PROCESS 5 4.61e-01 -1.91e-01 8.88e-01
THROMBOPOIETIN MEDIATED SIGNALING PATHWAY 5 4.61e-01 -1.90e-01 8.88e-01
EPITHELIAL MESENCHYMAL CELL SIGNALING 6 4.20e-01 1.90e-01 8.71e-01
RESPONSE TO MUSCLE ACTIVITY 28 8.18e-02 -1.90e-01 5.65e-01
TRANSLATIONAL READTHROUGH 9 3.24e-01 -1.90e-01 8.24e-01
REGULATION OF GROWTH HORMONE RECEPTOR SIGNALING PATHWAY 6 4.20e-01 1.90e-01 8.71e-01
ANTIGEN PROCESSING AND PRESENTATION OF ENDOGENOUS PEPTIDE ANTIGEN 25 1.00e-01 -1.90e-01 6.02e-01
NEGATIVE REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION 22 1.24e-01 -1.90e-01 6.44e-01
LIGAND GATED ION CHANNEL SIGNALING PATHWAY 33 5.94e-02 1.90e-01 5.02e-01
G1 TO G0 TRANSITION INVOLVED IN CELL DIFFERENTIATION 6 4.21e-01 -1.90e-01 8.72e-01
FERROPTOSIS 5 4.63e-01 -1.89e-01 8.89e-01
POSITIVE REGULATION OF HYPERSENSITIVITY 6 4.22e-01 1.89e-01 8.72e-01
POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO HYPOXIA 5 4.64e-01 1.89e-01 8.89e-01
CONSTITUTIVE HETEROCHROMATIN FORMATION 13 2.38e-01 1.89e-01 7.56e-01
REGULATION OF EATING BEHAVIOR 7 3.86e-01 1.89e-01 8.55e-01
NEGATIVE REGULATION OF ACTIVIN RECEPTOR SIGNALING PATHWAY 15 2.05e-01 -1.89e-01 7.29e-01
LEUCINE TRANSPORT 10 3.01e-01 -1.89e-01 8.07e-01
NOSE DEVELOPMENT 16 1.91e-01 1.89e-01 7.14e-01
MAINTENANCE OF PRESYNAPTIC ACTIVE ZONE STRUCTURE 6 4.24e-01 1.89e-01 8.73e-01
MONOCYTE CHEMOTAXIS 69 6.72e-03 1.89e-01 1.93e-01
AMYLOID PRECURSOR PROTEIN BIOSYNTHETIC PROCESS 27 8.99e-02 -1.89e-01 5.85e-01
NEGATIVE REGULATION OF CGMP MEDIATED SIGNALING 6 4.24e-01 -1.89e-01 8.73e-01
PROTEIN TO MEMBRANE DOCKING 5 4.65e-01 1.88e-01 8.90e-01
UREA TRANSMEMBRANE TRANSPORT 9 3.28e-01 1.88e-01 8.29e-01
RESPONSE TO BLUE LIGHT 6 4.24e-01 1.88e-01 8.73e-01
NEGATIVE REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY 19 1.56e-01 -1.88e-01 6.79e-01
REGULATION OF LIPOPROTEIN LIPASE ACTIVITY 16 1.93e-01 -1.88e-01 7.16e-01
NEPHRON TUBULE EPITHELIAL CELL DIFFERENTIATION 14 2.24e-01 -1.88e-01 7.41e-01
DIACYLGLYCEROL BIOSYNTHETIC PROCESS 9 3.29e-01 -1.88e-01 8.30e-01
REGULATION OF EXTRACELLULAR MATRIX CONSTITUENT SECRETION 9 3.29e-01 1.88e-01 8.30e-01
TRNA WOBBLE BASE MODIFICATION 20 1.46e-01 1.88e-01 6.75e-01
TELOMERASE RNA LOCALIZATION 19 1.57e-01 1.88e-01 6.79e-01
ENDOCARDIAL CUSHION FORMATION 31 7.06e-02 1.88e-01 5.37e-01
POSITIVE REGULATION OF GAP JUNCTION ASSEMBLY 7 3.90e-01 1.88e-01 8.56e-01
FOREGUT MORPHOGENESIS 10 3.05e-01 -1.87e-01 8.10e-01
GLOMERULAR BASEMENT MEMBRANE DEVELOPMENT 11 2.82e-01 -1.87e-01 7.90e-01
SUCCINATE METABOLIC PROCESS 5 4.69e-01 1.87e-01 8.90e-01
REGULATION OF TRANSLATIONAL TERMINATION 8 3.59e-01 -1.87e-01 8.46e-01
RESPONSE TO MERCURY ION 10 3.06e-01 -1.87e-01 8.11e-01
MAST CELL PROLIFERATION 7 3.91e-01 1.87e-01 8.57e-01
CELL CYCLE DNA REPLICATION INITIATION 5 4.69e-01 1.87e-01 8.90e-01
TRANSCRIPTION INITIATION AT RNA POLYMERASE I PROMOTER 12 2.62e-01 -1.87e-01 7.73e-01
7 METHYLGUANOSINE RNA CAPPING 8 3.60e-01 1.87e-01 8.46e-01
NEGATIVE REGULATION OF STRIATED MUSCLE CONTRACTION 9 3.32e-01 -1.87e-01 8.31e-01
REGULATION OF CARDIOBLAST DIFFERENTIATION 5 4.70e-01 1.87e-01 8.90e-01
NEGATIVE REGULATION OF KERATINOCYTE PROLIFERATION 24 1.13e-01 -1.87e-01 6.25e-01
3 UTR MEDIATED MRNA DESTABILIZATION 19 1.59e-01 -1.87e-01 6.79e-01
PURINE NUCLEOTIDE TRANSPORT 38 4.65e-02 -1.87e-01 4.52e-01
ER NUCLEUS SIGNALING PATHWAY 46 2.86e-02 -1.87e-01 3.73e-01
NUCLEOTIDE EXCISION REPAIR DNA GAP FILLING 6 4.29e-01 -1.87e-01 8.74e-01
COBALAMIN METABOLIC PROCESS 9 3.33e-01 1.86e-01 8.31e-01
RESPONSE TO AUDITORY STIMULUS 31 7.25e-02 1.86e-01 5.43e-01
POSITIVE REGULATION OF ACTIN FILAMENT DEPOLYMERIZATION 13 2.45e-01 -1.86e-01 7.63e-01
POSITIVE REGULATION OF JNK CASCADE 87 2.67e-03 -1.86e-01 1.18e-01
REGULATION OF LIPID CATABOLIC PROCESS 61 1.19e-02 -1.86e-01 2.53e-01
LEUKOCYTE AGGREGATION 13 2.45e-01 1.86e-01 7.63e-01
TRANSCRIPTION INITIATION COUPLED CHROMATIN REMODELING 38 4.71e-02 -1.86e-01 4.53e-01
OUTFLOW TRACT SEPTUM MORPHOGENESIS 26 1.01e-01 1.86e-01 6.03e-01
DE NOVO PYRIMIDINE NUCLEOBASE BIOSYNTHETIC PROCESS 6 4.30e-01 -1.86e-01 8.74e-01
VITAMIN K METABOLIC PROCESS 10 3.09e-01 1.86e-01 8.12e-01
2FE 2S CLUSTER ASSEMBLY 9 3.35e-01 1.86e-01 8.31e-01
REGULATION OF VITAMIN D BIOSYNTHETIC PROCESS 7 3.95e-01 1.86e-01 8.59e-01
EMBRYONIC BODY MORPHOGENESIS 11 2.86e-01 -1.86e-01 7.95e-01
REGULATION OF POTASSIUM ION EXPORT ACROSS PLASMA MEMBRANE 9 3.35e-01 -1.86e-01 8.31e-01
SMOOTH MUSCLE ADAPTATION 5 4.73e-01 -1.85e-01 8.91e-01
PML BODY ORGANIZATION 7 3.96e-01 -1.85e-01 8.59e-01
RESPONSE TO ACIDIC PH 29 8.39e-02 -1.85e-01 5.70e-01
CELL PROLIFERATION IN MIDBRAIN 8 3.64e-01 1.85e-01 8.47e-01
ETHANOL OXIDATION 9 3.36e-01 1.85e-01 8.31e-01
FATTY ACID ELONGATION 13 2.47e-01 1.85e-01 7.64e-01
POSITIVE REGULATION OF ACTIVIN RECEPTOR SIGNALING PATHWAY 8 3.65e-01 -1.85e-01 8.48e-01
PROTEIN IMPORT INTO PEROXISOME MATRIX SUBSTRATE RELEASE 5 4.74e-01 -1.85e-01 8.91e-01
INNER EAR RECEPTOR CELL FATE COMMITMENT 5 4.74e-01 -1.85e-01 8.91e-01
RESPONSE TO ELECTRICAL STIMULUS 44 3.41e-02 -1.85e-01 4.03e-01
INTESTINAL CHOLESTEROL ABSORPTION 18 1.75e-01 -1.85e-01 6.93e-01
T TUBULE ORGANIZATION 6 4.34e-01 1.85e-01 8.74e-01
POSITIVE REGULATION OF ENDOTHELIAL CELL DEVELOPMENT 6 4.34e-01 -1.84e-01 8.74e-01
REGULATION OF MYOFIBROBLAST DIFFERENTIATION 10 3.13e-01 -1.84e-01 8.15e-01
SEQUESTERING OF ACTIN MONOMERS 9 3.39e-01 1.84e-01 8.34e-01
G PROTEIN COUPLED SEROTONIN RECEPTOR SIGNALING PATHWAY 23 1.27e-01 1.84e-01 6.48e-01
REGULATION OF ERBB SIGNALING PATHWAY 70 7.81e-03 -1.84e-01 2.04e-01
REGULATION OF ENDOPLASMIC RETICULUM TUBULAR NETWORK ORGANIZATION 6 4.36e-01 1.84e-01 8.74e-01
ISOCITRATE METABOLIC PROCESS 6 4.36e-01 -1.84e-01 8.74e-01
POSITIVE REGULATION OF DENDRITIC CELL CYTOKINE PRODUCTION 13 2.52e-01 -1.84e-01 7.68e-01
ARTERIAL ENDOTHELIAL CELL DIFFERENTIATION 6 4.36e-01 -1.83e-01 8.74e-01
CYTOKINETIC PROCESS 42 3.97e-02 -1.83e-01 4.19e-01
CELLULAR RESPONSE TO NICOTINE 8 3.69e-01 -1.83e-01 8.48e-01
REGULATION OF STRESS GRANULE ASSEMBLY 8 3.70e-01 1.83e-01 8.48e-01
OTIC VESICLE DEVELOPMENT 15 2.19e-01 1.83e-01 7.38e-01
REGULATION OF VASCULAR PERMEABILITY 50 2.51e-02 -1.83e-01 3.65e-01
INTEGRIN ACTIVATION 26 1.07e-01 -1.83e-01 6.11e-01
REGULATION OF SREBP SIGNALING PATHWAY 8 3.71e-01 -1.83e-01 8.48e-01
REGULATION OF INTESTINAL ABSORPTION 12 2.73e-01 -1.83e-01 7.80e-01
MIDBODY ABSCISSION 17 1.92e-01 -1.83e-01 7.16e-01
PINOCYTOSIS 22 1.38e-01 -1.83e-01 6.63e-01
PROTEIN GERANYLGERANYLATION 7 4.03e-01 1.82e-01 8.63e-01
REGULATION OF MAINTENANCE OF SISTER CHROMATID COHESION 9 3.43e-01 1.82e-01 8.36e-01
REGULATION OF PROTEIN MONOUBIQUITINATION 6 4.39e-01 -1.82e-01 8.77e-01
PIECEMEAL MICROAUTOPHAGY OF THE NUCLEUS 10 3.18e-01 -1.82e-01 8.21e-01
REGULATION OF GASTRIC ACID SECRETION 6 4.40e-01 -1.82e-01 8.77e-01
REGULATION OF GUANYLATE CYCLASE ACTIVITY 6 4.40e-01 1.82e-01 8.77e-01
NEGATIVE REGULATION OF RESPONSE TO OXIDATIVE STRESS 11 2.95e-01 -1.82e-01 8.03e-01
REGULATION OF CHOLESTEROL STORAGE 19 1.70e-01 -1.82e-01 6.87e-01
REGULATION OF ANIMAL ORGAN FORMATION 28 9.56e-02 1.82e-01 5.96e-01
REGULATION OF RETINOIC ACID RECEPTOR SIGNALING PATHWAY 16 2.08e-01 1.82e-01 7.29e-01
NEGATIVE REGULATION OF GRANULOCYTE CHEMOTAXIS 5 4.81e-01 1.82e-01 8.94e-01
CEREBRAL CORTEX GABAERGIC INTERNEURON DEVELOPMENT 7 4.05e-01 -1.82e-01 8.63e-01
CELL VOLUME HOMEOSTASIS 35 6.28e-02 -1.82e-01 5.12e-01
POSITIVE REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS 24 1.23e-01 -1.82e-01 6.44e-01
TRICARBOXYLIC ACID METABOLIC PROCESS 15 2.23e-01 -1.82e-01 7.41e-01
POSITIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY 7 4.05e-01 -1.82e-01 8.63e-01
ACTIN FILAMENT NETWORK FORMATION 9 3.45e-01 -1.82e-01 8.37e-01
NEGATIVE REGULATION OF ENDOTHELIAL CELL APOPTOTIC PROCESS 37 5.59e-02 -1.82e-01 4.88e-01
REGULATION OF MEIOTIC CELL CYCLE PHASE TRANSITION 10 3.20e-01 -1.82e-01 8.22e-01
MITOCHONDRIAL ELECTRON TRANSPORT UBIQUINOL TO CYTOCHROME C 12 2.76e-01 1.82e-01 7.83e-01
DEFENSE RESPONSE TO GRAM POSITIVE BACTERIUM 113 8.52e-04 1.82e-01 5.71e-02
DETECTION OF CHEMICAL STIMULUS INVOLVED IN SENSORY PERCEPTION OF TASTE 46 3.31e-02 1.82e-01 3.99e-01
VIRAL BUDDING 25 1.16e-01 -1.82e-01 6.30e-01
DETERMINATION OF DORSAL VENTRAL ASYMMETRY 11 2.97e-01 -1.82e-01 8.04e-01
ANTIFUNGAL INNATE IMMUNE RESPONSE 20 1.60e-01 1.81e-01 6.80e-01
CLEAVAGE FURROW FORMATION 7 4.06e-01 -1.81e-01 8.63e-01
LIPID DIGESTION 22 1.41e-01 -1.81e-01 6.68e-01
REGULATION OF SYNAPTIC TRANSMISSION DOPAMINERGIC 9 3.46e-01 1.81e-01 8.37e-01
POSITIVE REGULATION OF SMOOTH MUSCLE CONTRACTION 30 8.57e-02 -1.81e-01 5.77e-01
URINARY TRACT SMOOTH MUSCLE CONTRACTION 9 3.46e-01 -1.81e-01 8.37e-01
REGULATION OF CELL COMMUNICATION BY ELECTRICAL COUPLING INVOLVED IN CARDIAC CONDUCTION 12 2.77e-01 1.81e-01 7.84e-01
POSITIVE REGULATION OF PROTEIN MATURATION 27 1.03e-01 -1.81e-01 6.07e-01
NEGATIVE REGULATION OF NOREPINEPHRINE SECRETION 5 4.83e-01 1.81e-01 8.94e-01
MAST CELL CHEMOTAXIS 11 2.98e-01 -1.81e-01 8.05e-01
REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR 38 5.33e-02 1.81e-01 4.78e-01
ANTEROGRADE DENDRITIC TRANSPORT 9 3.47e-01 -1.81e-01 8.37e-01
PURINE RIBONUCLEOSIDE CATABOLIC PROCESS 6 4.43e-01 -1.81e-01 8.78e-01
SENSORY PERCEPTION OF BITTER TASTE 44 3.78e-02 1.81e-01 4.13e-01
REGULATION OF HISTONE DEACETYLATION 6 4.43e-01 -1.81e-01 8.78e-01
WNT SIGNALING PATHWAY CALCIUM MODULATING PATHWAY 5 4.84e-01 1.81e-01 8.94e-01
POSITIVE REGULATION OF HELICASE ACTIVITY 6 4.43e-01 1.81e-01 8.78e-01
DOUBLE STRAND BREAK REPAIR VIA CLASSICAL NONHOMOLOGOUS END JOINING 6 4.43e-01 -1.81e-01 8.78e-01
RESPONSE TO PH 42 4.25e-02 -1.81e-01 4.33e-01
RESPONSE TO IRON ION 30 8.65e-02 -1.81e-01 5.77e-01
POSITIVE REGULATION OF MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS 16 2.11e-01 -1.81e-01 7.32e-01
NEGATIVE REGULATION OF T CELL DIFFERENTIATION IN THYMUS 10 3.22e-01 1.81e-01 8.23e-01
IMMUNOLOGICAL SYNAPSE FORMATION 16 2.11e-01 -1.81e-01 7.32e-01
NEGATIVE REGULATION OF EPITHELIAL CELL PROLIFERATION INVOLVED IN PROSTATE GLAND DEVELOPMENT 6 4.44e-01 -1.81e-01 8.78e-01
CENTROMERE COMPLEX ASSEMBLY 29 9.23e-02 1.81e-01 5.88e-01
PANCREATIC A CELL DIFFERENTIATION 11 3.00e-01 1.81e-01 8.06e-01
DTMP METABOLIC PROCESS 6 4.44e-01 1.81e-01 8.78e-01
PREVENTION OF POLYSPERMY 7 4.08e-01 -1.81e-01 8.64e-01
G0 TO G1 TRANSITION 39 5.10e-02 -1.81e-01 4.69e-01
NEGATIVE REGULATION OF DNA CATABOLIC PROCESS 5 4.85e-01 -1.81e-01 8.94e-01
NEURONAL ACTION POTENTIAL 33 7.27e-02 1.81e-01 5.43e-01
NEGATIVE REGULATION OF STEM CELL POPULATION MAINTENANCE 26 1.11e-01 1.80e-01 6.20e-01
NEGATIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION 22 1.43e-01 -1.80e-01 6.69e-01
DETECTION OF CALCIUM ION 13 2.60e-01 1.80e-01 7.72e-01
PEPTIDYL TYROSINE AUTOPHOSPHORYLATION 18 1.85e-01 -1.80e-01 7.07e-01
INNER CELL MASS CELL DIFFERENTIATION 8 3.77e-01 -1.80e-01 8.51e-01
ENDOCARDIUM DEVELOPMENT 12 2.80e-01 1.80e-01 7.87e-01
REGULATION OF DEFENSE RESPONSE TO BACTERIUM 20 1.63e-01 -1.80e-01 6.81e-01
POLYOL CATABOLIC PROCESS 10 3.24e-01 1.80e-01 8.24e-01
REGULATION OF LYSOSOME ORGANIZATION 12 2.80e-01 -1.80e-01 7.87e-01
MESODERMAL CELL MIGRATION 5 4.85e-01 -1.80e-01 8.94e-01
POSITIVE REGULATION OF EXOSOMAL SECRETION 15 2.27e-01 -1.80e-01 7.44e-01
HISTONE MODIFICATION 117 7.66e-04 -1.80e-01 5.31e-02
SOMATIC DIVERSIFICATION OF IMMUNE RECEPTORS VIA SOMATIC MUTATION 13 2.61e-01 1.80e-01 7.72e-01
ESTROGEN BIOSYNTHETIC PROCESS 11 3.02e-01 -1.80e-01 8.07e-01
PROGRAMMED CELL DEATH IN RESPONSE TO REACTIVE OXYGEN SPECIES 19 1.75e-01 -1.80e-01 6.92e-01
ANTIGEN PROCESSING AND PRESENTATION OF LIPID ANTIGEN VIA MHC CLASS IB 7 4.11e-01 1.80e-01 8.64e-01
VENTRAL MIDLINE DEVELOPMENT 6 4.46e-01 1.79e-01 8.79e-01
PHOSPHATIDYLSERINE METABOLIC PROCESS 23 1.36e-01 -1.79e-01 6.60e-01
POSITIVE REGULATION OF VIRAL LIFE CYCLE 24 1.28e-01 -1.79e-01 6.48e-01
NEGATIVE REGULATION OF VIRAL INDUCED CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY 36 6.28e-02 -1.79e-01 5.12e-01
NEGATIVE REGULATION OF RESPONSE TO TUMOR CELL 5 4.88e-01 -1.79e-01 8.94e-01
REGULATION OF MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS 24 1.29e-01 -1.79e-01 6.48e-01
PROTEIN UNFOLDING 5 4.88e-01 1.79e-01 8.94e-01
DOUBLE STRAND BREAK REPAIR VIA SINGLE STRAND ANNEALING 6 4.48e-01 -1.79e-01 8.80e-01
ESTABLISHMENT OF EPITHELIAL CELL POLARITY 36 6.33e-02 -1.79e-01 5.15e-01
ANTIMICROBIAL PEPTIDE PRODUCTION 11 3.05e-01 -1.79e-01 8.10e-01
POSITIVE REGULATION OF T HELPER 1 CELL DIFFERENTIATION 6 4.48e-01 1.79e-01 8.80e-01
REGULATION OF FERTILIZATION 17 2.02e-01 1.79e-01 7.29e-01
DETECTION OF MECHANICAL STIMULUS INVOLVED IN SENSORY PERCEPTION OF SOUND 15 2.31e-01 1.79e-01 7.49e-01
HEART TRABECULA FORMATION 15 2.31e-01 1.79e-01 7.49e-01
CELLULAR ALDEHYDE METABOLIC PROCESS 70 9.81e-03 -1.78e-01 2.32e-01
NEGATIVE REGULATION OF INTERLEUKIN 4 PRODUCTION 8 3.82e-01 1.78e-01 8.53e-01
POSITIVE REGULATION OF CELL ADHESION MOLECULE PRODUCTION 5 4.90e-01 1.78e-01 8.95e-01
RETINOIC ACID METABOLIC PROCESS 33 7.61e-02 1.78e-01 5.52e-01
REGULATION OF PROTEIN DEUBIQUITINATION 10 3.29e-01 -1.78e-01 8.30e-01
INTRACELLULAR MRNA LOCALIZATION 13 2.66e-01 -1.78e-01 7.76e-01
REGULATION OF SYNAPTIC TRANSMISSION GLUTAMATERGIC 79 6.15e-03 1.78e-01 1.83e-01
LIPOPROTEIN LOCALIZATION 21 1.57e-01 1.78e-01 6.79e-01
POSITIVE REGULATION OF PROTEIN KINASE C SIGNALING 9 3.55e-01 1.78e-01 8.44e-01
POSITIVE REGULATION OF OSTEOCLAST DIFFERENTIATION 27 1.09e-01 1.78e-01 6.17e-01
POSITIVE REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY 33 7.67e-02 1.78e-01 5.53e-01
NUCLEOBASE TRANSPORT 13 2.66e-01 -1.78e-01 7.76e-01
PARACRINE SIGNALING 7 4.15e-01 1.78e-01 8.67e-01
POSITIVE REGULATION OF CILIUM ASSEMBLY 28 1.03e-01 -1.78e-01 6.07e-01
SYNAPTIC TRANSMISSION GLUTAMATERGIC 111 1.20e-03 1.78e-01 7.28e-02
CELLULAR RESPONSE TO CAFFEINE 11 3.07e-01 1.78e-01 8.11e-01
MORPHOGENESIS OF AN ENDOTHELIUM 17 2.04e-01 -1.78e-01 7.29e-01
METANEPHRIC EPITHELIUM DEVELOPMENT 29 9.77e-02 -1.78e-01 5.97e-01
MATURATION OF 5 8S RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA 25 1.24e-01 -1.78e-01 6.45e-01
CARBOHYDRATE IMPORT ACROSS PLASMA MEMBRANE 6 4.51e-01 -1.78e-01 8.81e-01
REGULATION OF FATTY ACID OXIDATION 34 7.32e-02 -1.78e-01 5.45e-01
POSITIVE REGULATION OF VACUOLE ORGANIZATION 24 1.32e-01 -1.77e-01 6.56e-01
ACETYLCHOLINE SECRETION 5 4.92e-01 -1.77e-01 8.96e-01
MYOSIN FILAMENT ORGANIZATION 6 4.52e-01 -1.77e-01 8.81e-01
POSITIVE REGULATION BY HOST OF VIRAL GENOME REPLICATION 10 3.31e-01 1.77e-01 8.31e-01
ABSCISSION 6 4.52e-01 -1.77e-01 8.81e-01
ERBB2 ERBB4 SIGNALING PATHWAY 5 4.92e-01 -1.77e-01 8.96e-01
ADENYLATE CYCLASE INHIBITING DOPAMINE RECEPTOR SIGNALING PATHWAY 6 4.52e-01 -1.77e-01 8.81e-01
MITOTIC SISTER CHROMATID COHESION 31 8.74e-02 1.77e-01 5.79e-01
NERVE GROWTH FACTOR SIGNALING PATHWAY 13 2.68e-01 1.77e-01 7.77e-01
POSITIVE REGULATION OF MITOCHONDRIAL TRANSLATION 16 2.19e-01 1.77e-01 7.38e-01
ENDOCARDIUM MORPHOGENESIS 6 4.52e-01 1.77e-01 8.81e-01
PROGESTERONE RECEPTOR SIGNALING PATHWAY 11 3.09e-01 -1.77e-01 8.12e-01
TANGENTIAL MIGRATION FROM THE SUBVENTRICULAR ZONE TO THE OLFACTORY BULB 8 3.86e-01 1.77e-01 8.55e-01
MALONYL COA METABOLIC PROCESS 6 4.53e-01 -1.77e-01 8.81e-01
METANEPHRIC NEPHRON TUBULE EPITHELIAL CELL DIFFERENTIATION 6 4.53e-01 -1.77e-01 8.81e-01
OLIGOSACCHARIDE LIPID INTERMEDIATE BIOSYNTHETIC PROCESS 21 1.61e-01 1.77e-01 6.81e-01
VENTRICULAR SEPTUM MORPHOGENESIS 43 4.49e-02 1.77e-01 4.45e-01
POSITIVE REGULATION OF LYMPHOCYTE MIGRATION 40 5.31e-02 1.77e-01 4.77e-01
NEGATIVE REGULATION OF CELL SUBSTRATE ADHESION 65 1.37e-02 -1.77e-01 2.76e-01
POSITIVE REGULATION OF REGULATED SECRETORY PATHWAY 42 4.75e-02 -1.77e-01 4.55e-01
REGULATION OF GLUTAMATE RECEPTOR CLUSTERING 6 4.54e-01 1.77e-01 8.81e-01
AROMATIC AMINO ACID FAMILY CATABOLIC PROCESS 16 2.21e-01 -1.77e-01 7.40e-01
NEGATIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT 13 2.70e-01 -1.77e-01 7.79e-01
ENTRY OF BACTERIUM INTO HOST CELL 9 3.60e-01 -1.76e-01 8.46e-01
NEGATIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA NONHOMOLOGOUS END JOINING 7 4.19e-01 -1.76e-01 8.70e-01
REGULATION OF MITOCHONDRIAL MEMBRANE PERMEABILITY 59 1.91e-02 -1.76e-01 3.19e-01
INTERLEUKIN 13 PRODUCTION 21 1.62e-01 -1.76e-01 6.81e-01
CELLULAR HYPEROSMOTIC RESPONSE 20 1.72e-01 -1.76e-01 6.90e-01
SCHWANN CELL DEVELOPMENT 31 8.95e-02 -1.76e-01 5.83e-01
VESICLE MEDIATED TRANSPORT BETWEEN ENDOSOMAL COMPARTMENTS 49 3.28e-02 -1.76e-01 3.98e-01
STORE OPERATED CALCIUM ENTRY 22 1.52e-01 -1.76e-01 6.79e-01
REGULATION OF PLASMA LIPOPROTEIN PARTICLE LEVELS 92 3.49e-03 -1.76e-01 1.35e-01
MANGANESE ION TRANSPORT 11 3.12e-01 -1.76e-01 8.14e-01
MUCOSA ASSOCIATED LYMPHOID TISSUE DEVELOPMENT 8 3.88e-01 -1.76e-01 8.56e-01
SIRNA MEDIATED RETROTRANSPOSON SILENCING BY HETEROCHROMATIN FORMATION 11 3.12e-01 1.76e-01 8.14e-01
POSITIVE REGULATION OF CD8 POSITIVE ALPHA BETA T CELL DIFFERENTIATION 5 4.96e-01 1.76e-01 8.98e-01
NEGATIVE REGULATION OF EPIDERMAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY 27 1.13e-01 -1.76e-01 6.25e-01
POLYADENYLATION DEPENDENT RNA CATABOLIC PROCESS 8 3.89e-01 -1.76e-01 8.56e-01
REGULATION OF NEUROTROPHIN TRK RECEPTOR SIGNALING PATHWAY 11 3.12e-01 1.76e-01 8.14e-01
INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY 52 2.81e-02 -1.76e-01 3.73e-01
DICARBOXYLIC ACID CATABOLIC PROCESS 19 1.84e-01 -1.76e-01 7.06e-01
NEGATIVE REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION 21 1.63e-01 -1.76e-01 6.81e-01
NEGATIVE REGULATION OF MUSCLE ORGAN DEVELOPMENT 9 3.61e-01 -1.76e-01 8.46e-01
RETINA LAYER FORMATION 25 1.28e-01 1.76e-01 6.48e-01
GRANZYME MEDIATED PROGRAMMED CELL DEATH SIGNALING PATHWAY 8 3.89e-01 -1.76e-01 8.56e-01
CYTOPLASMIC SEQUESTERING OF NF KAPPAB 8 3.89e-01 1.76e-01 8.56e-01
SPERMATID NUCLEUS DIFFERENTIATION 27 1.14e-01 1.76e-01 6.26e-01
POSITIVE REGULATION OF BROWN FAT CELL DIFFERENTIATION 16 2.24e-01 1.76e-01 7.41e-01
APICAL JUNCTION ASSEMBLY 77 7.72e-03 -1.76e-01 2.03e-01
ADHESION OF SYMBIONT TO HOST 13 2.73e-01 1.76e-01 7.80e-01
URATE METABOLIC PROCESS 13 2.73e-01 1.75e-01 7.80e-01
NEUROTRANSMITTER METABOLIC PROCESS 27 1.15e-01 1.75e-01 6.27e-01
NEGATIVE REGULATION OF MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS 8 3.90e-01 -1.75e-01 8.56e-01
GANGLION DEVELOPMENT 17 2.11e-01 1.75e-01 7.32e-01
ACETATE ESTER METABOLIC PROCESS 6 4.58e-01 1.75e-01 8.84e-01
HUMORAL IMMUNE RESPONSE 239 3.09e-06 1.75e-01 9.43e-04
METANEPHRIC GLOMERULAR MESANGIUM DEVELOPMENT 5 4.98e-01 -1.75e-01 8.99e-01
HIPPO SIGNALING 44 4.46e-02 -1.75e-01 4.44e-01
RESPONSE TO LEAD ION 21 1.65e-01 -1.75e-01 6.84e-01
C21 STEROID HORMONE METABOLIC PROCESS 37 6.55e-02 1.75e-01 5.24e-01
INTERLEUKIN 6 MEDIATED SIGNALING PATHWAY 26 1.23e-01 -1.75e-01 6.41e-01
INTRACELLULAR LIPID TRANSPORT 51 3.08e-02 -1.75e-01 3.85e-01
FRUCTOSE 1 6 BISPHOSPHATE METABOLIC PROCESS 9 3.64e-01 -1.75e-01 8.47e-01
ENDOTHELIAL CELL MATRIX ADHESION 8 3.92e-01 -1.75e-01 8.57e-01
ORGAN INDUCTION 23 1.47e-01 1.75e-01 6.75e-01
HISTIDINE METABOLIC PROCESS 10 3.39e-01 -1.75e-01 8.35e-01
POSITIVE REGULATION OF PHOSPHOLIPASE A2 ACTIVITY 5 4.99e-01 1.74e-01 9.00e-01
ACTOMYOSIN STRUCTURE ORGANIZATION 208 1.44e-05 -1.74e-01 2.90e-03
MEMBRANE REPOLARIZATION DURING CARDIAC MUSCLE CELL ACTION POTENTIAL 25 1.32e-01 -1.74e-01 6.56e-01
REGULATION OF PHOSPHOLIPID TRANSLOCATION 6 4.61e-01 1.74e-01 8.88e-01
FRUCTOSE TRANSMEMBRANE TRANSPORT 10 3.41e-01 -1.74e-01 8.35e-01
POSITIVE REGULATION OF PROTEIN NEDDYLATION 5 5.01e-01 -1.74e-01 9.01e-01
POSITIVE REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION 30 9.97e-02 1.74e-01 6.02e-01
NEGATIVE REGULATION OF REGULATORY T CELL DIFFERENTIATION 7 4.26e-01 -1.74e-01 8.73e-01
FC RECEPTOR MEDIATED STIMULATORY SIGNALING PATHWAY 31 9.45e-02 -1.74e-01 5.92e-01
REGULATION OF PROTEIN K48 LINKED UBIQUITINATION 6 4.62e-01 -1.74e-01 8.88e-01
IMMUNE RESPONSE REGULATING CELL SURFACE RECEPTOR SIGNALING PATHWAY INVOLVED IN PHAGOCYTOSIS 25 1.33e-01 -1.73e-01 6.58e-01
TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY 108 1.84e-03 -1.73e-01 9.79e-02
REGULATION OF RETROGRADE TRANSPORT ENDOSOME TO GOLGI 7 4.27e-01 -1.73e-01 8.74e-01
POSITIVE REGULATION OF PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY 64 1.64e-02 -1.73e-01 2.97e-01
REGULATION OF HISTONE MODIFICATION 40 5.77e-02 -1.73e-01 4.96e-01
RESPONSE TO CORTICOTROPIN RELEASING HORMONE 5 5.02e-01 1.73e-01 9.01e-01
NOREPINEPHRINE UPTAKE 8 3.96e-01 -1.73e-01 8.59e-01
REGULATION OF T HELPER 1 CELL DIFFERENTIATION 11 3.20e-01 1.73e-01 8.22e-01
SIGNAL PEPTIDE PROCESSING 13 2.80e-01 1.73e-01 7.87e-01
REGULATION OF RAC PROTEIN SIGNAL TRANSDUCTION 20 1.80e-01 1.73e-01 7.01e-01
SPONTANEOUS SYNAPTIC TRANSMISSION 14 2.62e-01 1.73e-01 7.73e-01
CARDIAC PACEMAKER CELL DEVELOPMENT 9 3.69e-01 1.73e-01 8.48e-01
REGULATION OF SPROUTING ANGIOGENESIS 64 1.67e-02 -1.73e-01 2.98e-01
INTRACELLULAR NITROGEN HOMEOSTASIS 5 5.03e-01 -1.73e-01 9.02e-01
NEGATIVE REGULATION OF T CELL MEDIATED IMMUNITY 28 1.13e-01 1.73e-01 6.25e-01
PROTEIN TRANSPORT WITHIN LIPID BILAYER 7 4.28e-01 -1.73e-01 8.74e-01
POSITIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION 98 3.12e-03 -1.73e-01 1.30e-01
REGULATION OF HEPATOCYTE APOPTOTIC PROCESS 10 3.45e-01 -1.73e-01 8.37e-01
RETINAL ROD CELL DIFFERENTIATION 15 2.47e-01 -1.73e-01 7.64e-01
RENAL ABSORPTION 33 8.63e-02 -1.73e-01 5.77e-01
EXIT FROM MITOSIS 32 9.12e-02 -1.73e-01 5.86e-01
RESPONSE TO HISTAMINE 11 3.22e-01 1.73e-01 8.23e-01
METANEPHRIC MESENCHYMAL CELL DIFFERENTIATION 5 5.04e-01 -1.72e-01 9.02e-01
CALCIUM ION TRANSMEMBRANE TRANSPORT VIA HIGH VOLTAGE GATED CALCIUM CHANNEL 19 1.93e-01 -1.72e-01 7.16e-01
MITOCHONDRION DISTRIBUTION 17 2.19e-01 -1.72e-01 7.37e-01
REGULATION OF VENTRICULAR CARDIAC MUSCLE CELL MEMBRANE DEPOLARIZATION 7 4.30e-01 1.72e-01 8.74e-01
EMBRYONIC CAMERA TYPE EYE FORMATION 11 3.23e-01 -1.72e-01 8.23e-01
SUCKLING BEHAVIOR 12 3.02e-01 1.72e-01 8.07e-01
NEGATIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS 49 3.71e-02 -1.72e-01 4.10e-01
MAINTENANCE OF CELL POLARITY 18 2.06e-01 -1.72e-01 7.29e-01
APOPTOTIC PROCESS IN BONE MARROW CELL 6 4.66e-01 1.72e-01 8.90e-01
CELLULAR RESPONSE TO LIPOPROTEIN PARTICLE STIMULUS 41 5.70e-02 -1.72e-01 4.93e-01
NUCLEOLAR LARGE RRNA TRANSCRIPTION BY RNA POLYMERASE I 21 1.73e-01 -1.72e-01 6.90e-01
NADPH REGENERATION 23 1.54e-01 -1.72e-01 6.79e-01
POSITIVE REGULATION OF NEURON MIGRATION 19 1.95e-01 -1.72e-01 7.19e-01
NEGATIVE REGULATION OF DENDRITIC CELL APOPTOTIC PROCESS 8 4.01e-01 -1.72e-01 8.63e-01
MULTICELLULAR ORGANISMAL MOVEMENT 58 2.39e-02 -1.72e-01 3.59e-01
POSITIVE REGULATION OF RESPONSE TO WOUNDING 77 9.27e-03 -1.71e-01 2.26e-01
OVULATION 15 2.50e-01 1.71e-01 7.67e-01
NEGATIVE REGULATION OF NEUROINFLAMMATORY RESPONSE 18 2.08e-01 -1.71e-01 7.29e-01
NUCLEOBASE METABOLIC PROCESS 41 5.77e-02 1.71e-01 4.96e-01
MONOSACCHARIDE METABOLIC PROCESS 260 1.96e-06 -1.71e-01 6.70e-04
REGULATION OF PLASMA MEMBRANE ORGANIZATION 17 2.22e-01 -1.71e-01 7.41e-01
NEGATIVE REGULATION OF MAST CELL DEGRANULATION 6 4.68e-01 1.71e-01 8.90e-01
PROTEIN REPAIR 7 4.34e-01 -1.71e-01 8.74e-01
REGULATION OF SYNAPTIC VESICLE EXOCYTOSIS 43 5.25e-02 1.71e-01 4.75e-01
PYROPTOSIS 37 7.22e-02 -1.71e-01 5.42e-01
MEMBRANE DEPOLARIZATION DURING ACTION POTENTIAL 28 1.18e-01 1.71e-01 6.31e-01
POSITIVE REGULATION OF SPROUTING ANGIOGENESIS 28 1.19e-01 -1.70e-01 6.32e-01
NEGATIVE REGULATION OF CELL MATRIX ADHESION 40 6.24e-02 -1.70e-01 5.12e-01
POSITIVE REGULATION OF OPSONIZATION 9 3.77e-01 -1.70e-01 8.51e-01
TRNA THREONYLCARBAMOYLADENOSINE METABOLIC PROCESS 18 2.11e-01 1.70e-01 7.32e-01
PURINE RIBONUCLEOSIDE METABOLIC PROCESS 21 1.77e-01 -1.70e-01 6.97e-01
NEGATIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION 22 1.67e-01 1.70e-01 6.86e-01
MITOCHONDRIAL TRNA PROCESSING 14 2.71e-01 1.70e-01 7.79e-01
L GLUTAMINE IMPORT ACROSS PLASMA MEMBRANE 5 5.10e-01 -1.70e-01 9.05e-01
EMBRYONIC SKELETAL JOINT MORPHOGENESIS 11 3.29e-01 1.70e-01 8.30e-01
REGULATION OF AXON GUIDANCE 13 2.88e-01 1.70e-01 7.97e-01
VIRAL RELEASE FROM HOST CELL 28 1.20e-01 -1.70e-01 6.33e-01
REGULATION OF MRNA CATABOLIC PROCESS 245 4.57e-06 -1.70e-01 1.20e-03
ENDOPLASMIC RETICULUM TO CYTOSOL TRANSPORT 28 1.20e-01 1.70e-01 6.33e-01
PROLACTIN SECRETION 5 5.11e-01 -1.70e-01 9.06e-01
NEGATIVE REGULATION OF BEHAVIOR 13 2.89e-01 1.70e-01 7.99e-01
L CYSTINE TRANSPORT 6 4.72e-01 -1.70e-01 8.91e-01
RIBOSOMAL SMALL SUBUNIT ASSEMBLY 18 2.13e-01 -1.70e-01 7.32e-01
NUCLEAR PORE ORGANIZATION 15 2.56e-01 1.70e-01 7.70e-01
PROTEIN DEMETHYLATION 11 3.31e-01 -1.69e-01 8.31e-01
CELL PROLIFERATION IN FOREBRAIN 27 1.28e-01 1.69e-01 6.48e-01
EXTRACELLULAR REGULATION OF SIGNAL TRANSDUCTION 13 2.91e-01 -1.69e-01 7.99e-01
LUNG GROWTH 6 4.73e-01 1.69e-01 8.91e-01
TELOMERASE HOLOENZYME COMPLEX ASSEMBLY 6 4.73e-01 1.69e-01 8.91e-01
REGULATION OF FIBRINOLYSIS 18 2.15e-01 -1.69e-01 7.33e-01
POSITIVE REGULATION OF RECEPTOR RECYCLING 14 2.74e-01 -1.69e-01 7.81e-01
POSITIVE REGULATION OF METAPHASE ANAPHASE TRANSITION OF CELL CYCLE 15 2.58e-01 1.69e-01 7.71e-01
DICARBOXYLIC ACID METABOLIC PROCESS 93 4.89e-03 -1.69e-01 1.64e-01
XENOBIOTIC CATABOLIC PROCESS 25 1.44e-01 1.69e-01 6.72e-01
HEMATOPOIETIC STEM CELL MIGRATION 8 4.09e-01 1.69e-01 8.64e-01
EPITHELIAL CILIUM MOVEMENT INVOLVED IN DETERMINATION OF LEFT RIGHT ASYMMETRY 13 2.93e-01 1.68e-01 8.01e-01
CARBOHYDRATE CATABOLIC PROCESS 162 2.15e-04 -1.68e-01 2.16e-02
SUBSTRATE ADHESION DEPENDENT CELL SPREADING 100 3.60e-03 -1.68e-01 1.37e-01
NEGATIVE REGULATION OF CALCINEURIN MEDIATED SIGNALING 15 2.59e-01 -1.68e-01 7.72e-01
RESPONSE TO COPPER ION 36 8.06e-02 -1.68e-01 5.62e-01
NEGATIVE REGULATION OF VIRAL GENOME REPLICATION 55 3.09e-02 -1.68e-01 3.85e-01
RESPONSE TO PROSTAGLANDIN 32 9.97e-02 -1.68e-01 6.02e-01
REGULATION OF EXOSOMAL SECRETION 19 2.05e-01 -1.68e-01 7.29e-01
AMP BIOSYNTHETIC PROCESS 13 2.95e-01 1.68e-01 8.02e-01
NEGATIVE REGULATION BY HOST OF VIRAL PROCESS 16 2.45e-01 1.68e-01 7.63e-01
NEGATIVE REGULATION OF AMYLOID PRECURSOR PROTEIN BIOSYNTHETIC PROCESS 20 1.94e-01 -1.68e-01 7.17e-01
LIPOPROTEIN CATABOLIC PROCESS 15 2.61e-01 -1.68e-01 7.72e-01
NEGATIVE REGULATION OF CHOLESTEROL EFFLUX 22 1.73e-01 -1.68e-01 6.90e-01
REGULATION OF PHOSPHATIDYLINOSITOL DEPHOSPHORYLATION 6 4.77e-01 -1.68e-01 8.93e-01
POSITIVE REGULATION OF JUN KINASE ACTIVITY 31 1.06e-01 -1.68e-01 6.11e-01
G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY 1169 3.70e-22 1.68e-01 4.70e-19
REGULATION OF DNA METHYLATION 21 1.84e-01 -1.68e-01 7.05e-01
REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING 61 2.36e-02 -1.68e-01 3.58e-01
POSITIVE REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS BY VEGF ACTIVATED VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY 5 5.16e-01 1.68e-01 9.08e-01
POSITIVE REGULATION OF PROTEIN DEPOLYMERIZATION 19 2.07e-01 -1.67e-01 7.29e-01
OUTER EAR MORPHOGENESIS 8 4.13e-01 1.67e-01 8.65e-01
IRON IMPORT INTO CELL 10 3.60e-01 1.67e-01 8.46e-01
GAMMA AMINOBUTYRIC ACID BIOSYNTHETIC PROCESS 6 4.78e-01 -1.67e-01 8.93e-01
REGULATION OF ENDOCYTIC RECYCLING 21 1.85e-01 -1.67e-01 7.07e-01
POSITIVE REGULATION OF COAGULATION 30 1.13e-01 -1.67e-01 6.25e-01
POSITIVE REGULATION OF MRNA 3 END PROCESSING 6 4.78e-01 1.67e-01 8.93e-01
T CELL MIGRATION 70 1.56e-02 1.67e-01 2.95e-01
DIAPEDESIS 7 4.44e-01 1.67e-01 8.78e-01
AMYLOID BETA METABOLIC PROCESS 64 2.10e-02 -1.67e-01 3.41e-01
NEURON FATE DETERMINATION 10 3.62e-01 1.67e-01 8.46e-01
INTEGRIN BIOSYNTHETIC PROCESS 6 4.80e-01 1.67e-01 8.94e-01
ATRIAL CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION 11 3.39e-01 -1.67e-01 8.34e-01
VIRION ASSEMBLY 34 9.29e-02 -1.66e-01 5.89e-01
NEGATIVE REGULATION OF SODIUM ION TRANSPORT 18 2.22e-01 -1.66e-01 7.40e-01
REGULATION OF CHOLESTEROL METABOLIC PROCESS 42 6.20e-02 -1.66e-01 5.11e-01
PYRIMIDINE DEOXYRIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS 11 3.39e-01 1.66e-01 8.35e-01
REGULATION OF UNSATURATED FATTY ACID BIOSYNTHETIC PROCESS 15 2.65e-01 1.66e-01 7.75e-01
COCHLEA MORPHOGENESIS 24 1.59e-01 1.66e-01 6.79e-01
POSITIVE REGULATION OF RECEPTOR INTERNALIZATION 28 1.28e-01 1.66e-01 6.48e-01
NADP METABOLIC PROCESS 44 5.66e-02 -1.66e-01 4.91e-01
RESPONSE TO ARSENIC CONTAINING SUBSTANCE 32 1.04e-01 -1.66e-01 6.07e-01
POSITIVE REGULATION OF THYROID HORMONE GENERATION 5 5.20e-01 -1.66e-01 9.09e-01
CELL MIGRATION INVOLVED IN KIDNEY DEVELOPMENT 6 4.82e-01 -1.66e-01 8.94e-01
REGULATION OF GLUTAMATE SECRETION NEUROTRANSMISSION 5 5.21e-01 -1.66e-01 9.09e-01
DEFENSE RESPONSE TO TUMOR CELL 13 3.01e-01 1.66e-01 8.07e-01
PRIMITIVE ERYTHROCYTE DIFFERENTIATION 5 5.22e-01 1.66e-01 9.10e-01
TOLERANCE INDUCTION 30 1.17e-01 1.65e-01 6.30e-01
NEGATIVE REGULATION OF MAST CELL ACTIVATION 13 3.02e-01 1.65e-01 8.07e-01
LIPID DROPLET DISASSEMBLY 6 4.83e-01 -1.65e-01 8.94e-01
PYRIMIDINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS 12 3.22e-01 -1.65e-01 8.23e-01
REGULATION OF GAP JUNCTION ASSEMBLY 10 3.66e-01 1.65e-01 8.48e-01
DORSAL SPINAL CORD DEVELOPMENT 20 2.01e-01 1.65e-01 7.28e-01
OLFACTORY LOBE DEVELOPMENT 39 7.45e-02 1.65e-01 5.49e-01
ENDOPLASMIC RETICULUM LOCALIZATION 10 3.66e-01 -1.65e-01 8.48e-01
GUANINE METABOLIC PROCESS 5 5.23e-01 1.65e-01 9.10e-01
NEGATIVE REGULATION OF SMAD PROTEIN SIGNAL TRANSDUCTION 22 1.81e-01 -1.65e-01 7.01e-01
REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY RENIN ANGIOTENSIN 24 1.62e-01 1.65e-01 6.81e-01
NAD BIOSYNTHESIS VIA NICOTINAMIDE RIBOSIDE SALVAGE PATHWAY 10 3.67e-01 -1.65e-01 8.48e-01
POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS 19 2.14e-01 -1.65e-01 7.33e-01
METAPHASE ANAPHASE TRANSITION OF MEIOTIC CELL CYCLE 5 5.24e-01 -1.65e-01 9.10e-01
MAINTENANCE OF POSTSYNAPTIC SPECIALIZATION STRUCTURE 8 4.20e-01 -1.65e-01 8.71e-01
KIDNEY MESENCHYME DEVELOPMENT 17 2.40e-01 1.65e-01 7.59e-01
POSITIVE REGULATION OF RIG I SIGNALING PATHWAY 10 3.68e-01 -1.64e-01 8.48e-01
NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION INDEPENDENT DECAY 7 4.51e-01 1.64e-01 8.81e-01
DETECTION OF CELL DENSITY 10 3.68e-01 1.64e-01 8.48e-01
REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE 30 1.19e-01 -1.64e-01 6.33e-01
CELL PROLIFERATION INVOLVED IN HEART MORPHOGENESIS 20 2.04e-01 1.64e-01 7.29e-01
RELAXATION OF SMOOTH MUSCLE 9 3.94e-01 1.64e-01 8.59e-01
CHOLESTEROL STORAGE 25 1.56e-01 -1.64e-01 6.79e-01
POSITIVE REGULATION OF RNA SPLICING 39 7.65e-02 -1.64e-01 5.53e-01
REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS 55 3.56e-02 -1.64e-01 4.04e-01
POSITIVE REGULATION OF SYNAPTIC TRANSMISSION GABAERGIC 15 2.73e-01 -1.64e-01 7.80e-01
POSITIVE REGULATION OF MITOCHONDRION ORGANIZATION 75 1.44e-02 -1.63e-01 2.82e-01
REGULATION OF GERM CELL PROLIFERATION 8 4.24e-01 -1.63e-01 8.73e-01
ALDITOL CATABOLIC PROCESS 7 4.54e-01 1.63e-01 8.81e-01
POSITIVE REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE 103 4.19e-03 -1.63e-01 1.52e-01
NEGATIVE REGULATION OF MONOCYTE CHEMOTACTIC PROTEIN 1 PRODUCTION 6 4.89e-01 1.63e-01 8.94e-01
NEGATIVE REGULATION OF HAIR FOLLICLE DEVELOPMENT 5 5.27e-01 1.63e-01 9.10e-01
TACHYKININ RECEPTOR SIGNALING PATHWAY 8 4.24e-01 -1.63e-01 8.73e-01
REGULATION OF MONOCYTE CHEMOTAXIS 28 1.35e-01 1.63e-01 6.59e-01
MAMMARY GLAND BRANCHING INVOLVED IN PREGNANCY 7 4.55e-01 1.63e-01 8.82e-01
TYPE II PNEUMOCYTE DIFFERENTIATION 6 4.89e-01 1.63e-01 8.95e-01
SOFT PALATE DEVELOPMENT 5 5.28e-01 1.63e-01 9.10e-01
HYPEROSMOTIC RESPONSE 27 1.43e-01 -1.63e-01 6.69e-01
POSITIVE REGULATION OF CYTOSKELETON ORGANIZATION 184 1.38e-04 -1.63e-01 1.70e-02
REGULATION OF UBIQUITIN PROTEIN LIGASE ACTIVITY 18 2.32e-01 1.63e-01 7.49e-01
SCHWANN CELL DIFFERENTIATION 39 7.87e-02 -1.63e-01 5.58e-01
T CELL EXTRAVASATION 12 3.30e-01 1.62e-01 8.30e-01
POSITIVE REGULATION OF PROTEIN POLYUBIQUITINATION 17 2.47e-01 1.62e-01 7.64e-01
PROTEIN TRANSMEMBRANE IMPORT INTO INTRACELLULAR ORGANELLE 38 8.33e-02 1.62e-01 5.70e-01
VENOUS BLOOD VESSEL MORPHOGENESIS 9 3.99e-01 -1.62e-01 8.61e-01
BASE EXCISION REPAIR GAP FILLING 14 2.93e-01 -1.62e-01 8.02e-01
NEGATIVE REGULATION OF SISTER CHROMATID COHESION 5 5.30e-01 1.62e-01 9.11e-01
PURINE RIBONUCLEOTIDE SALVAGE 8 4.27e-01 1.62e-01 8.74e-01
UBIQUINONE METABOLIC PROCESS 19 2.22e-01 -1.62e-01 7.40e-01
ESTABLISHMENT OF MITOCHONDRION LOCALIZATION 30 1.25e-01 1.62e-01 6.46e-01
ACTIN FILAMENT BASED TRANSPORT 21 1.99e-01 -1.62e-01 7.25e-01
REGULATION OF MITOCHONDRIAL MEMBRANE PERMEABILITY INVOLVED IN APOPTOTIC PROCESS 47 5.49e-02 -1.62e-01 4.84e-01
EPITHELIAL CELL MORPHOGENESIS 33 1.08e-01 -1.62e-01 6.12e-01
POSITIVE REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION 32 1.13e-01 -1.62e-01 6.25e-01
CHOLESTEROL EFFLUX 73 1.71e-02 -1.61e-01 3.00e-01
CARDIAC VENTRICLE FORMATION 8 4.30e-01 -1.61e-01 8.74e-01
ESTABLISHMENT OF SPINDLE ORIENTATION 42 7.05e-02 -1.61e-01 5.37e-01
SPERM MITOCHONDRIAL SHEATH ASSEMBLY 6 4.94e-01 1.61e-01 8.97e-01
NEGATIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION 53 4.28e-02 -1.61e-01 4.35e-01
POSITIVE REGULATION OF CELL PROLIFERATION INVOLVED IN KIDNEY DEVELOPMENT 9 4.03e-01 1.61e-01 8.63e-01
HISTONE MRNA METABOLIC PROCESS 24 1.73e-01 1.61e-01 6.90e-01
AMINO ACID BETAINE TRANSPORT 14 2.98e-01 -1.61e-01 8.04e-01
MESENCHYMAL CELL DEVELOPMENT 6 4.95e-01 -1.61e-01 8.98e-01
AUTOPHAGY OF MITOCHONDRION 97 6.21e-03 -1.61e-01 1.83e-01
ANTERIOR HEAD DEVELOPMENT 7 4.61e-01 1.61e-01 8.88e-01
REGULATION OF SKELETAL MUSCLE TISSUE REGENERATION 8 4.31e-01 -1.61e-01 8.74e-01
DERMATAN SULFATE METABOLIC PROCESS 9 4.04e-01 -1.61e-01 8.63e-01
CYTOLYSIS 7 4.62e-01 -1.61e-01 8.88e-01
REGULATION OF MICROTUBULE POLYMERIZATION 61 3.00e-02 -1.61e-01 3.83e-01
MITOTIC CYTOKINETIC PROCESS 26 1.56e-01 -1.61e-01 6.79e-01
BERGMANN GLIAL CELL DIFFERENTIATION 11 3.56e-01 -1.61e-01 8.44e-01
REGULATION OF PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY 144 8.81e-04 -1.61e-01 5.83e-02
NEGATIVE REGULATION OF PROGRAMMED NECROTIC CELL DEATH 23 1.83e-01 -1.61e-01 7.03e-01
MULTIVESICULAR BODY ORGANIZATION 32 1.16e-01 -1.61e-01 6.30e-01
SUCCINATE TRANSMEMBRANE TRANSPORT 6 4.96e-01 -1.60e-01 8.99e-01
REGULATION OF GONAD DEVELOPMENT 12 3.36e-01 -1.60e-01 8.31e-01
ASPARTATE FAMILY AMINO ACID CATABOLIC PROCESS 17 2.52e-01 1.60e-01 7.68e-01
NUCLEAR MEMBRANE REASSEMBLY 25 1.65e-01 -1.60e-01 6.84e-01
AV NODE CELL TO BUNDLE OF HIS CELL SIGNALING 11 3.58e-01 1.60e-01 8.45e-01
EMBRYONIC RETINA MORPHOGENESIS IN CAMERA TYPE EYE 6 4.97e-01 1.60e-01 8.99e-01
POSITIVE REGULATION OF CELL CYCLE CHECKPOINT 18 2.40e-01 -1.60e-01 7.59e-01
LOW DENSITY LIPOPROTEIN PARTICLE REMODELING 16 2.68e-01 1.60e-01 7.77e-01
PERIPHERAL NERVOUS SYSTEM MYELIN MAINTENANCE 9 4.06e-01 -1.60e-01 8.63e-01
POSITIVE REGULATION OF TRANSFORMING GROWTH FACTOR BETA1 PRODUCTION 8 4.33e-01 -1.60e-01 8.74e-01
LATE ENDOSOME TO LYSOSOME TRANSPORT 21 2.05e-01 -1.60e-01 7.29e-01
GOLGI TO VACUOLE TRANSPORT 20 2.16e-01 -1.60e-01 7.33e-01
NEGATIVE REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY 13 3.18e-01 -1.60e-01 8.21e-01
VESICLE TETHERING INVOLVED IN EXOCYTOSIS 9 4.07e-01 1.60e-01 8.63e-01
NEGATIVE REGULATION OF CHEMOKINE PRODUCTION 31 1.24e-01 -1.60e-01 6.45e-01
SCARNA LOCALIZATION TO CAJAL BODY 5 5.36e-01 1.60e-01 9.13e-01
VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY 61 3.12e-02 -1.60e-01 3.85e-01
DERMATAN SULFATE PROTEOGLYCAN METABOLIC PROCESS 12 3.39e-01 -1.59e-01 8.34e-01
PROTEIN K63 LINKED UBIQUITINATION 58 3.58e-02 -1.59e-01 4.04e-01
REGULATION OF MESENCHYMAL TO EPITHELIAL TRANSITION INVOLVED IN METANEPHROS MORPHOGENESIS 7 4.65e-01 -1.59e-01 8.90e-01
POSITIVE REGULATION OF INTERLEUKIN 1 ALPHA PRODUCTION 6 5.00e-01 1.59e-01 9.00e-01
POSITIVE REGULATION OF AMYLOID FIBRIL FORMATION 5 5.38e-01 -1.59e-01 9.13e-01
CARDIAC MUSCLE CELL MYOBLAST DIFFERENTIATION 12 3.40e-01 1.59e-01 8.35e-01
PEPTIDYL LYSINE DIMETHYLATION 11 3.61e-01 -1.59e-01 8.46e-01
VIRAL TRANSLATIONAL TERMINATION REINITIATION 5 5.38e-01 -1.59e-01 9.13e-01
CARDIAC PACEMAKER CELL DIFFERENTIATION 11 3.61e-01 1.59e-01 8.46e-01
NEGATIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA JAK STAT 24 1.78e-01 1.59e-01 6.98e-01
PHOSPHATIDYLSERINE ACYL CHAIN REMODELING 9 4.09e-01 -1.59e-01 8.64e-01
DIENCEPHALON DEVELOPMENT 79 1.46e-02 1.59e-01 2.85e-01
GOLGI TO LYSOSOME TRANSPORT 12 3.41e-01 -1.59e-01 8.35e-01
CELLULAR RESPONSE TO OSMOTIC STRESS 53 4.56e-02 -1.59e-01 4.48e-01
T CELL MEDIATED IMMUNE RESPONSE TO TUMOR CELL 9 4.10e-01 -1.59e-01 8.64e-01
SKELETAL MUSCLE ATROPHY 5 5.39e-01 1.59e-01 9.13e-01
STRESS INDUCED PREMATURE SENESCENCE 8 4.37e-01 -1.59e-01 8.75e-01
THIAMINE TRANSPORT 8 4.37e-01 -1.59e-01 8.75e-01
REGULATION OF PROTEIN CATABOLIC PROCESS IN THE VACUOLE 13 3.22e-01 -1.59e-01 8.23e-01
STEM CELL FATE COMMITMENT 10 3.85e-01 -1.59e-01 8.55e-01
SPLICEOSOMAL TRI SNRNP COMPLEX ASSEMBLY 19 2.31e-01 -1.59e-01 7.49e-01
FOCAL ADHESION ASSEMBLY 85 1.15e-02 -1.59e-01 2.50e-01
POSITIVE REGULATION OF PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR SIGNALING PATHWAY 9 4.10e-01 1.59e-01 8.64e-01
NEGATIVE REGULATION OF LIPOPROTEIN METABOLIC PROCESS 5 5.39e-01 1.58e-01 9.13e-01
CORTICAL CYTOSKELETON ORGANIZATION 50 5.25e-02 -1.58e-01 4.75e-01
PURINE NUCLEOBASE TRANSMEMBRANE TRANSPORT 8 4.38e-01 -1.58e-01 8.76e-01
REGULATION OF MICROGLIAL CELL ACTIVATION 20 2.20e-01 1.58e-01 7.39e-01
REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION 60 3.39e-02 1.58e-01 4.03e-01
THYROID GLAND DEVELOPMENT 31 1.27e-01 -1.58e-01 6.48e-01
REGULATION OF RIBONUCLEASE ACTIVITY 9 4.11e-01 -1.58e-01 8.64e-01
REGULATION OF DNA LIGATION 6 5.02e-01 1.58e-01 9.01e-01
PROTEIN IMPORT INTO MITOCHONDRIAL MATRIX 20 2.20e-01 1.58e-01 7.39e-01
NEPHRIC DUCT FORMATION 5 5.40e-01 -1.58e-01 9.13e-01
T CELL PROLIFERATION INVOLVED IN IMMUNE RESPONSE 5 5.40e-01 1.58e-01 9.13e-01
PYRUVATE METABOLIC PROCESS 118 3.01e-03 -1.58e-01 1.28e-01
TRANS SYNAPTIC SIGNALING MODULATING SYNAPTIC TRANSMISSION 10 3.87e-01 1.58e-01 8.55e-01
AGGRESOME ASSEMBLY 6 5.03e-01 1.58e-01 9.02e-01
MACROPHAGE CYTOKINE PRODUCTION 37 9.66e-02 -1.58e-01 5.96e-01
QUATERNARY AMMONIUM GROUP TRANSPORT 30 1.35e-01 -1.58e-01 6.59e-01
REGULATION OF CELLULAR RESPONSE TO OSMOTIC STRESS 13 3.25e-01 -1.58e-01 8.25e-01
FOREBRAIN RADIAL GLIAL CELL DIFFERENTIATION 7 4.70e-01 -1.58e-01 8.90e-01
MHC CLASS I BIOSYNTHETIC PROCESS 8 4.40e-01 1.58e-01 8.77e-01
REGULATION OF MESODERMAL CELL DIFFERENTIATION 9 4.13e-01 -1.58e-01 8.65e-01
NEGATIVE REGULATION OF FATTY ACID OXIDATION 14 3.08e-01 -1.58e-01 8.11e-01
CELLULAR RESPONSE TO MAGNESIUM ION 7 4.71e-01 1.57e-01 8.90e-01
MACROMOLECULE DEACYLATION 69 2.37e-02 -1.57e-01 3.58e-01
DETECTION OF LIGHT STIMULUS 65 2.82e-02 -1.57e-01 3.73e-01
NEGATIVE REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA 20 2.23e-01 -1.57e-01 7.41e-01
NEGATIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE PROTEIN KINASE B SIGNAL TRANSDUCTION 68 2.50e-02 -1.57e-01 3.65e-01
POSITIVE REGULATION OF TYROSINE PHOSPHORYLATION OF STAT PROTEIN 66 2.72e-02 -1.57e-01 3.69e-01
PREASSEMBLY OF GPI ANCHOR IN ER MEMBRANE 8 4.41e-01 1.57e-01 8.78e-01
NEGATIVE REGULATION OF MESENCHYMAL CELL APOPTOTIC PROCESS 11 3.67e-01 1.57e-01 8.48e-01
ADENOSINE TO INOSINE EDITING 7 4.72e-01 -1.57e-01 8.91e-01
NEUROFILAMENT CYTOSKELETON ORGANIZATION 10 3.90e-01 1.57e-01 8.56e-01
CELLULAR RESPONSE TO GLUCOSE STARVATION 50 5.47e-02 -1.57e-01 4.84e-01
POSITIVE REGULATION OF MITOCHONDRIAL MEMBRANE PERMEABILITY 46 6.54e-02 -1.57e-01 5.24e-01
PHOSPHATIDYLETHANOLAMINE BIOSYNTHETIC PROCESS 10 3.91e-01 -1.57e-01 8.57e-01
NEGATIVE REGULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL 11 3.68e-01 1.57e-01 8.48e-01
POSTSYNAPTIC CYTOSKELETON ORGANIZATION 17 2.63e-01 -1.57e-01 7.74e-01
CELLULAR RESPONSE TO ACIDIC PH 17 2.63e-01 -1.57e-01 7.74e-01
REGULATION OF RECEPTOR BINDING 17 2.64e-01 -1.57e-01 7.74e-01
DETERMINATION OF PANCREATIC LEFT RIGHT ASYMMETRY 5 5.44e-01 1.57e-01 9.13e-01
NEGATIVE REGULATION OF ANDROGEN RECEPTOR SIGNALING PATHWAY 15 2.94e-01 -1.56e-01 8.02e-01
SINOATRIAL NODE CELL DEVELOPMENT 5 5.45e-01 1.56e-01 9.13e-01
PURINE NUCLEOSIDE CATABOLIC PROCESS 8 4.44e-01 -1.56e-01 8.78e-01
RESPONSE TO DISACCHARIDE 7 4.74e-01 1.56e-01 8.91e-01
CELLULAR RESPONSE TO FOLLICLE STIMULATING HORMONE STIMULUS 10 3.92e-01 1.56e-01 8.57e-01
KERATAN SULFATE METABOLIC PROCESS 18 2.51e-01 -1.56e-01 7.68e-01
POSITIVE REGULATION OF CARTILAGE DEVELOPMENT 31 1.32e-01 1.56e-01 6.56e-01
POSITIVE REGULATION OF NITRIC OXIDE MEDIATED SIGNAL TRANSDUCTION 5 5.45e-01 1.56e-01 9.13e-01
MITOCHONDRIAL DNA REPLICATION 14 3.13e-01 1.56e-01 8.14e-01
PROSTATE GLANDULAR ACINUS DEVELOPMENT 10 3.93e-01 -1.56e-01 8.58e-01
FOREBRAIN DORSAL VENTRAL PATTERN FORMATION 7 4.75e-01 1.56e-01 8.91e-01
ADULT HEART DEVELOPMENT 13 3.31e-01 1.56e-01 8.31e-01
POSITIVE REGULATION OF DEOXYRIBONUCLEASE ACTIVITY 5 5.46e-01 -1.56e-01 9.14e-01
GOLGI RIBBON FORMATION 10 3.93e-01 1.56e-01 8.58e-01
NEGATIVE REGULATION OF DEFENSE RESPONSE TO VIRUS 51 5.42e-02 -1.56e-01 4.81e-01
REGULATION OF OSTEOCLAST DIFFERENTIATION 69 2.53e-02 1.56e-01 3.65e-01
VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION 93 9.45e-03 -1.56e-01 2.28e-01
REGULATION OF NOTCH SIGNALING PATHWAY 95 8.73e-03 -1.56e-01 2.20e-01
GLUTAMATE RECEPTOR SIGNALING PATHWAY 50 5.70e-02 1.56e-01 4.93e-01
REGULATION OF T CELL CHEMOTAXIS 15 2.97e-01 1.55e-01 8.04e-01
SPHINGOMYELIN METABOLIC PROCESS 20 2.29e-01 -1.55e-01 7.46e-01
REGULATION OF ALDOSTERONE METABOLIC PROCESS 8 4.47e-01 1.55e-01 8.79e-01
ACTIN FILAMENT BASED PROCESS 799 8.03e-14 -1.55e-01 7.65e-11
10 FORMYLTETRAHYDROFOLATE METABOLIC PROCESS 6 5.11e-01 -1.55e-01 9.06e-01
REGULATION OF INOSITOL PHOSPHATE BIOSYNTHETIC PROCESS 17 2.69e-01 1.55e-01 7.78e-01
IRON COORDINATION ENTITY TRANSPORT 13 3.34e-01 -1.55e-01 8.31e-01
NEPHRON TUBULE FORMATION 20 2.31e-01 -1.55e-01 7.49e-01
OLIGOSACCHARIDE BIOSYNTHETIC PROCESS 29 1.49e-01 -1.55e-01 6.77e-01
REGULATION OF FATTY ACID TRANSPORT 31 1.36e-01 -1.55e-01 6.60e-01
NEGATIVE REGULATION OF AUTOPHAGY 89 1.17e-02 -1.55e-01 2.51e-01
NEGATIVE REGULATION OF COLLAGEN METABOLIC PROCESS 12 3.54e-01 1.54e-01 8.43e-01
SKELETAL MUSCLE ADAPTATION 25 1.81e-01 -1.54e-01 7.01e-01
ANTEROGRADE AXONAL TRANSPORT OF MITOCHONDRION 6 5.13e-01 1.54e-01 9.07e-01
DIPEPTIDE TRANSMEMBRANE TRANSPORT 7 4.80e-01 -1.54e-01 8.94e-01
RESPONSE TO VASOPRESSIN 8 4.50e-01 -1.54e-01 8.81e-01
D ASPARTATE IMPORT ACROSS PLASMA MEMBRANE 5 5.50e-01 -1.54e-01 9.17e-01
NEGATIVE REGULATION OF NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION DEPENDENT DECAY 12 3.55e-01 1.54e-01 8.44e-01
POST FERTILIZATION EPIGENETIC REGULATION OF GENE EXPRESSION 14 3.18e-01 -1.54e-01 8.21e-01
REGULATION OF LYSOSOMAL PROTEIN CATABOLIC PROCESS 11 3.76e-01 -1.54e-01 8.50e-01
POSITIVE REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING 42 8.40e-02 -1.54e-01 5.70e-01
CELL KILLING 219 8.44e-05 1.54e-01 1.24e-02
PROTEIN LOCALIZATION TO PLASMA MEMBRANE RAFT 5 5.51e-01 -1.54e-01 9.17e-01
NEGATIVE REGULATION OF B CELL MEDIATED IMMUNITY 15 3.02e-01 -1.54e-01 8.07e-01
NEGATIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE 35 1.15e-01 -1.54e-01 6.28e-01
REFLEX 21 2.22e-01 1.54e-01 7.41e-01
NEGATIVE REGULATION OF GRANULOCYTE DIFFERENTIATION 8 4.51e-01 -1.54e-01 8.81e-01
SYNAPTIC VESICLE TRANSPORT 40 9.23e-02 1.54e-01 5.88e-01
PYRIMIDINE RIBONUCLEOTIDE BIOSYNTHETIC PROCESS 24 1.92e-01 -1.54e-01 7.16e-01
POSITIVE REGULATION OF MAMMARY GLAND EPITHELIAL CELL PROLIFERATION 6 5.15e-01 -1.54e-01 9.07e-01
DENDRITIC CELL APOPTOTIC PROCESS 11 3.78e-01 -1.54e-01 8.51e-01
FLAVIN CONTAINING COMPOUND METABOLIC PROCESS 6 5.15e-01 1.53e-01 9.07e-01
RNA DESTABILIZATION 165 6.71e-04 -1.53e-01 4.73e-02
PURINE NUCLEOSIDE BIOSYNTHETIC PROCESS 11 3.78e-01 1.53e-01 8.51e-01
ESTROGEN METABOLIC PROCESS 38 1.02e-01 1.53e-01 6.04e-01
NEGATIVE REGULATION OF AMINE TRANSPORT 28 1.60e-01 1.53e-01 6.80e-01
REGULATION OF T CELL DIFFERENTIATION IN THYMUS 27 1.68e-01 1.53e-01 6.87e-01
PRIMITIVE STREAK FORMATION 11 3.79e-01 1.53e-01 8.51e-01
MIDDLE EAR MORPHOGENESIS 20 2.36e-01 1.53e-01 7.54e-01
CORONARY ARTERY MORPHOGENESIS 9 4.26e-01 1.53e-01 8.73e-01
REGULATION OF CARDIAC MUSCLE CELL ACTION POTENTIAL INVOLVED IN REGULATION OF CONTRACTION 8 4.53e-01 1.53e-01 8.81e-01
RETICULOPHAGY 18 2.62e-01 -1.53e-01 7.73e-01
AUTOPHAGIC CELL DEATH 9 4.28e-01 1.53e-01 8.74e-01
NEGATIVE REGULATION OF MICROTUBULE POLYMERIZATION 13 3.41e-01 -1.53e-01 8.35e-01
REGULATION OF T CELL MIGRATION 47 7.03e-02 1.53e-01 5.37e-01
PROTEIN KINASE C ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY 27 1.70e-01 -1.53e-01 6.87e-01
REGULATION OF ACTIN FILAMENT ORGANIZATION 268 1.72e-05 -1.52e-01 3.36e-03
NEGATIVE REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS 7 4.85e-01 -1.52e-01 8.94e-01
MITOTIC NUCLEAR MEMBRANE ORGANIZATION 10 4.04e-01 -1.52e-01 8.63e-01
LUTEINIZATION 12 3.61e-01 1.52e-01 8.46e-01
MICROGLIA DIFFERENTIATION 12 3.61e-01 -1.52e-01 8.46e-01
LYSOSOMAL TRANSPORT 132 2.55e-03 -1.52e-01 1.14e-01
REGULATION OF CELLULAR RESPONSE TO MACROPHAGE COLONY STIMULATING FACTOR STIMULUS 6 5.19e-01 -1.52e-01 9.09e-01
REGULATION OF MICROVILLUS ORGANIZATION 13 3.43e-01 -1.52e-01 8.36e-01
MICROTUBULE NUCLEATION BY MICROTUBULE ORGANIZING CENTER 5 5.57e-01 -1.52e-01 9.18e-01
REGULATION OF WNT PROTEIN SECRETION 5 5.57e-01 -1.52e-01 9.18e-01
REGULATION OF MITOCHONDRIAL RNA CATABOLIC PROCESS 5 5.57e-01 1.52e-01 9.18e-01
POSITIVE REGULATION OF DENDRITE DEVELOPMENT 16 2.94e-01 1.52e-01 8.02e-01
AMINOGLYCAN BIOSYNTHETIC PROCESS 74 2.42e-02 -1.52e-01 3.60e-01
CELL SUBSTRATE JUNCTION ORGANIZATION 102 8.17e-03 -1.52e-01 2.11e-01
NONRIBOSOMAL PEPTIDE BIOSYNTHETIC PROCESS 17 2.80e-01 -1.51e-01 7.87e-01
NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO MICROTUBULE 5 5.58e-01 -1.51e-01 9.19e-01
POSITIVE REGULATION OF EPITHELIAL CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT 7 4.88e-01 -1.51e-01 8.94e-01
NERVOUS SYSTEM PROCESS 1418 1.17e-21 1.51e-01 1.28e-18
NEGATIVE REGULATION OF SMOOTHENED SIGNALING PATHWAY 34 1.27e-01 -1.51e-01 6.48e-01
MONOCYTE DIFFERENTIATION 35 1.22e-01 -1.51e-01 6.39e-01
POSITIVE REGULATION OF CARDIAC MUSCLE CELL DIFFERENTIATION 11 3.86e-01 1.51e-01 8.55e-01
POSITIVE REGULATION OF MONOCYTE CHEMOTACTIC PROTEIN 1 PRODUCTION 15 3.12e-01 -1.51e-01 8.14e-01
OUTER DYNEIN ARM ASSEMBLY 24 2.01e-01 1.51e-01 7.27e-01
REGULATION OF CEREBELLAR GRANULE CELL PRECURSOR PROLIFERATION 11 3.87e-01 1.51e-01 8.55e-01
REGULATION OF ODONTOGENESIS OF DENTIN CONTAINING TOOTH 12 3.66e-01 1.51e-01 8.48e-01
MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS 47 7.41e-02 -1.51e-01 5.48e-01
NEUROTRANSMITTER RECEPTOR INTERNALIZATION 31 1.47e-01 -1.51e-01 6.75e-01
RESPONSE TO AXON INJURY 83 1.78e-02 -1.50e-01 3.07e-01
REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY 30 1.54e-01 -1.50e-01 6.79e-01
REGULATION OF LYMPHOCYTE MIGRATION 67 3.32e-02 1.50e-01 3.99e-01
POSITIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION 98 1.01e-02 1.50e-01 2.34e-01
REGULATION OF BONE REMODELING 49 6.89e-02 -1.50e-01 5.33e-01
DORSAL VENTRAL NEURAL TUBE PATTERNING 24 2.03e-01 1.50e-01 7.29e-01
DNA METHYLATION 49 6.91e-02 -1.50e-01 5.33e-01
NUCLEOTIDE BINDING DOMAIN LEUCINE RICH REPEAT CONTAINING RECEPTOR SIGNALING PATHWAY 29 1.62e-01 -1.50e-01 6.81e-01
POSITIVE REGULATION OF CEREBELLAR GRANULE CELL PRECURSOR PROLIFERATION 8 4.63e-01 1.50e-01 8.89e-01
VENTRICULAR TRABECULA MYOCARDIUM MORPHOGENESIS 14 3.31e-01 -1.50e-01 8.31e-01
REGULATION OF VASCULAR WOUND HEALING 13 3.49e-01 -1.50e-01 8.40e-01
DOPAMINE RECEPTOR SIGNALING PATHWAY 38 1.10e-01 -1.50e-01 6.17e-01
REGULATION OF PROTEIN ADP RIBOSYLATION 8 4.63e-01 -1.50e-01 8.89e-01
TERMINAL BUTTON ORGANIZATION 6 5.25e-01 -1.50e-01 9.10e-01
GLYCEROPHOSPHOLIPID CATABOLIC PROCESS 34 1.31e-01 -1.50e-01 6.54e-01
TRANSCRIPTION COUPLED NUCLEOTIDE EXCISION REPAIR 10 4.13e-01 -1.50e-01 8.65e-01
POSITIVE REGULATION OF PROTEIN MONOUBIQUITINATION 5 5.63e-01 -1.49e-01 9.21e-01
TOOTH MINERALIZATION 30 1.57e-01 -1.49e-01 6.79e-01
INNERVATION 26 1.88e-01 1.49e-01 7.09e-01
PROTEIN DNA COMPLEX DISASSEMBLY 21 2.36e-01 -1.49e-01 7.54e-01
INTRACILIARY TRANSPORT INVOLVED IN CILIUM ASSEMBLY 6 5.27e-01 -1.49e-01 9.10e-01
REGULATION OF T HELPER 1 TYPE IMMUNE RESPONSE 31 1.51e-01 1.49e-01 6.79e-01
NEGATIVE REGULATION OF PINOCYTOSIS 5 5.63e-01 -1.49e-01 9.21e-01
PROTEIN TRANSMEMBRANE TRANSPORT 67 3.47e-02 1.49e-01 4.03e-01
BONE CELL DEVELOPMENT 18 2.73e-01 -1.49e-01 7.80e-01
MAST CELL MIGRATION 14 3.34e-01 -1.49e-01 8.31e-01
ACTIN FILAMENT ORGANIZATION 459 4.28e-08 -1.49e-01 2.67e-05
REGULATION OF PROSTAGLANDIN SECRETION 13 3.52e-01 -1.49e-01 8.41e-01
NUCLEOLUS ORGANIZATION 18 2.74e-01 -1.49e-01 7.80e-01
REGULATION OF SENSORY PERCEPTION 17 2.87e-01 1.49e-01 7.97e-01
REGULATION OF STEROL TRANSPORT 80 2.13e-02 -1.49e-01 3.42e-01
RESPONSE TO INTERFERON BETA 33 1.39e-01 -1.49e-01 6.64e-01
NEGATIVE REGULATION OF ERBB SIGNALING PATHWAY 32 1.45e-01 -1.49e-01 6.74e-01
POSITIVE REGULATION OF TRIGLYCERIDE METABOLIC PROCESS 22 2.28e-01 -1.49e-01 7.44e-01
NEUROBLAST DIVISION 14 3.36e-01 1.49e-01 8.31e-01
SYNAPTIC VESICLE UNCOATING 6 5.29e-01 -1.49e-01 9.10e-01
CELLULAR RESPONSE TO PH 27 1.82e-01 -1.49e-01 7.01e-01
NEURONAL ION CHANNEL CLUSTERING 12 3.73e-01 -1.49e-01 8.49e-01
NEGATIVE REGULATION OF INTERLEUKIN 1 PRODUCTION 52 6.39e-02 -1.49e-01 5.18e-01
CARDIOBLAST DIFFERENTIATION 17 2.89e-01 1.48e-01 7.99e-01
POSITIVE REGULATION OF SODIUM PROTON ANTIPORTER ACTIVITY 5 5.65e-01 -1.48e-01 9.21e-01
MYELOID LEUKOCYTE CYTOKINE PRODUCTION 51 6.67e-02 -1.48e-01 5.28e-01
CELLULAR RESPONSE TO UV A 11 3.94e-01 1.48e-01 8.59e-01
CELLULAR RESPONSE TO UV B 12 3.74e-01 -1.48e-01 8.50e-01
CONVERGENT EXTENSION INVOLVED IN ORGANOGENESIS 5 5.66e-01 -1.48e-01 9.21e-01
FATTY ACYL COA CATABOLIC PROCESS 6 5.30e-01 1.48e-01 9.11e-01
FORELIMB MORPHOGENESIS 40 1.05e-01 1.48e-01 6.09e-01
HARD PALATE DEVELOPMENT 8 4.68e-01 1.48e-01 8.90e-01
PROTEIN NITROSYLATION 16 3.05e-01 1.48e-01 8.10e-01
NEGATIVE REGULATION OF VASOCONSTRICTION 8 4.69e-01 -1.48e-01 8.90e-01
REGULATION OF ACTIN FILAMENT BASED PROCESS 374 8.93e-07 -1.48e-01 3.58e-04
NEURAL PLATE MORPHOGENESIS 5 5.67e-01 -1.48e-01 9.21e-01
PROTEIN TRANSPORT INTO MEMBRANE RAFT 5 5.67e-01 -1.48e-01 9.21e-01
CORTICAL ACTIN CYTOSKELETON ORGANIZATION 42 9.78e-02 -1.48e-01 5.97e-01
KINETOCHORE ASSEMBLY 16 3.07e-01 1.48e-01 8.11e-01
INTRACELLULAR PROTEIN TRANSMEMBRANE TRANSPORT 55 5.82e-02 1.48e-01 4.97e-01
HEPATOCYTE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY 12 3.76e-01 -1.48e-01 8.50e-01
DEFENSE RESPONSE TO BACTERIUM 306 8.90e-06 1.48e-01 2.06e-03
POLYAMINE TRANSPORT 16 3.07e-01 -1.48e-01 8.11e-01
REGULATION OF KIDNEY DEVELOPMENT 34 1.36e-01 1.48e-01 6.60e-01
POSITIVE REGULATION OF ACUTE INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS 8 4.70e-01 1.48e-01 8.90e-01
VENTRAL SPINAL CORD DEVELOPMENT 46 8.36e-02 1.47e-01 5.70e-01
NEGATIVE REGULATION OF KERATINOCYTE DIFFERENTIATION 9 4.44e-01 1.47e-01 8.78e-01
REGULATION OF FLAGELLATED SPERM MOTILITY 20 2.54e-01 1.47e-01 7.69e-01
REGULATION OF NEURON PROJECTION ARBORIZATION 15 3.23e-01 -1.47e-01 8.24e-01
REGULATION OF GAMMA AMINOBUTYRIC ACID SECRETION 8 4.71e-01 -1.47e-01 8.90e-01
REGULATION OF COMPLEMENT ACTIVATION ALTERNATIVE PATHWAY 6 5.32e-01 1.47e-01 9.11e-01
RNA CAPPING 36 1.27e-01 1.47e-01 6.48e-01
DETOXIFICATION OF COPPER ION 16 3.08e-01 -1.47e-01 8.11e-01
STEROL TRANSPORT 141 2.56e-03 -1.47e-01 1.14e-01
PERICARDIUM DEVELOPMENT 19 2.67e-01 1.47e-01 7.77e-01
REGULATION OF SPINDLE ASSEMBLY 32 1.50e-01 -1.47e-01 6.78e-01
CELLULAR RESPONSE TO TESTOSTERONE STIMULUS 12 3.78e-01 1.47e-01 8.51e-01
ASYMMETRIC CELL DIVISION 19 2.68e-01 1.47e-01 7.77e-01
PHOSPHATIDYLETHANOLAMINE METABOLIC PROCESS 28 1.79e-01 -1.47e-01 6.99e-01
POST CHAPERONIN TUBULIN FOLDING PATHWAY 7 5.01e-01 1.47e-01 9.01e-01
FUNGIFORM PAPILLA MORPHOGENESIS 5 5.70e-01 1.47e-01 9.22e-01
PROSTATE GLAND GROWTH 11 3.99e-01 1.47e-01 8.61e-01
POSITIVE REGULATION OF LIPID BIOSYNTHETIC PROCESS 90 1.62e-02 -1.47e-01 2.97e-01
HEMOGLOBIN BIOSYNTHETIC PROCESS 14 3.42e-01 -1.47e-01 8.36e-01
ENDOPLASMIC RETICULUM MEMBRANE ORGANIZATION 13 3.60e-01 1.47e-01 8.46e-01
POSITIVE REGULATION OF EPITHELIAL TUBE FORMATION 8 4.73e-01 -1.47e-01 8.91e-01
SKELETAL MUSCLE SATELLITE CELL PROLIFERATION 17 2.96e-01 1.46e-01 8.04e-01
RESPONSE TO FRUCTOSE 8 4.73e-01 -1.46e-01 8.91e-01
CARDIAC SEPTUM MORPHOGENESIS 72 3.18e-02 1.46e-01 3.89e-01
DENDRITIC TRANSPORT 12 3.80e-01 -1.46e-01 8.51e-01
POSITIVE REGULATION OF PROTEIN POLYMERIZATION 91 1.59e-02 -1.46e-01 2.95e-01
IRIS MORPHOGENESIS 10 4.24e-01 -1.46e-01 8.73e-01
NEGATIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT 43 9.77e-02 1.46e-01 5.97e-01
CELL JUNCTION MAINTENANCE 46 8.67e-02 -1.46e-01 5.78e-01
REGULATION OF T HELPER 17 CELL DIFFERENTIATION 22 2.36e-01 -1.46e-01 7.54e-01
POLYADENYLATION DEPENDENT SNORNA 3 END PROCESSING 8 4.75e-01 -1.46e-01 8.91e-01
POSITIVE REGULATION OF CHROMATIN ORGANIZATION 14 3.45e-01 1.46e-01 8.37e-01
LEARNED VOCALIZATION BEHAVIOR OR VOCAL LEARNING 10 4.25e-01 -1.46e-01 8.73e-01
RESPONSE TO GLUCAGON 21 2.48e-01 1.46e-01 7.64e-01
POSITIVE REGULATION OF MITOTIC CELL CYCLE SPINDLE ASSEMBLY CHECKPOINT 12 3.83e-01 -1.46e-01 8.53e-01
AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS 67 3.93e-02 -1.46e-01 4.18e-01
REGULATION OF PROTEIN LOCALIZATION TO CILIUM 11 4.03e-01 -1.46e-01 8.63e-01
POSITIVE REGULATION OF MRNA METABOLIC PROCESS 194 4.73e-04 -1.46e-01 3.91e-02
CELLULAR RESPONSE TO GAMMA RADIATION 27 1.91e-01 -1.46e-01 7.14e-01
REGULATION OF POTASSIUM ION IMPORT 5 5.73e-01 1.45e-01 9.24e-01
RESPONSE TO INTERLEUKIN 9 7 5.05e-01 -1.45e-01 9.02e-01
THERMOCEPTION 8 4.76e-01 1.45e-01 8.93e-01
CARBOHYDRATE DERIVATIVE TRANSPORT 87 1.91e-02 -1.45e-01 3.19e-01
REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION 384 1.00e-06 -1.45e-01 3.83e-04
PEROXISOMAL TRANSPORT 24 2.18e-01 1.45e-01 7.36e-01
NEUROTROPHIN SIGNALING PATHWAY 39 1.17e-01 1.45e-01 6.30e-01
POSITIVE REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN 22 2.39e-01 -1.45e-01 7.57e-01
POSTSYNAPSE TO NUCLEUS SIGNALING PATHWAY 6 5.38e-01 -1.45e-01 9.13e-01
POSITIVE REGULATION OF RECEPTOR CATABOLIC PROCESS 7 5.06e-01 -1.45e-01 9.02e-01
GROWTH PLATE CARTILAGE CHONDROCYTE DIFFERENTIATION 10 4.27e-01 -1.45e-01 8.74e-01
NEGATIVE REGULATION OF DNA RECOMBINATION 49 7.91e-02 1.45e-01 5.59e-01
PYRIMIDINE NUCLEOSIDE MONOPHOSPHATE CATABOLIC PROCESS 8 4.78e-01 1.45e-01 8.93e-01
PROTEOGLYCAN BIOSYNTHETIC PROCESS 65 4.33e-02 -1.45e-01 4.36e-01
REGULATION OF MITOCHONDRION ORGANIZATION 151 2.12e-03 -1.45e-01 1.04e-01
REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY 35 1.38e-01 -1.45e-01 6.63e-01
REGULATION OF SODIUM DEPENDENT PHOSPHATE TRANSPORT 5 5.75e-01 -1.45e-01 9.24e-01
REGULATION OF CDC42 PROTEIN SIGNAL TRANSDUCTION 8 4.78e-01 -1.45e-01 8.93e-01
REGULATION OF PLASMA MEMBRANE REPAIR 7 5.08e-01 -1.45e-01 9.03e-01
ATRIAL CARDIAC MUSCLE CELL TO AV NODE CELL COMMUNICATION 19 2.76e-01 -1.44e-01 7.83e-01
BRANCHING INVOLVED IN PROSTATE GLAND MORPHOGENESIS 12 3.86e-01 1.44e-01 8.55e-01
NEGATIVE REGULATION OF MACROPHAGE APOPTOTIC PROCESS 7 5.08e-01 -1.44e-01 9.04e-01
PRESYNAPTIC ACTIVE ZONE ORGANIZATION 8 4.80e-01 1.44e-01 8.94e-01
BRANCHED CHAIN AMINO ACID BIOSYNTHETIC PROCESS 5 5.76e-01 -1.44e-01 9.24e-01
REGULATION OF MOTOR NEURON APOPTOTIC PROCESS 15 3.33e-01 -1.44e-01 8.31e-01
ANTIGEN PROCESSING AND PRESENTATION VIA MHC CLASS IB 25 2.12e-01 -1.44e-01 7.32e-01
CLUSTERING OF VOLTAGE GATED SODIUM CHANNELS 6 5.41e-01 -1.44e-01 9.13e-01
ENDOSOME TO LYSOSOME TRANSPORT 72 3.44e-02 -1.44e-01 4.03e-01
MYOBLAST MIGRATION 13 3.68e-01 1.44e-01 8.48e-01
POSITIVE REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT 20 2.65e-01 1.44e-01 7.75e-01
RESPONSE TO ACTIVITY 72 3.46e-02 -1.44e-01 4.03e-01
NEGATIVE REGULATION OF EPINEPHRINE SECRETION 5 5.77e-01 -1.44e-01 9.24e-01
STEROL BIOSYNTHETIC PROCESS 68 4.01e-02 -1.44e-01 4.21e-01
NEGATIVE REGULATION OF COMPLEMENT ACTIVATION 13 3.69e-01 -1.44e-01 8.48e-01
REGULATION OF LAMELLIPODIUM ASSEMBLY 41 1.11e-01 -1.44e-01 6.20e-01
CELLULAR RESPONSE TO LEUCINE 12 3.89e-01 -1.44e-01 8.56e-01
RESPONSE TO HYDROPEROXIDE 18 2.91e-01 -1.44e-01 7.99e-01
GLUCOSE METABOLIC PROCESS 192 5.91e-04 -1.44e-01 4.25e-02
PROTEIN TARGETING TO PEROXISOME 20 2.66e-01 1.44e-01 7.76e-01
POSITIVE REGULATION OF RRNA PROCESSING 10 4.31e-01 1.44e-01 8.74e-01
NEGATIVE REGULATION OF TRANSCRIPTION BY COMPETITIVE PROMOTER BINDING 12 3.89e-01 1.44e-01 8.56e-01
NUCLEOTIDE TRANSPORT 44 9.95e-02 -1.44e-01 6.02e-01
PROTEIN LOCALIZATION TO NUCLEAR BODY 12 3.89e-01 1.44e-01 8.56e-01
NEGATIVE REGULATION OF DEFENSE RESPONSE TO BACTERIUM 5 5.79e-01 1.43e-01 9.24e-01
REGULATION OF LAMELLIPODIUM ORGANIZATION 53 7.08e-02 -1.43e-01 5.37e-01
LEUKOCYTE ADHESION TO ARTERIAL ENDOTHELIAL CELL 6 5.43e-01 1.43e-01 9.13e-01
NEGATIVE REGULATION OF HORMONE METABOLIC PROCESS 12 3.90e-01 1.43e-01 8.56e-01
PROTEIN POLYUFMYLATION 5 5.79e-01 -1.43e-01 9.24e-01
ENDOPLASMIC RETICULUM CALCIUM ION HOMEOSTASIS 26 2.06e-01 -1.43e-01 7.29e-01
POSITIVE REGULATION OF CELLULAR EXTRAVASATION 17 3.06e-01 1.43e-01 8.11e-01
PROTEIN INSERTION INTO ER MEMBRANE 30 1.74e-01 -1.43e-01 6.92e-01
VITAMIN D METABOLIC PROCESS 20 2.67e-01 1.43e-01 7.77e-01
MRNA MODIFICATION 32 1.61e-01 1.43e-01 6.81e-01
REGULATION OF FATTY ACID BETA OXIDATION 20 2.68e-01 -1.43e-01 7.77e-01
TERTIARY ALCOHOL METABOLIC PROCESS 22 2.45e-01 1.43e-01 7.63e-01
HUMORAL IMMUNE RESPONSE MEDIATED BY CIRCULATING IMMUNOGLOBULIN 46 9.30e-02 -1.43e-01 5.89e-01
NEGATIVE REGULATION OF PROTEIN K63 LINKED UBIQUITINATION 5 5.79e-01 -1.43e-01 9.24e-01
BLEB ASSEMBLY 11 4.11e-01 -1.43e-01 8.65e-01
SPINAL CORD PATTERNING 21 2.57e-01 1.43e-01 7.71e-01
REGULATION OF VIRAL INDUCED CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY 93 1.71e-02 -1.43e-01 3.00e-01
REGULATION OF MRNA 3 END PROCESSING 12 3.91e-01 1.43e-01 8.57e-01
REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION 82 2.52e-02 -1.43e-01 3.65e-01
REGULATION OF PANCREATIC JUICE SECRETION 7 5.13e-01 -1.43e-01 9.07e-01
CELLULAR RESPONSE TO LEAD ION 5 5.80e-01 1.43e-01 9.24e-01
CYTOPLASMIC MICROTUBULE ORGANIZATION 59 5.79e-02 -1.43e-01 4.96e-01
POSITIVE REGULATION OF LIPID METABOLIC PROCESS 144 3.13e-03 -1.43e-01 1.30e-01
POSITIVE REGULATION OF GLUTAMATE SECRETION 11 4.13e-01 -1.43e-01 8.65e-01
REGULATION OF ENDOTHELIAL TUBE MORPHOGENESIS 6 5.45e-01 -1.43e-01 9.13e-01
REGULATION OF SPINDLE ORGANIZATION 46 9.44e-02 -1.43e-01 5.92e-01
REGULATION OF MEMBRANE PERMEABILITY 73 3.52e-02 -1.43e-01 4.03e-01
FLOOR PLATE DEVELOPMENT 11 4.14e-01 -1.42e-01 8.66e-01
REGULATION OF PROTEIN DEPOLYMERIZATION 86 2.26e-02 -1.42e-01 3.53e-01
REGULATION OF AMYLOID BETA CLEARANCE 20 2.71e-01 -1.42e-01 7.79e-01
NEGATIVE REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS 43 1.07e-01 -1.42e-01 6.11e-01
TRNA SURVEILLANCE 8 4.87e-01 -1.42e-01 8.94e-01
POSITIVE REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY 27 2.02e-01 -1.42e-01 7.28e-01
PROTEIN LOCALIZATION TO NUCLEAR ENVELOPE 13 3.76e-01 1.42e-01 8.50e-01
STEM CELL DIVISION 31 1.72e-01 1.42e-01 6.90e-01
PROTEIN LOCALIZATION TO CELL CORTEX 11 4.15e-01 -1.42e-01 8.67e-01
NEGATIVE REGULATION OF HYPOXIA INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY 6 5.48e-01 1.42e-01 9.14e-01
PROTEIN LOCALIZATION TO ENDOSOME 27 2.02e-01 -1.42e-01 7.29e-01
DNA REPLICATION INITIATION 37 1.36e-01 1.42e-01 6.60e-01
VITAMIN A METABOLIC PROCESS 8 4.88e-01 -1.42e-01 8.94e-01
HISTAMINE TRANSPORT 16 3.27e-01 -1.42e-01 8.28e-01
POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CILIUM 7 5.16e-01 -1.42e-01 9.08e-01
REGULATION OF ANTIFUNGAL INNATE IMMUNE RESPONSE 5 5.83e-01 -1.42e-01 9.24e-01
POSITIVE REGULATION OF VASCULAR ENDOTHELIAL CELL PROLIFERATION 27 2.03e-01 -1.42e-01 7.29e-01
NEURONAL ACTION POTENTIAL PROPAGATION 9 4.62e-01 -1.41e-01 8.89e-01
POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER INVOLVED IN CELLULAR RESPONSE TO CHEMICAL STIMULUS 17 3.13e-01 1.41e-01 8.14e-01
REGULATION OF NON CANONICAL NF KAPPAB SIGNAL TRANSDUCTION 114 9.08e-03 -1.41e-01 2.24e-01
LYMPHOCYTE MIGRATION 119 7.73e-03 1.41e-01 2.03e-01
ENDOSOMAL VESICLE FUSION 12 3.97e-01 -1.41e-01 8.59e-01
COLLAGEN CATABOLIC PROCESS 44 1.05e-01 -1.41e-01 6.09e-01
MICROGLIAL CELL MIGRATION 8 4.89e-01 1.41e-01 8.95e-01
POSITIVE REGULATION OF SEQUESTERING OF TRIGLYCERIDE 9 4.64e-01 -1.41e-01 8.89e-01
DUMP CATABOLIC PROCESS 6 5.50e-01 1.41e-01 9.16e-01
ENDOLYSOSOMAL TOLL LIKE RECEPTOR SIGNALING PATHWAY 46 9.81e-02 -1.41e-01 5.99e-01
REGULATION OF CELLULAR RESPONSE TO HEAT 16 3.29e-01 -1.41e-01 8.30e-01
ANDROGEN METABOLIC PROCESS 30 1.82e-01 1.41e-01 7.01e-01
PROTEIN LOCALIZATION TO CYTOPLASMIC STRESS GRANULE 8 4.90e-01 1.41e-01 8.95e-01
POSITIVE REGULATION OF LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY 10 4.41e-01 -1.41e-01 8.78e-01
CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE 81 2.85e-02 -1.41e-01 3.73e-01
POSITIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE 123 7.02e-03 -1.41e-01 1.97e-01
AMYLOID BETA CLEARANCE BY TRANSCYTOSIS 7 5.20e-01 -1.41e-01 9.09e-01
CHEMOREPULSION OF AXON 6 5.52e-01 1.40e-01 9.17e-01
LOW DENSITY LIPOPROTEIN PARTICLE CLEARANCE 34 1.57e-01 -1.40e-01 6.79e-01
REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO CHROMOSOME 12 4.00e-01 1.40e-01 8.62e-01
NEGATIVE REGULATION OF VIRAL TRANSCRIPTION 15 3.47e-01 -1.40e-01 8.37e-01
EOSINOPHIL MEDIATED IMMUNITY 8 4.92e-01 1.40e-01 8.96e-01
REGULATION OF ASYMMETRIC CELL DIVISION 5 5.87e-01 -1.40e-01 9.24e-01
NEGATIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION 43 1.12e-01 -1.40e-01 6.21e-01
PURINE DEOXYRIBONUCLEOSIDE METABOLIC PROCESS 5 5.87e-01 -1.40e-01 9.24e-01
INDOLALKYLAMINE METABOLIC PROCESS 12 4.01e-01 -1.40e-01 8.62e-01
NEGATIVE REGULATION OF CERAMIDE BIOSYNTHETIC PROCESS 5 5.87e-01 1.40e-01 9.24e-01
PRESYNAPTIC MODULATION OF CHEMICAL SYNAPTIC TRANSMISSION 32 1.70e-01 1.40e-01 6.87e-01
SRP DEPENDENT COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE TRANSLOCATION 8 4.93e-01 1.40e-01 8.96e-01
RESPONSE TO GAMMA RADIATION 51 8.37e-02 -1.40e-01 5.70e-01
ANGIOTENSIN ACTIVATED SIGNALING PATHWAY 19 2.91e-01 1.40e-01 7.99e-01
NEGATIVE REGULATION OF THYMOCYTE APOPTOTIC PROCESS 10 4.44e-01 1.40e-01 8.78e-01
TYROSINE PHOSPHORYLATION OF STAT PROTEIN 82 2.86e-02 -1.40e-01 3.73e-01
INTRA GOLGI VESICLE MEDIATED TRANSPORT 34 1.58e-01 -1.40e-01 6.79e-01
NEGATIVE REGULATION OF CYTOSKELETON ORGANIZATION 160 2.28e-03 -1.40e-01 1.08e-01
SKELETAL MUSCLE THIN FILAMENT ASSEMBLY 7 5.22e-01 1.40e-01 9.10e-01
REGULATION OF DNA DIRECTED DNA POLYMERASE ACTIVITY 9 4.68e-01 1.40e-01 8.90e-01
PROTEIN K11 LINKED UBIQUITINATION 29 1.93e-01 1.40e-01 7.16e-01
REGULATION OF CELLULAR EXTRAVASATION 40 1.27e-01 1.40e-01 6.48e-01
INTERLEUKIN 18 MEDIATED SIGNALING PATHWAY 9 4.69e-01 -1.40e-01 8.90e-01
HEPARAN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS 33 1.66e-01 -1.39e-01 6.84e-01
CANONICAL WNT SIGNALING PATHWAY INVOLVED IN REGULATION OF CELL PROLIFERATION 6 5.54e-01 -1.39e-01 9.18e-01
RESPONSE TO DSRNA 51 8.50e-02 1.39e-01 5.74e-01
HEMATOPOIETIC STEM CELL DIFFERENTIATION 36 1.48e-01 -1.39e-01 6.75e-01
CHONDROITIN SULFATE PROTEOGLYCAN METABOLIC PROCESS 32 1.72e-01 -1.39e-01 6.90e-01
NUCLEAR ENVELOPE ORGANIZATION 53 7.95e-02 -1.39e-01 5.59e-01
CALCIUM ION IMPORT ACROSS PLASMA MEMBRANE 54 7.69e-02 1.39e-01 5.53e-01
MRNA CIS SPLICING VIA SPLICEOSOME 26 2.20e-01 -1.39e-01 7.38e-01
MODIFICATION OF POSTSYNAPTIC ACTIN CYTOSKELETON 11 4.24e-01 -1.39e-01 8.73e-01
CORPUS CALLOSUM DEVELOPMENT 26 2.20e-01 -1.39e-01 7.38e-01
SKELETAL MUSCLE ACETYLCHOLINE GATED CHANNEL CLUSTERING 10 4.46e-01 -1.39e-01 8.79e-01
NEGATIVE REGULATION OF ORGANIC ACID TRANSPORT 24 2.38e-01 -1.39e-01 7.57e-01
COCHLEA DEVELOPMENT 47 9.92e-02 1.39e-01 6.02e-01
INTERMEMBRANE LIPID TRANSFER 54 7.73e-02 -1.39e-01 5.54e-01
PROTEIN LOCALIZATION TO CILIARY MEMBRANE 12 4.05e-01 1.39e-01 8.63e-01
SPLICEOSOMAL SNRNP ASSEMBLY 44 1.11e-01 -1.39e-01 6.20e-01
NUCLEAR PORE COMPLEX ASSEMBLY 11 4.26e-01 1.39e-01 8.73e-01
CARDIAC NEURAL CREST CELL MIGRATION INVOLVED IN OUTFLOW TRACT MORPHOGENESIS 11 4.26e-01 -1.39e-01 8.73e-01
ACETATE ESTER TRANSPORT 9 4.72e-01 -1.39e-01 8.91e-01
TRNA AMINOACYLATION FOR MITOCHONDRIAL PROTEIN TRANSLATION 8 4.98e-01 1.38e-01 8.99e-01
NEGATIVE REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN 12 4.06e-01 1.38e-01 8.63e-01
PENTOSE METABOLIC PROCESS 12 4.06e-01 1.38e-01 8.63e-01
REGULATION OF NEUTROPHIL EXTRAVASATION 7 5.26e-01 1.38e-01 9.10e-01
BRANCHED CHAIN AMINO ACID TRANSPORT 14 3.70e-01 -1.38e-01 8.48e-01
LAMELLIPODIUM ORGANIZATION 91 2.25e-02 -1.38e-01 3.52e-01
EYELID DEVELOPMENT IN CAMERA TYPE EYE 13 3.88e-01 -1.38e-01 8.56e-01
POSITIVE REGULATION OF TAU PROTEIN KINASE ACTIVITY 8 4.98e-01 -1.38e-01 8.99e-01
AV NODE CELL TO BUNDLE OF HIS CELL COMMUNICATION 14 3.71e-01 1.38e-01 8.48e-01
CRANIAL NERVE FORMATION 11 4.27e-01 -1.38e-01 8.74e-01
POSITIVE REGULATION OF SMAD PROTEIN SIGNAL TRANSDUCTION 26 2.23e-01 1.38e-01 7.41e-01
URETERIC BUD FORMATION 7 5.27e-01 1.38e-01 9.10e-01
VOLUNTARY MUSCULOSKELETAL MOVEMENT 7 5.28e-01 -1.38e-01 9.10e-01
MODULATION OF INHIBITORY POSTSYNAPTIC POTENTIAL 7 5.28e-01 -1.38e-01 9.10e-01
REGULATION OF CELL SHAPE 140 4.87e-03 -1.38e-01 1.63e-01
ACTIVATION OF PHOSPHOLIPASE C ACTIVITY 28 2.07e-01 1.38e-01 7.29e-01
NK T CELL PROLIFERATION 9 4.74e-01 -1.38e-01 8.91e-01
REGULATION OF GLUCOSE METABOLIC PROCESS 102 1.62e-02 -1.38e-01 2.97e-01
LACRIMAL GLAND DEVELOPMENT 7 5.28e-01 -1.38e-01 9.10e-01
METANEPHRIC NEPHRON EPITHELIUM DEVELOPMENT 25 2.33e-01 -1.38e-01 7.50e-01
REGULATION OF NEURONAL ACTION POTENTIAL 5 5.94e-01 -1.38e-01 9.26e-01
SMOOTH MUSCLE CELL PROLIFERATION 172 1.85e-03 -1.38e-01 9.79e-02
NEGATIVE REGULATION OF CARBOHYDRATE METABOLIC PROCESS 55 7.76e-02 -1.38e-01 5.55e-01
TRACHEA FORMATION 7 5.29e-01 -1.38e-01 9.10e-01
REGULATION OF ODONTOBLAST DIFFERENTIATION 5 5.94e-01 1.38e-01 9.26e-01
POSITIVE REGULATION OF IMMATURE T CELL PROLIFERATION 6 5.60e-01 1.37e-01 9.20e-01
POSITIVE REGULATION OF LAMELLIPODIUM ORGANIZATION 36 1.54e-01 -1.37e-01 6.79e-01
REGULATION OF TRANSCRIPTION BY GLUCOSE 10 4.52e-01 -1.37e-01 8.81e-01
PHYSIOLOGICAL CARDIAC MUSCLE HYPERTROPHY 30 1.93e-01 -1.37e-01 7.16e-01
NEGATIVE REGULATION OF OLIGODENDROCYTE DIFFERENTIATION 14 3.74e-01 1.37e-01 8.50e-01
PROGESTERONE METABOLIC PROCESS 16 3.42e-01 1.37e-01 8.36e-01
REGULATION OF INOSITOL TRISPHOSPHATE BIOSYNTHETIC PROCESS 6 5.61e-01 -1.37e-01 9.20e-01
EMBRYONIC AXIS SPECIFICATION 41 1.29e-01 1.37e-01 6.48e-01
REGULATION OF EPITHELIAL CELL PROLIFERATION INVOLVED IN LUNG MORPHOGENESIS 7 5.30e-01 -1.37e-01 9.11e-01
POSITIVE REGULATION OF LIPID KINASE ACTIVITY 26 2.26e-01 -1.37e-01 7.44e-01
REGULATION OF APOPTOTIC DNA FRAGMENTATION 11 4.32e-01 -1.37e-01 8.74e-01
REGULATION OF PIGMENT CELL DIFFERENTIATION 8 5.03e-01 1.37e-01 9.02e-01
THIAMINE DIPHOSPHATE METABOLIC PROCESS 5 5.96e-01 1.37e-01 9.27e-01
POSITIVE REGULATION OF G0 TO G1 TRANSITION 5 5.96e-01 1.37e-01 9.27e-01
REGULATION OF 3 UTR MEDIATED MRNA STABILIZATION 6 5.62e-01 -1.37e-01 9.20e-01
NEGATIVE REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS 39 1.40e-01 -1.37e-01 6.66e-01
CELLULAR RESPONSE TO PURINE CONTAINING COMPOUND 14 3.76e-01 1.37e-01 8.50e-01
POSITIVE REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS 35 1.62e-01 -1.37e-01 6.81e-01
POSITIVE THYMIC T CELL SELECTION 14 3.76e-01 -1.37e-01 8.51e-01
RIBOFLAVIN METABOLIC PROCESS 5 5.97e-01 1.36e-01 9.27e-01
POSITIVE REGULATION OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE 61 6.53e-02 -1.36e-01 5.24e-01
REGULATION OF ARACHIDONIC ACID SECRETION 7 5.32e-01 1.36e-01 9.11e-01
MITOPHAGY 38 1.46e-01 -1.36e-01 6.74e-01
REGULATION OF CILIUM ASSEMBLY 95 2.16e-02 -1.36e-01 3.44e-01
REGULATION OF INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY 35 1.63e-01 -1.36e-01 6.81e-01
PROTEIN LOCALIZATION TO CONDENSED CHROMOSOME 15 3.61e-01 -1.36e-01 8.46e-01
TRIGEMINAL NERVE DEVELOPMENT 11 4.34e-01 1.36e-01 8.74e-01
POSITIVE REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS 42 1.27e-01 -1.36e-01 6.48e-01
L METHIONINE SALVAGE FROM METHYLTHIOADENOSINE 5 5.98e-01 -1.36e-01 9.28e-01
FOLIC ACID CONTAINING COMPOUND BIOSYNTHETIC PROCESS 7 5.33e-01 1.36e-01 9.11e-01
MUSCLE ADAPTATION 118 1.07e-02 -1.36e-01 2.42e-01
MEDIUM CHAIN FATTY ACYL COA METABOLIC PROCESS 6 5.64e-01 1.36e-01 9.21e-01
DEHYDROASCORBIC ACID TRANSPORT 9 4.80e-01 -1.36e-01 8.94e-01
NEGATIVE REGULATION OF MACROPHAGE MIGRATION 14 3.79e-01 -1.36e-01 8.51e-01
CHOLESTEROL IMPORT 9 4.81e-01 -1.36e-01 8.94e-01
POSITIVE REGULATION OF T HELPER 1 TYPE IMMUNE RESPONSE 18 3.19e-01 1.36e-01 8.21e-01
NEGATIVE REGULATION OF NEURON PROJECTION REGENERATION 14 3.80e-01 -1.36e-01 8.51e-01
MUSCULAR SEPTUM MORPHOGENESIS 5 6.00e-01 1.35e-01 9.28e-01
PUTRESCINE METABOLIC PROCESS 8 5.07e-01 1.35e-01 9.03e-01
CDC42 PROTEIN SIGNAL TRANSDUCTION 17 3.34e-01 -1.35e-01 8.31e-01
LATE ENDOSOME TO VACUOLE TRANSPORT VIA MULTIVESICULAR BODY SORTING PATHWAY 26 2.32e-01 -1.35e-01 7.49e-01
FEMALE MEIOSIS CHROMOSOME SEGREGATION 6 5.66e-01 -1.35e-01 9.21e-01
ADENOSINE TRANSPORT 5 6.01e-01 -1.35e-01 9.28e-01
SPHINGOID METABOLIC PROCESS 22 2.73e-01 -1.35e-01 7.80e-01
POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO STRESS 18 3.22e-01 1.35e-01 8.23e-01
RHO PROTEIN SIGNAL TRANSDUCTION 136 6.62e-03 -1.35e-01 1.91e-01
REGULATION OF MEMBRANE DEPOLARIZATION DURING ACTION POTENTIAL 6 5.67e-01 1.35e-01 9.21e-01
REGULATION OF THE FORCE OF HEART CONTRACTION BY CHEMICAL SIGNAL 6 5.67e-01 -1.35e-01 9.21e-01
NEGATIVE REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY 15 3.66e-01 1.35e-01 8.48e-01
PURINE DEOXYRIBONUCLEOTIDE METABOLIC PROCESS 16 3.51e-01 -1.35e-01 8.41e-01
IMMUNOLOGICAL MEMORY PROCESS 17 3.36e-01 -1.35e-01 8.31e-01
TETRAHYDROBIOPTERIN METABOLIC PROCESS 8 5.09e-01 1.35e-01 9.05e-01
TELOMERIC D LOOP DISASSEMBLY 7 5.37e-01 -1.35e-01 9.13e-01
PROTEIN METHYLATION 78 3.97e-02 -1.35e-01 4.19e-01
NEGATIVE REGULATION OF DENDRITIC SPINE DEVELOPMENT 13 4.01e-01 -1.35e-01 8.62e-01
NEGATIVE REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY 80 3.73e-02 -1.35e-01 4.12e-01
POSITIVE REGULATION OF DNA METHYLATION DEPENDENT HETEROCHROMATIN FORMATION 11 4.40e-01 1.35e-01 8.77e-01
ESTABLISHMENT OF MITOTIC SPINDLE LOCALIZATION 40 1.41e-01 -1.35e-01 6.68e-01
POSITIVE REGULATION OF HETEROTYPIC CELL CELL ADHESION 14 3.84e-01 1.35e-01 8.54e-01
RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL BY ENDOPLASMIC RETICULUM 37 1.57e-01 1.34e-01 6.79e-01
MAINTENANCE OF PROTEIN LOCATION 91 2.66e-02 -1.34e-01 3.67e-01
ALDITOL PHOSPHATE METABOLIC PROCESS 11 4.40e-01 1.34e-01 8.77e-01
NEGATIVE REGULATION OF ISOTYPE SWITCHING 5 6.03e-01 1.34e-01 9.29e-01
EMBRYONIC FORELIMB MORPHOGENESIS 33 1.81e-01 1.34e-01 7.01e-01
CAMP METABOLIC PROCESS 23 2.65e-01 -1.34e-01 7.75e-01
CEREBELLAR CORTEX FORMATION 26 2.36e-01 1.34e-01 7.54e-01
REGULATION OF GENE EXPRESSION BY GENOMIC IMPRINTING 11 4.41e-01 -1.34e-01 8.78e-01
REGULATION OF SOMITOGENESIS 6 5.69e-01 -1.34e-01 9.22e-01
BILE ACID SIGNALING PATHWAY 11 4.42e-01 -1.34e-01 8.78e-01
NEGATIVE REGULATION OF FIBROBLAST APOPTOTIC PROCESS 7 5.40e-01 -1.34e-01 9.13e-01
MUSCLE CELL APOPTOTIC PROCESS 92 2.65e-02 -1.34e-01 3.66e-01
CYCLIC NUCLEOTIDE BIOSYNTHETIC PROCESS 21 2.88e-01 -1.34e-01 7.97e-01
REGULATION OF ASTROCYTE ACTIVATION 8 5.12e-01 -1.34e-01 9.07e-01
DE NOVO CENTRIOLE ASSEMBLY INVOLVED IN MULTI CILIATED EPITHELIAL CELL DIFFERENTIATION 5 6.04e-01 1.34e-01 9.29e-01
FORMATION OF EXTRACHROMOSOMAL CIRCULAR DNA 13 4.04e-01 -1.34e-01 8.63e-01
NEGATIVE REGULATION OF CYTOPLASMIC TRANSLATION 9 4.87e-01 1.34e-01 8.94e-01
STEROID HORMONE BIOSYNTHETIC PROCESS 44 1.25e-01 -1.34e-01 6.47e-01
CONVERGENT EXTENSION 15 3.70e-01 -1.34e-01 8.48e-01
LOCOMOTORY EXPLORATION BEHAVIOR 14 3.87e-01 -1.34e-01 8.55e-01
OXIDATIVE RNA DEMETHYLATION 5 6.05e-01 1.34e-01 9.29e-01
NON CANONICAL NF KAPPAB SIGNAL TRANSDUCTION 149 4.91e-03 -1.33e-01 1.64e-01
PHOSPHOLIPID DEPHOSPHORYLATION 41 1.39e-01 -1.33e-01 6.65e-01
RESPONSE TO FLUID SHEAR STRESS 34 1.78e-01 -1.33e-01 6.98e-01
RESPONSE TO PROSTAGLANDIN E 24 2.58e-01 -1.33e-01 7.71e-01
HISTAMINE SECRETION 13 4.05e-01 -1.33e-01 8.63e-01
SARCOPLASMIC RETICULUM CALCIUM ION TRANSPORT 42 1.35e-01 1.33e-01 6.59e-01
UV PROTECTION 12 4.24e-01 -1.33e-01 8.73e-01
SOMITE ROSTRAL CAUDAL AXIS SPECIFICATION 11 4.44e-01 1.33e-01 8.78e-01
AUTOPHAGOSOME MEMBRANE DOCKING 7 5.42e-01 -1.33e-01 9.13e-01
PROTEIN PROCESSING INVOLVED IN PROTEIN TARGETING TO MITOCHONDRION 7 5.42e-01 1.33e-01 9.13e-01
POSITIVE REGULATION OF NEUROINFLAMMATORY RESPONSE 18 3.28e-01 1.33e-01 8.29e-01
PROTEIN IMPORT 8 5.14e-01 -1.33e-01 9.07e-01
MINERALOCORTICOID METABOLIC PROCESS 14 3.89e-01 1.33e-01 8.56e-01
POSITIVE REGULATION OF T HELPER CELL DIFFERENTIATION 22 2.80e-01 -1.33e-01 7.87e-01
NEGATIVE REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY 10 4.66e-01 1.33e-01 8.90e-01
DUMP METABOLIC PROCESS 7 5.42e-01 1.33e-01 9.13e-01
PROTEIN DEACETYLATION 57 8.23e-02 -1.33e-01 5.68e-01
PORPHYRIN CONTAINING COMPOUND METABOLIC PROCESS 52 9.75e-02 -1.33e-01 5.97e-01
EMBRYONIC CLEAVAGE 8 5.16e-01 1.33e-01 9.07e-01
NEGATIVE REGULATION OF INTERLEUKIN 10 PRODUCTION 23 2.71e-01 1.33e-01 7.79e-01
EPITHELIAL CELL PROLIFERATION INVOLVED IN LUNG MORPHOGENESIS 10 4.68e-01 -1.33e-01 8.90e-01
NEGATIVE REGULATION OF CARDIAC MUSCLE CONTRACTION 7 5.43e-01 -1.33e-01 9.13e-01
REGULATION OF PHENOTYPIC SWITCHING 6 5.74e-01 -1.33e-01 9.24e-01
EMBRYO IMPLANTATION 59 7.82e-02 -1.33e-01 5.57e-01
REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION 292 9.69e-05 -1.33e-01 1.36e-02
POSITIVE REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY 20 3.05e-01 -1.32e-01 8.10e-01
CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS 95 2.57e-02 -1.32e-01 3.65e-01
VASCULAR ASSOCIATED SMOOTH MUSCLE CELL DIFFERENTIATION 40 1.47e-01 -1.32e-01 6.75e-01
POSITIVE REGULATION OF GRANULOCYTE CHEMOTAXIS 28 2.25e-01 -1.32e-01 7.43e-01
OLFACTORY NERVE DEVELOPMENT 7 5.44e-01 -1.32e-01 9.13e-01
VACUOLAR TRANSPORT 167 3.19e-03 -1.32e-01 1.30e-01
RESPONSE TO PROGESTERONE 40 1.48e-01 -1.32e-01 6.75e-01
MOTOR BEHAVIOR 23 2.73e-01 -1.32e-01 7.80e-01
POSITIVE REGULATION OF FIBROBLAST PROLIFERATION 52 9.93e-02 -1.32e-01 6.02e-01
ECTODERM DEVELOPMENT 22 2.84e-01 -1.32e-01 7.91e-01
VENTRAL SPINAL CORD INTERNEURON DIFFERENTIATION 13 4.10e-01 1.32e-01 8.64e-01
HISTONE MRNA CATABOLIC PROCESS 15 3.76e-01 1.32e-01 8.50e-01
AMINO SUGAR BIOSYNTHETIC PROCESS 11 4.49e-01 1.32e-01 8.80e-01
POSITIVE REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY 30 2.11e-01 -1.32e-01 7.32e-01
GLUCOCORTICOID SECRETION 12 4.29e-01 -1.32e-01 8.74e-01
REGULATION OF DNA STRAND ELONGATION 17 3.47e-01 1.32e-01 8.37e-01
PENETRATION OF ZONA PELLUCIDA 9 4.94e-01 1.32e-01 8.97e-01
POSITIVE REGULATION OF CATECHOLAMINE METABOLIC PROCESS 6 5.77e-01 1.32e-01 9.24e-01
RENAL SODIUM ION TRANSPORT 16 3.62e-01 -1.32e-01 8.46e-01
POSITIVE REGULATION OF CARBOHYDRATE METABOLIC PROCESS 81 4.07e-02 -1.32e-01 4.25e-01
BLOOD COAGULATION INTRINSIC PATHWAY 8 5.20e-01 -1.31e-01 9.09e-01
TRYPTOPHAN METABOLIC PROCESS 11 4.50e-01 -1.31e-01 8.81e-01
NEGATIVE REGULATION OF MYOFIBROBLAST DIFFERENTIATION 7 5.47e-01 -1.31e-01 9.14e-01
PROTEIN CATABOLIC PROCESS IN THE VACUOLE 24 2.66e-01 -1.31e-01 7.76e-01
REGULATION OF BONE DEVELOPMENT 10 4.73e-01 -1.31e-01 8.91e-01
POSITIVE REGULATION OF T CELL MIGRATION 33 1.92e-01 1.31e-01 7.16e-01
NEGATIVE REGULATION OF PROTEIN CATABOLIC PROCESS IN THE VACUOLE 5 6.12e-01 -1.31e-01 9.31e-01
PRO B CELL DIFFERENTIATION 12 4.32e-01 -1.31e-01 8.74e-01
NUCLEAR MEMBRANE ORGANIZATION 43 1.37e-01 -1.31e-01 6.61e-01
NEGATIVE REGULATION OF ACTIN FILAMENT POLYMERIZATION 64 7.02e-02 -1.31e-01 5.36e-01
POSITIVE REGULATION OF NEURON PROJECTION ARBORIZATION 8 5.22e-01 -1.31e-01 9.10e-01
LIPID STORAGE 94 2.84e-02 -1.31e-01 3.73e-01
NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS EXONUCLEOLYTIC 3 5 12 4.33e-01 -1.31e-01 8.74e-01
PROTEIN K29 LINKED UBIQUITINATION 7 5.49e-01 1.31e-01 9.16e-01
REGULATION OF KIDNEY SIZE 6 5.79e-01 1.31e-01 9.24e-01
RESPONSE TO INTERLEUKIN 7 14 3.97e-01 1.31e-01 8.59e-01
PEPTIDYL ARGININE MODIFICATION 10 4.74e-01 1.31e-01 8.91e-01
REGULATION OF MITOTIC SPINDLE ASSEMBLY 22 2.89e-01 -1.31e-01 7.97e-01
TETRAHYDROFOLATE METABOLIC PROCESS 15 3.81e-01 1.31e-01 8.52e-01
ENDOCYTIC RECYCLING 87 3.51e-02 -1.31e-01 4.03e-01
POSITIVE REGULATION OF SKELETAL MUSCLE TISSUE REGENERATION 5 6.13e-01 -1.31e-01 9.31e-01
NEUROENDOCRINE CELL DIFFERENTIATION 16 3.66e-01 1.31e-01 8.48e-01
REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE BY P53 CLASS MEDIATOR 17 3.51e-01 1.31e-01 8.41e-01
REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY 85 3.74e-02 1.31e-01 4.12e-01
RECEPTOR LOCALIZATION TO NON MOTILE CILIUM 5 6.13e-01 1.30e-01 9.31e-01
SPROUTING ANGIOGENESIS 192 1.82e-03 -1.30e-01 9.78e-02
ARACHIDONIC ACID METABOLIC PROCESS 58 8.57e-02 1.30e-01 5.77e-01
NEGATIVE REGULATION OF MITOCHONDRION ORGANIZATION 51 1.07e-01 -1.30e-01 6.11e-01
BASE EXCISION REPAIR AP SITE FORMATION 12 4.34e-01 1.30e-01 8.74e-01
THORAX AND ANTERIOR ABDOMEN DETERMINATION 5 6.14e-01 1.30e-01 9.31e-01
REGULATION OF PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY 24 2.70e-01 -1.30e-01 7.79e-01
POSITIVE REGULATION OF KERATINOCYTE PROLIFERATION 15 3.83e-01 1.30e-01 8.54e-01
REGULATION OF ELECTRON TRANSFER ACTIVITY 6 5.81e-01 -1.30e-01 9.24e-01
ACTIVATION OF MEIOSIS 6 5.82e-01 -1.30e-01 9.24e-01
REGULATION OF MUSCLE ADAPTATION 93 3.04e-02 -1.30e-01 3.84e-01
CYTOSOLIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY 147 6.56e-03 -1.30e-01 1.90e-01
REGULATION OF VACUOLE ORGANIZATION 57 8.99e-02 -1.30e-01 5.85e-01
ASYMMETRIC NEUROBLAST DIVISION 6 5.82e-01 1.30e-01 9.24e-01
DENDRITIC CELL CHEMOTAXIS 25 2.62e-01 1.30e-01 7.73e-01
TIGHT JUNCTION ORGANIZATION 82 4.24e-02 -1.30e-01 4.33e-01
NEGATIVE REGULATION OF PROTEIN POLYMERIZATION 78 4.78e-02 -1.30e-01 4.56e-01
G PROTEIN COUPLED RECEPTOR INTERNALIZATION 13 4.19e-01 1.30e-01 8.69e-01
REGULATION OF EXTRACELLULAR MATRIX DISASSEMBLY 16 3.70e-01 -1.30e-01 8.48e-01
CELLULAR RESPONSE TO LEPTIN STIMULUS 17 3.55e-01 1.30e-01 8.44e-01
ER TO GOLGI CERAMIDE TRANSPORT 5 6.16e-01 1.29e-01 9.32e-01
ZYGOTIC DETERMINATION OF ANTERIOR POSTERIOR AXIS EMBRYO 6 5.83e-01 1.29e-01 9.24e-01
INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS 63 7.56e-02 -1.29e-01 5.51e-01
SENSORY PERCEPTION OF SWEET TASTE 7 5.53e-01 -1.29e-01 9.18e-01
NEUTROPHIL APOPTOTIC PROCESS 8 5.26e-01 -1.29e-01 9.10e-01
REGULATION OF FEVER GENERATION 9 5.02e-01 1.29e-01 9.01e-01
CARDIOLIPIN ACYL CHAIN REMODELING 5 6.17e-01 1.29e-01 9.32e-01
ALDITOL METABOLIC PROCESS 22 2.94e-01 -1.29e-01 8.02e-01
ENDODERMAL CELL FATE SPECIFICATION 8 5.27e-01 -1.29e-01 9.10e-01
NEGATIVE REGULATION OF RESPIRATORY BURST 6 5.84e-01 1.29e-01 9.24e-01
NEGATIVE REGULATION OF ERK1 AND ERK2 CASCADE 77 5.01e-02 -1.29e-01 4.66e-01
NEGATIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION 49 1.18e-01 -1.29e-01 6.30e-01
POSITIVE REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY 36 1.80e-01 -1.29e-01 7.01e-01
INTERLEUKIN 5 PRODUCTION 20 3.18e-01 -1.29e-01 8.21e-01
CELLULAR RESPONSE TO UV C 5 6.17e-01 -1.29e-01 9.32e-01
RESPONSE TO OSMOTIC STRESS 82 4.35e-02 -1.29e-01 4.38e-01
TETRAPYRROLE BIOSYNTHETIC PROCESS 34 1.93e-01 -1.29e-01 7.16e-01
PHOSPHATIDYLCHOLINE CATABOLIC PROCESS 16 3.72e-01 -1.29e-01 8.49e-01
CHIASMA ASSEMBLY 7 5.55e-01 -1.29e-01 9.18e-01
POSITIVE REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION 21 3.07e-01 -1.29e-01 8.11e-01
REGULATION OF SYNAPTIC TRANSMISSION CHOLINERGIC 8 5.28e-01 1.29e-01 9.10e-01
PROTEIN LOCALIZATION TO MICROTUBULE 19 3.31e-01 -1.29e-01 8.31e-01
POSTSYNAPTIC DENSITY PROTEIN 95 CLUSTERING 9 5.04e-01 1.29e-01 9.02e-01
AMYLOID PRECURSOR PROTEIN METABOLIC PROCESS 95 3.02e-02 -1.29e-01 3.83e-01
REGULATION OF IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE 14 4.05e-01 -1.29e-01 8.63e-01
GROOMING BEHAVIOR 18 3.45e-01 1.29e-01 8.37e-01
ANGIOGENESIS INVOLVED IN WOUND HEALING 31 2.15e-01 -1.29e-01 7.33e-01
PERIPHERAL NERVOUS SYSTEM AXON REGENERATION 10 4.81e-01 -1.29e-01 8.94e-01
SUBTELOMERIC HETEROCHROMATIN FORMATION 9 5.04e-01 1.29e-01 9.02e-01
STEROL METABOLIC PROCESS 155 5.74e-03 -1.29e-01 1.74e-01
RESPONSE TO MURAMYL DIPEPTIDE 21 3.08e-01 -1.28e-01 8.11e-01
HEART TRABECULA MORPHOGENESIS 32 2.09e-01 1.28e-01 7.29e-01
TETRAPYRROLE CATABOLIC PROCESS 13 4.23e-01 -1.28e-01 8.73e-01
POSITIVE REGULATION OF MAST CELL ACTIVATION 19 3.33e-01 -1.28e-01 8.31e-01
SUPRAMOLECULAR FIBER ORGANIZATION 838 2.62e-10 -1.28e-01 1.99e-07
BASOLATERAL PROTEIN SECRETION 5 6.19e-01 -1.28e-01 9.32e-01
RESPONSE TO MINERALOCORTICOID 37 1.77e-01 1.28e-01 6.97e-01
SPINDLE LOCALIZATION 62 8.08e-02 -1.28e-01 5.62e-01
XENOBIOTIC TRANSPORT ACROSS BLOOD BRAIN BARRIER 6 5.87e-01 -1.28e-01 9.24e-01
POSITIVE REGULATION OF MITOTIC CYTOKINESIS 8 5.30e-01 -1.28e-01 9.11e-01
MICROTUBULE NUCLEATION 45 1.37e-01 -1.28e-01 6.61e-01
CHONDROITIN SULFATE METABOLIC PROCESS 27 2.49e-01 -1.28e-01 7.65e-01
REGULATION OF GRANULOCYTE CHEMOTAXIS 53 1.07e-01 -1.28e-01 6.11e-01
MRNA CATABOLIC PROCESS 303 1.27e-04 -1.28e-01 1.59e-02
NEGATIVE REGULATION OF LAMELLIPODIUM ASSEMBLY 6 5.87e-01 -1.28e-01 9.24e-01
ANDROGEN RECEPTOR SIGNALING PATHWAY 49 1.21e-01 -1.28e-01 6.37e-01
NEURONAL SIGNAL TRANSDUCTION 7 5.58e-01 -1.28e-01 9.19e-01
NEGATIVE REGULATION OF CALCIUM MEDIATED SIGNALING 21 3.11e-01 -1.28e-01 8.13e-01
REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY 122 1.48e-02 -1.28e-01 2.86e-01
PROTEIN INSERTION INTO MITOCHONDRIAL INNER MEMBRANE 13 4.25e-01 1.28e-01 8.73e-01
REGULATION OF LYSOSOME SIZE 8 5.32e-01 1.28e-01 9.11e-01
RESPONSE TO STILBENOID 8 5.32e-01 -1.28e-01 9.11e-01
NEGATIVE REGULATION OF HYDROGEN PEROXIDE METABOLIC PROCESS 6 5.89e-01 -1.27e-01 9.24e-01
RUFFLE ORGANIZATION 57 9.61e-02 -1.27e-01 5.96e-01
REGULATION OF FC GAMMA RECEPTOR SIGNALING PATHWAY INVOLVED IN PHAGOCYTOSIS 5 6.22e-01 -1.27e-01 9.32e-01
SYNAPTIC TRANSMISSION GLYCINERGIC 5 6.22e-01 -1.27e-01 9.32e-01
CHONDROCYTE DEVELOPMENT 32 2.13e-01 -1.27e-01 7.33e-01
REGULATION OF FATTY ACID METABOLIC PROCESS 100 2.80e-02 -1.27e-01 3.73e-01
POSITIVE REGULATION OF GLIAL CELL MIGRATION 13 4.27e-01 1.27e-01 8.74e-01
NEGATIVE REGULATION OF FATTY ACID METABOLIC PROCESS 42 1.54e-01 -1.27e-01 6.79e-01
POSITIVE REGULATION OF GASTRO INTESTINAL SYSTEM SMOOTH MUSCLE CONTRACTION 5 6.23e-01 -1.27e-01 9.32e-01
NEGATIVE REGULATION OF PROTEIN SUMOYLATION 10 4.87e-01 -1.27e-01 8.94e-01
TYROSINE METABOLIC PROCESS 17 3.65e-01 -1.27e-01 8.48e-01
NEGATIVE REGULATION OF ANOIKIS 18 3.52e-01 1.27e-01 8.41e-01
REGULATION OF PROTEIN LOCALIZATION TO CELL CORTEX 9 5.10e-01 -1.27e-01 9.05e-01
AMINO SUGAR CATABOLIC PROCESS 15 3.95e-01 1.27e-01 8.59e-01
NEGATIVE REGULATION OF AMIDE METABOLIC PROCESS 337 6.32e-05 -1.27e-01 1.01e-02
REGULATION OF NMDA RECEPTOR ACTIVITY 17 3.66e-01 1.27e-01 8.48e-01
SYNAPTIC VESICLE BUDDING 10 4.88e-01 1.27e-01 8.94e-01
MDA 5 SIGNALING PATHWAY 11 4.67e-01 -1.27e-01 8.90e-01
GLUTAMATE REUPTAKE 6 5.91e-01 -1.27e-01 9.26e-01
REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA 45 1.42e-01 -1.27e-01 6.69e-01
EXTRACELLULAR TRANSPORT 46 1.38e-01 1.27e-01 6.62e-01
PROTON TRANSPORTING V TYPE ATPASE COMPLEX ASSEMBLY 8 5.36e-01 -1.27e-01 9.13e-01
RESPONSE TO INTERLEUKIN 12 12 4.48e-01 -1.26e-01 8.80e-01
REGULATION OF AUTOPHAGOSOME ASSEMBLY 46 1.38e-01 -1.26e-01 6.63e-01
BRANCH ELONGATION OF AN EPITHELIUM 19 3.41e-01 1.26e-01 8.35e-01
GLIAL CELL DERIVED NEUROTROPHIC FACTOR RECEPTOR SIGNALING PATHWAY 9 5.12e-01 -1.26e-01 9.07e-01
REGULATION OF CALCIUM ION IMPORT 33 2.10e-01 1.26e-01 7.30e-01
REGULATION OF INCLUSION BODY ASSEMBLY 17 3.68e-01 -1.26e-01 8.48e-01
PROTEIN LOCALIZATION TO CYTOSKELETON 59 9.40e-02 -1.26e-01 5.92e-01
NEGATIVE REGULATION OF BLOOD CIRCULATION 25 2.76e-01 -1.26e-01 7.82e-01
KERATINOCYTE DEVELOPMENT 13 4.32e-01 -1.26e-01 8.74e-01
PURINE NUCLEOSIDE TRIPHOSPHATE CATABOLIC PROCESS 5 6.26e-01 -1.26e-01 9.34e-01
RELEASE OF CYTOCHROME C FROM MITOCHONDRIA 56 1.03e-01 -1.26e-01 6.07e-01
LNCRNA MEDIATED POST TRANSCRIPTIONAL GENE SILENCING 10 4.91e-01 1.26e-01 8.95e-01
REGULATION OF HETEROCHROMATIN ORGANIZATION 24 2.86e-01 1.26e-01 7.94e-01
POSITIVE REGULATION OF CHEMOKINE C C MOTIF LIGAND 5 PRODUCTION 6 5.94e-01 1.26e-01 9.26e-01
AORTA MORPHOGENESIS 38 1.80e-01 -1.26e-01 7.01e-01
POSITIVE REGULATION OF VASCULAR PERMEABILITY 18 3.56e-01 -1.26e-01 8.44e-01
NEGATIVE REGULATION OF MUSCLE CELL DIFFERENTIATION 70 6.92e-02 -1.26e-01 5.33e-01
METANEPHRIC MESENCHYME DEVELOPMENT 14 4.16e-01 1.26e-01 8.67e-01
REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION 62 8.74e-02 -1.26e-01 5.79e-01
REGULATION OF EPITHELIAL CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT 16 3.85e-01 -1.26e-01 8.55e-01
SUCCINYL COA METABOLIC PROCESS 10 4.92e-01 -1.25e-01 8.96e-01
NETRIN ACTIVATED SIGNALING PATHWAY 9 5.15e-01 1.25e-01 9.07e-01
CRANIOFACIAL SUTURE MORPHOGENESIS 18 3.57e-01 -1.25e-01 8.45e-01
CELLULAR RESPONSE TO L GLUTAMATE 5 6.28e-01 1.25e-01 9.35e-01
PLUS END DIRECTED ORGANELLE TRANSPORT ALONG MICROTUBULE 7 5.66e-01 -1.25e-01 9.21e-01
NEGATIVE REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY 145 9.20e-03 -1.25e-01 2.25e-01
POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRION 38 1.82e-01 -1.25e-01 7.01e-01
MIRNA MEDIATED GENE SILENCING BY INHIBITION OF TRANSLATION 96 3.41e-02 -1.25e-01 4.03e-01
ESTABLISHMENT OF LYMPHOCYTE POLARITY 16 3.86e-01 -1.25e-01 8.55e-01
WALKING BEHAVIOR 35 2.00e-01 1.25e-01 7.26e-01
CELLULAR RESPONSE TO AMYLOID BETA 45 1.47e-01 -1.25e-01 6.75e-01
REGULATION OF CARBOHYDRATE METABOLIC PROCESS 186 3.28e-03 -1.25e-01 1.31e-01
T HELPER 2 CELL CYTOKINE PRODUCTION 13 4.35e-01 -1.25e-01 8.74e-01
REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM 25 2.79e-01 1.25e-01 7.87e-01
POSITIVE REGULATION OF ISOTYPE SWITCHING TO IGG ISOTYPES 11 4.73e-01 1.25e-01 8.91e-01
RESPONSE TO HYDROGEN PEROXIDE 99 3.17e-02 -1.25e-01 3.89e-01
PEPTIDYL LYSINE METHYLATION 51 1.24e-01 -1.25e-01 6.44e-01
CELL MIGRATION INVOLVED IN HEART DEVELOPMENT 21 3.23e-01 -1.25e-01 8.24e-01
DETECTION OF VISIBLE LIGHT 50 1.28e-01 -1.25e-01 6.48e-01
REGULATION OF HYPERSENSITIVITY 9 5.18e-01 1.24e-01 9.09e-01
NEGATIVE REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION 164 5.96e-03 -1.24e-01 1.78e-01
TRIPARTITE REGIONAL SUBDIVISION 19 3.48e-01 1.24e-01 8.39e-01
REGULATION OF PERK MEDIATED UNFOLDED PROTEIN RESPONSE 11 4.75e-01 -1.24e-01 8.91e-01
REGULATION OF RESPIRATORY SYSTEM PROCESS 15 4.04e-01 -1.24e-01 8.63e-01
PERIPHERAL NERVOUS SYSTEM NEURON DIFFERENTIATION 15 4.04e-01 1.24e-01 8.63e-01
CLATHRIN COATED VESICLE CARGO LOADING 7 5.69e-01 1.24e-01 9.22e-01
ENDOTHELIAL CELL APOPTOTIC PROCESS 68 7.65e-02 -1.24e-01 5.53e-01
REGULATION OF CYTOPLASMIC TRANSLATION 33 2.17e-01 1.24e-01 7.36e-01
POSITIVE REGULATION OF RUFFLE ASSEMBLY 15 4.05e-01 -1.24e-01 8.63e-01
PERICENTRIC HETEROCHROMATIN FORMATION 5 6.31e-01 1.24e-01 9.36e-01
PHOSPHATIDYLINOSITOL 3 PHOSPHATE BIOSYNTHETIC PROCESS 22 3.14e-01 1.24e-01 8.16e-01
SECRETION BY TISSUE 44 1.55e-01 -1.24e-01 6.79e-01
REGULATION OF SISTER CHROMATID COHESION 17 3.76e-01 1.24e-01 8.50e-01
ENDOCARDIAL CUSHION MORPHOGENESIS 44 1.55e-01 1.24e-01 6.79e-01
REGULATION OF KETONE BIOSYNTHETIC PROCESS 21 3.26e-01 1.24e-01 8.27e-01
REGULATION OF AMACRINE CELL DIFFERENTIATION 6 5.99e-01 1.24e-01 9.28e-01
LATE ENDOSOME TO VACUOLE TRANSPORT 36 1.99e-01 -1.24e-01 7.25e-01
BRANCHING INVOLVED IN SALIVARY GLAND MORPHOGENESIS 21 3.26e-01 -1.24e-01 8.27e-01
TELENCEPHALON REGIONALIZATION 13 4.40e-01 1.24e-01 8.77e-01
MONOSACCHARIDE BIOSYNTHETIC PROCESS 101 3.17e-02 -1.24e-01 3.89e-01
COMPLEMENT ACTIVATION CLASSICAL PATHWAY 34 2.12e-01 -1.24e-01 7.32e-01
POSITIVE REGULATION OF T HELPER 2 CELL DIFFERENTIATION 7 5.71e-01 -1.24e-01 9.23e-01
LUNG SECRETORY CELL DIFFERENTIATION 11 4.78e-01 -1.24e-01 8.93e-01
REGULATION OF T HELPER 17 TYPE IMMUNE RESPONSE 32 2.27e-01 -1.23e-01 7.44e-01
PROTEIN AUTOPROCESSING 28 2.58e-01 -1.23e-01 7.72e-01
LIPID DROPLET ORGANIZATION 35 2.07e-01 -1.23e-01 7.29e-01
PROTEIN DEGLYCOSYLATION 15 4.08e-01 -1.23e-01 8.64e-01
NEGATIVE REGULATION OF PLASMA MEMBRANE BOUNDED CELL PROJECTION ASSEMBLY 38 1.89e-01 -1.23e-01 7.11e-01
SEBACEOUS GLAND DEVELOPMENT 10 5.00e-01 -1.23e-01 9.00e-01
SYNAPTIC VESICLE PRIMING 18 3.66e-01 1.23e-01 8.48e-01
L ARGININE IMPORT ACROSS PLASMA MEMBRANE 5 6.33e-01 1.23e-01 9.37e-01
AMINE CATABOLIC PROCESS 18 3.66e-01 -1.23e-01 8.48e-01
MYOFIBROBLAST DIFFERENTIATION 15 4.09e-01 -1.23e-01 8.64e-01
OPSONIZATION 17 3.79e-01 -1.23e-01 8.51e-01
REGULATION OF REMOVAL OF SUPEROXIDE RADICALS 9 5.22e-01 -1.23e-01 9.10e-01
RECEPTOR RECYCLING 47 1.45e-01 -1.23e-01 6.73e-01
REGULATION OF MRNA METABOLIC PROCESS 347 8.19e-05 -1.23e-01 1.22e-02
NEGATIVE REGULATION OF EXTRACELLULAR MATRIX ASSEMBLY 5 6.34e-01 1.23e-01 9.37e-01
MEMBRANE PROTEIN INTRACELLULAR DOMAIN PROTEOLYSIS 14 4.26e-01 -1.23e-01 8.73e-01
TOLL LIKE RECEPTOR 9 SIGNALING PATHWAY 18 3.66e-01 -1.23e-01 8.48e-01
REGULATION OF JUN KINASE ACTIVITY 44 1.58e-01 -1.23e-01 6.79e-01
NEGATIVE REGULATION OF AXON EXTENSION INVOLVED IN AXON GUIDANCE 28 2.60e-01 -1.23e-01 7.72e-01
GLYCOLIPID TRANSPORT 8 5.47e-01 -1.23e-01 9.14e-01
RETINAL CONE CELL DIFFERENTIATION 13 4.43e-01 -1.23e-01 8.78e-01
CEREBELLAR PURKINJE CELL LAYER FORMATION 15 4.10e-01 1.23e-01 8.64e-01
CDP CHOLINE PATHWAY 7 5.74e-01 -1.23e-01 9.24e-01
AMYGDALA DEVELOPMENT 5 6.35e-01 -1.23e-01 9.38e-01
REGULATION OF CYTOSKELETON ORGANIZATION 511 2.02e-06 -1.23e-01 6.70e-04
HYDROCARBON METABOLIC PROCESS 7 5.74e-01 1.23e-01 9.24e-01
RESPIRATORY CHAIN COMPLEX III ASSEMBLY 12 4.62e-01 1.23e-01 8.89e-01
CELL CELL JUNCTION ORGANIZATION 216 1.91e-03 -1.22e-01 9.93e-02
PYRIMIDINE RIBONUCLEOTIDE METABOLIC PROCESS 32 2.31e-01 -1.22e-01 7.48e-01
REGULATION OF ATRIAL CARDIAC MUSCLE CELL MEMBRANE DEPOLARIZATION 9 5.25e-01 1.22e-01 9.10e-01
RESPONSE TO ANGIOTENSIN 38 1.92e-01 1.22e-01 7.15e-01
NEGATIVE REGULATION OF PROTEIN KINASE ACTIVITY BY REGULATION OF PROTEIN PHOSPHORYLATION 6 6.04e-01 -1.22e-01 9.29e-01
REGULATION OF CD40 SIGNALING PATHWAY 6 6.04e-01 -1.22e-01 9.29e-01
POSITIVE REGULATION OF MEMORY T CELL DIFFERENTIATION 9 5.25e-01 1.22e-01 9.10e-01
REGULATION OF NUCLEAR TRANSCRIBED MRNA POLY A TAIL SHORTENING 15 4.12e-01 -1.22e-01 8.65e-01
REGULATION OF TRANSFORMING GROWTH FACTOR BETA1 PRODUCTION 14 4.28e-01 -1.22e-01 8.74e-01
COPII COATED VESICLE CARGO LOADING 16 3.97e-01 -1.22e-01 8.59e-01
POSITIVE REGULATION OF KERATINOCYTE DIFFERENTIATION 19 3.56e-01 -1.22e-01 8.44e-01
INTESTINAL HEXOSE ABSORPTION 5 6.36e-01 -1.22e-01 9.38e-01
LUTEOLYSIS 6 6.04e-01 1.22e-01 9.29e-01
APOPTOTIC DNA FRAGMENTATION 20 3.45e-01 1.22e-01 8.37e-01
INTESTINAL EPITHELIAL CELL DIFFERENTIATION 28 2.64e-01 -1.22e-01 7.74e-01
POSITIVE REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY 12 4.65e-01 -1.22e-01 8.90e-01
POSITIVE REGULATION OF SMOOTHENED SIGNALING PATHWAY 37 2.00e-01 -1.22e-01 7.25e-01
PEPTIDYL LYSINE OXIDATION 5 6.37e-01 -1.22e-01 9.38e-01
PROTEIN RETENTION IN GOLGI APPARATUS 5 6.37e-01 1.22e-01 9.38e-01
EPITHELIAL TUBE FORMATION 137 1.38e-02 -1.22e-01 2.76e-01
POSITIVE REGULATION OF CORTICOSTEROID HORMONE SECRETION 7 5.77e-01 -1.22e-01 9.24e-01
MANCHETTE ASSEMBLY 6 6.05e-01 -1.22e-01 9.29e-01
U2 TYPE PRESPLICEOSOME ASSEMBLY 24 3.02e-01 1.22e-01 8.07e-01
POSITIVE REGULATION OF FATTY ACID METABOLIC PROCESS 41 1.78e-01 -1.22e-01 6.97e-01
DOPAMINE SECRETION 41 1.78e-01 1.22e-01 6.97e-01
EXOCRINE SYSTEM DEVELOPMENT 46 1.53e-01 -1.22e-01 6.79e-01
REGULATION OF PROTEIN POLYMERIZATION 202 2.87e-03 -1.22e-01 1.24e-01
FOLIC ACID TRANSPORT 10 5.05e-01 -1.22e-01 9.02e-01
DOPAMINE METABOLIC PROCESS 39 1.89e-01 1.22e-01 7.11e-01
POSITIVE REGULATION OF NON CANONICAL WNT SIGNALING PATHWAY 15 4.15e-01 -1.22e-01 8.67e-01
REGULATION OF WNT SIGNALING PATHWAY INVOLVED IN HEART DEVELOPMENT 9 5.28e-01 1.21e-01 9.10e-01
POSITIVE REGULATION OF PLASMA MEMBRANE BOUNDED CELL PROJECTION ASSEMBLY 109 2.85e-02 -1.21e-01 3.73e-01
NEGATIVE REGULATION OF MICROGLIAL CELL ACTIVATION 8 5.52e-01 -1.21e-01 9.18e-01
REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION 46 1.54e-01 1.21e-01 6.79e-01
POSITIVE REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY 18 3.73e-01 -1.21e-01 8.49e-01
NEGATIVE REGULATION OF NEUTROPHIL MIGRATION 6 6.07e-01 1.21e-01 9.30e-01
POSITIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT 24 3.04e-01 1.21e-01 8.09e-01
NEGATIVE REGULATION BY HOST OF VIRAL TRANSCRIPTION 14 4.32e-01 1.21e-01 8.74e-01
CAMERA TYPE EYE PHOTORECEPTOR CELL DIFFERENTIATION 30 2.50e-01 -1.21e-01 7.67e-01
PROSTAGLANDIN TRANSPORT 28 2.67e-01 -1.21e-01 7.77e-01
AMEBOIDAL TYPE CELL MIGRATION 497 3.70e-06 -1.21e-01 1.01e-03
AMINO ACID SALVAGE 7 5.79e-01 -1.21e-01 9.24e-01
GLUTAMATE METABOLIC PROCESS 33 2.29e-01 -1.21e-01 7.45e-01
XYLULOSE 5 PHOSPHATE METABOLIC PROCESS 6 6.08e-01 -1.21e-01 9.30e-01
REGULATION OF INFLAMMATORY RESPONSE TO WOUNDING 12 4.68e-01 -1.21e-01 8.90e-01
REGULATION OF FIBROBLAST PROLIFERATION 88 4.98e-02 -1.21e-01 4.66e-01
POSITIVE REGULATION OF DENDRITIC SPINE DEVELOPMENT 39 1.91e-01 -1.21e-01 7.14e-01
POSITIVE REGULATION OF MEMBRANE DEPOLARIZATION 11 4.87e-01 -1.21e-01 8.94e-01
SECONDARY HEART FIELD SPECIFICATION 11 4.88e-01 1.21e-01 8.94e-01
REGULATION OF LIGASE ACTIVITY 9 5.30e-01 1.21e-01 9.11e-01
RESPONSE TO OXYGEN RADICAL 28 2.69e-01 -1.21e-01 7.78e-01
NEGATIVE REGULATION OF EXECUTION PHASE OF APOPTOSIS 9 5.30e-01 -1.21e-01 9.11e-01
GLOMERULAR MESANGIAL CELL DEVELOPMENT 5 6.40e-01 -1.21e-01 9.39e-01
APOPTOTIC MITOCHONDRIAL CHANGES 108 3.01e-02 -1.21e-01 3.83e-01
POSITIVE REGULATION OF SMALL MOLECULE METABOLIC PROCESS 145 1.21e-02 -1.21e-01 2.55e-01
REGULATION OF DOPAMINE RECEPTOR SIGNALING PATHWAY 11 4.88e-01 1.21e-01 8.94e-01
POSITIVE REGULATION OF CELL MATURATION 7 5.80e-01 1.21e-01 9.24e-01
BONE RESORPTION 65 9.25e-02 -1.21e-01 5.89e-01
MITOCHONDRIAL RNA 3 END PROCESSING 6 6.09e-01 1.21e-01 9.31e-01
NEURON RECOGNITION 45 1.62e-01 1.20e-01 6.81e-01
COMPLEMENT ACTIVATION ALTERNATIVE PATHWAY 18 3.76e-01 1.20e-01 8.51e-01
CELLULAR RESPONSE TO PEPTIDOGLYCAN 6 6.10e-01 -1.20e-01 9.31e-01
TAIL ANCHORED MEMBRANE PROTEIN INSERTION INTO ER MEMBRANE 17 3.90e-01 -1.20e-01 8.56e-01
BRAIN DERIVED NEUROTROPHIC FACTOR RECEPTOR SIGNALING PATHWAY 6 6.10e-01 1.20e-01 9.31e-01
G2 MI TRANSITION OF MEIOTIC CELL CYCLE 7 5.81e-01 1.20e-01 9.24e-01
GLYCEROLIPID CATABOLIC PROCESS 65 9.35e-02 -1.20e-01 5.91e-01
INTERMEDIATE FILAMENT BUNDLE ASSEMBLY 8 5.56e-01 -1.20e-01 9.18e-01
REGULATION OF SULFUR METABOLIC PROCESS 14 4.36e-01 -1.20e-01 8.74e-01
REGULATION OF ENDOSOME SIZE 13 4.53e-01 1.20e-01 8.81e-01
REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION 45 1.63e-01 -1.20e-01 6.81e-01
POSITIVE REGULATION OF STEM CELL DIFFERENTIATION 21 3.41e-01 1.20e-01 8.35e-01
MUSCLE CELL CELLULAR HOMEOSTASIS 24 3.08e-01 1.20e-01 8.11e-01
POSITIVE REGULATION OF AXONOGENESIS 78 6.66e-02 -1.20e-01 5.28e-01
ONCOGENE INDUCED CELL SENESCENCE 6 6.11e-01 -1.20e-01 9.31e-01
SMALL NUCLEOLAR RIBONUCLEOPROTEIN COMPLEX ASSEMBLY 12 4.72e-01 1.20e-01 8.91e-01
REGULATION OF PROTEIN SUMOYLATION 23 3.20e-01 -1.20e-01 8.21e-01
NEGATIVE REGULATION OF BONE MINERALIZATION 20 3.53e-01 1.20e-01 8.43e-01
REGULATION OF CGMP MEDIATED SIGNALING 11 4.91e-01 -1.20e-01 8.95e-01
REGULATION OF TRANSCRIPTION BY RNA POLYMERASE I 46 1.60e-01 -1.20e-01 6.80e-01
INTERLEUKIN 12 MEDIATED SIGNALING PATHWAY 9 5.34e-01 -1.20e-01 9.12e-01
POSITIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL MIGRATION 25 3.00e-01 -1.20e-01 8.06e-01
TRNA 3 END PROCESSING 7 5.84e-01 1.20e-01 9.24e-01
NEGATIVE REGULATION OF TYPE I INTERFERON PRODUCTION 45 1.65e-01 -1.20e-01 6.84e-01
POSITIVE REGULATION OF SMOOTH MUSCLE CELL APOPTOTIC PROCESS 16 4.08e-01 1.20e-01 8.64e-01
NEGATIVE REGULATION OF OSTEOCLAST DIFFERENTIATION 33 2.35e-01 1.19e-01 7.54e-01
NEGATIVE REGULATION OF BONE REMODELING 18 3.80e-01 -1.19e-01 8.51e-01
MULTIVESICULAR BODY SORTING PATHWAY 47 1.57e-01 -1.19e-01 6.79e-01
SIGNALING RECEPTOR LIGAND PRECURSOR PROCESSING 39 1.97e-01 1.19e-01 7.21e-01
PROGRAMMED NECROTIC CELL DEATH 60 1.10e-01 -1.19e-01 6.17e-01
CARBOHYDRATE METABOLIC PROCESS 563 1.29e-06 -1.19e-01 4.69e-04
HORMONE BIOSYNTHETIC PROCESS 65 9.65e-02 -1.19e-01 5.96e-01
NEUTROPHIL CLEARANCE 6 6.13e-01 1.19e-01 9.31e-01
TUBE FORMATION 151 1.15e-02 -1.19e-01 2.50e-01
REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS 54 1.30e-01 -1.19e-01 6.50e-01
CELLULAR RESPONSE TO WATER STIMULUS 6 6.13e-01 -1.19e-01 9.31e-01
POSITIVE REGULATION OF ACTIVATED T CELL PROLIFERATION 27 2.84e-01 -1.19e-01 7.91e-01
REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE 181 5.70e-03 -1.19e-01 1.74e-01
NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO CHROMATIN 6 6.13e-01 -1.19e-01 9.31e-01
MEIOTIC CHROMOSOME CONDENSATION 6 6.14e-01 -1.19e-01 9.32e-01
XENOBIOTIC EXPORT FROM CELL 25 3.04e-01 -1.19e-01 8.09e-01
FC EPSILON RECEPTOR SIGNALING PATHWAY 25 3.04e-01 1.19e-01 8.09e-01
NEGATIVE REGULATION OF FIBROBLAST PROLIFERATION 35 2.25e-01 -1.19e-01 7.42e-01
RESPONSE TO INTERFERON ALPHA 17 3.97e-01 -1.19e-01 8.59e-01
REGULATION OF CELLULAR PH REDUCTION 8 5.62e-01 -1.18e-01 9.20e-01
RESPONSE TO AMYLOID BETA 55 1.29e-01 -1.18e-01 6.48e-01
PHOSPHATIDYLGLYCEROL METABOLIC PROCESS 34 2.32e-01 -1.18e-01 7.49e-01
TELOMERE MAINTENANCE IN RESPONSE TO DNA DAMAGE 29 2.70e-01 1.18e-01 7.79e-01
PIGMENT GRANULE MATURATION 10 5.17e-01 1.18e-01 9.08e-01
REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO OSMOTIC STRESS 8 5.62e-01 -1.18e-01 9.20e-01
HISTONE H4 K16 ACETYLATION 7 5.88e-01 1.18e-01 9.24e-01
POSITIVE REGULATION OF OSSIFICATION 53 1.36e-01 1.18e-01 6.60e-01
NEGATIVE REGULATION OF KIDNEY DEVELOPMENT 5 6.47e-01 1.18e-01 9.41e-01
POSITIVE REGULATION OF ORGANELLE ASSEMBLY 84 6.11e-02 -1.18e-01 5.08e-01
CATECHOL CONTAINING COMPOUND CATABOLIC PROCESS 7 5.89e-01 1.18e-01 9.24e-01
MACROPHAGE COLONY STIMULATING FACTOR PRODUCTION 7 5.89e-01 1.18e-01 9.24e-01
POSITIVE REGULATION OF INOSITOL PHOSPHATE BIOSYNTHETIC PROCESS 14 4.44e-01 1.18e-01 8.78e-01
POSITIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL APOPTOTIC PROCESS 11 4.98e-01 -1.18e-01 8.99e-01
NEGATIVE REGULATION OF MYELOID CELL APOPTOTIC PROCESS 19 3.73e-01 -1.18e-01 8.49e-01
POSITIVE REGULATION OF MYOBLAST PROLIFERATION 14 4.45e-01 1.18e-01 8.78e-01
REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR 34 2.34e-01 1.18e-01 7.52e-01
POSITIVE REGULATION OF NOTCH SIGNALING PATHWAY 45 1.71e-01 -1.18e-01 6.89e-01
REGULATION OF GLUCOCORTICOID METABOLIC PROCESS 11 4.99e-01 -1.18e-01 8.99e-01
HEART FIELD SPECIFICATION 17 4.00e-01 1.18e-01 8.62e-01
PROTEOGLYCAN METABOLIC PROCESS 90 5.35e-02 -1.18e-01 4.79e-01
POSITIVE REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA 25 3.08e-01 -1.18e-01 8.11e-01
POSITIVE REGULATION OF WOUND HEALING 62 1.09e-01 -1.18e-01 6.17e-01
ESTABLISHMENT OF ENDOTHELIAL INTESTINAL BARRIER 15 4.30e-01 -1.18e-01 8.74e-01
REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY 56 1.28e-01 -1.18e-01 6.48e-01
POSITIVE REGULATION OF CELLULAR CATABOLIC PROCESS 392 6.36e-05 -1.18e-01 1.01e-02
POSITIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL PROLIFERATION INVOLVED IN SPROUTING ANGIOGENESIS 22 3.40e-01 -1.18e-01 8.35e-01
VITAMIN E METABOLIC PROCESS 6 6.18e-01 1.18e-01 9.32e-01
TOXIN TRANSPORT 11 5.00e-01 -1.18e-01 9.00e-01
RESPONSE TO GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR 9 5.42e-01 -1.18e-01 9.13e-01
CHRONIC INFLAMMATORY RESPONSE 19 3.75e-01 -1.18e-01 8.50e-01
REGULATION OF PROTEIN TARGETING 78 7.28e-02 -1.17e-01 5.43e-01
REGULATION OF CAMP MEDIATED SIGNALING 29 2.74e-01 1.17e-01 7.80e-01
NEGATIVE REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS 26 3.00e-01 -1.17e-01 8.06e-01
PHARYNGEAL ARCH ARTERY MORPHOGENESIS 10 5.20e-01 1.17e-01 9.09e-01
LUNG VASCULATURE DEVELOPMENT 8 5.65e-01 1.17e-01 9.21e-01
SARCOMERE ORGANIZATION 45 1.73e-01 -1.17e-01 6.90e-01
VESICLE BUDDING FROM MEMBRANE 82 6.62e-02 -1.17e-01 5.26e-01
MITOCHONDRIAL RNA PROCESSING 21 3.52e-01 1.17e-01 8.42e-01
SULFUR AMINO ACID METABOLIC PROCESS 33 2.44e-01 -1.17e-01 7.63e-01
POSITIVE REGULATION OF GLOMERULAR MESANGIAL CELL PROLIFERATION 7 5.91e-01 1.17e-01 9.26e-01
CELLULAR RESPONSE TO ARSENIC CONTAINING SUBSTANCE 18 3.90e-01 -1.17e-01 8.56e-01
WATER TRANSPORT 28 2.84e-01 -1.17e-01 7.91e-01
SKELETAL MUSCLE CELL PROLIFERATION 24 3.21e-01 1.17e-01 8.23e-01
RNA 5 END PROCESSING 22 3.42e-01 1.17e-01 8.36e-01
L ARGININE TRANSMEMBRANE TRANSPORT 15 4.33e-01 -1.17e-01 8.74e-01
REGULATION OF SKELETAL MUSCLE SATELLITE CELL PROLIFERATION 12 4.83e-01 1.17e-01 8.94e-01
POSITIVE REGULATION OF CARDIAC MUSCLE ADAPTATION 9 5.44e-01 1.17e-01 9.13e-01
COLLECTING DUCT DEVELOPMENT 15 4.33e-01 -1.17e-01 8.74e-01
NEGATIVE REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION 14 4.49e-01 1.17e-01 8.80e-01
POSITIVE REGULATION OF MACROAUTOPHAGY 75 8.04e-02 -1.17e-01 5.61e-01
REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY 12 4.84e-01 -1.17e-01 8.94e-01
SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION 487 1.02e-05 -1.17e-01 2.28e-03
NEGATIVE REGULATION OF HORMONE SECRETION 66 1.01e-01 -1.17e-01 6.04e-01
PROTEIN DEPOLYMERIZATION 116 3.00e-02 -1.17e-01 3.83e-01
BICARBONATE TRANSPORT 35 2.33e-01 -1.17e-01 7.50e-01
CELL DIFFERENTIATION IN SPINAL CORD 50 1.54e-01 1.17e-01 6.79e-01
RESPONSE TO HEPATOCYTE GROWTH FACTOR 17 4.05e-01 -1.17e-01 8.63e-01
DEADENYLATION DEPENDENT DECAPPING OF NUCLEAR TRANSCRIBED MRNA 11 5.03e-01 1.17e-01 9.02e-01
PURINERGIC NUCLEOTIDE RECEPTOR SIGNALING PATHWAY 31 2.61e-01 -1.17e-01 7.72e-01
PYRIMIDINE NUCLEOSIDE TRANSPORT 6 6.21e-01 -1.17e-01 9.32e-01
POSITIVE REGULATION OF ORGAN GROWTH 51 1.50e-01 1.17e-01 6.78e-01
MESENCHYMAL CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT 7 5.94e-01 -1.16e-01 9.26e-01
OXALATE TRANSPORT 12 4.86e-01 -1.16e-01 8.94e-01
STRIATED MUSCLE ADAPTATION 55 1.36e-01 -1.16e-01 6.60e-01
GLUCOSE IMPORT ACROSS PLASMA MEMBRANE 5 6.53e-01 -1.16e-01 9.41e-01
NEGATIVE REGULATION OF TRIGLYCERIDE BIOSYNTHETIC PROCESS 5 6.53e-01 -1.16e-01 9.41e-01
SERINE FAMILY AMINO ACID CATABOLIC PROCESS 14 4.52e-01 -1.16e-01 8.81e-01
DOLICHYL DIPHOSPHATE METABOLIC PROCESS 5 6.53e-01 1.16e-01 9.41e-01
XENOBIOTIC TRANSPORT 58 1.26e-01 -1.16e-01 6.48e-01
LENS FIBER CELL MORPHOGENESIS 6 6.22e-01 1.16e-01 9.32e-01
METANEPHRIC GLOMERULUS VASCULATURE DEVELOPMENT 9 5.46e-01 -1.16e-01 9.14e-01
BASEMENT MEMBRANE ORGANIZATION 36 2.28e-01 -1.16e-01 7.45e-01
NEUROTRANSMITTER RECEPTOR TRANSPORT TO PLASMA MEMBRANE 17 4.07e-01 1.16e-01 8.63e-01
CO TRANSCRIPTIONAL MRNA 3 END PROCESSING CLEAVAGE AND POLYADENYLATION PATHWAY 5 6.53e-01 1.16e-01 9.41e-01
AMYLOID FIBRIL FORMATION 40 2.04e-01 -1.16e-01 7.29e-01
SPINAL CORD DEVELOPMENT 102 4.30e-02 1.16e-01 4.36e-01
REGULATION OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE 108 3.75e-02 -1.16e-01 4.12e-01
COMPLEMENT ACTIVATION LECTIN PATHWAY 11 5.06e-01 1.16e-01 9.02e-01
ADHERENS JUNCTION ORGANIZATION 57 1.30e-01 -1.16e-01 6.51e-01
PROTEIN K6 LINKED UBIQUITINATION 11 5.06e-01 1.16e-01 9.02e-01
MORPHOGENESIS OF AN EPITHELIAL SHEET 61 1.18e-01 -1.16e-01 6.30e-01
REGULATION OF XENOBIOTIC DETOXIFICATION BY TRANSMEMBRANE EXPORT ACROSS THE PLASMA MEMBRANE 11 5.06e-01 -1.16e-01 9.02e-01
GLUCOCORTICOID METABOLIC PROCESS 25 3.17e-01 -1.16e-01 8.20e-01
GROWTH PLATE CARTILAGE DEVELOPMENT 20 3.71e-01 -1.16e-01 8.48e-01
NEGATIVE REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION 15 4.39e-01 1.16e-01 8.77e-01
POSITIVE REGULATION OF INTERLEUKIN 12 PRODUCTION 43 1.90e-01 1.16e-01 7.12e-01
CHONDROITIN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS 24 3.27e-01 -1.15e-01 8.29e-01
NEGATIVE REGULATION OF SYNAPTIC TRANSMISSION 54 1.42e-01 1.15e-01 6.69e-01
POSITIVE REGULATION OF INTEGRIN ACTIVATION 11 5.08e-01 -1.15e-01 9.03e-01
MITOCHONDRIAL FRAGMENTATION INVOLVED IN APOPTOTIC PROCESS 10 5.28e-01 -1.15e-01 9.10e-01
CELL CELL JUNCTION ASSEMBLY 158 1.23e-02 -1.15e-01 2.58e-01
MICROTUBULE POLYMERIZATION 95 5.24e-02 -1.15e-01 4.75e-01
INTEGRIN MEDIATED SIGNALING PATHWAY 113 3.45e-02 -1.15e-01 4.03e-01
D AMINO ACID TRANSPORT 6 6.25e-01 -1.15e-01 9.34e-01
PROTEIN K27 LINKED UBIQUITINATION 7 5.98e-01 1.15e-01 9.28e-01
RESPONSE TO DIETARY EXCESS 35 2.39e-01 -1.15e-01 7.57e-01
DNA TEMPLATED TRANSCRIPTION TERMINATION 24 3.29e-01 -1.15e-01 8.30e-01
EMBRYONIC EYE MORPHOGENESIS 35 2.39e-01 1.15e-01 7.57e-01
REGULATION OF RESPONSE TO WOUNDING 172 9.28e-03 -1.15e-01 2.26e-01
SPINAL CORD MOTOR NEURON DIFFERENTIATION 29 2.84e-01 1.15e-01 7.91e-01
ADIPOSE TISSUE DEVELOPMENT 58 1.30e-01 -1.15e-01 6.50e-01
GLYCEROLIPID BIOSYNTHETIC PROCESS 247 1.86e-03 -1.15e-01 9.80e-02
NEGATIVE REGULATION OF NOTCH SIGNALING PATHWAY 39 2.15e-01 -1.15e-01 7.33e-01
GLUTAMINE FAMILY AMINO ACID BIOSYNTHETIC PROCESS 17 4.13e-01 1.15e-01 8.65e-01
REGULATION OF CELL PROJECTION ASSEMBLY 229 2.76e-03 -1.15e-01 1.21e-01
DITERPENOID BIOSYNTHETIC PROCESS 10 5.30e-01 1.15e-01 9.11e-01
PODOCYTE CELL MIGRATION 7 5.99e-01 1.15e-01 9.28e-01
ENDOPLASMIC RETICULUM TUBULAR NETWORK FORMATION 5 6.57e-01 -1.15e-01 9.43e-01
PHOSPHATIDYLINOSITOL 3 KINASE PROTEIN KINASE B SIGNAL TRANSDUCTION 289 7.98e-04 -1.15e-01 5.48e-02
POSITIVE REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION 53 1.49e-01 1.15e-01 6.76e-01
RECEPTOR MEDIATED VIRION ATTACHMENT TO HOST CELL 5 6.57e-01 1.15e-01 9.43e-01
DICARBOXYLIC ACID BIOSYNTHETIC PROCESS 13 4.75e-01 -1.14e-01 8.91e-01
POSITIVE REGULATION OF MAINTENANCE OF SISTER CHROMATID COHESION 6 6.27e-01 1.14e-01 9.35e-01
REGULATION OF MDA 5 SIGNALING PATHWAY 7 6.00e-01 -1.14e-01 9.28e-01
RESPONSE TO REACTIVE OXYGEN SPECIES 201 5.20e-03 -1.14e-01 1.68e-01
REGULATION OF CHOLESTEROL EFFLUX 54 1.46e-01 -1.14e-01 6.75e-01
POLYSACCHARIDE BIOSYNTHETIC PROCESS 66 1.09e-01 -1.14e-01 6.15e-01
NUCLEAR PORE LOCALIZATION 5 6.58e-01 -1.14e-01 9.43e-01
NEGATIVE REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY 19 3.89e-01 -1.14e-01 8.56e-01
APOPTOTIC PROCESS INVOLVED IN MORPHOGENESIS 27 3.05e-01 -1.14e-01 8.10e-01
NUCLEOTIDE EXCISION REPAIR 86 6.74e-02 -1.14e-01 5.30e-01
REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS 114 3.54e-02 -1.14e-01 4.03e-01
POSITIVE REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL 13 4.76e-01 1.14e-01 8.93e-01
NEGATIVE REGULATION OF SMALL MOLECULE METABOLIC PROCESS 114 3.54e-02 -1.14e-01 4.03e-01
PROTEIN OXIDATION 13 4.77e-01 -1.14e-01 8.93e-01
POSITIVE REGULATION OF BEHAVIOR 25 3.24e-01 -1.14e-01 8.25e-01
POSITIVE REGULATION OF HISTONE ACETYLATION 10 5.33e-01 1.14e-01 9.11e-01
PROTEIN DEGLUTAMYLATION 6 6.29e-01 1.14e-01 9.35e-01
NEURON REMODELING 15 4.45e-01 -1.14e-01 8.79e-01
C TERMINAL PROTEIN AMINO ACID MODIFICATION 12 4.95e-01 1.14e-01 8.98e-01
PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY 58 1.34e-01 -1.14e-01 6.58e-01
POSITIVE REGULATION OF T CELL MEDIATED CYTOTOXICITY 40 2.13e-01 -1.14e-01 7.33e-01
CHEMOKINE C X C MOTIF LIGAND 12 SIGNALING PATHWAY 7 6.02e-01 1.14e-01 9.29e-01
REGULATION OF CHAPERONE MEDIATED AUTOPHAGY 8 5.78e-01 -1.14e-01 9.24e-01
VOCALIZATION BEHAVIOR 19 3.91e-01 1.14e-01 8.57e-01
POSITIVE REGULATION OF MACROPHAGE CYTOKINE PRODUCTION 24 3.35e-01 -1.14e-01 8.31e-01
EPIGENETIC PROGRAMMING IN THE ZYGOTIC PRONUCLEI 9 5.55e-01 -1.14e-01 9.18e-01
TUBE LUMEN CAVITATION 5 6.60e-01 -1.14e-01 9.43e-01
RESPONSE TO DIACYL BACTERIAL LIPOPEPTIDE 5 6.60e-01 -1.13e-01 9.43e-01
SUBPALLIUM DEVELOPMENT 28 2.99e-01 1.13e-01 8.05e-01
UREA CYCLE 11 5.15e-01 1.13e-01 9.07e-01
LIMB JOINT MORPHOGENESIS 5 6.61e-01 -1.13e-01 9.43e-01
CARDIAC CHAMBER FORMATION 12 4.97e-01 1.13e-01 8.99e-01
NEGATIVE REGULATION OF LYASE ACTIVITY 18 4.05e-01 1.13e-01 8.63e-01
GLYCEROPHOSPHOLIPID BIOSYNTHETIC PROCESS 207 4.94e-03 -1.13e-01 1.64e-01
TRANSCRIPTION ELONGATION COUPLED CHROMATIN REMODELING 7 6.04e-01 1.13e-01 9.29e-01
POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY 53 1.54e-01 -1.13e-01 6.79e-01
REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT 5 6.61e-01 1.13e-01 9.44e-01
INTESTINAL LIPID ABSORPTION 22 3.58e-01 -1.13e-01 8.46e-01
CELLULAR RESPONSE TO MECHANICAL STIMULUS 71 9.92e-02 -1.13e-01 6.02e-01
QUINONE METABOLIC PROCESS 39 2.21e-01 1.13e-01 7.40e-01
DETECTION OF EXTERNAL BIOTIC STIMULUS 26 3.18e-01 -1.13e-01 8.21e-01
NEGATIVE REGULATION OF TRANSLATIONAL INITIATION 22 3.58e-01 -1.13e-01 8.46e-01
POSITIVE REGULATION OF CELL MATRIX ADHESION 56 1.43e-01 -1.13e-01 6.70e-01
PURINE CONTAINING COMPOUND TRANSMEMBRANE TRANSPORT 37 2.34e-01 -1.13e-01 7.52e-01
GAMMA DELTA T CELL ACTIVATION 23 3.48e-01 1.13e-01 8.39e-01
REGULATION OF ACTIN FILAMENT LENGTH 155 1.52e-02 -1.13e-01 2.90e-01
IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE 20 3.82e-01 -1.13e-01 8.53e-01
POST EMBRYONIC ANIMAL ORGAN MORPHOGENESIS 11 5.17e-01 -1.13e-01 9.08e-01
EXTRACELLULAR MATRIX ASSEMBLY 45 1.90e-01 -1.13e-01 7.12e-01
CELLULAR RESPONSE TO HEAT 64 1.18e-01 -1.13e-01 6.31e-01
REGULATION OF JNK CASCADE 132 2.52e-02 -1.13e-01 3.65e-01
CD4 POSITIVE ALPHA BETA T CELL PROLIFERATION 21 3.71e-01 1.13e-01 8.48e-01
REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY 52 1.59e-01 1.13e-01 6.80e-01
POTASSIUM ION IMPORT ACROSS PLASMA MEMBRANE 46 1.86e-01 1.13e-01 7.08e-01
MITOCHONDRIAL PROTEIN CATABOLIC PROCESS 6 6.33e-01 -1.13e-01 9.36e-01
NEGATIVE REGULATION OF LENS FIBER CELL DIFFERENTIATION 6 6.33e-01 1.13e-01 9.36e-01
SNRNA 3 END PROCESSING 22 3.60e-01 1.13e-01 8.46e-01
NEGATIVE REGULATION OF VOLTAGE GATED POTASSIUM CHANNEL ACTIVITY 19 3.95e-01 1.13e-01 8.59e-01
CALCIUM DEPENDENT CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES 47 1.81e-01 -1.13e-01 7.01e-01
PROTEIN UFMYLATION 6 6.33e-01 -1.13e-01 9.36e-01
GLUTAMATE SECRETION NEUROTRANSMISSION 8 5.81e-01 1.13e-01 9.24e-01
TISSUE MIGRATION 379 1.66e-04 -1.13e-01 1.81e-02
VESICLE COATING 39 2.24e-01 -1.13e-01 7.41e-01
POSITIVE CHEMOTAXIS 64 1.19e-01 1.13e-01 6.33e-01
REGULATION OF CELL MORPHOGENESIS 246 2.36e-03 -1.13e-01 1.08e-01
GLYCEROLIPID METABOLIC PROCESS 387 1.44e-04 -1.12e-01 1.74e-02
T HELPER 17 CELL LINEAGE COMMITMENT 16 4.36e-01 1.12e-01 8.74e-01
PLANAR CELL POLARITY PATHWAY INVOLVED IN NEURAL TUBE CLOSURE 11 5.19e-01 -1.12e-01 9.09e-01
MITOCHONDRION MORPHOGENESIS 21 3.73e-01 -1.12e-01 8.49e-01
REGULATION OF GENERATION OF PRECURSOR METABOLITES AND ENERGY 137 2.32e-02 -1.12e-01 3.57e-01
PRE MIRNA PROCESSING 17 4.23e-01 1.12e-01 8.73e-01
CHAPERONE MEDIATED PROTEIN COMPLEX ASSEMBLY 22 3.62e-01 1.12e-01 8.46e-01
ACTIN FILAMENT BASED MOVEMENT 133 2.54e-02 -1.12e-01 3.65e-01
EPITHELIAL STRUCTURE MAINTENANCE 34 2.58e-01 -1.12e-01 7.71e-01
REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS 80 8.28e-02 -1.12e-01 5.70e-01
DETOXIFICATION OF NITROGEN COMPOUND 5 6.64e-01 -1.12e-01 9.44e-01
POLARIZED EPITHELIAL CELL DIFFERENTIATION 27 3.13e-01 -1.12e-01 8.15e-01
BROWN FAT CELL DIFFERENTIATION 54 1.54e-01 1.12e-01 6.79e-01
NEGATIVE REGULATION OF CARDIOCYTE DIFFERENTIATION 14 4.68e-01 -1.12e-01 8.90e-01
REGULATION OF COMPLEMENT DEPENDENT CYTOTOXICITY 11 5.20e-01 -1.12e-01 9.09e-01
ACTIN POLYMERIZATION OR DEPOLYMERIZATION 194 7.12e-03 -1.12e-01 1.97e-01
NEGATIVE REGULATION OF RELAXATION OF MUSCLE 7 6.08e-01 -1.12e-01 9.30e-01
NEGATIVE REGULATION OF NEUROTRANSMITTER TRANSPORT 9 5.61e-01 1.12e-01 9.20e-01
INTERNEURON MIGRATION FROM THE SUBPALLIUM TO THE CORTEX 8 5.83e-01 1.12e-01 9.24e-01
BIOLOGICAL PROCESS INVOLVED IN INTERACTION WITH HOST 208 5.39e-03 -1.12e-01 1.72e-01
ESTABLISHMENT OR MAINTENANCE OF TRANSMEMBRANE ELECTROCHEMICAL GRADIENT 11 5.21e-01 -1.12e-01 9.09e-01
UREA TRANSPORT 11 5.21e-01 1.12e-01 9.09e-01
CEREBRAL CORTEX NEURON DIFFERENTIATION 27 3.15e-01 1.12e-01 8.17e-01
LAMELLIPODIUM ASSEMBLY 72 1.01e-01 -1.12e-01 6.04e-01
ESTABLISHMENT OR MAINTENANCE OF CELL POLARITY 230 3.49e-03 -1.12e-01 1.35e-01
CITRULLINE METABOLIC PROCESS 8 5.84e-01 -1.12e-01 9.24e-01
RESPONSE TO GRAVITY 9 5.62e-01 1.11e-01 9.20e-01
SISTER CHROMATID COHESION 58 1.42e-01 1.11e-01 6.69e-01
MAMMARY GLAND EPITHELIUM DEVELOPMENT 66 1.17e-01 -1.11e-01 6.30e-01
LENS FIBER CELL DIFFERENTIATION 37 2.41e-01 1.11e-01 7.59e-01
PEPTIDE ANTIGEN ASSEMBLY WITH MHC CLASS II PROTEIN COMPLEX 14 4.70e-01 1.11e-01 8.90e-01
MINERALOCORTICOID BIOSYNTHETIC PROCESS 12 5.04e-01 1.11e-01 9.02e-01
NEGATIVE REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS 31 2.84e-01 -1.11e-01 7.91e-01
POSITIVE REGULATION OF CHONDROCYTE DIFFERENTIATION 20 3.89e-01 1.11e-01 8.56e-01
POSITIVE REGULATION OF AXON EXTENSION 37 2.42e-01 -1.11e-01 7.61e-01
PHOSPHATIDYLINOSITOL DEPHOSPHORYLATION 27 3.17e-01 -1.11e-01 8.20e-01
NEURAL TUBE FORMATION 104 5.00e-02 -1.11e-01 4.66e-01
POSITIVE REGULATION OF LAMELLIPODIUM ASSEMBLY 28 3.08e-01 -1.11e-01 8.11e-01
NEGATIVE REGULATION OF EPITHELIAL CELL MIGRATION 116 3.86e-02 -1.11e-01 4.16e-01
MEMBRANE FISSION 42 2.13e-01 -1.11e-01 7.32e-01
SUPEROXIDE METABOLIC PROCESS 69 1.10e-01 -1.11e-01 6.18e-01
DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR 73 1.01e-01 1.11e-01 6.03e-01
CYCLOOXYGENASE PATHWAY 9 5.64e-01 1.11e-01 9.21e-01
NEGATIVE REGULATION OF CELLULAR CATABOLIC PROCESS 202 6.49e-03 -1.11e-01 1.90e-01
POSITIVE REGULATION OF CELL SIZE 11 5.24e-01 1.11e-01 9.10e-01
DETECTION OF MECHANICAL STIMULUS INVOLVED IN SENSORY PERCEPTION 35 2.56e-01 1.11e-01 7.70e-01
VESICLE FUSION TO PLASMA MEMBRANE 24 3.47e-01 1.11e-01 8.37e-01
REGULATION OF MEMBRANE INVAGINATION 15 4.57e-01 1.11e-01 8.84e-01
REGULATION OF RESPONSE TO CYTOKINE STIMULUS 181 1.00e-02 -1.11e-01 2.34e-01
POSITIVE REGULATION OF OLIGODENDROCYTE DIFFERENTIATION 27 3.18e-01 1.11e-01 8.21e-01
GLYCOSPHINGOLIPID METABOLIC PROCESS 63 1.28e-01 -1.11e-01 6.48e-01
ENDOCARDIAL CUSHION DEVELOPMENT 54 1.59e-01 1.11e-01 6.79e-01
REGULATION OF GLYCOPROTEIN METABOLIC PROCESS 61 1.34e-01 -1.11e-01 6.59e-01
INOSITOL TRISPHOSPHATE BIOSYNTHETIC PROCESS 8 5.87e-01 -1.11e-01 9.24e-01
REGULATION OF ASTROCYTE DIFFERENTIATION 32 2.78e-01 -1.11e-01 7.85e-01
ANDROGEN BIOSYNTHETIC PROCESS 10 5.44e-01 -1.11e-01 9.13e-01
ANTIBACTERIAL INNATE IMMUNE RESPONSE 6 6.38e-01 1.11e-01 9.39e-01
NEUTRAL LIPID METABOLIC PROCESS 134 2.68e-02 -1.11e-01 3.67e-01
ENDOTHELIAL CELL MIGRATION 283 1.34e-03 -1.11e-01 7.87e-02
GMP METABOLIC PROCESS 28 3.11e-01 1.11e-01 8.13e-01
POSITIVE REGULATION OF COMPLEMENT ACTIVATION 7 6.12e-01 1.11e-01 9.31e-01
CERAMIDE TRANSPORT 17 4.30e-01 1.11e-01 8.74e-01
NUCLEAR RNA SURVEILLANCE 14 4.74e-01 -1.11e-01 8.91e-01
POSITIVE REGULATION OF INTRACELLULAR TRANSPORT 196 7.57e-03 -1.11e-01 2.00e-01
NEGATIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR PRODUCTION 25 3.38e-01 -1.11e-01 8.34e-01
AUTONOMIC NERVOUS SYSTEM DEVELOPMENT 46 1.94e-01 1.11e-01 7.18e-01
POSITIVE REGULATION OF SPINDLE ASSEMBLY 8 5.88e-01 -1.11e-01 9.24e-01
AUTOPHAGOSOME ORGANIZATION 120 3.64e-02 -1.11e-01 4.07e-01
NEGATIVE REGULATION OF INTERFERON ALPHA PRODUCTION 6 6.39e-01 -1.11e-01 9.39e-01
REGULATION OF RAS PROTEIN SIGNAL TRANSDUCTION 180 1.06e-02 -1.10e-01 2.42e-01
PROTEIN LOCALIZATION TO NUCLEOPLASM 14 4.75e-01 1.10e-01 8.91e-01
REGULATION OF CELLULAR CATABOLIC PROCESS 711 5.45e-07 -1.10e-01 2.45e-04
NEGATIVE REGULATION OF CAMP MEDIATED SIGNALING 11 5.27e-01 1.10e-01 9.10e-01
REGULATION OF SYNAPTIC ASSEMBLY AT NEUROMUSCULAR JUNCTION 6 6.41e-01 1.10e-01 9.39e-01
DEOXYRIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS 8 5.90e-01 -1.10e-01 9.26e-01
ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRIAL MEMBRANE 38 2.41e-01 1.10e-01 7.59e-01
NEGATIVE REGULATION OF RESPONSE TO CYTOKINE STIMULUS 92 6.83e-02 -1.10e-01 5.32e-01
MEMBRANE PROTEIN PROTEOLYSIS 59 1.44e-01 -1.10e-01 6.72e-01
REGULATION OF CARDIAC MUSCLE ADAPTATION 17 4.33e-01 1.10e-01 8.74e-01
FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY 86 7.83e-02 -1.10e-01 5.57e-01
CELLULAR COMPONENT MAINTENANCE 72 1.07e-01 -1.10e-01 6.11e-01
NATURAL KILLER CELL ACTIVATION 90 7.18e-02 1.10e-01 5.42e-01
TRNA TRANSCRIPTION 11 5.29e-01 -1.10e-01 9.10e-01
CATECHOLAMINE UPTAKE 18 4.20e-01 -1.10e-01 8.71e-01
ANTIGEN PROCESSING AND PRESENTATION OF ENDOGENOUS ANTIGEN 32 2.83e-01 -1.10e-01 7.90e-01
BONE DEVELOPMENT 212 5.89e-03 -1.10e-01 1.77e-01
REGULATION OF MITOCHONDRIAL TRANSLATION 25 3.42e-01 1.10e-01 8.36e-01
MULTICELLULAR ORGANISMAL LEVEL IRON ION HOMEOSTASIS 25 3.43e-01 -1.10e-01 8.36e-01
RESPONSE TO DEXAMETHASONE 39 2.36e-01 -1.10e-01 7.54e-01
REGULATION OF INFLAMMASOME MEDIATED SIGNALING PATHWAY 37 2.49e-01 -1.10e-01 7.65e-01
CAVEOLA ASSEMBLY 5 6.72e-01 -1.10e-01 9.46e-01
NEGATIVE REGULATION OF INTERLEUKIN 5 PRODUCTION 8 5.92e-01 1.09e-01 9.26e-01
REGULATION OF T HELPER 2 CELL DIFFERENTIATION 12 5.11e-01 1.09e-01 9.07e-01
POSITIVE REGULATION OF ACTIN FILAMENT POLYMERIZATION 52 1.72e-01 -1.09e-01 6.90e-01
REGULATION OF HOMOPHILIC CELL ADHESION 5 6.72e-01 -1.09e-01 9.46e-01
NUCLEOSIDE METABOLIC PROCESS 54 1.65e-01 -1.09e-01 6.83e-01
MYELOID DENDRITIC CELL DIFFERENTIATION 20 3.98e-01 -1.09e-01 8.59e-01
WATER SOLUBLE VITAMIN BIOSYNTHETIC PROCESS 12 5.12e-01 -1.09e-01 9.07e-01
SKELETAL MUSCLE CELL DIFFERENTIATION 72 1.09e-01 1.09e-01 6.17e-01
POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CENTROSOME 7 6.17e-01 -1.09e-01 9.32e-01
MORPHOGENESIS OF EMBRYONIC EPITHELIUM 152 2.02e-02 -1.09e-01 3.32e-01
POSITIVE REGULATION OF SKELETAL MUSCLE FIBER DEVELOPMENT 9 5.71e-01 1.09e-01 9.23e-01
VESICLE TARGETING TO FROM OR WITHIN GOLGI 33 2.78e-01 -1.09e-01 7.85e-01
VESICLE UNCOATING 8 5.93e-01 -1.09e-01 9.26e-01
POSITIVE REGULATION OF CHEMOKINE C X C MOTIF LIGAND 1 PRODUCTION 5 6.73e-01 1.09e-01 9.46e-01
POSITIVE REGULATION OF MHC CLASS II BIOSYNTHETIC PROCESS 14 4.80e-01 -1.09e-01 8.94e-01
POSITIVE REGULATION OF SARCOMERE ORGANIZATION 6 6.43e-01 1.09e-01 9.41e-01
NEGATIVE REGULATION OF SERINE TYPE PEPTIDASE ACTIVITY 5 6.73e-01 1.09e-01 9.46e-01
PURINE NUCLEOSIDE DIPHOSPHATE METABOLIC PROCESS 20 3.98e-01 -1.09e-01 8.60e-01
NEGATIVE REGULATION OF HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION 14 4.80e-01 1.09e-01 8.94e-01
RUFFLE ASSEMBLY 45 2.06e-01 -1.09e-01 7.29e-01
ORGANIC HYDROXY COMPOUND CATABOLIC PROCESS 55 1.62e-01 1.09e-01 6.81e-01
HISTONE H4 ACETYLATION 13 4.96e-01 1.09e-01 8.99e-01
GASTRULATION WITH MOUTH FORMING SECOND 28 3.18e-01 -1.09e-01 8.21e-01
SYNAPTIC TRANSMISSION GABAERGIC 58 1.51e-01 1.09e-01 6.79e-01
POSITIVE REGULATION OF DIGESTIVE SYSTEM PROCESS 12 5.14e-01 -1.09e-01 9.07e-01
NEGATIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION 29 3.10e-01 -1.09e-01 8.13e-01
POSITIVE REGULATION OF SKELETAL MUSCLE CELL DIFFERENTIATION 7 6.18e-01 1.09e-01 9.32e-01
POSITIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING 37 2.52e-01 1.09e-01 7.68e-01
REGULATION OF NEUTROPHIL MIGRATION 45 2.07e-01 -1.09e-01 7.29e-01
SELECTIVE AUTOPHAGY 96 6.57e-02 -1.09e-01 5.24e-01
AROMATIC AMINO ACID TRANSPORT 12 5.15e-01 -1.09e-01 9.07e-01
REGULATION OF SMOOTH MUSCLE CONTRACTION 61 1.42e-01 -1.09e-01 6.69e-01
REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY 137 2.82e-02 -1.09e-01 3.73e-01
BLOOD VESSEL ENDOTHELIAL CELL MIGRATION 181 1.17e-02 -1.09e-01 2.51e-01
REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY 38 2.47e-01 1.08e-01 7.64e-01
SALIVA SECRETION 13 4.98e-01 1.08e-01 8.99e-01
MRNA ALTERNATIVE POLYADENYLATION 5 6.75e-01 -1.08e-01 9.47e-01
INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO HYPOXIA 9 5.74e-01 1.08e-01 9.24e-01
NEGATIVE REGULATION OF CELL PROJECTION ORGANIZATION 191 9.89e-03 -1.08e-01 2.32e-01
NEGATIVE REGULATION OF DELAYED RECTIFIER POTASSIUM CHANNEL ACTIVITY 11 5.34e-01 1.08e-01 9.12e-01
EXECUTION PHASE OF APOPTOSIS 76 1.03e-01 -1.08e-01 6.07e-01
REGULATION OF DNA TEMPLATED DNA REPLICATION 47 2.00e-01 1.08e-01 7.25e-01
CHEMOKINE C C MOTIF LIGAND 5 PRODUCTION 11 5.35e-01 -1.08e-01 9.12e-01
RECEPTOR MEDIATED ENDOCYTOSIS OF VIRUS BY HOST CELL 11 5.35e-01 1.08e-01 9.12e-01
REGULATION OF DENDRITIC SPINE MORPHOGENESIS 42 2.26e-01 1.08e-01 7.44e-01
REGULATION OF MITOCHONDRIAL GENE EXPRESSION 30 3.06e-01 1.08e-01 8.11e-01
ICOSANOID CATABOLIC PROCESS 9 5.75e-01 1.08e-01 9.24e-01
NEGATIVE REGULATION OF CAMP DEPENDENT PROTEIN KINASE ACTIVITY 9 5.75e-01 -1.08e-01 9.24e-01
POSITIVE REGULATION OF B CELL RECEPTOR SIGNALING PATHWAY 10 5.55e-01 -1.08e-01 9.18e-01
DRINKING BEHAVIOR 10 5.55e-01 1.08e-01 9.18e-01
REGULATION OF CD8 POSITIVE ALPHA BETA T CELL ACTIVATION 21 3.93e-01 -1.08e-01 8.58e-01
POSITIVE REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE 12 5.19e-01 1.08e-01 9.09e-01
POSITIVE REGULATION OF DNA TEMPLATED DNA REPLICATION 13 5.02e-01 1.08e-01 9.01e-01
BONE REMODELING 89 7.96e-02 -1.08e-01 5.59e-01
NEGATIVE REGULATION OF BICELLULAR TIGHT JUNCTION ASSEMBLY 6 6.49e-01 1.07e-01 9.41e-01
REGULATION OF LEUKOCYTE DEGRANULATION 43 2.23e-01 -1.07e-01 7.41e-01
LABYRINTHINE LAYER BLOOD VESSEL DEVELOPMENT 19 4.18e-01 -1.07e-01 8.68e-01
REGULATION OF ENDOTHELIAL CELL DEVELOPMENT 18 4.31e-01 -1.07e-01 8.74e-01
REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL BY SARCOPLASMIC RETICULUM 31 3.01e-01 1.07e-01 8.07e-01
REGULATION OF PROTEIN LOCALIZATION TO NUCLEOLUS 10 5.57e-01 -1.07e-01 9.18e-01
REGULATION OF NODAL SIGNALING PATHWAY 9 5.78e-01 1.07e-01 9.24e-01
TONGUE DEVELOPMENT 20 4.07e-01 1.07e-01 8.63e-01
TRANSMISSION OF NERVE IMPULSE 69 1.24e-01 1.07e-01 6.45e-01
CELL SUBSTRATE ADHESION 354 5.34e-04 -1.07e-01 3.95e-02
REGULATION OF MUSCLE CONTRACTION 168 1.66e-02 -1.07e-01 2.98e-01
INTRACELLULAR AMINO ACID HOMEOSTASIS 8 6.00e-01 1.07e-01 9.28e-01
NEGATIVE REGULATION OF MRNA METABOLIC PROCESS 94 7.29e-02 -1.07e-01 5.43e-01
WNT SIGNALING PATHWAY INVOLVED IN HEART DEVELOPMENT 12 5.21e-01 1.07e-01 9.09e-01
REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY 417 1.78e-04 -1.07e-01 1.89e-02
ACTIVATION OF GTPASE ACTIVITY 98 6.76e-02 -1.07e-01 5.31e-01
POSITIVE REGULATION OF MYELOID LEUKOCYTE CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE 36 2.67e-01 -1.07e-01 7.77e-01
REGULATION OF RNA POLYMERASE II TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY 7 6.25e-01 -1.07e-01 9.33e-01
CONSTITUTIVE SECRETORY PATHWAY 7 6.25e-01 -1.07e-01 9.33e-01
REGULATION OF PROTEIN LOCALIZATION TO CHROMOSOME TELOMERIC REGION 14 4.90e-01 1.07e-01 8.95e-01
NEGATIVE REGULATION OF LEUKOCYTE APOPTOTIC PROCESS 58 1.61e-01 -1.07e-01 6.81e-01
REGULATION OF STORE OPERATED CALCIUM CHANNEL ACTIVITY 6 6.52e-01 -1.06e-01 9.41e-01
TELOMERE LOCALIZATION 12 5.23e-01 -1.06e-01 9.10e-01
LYMPHOID PROGENITOR CELL DIFFERENTIATION 24 3.67e-01 -1.06e-01 8.48e-01
NUCLEOSIDE SALVAGE 9 5.81e-01 1.06e-01 9.24e-01
FLUID TRANSPORT 37 2.63e-01 -1.06e-01 7.74e-01
REGULATION OF ATP METABOLIC PROCESS 23 3.78e-01 -1.06e-01 8.51e-01
INNATE IMMUNE RESPONSE ACTIVATING CELL SURFACE RECEPTOR SIGNALING PATHWAY 90 8.14e-02 -1.06e-01 5.64e-01
NEGATIVE REGULATION OF VASCULAR PERMEABILITY 18 4.35e-01 -1.06e-01 8.74e-01
NEGATIVE REGULATION OF HUMORAL IMMUNE RESPONSE 16 4.62e-01 -1.06e-01 8.88e-01
CYTOSKELETON ORGANIZATION 1496 5.87e-12 -1.06e-01 4.97e-09
ASTROCYTE CELL MIGRATION 9 5.81e-01 1.06e-01 9.24e-01
REGULATION OF TRIGLYCERIDE METABOLIC PROCESS 44 2.23e-01 -1.06e-01 7.41e-01
NEGATIVE REGULATION OF RESPONSE TO FOOD 10 5.61e-01 1.06e-01 9.20e-01
HEXOSE PHOSPHATE TRANSPORT 7 6.27e-01 -1.06e-01 9.34e-01
RESPONSE TO MACROPHAGE COLONY STIMULATING FACTOR 17 4.49e-01 -1.06e-01 8.80e-01
POSITIVE REGULATION OF MUSCLE CONTRACTION 47 2.08e-01 -1.06e-01 7.29e-01
LYMPHOCYTE COSTIMULATION 49 1.99e-01 1.06e-01 7.25e-01
ISOTYPE SWITCHING TO IGA ISOTYPES 8 6.03e-01 1.06e-01 9.29e-01
PURINE NUCLEOSIDE METABOLIC PROCESS 26 3.49e-01 -1.06e-01 8.40e-01
POSITIVE REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY 17 4.49e-01 -1.06e-01 8.80e-01
SIRNA PROCESSING 9 5.82e-01 -1.06e-01 9.24e-01
MUCOPOLYSACCHARIDE METABOLIC PROCESS 92 7.88e-02 -1.06e-01 5.58e-01
FATTY ACID BETA OXIDATION 76 1.10e-01 -1.06e-01 6.17e-01
REGULATION OF NEUROTRANSMITTER UPTAKE 19 4.24e-01 -1.06e-01 8.73e-01
POSITIVE REGULATION OF MAP KINASE ACTIVITY 89 8.41e-02 -1.06e-01 5.70e-01
POSITIVE REGULATION OF PROTEIN ACETYLATION 24 3.69e-01 1.06e-01 8.48e-01
O GLYCAN PROCESSING 43 2.30e-01 -1.06e-01 7.46e-01
MODULATION BY HOST OF VIRAL RNA GENOME REPLICATION 5 6.82e-01 1.06e-01 9.50e-01
INSULIN RECEPTOR SIGNALING PATHWAY 126 4.03e-02 -1.06e-01 4.22e-01
POSITIVE REGULATION OF HEAT GENERATION 9 5.83e-01 1.06e-01 9.24e-01
NEGATIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT 15 4.78e-01 -1.06e-01 8.93e-01
CGMP METABOLIC PROCESS 17 4.50e-01 1.06e-01 8.81e-01
RENAL SYSTEM PROCESS INVOLVED IN REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE 23 3.80e-01 1.06e-01 8.51e-01
PHOSPHOLIPID METABOLIC PROCESS 373 4.51e-04 -1.06e-01 3.87e-02
NADH METABOLIC PROCESS 11 5.44e-01 -1.06e-01 9.13e-01
MACROPHAGE MIGRATION 61 1.54e-01 -1.06e-01 6.79e-01
CELLULAR RESPONSE TO OXYGEN RADICAL 24 3.71e-01 -1.06e-01 8.48e-01
POSITIVE REGULATION OF VESICLE TRANSPORT ALONG MICROTUBULE 5 6.83e-01 -1.06e-01 9.50e-01
POSITIVE REGULATION OF MONONUCLEAR CELL MIGRATION 70 1.27e-01 1.06e-01 6.48e-01
NEGATIVE REGULATION OF CD8 POSITIVE ALPHA BETA T CELL ACTIVATION 8 6.05e-01 -1.06e-01 9.29e-01
NEGATIVE REGULATION OF CELLULAR SENESCENCE 25 3.61e-01 -1.06e-01 8.46e-01
CHONDROCYTE HYPERTROPHY 6 6.55e-01 -1.05e-01 9.42e-01
EPITHELIAL CELL PROLIFERATION INVOLVED IN PROSTATE GLAND DEVELOPMENT 11 5.45e-01 -1.05e-01 9.13e-01
POSITIVE REGULATION OF TOLL LIKE RECEPTOR 2 SIGNALING PATHWAY 6 6.55e-01 1.05e-01 9.42e-01
DENDRITIC CELL MIGRATION 32 3.03e-01 1.05e-01 8.07e-01
CARBOHYDRATE BIOSYNTHETIC PROCESS 213 8.08e-03 -1.05e-01 2.09e-01
COBALAMIN TRANSPORT 8 6.06e-01 1.05e-01 9.29e-01
POSITIVE REGULATION OF POST TRANSCRIPTIONAL GENE SILENCING 15 4.81e-01 -1.05e-01 8.94e-01
REGULATION OF ANGIOTENSIN LEVELS IN BLOOD 10 5.65e-01 1.05e-01 9.21e-01
TOXIN METABOLIC PROCESS 14 4.96e-01 1.05e-01 8.99e-01
GLYCEROPHOSPHOLIPID METABOLIC PROCESS 295 1.91e-03 -1.05e-01 9.93e-02
ASPARTATE METABOLIC PROCESS 8 6.07e-01 -1.05e-01 9.30e-01
REGULATION OF CHEMOKINE MEDIATED SIGNALING PATHWAY 10 5.66e-01 1.05e-01 9.21e-01
NEUROEPITHELIAL CELL DIFFERENTIATION 38 2.63e-01 1.05e-01 7.74e-01
NEGATIVE REGULATION OF SKELETAL MUSCLE CELL PROLIFERATION 5 6.85e-01 1.05e-01 9.50e-01
POSITIVE REGULATION OF CATABOLIC PROCESS 598 1.17e-05 -1.05e-01 2.55e-03
PEPTIDYL ARGININE METHYLATION 7 6.31e-01 1.05e-01 9.36e-01
REGULATION OF MUSCLE SYSTEM PROCESS 245 4.75e-03 -1.05e-01 1.62e-01
NEGATIVE REGULATION OF GLYCOPROTEIN METABOLIC PROCESS 28 3.38e-01 -1.05e-01 8.33e-01
CELLULAR RESPONSE TO MACROPHAGE COLONY STIMULATING FACTOR STIMULUS 13 5.13e-01 -1.05e-01 9.07e-01
REGENERATION 187 1.35e-02 -1.05e-01 2.74e-01
RESPONSE TO NITROSATIVE STRESS 10 5.67e-01 1.05e-01 9.21e-01
NEGATIVE REGULATION OF LIPID STORAGE 22 3.96e-01 -1.05e-01 8.59e-01
ALCOHOL CATABOLIC PROCESS 34 2.92e-01 1.05e-01 7.99e-01
TRIGLYCERIDE METABOLIC PROCESS 105 6.42e-02 -1.05e-01 5.19e-01
PROTEIN LOCALIZATION TO PLASMA MEMBRANE 289 2.24e-03 -1.04e-01 1.07e-01
POSITIVE REGULATION OF HEART GROWTH 40 2.53e-01 1.04e-01 7.68e-01
GLUTAMATE SECRETION 28 3.39e-01 1.04e-01 8.34e-01
VASCULAR WOUND HEALING 22 3.97e-01 -1.04e-01 8.59e-01
GENERAL ADAPTATION SYNDROME BEHAVIORAL PROCESS 5 6.86e-01 1.04e-01 9.50e-01
REGULATION OF ESTABLISHMENT OF PLANAR POLARITY 53 1.89e-01 -1.04e-01 7.11e-01
LOCOMOTION INVOLVED IN LOCOMOTORY BEHAVIOR 12 5.32e-01 -1.04e-01 9.11e-01
TRNA PSEUDOURIDINE SYNTHESIS 6 6.59e-01 1.04e-01 9.43e-01
ACTIVATION INDUCED CELL DEATH OF T CELLS 9 5.89e-01 1.04e-01 9.24e-01
REGULATION OF LIPID TRANSPORT 153 2.62e-02 -1.04e-01 3.65e-01
DE NOVO AMP BIOSYNTHETIC PROCESS 8 6.10e-01 1.04e-01 9.31e-01
TRYPTOPHAN CATABOLIC PROCESS TO KYNURENINE 5 6.87e-01 1.04e-01 9.50e-01
POSITIVE REGULATION OF HIPPO SIGNALING 10 5.69e-01 -1.04e-01 9.22e-01
NEGATIVE REGULATION OF ACTIN NUCLEATION 9 5.89e-01 -1.04e-01 9.25e-01
POSITIVE REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS 16 4.72e-01 -1.04e-01 8.91e-01
UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS VIA THE C END DEGRON RULE PATHWAY 12 5.33e-01 1.04e-01 9.11e-01
INTERMEDIATE FILAMENT BASED PROCESS 95 8.00e-02 -1.04e-01 5.60e-01
BODY FLUID SECRETION 90 8.84e-02 -1.04e-01 5.82e-01
POSITIVE REGULATION OF PHOSPHOPROTEIN PHOSPHATASE ACTIVITY 19 4.34e-01 1.04e-01 8.74e-01
GLUCAN BIOSYNTHETIC PROCESS 46 2.24e-01 -1.04e-01 7.41e-01
MESENCHYME MORPHOGENESIS 60 1.65e-01 1.04e-01 6.84e-01
VASCULAR ASSOCIATED SMOOTH MUSCLE CONTRACTION 26 3.61e-01 -1.04e-01 8.46e-01
PRESYNAPSE ORGANIZATION 52 1.96e-01 1.04e-01 7.20e-01
PROSTATE GLANDULAR ACINUS MORPHOGENESIS 6 6.61e-01 -1.04e-01 9.43e-01
POSITIVE REGULATION OF UNSATURATED FATTY ACID BIOSYNTHETIC PROCESS 9 5.91e-01 1.04e-01 9.26e-01
PROTEIN K29 LINKED DEUBIQUITINATION 5 6.89e-01 -1.04e-01 9.50e-01
POSITIVE REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING 22 4.01e-01 -1.03e-01 8.63e-01
ORGANIC ACID TRANSMEMBRANE TRANSPORT 156 2.58e-02 -1.03e-01 3.65e-01
POSITIVE REGULATION OF MEMBRANE PERMEABILITY 50 2.06e-01 -1.03e-01 7.29e-01
MICTURITION 8 6.13e-01 1.03e-01 9.31e-01
HYDROGEN PEROXIDE METABOLIC PROCESS 54 1.89e-01 1.03e-01 7.11e-01
DISTAL CONVOLUTED TUBULE DEVELOPMENT 5 6.89e-01 1.03e-01 9.50e-01
NEGATIVE REGULATION OF HORMONE BIOSYNTHETIC PROCESS 10 5.72e-01 1.03e-01 9.24e-01
POSITIVE REGULATION OF INTERLEUKIN 8 PRODUCTION 63 1.57e-01 -1.03e-01 6.79e-01
PLASMA MEMBRANE PHOSPHOLIPID SCRAMBLING 25 3.72e-01 1.03e-01 8.49e-01
POSITIVE REGULATION OF NEUROTROPHIN TRK RECEPTOR SIGNALING PATHWAY 5 6.90e-01 -1.03e-01 9.50e-01
NEGATIVE REGULATION OF NEURON PROJECTION DEVELOPMENT 140 3.52e-02 -1.03e-01 4.03e-01
POSITIVE REGULATION OF CANONICAL NF KAPPAB SIGNAL TRANSDUCTION 196 1.28e-02 -1.03e-01 2.65e-01
EXTRINSIC APOPTOTIC SIGNALING PATHWAY 229 7.21e-03 -1.03e-01 1.98e-01
PEPTIDYL THREONINE MODIFICATION 110 6.19e-02 -1.03e-01 5.11e-01
REGULATION OF EPITHELIAL CELL MIGRATION 295 2.33e-03 -1.03e-01 1.08e-01
REGULATION OF SKELETAL MUSCLE TISSUE GROWTH 7 6.37e-01 -1.03e-01 9.38e-01
REGULATION OF PROTEIN EXPORT FROM NUCLEUS 33 3.06e-01 -1.03e-01 8.11e-01
ANOIKIS 34 2.99e-01 -1.03e-01 8.05e-01
STRIATED MUSCLE CELL DEVELOPMENT 73 1.28e-01 -1.03e-01 6.48e-01
MATURE B CELL DIFFERENTIATION 37 2.79e-01 -1.03e-01 7.85e-01
VESICLE MEDIATED TRANSPORT TO THE PLASMA MEMBRANE 149 3.02e-02 -1.03e-01 3.83e-01
POSITIVE REGULATION OF GLYCOLYTIC PROCESS 22 4.04e-01 -1.03e-01 8.63e-01
VACUOLAR PROTON TRANSPORTING V TYPE ATPASE COMPLEX ASSEMBLY 6 6.63e-01 -1.03e-01 9.44e-01
POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY 73 1.29e-01 -1.03e-01 6.48e-01
POSITIVE REGULATION OF INTERLEUKIN 18 PRODUCTION 8 6.15e-01 1.03e-01 9.32e-01
REGULATION OF GOLGI ORGANIZATION 17 4.64e-01 -1.03e-01 8.89e-01
CYTOSOLIC TRANSPORT 183 1.66e-02 -1.03e-01 2.98e-01
REGULATION OF NON MOTILE CILIUM ASSEMBLY 11 5.56e-01 -1.03e-01 9.18e-01
REGULATION OF ENDOTHELIAL CELL MIGRATION 231 7.24e-03 -1.03e-01 1.98e-01
NUCLEAR BODY ORGANIZATION 16 4.78e-01 -1.03e-01 8.93e-01
ENTRY INTO HOST 160 2.53e-02 -1.02e-01 3.65e-01
POSITIVE REGULATION OF IMMUNOGLOBULIN PRODUCTION 54 1.93e-01 -1.02e-01 7.16e-01
NEGATIVE REGULATION OF GLUCOSE IMPORT 16 4.78e-01 -1.02e-01 8.93e-01
PROSTATE GLAND MORPHOGENESIS 28 3.49e-01 1.02e-01 8.40e-01
NEUTROPHIL MEDIATED KILLING OF SYMBIONT CELL 12 5.40e-01 1.02e-01 9.13e-01
NEGATIVE REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORT 30 3.33e-01 1.02e-01 8.31e-01
THYMIC T CELL SELECTION 23 3.97e-01 -1.02e-01 8.59e-01
ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN 69 1.43e-01 -1.02e-01 6.69e-01
GALACTOSE TRANSMEMBRANE TRANSPORT 5 6.93e-01 -1.02e-01 9.50e-01
REGULATION OF CORTICOSTEROID HORMONE SECRETION 16 4.80e-01 -1.02e-01 8.94e-01
POSITIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT 154 2.89e-02 -1.02e-01 3.73e-01
REGULATION OF MITOCHONDRIAL MRNA STABILITY 7 6.40e-01 -1.02e-01 9.39e-01
NEGATIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION 80 1.15e-01 -1.02e-01 6.28e-01
NEGATIVE REGULATION OF VIRAL PROCESS 92 9.11e-02 -1.02e-01 5.86e-01
CELLULAR RESPONSE TO NITROGEN STARVATION 12 5.41e-01 1.02e-01 9.13e-01
REGULATION OF RESPIRATORY GASEOUS EXCHANGE 24 3.88e-01 -1.02e-01 8.56e-01
POST ANAL TAIL MORPHOGENESIS 19 4.42e-01 -1.02e-01 8.78e-01
ANTIGEN PROCESSING AND PRESENTATION 113 6.13e-02 -1.02e-01 5.08e-01
MAINTENANCE OF PROTEIN LOCATION IN CELL 63 1.62e-01 -1.02e-01 6.81e-01
REGULATION OF MYELINATION 45 2.37e-01 -1.02e-01 7.56e-01
ASTROCYTE DEVELOPMENT 43 2.48e-01 -1.02e-01 7.64e-01
NEGATIVE REGULATION OF NUCLEAR DIVISION 63 1.62e-01 1.02e-01 6.81e-01
NON CANONICAL WNT SIGNALING PATHWAY 68 1.47e-01 -1.02e-01 6.75e-01
REGULATION OF CELL MATRIX ADHESION 125 4.93e-02 -1.02e-01 4.63e-01
NEGATIVE REGULATION OF TOR SIGNALING 73 1.33e-01 -1.02e-01 6.56e-01
POSITIVE REGULATION OF CILIUM MOVEMENT 12 5.42e-01 1.02e-01 9.13e-01
REGULATION OF LIPID LOCALIZATION 183 1.77e-02 -1.02e-01 3.07e-01
REGULATION OF WNT SIGNALING PATHWAY PLANAR CELL POLARITY PATHWAY 16 4.82e-01 -1.02e-01 8.94e-01
AXONOGENESIS INVOLVED IN INNERVATION 9 5.98e-01 1.02e-01 9.28e-01
RRNA TRANSCRIPTION 37 2.85e-01 -1.02e-01 7.93e-01
GLUTAMATERGIC NEURON DIFFERENTIATION 17 4.69e-01 -1.02e-01 8.90e-01
GLUCOSYLCERAMIDE METABOLIC PROCESS 7 6.42e-01 -1.01e-01 9.40e-01
ASPARTATE FAMILY AMINO ACID BIOSYNTHETIC PROCESS 21 4.21e-01 1.01e-01 8.72e-01
LUNG EPITHELIUM DEVELOPMENT 44 2.45e-01 -1.01e-01 7.63e-01
REGULATION OF SMALL MOLECULE METABOLIC PROCESS 335 1.42e-03 -1.01e-01 8.04e-02
POST EMBRYONIC CAMERA TYPE EYE DEVELOPMENT 8 6.20e-01 1.01e-01 9.32e-01
REGULATION OF VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL 12 5.43e-01 -1.01e-01 9.13e-01
POSITIVE REGULATION OF HISTONE DEACETYLATION 5 6.95e-01 -1.01e-01 9.51e-01
REGULATION OF ANTIMICROBIAL PEPTIDE PRODUCTION 9 5.99e-01 -1.01e-01 9.28e-01
ENDOSOME ORGANIZATION 95 8.87e-02 -1.01e-01 5.82e-01
CATECHOLAMINE SECRETION 61 1.72e-01 1.01e-01 6.90e-01
FAT PAD DEVELOPMENT 8 6.21e-01 1.01e-01 9.32e-01
NEGATIVE REGULATION OF PROTEIN SECRETION 73 1.36e-01 -1.01e-01 6.60e-01
REGULATION OF DNA DEMETHYLATION 12 5.45e-01 1.01e-01 9.13e-01
CELLULAR RESPONSE TO COPPER ION 26 3.73e-01 -1.01e-01 8.49e-01
NEGATIVE REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY 24 3.92e-01 -1.01e-01 8.57e-01
PROTEIN HETEROOLIGOMERIZATION 28 3.56e-01 -1.01e-01 8.44e-01
POSITIVE REGULATION OF CYTOKINESIS 44 2.47e-01 -1.01e-01 7.64e-01
DNA DOUBLE STRAND BREAK PROCESSING 19 4.47e-01 1.01e-01 8.79e-01
PROTEIN LOCALIZATION TO GOLGI APPARATUS 30 3.39e-01 -1.01e-01 8.35e-01
CIRCADIAN SLEEP WAKE CYCLE 21 4.24e-01 -1.01e-01 8.73e-01
TRANSEPITHELIAL CHLORIDE TRANSPORT 9 6.01e-01 -1.01e-01 9.28e-01
REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION 154 3.10e-02 -1.01e-01 3.85e-01
POSITIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE 81 1.17e-01 -1.01e-01 6.30e-01
MAINTENANCE OF ORGANELLE LOCATION 13 5.30e-01 1.01e-01 9.11e-01
REGULATION OF CATECHOLAMINE METABOLIC PROCESS 20 4.36e-01 1.01e-01 8.74e-01
TOLL LIKE RECEPTOR 8 SIGNALING PATHWAY 5 6.97e-01 1.00e-01 9.52e-01
REGULATION OF TORC2 SIGNALING 8 6.23e-01 1.00e-01 9.32e-01
ASPARAGINE METABOLIC PROCESS 5 6.97e-01 1.00e-01 9.52e-01
POSITIVE REGULATION OF T CELL CYTOKINE PRODUCTION 26 3.75e-01 -1.00e-01 8.50e-01
COMMON MYELOID PROGENITOR CELL PROLIFERATION 9 6.02e-01 -1.00e-01 9.29e-01
RESPONSE TO CAFFEINE 15 5.01e-01 1.00e-01 9.01e-01
POSITIVE REGULATION OF FATTY ACID OXIDATION 15 5.01e-01 -1.00e-01 9.01e-01
NATURAL KILLER CELL MEDIATED IMMUNITY 78 1.26e-01 1.00e-01 6.48e-01
IMMATURE T CELL PROLIFERATION 13 5.31e-01 1.00e-01 9.11e-01
STABILIZATION OF MEMBRANE POTENTIAL 17 4.74e-01 1.00e-01 8.91e-01
INFLAMMASOME MEDIATED SIGNALING PATHWAY 42 2.61e-01 -1.00e-01 7.72e-01
NEGATIVE REGULATION OF MAST CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE 9 6.03e-01 1.00e-01 9.29e-01
SUGAR MEDIATED SIGNALING PATHWAY 9 6.03e-01 -1.00e-01 9.29e-01
SIGNAL TRANSDUCTION INVOLVED IN REGULATION OF GENE EXPRESSION 22 4.16e-01 -1.00e-01 8.67e-01
REGULATION OF NEUTROPHIL CHEMOTAXIS 34 3.12e-01 -1.00e-01 8.14e-01
MITOTIC CHROMOSOME CONDENSATION 19 4.50e-01 -1.00e-01 8.81e-01
HOMOPHILIC CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES 170 2.44e-02 -1.00e-01 3.62e-01
REGULATION OF GLYCOGEN CATABOLIC PROCESS 7 6.47e-01 -9.98e-02 9.41e-01
ISG15 PROTEIN CONJUGATION 6 6.72e-01 9.98e-02 9.46e-01
DAMP METABOLIC PROCESS 7 6.48e-01 -9.97e-02 9.41e-01
REGULATION OF NON CANONICAL WNT SIGNALING PATHWAY 26 3.79e-01 -9.97e-02 8.51e-01
RESPONSE TO VITAMIN D 37 2.94e-01 9.97e-02 8.02e-01
POSITIVE REGULATION OF EPIDERMIS DEVELOPMENT 32 3.29e-01 -9.96e-02 8.30e-01
POSITIVE REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION 110 7.11e-02 -9.96e-02 5.39e-01
PURINE CONTAINING COMPOUND SALVAGE 15 5.04e-01 9.96e-02 9.02e-01
ENDONUCLEOLYTIC CLEAVAGE IN ITS1 TO SEPARATE SSU RRNA FROM 5 8S RRNA AND LSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA 10 5.86e-01 -9.95e-02 9.24e-01
IMP CATABOLIC PROCESS 5 7.00e-01 -9.94e-02 9.52e-01
POSITIVE REGULATION OF HEART RATE 27 3.71e-01 -9.94e-02 8.48e-01
ANATOMICAL STRUCTURE REGRESSION 16 4.91e-01 -9.94e-02 8.95e-01
BRADYKININ CATABOLIC PROCESS 7 6.49e-01 -9.94e-02 9.41e-01
RESPONSE TO MOLECULE OF FUNGAL ORIGIN 5 7.01e-01 -9.93e-02 9.52e-01
REGULATION OF GLYCOGEN METABOLIC PROCESS 37 2.96e-01 -9.93e-02 8.04e-01
NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS NONSENSE MEDIATED DECAY 44 2.55e-01 -9.92e-02 7.70e-01
CELLULAR RESPONSE TO INSULIN STIMULUS 207 1.38e-02 -9.92e-02 2.76e-01
AMINO ACID BETAINE METABOLIC PROCESS 17 4.79e-01 -9.92e-02 8.93e-01
REGULATION OF CELLULAR KETONE METABOLIC PROCESS 144 3.98e-02 -9.92e-02 4.19e-01
PROTEIN LOCALIZATION TO CELL SURFACE 68 1.57e-01 -9.92e-02 6.79e-01
GOLGI LOCALIZATION 14 5.21e-01 -9.91e-02 9.09e-01
REGULATION OF MITOCHONDRIAL TRANSCRIPTION 5 7.01e-01 9.91e-02 9.52e-01
GLUCOSAMINE CONTAINING COMPOUND METABOLIC PROCESS 25 3.91e-01 9.91e-02 8.57e-01
COBALT ION TRANSPORT 7 6.50e-01 9.91e-02 9.41e-01
SECONDARY PALATE DEVELOPMENT 26 3.82e-01 9.90e-02 8.53e-01
REGULATION OF PH 102 8.39e-02 -9.90e-02 5.70e-01
RNA CATABOLIC PROCESS 359 1.28e-03 -9.89e-02 7.54e-02
PROSTATE GLAND DEVELOPMENT 50 2.26e-01 9.89e-02 7.44e-01
NEGATIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION 40 2.79e-01 -9.89e-02 7.86e-01
ANIMAL ORGAN MATURATION 32 3.33e-01 -9.89e-02 8.31e-01
FEEDING BEHAVIOR 106 7.88e-02 9.88e-02 5.58e-01
REGULATION OF CATABOLIC PROCESS 1072 4.55e-08 -9.87e-02 2.67e-05
REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION 95 9.65e-02 -9.86e-02 5.96e-01
NEUTROPHIL DEGRANULATION 13 5.38e-01 -9.86e-02 9.13e-01
ENDONUCLEOLYTIC CLEAVAGE OF TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA 17 4.81e-01 -9.86e-02 8.94e-01
CELL FATE DETERMINATION 42 2.69e-01 9.86e-02 7.78e-01
PEPTIDYL METHIONINE MODIFICATION 12 5.54e-01 -9.86e-02 9.18e-01
NEGATIVE REGULATION OF INTRACELLULAR TRANSPORT 60 1.86e-01 9.86e-02 7.08e-01
POSITIVE REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM 13 5.38e-01 -9.86e-02 9.13e-01
CELLULAR EXTRAVASATION 73 1.45e-01 9.86e-02 6.74e-01
MODIFIED AMINO ACID TRANSPORT 50 2.28e-01 -9.85e-02 7.45e-01
REGULATION OF MONOATOMIC ANION TRANSPORT 17 4.82e-01 9.85e-02 8.94e-01
GABAERGIC NEURON DIFFERENTIATION 20 4.46e-01 9.85e-02 8.79e-01
INOSITOL TRISPHOSPHATE METABOLIC PROCESS 12 5.55e-01 -9.85e-02 9.18e-01
NEGATIVE REGULATION OF CHROMATIN ORGANIZATION 6 6.76e-01 -9.85e-02 9.48e-01
SEX DETERMINATION 21 4.35e-01 9.85e-02 8.74e-01
AMMONIUM TRANSMEMBRANE TRANSPORT 12 5.55e-01 -9.85e-02 9.18e-01
POSITIVE REGULATION OF TRIGLYCERIDE BIOSYNTHETIC PROCESS 14 5.24e-01 -9.85e-02 9.10e-01
RESPONSE TO INSECTICIDE 6 6.76e-01 -9.85e-02 9.48e-01
TOLERANCE INDUCTION DEPENDENT UPON IMMUNE RESPONSE 6 6.76e-01 9.84e-02 9.48e-01
PEPTIDE CATABOLIC PROCESS 22 4.24e-01 -9.84e-02 8.73e-01
RIBONUCLEOSIDE DIPHOSPHATE METABOLIC PROCESS 30 3.51e-01 -9.84e-02 8.41e-01
POSITIVE REGULATION OF INTERLEUKIN 6 PRODUCTION 100 8.90e-02 -9.84e-02 5.82e-01
CELL COMMUNICATION BY ELECTRICAL COUPLING 34 3.21e-01 9.84e-02 8.23e-01
NEGATIVE REGULATION OF GLIAL CELL PROLIFERATION 17 4.83e-01 -9.83e-02 8.94e-01
DENDRITIC SPINE MAINTENANCE 21 4.35e-01 -9.83e-02 8.74e-01
ACTIVATION OF NF KAPPAB INDUCING KINASE ACTIVITY 16 4.96e-01 -9.83e-02 8.99e-01
SNRNA MODIFICATION 7 6.52e-01 9.83e-02 9.41e-01
CELL MATRIX ADHESION 238 8.98e-03 -9.83e-02 2.22e-01
KERATINOCYTE MIGRATION 20 4.47e-01 -9.83e-02 8.79e-01
CARDIAC CHAMBER MORPHOGENESIS 127 5.58e-02 9.83e-02 4.88e-01
AUTOPHAGY OF PEROXISOME 10 5.91e-01 9.83e-02 9.26e-01
PEPTIDYL LYSINE HYDROXYLATION 8 6.30e-01 9.82e-02 9.36e-01
MALE GENITALIA DEVELOPMENT 24 4.05e-01 9.82e-02 8.63e-01
POSITIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE III 18 4.71e-01 -9.82e-02 8.90e-01
COLLAGEN METABOLIC PROCESS 104 8.37e-02 -9.81e-02 5.70e-01
INSULIN METABOLIC PROCESS 16 4.97e-01 -9.81e-02 8.99e-01
ACROSOME REACTION 40 2.83e-01 9.81e-02 7.91e-01
RESPONSE TO ESTROGEN 69 1.59e-01 -9.81e-02 6.79e-01
PHAGOSOME MATURATION 29 3.61e-01 -9.80e-02 8.46e-01
REGULATION OF MESODERMAL CELL FATE SPECIFICATION 5 7.04e-01 -9.80e-02 9.52e-01
CELLULAR RESPONSE TO HEPARIN 5 7.04e-01 9.80e-02 9.52e-01
CANONICAL WNT SIGNALING PATHWAY INVOLVED IN CARDIAC MUSCLE CELL FATE COMMITMENT 5 7.04e-01 9.80e-02 9.52e-01
HEPARAN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS ENZYMATIC MODIFICATION 12 5.57e-01 -9.79e-02 9.18e-01
PHOSPHOLIPID BIOSYNTHETIC PROCESS 251 7.55e-03 -9.79e-02 2.00e-01
REGULATION OF THYMOCYTE APOPTOTIC PROCESS 14 5.26e-01 9.79e-02 9.10e-01
REGULATION OF NEUROBLAST PROLIFERATION 53 2.18e-01 9.79e-02 7.36e-01
POSITIVE REGULATION OF GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR PRODUCTION 15 5.12e-01 -9.79e-02 9.07e-01
REGULATORY NCRNA MEDIATED GENE SILENCING 654 1.93e-05 -9.79e-02 3.59e-03
PYRIMIDINE NUCLEOBASE METABOLIC PROCESS 21 4.38e-01 9.78e-02 8.75e-01
PYRUVATE TRANSPORT 8 6.32e-01 9.78e-02 9.36e-01
GLIAL CELL PROLIFERATION 59 1.94e-01 -9.78e-02 7.17e-01
POSITIVE REGULATION OF CHROMOSOME SEGREGATION 27 3.79e-01 -9.78e-02 8.51e-01
SMOOTH MUSCLE CELL MIGRATION 94 1.01e-01 -9.77e-02 6.04e-01
NEGATIVE REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE 22 4.27e-01 -9.77e-02 8.74e-01
VACUOLE ORGANIZATION 230 1.07e-02 -9.77e-02 2.42e-01
NEURON GLIAL CELL SIGNALING 5 7.05e-01 9.76e-02 9.52e-01
REGULATION OF LIPID METABOLIC PROCESS 340 1.97e-03 -9.76e-02 1.01e-01
NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE 30 3.55e-01 9.76e-02 8.44e-01
PHOSPHATE ION TRANSMEMBRANE TRANSPORT 17 4.87e-01 -9.74e-02 8.94e-01
LEYDIG CELL DIFFERENTIATION 11 5.76e-01 9.73e-02 9.24e-01
RESPONSE TO LAMINAR FLUID SHEAR STRESS 14 5.29e-01 -9.72e-02 9.10e-01
POSITIVE REGULATION OF FIBROBLAST APOPTOTIC PROCESS 10 5.94e-01 -9.72e-02 9.26e-01
NEGATIVE REGULATION OF BIOMINERAL TISSUE DEVELOPMENT 28 3.73e-01 9.72e-02 8.49e-01
REPLICATIVE SENESCENCE 17 4.88e-01 9.71e-02 8.94e-01
RECEPTOR GUANYLYL CYCLASE SIGNALING PATHWAY 11 5.77e-01 -9.71e-02 9.24e-01
CELL ADHESION MOLECULE PRODUCTION 22 4.31e-01 -9.71e-02 8.74e-01
AMYLIN RECEPTOR SIGNALING PATHWAY 6 6.81e-01 9.70e-02 9.50e-01
LIPID LOCALIZATION 501 1.99e-04 -9.70e-02 2.05e-02
SYNAPTIC VESICLE LOCALIZATION 54 2.18e-01 9.70e-02 7.36e-01
LYSOSOMAL PROTEIN CATABOLIC PROCESS 20 4.53e-01 -9.70e-02 8.81e-01
POSITIVE REGULATION OF CELL FATE COMMITMENT 13 5.45e-01 9.70e-02 9.13e-01
PRODUCTION OF MOLECULAR MEDIATOR INVOLVED IN INFLAMMATORY RESPONSE 108 8.16e-02 -9.70e-02 5.65e-01
EPITHELIAL CELL PROLIFERATION INVOLVED IN SALIVARY GLAND MORPHOGENESIS 5 7.08e-01 9.69e-02 9.53e-01
REGULATION OF DEOXYRIBONUCLEASE ACTIVITY 10 5.96e-01 9.68e-02 9.27e-01
SECONDARY METABOLIC PROCESS 57 2.06e-01 9.68e-02 7.29e-01
REGULATION OF MACROPHAGE MIGRATION 45 2.61e-01 -9.68e-02 7.72e-01
NEGATIVE REGULATION OF LAMELLIPODIUM ORGANIZATION 8 6.35e-01 -9.68e-02 9.38e-01
G PROTEIN COUPLED OPIOID RECEPTOR SIGNALING PATHWAY 11 5.78e-01 9.68e-02 9.24e-01
SNO S RNA PROCESSING 14 5.31e-01 -9.68e-02 9.11e-01
NEGATIVE REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR 15 5.16e-01 9.68e-02 9.08e-01
REGULATION OF MESENCHYMAL STEM CELL DIFFERENTIATION 8 6.36e-01 9.67e-02 9.38e-01
POSITIVE REGULATION OF INTERLEUKIN 2 PRODUCTION 34 3.29e-01 9.67e-02 8.30e-01
PROTEIN LIPOYLATION 5 7.08e-01 -9.67e-02 9.53e-01
BRANCHING INVOLVED IN BLOOD VESSEL MORPHOGENESIS 36 3.16e-01 9.66e-02 8.19e-01
GLOMERULAR EPITHELIAL CELL DEVELOPMENT 12 5.62e-01 9.66e-02 9.20e-01
RESPONSE TO SELENIUM ION 9 6.16e-01 9.66e-02 9.32e-01
BASE CONVERSION OR SUBSTITUTION EDITING 19 4.66e-01 -9.65e-02 8.90e-01
NEGATIVE REGULATION OF AXON EXTENSION 46 2.58e-01 -9.65e-02 7.71e-01
AMINO ACID BETAINE BIOSYNTHETIC PROCESS 6 6.82e-01 -9.64e-02 9.50e-01
GOLGI TO PLASMA MEMBRANE PROTEIN TRANSPORT 39 2.97e-01 -9.64e-02 8.04e-01
CALCINEURIN MEDIATED SIGNALING 48 2.48e-01 -9.64e-02 7.64e-01
MATURE B CELL DIFFERENTIATION INVOLVED IN IMMUNE RESPONSE 31 3.53e-01 -9.64e-02 8.43e-01
DETOXIFICATION OF INORGANIC COMPOUND 22 4.34e-01 -9.64e-02 8.74e-01
SYNAPTIC VESICLE ENDOSOMAL PROCESSING 9 6.17e-01 9.64e-02 9.32e-01
BONE MATURATION 28 3.77e-01 -9.64e-02 8.51e-01
NEGATIVE REGULATION OF TISSUE REMODELING 21 4.45e-01 -9.64e-02 8.78e-01
ODONTOBLAST DIFFERENTIATION 11 5.80e-01 9.63e-02 9.24e-01
REGULATION OF RELAXATION OF MUSCLE 14 5.33e-01 9.63e-02 9.11e-01
NEGATIVE REGULATION OF CELL CHEMOTAXIS TO FIBROBLAST GROWTH FACTOR 5 7.09e-01 9.63e-02 9.53e-01
HEPARAN SULFATE PROTEOGLYCAN METABOLIC PROCESS 16 5.05e-01 -9.63e-02 9.02e-01
REGULATION OF ACYL COA BIOSYNTHETIC PROCESS 5 7.09e-01 9.63e-02 9.53e-01
NEGATIVE REGULATION OF STEM CELL DIFFERENTIATION 26 3.96e-01 9.62e-02 8.59e-01
RESPONSE TO WATER DEPRIVATION 5 7.10e-01 9.61e-02 9.53e-01
STRIATED MUSCLE CELL PROLIFERATION 81 1.35e-01 9.61e-02 6.59e-01
MESENCHYMAL STEM CELL DIFFERENTIATION 12 5.64e-01 9.61e-02 9.21e-01
CERAMIDE METABOLIC PROCESS 107 8.59e-02 -9.61e-02 5.77e-01
ATRIOVENTRICULAR VALVE DEVELOPMENT 29 3.71e-01 -9.61e-02 8.48e-01
NEGATIVE REGULATION OF CATABOLIC PROCESS 340 2.32e-03 -9.61e-02 1.08e-01
REGULATION OF AMIDE METABOLIC PROCESS 587 6.94e-05 -9.60e-02 1.08e-02
FATTY ACID DERIVATIVE BIOSYNTHETIC PROCESS 47 2.55e-01 -9.60e-02 7.70e-01
NEGATIVE REGULATION OF PEPTIDASE ACTIVITY 133 5.59e-02 9.60e-02 4.88e-01
INFLAMMATORY RESPONSE TO WOUNDING 28 3.79e-01 -9.60e-02 8.51e-01
SENSORY PERCEPTION OF TASTE 66 1.78e-01 9.60e-02 6.97e-01
NECROPTOTIC PROCESS 49 2.45e-01 -9.60e-02 7.63e-01
MUSCLE SYSTEM PROCESS 449 4.89e-04 -9.59e-02 3.91e-02
INTERMEDIATE FILAMENT ORGANIZATION 73 1.57e-01 -9.58e-02 6.79e-01
SPHINGOSINE 1 PHOSPHATE RECEPTOR SIGNALING PATHWAY 15 5.20e-01 9.58e-02 9.09e-01
UDP N ACETYLGLUCOSAMINE BIOSYNTHETIC PROCESS 9 6.19e-01 9.58e-02 9.32e-01
EAR DEVELOPMENT 221 1.41e-02 9.58e-02 2.79e-01
EMBRYONIC HEART TUBE LEFT RIGHT PATTERN FORMATION 5 7.11e-01 -9.58e-02 9.54e-01
NEGATIVE REGULATION OF CHOLESTEROL STORAGE 11 5.82e-01 -9.58e-02 9.24e-01
PROTEIN LOCALIZATION TO MICROTUBULE ORGANIZING CENTER 35 3.28e-01 -9.56e-02 8.29e-01
PROTEIN N LINKED GLYCOSYLATION 70 1.67e-01 9.55e-02 6.86e-01
NEUROINFLAMMATORY RESPONSE 82 1.35e-01 -9.55e-02 6.59e-01
POSITIVE REGULATION OF SYNAPSE MATURATION 9 6.20e-01 9.55e-02 9.32e-01
REGULATION OF GLUCOCORTICOID RECEPTOR SIGNALING PATHWAY 7 6.62e-01 9.54e-02 9.44e-01
POSITIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS 93 1.12e-01 -9.54e-02 6.21e-01
TROPHOBLAST GIANT CELL DIFFERENTIATION 12 5.67e-01 -9.53e-02 9.21e-01
RESPONSE TO WOUNDING 555 1.25e-04 -9.52e-02 1.59e-02
POSITIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT 51 2.40e-01 -9.51e-02 7.59e-01
REGULATION OF ACTIVATION OF JANUS KINASE ACTIVITY 8 6.42e-01 -9.51e-02 9.40e-01
DNA SYNTHESIS INVOLVED IN DNA REPAIR 40 2.98e-01 9.50e-02 8.05e-01
RESPONSE TO THYROID HORMONE 29 3.76e-01 -9.50e-02 8.50e-01
POSITIVE REGULATION OF CIRCADIAN RHYTHM 18 4.85e-01 -9.50e-02 8.94e-01
CHOLESTEROL CATABOLIC PROCESS 9 6.22e-01 9.50e-02 9.32e-01
NEGATIVE REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS 65 1.86e-01 -9.49e-02 7.08e-01
CANONICAL NF KAPPAB SIGNAL TRANSDUCTION 300 4.69e-03 -9.49e-02 1.62e-01
ESTABLISHMENT OF CELL POLARITY 158 3.96e-02 -9.48e-02 4.19e-01
INORGANIC ION IMPORT ACROSS PLASMA MEMBRANE 137 5.54e-02 9.48e-02 4.86e-01
RESPONSE TO 2 3 7 8 TETRACHLORODIBENZODIOXINE 5 7.14e-01 9.47e-02 9.55e-01
REGULATION OF NK T CELL DIFFERENTIATION 6 6.88e-01 -9.46e-02 9.50e-01
CELLULAR DEFENSE RESPONSE 50 2.47e-01 9.46e-02 7.64e-01
FORMATION OF TRANSLATION PREINITIATION COMPLEX 9 6.24e-01 9.45e-02 9.33e-01
REGULATION OF SYNAPTIC TRANSMISSION GABAERGIC 35 3.34e-01 9.44e-02 8.31e-01
AMIDE CATABOLIC PROCESS 20 4.65e-01 -9.44e-02 8.90e-01
TAURINE METABOLIC PROCESS 9 6.24e-01 -9.43e-02 9.33e-01
LEUKOCYTE TETHERING OR ROLLING 34 3.41e-01 9.43e-02 8.35e-01
RENAL PROTEIN ABSORPTION 7 6.66e-01 -9.42e-02 9.45e-01
CATECHOL CONTAINING COMPOUND BIOSYNTHETIC PROCESS 22 4.45e-01 9.41e-02 8.78e-01
REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS 119 7.61e-02 -9.41e-02 5.52e-01
NEGATIVE T CELL SELECTION 13 5.57e-01 9.41e-02 9.18e-01
POSITIVE REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY 199 2.21e-02 -9.41e-02 3.48e-01
PROTEIN O LINKED GLYCOSYLATION 98 1.07e-01 -9.41e-02 6.12e-01
REGULATION OF CARDIAC EPITHELIAL TO MESENCHYMAL TRANSITION 12 5.73e-01 -9.40e-02 9.24e-01
LYSOSOMAL MEMBRANE ORGANIZATION 14 5.43e-01 -9.40e-02 9.13e-01
PROTEIN TRIMERIZATION 17 5.03e-01 -9.39e-02 9.02e-01
LYTIC VACUOLE ORGANIZATION 108 9.16e-02 -9.39e-02 5.88e-01
TRICUSPID VALVE DEVELOPMENT 6 6.90e-01 -9.39e-02 9.50e-01
GLYCOSYLCERAMIDE CATABOLIC PROCESS 7 6.67e-01 9.39e-02 9.46e-01
TELENCEPHALON GLIAL CELL MIGRATION 27 3.99e-01 -9.39e-02 8.60e-01
PEPTIDYL TYROSINE MODIFICATION 276 7.32e-03 -9.38e-02 1.99e-01
PROTEIN CONTAINING COMPLEX DISASSEMBLY 248 1.10e-02 -9.37e-02 2.45e-01
PEPTIDYL TYROSINE DEPHOSPHORYLATION INVOLVED IN INACTIVATION OF PROTEIN KINASE ACTIVITY 8 6.46e-01 9.37e-02 9.41e-01
POSITIVE REGULATION OF NEUTROPHIL MIGRATION 33 3.52e-01 -9.36e-02 8.41e-01
CIRCADIAN SLEEP WAKE CYCLE NON REM SLEEP 6 6.92e-01 -9.35e-02 9.50e-01
EATING BEHAVIOR 37 3.25e-01 9.35e-02 8.25e-01
OBSERVATIONAL LEARNING 7 6.68e-01 -9.35e-02 9.46e-01
POSITIVE REGULATION OF NEUROTRANSMITTER UPTAKE 6 6.92e-01 9.34e-02 9.50e-01
DETECTION OF TEMPERATURE STIMULUS 24 4.28e-01 -9.34e-02 8.74e-01
REGULATION OF AMPA RECEPTOR ACTIVITY 24 4.29e-01 9.33e-02 8.74e-01
NUCLEOTIDE SALVAGE 18 4.93e-01 -9.33e-02 8.96e-01
REGULATION OF POSTSYNAPTIC MEMBRANE POTENTIAL 148 5.00e-02 9.33e-02 4.66e-01
REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO STRESS 33 3.54e-01 9.33e-02 8.43e-01
SOMATIC STEM CELL DIVISION 11 5.92e-01 9.32e-02 9.26e-01
POSITIVE REGULATION OF NUCLEASE ACTIVITY 7 6.69e-01 -9.32e-02 9.46e-01
NEGATIVE REGULATION OF MACROPHAGE DIFFERENTIATION 8 6.48e-01 -9.32e-02 9.41e-01
CHONDROITIN SULFATE BIOSYNTHETIC PROCESS 19 4.82e-01 -9.32e-02 8.94e-01
APOPTOTIC PROCESS INVOLVED IN DEVELOPMENT 42 2.96e-01 9.32e-02 8.04e-01
RAS PROTEIN SIGNAL TRANSDUCTION 337 3.27e-03 -9.32e-02 1.31e-01
PARATHYROID GLAND DEVELOPMENT 7 6.70e-01 -9.32e-02 9.46e-01
C TERMINAL PROTEIN LIPIDATION 5 7.18e-01 9.31e-02 9.55e-01
NEGATIVE REGULATION OF COLLATERAL SPROUTING 11 5.93e-01 9.31e-02 9.26e-01
REGULATION OF MYOSIN LIGHT CHAIN PHOSPHATASE ACTIVITY 7 6.70e-01 9.30e-02 9.46e-01
POSITIVE REGULATION OF CENTRIOLE REPLICATION 9 6.29e-01 9.30e-02 9.36e-01
BLOOD VESSEL REMODELING 50 2.56e-01 -9.29e-02 7.70e-01
L ALPHA AMINO ACID TRANSMEMBRANE TRANSPORT 70 1.79e-01 -9.29e-02 6.99e-01
CELLULAR LIPID CATABOLIC PROCESS 224 1.67e-02 -9.28e-02 2.98e-01
ASTROCYTE DIFFERENTIATION 87 1.35e-01 -9.28e-02 6.59e-01
CELLULAR METABOLIC COMPOUND SALVAGE 30 3.79e-01 -9.28e-02 8.51e-01
RETROGRADE TRANS SYNAPTIC SIGNALING 10 6.11e-01 9.28e-02 9.31e-01
REGULATION OF LEUKOCYTE ADHESION TO ARTERIAL ENDOTHELIAL CELL 5 7.19e-01 9.28e-02 9.55e-01
NEUTRAL LIPID BIOSYNTHETIC PROCESS 50 2.57e-01 -9.27e-02 7.71e-01
DOSAGE COMPENSATION 33 3.57e-01 -9.27e-02 8.44e-01
POSITIVE REGULATION OF CELLULAR COMPONENT BIOGENESIS 501 3.82e-04 -9.26e-02 3.39e-02
REGULATION OF BLOOD BRAIN BARRIER PERMEABILITY 9 6.30e-01 -9.26e-02 9.36e-01
REGULATION OF SPHINGOLIPID BIOSYNTHETIC PROCESS 13 5.63e-01 -9.26e-02 9.21e-01
NEGATIVE REGULATION OF OSTEOBLAST DIFFERENTIATION 65 1.97e-01 -9.25e-02 7.21e-01
SULFUR COMPOUND BIOSYNTHETIC PROCESS 155 4.68e-02 -9.25e-02 4.52e-01
SIGNAL COMPLEX ASSEMBLY 8 6.51e-01 -9.25e-02 9.41e-01
NEGATIVE ADAPTATION OF SIGNALING PATHWAY 21 4.63e-01 9.25e-02 8.89e-01
REGULATION OF AMINO ACID TRANSMEMBRANE TRANSPORT 16 5.22e-01 -9.25e-02 9.10e-01
SYNAPSE PRUNING 14 5.49e-01 9.25e-02 9.16e-01
ANTERIOR COMMISSURE MORPHOGENESIS 7 6.72e-01 9.23e-02 9.46e-01
ROOF OF MOUTH DEVELOPMENT 91 1.28e-01 9.23e-02 6.48e-01
RESPONSE TO STARVATION 215 1.96e-02 -9.23e-02 3.25e-01
POLE PLASM ASSEMBLY 6 6.95e-01 9.23e-02 9.51e-01
VENTRICULAR COMPACT MYOCARDIUM MORPHOGENESIS 8 6.51e-01 9.23e-02 9.41e-01
NEGATIVE REGULATION OF PROTEIN IMPORT INTO NUCLEUS 15 5.36e-01 9.22e-02 9.13e-01
NEGATIVE REGULATION OF EXOCYTOSIS 34 3.52e-01 9.22e-02 8.41e-01
MICROTUBULE SEVERING 8 6.51e-01 -9.22e-02 9.41e-01
NEGATIVE REGULATION OF CELL ADHESION 309 5.33e-03 -9.21e-02 1.71e-01
EYE PIGMENTATION 7 6.73e-01 9.21e-02 9.47e-01
CENTRIOLE CENTRIOLE COHESION 15 5.37e-01 9.21e-02 9.13e-01
REGULATION OF B CELL DIFFERENTIATION 33 3.60e-01 -9.21e-02 8.46e-01
NEUTRAL LIPID CATABOLIC PROCESS 38 3.26e-01 -9.21e-02 8.27e-01
RESPONSE TO INTERLEUKIN 6 43 2.97e-01 -9.20e-02 8.04e-01
REGULATION OF GLUTAMATE SECRETION 20 4.76e-01 9.20e-02 8.93e-01
ASCENDING AORTA DEVELOPMENT 5 7.22e-01 9.20e-02 9.56e-01
MUSCLE CONTRACTION 348 3.19e-03 -9.19e-02 1.30e-01
EARLY ENDOSOME TO GOLGI TRANSPORT 13 5.66e-01 -9.19e-02 9.21e-01
SMALL MOLECULE CATABOLIC PROCESS 375 2.23e-03 -9.19e-02 1.07e-01
MAMMARY GLAND ALVEOLUS DEVELOPMENT 20 4.77e-01 9.19e-02 8.93e-01
DNA LIGATION 16 5.25e-01 -9.19e-02 9.10e-01
RETROGRADE TRANSPORT ENDOSOME TO GOLGI 99 1.14e-01 -9.18e-02 6.27e-01
REGULATION OF RRNA PROCESSING 16 5.25e-01 9.18e-02 9.10e-01
REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING 40 3.15e-01 -9.17e-02 8.18e-01
REGULATION OF CELL SUBSTRATE ADHESION 220 1.91e-02 -9.16e-02 3.19e-01
NEGATIVE REGULATION OF VIRAL LIFE CYCLE 27 4.10e-01 -9.16e-02 8.64e-01
POST TRANSCRIPTIONAL REGULATION OF GENE EXPRESSION 1025 6.84e-07 -9.16e-02 2.90e-04
POSITIVE REGULATION OF CYCLIN DEPENDENT PROTEIN SERINE THREONINE KINASE ACTIVITY 15 5.39e-01 -9.16e-02 9.13e-01
REGULATION OF CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION 28 4.02e-01 -9.15e-02 8.63e-01
POSITIVE REGULATION OF PROGRAMMED NECROTIC CELL DEATH 11 5.99e-01 -9.15e-02 9.28e-01
TRIGLYCERIDE BIOSYNTHETIC PROCESS 42 3.05e-01 -9.15e-02 8.10e-01
POSITIVE REGULATION OF NUCLEOTIDE METABOLIC PROCESS 19 4.91e-01 -9.14e-02 8.95e-01
GLUTATHIONE METABOLIC PROCESS 54 2.46e-01 -9.13e-02 7.64e-01
REGULATION OF RNA SPLICING 172 3.88e-02 -9.13e-02 4.16e-01
BEHAVIORAL RESPONSE TO NICOTINE 9 6.35e-01 9.13e-02 9.38e-01
PYRIMIDINE DEOXYRIBONUCLEOTIDE BIOSYNTHETIC PROCESS 6 6.99e-01 9.13e-02 9.52e-01
NEGATIVE REGULATION OF VASCULATURE DEVELOPMENT 150 5.37e-02 -9.12e-02 4.79e-01
CERAMIDE CATABOLIC PROCESS 21 4.69e-01 -9.12e-02 8.90e-01
ESTABLISHMENT OR MAINTENANCE OF BIPOLAR CELL POLARITY 59 2.26e-01 -9.12e-02 7.43e-01
CELL AGGREGATION 23 4.49e-01 9.12e-02 8.80e-01
VESICLE TARGETING ROUGH ER TO CIS GOLGI 26 4.21e-01 -9.12e-02 8.72e-01
CELLULAR DETOXIFICATION OF ALDEHYDE 9 6.36e-01 -9.11e-02 9.38e-01
FAT CELL PROLIFERATION 14 5.55e-01 -9.11e-02 9.18e-01
BRANCHED CHAIN AMINO ACID CATABOLIC PROCESS 21 4.70e-01 -9.11e-02 8.90e-01
CATECHOL CONTAINING COMPOUND METABOLIC PROCESS 55 2.43e-01 9.10e-02 7.63e-01
INTRACILIARY RETROGRADE TRANSPORT 14 5.55e-01 -9.10e-02 9.18e-01
REGULATION OF STEM CELL DIVISION 12 5.86e-01 9.09e-02 9.24e-01
BRANCHING INVOLVED IN MAMMARY GLAND DUCT MORPHOGENESIS 21 4.71e-01 -9.09e-02 8.90e-01
POSITIVE REGULATION OF ODONTOGENESIS 7 6.77e-01 9.08e-02 9.48e-01
REGULATION OF SKELETAL MUSCLE CELL PROLIFERATION 15 5.43e-01 9.08e-02 9.13e-01
PIGMENT METABOLIC PROCESS 80 1.60e-01 -9.08e-02 6.80e-01
INTEGRATED STRESS RESPONSE SIGNALING 42 3.09e-01 9.08e-02 8.11e-01
LUNG MORPHOGENESIS 54 2.49e-01 -9.08e-02 7.65e-01
NEGATIVE REGULATION OF STEROID METABOLIC PROCESS 34 3.60e-01 9.07e-02 8.46e-01
SKIN EPIDERMIS DEVELOPMENT 128 7.64e-02 -9.07e-02 5.53e-01
NEURAL PRECURSOR CELL PROLIFERATION 167 4.31e-02 9.07e-02 4.36e-01
MYELOID DENDRITIC CELL ACTIVATION 29 3.98e-01 -9.06e-02 8.60e-01
POSITIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY 18 5.06e-01 -9.06e-02 9.02e-01
NEGATIVE REGULATION OF SIGNALING RECEPTOR ACTIVITY 27 4.15e-01 -9.06e-02 8.67e-01
REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION 228 1.84e-02 -9.06e-02 3.12e-01
REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE 190 3.12e-02 -9.06e-02 3.85e-01
RRNA MODIFICATION 34 3.61e-01 9.06e-02 8.46e-01
REGULATION OF NUCLEAR CELL CYCLE DNA REPLICATION 13 5.72e-01 9.06e-02 9.24e-01
SPHINGOLIPID MEDIATED SIGNALING PATHWAY 18 5.06e-01 9.05e-02 9.02e-01
RIBOSOME ASSOCIATED UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS 7 6.78e-01 -9.05e-02 9.49e-01
REGULATION OF RESPONSE TO REACTIVE OXYGEN SPECIES 13 5.72e-01 -9.05e-02 9.24e-01
CHONDROCYTE DIFFERENTIATION INVOLVED IN ENDOCHONDRAL BONE MORPHOGENESIS 15 5.44e-01 -9.05e-02 9.13e-01
POSITIVE REGULATION OF RECEPTOR BINDING 6 7.01e-01 9.04e-02 9.52e-01
MONONUCLEAR CELL MIGRATION 202 2.67e-02 9.04e-02 3.67e-01
NEGATIVE REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS 19 4.95e-01 -9.04e-02 8.98e-01
SALIVARY GLAND DEVELOPMENT 34 3.62e-01 -9.04e-02 8.46e-01
DNA STRAND ELONGATION 37 3.42e-01 9.04e-02 8.35e-01
GLYCOSIDE METABOLIC PROCESS 21 4.74e-01 9.03e-02 8.91e-01
POSITIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY 144 6.13e-02 -9.03e-02 5.08e-01
RHYTHMIC BEHAVIOR 44 3.00e-01 -9.03e-02 8.06e-01
HINDBRAIN RADIAL GLIA GUIDED CELL MIGRATION 9 6.39e-01 9.03e-02 9.39e-01
ODONTOGENESIS 130 7.55e-02 -9.03e-02 5.51e-01
ENDOTHELIAL CELL MORPHOGENESIS 10 6.21e-01 -9.03e-02 9.32e-01
FLAVONOID METABOLIC PROCESS 11 6.04e-01 9.02e-02 9.29e-01
REGULATION OF PHOSPHATASE ACTIVITY 61 2.23e-01 9.02e-02 7.41e-01
METANEPHRIC LOOP OF HENLE DEVELOPMENT 6 7.02e-01 -9.02e-02 9.52e-01
POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR 85 1.50e-01 -9.02e-02 6.79e-01
NEGATIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC PROCESS 50 2.70e-01 -9.02e-02 7.79e-01
NEGATIVE REGULATION OF DENDRITE DEVELOPMENT 8 6.59e-01 -9.02e-02 9.43e-01
SKELETAL MUSCLE TISSUE REGENERATION 37 3.42e-01 -9.02e-02 8.36e-01
REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY 35 3.56e-01 -9.02e-02 8.44e-01
DETECTION OF STIMULUS INVOLVED IN SENSORY PERCEPTION OF PAIN 26 4.26e-01 -9.02e-02 8.73e-01
CHOLANGIOCYTE PROLIFERATION 5 7.27e-01 -9.01e-02 9.57e-01
REGULATION OF LIPID STORAGE 54 2.52e-01 -9.01e-02 7.68e-01
REGULATION OF POLYSACCHARIDE METABOLIC PROCESS 45 2.96e-01 -9.00e-02 8.04e-01
ADENOHYPOPHYSIS DEVELOPMENT 16 5.33e-01 9.00e-02 9.11e-01
NEGATIVE REGULATION OF DIGESTIVE SYSTEM PROCESS 14 5.60e-01 -8.99e-02 9.20e-01
SEQUESTERING OF IRON ION 7 6.80e-01 8.99e-02 9.50e-01
OLFACTORY BEHAVIOR 10 6.23e-01 -8.99e-02 9.32e-01
REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY 139 6.73e-02 -8.99e-02 5.30e-01
ACTIVATION OF PROTEIN KINASE C ACTIVITY 5 7.28e-01 8.99e-02 9.58e-01
RESPONSE TO EPINEPHRINE 14 5.61e-01 -8.98e-02 9.20e-01
TRANSFORMING GROWTH FACTOR BETA PRODUCTION 45 2.97e-01 -8.98e-02 8.04e-01
NEGATIVE REGULATION OF CILIUM ASSEMBLY 19 4.99e-01 -8.97e-02 8.99e-01
MORPHOGENESIS OF A POLARIZED EPITHELIUM 94 1.33e-01 -8.96e-02 6.58e-01
SECRETORY GRANULE LOCALIZATION 14 5.62e-01 8.95e-02 9.20e-01
NEGATIVE REGULATION OF INTERLEUKIN 8 PRODUCTION 37 3.46e-01 8.95e-02 8.37e-01
MEIOTIC DNA DOUBLE STRAND BREAK FORMATION 6 7.05e-01 8.94e-02 9.52e-01
DNA METHYLATION DEPENDENT HETEROCHROMATIN FORMATION 28 4.13e-01 8.93e-02 8.66e-01
MACROAUTOPHAGY 331 5.23e-03 -8.93e-02 1.68e-01
BRANCHING MORPHOGENESIS OF A NERVE 12 5.93e-01 8.91e-02 9.26e-01
NEGATIVE REGULATION OF ENDOTHELIAL CELL DIFFERENTIATION 12 5.93e-01 -8.91e-02 9.26e-01
POSITIVE REGULATION OF SMOOTH MUSCLE CELL MIGRATION 49 2.81e-01 -8.90e-02 7.89e-01
REGULATION OF MITOTIC RECOMBINATION 7 6.84e-01 8.89e-02 9.50e-01
CENTRAL NERVOUS SYSTEM PROJECTION NEURON AXONOGENESIS 29 4.07e-01 -8.89e-02 8.63e-01
RESPIRATORY BURST INVOLVED IN INFLAMMATORY RESPONSE 9 6.44e-01 -8.89e-02 9.41e-01
REGULATION OF PHOSPHOLIPASE ACTIVITY 59 2.38e-01 8.89e-02 7.56e-01
ADAPTIVE THERMOGENESIS 168 4.68e-02 -8.89e-02 4.52e-01
POSITIVE REGULATION OF ACUTE INFLAMMATORY RESPONSE 28 4.16e-01 8.89e-02 8.67e-01
ORGANIC CATION TRANSPORT 63 2.23e-01 -8.88e-02 7.41e-01
ORGANELLE DISASSEMBLY 145 6.48e-02 -8.88e-02 5.22e-01
HEAT ACCLIMATION 6 7.07e-01 8.88e-02 9.53e-01
RESPONSE TO ERYTHROPOIETIN 7 6.84e-01 8.87e-02 9.50e-01
REGULATION OF TISSUE REMODELING 86 1.55e-01 -8.87e-02 6.79e-01
PROTEIN O LINKED GLYCOSYLATION VIA SERINE 10 6.27e-01 -8.87e-02 9.35e-01
GLOMERULUS MORPHOGENESIS 9 6.45e-01 8.87e-02 9.41e-01
NEURAL TUBE DEVELOPMENT 162 5.14e-02 -8.87e-02 4.71e-01
CELLULAR RESPONSE TO ESTRADIOL STIMULUS 38 3.44e-01 8.87e-02 8.37e-01
AROMATIC AMINO ACID METABOLIC PROCESS 32 3.86e-01 -8.86e-02 8.55e-01
NUCLEOSIDE DIPHOSPHATE METABOLIC PROCESS 37 3.51e-01 -8.86e-02 8.41e-01
POSITIVE REGULATION OF CALCIUM MEDIATED SIGNALING 42 3.21e-01 8.85e-02 8.23e-01
CIRCADIAN SLEEP WAKE CYCLE SLEEP 16 5.40e-01 -8.85e-02 9.13e-01
IRES DEPENDENT VIRAL TRANSLATIONAL INITIATION 11 6.11e-01 -8.85e-02 9.31e-01
S ADENOSYLMETHIONINE METABOLIC PROCESS 15 5.53e-01 -8.85e-02 9.18e-01
REGULATION OF LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY 28 4.18e-01 8.84e-02 8.69e-01
LYMPH NODE DEVELOPMENT 18 5.16e-01 8.84e-02 9.08e-01
SEQUESTERING OF EXTRACELLULAR LIGAND FROM RECEPTOR 11 6.12e-01 -8.84e-02 9.31e-01
NEGATIVE REGULATION OF INSULIN SECRETION INVOLVED IN CELLULAR RESPONSE TO GLUCOSE STIMULUS 9 6.46e-01 8.84e-02 9.41e-01
TRAIL ACTIVATED APOPTOTIC SIGNALING PATHWAY 13 5.81e-01 -8.84e-02 9.24e-01
POSITIVE REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE 136 7.53e-02 -8.83e-02 5.51e-01
NEUROBLAST PROLIFERATION 81 1.69e-01 8.83e-02 6.87e-01
POSITIVE REGULATION OF VITAMIN D RECEPTOR SIGNALING PATHWAY 6 7.08e-01 -8.83e-02 9.53e-01
RESPONSE TO TESTOSTERONE 45 3.06e-01 -8.82e-02 8.11e-01
REGULATION OF PROTEIN KINASE C ACTIVITY 5 7.33e-01 -8.82e-02 9.58e-01
HYPOTHALAMUS GONADOTROPHIN RELEASING HORMONE NEURON DIFFERENTIATION 8 6.66e-01 -8.82e-02 9.45e-01
CARDIAC VENTRICLE DEVELOPMENT 127 8.62e-02 8.81e-02 5.77e-01
POSITIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION 165 5.09e-02 -8.81e-02 4.69e-01
EMBRYONIC VISCEROCRANIUM MORPHOGENESIS 10 6.30e-01 -8.81e-02 9.36e-01
SERINE FAMILY AMINO ACID BIOSYNTHETIC PROCESS 19 5.07e-01 8.80e-02 9.03e-01
ESCRT COMPLEX DISASSEMBLY 10 6.30e-01 -8.80e-02 9.36e-01
POSITIVE REGULATION OF MITOCHONDRIAL MEMBRANE POTENTIAL 10 6.30e-01 -8.79e-02 9.36e-01
REGULATION OF ANAPHASE PROMOTING COMPLEX DEPENDENT CATABOLIC PROCESS 5 7.33e-01 -8.79e-02 9.58e-01
EXPORT ACROSS PLASMA MEMBRANE 80 1.74e-01 -8.79e-02 6.91e-01
METANEPHRIC DISTAL TUBULE DEVELOPMENT 7 6.87e-01 -8.79e-02 9.50e-01
EXTRAEMBRYONIC MEMBRANE DEVELOPMENT 13 5.83e-01 8.79e-02 9.24e-01
CELLULAR COMPONENT DISASSEMBLY 496 8.08e-04 -8.78e-02 5.50e-02
SPHINGOLIPID METABOLIC PROCESS 163 5.32e-02 -8.77e-02 4.78e-01
G PROTEIN COUPLED ACETYLCHOLINE RECEPTOR SIGNALING PATHWAY 21 4.87e-01 -8.77e-02 8.94e-01
CENTROMERIC SISTER CHROMATID COHESION 11 6.15e-01 8.76e-02 9.32e-01
REGULATION OF ANDROGEN RECEPTOR SIGNALING PATHWAY 28 4.22e-01 -8.76e-02 8.72e-01
DETERMINATION OF DIGESTIVE TRACT LEFT RIGHT ASYMMETRY 7 6.88e-01 8.76e-02 9.50e-01
PLASMA MEMBRANE ORGANIZATION 168 5.00e-02 -8.76e-02 4.66e-01
ENERGY HOMEOSTASIS 78 1.81e-01 -8.76e-02 7.01e-01
AMINOPHOSPHOLIPID TRANSLOCATION 7 6.88e-01 8.76e-02 9.50e-01
MARGINAL ZONE B CELL DIFFERENTIATION 9 6.49e-01 -8.76e-02 9.41e-01
SEQUESTERING OF TRIGLYCERIDE 18 5.20e-01 -8.75e-02 9.09e-01
RECEPTOR METABOLIC PROCESS 73 1.96e-01 -8.75e-02 7.20e-01
REGULATION OF APPETITE 20 4.98e-01 8.75e-02 8.99e-01
PYRIMIDINE NUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS 15 5.58e-01 -8.74e-02 9.19e-01
RESPONSE TO INTERLEUKIN 18 11 6.16e-01 -8.74e-02 9.32e-01
CAMP MEDIATED SIGNALING 53 2.71e-01 8.73e-02 7.79e-01
NEGATIVE REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS 43 3.22e-01 -8.73e-02 8.23e-01
ENDOTHELIAL CELL CHEMOTAXIS 30 4.08e-01 -8.72e-02 8.64e-01
MEMBRANE RAFT ORGANIZATION 26 4.42e-01 -8.72e-02 8.78e-01
SKELETAL MUSCLE SATELLITE CELL MAINTENANCE INVOLVED IN SKELETAL MUSCLE REGENERATION 5 7.36e-01 8.71e-02 9.58e-01
REGULATION OF MAST CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE 30 4.09e-01 -8.71e-02 8.64e-01
STEROID CATABOLIC PROCESS 25 4.51e-01 8.71e-02 8.81e-01
CELLULAR RESPONSE TO EXTERNAL STIMULUS 341 5.73e-03 -8.70e-02 1.74e-01
PHOTORECEPTOR CELL OUTER SEGMENT ORGANIZATION 13 5.87e-01 -8.69e-02 9.24e-01
OUTFLOW TRACT MORPHOGENESIS 82 1.74e-01 8.69e-02 6.90e-01
PYRIMIDINE NUCLEOSIDE CATABOLIC PROCESS 16 5.48e-01 8.68e-02 9.14e-01
NEURON FATE COMMITMENT 73 2.00e-01 8.68e-02 7.25e-01
NEURON PROJECTION EXTENSION 178 4.57e-02 -8.68e-02 4.48e-01
CELLULAR RESPONSE TO ABIOTIC STIMULUS 332 6.54e-03 -8.68e-02 1.90e-01
POSITIVE REGULATION OF PROTEIN LOCALIZATION 472 1.23e-03 -8.68e-02 7.34e-02
NUCLEOBASE CONTAINING SMALL MOLECULE BIOSYNTHETIC PROCESS 16 5.48e-01 -8.67e-02 9.15e-01
REGULATION OF PROGRAMMED NECROTIC CELL DEATH 40 3.42e-01 -8.67e-02 8.36e-01
ORGANIC ACID CATABOLIC PROCESS 252 1.78e-02 -8.67e-02 3.07e-01
REGULATION OF EXCRETION 11 6.19e-01 8.67e-02 9.32e-01
NEGATIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO STRESS 8 6.71e-01 8.66e-02 9.46e-01
CARDIAC CHAMBER DEVELOPMENT 168 5.26e-02 8.66e-02 4.75e-01
ANGIOGENESIS INVOLVED IN CORONARY VASCULAR MORPHOGENESIS 5 7.37e-01 -8.66e-02 9.58e-01
PHOSPHATIDIC ACID METABOLIC PROCESS 35 3.75e-01 -8.66e-02 8.50e-01
SLEEP 22 4.82e-01 -8.66e-02 8.94e-01
POSITIVE REGULATION OF DEVELOPMENTAL PIGMENTATION 9 6.53e-01 8.66e-02 9.41e-01
INTESTINAL STEM CELL HOMEOSTASIS 6 7.14e-01 -8.65e-02 9.55e-01
TRANS SYNAPTIC SIGNALING BY LIPID 7 6.92e-01 8.65e-02 9.50e-01
PHENOL CONTAINING COMPOUND BIOSYNTHETIC PROCESS 48 3.00e-01 8.65e-02 8.06e-01
ZYMOGEN ACTIVATION 59 2.51e-01 -8.65e-02 7.67e-01
ENDOSOME TO PLASMA MEMBRANE PROTEIN TRANSPORT 17 5.37e-01 8.64e-02 9.13e-01
CHORIONIC TROPHOBLAST CELL DIFFERENTIATION 7 6.92e-01 8.64e-02 9.50e-01
POSITIVE REGULATION OF MITOCHONDRIAL DEPOLARIZATION 9 6.54e-01 -8.64e-02 9.41e-01
SPINAL CORD ASSOCIATION NEURON DIFFERENTIATION 12 6.04e-01 8.64e-02 9.29e-01
PROPRIOCEPTION 5 7.38e-01 -8.64e-02 9.58e-01
HISTONE UBIQUITINATION 9 6.54e-01 -8.64e-02 9.41e-01
CELLULAR RESPONSE TO ZINC ION 24 4.64e-01 -8.63e-02 8.89e-01
REGULATION OF DENDRITIC CELL CHEMOTAXIS 11 6.20e-01 8.63e-02 9.32e-01
ASPARTATE TRANSMEMBRANE TRANSPORT 19 5.15e-01 -8.63e-02 9.07e-01
LIPOPROTEIN METABOLIC PROCESS 134 8.46e-02 -8.63e-02 5.72e-01
CELLULAR RESPONSE TO REACTIVE NITROGEN SPECIES 17 5.38e-01 -8.63e-02 9.13e-01
CLATHRIN DEPENDENT ENDOCYTOSIS 48 3.01e-01 -8.62e-02 8.07e-01
TYPE II INTERFERON MEDIATED SIGNALING PATHWAY 26 4.47e-01 -8.61e-02 8.79e-01
WOUND HEALING 421 2.42e-03 -8.61e-02 1.10e-01
AXONEMAL DYNEIN COMPLEX ASSEMBLY 40 3.46e-01 8.61e-02 8.37e-01
REGULATION OF HYDROGEN PEROXIDE BIOSYNTHETIC PROCESS 7 6.93e-01 -8.61e-02 9.50e-01
VASCULAR ASSOCIATED SMOOTH MUSCLE CELL DEVELOPMENT 12 6.06e-01 -8.61e-02 9.29e-01
ENDOSOMAL TRANSPORT 251 1.88e-02 -8.61e-02 3.18e-01
SULFUR COMPOUND METABOLIC PROCESS 305 9.72e-03 -8.61e-02 2.32e-01
POSITIVE REGULATION OF CALCINEURIN MEDIATED SIGNALING 21 4.95e-01 -8.60e-02 8.98e-01
REGULATION OF G2 MI TRANSITION OF MEIOTIC CELL CYCLE 5 7.39e-01 8.60e-02 9.58e-01
CALCIUM ION IMPORT 48 3.03e-01 8.60e-02 8.07e-01
NEGATIVE REGULATION OF PHAGOCYTOSIS 20 5.06e-01 8.59e-02 9.02e-01
REGULATION OF AXON EXTENSION 92 1.55e-01 -8.58e-02 6.79e-01
POSITIVE REGULATION OF SYNAPTIC PLASTICITY 11 6.22e-01 8.58e-02 9.32e-01
CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE 122 1.02e-01 -8.58e-02 6.04e-01
REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS 72 2.08e-01 -8.58e-02 7.29e-01
RESPONSE TO OXYGEN GLUCOSE DEPRIVATION 14 5.79e-01 8.57e-02 9.24e-01
CELLULAR RESPONSE TO UNFOLDED PROTEIN 89 1.62e-01 -8.57e-02 6.81e-01
TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE SIGNALING PATHWAY 634 2.27e-04 -8.57e-02 2.25e-02
TETRAPYRROLE METABOLIC PROCESS 61 2.47e-01 -8.57e-02 7.64e-01
COPII COATED VESICLE BUDDING 43 3.31e-01 -8.57e-02 8.31e-01
CYTOLYSIS BY HOST OF SYMBIONT CELLS 6 7.16e-01 8.56e-02 9.55e-01
REGULATION OF DENDRITIC SPINE DEVELOPMENT 57 2.63e-01 -8.56e-02 7.74e-01
REGULATION OF FC RECEPTOR MEDIATED STIMULATORY SIGNALING PATHWAY 10 6.39e-01 -8.56e-02 9.39e-01
MATERNAL PLACENTA DEVELOPMENT 35 3.81e-01 -8.56e-02 8.52e-01
FIBROBLAST GROWTH FACTOR PRODUCTION 9 6.56e-01 -8.56e-02 9.42e-01
ERBB4 SIGNALING PATHWAY 10 6.39e-01 -8.56e-02 9.39e-01
MATURATION OF SSU RRNA 52 2.86e-01 8.56e-02 7.94e-01
POSITIVE REGULATION OF INTEGRIN MEDIATED SIGNALING PATHWAY 12 6.08e-01 -8.55e-02 9.30e-01
POSITIVE REGULATION OF ORGANELLE ORGANIZATION 505 9.95e-04 -8.55e-02 6.31e-02
BENZENE CONTAINING COMPOUND METABOLIC PROCESS 26 4.50e-01 -8.55e-02 8.81e-01
SPERM DNA CONDENSATION 17 5.42e-01 8.55e-02 9.13e-01
CELLULAR RESPONSE TO CHEMICAL STRESS 317 8.86e-03 -8.55e-02 2.22e-01
NEGATIVE REGULATION OF MONOOXYGENASE ACTIVITY 15 5.67e-01 8.54e-02 9.21e-01
PROCESS UTILIZING AUTOPHAGIC MECHANISM 574 4.65e-04 -8.54e-02 3.91e-02
POSITIVE REGULATION OF CELL MORPHOGENESIS 36 3.75e-01 -8.54e-02 8.50e-01
AORTA DEVELOPMENT 65 2.34e-01 -8.53e-02 7.52e-01
DENDRITE SELF AVOIDANCE 14 5.81e-01 8.53e-02 9.24e-01
URETERIC BUD ELONGATION 8 6.76e-01 8.53e-02 9.48e-01
FIBROBLAST PROLIFERATION 106 1.29e-01 -8.53e-02 6.48e-01
GLYCEROL 3 PHOSPHATE METABOLIC PROCESS 8 6.76e-01 8.52e-02 9.48e-01
REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY 31 4.12e-01 -8.52e-02 8.65e-01
EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS 86 1.72e-01 -8.51e-02 6.90e-01
RNA 3 URIDYLATION 5 7.42e-01 -8.50e-02 9.59e-01
POSITIVE REGULATION OF SYNAPTIC TRANSMISSION GLUTAMATERGIC 35 3.84e-01 8.50e-02 8.54e-01
INTERFERON BETA PRODUCTION 59 2.59e-01 -8.50e-02 7.72e-01
NEUTROPHIL CHEMOTAXIS 104 1.34e-01 8.50e-02 6.59e-01
MEMBRANE DEPOLARIZATION DURING CARDIAC MUSCLE CELL ACTION POTENTIAL 22 4.90e-01 8.50e-02 8.95e-01
POSITIVE REGULATION OF LONG TERM SYNAPTIC POTENTIATION 22 4.91e-01 8.49e-02 8.95e-01
REGULATION OF NCRNA TRANSCRIPTION 93 1.57e-01 -8.49e-02 6.79e-01
NEGATIVE REGULATION OF GLIAL CELL MIGRATION 6 7.19e-01 -8.48e-02 9.55e-01
CELLULAR CATABOLIC PROCESS 1588 1.59e-08 -8.48e-02 1.10e-05
PRIMITIVE HEMOPOIESIS 9 6.60e-01 8.48e-02 9.43e-01
MESENCHYMAL CELL PROLIFERATION 44 3.31e-01 8.48e-02 8.31e-01
CARBON DIOXIDE TRANSPORT 15 5.70e-01 8.48e-02 9.22e-01
METANEPHRIC RENAL VESICLE MORPHOGENESIS 14 5.83e-01 8.47e-02 9.24e-01
MITOCHONDRIAL PROTON TRANSPORTING ATP SYNTHASE COMPLEX ASSEMBLY 8 6.78e-01 8.47e-02 9.49e-01
SNRNA TRANSPORT 6 7.19e-01 -8.47e-02 9.55e-01
COLLAGEN FIBRIL ORGANIZATION 64 2.41e-01 -8.47e-02 7.61e-01
RETINOL METABOLIC PROCESS 52 2.91e-01 8.46e-02 7.99e-01
REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY 72 2.15e-01 -8.44e-02 7.33e-01
SMOOTH MUSCLE CONTRACTION 109 1.28e-01 -8.44e-02 6.48e-01
NEUROTRANSMITTER RECEPTOR TRANSPORT 26 4.56e-01 8.44e-02 8.84e-01
THROMBIN ACTIVATED RECEPTOR SIGNALING PATHWAY 13 5.98e-01 8.44e-02 9.28e-01
REGULATION OF COLLATERAL SPROUTING 21 5.03e-01 8.44e-02 9.02e-01
ECTODERMAL CELL DIFFERENTIATION 7 6.99e-01 -8.44e-02 9.52e-01
NOREPINEPHRINE METABOLIC PROCESS 14 5.85e-01 8.44e-02 9.24e-01
NEGATIVE REGULATION OF DOPAMINE SECRETION 5 7.44e-01 8.44e-02 9.59e-01
TRACHEA MORPHOGENESIS 11 6.28e-01 -8.43e-02 9.35e-01
CELLULAR RESPONSE TO EXTRACELLULAR STIMULUS 277 1.58e-02 -8.43e-02 2.95e-01
CELLULAR RESPONSE TO REACTIVE OXYGEN SPECIES 153 7.20e-02 -8.43e-02 5.42e-01
LIPID BIOSYNTHETIC PROCESS 732 1.03e-04 -8.42e-02 1.37e-02
REGULATION OF PLATELET AGGREGATION 27 4.49e-01 -8.42e-02 8.80e-01
MYELIN ASSEMBLY 24 4.75e-01 -8.42e-02 8.91e-01
KIDNEY MORPHOGENESIS 99 1.48e-01 8.42e-02 6.75e-01
MEIOTIC SISTER CHROMATID COHESION 14 5.85e-01 8.42e-02 9.24e-01
MITOCHONDRIAL DNA REPAIR 5 7.44e-01 -8.42e-02 9.59e-01
GENITALIA MORPHOGENESIS 12 6.14e-01 8.42e-02 9.31e-01
MACROPHAGE ACTIVATION 109 1.29e-01 -8.41e-02 6.48e-01
TISSUE REMODELING 184 4.90e-02 -8.41e-02 4.61e-01
REGULATION OF GLIAL CELL MIGRATION 21 5.05e-01 8.41e-02 9.02e-01
PROTEIN O LINKED GLYCOSYLATION VIA THREONINE 10 6.45e-01 -8.41e-02 9.41e-01
POSITIVE REGULATION OF MITOTIC SISTER CHROMATID SEGREGATION 6 7.21e-01 8.40e-02 9.56e-01
CELL CELL ADHESION INVOLVED IN GASTRULATION 12 6.14e-01 -8.40e-02 9.32e-01
RECOGNITION OF APOPTOTIC CELL 7 7.00e-01 -8.40e-02 9.52e-01
RESPONSE TO TYPE I INTERFERON 83 1.86e-01 -8.40e-02 7.08e-01
PRIMARY ALCOHOL CATABOLIC PROCESS 13 6.00e-01 8.40e-02 9.28e-01
ENDOCYTOSIS 703 1.48e-04 -8.39e-02 1.74e-02
PYRIMIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS 42 3.47e-01 -8.39e-02 8.37e-01
MOTOR NEURON APOPTOTIC PROCESS 21 5.06e-01 -8.39e-02 9.02e-01
BEHAVIORAL RESPONSE TO ETHANOL 10 6.46e-01 8.38e-02 9.41e-01
EXTRACELLULAR MATRIX CONSTITUENT SECRETION 13 6.01e-01 8.38e-02 9.28e-01
PARANODAL JUNCTION ASSEMBLY 6 7.22e-01 8.38e-02 9.56e-01
ORGANOPHOSPHATE ESTER TRANSPORT 153 7.38e-02 -8.37e-02 5.48e-01
CARDIAC MUSCLE CELL PROLIFERATION 58 2.70e-01 8.37e-02 7.79e-01
ENTERIC NERVOUS SYSTEM DEVELOPMENT 12 6.16e-01 -8.37e-02 9.32e-01
PEXOPHAGY 6 7.23e-01 8.37e-02 9.56e-01
TRANSLATIONAL ELONGATION 68 2.33e-01 -8.36e-02 7.50e-01
REGULATION OF GTP BINDING 11 6.31e-01 -8.35e-02 9.36e-01
LIPID MODIFICATION 193 4.54e-02 -8.35e-02 4.48e-01
POSITIVE REGULATION OF VASCULATURE DEVELOPMENT 185 5.01e-02 -8.35e-02 4.66e-01
NEGATIVE REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS 39 3.67e-01 -8.35e-02 8.48e-01
LEUKOCYTE ACTIVATION INVOLVED IN INFLAMMATORY RESPONSE 52 2.98e-01 -8.35e-02 8.04e-01
POSITIVE REGULATION OF CYTOPLASMIC TRANSLATIONAL INITIATION 5 7.47e-01 8.34e-02 9.59e-01
POSITIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT 19 5.29e-01 8.34e-02 9.10e-01
PHENOL CONTAINING COMPOUND METABOLIC PROCESS 112 1.27e-01 8.34e-02 6.48e-01
REGULATION OF OXIDOREDUCTASE ACTIVITY 81 1.94e-01 -8.34e-02 7.18e-01
RIGHTING REFLEX 8 6.83e-01 8.34e-02 9.50e-01
RESPONSE TO OXIDATIVE STRESS 395 4.43e-03 -8.34e-02 1.58e-01
ELASTIN METABOLIC PROCESS 9 6.65e-01 8.33e-02 9.45e-01
PROTEIN LOCALIZATION TO GOLGI MEMBRANE 5 7.47e-01 -8.33e-02 9.59e-01
NEGATIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERASE 20 5.19e-01 -8.32e-02 9.09e-01
MAMMARY GLAND DEVELOPMENT 130 1.01e-01 -8.32e-02 6.04e-01
RESPONSE TO MANGANESE ION 18 5.41e-01 -8.32e-02 9.13e-01
DORSAL VENTRAL PATTERN FORMATION 97 1.57e-01 8.31e-02 6.79e-01
REGULATION OF NEUROTRANSMITTER SECRETION 81 1.96e-01 8.31e-02 7.20e-01
REGULATION OF CIRCADIAN SLEEP WAKE CYCLE NON REM SLEEP 5 7.48e-01 -8.31e-02 9.59e-01
REGULATION OF CATECHOLAMINE UPTAKE INVOLVED IN SYNAPTIC TRANSMISSION 8 6.84e-01 8.31e-02 9.50e-01
C21 STEROID HORMONE BIOSYNTHETIC PROCESS 20 5.20e-01 -8.31e-02 9.09e-01
GLIAL CELL ACTIVATION 57 2.78e-01 -8.30e-02 7.85e-01
MUSCLE ATROPHY 10 6.50e-01 -8.30e-02 9.41e-01
MITOTIC INTRA S DNA DAMAGE CHECKPOINT SIGNALING 17 5.54e-01 -8.30e-02 9.18e-01
REGULATION OF CELLULAR COMPONENT BIOGENESIS 1001 8.91e-06 -8.29e-02 2.06e-03
BONE MARROW DEVELOPMENT 9 6.67e-01 -8.29e-02 9.46e-01
ESTABLISHMENT OF EPITHELIAL CELL APICAL BASAL POLARITY 19 5.32e-01 -8.28e-02 9.11e-01
CELL CYCLE DNA REPLICATION 45 3.37e-01 8.28e-02 8.31e-01
BLASTODERM SEGMENTATION 24 4.83e-01 8.27e-02 8.94e-01
REGULATION OF DNA CATABOLIC PROCESS 13 6.06e-01 -8.27e-02 9.29e-01
REGULATION OF REGULATORY NCRNA PROCESSING 17 5.55e-01 8.27e-02 9.18e-01
NEGATIVE REGULATION OF RIBOSOME BIOGENESIS 7 7.05e-01 -8.26e-02 9.52e-01
REGULATION OF ISOTYPE SWITCHING TO IGE ISOTYPES 7 7.05e-01 -8.26e-02 9.52e-01
INOSITOL METABOLIC PROCESS 9 6.68e-01 -8.26e-02 9.46e-01
REGULATION OF MYOTUBE DIFFERENTIATION 48 3.22e-01 -8.26e-02 8.23e-01
LACTATION 40 3.66e-01 -8.26e-02 8.48e-01
SMOOTH MUSCLE CELL CHEMOTAXIS 9 6.68e-01 8.26e-02 9.46e-01
REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION 111 1.33e-01 -8.26e-02 6.56e-01
RESPONSE TO TUMOR NECROSIS FACTOR 253 2.37e-02 -8.26e-02 3.58e-01
REGULATION OF CELL PROLIFERATION IN BONE MARROW 9 6.68e-01 8.26e-02 9.46e-01
SIGNAL TRANSDUCTION IN ABSENCE OF LIGAND 67 2.43e-01 -8.25e-02 7.63e-01
NEGATIVE REGULATION OF MYOBLAST DIFFERENTIATION 25 4.75e-01 -8.25e-02 8.91e-01
SELF PROTEOLYSIS 12 6.21e-01 -8.25e-02 9.32e-01
RESPONSE TO LEUCINE 15 5.80e-01 -8.24e-02 9.24e-01
SULFUR COMPOUND TRANSPORT 54 2.95e-01 -8.24e-02 8.02e-01
MESODERMAL CELL FATE COMMITMENT 17 5.56e-01 8.24e-02 9.18e-01
SPHINGOSINE BIOSYNTHETIC PROCESS 14 5.94e-01 -8.23e-02 9.26e-01
PANCREAS DEVELOPMENT 79 2.07e-01 8.22e-02 7.29e-01
NEGATIVE REGULATION OF MUSCLE ADAPTATION 10 6.53e-01 -8.22e-02 9.41e-01
REGULATION OF VASCULATURE DEVELOPMENT 353 7.98e-03 -8.22e-02 2.08e-01
AMMONIUM ION METABOLIC PROCESS 23 4.95e-01 8.21e-02 8.98e-01
LOCOMOTOR RHYTHM 15 5.82e-01 -8.21e-02 9.24e-01
PURINE DEOXYRIBONUCLEOTIDE CATABOLIC PROCESS 10 6.53e-01 -8.21e-02 9.41e-01
REGULATION OF T HELPER CELL DIFFERENTIATION 43 3.52e-01 -8.21e-02 8.41e-01
CELLULAR RESPONSE TO CHOLESTEROL 20 5.25e-01 -8.21e-02 9.10e-01
CELLULAR RESPONSE TO ETHER 6 7.28e-01 -8.21e-02 9.58e-01
CELLULAR RESPONSE TO STARVATION 176 6.04e-02 -8.20e-02 5.05e-01
PYRIMIDINE NUCLEOTIDE BIOSYNTHETIC PROCESS 32 4.22e-01 -8.20e-02 8.72e-01
REGULATION OF INSULIN RECEPTOR SIGNALING PATHWAY 70 2.35e-01 -8.20e-02 7.54e-01
POSITIVE REGULATION OF PROTEIN SUMOYLATION 12 6.23e-01 -8.20e-02 9.32e-01
POSITIVE REGULATION OF CELL SUBSTRATE ADHESION 123 1.17e-01 -8.19e-02 6.30e-01
REGULATION OF TELOMERE CAPPING 26 4.70e-01 -8.18e-02 8.90e-01
LYMPHOCYTE HOMEOSTASIS 77 2.14e-01 -8.18e-02 7.33e-01
RRNA CATABOLIC PROCESS 21 5.16e-01 -8.18e-02 9.08e-01
CIRCADIAN REGULATION OF GENE EXPRESSION 70 2.37e-01 -8.18e-02 7.56e-01
C4 DICARBOXYLATE TRANSPORT 27 4.62e-01 -8.17e-02 8.89e-01
LONG CHAIN FATTY ACID TRANSPORT 67 2.47e-01 -8.17e-02 7.64e-01
RESPONSE TO PAIN 34 4.10e-01 -8.17e-02 8.64e-01
REGULATION OF HAIR CYCLE 28 4.54e-01 -8.17e-02 8.81e-01
SOMATIC MOTOR NEURON DIFFERENTIATION 5 7.52e-01 8.16e-02 9.60e-01
LIGHT ADAPTION 5 7.52e-01 -8.15e-02 9.60e-01
REGULATION OF ISOMERASE ACTIVITY 8 6.90e-01 -8.15e-02 9.50e-01
EXTRACELLULAR VESICLE BIOGENESIS 25 4.81e-01 -8.15e-02 8.94e-01
REGULATION OF INSULIN SECRETION 164 7.19e-02 -8.14e-02 5.42e-01
ETHANOL CATABOLIC PROCESS 10 6.56e-01 -8.14e-02 9.42e-01
VITAMIN TRANSPORT 52 3.10e-01 -8.13e-02 8.13e-01
MEMBRANE DEPOLARIZATION DURING AV NODE CELL ACTION POTENTIAL 6 7.30e-01 8.13e-02 9.58e-01
RESPONSE TO HUMAN CHORIONIC GONADOTROPIN 5 7.53e-01 8.13e-02 9.60e-01
REGULATION OF PROTEIN LOCALIZATION TO ENDOSOME 13 6.12e-01 -8.13e-02 9.31e-01
NEGATIVE REGULATION OF AMYLOID FIBRIL FORMATION 13 6.12e-01 -8.13e-02 9.31e-01
PEPTIDYL SERINE DEPHOSPHORYLATION 14 5.98e-01 -8.13e-02 9.28e-01
NEGATIVE REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY 15 5.86e-01 -8.13e-02 9.24e-01
FORMATION OF ANATOMICAL BOUNDARY 7 7.10e-01 8.13e-02 9.53e-01
REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY 158 7.79e-02 -8.13e-02 5.57e-01
REGULATION OF ORGANELLE ASSEMBLY 241 2.98e-02 -8.13e-02 3.83e-01
CORTICOSTEROID HORMONE SECRETION 19 5.40e-01 -8.12e-02 9.13e-01
RETROGRADE TRANSPORT VESICLE RECYCLING WITHIN GOLGI 9 6.73e-01 -8.11e-02 9.47e-01
REGULATION OF PHOSPHOLIPID TRANSPORT 15 5.87e-01 8.11e-02 9.24e-01
MATURE CONVENTIONAL DENDRITIC CELL DIFFERENTIATION 5 7.54e-01 -8.11e-02 9.60e-01
NEURAL TUBE PATTERNING 40 3.75e-01 8.11e-02 8.50e-01
RESPONSE TO AMPHETAMINE 31 4.35e-01 8.11e-02 8.74e-01
HYPOTHALAMUS CELL MIGRATION 7 7.10e-01 -8.10e-02 9.54e-01
CARDIAC RIGHT VENTRICLE MORPHOGENESIS 21 5.20e-01 -8.10e-02 9.09e-01
GLOMERULAR EPITHELIUM DEVELOPMENT 25 4.83e-01 8.10e-02 8.94e-01
NEGATIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION 68 2.48e-01 -8.10e-02 7.64e-01
CANNABINOID SIGNALING PATHWAY 9 6.74e-01 -8.10e-02 9.47e-01
REGULATION OF LENS FIBER CELL DIFFERENTIATION 9 6.74e-01 8.10e-02 9.47e-01
METANEPHROS DEVELOPMENT 94 1.75e-01 8.09e-02 6.92e-01
NEGATIVE REGULATION OF NERVOUS SYSTEM PROCESS 15 5.87e-01 -8.09e-02 9.24e-01
ACUTE PHASE RESPONSE 48 3.32e-01 8.09e-02 8.31e-01
RESPONSE TO SODIUM PHOSPHATE 8 6.92e-01 8.08e-02 9.50e-01
CELL ADHESION MEDIATED BY INTEGRIN 87 1.93e-01 -8.07e-02 7.16e-01
CORTICOTROPIN SECRETION 7 7.11e-01 -8.07e-02 9.54e-01
RESPONSE TO ENDOPLASMIC RETICULUM STRESS 263 2.42e-02 -8.07e-02 3.60e-01
GLUCOCORTICOID BIOSYNTHETIC PROCESS 16 5.76e-01 -8.07e-02 9.24e-01
HETEROCYCLE CATABOLIC PROCESS 535 1.42e-03 -8.06e-02 8.04e-02
ARGININE CATABOLIC PROCESS 11 6.44e-01 -8.06e-02 9.41e-01
FAT SOLUBLE VITAMIN METABOLIC PROCESS 45 3.50e-01 8.05e-02 8.41e-01
MYOTUBE DIFFERENTIATION 128 1.16e-01 -8.05e-02 6.30e-01
NCRNA TRANSCRIPTION 136 1.05e-01 -8.04e-02 6.09e-01
NEGATIVE REGULATION OF MUSCLE HYPERTROPHY 37 3.97e-01 -8.04e-02 8.59e-01
RAP PROTEIN SIGNAL TRANSDUCTION 13 6.16e-01 8.04e-02 9.32e-01
ETHANOLAMINE CONTAINING COMPOUND METABOLIC PROCESS 8 6.94e-01 8.03e-02 9.51e-01
PHOSPHATIDYLINOSITOL MEDIATED SIGNALING 26 4.79e-01 8.03e-02 8.93e-01
MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION 136 1.06e-01 -8.03e-02 6.11e-01
POSITIVE REGULATION OF TRANSMISSION OF NERVE IMPULSE 7 7.13e-01 8.02e-02 9.55e-01
SA NODE CELL TO ATRIAL CARDIAC MUSCLE CELL COMMUNICATION 11 6.45e-01 8.02e-02 9.41e-01
LABYRINTHINE LAYER MORPHOGENESIS 22 5.15e-01 -8.01e-02 9.07e-01
REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS 143 9.85e-02 -8.00e-02 6.00e-01
CELLULAR RESPONSE TO INSULIN LIKE GROWTH FACTOR STIMULUS 8 6.95e-01 -7.99e-02 9.51e-01
POSITIVE REGULATION OF CELL GROWTH 161 8.01e-02 -7.99e-02 5.60e-01
STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE 238 3.37e-02 -7.99e-02 4.03e-01
POLYAMINE BIOSYNTHETIC PROCESS 14 6.05e-01 -7.99e-02 9.29e-01
NEGATIVE REGULATION OF EPITHELIAL CELL PROLIFERATION 174 6.93e-02 -7.98e-02 5.33e-01
REGULATION OF ATTACHMENT OF SPINDLE MICROTUBULES TO KINETOCHORE 21 5.27e-01 -7.98e-02 9.10e-01
TEMPERATURE HOMEOSTASIS 183 6.27e-02 -7.98e-02 5.12e-01
FATTY ACID BIOSYNTHETIC PROCESS 165 7.71e-02 -7.97e-02 5.54e-01
REGULATION OF POSTSYNAPSE ORGANIZATION 102 1.64e-01 7.97e-02 6.83e-01
POSITIVE REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION 19 5.48e-01 -7.97e-02 9.14e-01
POSITIVE REGULATION OF COA TRANSFERASE ACTIVITY 8 6.96e-01 -7.97e-02 9.52e-01
GLOMERULAR MESANGIUM DEVELOPMENT 18 5.59e-01 -7.96e-02 9.19e-01
REGULATION OF VIRAL GENOME REPLICATION 85 2.05e-01 -7.96e-02 7.29e-01
NAIL DEVELOPMENT 11 6.48e-01 -7.96e-02 9.41e-01
REGULATION OF MALE GONAD DEVELOPMENT 8 6.97e-01 -7.95e-02 9.52e-01
PYRIMIDINE DEOXYRIBONUCLEOTIDE METABOLIC PROCESS 23 5.09e-01 7.95e-02 9.05e-01
NEGATIVE REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION 38 3.97e-01 -7.94e-02 8.59e-01
CYCLIC NUCLEOTIDE METABOLIC PROCESS 41 3.79e-01 -7.94e-02 8.51e-01
NUCLEOBASE CATABOLIC PROCESS 10 6.64e-01 7.94e-02 9.44e-01
REGULATION OF LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL 41 3.79e-01 -7.93e-02 8.51e-01
PYRAMIDAL NEURON DEVELOPMENT 11 6.49e-01 -7.93e-02 9.41e-01
TAURINE TRANSPORT 8 6.98e-01 7.93e-02 9.52e-01
POSITIVE REGULATION OF LEUKOCYTE APOPTOTIC PROCESS 28 4.68e-01 7.93e-02 8.90e-01
CELLULAR RESPONSE TO INTERFERON ALPHA 7 7.17e-01 7.93e-02 9.55e-01
JNK CASCADE 163 8.08e-02 -7.92e-02 5.62e-01
NEGATIVE REGULATION OF CELL POPULATION PROLIFERATION 948 3.50e-05 -7.92e-02 5.93e-03
PEPTIDYL LYSINE DEACETYLATION 7 7.17e-01 -7.92e-02 9.55e-01
REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION 131 1.17e-01 7.92e-02 6.30e-01
REGULATION OF LIPID BIOSYNTHETIC PROCESS 189 6.05e-02 -7.92e-02 5.05e-01
NUCLEOSOME ORGANIZATION 125 1.26e-01 -7.91e-02 6.48e-01
POSITIVE REGULATION OF MESENCHYMAL CELL PROLIFERATION 25 4.94e-01 7.91e-02 8.97e-01
POSITIVE REGULATION OF ATP METABOLIC PROCESS 11 6.50e-01 -7.91e-02 9.41e-01
LYMPHOCYTE APOPTOTIC PROCESS 82 2.16e-01 -7.91e-02 7.33e-01
SMOOTHENED SIGNALING PATHWAY INVOLVED IN VENTRAL SPINAL CORD PATTERNING 8 6.99e-01 -7.91e-02 9.52e-01
IMMUNE RESPONSE TO TUMOR CELL 26 4.85e-01 -7.90e-02 8.94e-01
DETERMINATION OF LIVER LEFT RIGHT ASYMMETRY 6 7.38e-01 7.90e-02 9.58e-01
MULTI MULTICELLULAR ORGANISM PROCESS 212 4.74e-02 -7.90e-02 4.54e-01
ADHESION OF SYMBIONT TO HOST CELL 9 6.82e-01 7.90e-02 9.50e-01
RESPONSE TO EXTRACELLULAR STIMULUS 520 2.05e-03 -7.89e-02 1.04e-01
CEREBELLAR CORTEX MORPHOGENESIS 36 4.13e-01 7.89e-02 8.65e-01
L PROLINE BIOSYNTHETIC PROCESS 6 7.38e-01 -7.89e-02 9.58e-01
CARTILAGE DEVELOPMENT INVOLVED IN ENDOCHONDRAL BONE MORPHOGENESIS 33 4.33e-01 -7.89e-02 8.74e-01
NEGATIVE REGULATION OF VIRAL ENTRY INTO HOST CELL 23 5.13e-01 -7.88e-02 9.07e-01
HEART VALVE MORPHOGENESIS 60 2.91e-01 -7.88e-02 7.99e-01
NEGATIVE REGULATION OF INTERLEUKIN 2 PRODUCTION 28 4.71e-01 -7.87e-02 8.90e-01
INHIBITORY POSTSYNAPTIC POTENTIAL 17 5.74e-01 -7.87e-02 9.24e-01
OVULATION CYCLE PROCESS 50 3.36e-01 7.87e-02 8.31e-01
GASTRO INTESTINAL SYSTEM SMOOTH MUSCLE CONTRACTION 12 6.37e-01 -7.87e-02 9.38e-01
PROTEIN INSERTION INTO MITOCHONDRIAL MEMBRANE INVOLVED IN APOPTOTIC SIGNALING PATHWAY 6 7.39e-01 -7.87e-02 9.58e-01
REGULATION OF POSITIVE CHEMOTAXIS 26 4.88e-01 7.86e-02 8.94e-01
AXON EXTENSION 121 1.36e-01 -7.86e-02 6.60e-01
B CELL PROLIFERATION 97 1.81e-01 7.85e-02 7.01e-01
POSITIVE REGULATION OF COLD INDUCED THERMOGENESIS 101 1.73e-01 -7.85e-02 6.90e-01
POSITIVE REGULATION OF ADIPOSE TISSUE DEVELOPMENT 10 6.67e-01 -7.85e-02 9.46e-01
CORTICOSTEROID RECEPTOR SIGNALING PATHWAY 14 6.11e-01 7.85e-02 9.31e-01
SNRNA PROCESSING 27 4.81e-01 7.84e-02 8.94e-01
NEGATIVE REGULATION OF PEPTIDE SECRETION 45 3.63e-01 -7.84e-02 8.47e-01
GLIAL CELL DEVELOPMENT 122 1.35e-01 -7.83e-02 6.59e-01
CARBOHYDRATE TRANSPORT 157 9.04e-02 -7.83e-02 5.85e-01
LEUKOTRIENE SIGNALING PATHWAY 5 7.62e-01 -7.83e-02 9.61e-01
REGULATION OF GLUCONEOGENESIS 52 3.29e-01 -7.82e-02 8.30e-01
SECRETION OF LYSOSOMAL ENZYMES 7 7.20e-01 7.82e-02 9.56e-01
EPINEPHRINE TRANSPORT 11 6.53e-01 -7.82e-02 9.41e-01
RECEPTOR MEDIATED ENDOCYTOSIS 260 2.99e-02 -7.82e-02 3.83e-01
SYMPATHETIC NEURON PROJECTION EXTENSION 5 7.62e-01 -7.81e-02 9.61e-01
CELLULAR RESPONSE TO COLD 13 6.26e-01 -7.81e-02 9.34e-01
NEUROTRANSMITTER BIOSYNTHETIC PROCESS 14 6.13e-01 7.81e-02 9.31e-01
PROTEIN LOCALIZATION TO CELL PERIPHERY 352 1.19e-02 -7.80e-02 2.53e-01
STRIATUM DEVELOPMENT 22 5.27e-01 7.80e-02 9.10e-01
IMMUNOLOGICAL MEMORY FORMATION PROCESS 14 6.14e-01 -7.79e-02 9.31e-01
DETERMINATION OF LEFT RIGHT ASYMMETRY IN LATERAL MESODERM 8 7.03e-01 7.79e-02 9.52e-01
NEGATIVE REGULATION OF GENE EXPRESSION 1550 2.86e-07 -7.79e-02 1.46e-04
MAMMARY GLAND DUCT MORPHOGENESIS 29 4.68e-01 -7.79e-02 8.90e-01
PROTEIN K48 LINKED UBIQUITINATION 65 2.77e-01 -7.79e-02 7.85e-01
FATTY ACID TRANSPORT 115 1.49e-01 -7.79e-02 6.76e-01
AXONAL TRANSPORT 66 2.74e-01 7.78e-02 7.81e-01
CELLULAR RESPONSE TO HYDROPEROXIDE 8 7.03e-01 7.78e-02 9.52e-01
EPITHELIAL CELL APOPTOTIC PROCESS 144 1.07e-01 -7.78e-02 6.11e-01
REGULATION OF GLYCOGEN BIOSYNTHETIC PROCESS 31 4.54e-01 -7.77e-02 8.81e-01
POSITIVE REGULATION OF DENDRITIC SPINE MAINTENANCE 5 7.64e-01 -7.77e-02 9.61e-01
INTERLEUKIN 1 PRODUCTION 128 1.29e-01 -7.77e-02 6.48e-01
NEGATIVE REGULATION OF POTASSIUM ION TRANSPORT 37 4.14e-01 7.77e-02 8.66e-01
INTERFERON MEDIATED SIGNALING PATHWAY 101 1.77e-01 -7.77e-02 6.97e-01
NEURON MATURATION 48 3.52e-01 -7.77e-02 8.41e-01
POSITIVE REGULATION OF MEGAKARYOCYTE DIFFERENTIATION 10 6.71e-01 -7.76e-02 9.46e-01
NEGATIVE REGULATION OF ACTION POTENTIAL 6 7.42e-01 7.76e-02 9.59e-01
REGULATION OF VESICLE SIZE 19 5.58e-01 7.76e-02 9.19e-01
VASODILATION 47 3.57e-01 7.76e-02 8.45e-01
ACTIN MEDIATED CELL CONTRACTION 105 1.70e-01 -7.76e-02 6.87e-01
CELLULAR RESPONSE TO LIGHT STIMULUS 121 1.41e-01 -7.76e-02 6.68e-01
POSITIVE REGULATION OF MYELINATION 17 5.80e-01 -7.75e-02 9.24e-01
RESPONSE TO HEAT 101 1.78e-01 -7.75e-02 6.98e-01
ACTIVATION OF INNATE IMMUNE RESPONSE 274 2.72e-02 -7.75e-02 3.69e-01
REGULATION OF INTERLEUKIN 1 MEDIATED SIGNALING PATHWAY 10 6.71e-01 -7.75e-02 9.46e-01
POSITIVE REGULATION OF INTERLEUKIN 17 PRODUCTION 27 4.86e-01 -7.75e-02 8.94e-01
CRANIAL NERVE MORPHOGENESIS 30 4.64e-01 -7.73e-02 8.89e-01
TRANS SYNAPTIC SIGNALING BY TRANS SYNAPTIC COMPLEX 7 7.23e-01 -7.73e-02 9.56e-01
REGULATION OF PROTEIN LOCALIZATION TO LYSOSOME 5 7.65e-01 -7.72e-02 9.61e-01
NEUTROPHIL HOMEOSTASIS 21 5.40e-01 -7.72e-02 9.13e-01
REGULATION OF ENDODEOXYRIBONUCLEASE ACTIVITY 8 7.05e-01 7.72e-02 9.52e-01
NEGATIVE REGULATION OF P38MAPK CASCADE 8 7.05e-01 -7.72e-02 9.52e-01
POSITIVE REGULATION OF NATURAL KILLER CELL DIFFERENTIATION 7 7.24e-01 7.72e-02 9.56e-01
CORNIFICATION 9 6.88e-01 7.72e-02 9.50e-01
REGULATION OF RYANODINE SENSITIVE CALCIUM RELEASE CHANNEL ACTIVITY 25 5.04e-01 7.71e-02 9.02e-01
REGULATION OF MONONUCLEAR CELL MIGRATION 121 1.43e-01 7.71e-02 6.69e-01
FACIAL NERVE STRUCTURAL ORGANIZATION 8 7.06e-01 -7.71e-02 9.52e-01
POSITIVE REGULATION OF CHEMOKINE PRODUCTION 72 2.59e-01 -7.70e-02 7.72e-01
GTP METABOLIC PROCESS 24 5.14e-01 -7.70e-02 9.07e-01
CENTRAL NERVOUS SYSTEM NEURON AXONOGENESIS 39 4.05e-01 -7.70e-02 8.63e-01
AMINOGLYCAN METABOLIC PROCESS 121 1.44e-01 -7.70e-02 6.70e-01
LUNG LOBE DEVELOPMENT 7 7.25e-01 -7.69e-02 9.57e-01
IRON ION TRANSMEMBRANE TRANSPORT 31 4.59e-01 -7.69e-02 8.86e-01
GLAND MORPHOGENESIS 123 1.41e-01 -7.69e-02 6.68e-01
SINGLE FERTILIZATION 162 9.14e-02 7.68e-02 5.87e-01
MULTI CILIATED EPITHELIAL CELL DIFFERENTIATION 9 6.90e-01 -7.68e-02 9.50e-01
NEUTROPHIL DIFFERENTIATION 11 6.59e-01 7.68e-02 9.43e-01
REGULATION OF ENDOTHELIAL CELL DIFFERENTIATION 48 3.58e-01 -7.67e-02 8.45e-01
EAR MORPHOGENESIS 126 1.37e-01 7.67e-02 6.61e-01
MAINTENANCE OF SISTER CHROMATID COHESION 13 6.32e-01 7.67e-02 9.36e-01
REGULATION OF EXCITATORY SYNAPSE ASSEMBLY 15 6.07e-01 7.66e-02 9.30e-01
CALCIUM MEDIATED SIGNALING USING INTRACELLULAR CALCIUM SOURCE 22 5.34e-01 -7.65e-02 9.12e-01
CRISTAE FORMATION 17 5.85e-01 -7.65e-02 9.24e-01
RNA STABILIZATION 69 2.72e-01 -7.65e-02 7.80e-01
REGULATION OF SUPEROXIDE METABOLIC PROCESS 30 4.69e-01 -7.64e-02 8.90e-01
REGULATION OF ORGANELLE ORGANIZATION 1188 8.92e-06 -7.64e-02 2.06e-03
RESPONSE TO CALCIUM ION 142 1.16e-01 7.64e-02 6.30e-01
CELLULAR RESPONSE TO OXIDATIVE STRESS 255 3.57e-02 -7.64e-02 4.04e-01
MONOCARBOXYLIC ACID BIOSYNTHETIC PROCESS 223 4.94e-02 -7.63e-02 4.63e-01
DEVELOPMENTAL CELL GROWTH 238 4.25e-02 -7.63e-02 4.33e-01
CORNEA DEVELOPMENT IN CAMERA TYPE EYE 12 6.47e-01 -7.63e-02 9.41e-01
NEGATIVE REGULATION OF STEM CELL PROLIFERATION 28 4.85e-01 -7.62e-02 8.94e-01
POSITIVE REGULATION OF CELL KILLING 75 2.54e-01 7.62e-02 7.69e-01
BONE MORPHOGENESIS 98 1.92e-01 -7.62e-02 7.16e-01
NEGATIVE REGULATION OF CARDIAC MUSCLE ADAPTATION 8 7.09e-01 -7.62e-02 9.53e-01
NEGATIVE REGULATION OF MIRNA METABOLIC PROCESS 26 5.01e-01 -7.62e-02 9.01e-01
POSITIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY 30 4.70e-01 -7.62e-02 8.90e-01
CD8 POSITIVE ALPHA BETA T CELL ACTIVATION 29 4.78e-01 -7.62e-02 8.93e-01
PROTEIN LOCALIZATION TO BICELLULAR TIGHT JUNCTION 5 7.68e-01 -7.62e-02 9.63e-01
REGULATION OF HAIR FOLLICLE DEVELOPMENT 19 5.65e-01 -7.62e-02 9.21e-01
REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION 68 2.78e-01 -7.61e-02 7.85e-01
RESPONSE TO MITOCHONDRIAL DEPOLARISATION 21 5.46e-01 -7.61e-02 9.14e-01
NEGATIVE REGULATION OF LOCOMOTION 419 7.52e-03 -7.61e-02 2.00e-01
PROTEIN AUTOPHOSPHORYLATION 199 6.42e-02 -7.61e-02 5.19e-01
REGULATION OF PROTEIN GLYCOSYLATION 12 6.48e-01 -7.61e-02 9.41e-01
POSITIVE REGULATION OF ENDOCYTOSIS 154 1.03e-01 -7.60e-02 6.07e-01
RESPONSE TO LIGHT INTENSITY 17 5.87e-01 -7.60e-02 9.24e-01
REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS 80 2.40e-01 -7.60e-02 7.59e-01
REGULATION OF MIRNA TRANSCRIPTION 71 2.68e-01 -7.60e-02 7.77e-01
PROTEIN SUMOYLATION 66 2.86e-01 -7.59e-02 7.94e-01
ESTABLISHMENT OF PROTEIN LOCALIZATION TO ENDOPLASMIC RETICULUM 43 3.89e-01 7.59e-02 8.56e-01
MACROPHAGE APOPTOTIC PROCESS 14 6.23e-01 7.59e-02 9.32e-01
SPHINGOLIPID BIOSYNTHETIC PROCESS 110 1.69e-01 -7.59e-02 6.87e-01
CELLULAR COMPONENT ASSEMBLY INVOLVED IN MORPHOGENESIS 128 1.38e-01 -7.59e-02 6.63e-01
INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO OSMOTIC STRESS 10 6.78e-01 -7.59e-02 9.49e-01
REGULATION OF INTEGRIN MEDIATED SIGNALING PATHWAY 21 5.47e-01 -7.59e-02 9.14e-01
INTERNAL PROTEIN AMINO ACID ACETYLATION 56 3.26e-01 -7.59e-02 8.27e-01
PEPTIDYL PROLINE HYDROXYLATION 11 6.63e-01 -7.58e-02 9.44e-01
TUBE DEVELOPMENT 1162 1.28e-05 -7.58e-02 2.64e-03
TRUNK SEGMENTATION 5 7.69e-01 -7.58e-02 9.63e-01
NEUTROPHIL MEDIATED CYTOTOXICITY 14 6.24e-01 7.57e-02 9.33e-01
EMBRYONIC HINDLIMB MORPHOGENESIS 28 4.88e-01 7.56e-02 8.94e-01
IMP METABOLIC PROCESS 18 5.79e-01 7.56e-02 9.24e-01
REGULATION OF MIRNA METABOLIC PROCESS 86 2.25e-01 -7.56e-02 7.43e-01
ANTEROGRADE AXONAL TRANSPORT 51 3.50e-01 7.56e-02 8.41e-01
REGULATION OF PROTEIN AUTOUBIQUITINATION 6 7.48e-01 7.56e-02 9.59e-01
NEGATIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION 725 5.22e-04 -7.56e-02 3.95e-02
RRNA TRANSPORT 5 7.70e-01 -7.55e-02 9.63e-01
PIGMENT GRANULE LOCALIZATION 25 5.14e-01 7.55e-02 9.07e-01
VIRAL LIFE CYCLE 315 2.13e-02 -7.54e-02 3.42e-01
HINDBRAIN MORPHOGENESIS 46 3.76e-01 7.54e-02 8.50e-01
ICOSANOID SECRETION 46 3.76e-01 7.54e-02 8.50e-01
CELLULAR RESPONSE TO TOPOLOGICALLY INCORRECT PROTEIN 109 1.74e-01 -7.54e-02 6.91e-01
POSITIVE REGULATION OF CELLULAR PH REDUCTION 5 7.70e-01 -7.54e-02 9.63e-01
NEGATIVE REGULATION OF RNA CATABOLIC PROCESS 82 2.39e-01 -7.53e-02 7.57e-01
HYDROGEN PEROXIDE CATABOLIC PROCESS 31 4.69e-01 7.52e-02 8.90e-01
POSITIVE REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS 117 1.60e-01 -7.52e-02 6.80e-01
POSITIVE REGULATION OF EPITHELIAL CELL MIGRATION 176 8.54e-02 -7.52e-02 5.75e-01
DNA TEMPLATED DNA REPLICATION 161 9.98e-02 7.51e-02 6.02e-01
RIBONUCLEOSIDE METABOLIC PROCESS 35 4.42e-01 -7.51e-02 8.78e-01
MAINTENANCE OF PROTEIN LOCATION IN EXTRACELLULAR REGION 8 7.13e-01 -7.51e-02 9.55e-01
REGULATION OF ORGAN GROWTH 98 1.99e-01 7.51e-02 7.25e-01
FATTY ACID DERIVATIVE CATABOLIC PROCESS 18 5.81e-01 7.50e-02 9.24e-01
MACROPHAGE DIFFERENTIATION 64 2.99e-01 -7.50e-02 8.06e-01
GLIAL CELL FATE SPECIFICATION 7 7.31e-01 7.49e-02 9.58e-01
NEGATIVE REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE 15 6.15e-01 -7.49e-02 9.32e-01
LEFT RIGHT AXIS SPECIFICATION 14 6.27e-01 7.49e-02 9.35e-01
REGULATION OF ENDOCYTOSIS 292 2.76e-02 -7.49e-02 3.73e-01
RAC PROTEIN SIGNAL TRANSDUCTION 42 4.01e-01 7.49e-02 8.63e-01
NEUTROPHIL MEDIATED KILLING OF GRAM NEGATIVE BACTERIUM 6 7.51e-01 7.48e-02 9.59e-01
POSITIVE REGULATION OF HORMONE METABOLIC PROCESS 15 6.16e-01 -7.48e-02 9.32e-01
NEGATIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION 7 7.32e-01 -7.48e-02 9.58e-01
CILIUM DISASSEMBLY 6 7.51e-01 -7.48e-02 9.59e-01
POSITIVE REGULATION OF COLLATERAL SPROUTING 10 6.82e-01 7.48e-02 9.50e-01
MEMBRANE REPOLARIZATION DURING ACTION POTENTIAL 31 4.72e-01 -7.47e-02 8.91e-01
REGULATION OF PROTEIN FOLDING 8 7.14e-01 -7.47e-02 9.55e-01
PROTOPORPHYRINOGEN IX METABOLIC PROCESS 11 6.68e-01 -7.47e-02 9.46e-01
REGULATION OF SYNAPSE ASSEMBLY 114 1.68e-01 7.46e-02 6.87e-01
REGULATION OF TRANSLATIONAL INITIATION 79 2.52e-01 -7.45e-02 7.68e-01
ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE 75 2.65e-01 -7.45e-02 7.75e-01
AXO DENDRITIC PROTEIN TRANSPORT 9 6.99e-01 7.44e-02 9.52e-01
ORGANOPHOSPHATE CATABOLIC PROCESS 146 1.20e-01 -7.44e-02 6.34e-01
NOTCH SIGNALING PATHWAY 178 8.67e-02 -7.44e-02 5.78e-01
POSITIVE REGULATION OF KINASE ACTIVITY 336 1.90e-02 -7.44e-02 3.19e-01
POSITIVE REGULATION OF PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS 94 2.13e-01 -7.44e-02 7.32e-01
EGG ACTIVATION 11 6.69e-01 -7.43e-02 9.46e-01
FEMALE GENITALIA DEVELOPMENT 19 5.75e-01 -7.43e-02 9.24e-01
OPTIC CUP MORPHOGENESIS INVOLVED IN CAMERA TYPE EYE DEVELOPMENT 7 7.33e-01 -7.43e-02 9.58e-01
EMBRYO DEVELOPMENT ENDING IN BIRTH OR EGG HATCHING 674 1.00e-03 -7.43e-02 6.31e-02
GAMMA AMINOBUTYRIC ACID METABOLIC PROCESS 8 7.16e-01 -7.42e-02 9.55e-01
POSITIVE REGULATION OF CELL PROJECTION ORGANIZATION 354 1.64e-02 -7.42e-02 2.98e-01
LIPID CATABOLIC PROCESS 335 1.96e-02 -7.41e-02 3.25e-01
REGULATION OF NUCLEOTIDE METABOLIC PROCESS 47 3.80e-01 -7.41e-02 8.51e-01
ROSTROCAUDAL NEURAL TUBE PATTERNING 11 6.71e-01 -7.40e-02 9.46e-01
TYPE 2 IMMUNE RESPONSE 42 4.07e-01 -7.40e-02 8.63e-01
NEGATIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION 578 2.36e-03 -7.40e-02 1.08e-01
INTERLEUKIN 1 MEDIATED SIGNALING PATHWAY 32 4.69e-01 -7.40e-02 8.90e-01
REGULATION OF COAGULATION 73 2.75e-01 -7.39e-02 7.81e-01
RESPONSE TO PARATHYROID HORMONE 13 6.45e-01 7.38e-02 9.41e-01
CELL GROWTH 497 4.82e-03 -7.38e-02 1.63e-01
MRNA 3 END PROCESSING 50 3.67e-01 7.38e-02 8.48e-01
REGULATION OF CELL PROJECTION ORGANIZATION 689 9.58e-04 -7.37e-02 6.25e-02
POSITIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY 141 1.32e-01 -7.35e-02 6.55e-01
DETERMINATION OF ADULT LIFESPAN 35 4.52e-01 7.35e-02 8.81e-01
POSITIVE REGULATION OF CALCIUM ION DEPENDENT EXOCYTOSIS 13 6.46e-01 -7.35e-02 9.41e-01
STEROL HOMEOSTASIS 101 2.02e-01 -7.34e-02 7.29e-01
VASCULATURE DEVELOPMENT 824 3.38e-04 -7.34e-02 3.13e-02
DEVELOPMENTAL INDUCTION 34 4.59e-01 7.34e-02 8.86e-01
ACYLGLYCEROL HOMEOSTASIS 43 4.05e-01 -7.33e-02 8.63e-01
NEGATIVE REGULATION OF RECEPTOR RECYCLING 5 7.77e-01 7.32e-02 9.64e-01
REGULATION OF TRIGLYCERIDE BIOSYNTHETIC PROCESS 22 5.53e-01 -7.31e-02 9.18e-01
AXIAL MESODERM DEVELOPMENT 9 7.04e-01 -7.31e-02 9.52e-01
PROTEIN AUTO ADP RIBOSYLATION 11 6.75e-01 -7.31e-02 9.47e-01
NEGATIVE REGULATION OF CHROMOSOME SEGREGATION 50 3.71e-01 7.31e-02 8.48e-01
REGULATION OF CYTOPLASMIC TRANSPORT 32 4.75e-01 -7.30e-02 8.91e-01
DOPAMINERGIC NEURON DIFFERENTIATION 42 4.13e-01 7.30e-02 8.65e-01
ESTABLISHMENT OF TISSUE POLARITY 70 2.91e-01 -7.30e-02 7.99e-01
PROTEIN POLYMERIZATION 285 3.40e-02 -7.30e-02 4.03e-01
RNA SPLICING VIA ENDONUCLEOLYTIC CLEAVAGE AND LIGATION 14 6.37e-01 7.29e-02 9.38e-01
EXTERNAL ENCAPSULATING STRUCTURE ORGANIZATION 320 2.48e-02 -7.29e-02 3.65e-01
METHYLATION 270 3.91e-02 -7.29e-02 4.17e-01
SYNAPTIC VESICLE EXOCYTOSIS 96 2.17e-01 7.29e-02 7.36e-01
VIRAL PROCESS 423 1.01e-02 -7.29e-02 2.34e-01
MITOCHONDRIAL RNA METABOLIC PROCESS 52 3.63e-01 7.28e-02 8.47e-01
NEGATIVE REGULATION OF TORC1 SIGNALING 46 3.93e-01 -7.28e-02 8.58e-01
COMMA SHAPED BODY MORPHOGENESIS 5 7.78e-01 7.28e-02 9.64e-01
POSITIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE PROTEIN KINASE B SIGNAL TRANSDUCTION 170 1.02e-01 -7.27e-02 6.04e-01
REGULATION OF BROWN FAT CELL DIFFERENTIATION 25 5.29e-01 7.27e-02 9.10e-01
REGULATION OF LEUKOCYTE TETHERING OR ROLLING 18 5.94e-01 7.26e-02 9.26e-01
ISOPRENOID BIOSYNTHETIC PROCESS 29 4.99e-01 -7.26e-02 8.99e-01
LOCALIZATION WITHIN MEMBRANE 686 1.18e-03 -7.26e-02 7.28e-02
PHOTORECEPTOR CELL MORPHOGENESIS 5 7.79e-01 -7.25e-02 9.64e-01
MESENCHYMAL TO EPITHELIAL TRANSITION 19 5.84e-01 7.25e-02 9.24e-01
BRONCHIOLE DEVELOPMENT 5 7.79e-01 -7.25e-02 9.64e-01
CYTOCHROME COMPLEX ASSEMBLY 39 4.34e-01 7.24e-02 8.74e-01
ENDOMEMBRANE SYSTEM ORGANIZATION 584 2.81e-03 -7.23e-02 1.22e-01
DETECTION OF MECHANICAL STIMULUS INVOLVED IN SENSORY PERCEPTION OF PAIN 15 6.28e-01 7.23e-02 9.35e-01
NEGATIVE REGULATION OF TRIGLYCERIDE METABOLIC PROCESS 15 6.28e-01 -7.23e-02 9.35e-01
NEGATIVE REGULATION OF POST TRANSCRIPTIONAL GENE SILENCING 13 6.52e-01 -7.22e-02 9.41e-01
TUBE MORPHOGENESIS 947 1.63e-04 -7.22e-02 1.80e-02
SODIUM ION HOMEOSTASIS 46 3.97e-01 7.22e-02 8.59e-01
BIOLOGICAL PROCESS INVOLVED IN INTERACTION WITH SYMBIONT 118 1.75e-01 7.22e-02 6.93e-01
POSITIVE REGULATION OF FATTY ACID BETA OXIDATION 11 6.79e-01 -7.22e-02 9.49e-01
INNER EAR MORPHOGENESIS 105 2.01e-01 7.21e-02 7.28e-01
RESPONSE TO LITHIUM ION 15 6.29e-01 -7.21e-02 9.35e-01
REGULATION OF NOREPINEPHRINE SECRETION 13 6.53e-01 7.21e-02 9.41e-01
NEGATIVE REGULATION OF WNT SIGNALING PATHWAY INVOLVED IN HEART DEVELOPMENT 7 7.41e-01 7.21e-02 9.59e-01
FOREBRAIN REGIONALIZATION 24 5.41e-01 7.21e-02 9.13e-01
REGULATION OF ASPARTIC TYPE PEPTIDASE ACTIVITY 10 6.93e-01 -7.21e-02 9.50e-01
REGULATION OF CYTOKINESIS 90 2.37e-01 -7.20e-02 7.56e-01
NEGATIVE REGULATION OF TRANSFORMING GROWTH FACTOR BETA1 PRODUCTION 6 7.60e-01 -7.20e-02 9.61e-01
REGULATION OF MITOTIC CELL CYCLE SPINDLE ASSEMBLY CHECKPOINT 21 5.68e-01 -7.20e-02 9.21e-01
POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION 320 2.67e-02 -7.20e-02 3.67e-01
MRNA SPLICE SITE RECOGNITION 35 4.61e-01 -7.20e-02 8.88e-01
POSITIVE REGULATION OF FEEDING BEHAVIOR 10 6.93e-01 -7.20e-02 9.50e-01
REGULATION OF AUTOPHAGY 352 2.03e-02 -7.20e-02 3.32e-01
RESPONSE TO INSULIN 270 4.17e-02 -7.20e-02 4.31e-01
REGULATION OF CYTOCHROME C OXIDASE ACTIVITY 5 7.80e-01 -7.20e-02 9.65e-01
NEGATIVE REGULATION OF ENDOCYTOSIS 76 2.78e-01 -7.20e-02 7.85e-01
POSITIVE REGULATION OF BONE MINERALIZATION 44 4.09e-01 7.20e-02 8.64e-01
NEGATIVE REGULATION OF SIGNAL TRANSDUCTION IN ABSENCE OF LIGAND 35 4.61e-01 -7.20e-02 8.88e-01
POSITIVE REGULATION OF CELL DIVISION 91 2.35e-01 -7.19e-02 7.54e-01
RECEPTOR CATABOLIC PROCESS 28 5.10e-01 -7.19e-02 9.05e-01
POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS 14 6.41e-01 -7.19e-02 9.40e-01
REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION 100 2.14e-01 7.18e-02 7.33e-01
GERMINAL CENTER FORMATION 14 6.42e-01 -7.18e-02 9.40e-01
NEGATIVE REGULATION OF NITRIC OXIDE METABOLIC PROCESS 16 6.19e-01 -7.18e-02 9.32e-01
THYROID HORMONE TRANSPORT 12 6.67e-01 7.18e-02 9.46e-01
UDP N ACETYLGLUCOSAMINE METABOLIC PROCESS 14 6.42e-01 7.17e-02 9.40e-01
INCLUSION BODY ASSEMBLY 24 5.43e-01 -7.17e-02 9.13e-01
INTERLEUKIN 23 PRODUCTION 9 7.09e-01 7.17e-02 9.53e-01
STRESS GRANULE ASSEMBLY 31 4.90e-01 -7.17e-02 8.95e-01
POSITIVE REGULATION OF PROTEIN KINASE ACTIVITY 282 3.83e-02 -7.17e-02 4.15e-01
REGULATION OF MICROTUBULE CYTOSKELETON ORGANIZATION 161 1.17e-01 -7.16e-02 6.30e-01
CANONICAL WNT SIGNALING PATHWAY INVOLVED IN HEART DEVELOPMENT 6 7.61e-01 7.16e-02 9.61e-01
HYALURONAN METABOLIC PROCESS 34 4.70e-01 -7.15e-02 8.90e-01
BLOOD VESSEL MORPHOGENESIS 704 1.21e-03 -7.15e-02 7.28e-02
REGULATION OF POLYSACCHARIDE BIOSYNTHETIC PROCESS 39 4.40e-01 -7.15e-02 8.77e-01
NEGATIVE REGULATION OF B CELL ACTIVATION 32 4.84e-01 7.14e-02 8.94e-01
RETROGRADE AXONAL TRANSPORT 22 5.62e-01 -7.14e-02 9.20e-01
MODULATION BY HOST OF VIRAL GENOME REPLICATION 26 5.28e-01 7.14e-02 9.10e-01
NEGATIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL PROLIFERATION 11 6.82e-01 7.14e-02 9.50e-01
GLYCOSYLCERAMIDE METABOLIC PROCESS 17 6.10e-01 -7.14e-02 9.31e-01
LONG CHAIN FATTY ACYL COA BIOSYNTHETIC PROCESS 19 5.90e-01 7.13e-02 9.26e-01
ENDOPLASMIC RETICULUM ORGANIZATION 99 2.20e-01 -7.13e-02 7.39e-01
REGULATION OF DEFENSE RESPONSE TO VIRUS 96 2.27e-01 -7.13e-02 7.44e-01
ORGANIC CYCLIC COMPOUND CATABOLIC PROCESS 580 3.32e-03 -7.13e-02 1.31e-01
DECIDUALIZATION 25 5.37e-01 -7.13e-02 9.13e-01
N ACYLETHANOLAMINE METABOLIC PROCESS 5 7.83e-01 -7.13e-02 9.65e-01
NEGATIVE REGULATION OF CELL DIVISION 17 6.11e-01 -7.12e-02 9.31e-01
INTERLEUKIN 6 PRODUCTION 174 1.05e-01 -7.12e-02 6.09e-01
AMINO ACID CATABOLIC PROCESS 112 1.93e-01 -7.12e-02 7.16e-01
DIRECT OSSIFICATION 7 7.44e-01 -7.12e-02 9.59e-01
CELLULAR RESPONSE TO HYDROGEN PEROXIDE 67 3.14e-01 -7.12e-02 8.16e-01
CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION 39 4.42e-01 -7.11e-02 8.78e-01
REGULATION OF INWARD RECTIFIER POTASSIUM CHANNEL ACTIVITY 7 7.45e-01 7.11e-02 9.59e-01
GOLGI ORGANIZATION 142 1.43e-01 -7.11e-02 6.70e-01
REGULATION OF NEUROTRANSMITTER RECEPTOR LOCALIZATION TO POSTSYNAPTIC SPECIALIZATION MEMBRANE 11 6.83e-01 -7.11e-02 9.50e-01
PARASYMPATHETIC NERVOUS SYSTEM DEVELOPMENT 18 6.01e-01 7.11e-02 9.28e-01
L KYNURENINE METABOLIC PROCESS 7 7.45e-01 -7.11e-02 9.59e-01
EXOCRINE PANCREAS DEVELOPMENT 7 7.45e-01 -7.11e-02 9.59e-01
POSITIVE REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY 10 6.97e-01 -7.11e-02 9.52e-01
TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION 191 9.02e-02 -7.11e-02 5.85e-01
REGULATION OF MITOTIC CYTOKINESIS 11 6.84e-01 -7.10e-02 9.50e-01
FOREBRAIN CELL MIGRATION 66 3.19e-01 7.10e-02 8.21e-01
POSITIVE REGULATION OF HEMATOPOIETIC STEM CELL PROLIFERATION 9 7.12e-01 -7.10e-02 9.55e-01
MEMBRANE LIPID METABOLIC PROCESS 210 7.63e-02 -7.09e-02 5.53e-01
LEUKOCYTE HOMEOSTASIS 109 2.01e-01 -7.09e-02 7.27e-01
DISACCHARIDE METABOLIC PROCESS 11 6.84e-01 -7.09e-02 9.50e-01
GLYCEROL TRANSMEMBRANE TRANSPORT 7 7.45e-01 -7.09e-02 9.59e-01
REGULATION OF CELLULAR COMPONENT SIZE 368 1.97e-02 -7.08e-02 3.25e-01
POSITIVE REGULATION OF CENTRIOLE ELONGATION 5 7.84e-01 -7.07e-02 9.65e-01
NEGATIVE REGULATION OF DENDRITIC SPINE MORPHOGENESIS 6 7.64e-01 -7.07e-02 9.61e-01
NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY 99 2.24e-01 -7.07e-02 7.41e-01
MEIOTIC CELL CYCLE PHASE TRANSITION 13 6.59e-01 -7.07e-02 9.43e-01
RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS 35 4.70e-01 7.06e-02 8.90e-01
SMOOTHENED SIGNALING PATHWAY INVOLVED IN DORSAL VENTRAL NEURAL TUBE PATTERNING 13 6.59e-01 7.06e-02 9.43e-01
NEGATIVE REGULATION OF BLOOD PRESSURE 48 3.97e-01 7.06e-02 8.59e-01
SYNAPTIC VESICLE COATING 5 7.85e-01 7.06e-02 9.65e-01
RESPONSE TO L ASCORBIC ACID 6 7.65e-01 7.06e-02 9.61e-01
POSITIVE REGULATION OF INSULIN SECRETION 84 2.64e-01 -7.06e-02 7.74e-01
REGULATION OF CELLULAR RESPIRATION 48 3.98e-01 -7.05e-02 8.60e-01
CONVERGENT EXTENSION INVOLVED IN GASTRULATION 9 7.14e-01 -7.05e-02 9.55e-01
MIRNA METABOLIC PROCESS 104 2.14e-01 -7.05e-02 7.33e-01
REGULATION OF ENTRY OF BACTERIUM INTO HOST CELL 7 7.47e-01 -7.05e-02 9.59e-01
CARDIAC SEPTUM DEVELOPMENT 108 2.06e-01 7.05e-02 7.29e-01
REGULATION OF ACUTE INFLAMMATORY RESPONSE 48 3.98e-01 7.05e-02 8.60e-01
TISSUE MORPHOGENESIS 634 2.48e-03 -7.04e-02 1.12e-01
PEPTIDYL LYSINE MODIFICATION 213 7.69e-02 -7.03e-02 5.53e-01
T CELL HOMEOSTASIS 47 4.04e-01 -7.03e-02 8.63e-01
REGULATION OF MITOCHONDRIAL FUSION 12 6.73e-01 -7.03e-02 9.47e-01
CELLULAR RESPONSE TO EPINEPHRINE STIMULUS 11 6.87e-01 -7.02e-02 9.50e-01
POSITIVE REGULATION OF HEART RATE BY EPINEPHRINE NOREPINEPHRINE 5 7.86e-01 7.02e-02 9.65e-01
LIPOSACCHARIDE METABOLIC PROCESS 108 2.07e-01 -7.02e-02 7.29e-01
REGULATION OF MIRNA CATABOLIC PROCESS 10 7.01e-01 7.01e-02 9.52e-01
PROTEIN IMPORT INTO PEROXISOME MATRIX RECEPTOR RECYCLING 7 7.48e-01 7.01e-02 9.59e-01
MUSCLE CELL MIGRATION 108 2.08e-01 -7.01e-02 7.29e-01
NATURAL KILLER CELL DEGRANULATION 10 7.01e-01 -7.00e-02 9.52e-01
AXONAL FASCICULATION 21 5.79e-01 7.00e-02 9.24e-01
ANATOMICAL STRUCTURE FORMATION INVOLVED IN MORPHOGENESIS 1249 3.10e-05 -7.00e-02 5.37e-03
INNER EAR RECEPTOR CELL DEVELOPMENT 46 4.12e-01 7.00e-02 8.65e-01
NEGATIVE REGULATION OF MEGAKARYOCYTE DIFFERENTIATION 17 6.18e-01 -6.99e-02 9.32e-01
CALCIUM ION EXPORT ACROSS PLASMA MEMBRANE 10 7.02e-01 -6.99e-02 9.52e-01
3 PHOSPHOADENOSINE 5 PHOSPHOSULFATE METABOLIC PROCESS 14 6.51e-01 -6.99e-02 9.41e-01
POSITIVE REGULATION OF PROTEIN AUTOPHOSPHORYLATION 26 5.38e-01 6.98e-02 9.13e-01
MITOCHONDRION ENDOPLASMIC RETICULUM MEMBRANE TETHERING 7 7.49e-01 -6.98e-02 9.59e-01
FATTY ACID CATABOLIC PROCESS 106 2.15e-01 -6.97e-02 7.33e-01
MACROMOLECULE METHYLATION 204 8.61e-02 -6.97e-02 5.77e-01
ACINAR CELL DIFFERENTIATION 5 7.87e-01 6.96e-02 9.65e-01
ORGANIC ACID TRANSPORT 352 2.49e-02 -6.96e-02 3.65e-01
REGULATION OF HOMOTYPIC CELL CELL ADHESION 34 4.83e-01 -6.96e-02 8.94e-01
RESPONSE TO FIBROBLAST GROWTH FACTOR 122 1.85e-01 -6.95e-02 7.07e-01
FLAVONE METABOLIC PROCESS 6 7.68e-01 -6.95e-02 9.63e-01
REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION 104 2.21e-01 -6.95e-02 7.40e-01
NEURAL PLATE PATTERN SPECIFICATION 8 7.34e-01 -6.95e-02 9.58e-01
CELLULAR RESPONSE TO CALCIUM ION 84 2.71e-01 6.94e-02 7.79e-01
GAMMA AMINOBUTYRIC ACID IMPORT 6 7.68e-01 -6.94e-02 9.63e-01
SOMITE DEVELOPMENT 84 2.72e-01 6.94e-02 7.79e-01
MRNA POLYADENYLATION 24 5.57e-01 6.93e-02 9.18e-01
RESPONSE TO GONADOTROPIN 28 5.25e-01 -6.93e-02 9.10e-01
POSITIVE REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY 21 5.83e-01 6.93e-02 9.24e-01
REGULATION OF MACROAUTOPHAGY 159 1.32e-01 -6.93e-02 6.55e-01
CELL PROJECTION ASSEMBLY 616 3.32e-03 -6.92e-02 1.31e-01
NEURAL PLATE DEVELOPMENT 9 7.19e-01 6.92e-02 9.55e-01
NEGATIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT 50 3.97e-01 -6.92e-02 8.59e-01
POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION 37 4.66e-01 -6.92e-02 8.90e-01
POSITIVE REGULATION OF CELL CYCLE G2 M PHASE TRANSITION 32 4.98e-01 6.92e-02 8.99e-01
PROTEIN RNA COMPLEX DISASSEMBLY 8 7.35e-01 -6.91e-02 9.58e-01
REGULATION OF AXONOGENESIS 157 1.35e-01 -6.91e-02 6.59e-01
REGULATION OF PIGMENTATION 17 6.22e-01 -6.91e-02 9.32e-01
POSITIVE REGULATION OF ENDOTHELIAL CELL MIGRATION 130 1.74e-01 -6.91e-02 6.90e-01
TOLL LIKE RECEPTOR SIGNALING PATHWAY 72 3.12e-01 -6.89e-02 8.14e-01
CARBOHYDRATE TRANSMEMBRANE TRANSPORT 134 1.68e-01 -6.89e-02 6.87e-01
RIBOSOMAL SMALL SUBUNIT EXPORT FROM NUCLEUS 8 7.36e-01 6.89e-02 9.58e-01
GRANULOCYTE DIFFERENTIATION 42 4.40e-01 6.89e-02 8.77e-01
POSITIVE REGULATION OF ANIMAL ORGAN MORPHOGENESIS 35 4.81e-01 6.89e-02 8.94e-01
REGULATION OF MORPHOGENESIS OF A BRANCHING STRUCTURE 52 3.90e-01 6.89e-02 8.56e-01
DETECTION OF ABIOTIC STIMULUS 137 1.64e-01 -6.88e-02 6.83e-01
POSITIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION 77 2.97e-01 -6.88e-02 8.04e-01
CAMKK AMPK SIGNALING CASCADE 9 7.21e-01 6.88e-02 9.56e-01
5S CLASS RRNA TRANSCRIPTION BY RNA POLYMERASE III 6 7.71e-01 6.88e-02 9.63e-01
PROTEIN LOCALIZATION TO POSTSYNAPSE 45 4.25e-01 6.87e-02 8.73e-01
B CELL MEDIATED IMMUNITY 134 1.70e-01 -6.87e-02 6.87e-01
METANEPHRIC NEPHRON MORPHOGENESIS 24 5.61e-01 -6.86e-02 9.20e-01
ORGANOPHOSPHATE METABOLIC PROCESS 948 3.41e-04 -6.86e-02 3.13e-02
STRIATED MUSCLE CONTRACTION 183 1.10e-01 -6.86e-02 6.17e-01
T HELPER 17 TYPE IMMUNE RESPONSE 47 4.16e-01 -6.85e-02 8.67e-01
LIPID METABOLIC PROCESS 1388 1.88e-05 -6.84e-02 3.58e-03
NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR 23 5.70e-01 6.84e-02 9.23e-01
RRNA 3 END PROCESSING 10 7.08e-01 -6.83e-02 9.53e-01
DOUBLE STRAND BREAK REPAIR VIA SYNTHESIS DEPENDENT STRAND ANNEALING 8 7.38e-01 6.83e-02 9.58e-01
POSITIVE REGULATION OF SEQUESTERING OF CALCIUM ION 16 6.36e-01 6.83e-02 9.38e-01
REGULATION OF TOLL LIKE RECEPTOR 2 SIGNALING PATHWAY 12 6.82e-01 6.82e-02 9.50e-01
POSITIVE REGULATION OF GONAD DEVELOPMENT 8 7.38e-01 6.82e-02 9.58e-01
4FE 4S CLUSTER ASSEMBLY 5 7.92e-01 -6.82e-02 9.67e-01
CELL MIGRATION IN HINDBRAIN 17 6.26e-01 6.82e-02 9.34e-01
LIPID OXIDATION 114 2.09e-01 -6.82e-02 7.29e-01
APOPTOTIC CELL CLEARANCE 47 4.19e-01 -6.82e-02 8.69e-01
MYELIN MAINTENANCE 18 6.17e-01 -6.82e-02 9.32e-01
RESPONSE TO GONADOTROPIN RELEASING HORMONE 8 7.39e-01 -6.81e-02 9.58e-01
NEGATIVE REGULATION OF MACROPHAGE ACTIVATION 18 6.17e-01 -6.81e-02 9.32e-01
RENAL SYSTEM PROCESS INVOLVED IN REGULATION OF BLOOD VOLUME 13 6.71e-01 6.81e-02 9.46e-01
REGULATION OF CIRCADIAN RHYTHM 114 2.09e-01 -6.81e-02 7.30e-01
CENTROSOME SEPARATION 15 6.48e-01 -6.80e-02 9.41e-01
NEGATIVE REGULATION OF MIRNA PROCESSING 10 7.10e-01 6.80e-02 9.53e-01
G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY COUPLED TO CYCLIC NUCLEOTIDE SECOND MESSENGER 56 3.79e-01 6.79e-02 8.51e-01
REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY 79 2.97e-01 -6.79e-02 8.04e-01
L GLUTAMATE TRANSMEMBRANE TRANSPORT 29 5.27e-01 -6.79e-02 9.10e-01
REGULATION OF EARLY ENDOSOME TO LATE ENDOSOME TRANSPORT 19 6.09e-01 -6.78e-02 9.31e-01
POSITIVE REGULATION OF TELOMERE MAINTENANCE 68 3.34e-01 6.78e-02 8.31e-01
POSITIVE REGULATION OF SODIUM ION TRANSPORT 32 5.07e-01 6.78e-02 9.03e-01
SPERMINE METABOLIC PROCESS 5 7.93e-01 -6.77e-02 9.67e-01
NUCLEIC ACID PHOSPHODIESTER BOND HYDROLYSIS 24 5.66e-01 6.77e-02 9.21e-01
NEGATIVE REGULATION OF NUCLEASE ACTIVITY 7 7.57e-01 -6.77e-02 9.61e-01
PURINE NUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS 21 5.92e-01 6.76e-02 9.26e-01
POSITIVE REGULATION OF INTERLEUKIN 10 PRODUCTION 42 4.48e-01 -6.76e-02 8.80e-01
ATTACHMENT OF GPI ANCHOR TO PROTEIN 6 7.74e-01 -6.76e-02 9.63e-01
POSITIVE REGULATION OF CHROMOSOME ORGANIZATION 106 2.29e-01 6.76e-02 7.46e-01
PIGMENT BIOSYNTHETIC PROCESS 57 3.78e-01 -6.76e-02 8.51e-01
POSITIVE REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY 7 7.57e-01 -6.76e-02 9.61e-01
FEAR RESPONSE 46 4.28e-01 6.76e-02 8.74e-01
AMINO ACID TRANSMEMBRANE TRANSPORT 100 2.43e-01 -6.75e-02 7.63e-01
CILIARY BASAL BODY ORGANIZATION 5 7.94e-01 6.75e-02 9.67e-01
AXON ENSHEATHMENT IN CENTRAL NERVOUS SYSTEM 27 5.44e-01 -6.75e-02 9.13e-01
REGULATION OF DEVELOPMENT HETEROCHRONIC 12 6.86e-01 6.74e-02 9.50e-01
PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR SIGNALING PATHWAY 24 5.68e-01 6.74e-02 9.21e-01
REGULATION OF MESONEPHROS DEVELOPMENT 5 7.94e-01 6.73e-02 9.67e-01
NEGATIVE REGULATION OF NEUROBLAST PROLIFERATION 11 6.99e-01 6.73e-02 9.52e-01
GLYCOSAMINOGLYCAN CATABOLIC PROCESS 28 5.38e-01 -6.73e-02 9.13e-01
CONNECTIVE TISSUE DEVELOPMENT 283 5.13e-02 -6.73e-02 4.71e-01
MORPHOGENESIS OF AN EPITHELIUM 519 8.67e-03 -6.73e-02 2.20e-01
REGULATION OF DNA TEMPLATED DNA REPLICATION INITIATION 15 6.52e-01 -6.73e-02 9.41e-01
T HELPER 2 CELL DIFFERENTIATION 19 6.12e-01 -6.73e-02 9.31e-01
RESPONSE TO VITAMIN A 15 6.52e-01 -6.72e-02 9.41e-01
GANGLIOSIDE METABOLIC PROCESS 28 5.38e-01 -6.72e-02 9.13e-01
POSITIVE REGULATION OF ALPHA BETA T CELL PROLIFERATION 25 5.61e-01 -6.72e-02 9.20e-01
COPPER ION TRANSPORT 18 6.22e-01 -6.72e-02 9.32e-01
NEGATIVE REGULATION OF ORGANELLE ORGANIZATION 356 2.95e-02 -6.71e-02 3.80e-01
LABYRINTHINE LAYER DEVELOPMENT 46 4.31e-01 -6.71e-02 8.74e-01
REGULATION OF ANATOMICAL STRUCTURE MORPHOGENESIS 932 5.13e-04 -6.71e-02 3.95e-02
GLUCURONATE CATABOLIC PROCESS TO XYLULOSE 5 PHOSPHATE 5 7.95e-01 -6.71e-02 9.67e-01
CARDIAC LEFT VENTRICLE MORPHOGENESIS 16 6.42e-01 6.71e-02 9.40e-01
REGULATION OF LEUKOCYTE MEDIATED CYTOTOXICITY 94 2.61e-01 6.70e-02 7.72e-01
VESICLE MEDIATED TRANSPORT 1519 1.23e-05 -6.70e-02 2.60e-03
NEGATIVE REGULATION OF TRANSLATIONAL ELONGATION 5 7.95e-01 -6.70e-02 9.67e-01
RESPONSE TO THYROXINE 5 7.95e-01 -6.70e-02 9.67e-01
REGULATION OF RECEPTOR LOCALIZATION TO SYNAPSE 21 5.95e-01 -6.70e-02 9.27e-01
UTERUS MORPHOGENESIS 6 7.76e-01 6.70e-02 9.64e-01
IMPORT INTO CELL 930 5.32e-04 -6.69e-02 3.95e-02
REELIN MEDIATED SIGNALING PATHWAY 7 7.59e-01 -6.69e-02 9.61e-01
INTRACELLULAR RECEPTOR SIGNALING PATHWAY 353 3.06e-02 -6.69e-02 3.85e-01
XENOBIOTIC METABOLIC PROCESS 120 2.06e-01 6.69e-02 7.29e-01
HEMATOPOIETIC STEM CELL HOMEOSTASIS 23 5.79e-01 -6.69e-02 9.24e-01
REGULATION OF GROWTH RATE 5 7.96e-01 -6.68e-02 9.67e-01
VENOUS BLOOD VESSEL DEVELOPMENT 16 6.43e-01 -6.68e-02 9.41e-01
CELL FATE COMMITMENT INVOLVED IN FORMATION OF PRIMARY GERM LAYER 32 5.13e-01 6.68e-02 9.07e-01
INTERLEUKIN 33 MEDIATED SIGNALING PATHWAY 8 7.44e-01 6.68e-02 9.59e-01
ALCOHOL BIOSYNTHETIC PROCESS 144 1.67e-01 -6.68e-02 6.85e-01
MECHANORECEPTOR DIFFERENTIATION 68 3.41e-01 6.68e-02 8.35e-01
FERTILIZATION 200 1.04e-01 6.67e-02 6.07e-01
TYPE B PANCREATIC CELL APOPTOTIC PROCESS 10 7.15e-01 -6.67e-02 9.55e-01
MONOCARBOXYLIC ACID METABOLIC PROCESS 627 4.34e-03 -6.67e-02 1.55e-01
REGULATION OF CILIUM MOVEMENT 40 4.66e-01 6.67e-02 8.90e-01
REGULATION OF CELL DIVISION 182 1.21e-01 -6.65e-02 6.37e-01
CELLULAR LIPID METABOLIC PROCESS 999 3.70e-04 -6.65e-02 3.32e-02
PLASMA MEMBRANE FUSION 32 5.15e-01 -6.65e-02 9.07e-01
DOPAMINE BIOSYNTHETIC PROCESS 12 6.90e-01 6.64e-02 9.50e-01
GLYCOSPHINGOLIPID BIOSYNTHETIC PROCESS 34 5.03e-01 -6.64e-02 9.02e-01
CELLULAR KETONE METABOLIC PROCESS 226 8.57e-02 -6.63e-02 5.77e-01
BINDING OF SPERM TO ZONA PELLUCIDA 38 4.79e-01 6.63e-02 8.94e-01
PROTEIN LOCALIZATION TO CENP A CONTAINING CHROMATIN 15 6.57e-01 6.63e-02 9.42e-01
CELLULAR MODIFIED AMINO ACID BIOSYNTHETIC PROCESS 26 5.58e-01 -6.63e-02 9.19e-01
CENTRAL NERVOUS SYSTEM MATURATION 7 7.61e-01 -6.63e-02 9.61e-01
REGULATION OF NEUROMUSCULAR JUNCTION DEVELOPMENT 8 7.45e-01 6.63e-02 9.59e-01
PROTEIN LOCALIZATION TO SYNAPSE 78 3.12e-01 6.63e-02 8.14e-01
POSITIVE REGULATION OF T CELL MEDIATED IMMUNE RESPONSE TO TUMOR CELL 5 7.98e-01 -6.62e-02 9.67e-01
SPERM AXONEME ASSEMBLY 28 5.44e-01 6.62e-02 9.13e-01
ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION 44 4.47e-01 6.62e-02 8.79e-01
NEGATIVE REGULATION OF FATTY ACID BETA OXIDATION 6 7.79e-01 -6.62e-02 9.64e-01
REGULATION OF TRANSMISSION OF NERVE IMPULSE 16 6.47e-01 6.62e-02 9.41e-01
POSITIVE REGULATION OF STRIATED MUSCLE CELL APOPTOTIC PROCESS 19 6.17e-01 -6.62e-02 9.32e-01
RETINAL ROD CELL DEVELOPMENT 8 7.46e-01 6.62e-02 9.59e-01
CHONDROCYTE PROLIFERATION 24 5.75e-01 -6.62e-02 9.24e-01
BLASTOCYST FORMATION 45 4.42e-01 -6.62e-02 8.78e-01
HEART VALVE DEVELOPMENT 72 3.32e-01 -6.62e-02 8.31e-01
REGULATION OF PHOSPHOLIPASE C ACTIVITY 40 4.69e-01 6.61e-02 8.90e-01
REGULATION OF B CELL MEDIATED IMMUNITY 62 3.68e-01 -6.61e-02 8.48e-01
REGULATION OF NUCLEASE ACTIVITY 22 5.92e-01 -6.61e-02 9.26e-01
PURINE DEOXYRIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS 10 7.18e-01 -6.60e-02 9.55e-01
NEGATIVE REGULATION OF CREB TRANSCRIPTION FACTOR ACTIVITY 5 7.98e-01 6.60e-02 9.67e-01
REGULATION OF MICROTUBULE BASED MOVEMENT 55 3.97e-01 6.60e-02 8.59e-01
POSITIVE REGULATION OF MACROPHAGE MIGRATION 26 5.60e-01 -6.60e-02 9.20e-01
REGULATION OF SEQUESTERING OF TRIGLYCERIDE 15 6.58e-01 -6.60e-02 9.43e-01
VITAMIN BIOSYNTHETIC PROCESS 25 5.68e-01 6.59e-02 9.22e-01
POSITIVE REGULATION OF TRANSCRIPTION OF NUCLEOLAR LARGE RRNA BY RNA POLYMERASE I 10 7.18e-01 -6.59e-02 9.55e-01
MUSCLE HYPERTROPHY 104 2.46e-01 -6.59e-02 7.64e-01
REGULATION OF ADHERENS JUNCTION ORGANIZATION 5 7.99e-01 -6.58e-02 9.67e-01
NEGATIVE REGULATION OF NITRIC OXIDE SYNTHASE ACTIVITY 9 7.32e-01 6.58e-02 9.58e-01
RNA 3 END PROCESSING 95 2.68e-01 6.57e-02 7.77e-01
ALLANTOIN METABOLIC PROCESS 9 7.33e-01 -6.57e-02 9.58e-01
MYOBLAST FUSION 47 4.36e-01 -6.56e-02 8.74e-01
CERAMIDE BIOSYNTHETIC PROCESS 68 3.49e-01 -6.56e-02 8.40e-01
IN UTERO EMBRYONIC DEVELOPMENT 392 2.57e-02 -6.56e-02 3.65e-01
PORE COMPLEX ASSEMBLY 20 6.12e-01 6.56e-02 9.31e-01
CARDIAC MYOFIBRIL ASSEMBLY 19 6.21e-01 6.56e-02 9.32e-01
RESPONSE TO INCREASED OXYGEN LEVELS 26 5.63e-01 -6.55e-02 9.21e-01
GOLGI VESICLE TRANSPORT 292 5.40e-02 -6.55e-02 4.81e-01
DNA INTEGRATION 8 7.48e-01 -6.55e-02 9.59e-01
DENDRITIC SPINE MORPHOGENESIS 56 3.97e-01 6.55e-02 8.59e-01
NEGATIVE REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS 127 2.03e-01 -6.55e-02 7.29e-01
RESCUE OF STALLED RIBOSOME 29 5.42e-01 -6.54e-02 9.13e-01
REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS 56 3.97e-01 -6.54e-02 8.59e-01
NEGATIVE REGULATION OF RESPONSE TO WOUNDING 96 2.68e-01 -6.54e-02 7.77e-01
SYNAPTIC VESICLE MATURATION 27 5.56e-01 6.54e-02 9.18e-01
REGULATION OF CARDIAC MUSCLE CELL DIFFERENTIATION 22 5.95e-01 6.54e-02 9.27e-01
NEGATIVE REGULATION OF CANONICAL NF KAPPAB SIGNAL TRANSDUCTION 53 4.10e-01 -6.54e-02 8.64e-01
TRANSEPITHELIAL TRANSPORT 35 5.03e-01 -6.54e-02 9.02e-01
REGULATION OF HEMATOPOIETIC STEM CELL PROLIFERATION 17 6.41e-01 6.54e-02 9.39e-01
TYPE B PANCREATIC CELL DEVELOPMENT 24 5.79e-01 6.54e-02 9.24e-01
REGULATION OF CARBOHYDRATE BIOSYNTHETIC PROCESS 104 2.49e-01 -6.54e-02 7.65e-01
SMALL MOLECULE METABOLIC PROCESS 1837 3.23e-06 -6.54e-02 9.46e-04
S ADENOSYLMETHIONINE CYCLE 7 7.65e-01 -6.54e-02 9.61e-01
LATERAL MESODERM DEVELOPMENT 15 6.62e-01 6.53e-02 9.44e-01
MONOCARBOXYLIC ACID CATABOLIC PROCESS 131 1.97e-01 -6.53e-02 7.21e-01
POSITIVE REGULATION OF 3 UTR MEDIATED MRNA STABILIZATION 5 8.00e-01 -6.53e-02 9.68e-01
REGULATION OF CYCLIC NUCLEOTIDE PHOSPHODIESTERASE ACTIVITY 8 7.49e-01 -6.52e-02 9.59e-01
INTRACELLULAR POTASSIUM ION HOMEOSTASIS 15 6.62e-01 6.52e-02 9.44e-01
NEGATIVE REGULATION OF WNT SIGNALING PATHWAY 172 1.40e-01 -6.52e-02 6.68e-01
NEGATIVE REGULATION OF MRNA PROCESSING 24 5.81e-01 -6.51e-02 9.24e-01
NEGATIVE REGULATION OF HYDROLASE ACTIVITY 213 1.02e-01 6.51e-02 6.04e-01
NUCLEOSIDE TRANSMEMBRANE TRANSPORT 8 7.50e-01 -6.50e-02 9.59e-01
SUPPRESSION OF VIRAL RELEASE BY HOST 16 6.53e-01 -6.50e-02 9.41e-01
NOTOCHORD MORPHOGENESIS 8 7.50e-01 -6.49e-02 9.59e-01
POSITIVE REGULATION OF MUSCLE ADAPTATION 13 6.85e-01 -6.49e-02 9.50e-01
NEGATIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING 25 5.74e-01 -6.49e-02 9.24e-01
REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY 45 4.51e-01 -6.49e-02 8.81e-01
REGULATION OF MYOBLAST PROLIFERATION 25 5.74e-01 6.49e-02 9.24e-01
MESONEPHRIC DUCT DEVELOPMENT 9 7.36e-01 -6.49e-02 9.58e-01
ENZYME LINKED RECEPTOR PROTEIN SIGNALING PATHWAY 1010 4.84e-04 -6.48e-02 3.91e-02
RESPONSE TO CAMP 85 3.02e-01 -6.48e-02 8.07e-01
EMBRYONIC PLACENTA MORPHOGENESIS 27 5.60e-01 -6.47e-02 9.20e-01
POSITIVE REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS 26 5.68e-01 -6.47e-02 9.21e-01
HEPATIC STELLATE CELL ACTIVATION 9 7.37e-01 -6.47e-02 9.58e-01
OLEFINIC COMPOUND METABOLIC PROCESS 162 1.55e-01 6.47e-02 6.79e-01
POSITIVE REGULATION OF INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY 13 6.87e-01 -6.46e-02 9.50e-01
REGULATION OF PROTEIN AUTOPHOSPHORYLATION 41 4.74e-01 6.46e-02 8.91e-01
GLOMERULAR EPITHELIAL CELL DIFFERENTIATION 22 6.00e-01 6.46e-02 9.28e-01
MEMBRANE LIPID CATABOLIC PROCESS 39 4.85e-01 -6.46e-02 8.94e-01
REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT 26 5.69e-01 6.46e-02 9.22e-01
MITOCHONDRIAL CALCIUM ION TRANSMEMBRANE TRANSPORT 18 6.35e-01 -6.46e-02 9.38e-01
TRNA PROCESSING 132 2.00e-01 6.45e-02 7.26e-01
REGULATION OF STEROID METABOLIC PROCESS 104 2.55e-01 -6.45e-02 7.70e-01
SYNAPSE ASSEMBLY 200 1.16e-01 6.44e-02 6.30e-01
CELLULAR RESPONSE TO ALKALOID 36 5.04e-01 -6.44e-02 9.02e-01
ALANINE TRANSPORT 18 6.36e-01 6.44e-02 9.38e-01
PHAGOCYTOSIS 233 9.04e-02 -6.44e-02 5.85e-01
POSITIVE REGULATION OF OSTEOBLAST PROLIFERATION 13 6.88e-01 6.43e-02 9.50e-01
NEUTROPHIL MIGRATION 125 2.15e-01 6.43e-02 7.33e-01
LAYER FORMATION IN CEREBRAL CORTEX 14 6.77e-01 -6.42e-02 9.48e-01
LEUKOTRIENE METABOLIC PROCESS 30 5.43e-01 -6.42e-02 9.13e-01
SODIUM ION IMPORT ACROSS PLASMA MEMBRANE 26 5.71e-01 -6.42e-02 9.23e-01
CELL CELL RECOGNITION 73 3.43e-01 -6.42e-02 8.36e-01
REGULATION OF PROTEIN SECRETION 265 7.21e-02 -6.42e-02 5.42e-01
GLYCOSIDE TRANSPORT 5 8.04e-01 -6.41e-02 9.68e-01
MESONEPHRIC TUBULE MORPHOGENESIS 68 3.60e-01 6.41e-02 8.46e-01
PUTRESCINE BIOSYNTHETIC PROCESS 5 8.04e-01 -6.41e-02 9.68e-01
NEGATIVE REGULATION OF CELL CELL ADHESION MEDIATED BY CADHERIN 10 7.26e-01 6.41e-02 9.57e-01
TRANSLESION SYNTHESIS 25 5.79e-01 6.40e-02 9.24e-01
SYNAPSE MATURATION 34 5.19e-01 6.40e-02 9.09e-01
REGULATION OF CELL PROLIFERATION INVOLVED IN KIDNEY DEVELOPMENT 16 6.58e-01 -6.39e-02 9.43e-01
POSITIVE REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY 27 5.65e-01 -6.39e-02 9.21e-01
REGULATION OF MODIFICATION OF SYNAPTIC STRUCTURE 13 6.90e-01 6.39e-02 9.50e-01
POSITIVE REGULATION OF NUCLEAR CELL CYCLE DNA REPLICATION 6 7.87e-01 6.38e-02 9.65e-01
MITOTIC SPINDLE ASSEMBLY 72 3.49e-01 -6.38e-02 8.40e-01
APPENDAGE MORPHOGENESIS 145 1.85e-01 6.37e-02 7.07e-01
POSITIVE REGULATION OF CATECHOLAMINE SECRETION 12 7.02e-01 6.37e-02 9.52e-01
PROTEIN DNA COVALENT CROSS LINKING REPAIR 7 7.70e-01 6.37e-02 9.63e-01
IRON ION TRANSPORT 58 4.01e-01 -6.37e-02 8.63e-01
STRESS GRANULE DISASSEMBLY 5 8.05e-01 6.37e-02 9.68e-01
REGULATION OF T CELL MEDIATED IMMUNE RESPONSE TO TUMOR CELL 8 7.55e-01 -6.37e-02 9.60e-01
REGULATION OF PROTEIN K63 LINKED UBIQUITINATION 14 6.80e-01 -6.37e-02 9.50e-01
REGULATION OF PROTEIN KINASE C SIGNALING 18 6.40e-01 6.36e-02 9.39e-01
ERYTHROCYTE DEVELOPMENT 40 4.86e-01 6.36e-02 8.94e-01
VESTIBULOCOCHLEAR NERVE DEVELOPMENT 11 7.15e-01 -6.36e-02 9.55e-01
MODIFICATION OF POSTSYNAPTIC STRUCTURE 21 6.14e-01 6.36e-02 9.32e-01
HEART FORMATION 33 5.28e-01 6.35e-02 9.10e-01
DEVELOPMENTAL GROWTH INVOLVED IN MORPHOGENESIS 243 8.82e-02 -6.35e-02 5.81e-01
NEGATIVE REGULATION OF ATP DEPENDENT ACTIVITY 17 6.50e-01 -6.35e-02 9.41e-01
PEPTIDYL L CYSTEINE S PALMITOYLATION 22 6.06e-01 -6.35e-02 9.29e-01
CARNITINE METABOLIC PROCESS 12 7.04e-01 -6.34e-02 9.52e-01
REGULATION OF AEROBIC RESPIRATION 32 5.35e-01 -6.34e-02 9.12e-01
POSITIVE REGULATION OF PHOSPHOLIPASE ACTIVITY 49 4.43e-01 6.34e-02 8.78e-01
RESPONSE TO LIGHT STIMULUS 313 5.36e-02 -6.34e-02 4.79e-01
NEGATIVE REGULATION OF CHOLESTEROL METABOLIC PROCESS 11 7.16e-01 -6.34e-02 9.55e-01
PROTEIN LOCALIZATION TO SITE OF DOUBLE STRAND BREAK 6 7.88e-01 6.34e-02 9.65e-01
GLIAL CELL DIFFERENTIATION 252 8.31e-02 -6.34e-02 5.70e-01
MYOTUBE CELL DEVELOPMENT 41 4.83e-01 -6.33e-02 8.94e-01
VENTRICULAR SEPTUM DEVELOPMENT 74 3.46e-01 6.33e-02 8.37e-01
MELANOCYTE DIFFERENTIATION 25 5.84e-01 6.33e-02 9.24e-01
DICHOTOMOUS SUBDIVISION OF AN EPITHELIAL TERMINAL UNIT 8 7.57e-01 -6.33e-02 9.61e-01
ANIMAL ORGAN REGENERATION 63 3.85e-01 -6.33e-02 8.55e-01
T CELL DIFFERENTIATION INVOLVED IN IMMUNE RESPONSE 84 3.16e-01 -6.32e-02 8.19e-01
CIRCULATORY SYSTEM DEVELOPMENT 1210 2.11e-04 -6.32e-02 2.15e-02
ADENYLATE CYCLASE ACTIVATING ADRENERGIC RECEPTOR SIGNALING PATHWAY 27 5.70e-01 6.31e-02 9.22e-01
CAP DEPENDENT TRANSLATIONAL INITIATION 7 7.72e-01 6.31e-02 9.63e-01
SPECIFICATION OF ANIMAL ORGAN IDENTITY 36 5.12e-01 6.31e-02 9.07e-01
MUSCLE CELL PROLIFERATION 242 9.06e-02 -6.31e-02 5.85e-01
REGULATION OF VASOCONSTRICTION 64 3.82e-01 -6.31e-02 8.53e-01
RETINA HOMEOSTASIS 76 3.41e-01 6.31e-02 8.35e-01
MAINTENANCE OF DNA REPEAT ELEMENTS 7 7.73e-01 6.31e-02 9.63e-01
SINGLE STRAND BREAK REPAIR 11 7.17e-01 -6.31e-02 9.55e-01
CHROMATIN REMODELING 610 7.77e-03 -6.31e-02 2.04e-01
RESPONSE TO OXYGEN LEVELS 339 4.61e-02 -6.30e-02 4.48e-01
REGULATION OF OSTEOCLAST DEVELOPMENT 11 7.18e-01 6.29e-02 9.55e-01
BRANCHED CHAIN AMINO ACID METABOLIC PROCESS 27 5.72e-01 -6.29e-02 9.24e-01
POSITIVE REGULATION OF NEUROGENESIS 242 9.19e-02 -6.29e-02 5.88e-01
OVARIAN FOLLICLE DEVELOPMENT 56 4.16e-01 -6.29e-02 8.67e-01
MAST CELL CYTOKINE PRODUCTION 6 7.90e-01 -6.28e-02 9.66e-01
ESTABLISHMENT OF PROTEIN LOCALIZATION TO VACUOLE 65 3.81e-01 -6.28e-02 8.52e-01
POTASSIUM ION TRANSPORT 241 9.29e-02 6.28e-02 5.89e-01
POSITIVE REGULATION OF PROTEOLYSIS 351 4.33e-02 -6.28e-02 4.36e-01
CELLULAR RESPONSE TO PEPTIDE HORMONE STIMULUS 309 5.78e-02 -6.27e-02 4.96e-01
CAMP CATABOLIC PROCESS 9 7.45e-01 6.27e-02 9.59e-01
EMBRYONIC PATTERN SPECIFICATION 73 3.54e-01 6.27e-02 8.43e-01
L SERINE METABOLIC PROCESS 12 7.07e-01 6.27e-02 9.53e-01
POSITIVE REGULATION OF ACROSOME REACTION 11 7.19e-01 6.27e-02 9.55e-01
MICROTUBULE ORGANIZING CENTER ORGANIZATION 155 1.78e-01 -6.27e-02 6.98e-01
DEMETHYLATION 54 4.26e-01 6.27e-02 8.73e-01
POSITIVE REGULATION OF PROTEIN CATABOLIC PROCESS 210 1.18e-01 -6.26e-02 6.30e-01
RESPONSE TO ATP 33 5.33e-01 6.26e-02 9.11e-01
GLANDULAR EPITHELIAL CELL MATURATION 9 7.45e-01 6.26e-02 9.59e-01
IP 10 PRODUCTION 5 8.09e-01 -6.25e-02 9.69e-01
MONOUBIQUITINATED PROTEIN DEUBIQUITINATION 8 7.59e-01 6.25e-02 9.61e-01
STEROID HORMONE MEDIATED SIGNALING PATHWAY 137 2.06e-01 -6.25e-02 7.29e-01
CEREBELLAR CORTEX DEVELOPMENT 51 4.40e-01 6.25e-02 8.77e-01
GLUCOSE IMPORT 77 3.43e-01 -6.25e-02 8.36e-01
ANDROGEN CATABOLIC PROCESS 5 8.09e-01 6.25e-02 9.69e-01
ESTABLISHMENT OF PROTEIN LOCALIZATION TO TELOMERE 18 6.46e-01 6.24e-02 9.41e-01
NEGATIVE REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION 19 6.38e-01 -6.24e-02 9.38e-01
SKELETAL SYSTEM DEVELOPMENT 525 1.44e-02 -6.24e-02 2.82e-01
REGULATION OF MEIOTIC NUCLEAR DIVISION 33 5.35e-01 6.24e-02 9.12e-01
REGULATION OF MICROTUBULE DEPOLYMERIZATION 30 5.54e-01 -6.23e-02 9.18e-01
ANAPHASE PROMOTING COMPLEX DEPENDENT CATABOLIC PROCESS 24 5.97e-01 6.23e-02 9.27e-01
INTRACELLULAR PHOSPHATE ION HOMEOSTASIS 10 7.33e-01 -6.23e-02 9.58e-01
RRNA BASE METHYLATION 9 7.46e-01 -6.23e-02 9.59e-01
POSITIVE REGULATION OF AMINE METABOLIC PROCESS 8 7.60e-01 6.23e-02 9.61e-01
TOLL LIKE RECEPTOR 7 SIGNALING PATHWAY 12 7.09e-01 6.23e-02 9.53e-01
MAINTENANCE OF LOCATION 346 4.66e-02 -6.22e-02 4.52e-01
LYMPHATIC ENDOTHELIAL CELL DIFFERENTIATION 8 7.61e-01 6.22e-02 9.61e-01
CELLULAR RESPONSE TO PEPTIDE 375 3.85e-02 -6.22e-02 4.16e-01
MACROPHAGE CHEMOTAXIS 41 4.91e-01 -6.22e-02 8.95e-01
SENSORY PERCEPTION OF PAIN 77 3.46e-01 6.21e-02 8.37e-01
DIOL METABOLIC PROCESS 30 5.56e-01 -6.21e-02 9.18e-01
CYTOPLASMIC TRANSLATION 151 1.88e-01 6.21e-02 7.09e-01
NEGATIVE REGULATION OF MEIOTIC CELL CYCLE 17 6.58e-01 -6.21e-02 9.43e-01
POSITIVE REGULATION OF SYNAPTIC VESICLE RECYCLING 8 7.61e-01 6.21e-02 9.61e-01
PYRIMIDINE RIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS 16 6.68e-01 -6.20e-02 9.46e-01
MATURATION OF 5 8S RRNA 36 5.20e-01 -6.20e-02 9.09e-01
NEURON FATE SPECIFICATION 34 5.32e-01 6.19e-02 9.11e-01
REGULATION OF MUSCLE HYPERTROPHY 70 3.71e-01 -6.18e-02 8.48e-01
POSITIVE REGULATION OF AMYLOID BETA FORMATION 20 6.32e-01 -6.18e-02 9.36e-01
NEGATIVE REGULATION OF MAP KINASE ACTIVITY 51 4.46e-01 6.17e-02 8.79e-01
REGULATION OF CALCIUM ION DEPENDENT EXOCYTOSIS 39 5.05e-01 -6.17e-02 9.02e-01
IRON SULFUR CLUSTER ASSEMBLY 28 5.72e-01 -6.17e-02 9.24e-01
HINDBRAIN MATURATION 5 8.11e-01 6.17e-02 9.69e-01
PROTEIN TARGETING TO VACUOLE 48 4.60e-01 -6.17e-02 8.87e-01
GLOMERULAR MESANGIAL CELL PROLIFERATION 13 7.00e-01 -6.17e-02 9.52e-01
TRNA MODIFICATION 92 3.07e-01 6.17e-02 8.11e-01
CELLULAR RESPONSE TO DEXAMETHASONE STIMULUS 24 6.01e-01 -6.17e-02 9.28e-01
ENDOCARDIAL CUSHION FUSION 5 8.11e-01 -6.16e-02 9.69e-01
REGULATION OF CELL SIZE 188 1.45e-01 -6.16e-02 6.74e-01
POSITIVE REGULATION OF SKELETAL MUSCLE TISSUE GROWTH 5 8.11e-01 -6.16e-02 9.69e-01
NEGATIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS 374 4.07e-02 -6.16e-02 4.25e-01
RELAXATION OF CARDIAC MUSCLE 17 6.60e-01 6.16e-02 9.43e-01
ACTIVATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC PROCESS 68 3.80e-01 -6.16e-02 8.51e-01
REGULATION OF CELLULAR LOCALIZATION 975 1.12e-03 -6.16e-02 6.94e-02
REGULATION OF INTRACELLULAR TRANSPORT 331 5.42e-02 -6.15e-02 4.81e-01
REGULATION OF GOLGI TO PLASMA MEMBRANE PROTEIN TRANSPORT 9 7.49e-01 -6.15e-02 9.59e-01
POSITIVE REGULATION OF STRIATED MUSCLE CONTRACTION 14 6.90e-01 6.15e-02 9.50e-01
MUSCLE CELL DEVELOPMENT 194 1.39e-01 -6.15e-02 6.65e-01
POSITIVE REGULATION OF B CELL DIFFERENTIATION 16 6.71e-01 -6.14e-02 9.46e-01
ONE CARBON METABOLIC PROCESS 39 5.07e-01 -6.14e-02 9.03e-01
INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE BY P53 CLASS MEDIATOR 44 4.81e-01 -6.13e-02 8.94e-01
PROTEIN K11 LINKED DEUBIQUITINATION 10 7.37e-01 -6.13e-02 9.58e-01
POSITIVE REGULATION OF SIGNALING RECEPTOR ACTIVITY 31 5.55e-01 -6.13e-02 9.18e-01
REGULATION OF HELICASE ACTIVITY 10 7.37e-01 6.13e-02 9.58e-01
NEUROTRANSMITTER SECRETION 144 2.04e-01 6.13e-02 7.29e-01
REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE 190 1.46e-01 -6.12e-02 6.74e-01
PROTEIN LOCALIZATION TO VACUOLE 88 3.21e-01 -6.12e-02 8.23e-01
CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS 74 3.63e-01 -6.12e-02 8.47e-01
POSITIVE REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS 27 5.82e-01 -6.12e-02 9.24e-01
POSITIVE REGULATION OF CHROMOSOME CONDENSATION 8 7.65e-01 -6.11e-02 9.61e-01
CYTIDINE TO URIDINE EDITING 12 7.14e-01 -6.11e-02 9.55e-01
POSITIVE REGULATION OF VASOCONSTRICTION 32 5.50e-01 -6.11e-02 9.16e-01
TRYPTOPHAN TRANSPORT 6 7.95e-01 6.11e-02 9.67e-01
MONOCYTE CHEMOTACTIC PROTEIN 1 PRODUCTION 21 6.28e-01 -6.11e-02 9.35e-01
REGULATION OF MONOCYTE EXTRAVASATION 7 7.80e-01 6.11e-02 9.65e-01
RIBONUCLEOTIDE CATABOLIC PROCESS 52 4.46e-01 6.11e-02 8.79e-01
REGULATION OF INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY 25 5.97e-01 -6.11e-02 9.27e-01
NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS EXONUCLEOLYTIC 20 6.36e-01 -6.10e-02 9.38e-01
MYELOID DENDRITIC CELL CHEMOTAXIS 5 8.13e-01 -6.10e-02 9.70e-01
DETECTION OF VIRUS 6 7.96e-01 6.10e-02 9.67e-01
T CELL RECEPTOR SIGNALING PATHWAY 137 2.18e-01 -6.10e-02 7.36e-01
REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY 57 4.26e-01 6.10e-02 8.73e-01
NEGATIVE REGULATION OF INTERLEUKIN 12 PRODUCTION 19 6.46e-01 -6.09e-02 9.41e-01
COPULATION 19 6.46e-01 6.09e-02 9.41e-01
POSITIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY 15 6.83e-01 6.09e-02 9.50e-01
STRIATED MUSCLE CELL DIFFERENTIATION 302 6.86e-02 -6.09e-02 5.32e-01
MESODERMAL CELL FATE SPECIFICATION 12 7.15e-01 -6.08e-02 9.55e-01
PYRIMIDINE NUCLEOTIDE METABOLIC PROCESS 53 4.44e-01 -6.08e-02 8.78e-01
NEGATIVE REGULATION OF SYNAPTIC VESICLE EXOCYTOSIS 5 8.14e-01 6.08e-02 9.70e-01
POSITIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY 63 4.04e-01 -6.08e-02 8.63e-01
ACTOMYOSIN CONTRACTILE RING ORGANIZATION 10 7.39e-01 -6.07e-02 9.58e-01
PEPTIDYL LYSINE TRIMETHYLATION 9 7.53e-01 6.07e-02 9.60e-01
CELLULAR RESPONSE TO RADIATION 179 1.61e-01 -6.07e-02 6.81e-01
CELL SURFACE RECEPTOR SIGNALING PATHWAY INVOLVED IN HEART DEVELOPMENT 26 5.93e-01 6.06e-02 9.26e-01
GASTRULATION 194 1.45e-01 -6.06e-02 6.74e-01
CARDIAC NEURAL CREST CELL DIFFERENTIATION INVOLVED IN HEART DEVELOPMENT 16 6.75e-01 -6.06e-02 9.47e-01
POSITIVE REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION 172 1.70e-01 6.06e-02 6.87e-01
CELL ADHESION 1518 7.78e-05 -6.06e-02 1.19e-02
BLASTOCYST GROWTH 21 6.31e-01 -6.05e-02 9.36e-01
POSITIVE REGULATION OF FAT CELL DIFFERENTIATION 71 3.78e-01 6.05e-02 8.51e-01
CELLULAR RESPONSE TO KETONE 102 2.91e-01 -6.05e-02 7.99e-01
LEUKOCYTE MEDIATED CYTOTOXICITY 135 2.25e-01 6.05e-02 7.42e-01
REGULATION OF HEXOKINASE ACTIVITY 7 7.82e-01 6.04e-02 9.65e-01
FOREBRAIN DEVELOPMENT 406 3.66e-02 6.04e-02 4.08e-01
REGULATION OF PROTEIN LIPIDATION 11 7.29e-01 6.04e-02 9.58e-01
MACROMOLECULE CATABOLIC PROCESS 1397 1.51e-04 -6.04e-02 1.74e-02
FEVER GENERATION 11 7.29e-01 -6.04e-02 9.58e-01
REGULATION OF MITOTIC SISTER CHROMATID SEGREGATION 54 4.43e-01 6.04e-02 8.78e-01
INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE 102 2.92e-01 -6.03e-02 8.00e-01
POSITIVE REGULATION OF LIPID STORAGE 27 5.88e-01 -6.03e-02 9.24e-01
REGULATION OF PRESYNAPSE ORGANIZATION 33 5.49e-01 6.03e-02 9.16e-01
POSITIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION 111 2.73e-01 -6.02e-02 7.80e-01
NEGATIVE REGULATION OF CELL CELL ADHESION 202 1.40e-01 -6.02e-02 6.66e-01
EPITHELIAL TO MESENCHYMAL TRANSITION 180 1.63e-01 -6.02e-02 6.81e-01
HYPOTHALAMUS CELL DIFFERENTIATION 13 7.07e-01 6.02e-02 9.53e-01
HEMOGLOBIN METABOLIC PROCESS 18 6.58e-01 -6.02e-02 9.43e-01
ENDOTHELIUM DEVELOPMENT 148 2.06e-01 -6.02e-02 7.29e-01
REGULATION OF INTEGRIN ACTIVATION 17 6.68e-01 -6.02e-02 9.46e-01
REGULATION OF CELLULAR RESPONSE TO STRESS 652 8.72e-03 -6.02e-02 2.20e-01
STEROID BIOSYNTHETIC PROCESS 184 1.59e-01 -6.02e-02 6.80e-01
FC GAMMA RECEPTOR SIGNALING PATHWAY 32 5.57e-01 -6.00e-02 9.18e-01
REGULATION OF SYNCYTIUM FORMATION BY PLASMA MEMBRANE FUSION 30 5.69e-01 6.00e-02 9.22e-01
ENDOTHELIAL CELL DEVELOPMENT 69 3.89e-01 -6.00e-02 8.56e-01
SENSORY PERCEPTION OF MECHANICAL STIMULUS 181 1.64e-01 6.00e-02 6.82e-01
RECEPTOR CLUSTERING 57 4.34e-01 -6.00e-02 8.74e-01
POSITIVE REGULATION BY HOST OF VIRAL TRANSCRIPTION 17 6.69e-01 -5.99e-02 9.46e-01
RESPONSE TO KETONE 207 1.37e-01 -5.99e-02 6.61e-01
TRNA CATABOLIC PROCESS 16 6.78e-01 -5.99e-02 9.49e-01
NEGATIVE REGULATION OF PERK MEDIATED UNFOLDED PROTEIN RESPONSE 6 7.99e-01 -5.99e-02 9.67e-01
PIGMENT ACCUMULATION 12 7.19e-01 5.99e-02 9.55e-01
COENZYME A METABOLIC PROCESS 19 6.51e-01 -5.99e-02 9.41e-01
POSITIVE REGULATION OF B CELL PROLIFERATION 45 4.87e-01 -5.99e-02 8.94e-01
HEMATOPOIETIC STEM CELL PROLIFERATION 36 5.34e-01 -5.99e-02 9.12e-01
CELLULAR RESPONSE TO MANGANESE ION 10 7.43e-01 -5.99e-02 9.59e-01
NUCLEAR TRANSCRIBED MRNA POLY A TAIL SHORTENING 34 5.46e-01 -5.98e-02 9.14e-01
NEGATIVE REGULATION OF MYOSIN LIGHT CHAIN PHOSPHATASE ACTIVITY 5 8.17e-01 -5.98e-02 9.70e-01
TROPHOBLAST CELL MIGRATION 18 6.60e-01 -5.98e-02 9.43e-01
ORGANIC ANION TRANSPORT 442 3.11e-02 -5.98e-02 3.85e-01
N ACETYLNEURAMINATE CATABOLIC PROCESS 7 7.84e-01 -5.97e-02 9.65e-01
HORMONE MEDIATED SIGNALING PATHWAY 190 1.56e-01 -5.97e-02 6.79e-01
MRNA METABOLIC PROCESS 773 4.72e-03 -5.97e-02 1.62e-01
NEGATIVE REGULATION OF CELL CYCLE G2 M PHASE TRANSITION 70 3.88e-01 -5.97e-02 8.56e-01
PEPTIDE CROSS LINKING 26 5.99e-01 5.97e-02 9.28e-01
POSITIVE REGULATION OF OXIDOREDUCTASE ACTIVITY 46 4.84e-01 -5.97e-02 8.94e-01
PROTEIN EXPORT FROM NUCLEUS 60 4.24e-01 -5.96e-02 8.73e-01
REGULATION OF CALCIDIOL 1 MONOOXYGENASE ACTIVITY 7 7.85e-01 -5.96e-02 9.65e-01
REGULATION OF CELL ADHESION 798 4.19e-03 -5.96e-02 1.52e-01
RESPONSE TO INTERLEUKIN 3 6 8.01e-01 5.95e-02 9.68e-01
REGULATION OF CELL GROWTH 417 3.69e-02 -5.95e-02 4.09e-01
MUSCLE STRUCTURE DEVELOPMENT 692 7.56e-03 -5.95e-02 2.00e-01
SPINDLE ORGANIZATION 202 1.45e-01 -5.95e-02 6.73e-01
NEGATIVE REGULATION OF LEUKOCYTE DEGRANULATION 12 7.21e-01 5.95e-02 9.56e-01
POSITIVE REGULATION OF DENDRITIC SPINE MORPHOGENESIS 17 6.71e-01 5.95e-02 9.46e-01
POSITIVE REGULATION OF NEURON APOPTOTIC PROCESS 56 4.41e-01 -5.95e-02 8.78e-01
SYNCYTIUM FORMATION 65 4.07e-01 -5.94e-02 8.63e-01
GLUTAMINE FAMILY AMINO ACID CATABOLIC PROCESS 27 5.93e-01 -5.94e-02 9.26e-01
CARTILAGE MORPHOGENESIS 10 7.45e-01 -5.94e-02 9.59e-01
EMBRYONIC PLACENTA DEVELOPMENT 89 3.33e-01 -5.94e-02 8.31e-01
MODIFICATION OF SYNAPTIC STRUCTURE 28 5.87e-01 5.93e-02 9.24e-01
NEGATIVE REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED EIF2 ALPHA PHOSPHORYLATION 5 8.18e-01 5.93e-02 9.70e-01
ORGANIC ACID METABOLIC PROCESS 961 1.82e-03 -5.93e-02 9.78e-02
CELL MIGRATION INVOLVED IN GASTRULATION 15 6.91e-01 -5.93e-02 9.50e-01
METANEPHROS MORPHOGENESIS 31 5.68e-01 5.93e-02 9.21e-01
REGULATION OF CARDIAC MUSCLE CONTRACTION BY REGULATION OF THE RELEASE OF SEQUESTERED CALCIUM ION 22 6.31e-01 5.92e-02 9.36e-01
PROTEIN TETRAMERIZATION 90 3.32e-01 5.92e-02 8.31e-01
NK T CELL ACTIVATION 13 7.12e-01 5.92e-02 9.54e-01
REGULATION OF TELOMERE MAINTENANCE IN RESPONSE TO DNA DAMAGE 19 6.55e-01 5.92e-02 9.42e-01
DEOXYRIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS 8 7.72e-01 -5.91e-02 9.63e-01
POSITIVE REGULATION OF EXOCYTOSIS 76 3.73e-01 -5.91e-02 8.49e-01
NEURAL CREST FORMATION 15 6.92e-01 -5.91e-02 9.50e-01
REGULATION OF DNA REPLICATION 124 2.56e-01 5.91e-02 7.70e-01
DENDRITE EXTENSION 36 5.40e-01 -5.91e-02 9.13e-01
EYE PHOTORECEPTOR CELL DIFFERENTIATION 48 4.79e-01 -5.90e-02 8.94e-01
CELL CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES 281 8.86e-02 -5.90e-02 5.82e-01
REGULATION OF ACTION POTENTIAL 59 4.33e-01 -5.90e-02 8.74e-01
REGULATION OF CELLULAR SENESCENCE 53 4.58e-01 -5.90e-02 8.84e-01
REGULATION OF SOMATIC STEM CELL POPULATION MAINTENANCE 12 7.24e-01 -5.90e-02 9.56e-01
LIPID HOMEOSTASIS 175 1.78e-01 -5.90e-02 6.98e-01
REGULATION OF SYNAPSE STRUCTURE OR ACTIVITY 249 1.09e-01 5.89e-02 6.17e-01
MESODERM MORPHOGENESIS 76 3.74e-01 -5.89e-02 8.50e-01
INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO OXIDATIVE STRESS 63 4.19e-01 -5.89e-02 8.69e-01
UBIQUITIN DEPENDENT GLYCOPROTEIN ERAD PATHWAY 7 7.87e-01 5.89e-02 9.65e-01
REGULATION OF ACTIN FILAMENT BASED MOVEMENT 41 5.15e-01 -5.88e-02 9.07e-01
REGULATION OF SYSTEM PROCESS 557 1.76e-02 -5.88e-02 3.06e-01
INTERLEUKIN 4 PRODUCTION 35 5.47e-01 5.88e-02 9.14e-01
AMINO ACID TRANSPORT 151 2.13e-01 -5.88e-02 7.32e-01
PROTEIN INSERTION INTO ER MEMBRANE BY STOP TRANSFER MEMBRANE ANCHOR SEQUENCE 11 7.36e-01 5.87e-02 9.58e-01
PHOSPHORYLATION 1577 9.72e-05 -5.87e-02 1.36e-02
CYCLIC NUCLEOTIDE CATABOLIC PROCESS 14 7.04e-01 5.87e-02 9.52e-01
REGULATION OF MACROPHAGE FUSION 5 8.20e-01 -5.87e-02 9.71e-01
R LOOP PROCESSING 6 8.04e-01 -5.86e-02 9.68e-01
MESODERMAL CELL DIFFERENTIATION 34 5.55e-01 -5.85e-02 9.18e-01
DEVELOPMENTAL PIGMENTATION 50 4.74e-01 5.85e-02 8.91e-01
AGGREPHAGY 10 7.49e-01 -5.85e-02 9.59e-01
REGULATION OF BODY FLUID LEVELS 364 5.54e-02 -5.84e-02 4.86e-01
MITOTIC RECOMBINATION 25 6.13e-01 5.84e-02 9.31e-01
POSITIVE REGULATION OF T CELL PROLIFERATION 105 3.01e-01 5.84e-02 8.07e-01
POSITIVE REGULATION OF ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION 8 7.75e-01 5.84e-02 9.64e-01
RADIAL GLIAL CELL DIFFERENTIATION 14 7.05e-01 -5.84e-02 9.52e-01
VESICLE TETHERING 32 5.67e-01 5.84e-02 9.21e-01
REGULATION OF DENDRITIC SPINE MAINTENANCE 12 7.26e-01 5.84e-02 9.57e-01
MOLTING CYCLE 116 2.78e-01 -5.83e-02 7.85e-01
POSITIVE REGULATION OF MACROPHAGE CHEMOTAXIS 19 6.60e-01 -5.83e-02 9.43e-01
PEPTIDE TRANSPORT 261 1.05e-01 -5.83e-02 6.09e-01
INTERLEUKIN 18 PRODUCTION 14 7.06e-01 5.83e-02 9.52e-01
POSITIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION 1110 1.04e-03 -5.83e-02 6.47e-02
REGULATION OF CORTISOL BIOSYNTHETIC PROCESS 7 7.90e-01 -5.82e-02 9.66e-01
CALCIUM ION REGULATED EXOCYTOSIS OF NEUROTRANSMITTER 21 6.44e-01 5.82e-02 9.41e-01
PROTEIN LOCALIZATION TO PERINUCLEAR REGION OF CYTOPLASM 9 7.62e-01 -5.82e-02 9.61e-01
PROTEIN LOCALIZATION TO NUCLEUS 308 7.88e-02 -5.82e-02 5.58e-01
MITOTIC SISTER CHROMATID SEPARATION 62 4.28e-01 5.82e-02 8.74e-01
INSULIN SECRETION 198 1.58e-01 -5.82e-02 6.79e-01
REGULATION OF LOCOMOTION 1127 9.72e-04 -5.82e-02 6.28e-02
PEPTIDYL LYSINE ACETYLATION 66 4.14e-01 -5.82e-02 8.66e-01
PROTEIN LOCALIZATION TO EXTRACELLULAR REGION 371 5.46e-02 -5.81e-02 4.84e-01
MITOTIC METAPHASE CHROMOSOME ALIGNMENT 58 4.44e-01 -5.81e-02 8.78e-01
EMBRYONIC SKELETAL JOINT DEVELOPMENT 15 6.97e-01 5.80e-02 9.52e-01
RESPONSE TO UV B 21 6.45e-01 -5.80e-02 9.41e-01
NEGATIVE REGULATION OF ORGANELLE ASSEMBLY 45 5.01e-01 -5.80e-02 9.01e-01
REACTIVE NITROGEN SPECIES METABOLIC PROCESS 79 3.73e-01 -5.80e-02 8.49e-01
DNA TEMPLATED DNA REPLICATION MAINTENANCE OF FIDELITY 55 4.57e-01 5.80e-02 8.84e-01
SUPEROXIDE ANION GENERATION 39 5.31e-01 -5.79e-02 9.11e-01
NON MEMBRANE BOUNDED ORGANELLE ASSEMBLY 405 4.57e-02 -5.78e-02 4.48e-01
ESTABLISHMENT OF PLANAR POLARITY INVOLVED IN NEURAL TUBE CLOSURE 13 7.18e-01 -5.78e-02 9.55e-01
REGULATION OF WOUND HEALING 132 2.51e-01 -5.78e-02 7.68e-01
ADULT LOCOMOTORY BEHAVIOR 81 3.69e-01 5.78e-02 8.48e-01
PROTEIN LOCALIZATION TO EARLY ENDOSOME 12 7.29e-01 5.77e-02 9.58e-01
MITOCHONDRION ORGANIZATION 544 2.15e-02 -5.76e-02 3.43e-01
INTESTINAL ABSORPTION 41 5.23e-01 -5.76e-02 9.10e-01
RESPONSE TO AMINO ACID STARVATION 54 4.64e-01 -5.76e-02 8.89e-01
CELLULAR RESPONSE TO GLUCOCORTICOID STIMULUS 49 4.86e-01 -5.75e-02 8.94e-01
CARDIAC EPITHELIAL TO MESENCHYMAL TRANSITION 38 5.39e-01 -5.75e-02 9.13e-01
CELLULAR RESPONSE TO FLUID SHEAR STRESS 21 6.48e-01 -5.75e-02 9.41e-01
PROTEIN DEPALMITOYLATION 8 7.78e-01 -5.75e-02 9.64e-01
POST EMBRYONIC DEVELOPMENT 94 3.35e-01 -5.75e-02 8.31e-01
AXONEME ASSEMBLY 95 3.33e-01 5.75e-02 8.31e-01
NEGATIVE REGULATION OF LIPID CATABOLIC PROCESS 27 6.05e-01 -5.75e-02 9.29e-01
SULFATE TRANSPORT 17 6.82e-01 -5.74e-02 9.50e-01
FIBRINOLYSIS 27 6.06e-01 5.73e-02 9.29e-01
MAMMARY GLAND MORPHOGENESIS 43 5.16e-01 -5.73e-02 9.07e-01
MITOCHONDRIAL MEMBRANE ORGANIZATION 117 2.85e-01 -5.73e-02 7.92e-01
SNRNA CATABOLIC PROCESS 5 8.25e-01 5.71e-02 9.71e-01
NEGATIVE REGULATION OF GLYCOGEN METABOLIC PROCESS 10 7.55e-01 5.71e-02 9.60e-01
CELLULAR MODIFIED AMINO ACID METABOLIC PROCESS 124 2.73e-01 -5.70e-02 7.80e-01
DISTAL TUBULE DEVELOPMENT 12 7.33e-01 -5.70e-02 9.58e-01
THYROID HORMONE METABOLIC PROCESS 29 5.96e-01 5.70e-02 9.27e-01
PROTEIN KINASE A SIGNALING 37 5.49e-01 5.69e-02 9.16e-01
CD4 POSITIVE OR CD8 POSITIVE ALPHA BETA T CELL LINEAGE COMMITMENT 26 6.16e-01 5.69e-02 9.32e-01
MACROPHAGE COLONY STIMULATING FACTOR SIGNALING PATHWAY 7 7.95e-01 -5.68e-02 9.67e-01
APOPTOTIC SIGNALING PATHWAY 617 1.59e-02 -5.68e-02 2.95e-01
PHOSPHOLIPID TRANSPORT 103 3.19e-01 -5.68e-02 8.21e-01
VIRAL PROTEIN PROCESSING 31 5.84e-01 -5.68e-02 9.24e-01
POSITIVE REGULATION OF T CELL APOPTOTIC PROCESS 13 7.23e-01 -5.68e-02 9.56e-01
CHROMOSOME CONDENSATION 47 5.01e-01 -5.68e-02 9.01e-01
REGULATION OF OOCYTE MATURATION 7 7.95e-01 5.68e-02 9.67e-01
TYPE B PANCREATIC CELL PROLIFERATION 28 6.03e-01 -5.67e-02 9.29e-01
RESPONSE TO TEMPERATURE STIMULUS 169 2.03e-01 -5.67e-02 7.29e-01
DNA TEMPLATED TRANSCRIPTION ELONGATION 134 2.57e-01 -5.67e-02 7.71e-01
NEGATIVE REGULATION OF CELL CYCLE CHECKPOINT 6 8.10e-01 -5.67e-02 9.69e-01
RETINOIC ACID RECEPTOR SIGNALING PATHWAY 32 5.79e-01 5.66e-02 9.24e-01
MAGNESIUM ION TRANSPORT 18 6.77e-01 5.66e-02 9.48e-01
DEPHOSPHORYLATION 299 9.20e-02 -5.66e-02 5.88e-01
NEGATIVE REGULATION OF CYTOKINE PRODUCTION 376 5.93e-02 -5.66e-02 5.02e-01
MEMBRANE RAFT ASSEMBLY 11 7.45e-01 -5.66e-02 9.59e-01
OSTEOBLAST PROLIFERATION 37 5.51e-01 5.66e-02 9.17e-01
MUSCLE CELL DIFFERENTIATION 416 4.76e-02 -5.66e-02 4.55e-01
ATRIAL SEPTUM DEVELOPMENT 23 6.39e-01 5.66e-02 9.39e-01
COPPER ION HOMEOSTASIS 20 6.62e-01 5.65e-02 9.44e-01
BIOLOGICAL PROCESS INVOLVED IN SYMBIOTIC INTERACTION 315 8.45e-02 -5.65e-02 5.72e-01
GAS TRANSPORT 22 6.46e-01 5.65e-02 9.41e-01
POSITIVE REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS 25 6.25e-01 -5.65e-02 9.33e-01
ESTABLISHMENT OF PROTEIN LOCALIZATION TO MEMBRANE 270 1.10e-01 -5.65e-02 6.17e-01
ADRENERGIC RECEPTOR SIGNALING PATHWAY 33 5.75e-01 5.64e-02 9.24e-01
CHEMOKINE PRODUCTION 105 3.18e-01 -5.64e-02 8.21e-01
AMINO ACID BIOSYNTHETIC PROCESS 76 3.96e-01 5.64e-02 8.59e-01
NEGATIVE REGULATION OF RESPONSE TO TYPE II INTERFERON 7 7.96e-01 5.63e-02 9.67e-01
AMP METABOLIC PROCESS 23 6.40e-01 -5.63e-02 9.39e-01
PROTEIN POLYUBIQUITINATION 224 1.46e-01 -5.63e-02 6.75e-01
REGULATION OF MRNA EXPORT FROM NUCLEUS 7 7.97e-01 5.63e-02 9.67e-01
CARDIOCYTE DIFFERENTIATION 165 2.12e-01 -5.63e-02 7.32e-01
INNER EAR RECEPTOR CELL STEREOCILIUM ORGANIZATION 35 5.65e-01 5.63e-02 9.21e-01
RNA POLYMERASE II PREINITIATION COMPLEX ASSEMBLY 56 4.67e-01 5.62e-02 8.90e-01
REGULATION OF TRANSLATION INITIATION IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS 8 7.83e-01 5.62e-02 9.65e-01
PLASMINOGEN ACTIVATION 27 6.14e-01 -5.61e-02 9.31e-01
GLIAL CELL MIGRATION 60 4.52e-01 -5.61e-02 8.81e-01
REGULATION OF PLATELET ACTIVATION 49 4.97e-01 -5.61e-02 8.99e-01
FATTY ACYL COA METABOLIC PROCESS 39 5.45e-01 5.60e-02 9.13e-01
RENAL FILTRATION 26 6.21e-01 -5.60e-02 9.32e-01
UREA METABOLIC PROCESS 13 7.27e-01 5.60e-02 9.57e-01
RESPONSE TO CADMIUM ION 59 4.57e-01 -5.60e-02 8.84e-01
LIMBIC SYSTEM DEVELOPMENT 123 2.84e-01 5.60e-02 7.91e-01
ICOSANOID TRANSPORT 63 4.43e-01 -5.59e-02 8.78e-01
MITOCHONDRIAL TRANSPORT 188 1.86e-01 -5.59e-02 7.08e-01
ACTIVATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC PROCESS BY CYTOCHROME C 6 8.13e-01 5.59e-02 9.70e-01
OOCYTE CONSTRUCTION 8 7.84e-01 5.58e-02 9.65e-01
CELLULAR COMPONENT DISASSEMBLY INVOLVED IN EXECUTION PHASE OF APOPTOSIS 32 5.85e-01 -5.58e-02 9.24e-01
NEGATIVE REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION 79 3.91e-01 -5.58e-02 8.57e-01
NEURON PROJECTION EXTENSION INVOLVED IN NEURON PROJECTION GUIDANCE 38 5.52e-01 -5.57e-02 9.18e-01
POSITIVE REGULATION OF MITOTIC SISTER CHROMATID SEPARATION 18 6.82e-01 5.57e-02 9.50e-01
POSITIVE REGULATION OF MORPHOGENESIS OF AN EPITHELIUM 36 5.63e-01 5.57e-02 9.21e-01
ORGANOPHOSPHATE BIOSYNTHETIC PROCESS 584 2.14e-02 -5.57e-02 3.42e-01
NEGATIVE REGULATION OF T CELL APOPTOTIC PROCESS 25 6.30e-01 5.57e-02 9.36e-01
GRANULOCYTE CHEMOTAXIS 127 2.78e-01 5.57e-02 7.85e-01
REGULATION OF CARDIAC MUSCLE CONTRACTION BY CALCIUM ION SIGNALING 26 6.23e-01 -5.57e-02 9.32e-01
REGULATION PROTEIN CATABOLIC PROCESS AT SYNAPSE 6 8.13e-01 5.57e-02 9.70e-01
7 METHYLGUANOSINE CAP HYPERMETHYLATION 8 7.85e-01 5.57e-02 9.65e-01
EPITHELIAL CELL PROLIFERATION 490 3.48e-02 -5.57e-02 4.03e-01
POSITIVE REGULATION OF NUCLEOBASE CONTAINING COMPOUND TRANSPORT 6 8.14e-01 -5.56e-02 9.70e-01
PROTEIN LOCALIZATION TO CHROMOSOME TELOMERIC REGION 31 5.92e-01 5.56e-02 9.26e-01
NEGATIVE REGULATION OF TELOMERE CAPPING 8 7.86e-01 -5.55e-02 9.65e-01
PROTEIN TARGETING TO MEMBRANE 125 2.84e-01 -5.55e-02 7.91e-01
GAP JUNCTION ASSEMBLY 18 6.84e-01 5.55e-02 9.50e-01
MEMBRANE BIOGENESIS 63 4.47e-01 -5.54e-02 8.79e-01
RESPONSE TO PROSTAGLANDIN D 5 8.30e-01 -5.54e-02 9.71e-01
AORTIC VALVE MORPHOGENESIS 38 5.55e-01 -5.54e-02 9.18e-01
NEURAL RETINA DEVELOPMENT 80 3.92e-01 5.54e-02 8.57e-01
BUNDLE OF HIS CELL TO PURKINJE MYOCYTE SIGNALING 7 8.00e-01 -5.53e-02 9.67e-01
POSITIVE REGULATION OF OSTEOBLAST DIFFERENTIATION 73 4.14e-01 5.53e-02 8.66e-01
FILOPODIUM ASSEMBLY 70 4.24e-01 -5.52e-02 8.73e-01
NEGATIVE REGULATION OF PROTEIN METABOLIC PROCESS 990 3.24e-03 -5.52e-02 1.31e-01
VASCULAR ENDOTHELIAL CELL PROLIFERATION 54 4.83e-01 -5.52e-02 8.94e-01
CELLULAR RESPONSE TO PARATHYROID HORMONE STIMULUS 10 7.62e-01 -5.52e-02 9.61e-01
INTRACELLULAR TRANSPORT 1564 2.62e-04 -5.52e-02 2.57e-02
NEGATIVE REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY 37 5.61e-01 -5.52e-02 9.20e-01
GLYCOPROTEIN METABOLIC PROCESS 371 6.80e-02 -5.52e-02 5.32e-01
POSITIVE REGULATION OF HEPATOCYTE PROLIFERATION 10 7.63e-01 -5.51e-02 9.61e-01
SPINDLE ELONGATION 14 7.21e-01 -5.51e-02 9.56e-01
CARDIAC MUSCLE TISSUE MORPHOGENESIS 61 4.56e-01 5.51e-02 8.84e-01
POSITIVE REGULATION OF MRNA PROCESSING 30 6.01e-01 -5.51e-02 9.28e-01
GERMINAL CENTER B CELL DIFFERENTIATION 9 7.75e-01 5.51e-02 9.64e-01
REDUCTION OF FOOD INTAKE IN RESPONSE TO DIETARY EXCESS 5 8.31e-01 5.51e-02 9.71e-01
REGULATION OF ACTIVIN RECEPTOR SIGNALING PATHWAY 27 6.20e-01 -5.51e-02 9.32e-01
EXTRACELLULAR MATRIX DISASSEMBLY 62 4.53e-01 -5.51e-02 8.81e-01
NEGATIVE REGULATION OF INTERLEUKIN 17 PRODUCTION 22 6.55e-01 5.50e-02 9.42e-01
SPHINGOLIPID CATABOLIC PROCESS 33 5.85e-01 -5.50e-02 9.24e-01
DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR RESULTING IN CELL CYCLE ARREST 18 6.87e-01 5.49e-02 9.50e-01
MEGAKARYOCYTE DIFFERENTIATION 62 4.54e-01 -5.49e-02 8.81e-01
REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNE RESPONSE TO TUMOR CELL 10 7.64e-01 -5.49e-02 9.61e-01
PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE 226 1.55e-01 -5.49e-02 6.79e-01
VIRAL GENOME REPLICATION 129 2.82e-01 -5.49e-02 7.90e-01
MEMBRANE ORGANIZATION 804 8.13e-03 -5.49e-02 2.10e-01
INTRACELLULAR PH REDUCTION 54 4.86e-01 -5.48e-02 8.94e-01
REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR 106 3.29e-01 5.48e-02 8.30e-01
ESTABLISHMENT OF LEFT RIGHT ASYMMETRY 6 8.16e-01 5.48e-02 9.70e-01
NUCLEOSIDE BISPHOSPHATE BIOSYNTHETIC PROCESS 57 4.74e-01 -5.48e-02 8.91e-01
REGULATION OF RIBOSOME BIOGENESIS 9 7.76e-01 5.48e-02 9.64e-01
POSITIVE REGULATION OF LOCOMOTION 605 2.13e-02 -5.48e-02 3.42e-01
GRANULOCYTE MIGRATION 152 2.44e-01 5.48e-02 7.63e-01
POSITIVE REGULATION OF T CELL MEDIATED IMMUNITY 68 4.35e-01 -5.47e-02 8.74e-01
NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS 173 2.15e-01 -5.47e-02 7.33e-01
MRNA 5 SPLICE SITE RECOGNITION 10 7.65e-01 -5.47e-02 9.61e-01
NEGATIVE REGULATION OF OXIDATIVE PHOSPHORYLATION 8 7.89e-01 -5.47e-02 9.66e-01
DIGESTIVE SYSTEM PROCESS 103 3.38e-01 -5.47e-02 8.33e-01
PROTEIN RNA COMPLEX ORGANIZATION 213 1.69e-01 -5.46e-02 6.87e-01
NEGATIVE REGULATION OF SIGNALING 1447 4.96e-04 -5.46e-02 3.91e-02
POSITIVE REGULATION OF TYPE II INTERFERON PRODUCTION 77 4.07e-01 5.46e-02 8.63e-01
REGULATION OF DNA RECOMBINATION 135 2.73e-01 5.46e-02 7.80e-01
RENAL CONTROL OF PERIPHERAL VASCULAR RESISTANCE INVOLVED IN REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE 5 8.33e-01 5.46e-02 9.71e-01
REGULATION OF STRIATED MUSCLE CONTRACTION 97 3.53e-01 -5.46e-02 8.43e-01
STEM CELL PROLIFERATION 125 2.93e-01 -5.45e-02 8.01e-01
ESTABLISHMENT OR MAINTENANCE OF MONOPOLAR CELL POLARITY 27 6.24e-01 -5.45e-02 9.33e-01
RNA SURVEILLANCE 17 6.98e-01 -5.44e-02 9.52e-01
REGULATION OF GLIAL CELL PROLIFERATION 41 5.46e-01 -5.44e-02 9.14e-01
POLYOL TRANSMEMBRANE TRANSPORT 10 7.66e-01 5.44e-02 9.62e-01
NERVE DEVELOPMENT 96 3.58e-01 5.43e-02 8.45e-01
ORGANIC HYDROXY COMPOUND TRANSPORT 306 1.02e-01 -5.43e-02 6.06e-01
POSITIVE REGULATION OF PROTEIN EXPORT FROM NUCLEUS 18 6.90e-01 -5.42e-02 9.50e-01
SNRNA METABOLIC PROCESS 56 4.83e-01 5.42e-02 8.94e-01
BRANCHIOMOTOR NEURON AXON GUIDANCE 5 8.34e-01 5.42e-02 9.71e-01
REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS 24 6.46e-01 -5.42e-02 9.41e-01
GLOMERULUS DEVELOPMENT 70 4.33e-01 5.42e-02 8.74e-01
POSITIVE REGULATION OF SIGNALING 1778 1.46e-04 -5.41e-02 1.74e-02
FARNESYL DIPHOSPHATE METABOLIC PROCESS 6 8.18e-01 -5.41e-02 9.70e-01
REGULATION OF SPONTANEOUS SYNAPTIC TRANSMISSION 6 8.19e-01 -5.41e-02 9.70e-01
MEMBRANE LIPID BIOSYNTHETIC PROCESS 149 2.55e-01 -5.40e-02 7.70e-01
MYD88 INDEPENDENT TOLL LIKE RECEPTOR SIGNALING PATHWAY 16 7.08e-01 -5.40e-02 9.53e-01
REGULATION OF CENTROSOME CYCLE 54 4.92e-01 -5.40e-02 8.96e-01
NEGATIVE REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION 41 5.50e-01 -5.40e-02 9.16e-01
RENAL WATER HOMEOSTASIS 24 6.47e-01 -5.39e-02 9.41e-01
VASCULAR ASSOCIATED SMOOTH MUSCLE CELL MIGRATION 51 5.05e-01 -5.39e-02 9.02e-01
SEMI LUNAR VALVE DEVELOPMENT 47 5.22e-01 -5.39e-02 9.10e-01
POSITIVE REGULATION OF TOR SIGNALING 68 4.42e-01 5.39e-02 8.78e-01
RENAL SODIUM ION ABSORPTION 13 7.36e-01 -5.39e-02 9.58e-01
GENITALIA DEVELOPMENT 47 5.23e-01 5.39e-02 9.10e-01
REGULATION OF POSTSYNAPTIC SPECIALIZATION ASSEMBLY 14 7.27e-01 5.39e-02 9.57e-01
WHITE FAT CELL DIFFERENTIATION 17 7.01e-01 5.38e-02 9.52e-01
HINDLIMB MORPHOGENESIS 36 5.76e-01 5.38e-02 9.24e-01
RESPONSE TO HEPARIN 7 8.05e-01 -5.38e-02 9.68e-01
BLASTOCYST DEVELOPMENT 115 3.20e-01 -5.37e-02 8.21e-01
ISOLEUCINE METABOLIC PROCESS 7 8.06e-01 5.36e-02 9.68e-01
NEGATIVE REGULATION OF TYPE B PANCREATIC CELL APOPTOTIC PROCESS 6 8.20e-01 -5.36e-02 9.71e-01
HEAT GENERATION 17 7.02e-01 -5.36e-02 9.52e-01
PRONEPHROS DEVELOPMENT 9 7.81e-01 -5.36e-02 9.65e-01
POLYSACCHARIDE CATABOLIC PROCESS 21 6.71e-01 5.36e-02 9.46e-01
PHOTORECEPTOR CELL DIFFERENTIATION 64 4.59e-01 -5.36e-02 8.86e-01
PROTEIN CATABOLIC PROCESS 969 4.71e-03 -5.36e-02 1.62e-01
PURINE NUCLEOTIDE SALVAGE 11 7.58e-01 5.35e-02 9.61e-01
RESPONSE TO BACTERIUM 690 1.65e-02 5.35e-02 2.98e-01
EPITHELIAL TUBE MORPHOGENESIS 334 9.28e-02 -5.35e-02 5.89e-01
TRANSCRIPTION BY RNA POLYMERASE I 70 4.39e-01 -5.35e-02 8.77e-01
LIPOPROTEIN BIOSYNTHETIC PROCESS 96 3.65e-01 -5.35e-02 8.48e-01
ESTABLISHMENT OF PROTEIN LOCALIZATION TO CHROMATIN 9 7.81e-01 -5.34e-02 9.65e-01
L AMINO ACID TRANSPORT 89 3.84e-01 -5.34e-02 8.54e-01
MEIOTIC CHROMOSOME SEGREGATION 90 3.81e-01 5.34e-02 8.52e-01
RESPONSE TO TOPOLOGICALLY INCORRECT PROTEIN 158 2.47e-01 -5.34e-02 7.64e-01
REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRION 51 5.10e-01 -5.34e-02 9.05e-01
OXIDATIVE PHOSPHORYLATION 131 2.92e-01 5.34e-02 7.99e-01
N GLYCAN PROCESSING 17 7.03e-01 5.33e-02 9.52e-01
NEGATIVE REGULATION OF PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY 13 7.39e-01 -5.33e-02 9.58e-01
INTERSTRAND CROSS LINK REPAIR 38 5.70e-01 5.33e-02 9.22e-01
VASCULAR TRANSPORT 87 3.90e-01 -5.33e-02 8.56e-01
REGULATION OF MACROPHAGE APOPTOTIC PROCESS 11 7.60e-01 5.33e-02 9.61e-01
POSITIVE REGULATION OF RESPONSE TO BIOTIC STIMULUS 366 8.02e-02 -5.32e-02 5.60e-01
NEUROTRANSMITTER GATED ION CHANNEL CLUSTERING 17 7.04e-01 5.32e-02 9.52e-01
MELANOSOME ASSEMBLY 19 6.88e-01 -5.32e-02 9.50e-01
RESPONSE TO HYDROXYUREA 12 7.50e-01 -5.32e-02 9.59e-01
MITOCHONDRIAL PROTEIN PROCESSING 13 7.40e-01 5.32e-02 9.58e-01
GLUCAN METABOLIC PROCESS 77 4.20e-01 -5.32e-02 8.70e-01
REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC PROCESS 161 2.44e-01 -5.32e-02 7.63e-01
ACTIVATION OF IMMUNE RESPONSE 517 3.89e-02 -5.30e-02 4.16e-01
AXO DENDRITIC TRANSPORT 78 4.18e-01 5.30e-02 8.69e-01
GLIOGENESIS 338 9.39e-02 -5.30e-02 5.92e-01
BODY MORPHOGENESIS 48 5.26e-01 -5.30e-02 9.10e-01
NEGATIVE REGULATION OF RNA SPLICING 27 6.34e-01 -5.29e-02 9.38e-01
REGULATION OF BICELLULAR TIGHT JUNCTION ASSEMBLY 22 6.68e-01 -5.28e-02 9.46e-01
MEIOTIC CYTOKINESIS 8 7.96e-01 5.28e-02 9.67e-01
HETEROTYPIC CELL CELL ADHESION 62 4.72e-01 5.28e-02 8.91e-01
POSITIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY 103 3.56e-01 -5.27e-02 8.44e-01
POSITIVE REGULATION OF PROTEIN UBIQUITINATION 107 3.47e-01 5.27e-02 8.37e-01
LEUKOCYTE APOPTOTIC PROCESS 120 3.19e-01 -5.26e-02 8.21e-01
HINDBRAIN DEVELOPMENT 153 2.61e-01 5.26e-02 7.72e-01
TRANSITION METAL ION TRANSPORT 98 3.68e-01 -5.26e-02 8.48e-01
RESOLUTION OF RECOMBINATION INTERMEDIATES 6 8.24e-01 5.26e-02 9.71e-01
POSITIVE REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION 63 4.71e-01 5.25e-02 8.90e-01
GENERATION OF PRECURSOR METABOLITES AND ENERGY 492 4.59e-02 -5.25e-02 4.48e-01
PYRIMIDINE NUCLEOSIDE METABOLIC PROCESS 24 6.56e-01 -5.25e-02 9.42e-01
CELL CELL SIGNALING BY WNT 459 5.43e-02 -5.24e-02 4.82e-01
ERBB4 ERBB4 SIGNALING PATHWAY 6 8.24e-01 5.24e-02 9.71e-01
POLYSACCHARIDE METABOLIC PROCESS 101 3.64e-01 -5.23e-02 8.47e-01
POSITIVE REGULATION OF B CELL ACTIVATION 83 4.10e-01 -5.23e-02 8.64e-01
SMOOTH MUSCLE CELL DIFFERENTIATION 76 4.31e-01 -5.23e-02 8.74e-01
PEPTIDYL AMINO ACID MODIFICATION 919 7.14e-03 -5.23e-02 1.97e-01
REGULATION OF CORTICOTROPIN SECRETION 5 8.40e-01 5.23e-02 9.72e-01
REGULATION OF SYNAPSE MATURATION 20 6.86e-01 5.22e-02 9.50e-01
CEREBRAL CORTEX GABAERGIC INTERNEURON DIFFERENTIATION 11 7.64e-01 5.22e-02 9.61e-01
CARDIAC MUSCLE CELL FATE COMMITMENT 11 7.64e-01 5.22e-02 9.61e-01
REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY IN ABSENCE OF LIGAND 46 5.40e-01 -5.22e-02 9.13e-01
POSITIVE REGULATION OF MONOOXYGENASE ACTIVITY 28 6.33e-01 -5.22e-02 9.36e-01
POSITIVE REGULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL 32 6.09e-01 -5.22e-02 9.31e-01
REGULATION OF HORMONE METABOLIC PROCESS 39 5.73e-01 -5.21e-02 9.24e-01
NEGATIVE REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY 166 2.47e-01 -5.21e-02 7.64e-01
AMINO ACID ACTIVATION 43 5.54e-01 -5.21e-02 9.18e-01
TRANSLATIONAL TERMINATION 16 7.18e-01 -5.21e-02 9.55e-01
POSITIVE REGULATION OF MAPK CASCADE 475 5.18e-02 -5.21e-02 4.74e-01
REGULATION OF TRANSCRIPTION ELONGATION BY RNA POLYMERASE II 86 4.04e-01 -5.21e-02 8.63e-01
NEGATIVE REGULATION OF PROTEOLYSIS 228 1.76e-01 5.20e-02 6.94e-01
REGULATION OF OXIDATIVE PHOSPHORYLATION 23 6.66e-01 5.20e-02 9.45e-01
NEGATIVE REGULATION OF INFLAMMATORY RESPONSE TO WOUNDING 9 7.87e-01 -5.20e-02 9.65e-01
REGULATION OF MEMBRANE POTENTIAL 440 6.14e-02 5.20e-02 5.08e-01
NEGATIVE REGULATION OF LOW DENSITY LIPOPROTEIN RECEPTOR ACTIVITY 10 7.76e-01 -5.20e-02 9.64e-01
NEUROTROPHIN TRK RECEPTOR SIGNALING PATHWAY 25 6.53e-01 5.20e-02 9.41e-01
T HELPER 17 CELL DIFFERENTIATION 33 6.06e-01 -5.19e-02 9.29e-01
PROTEIN CONTAINING COMPLEX LOCALIZATION 185 2.24e-01 -5.19e-02 7.41e-01
POSITIVE REGULATION OF TELOMERE CAPPING 17 7.11e-01 -5.18e-02 9.54e-01
DOUBLE STRAND BREAK REPAIR VIA BREAK INDUCED REPLICATION 12 7.56e-01 5.18e-02 9.61e-01
REGULATION OF CELL KILLING 112 3.43e-01 5.18e-02 8.36e-01
RESPONSE TO ABIOTIC STIMULUS 1118 3.44e-03 -5.18e-02 1.34e-01
CELLULAR RESPONSE TO NUTRIENT 47 5.39e-01 -5.17e-02 9.13e-01
REGULATION OF RECEPTOR CATABOLIC PROCESS 11 7.67e-01 -5.17e-02 9.63e-01
PYRIMIDINE DEOXYRIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS 6 8.27e-01 5.17e-02 9.71e-01
POSITIVE REGULATION OF NEURON DIFFERENTIATION 95 3.84e-01 5.16e-02 8.54e-01
NEGATIVE REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION 25 6.55e-01 -5.16e-02 9.42e-01
REGULATION OF ENDOCRINE PROCESS 39 5.77e-01 5.16e-02 9.24e-01
NEGATIVE REGULATION BY HOST OF VIRAL GENOME REPLICATION 11 7.67e-01 5.16e-02 9.63e-01
NITRIC OXIDE MEDIATED SIGNAL TRANSDUCTION 29 6.31e-01 5.16e-02 9.36e-01
REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION 529 4.26e-02 -5.15e-02 4.33e-01
REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION 1776 3.05e-04 -5.15e-02 2.87e-02
TELOMERE MAINTENANCE VIA SEMI CONSERVATIVE REPLICATION 9 7.89e-01 -5.15e-02 9.66e-01
MHC CLASS II BIOSYNTHETIC PROCESS 20 6.90e-01 -5.15e-02 9.50e-01
NEGATIVE REGULATION OF ALPHA BETA T CELL DIFFERENTIATION 28 6.37e-01 5.14e-02 9.38e-01
ENTEROENDOCRINE CELL DIFFERENTIATION 36 5.93e-01 5.14e-02 9.26e-01
POSITIVE REGULATION OF MITOPHAGY IN RESPONSE TO MITOCHONDRIAL DEPOLARIZATION 10 7.78e-01 5.14e-02 9.64e-01
REGULATION OF SMOOTHENED SIGNALING PATHWAY 86 4.10e-01 -5.14e-02 8.64e-01
DNA UNWINDING INVOLVED IN DNA REPLICATION 21 6.83e-01 5.14e-02 9.50e-01
ORGANONITROGEN COMPOUND BIOSYNTHETIC PROCESS 1823 2.66e-04 -5.14e-02 2.57e-02
CARDIAC MUSCLE CELL ACTION POTENTIAL INVOLVED IN CONTRACTION 53 5.18e-01 -5.14e-02 9.09e-01
REGULATION OF EXTENT OF CELL GROWTH 109 3.54e-01 -5.14e-02 8.43e-01
SMALL MOLECULE BIOSYNTHETIC PROCESS 597 3.21e-02 -5.13e-02 3.92e-01
CELL JUNCTION ASSEMBLY 447 6.30e-02 -5.13e-02 5.13e-01
POSITIVE REGULATION OF DENDRITIC CELL CHEMOTAXIS 9 7.90e-01 5.12e-02 9.66e-01
REGULATION OF VIRAL TRANSCRIPTION 19 6.99e-01 -5.12e-02 9.52e-01
REGULATION OF HIGH VOLTAGE GATED CALCIUM CHANNEL ACTIVITY 11 7.69e-01 -5.12e-02 9.63e-01
CELLULAR RESPONSE TO ALCOHOL 103 3.69e-01 -5.12e-02 8.48e-01
FIBROBLAST ACTIVATION 15 7.32e-01 5.12e-02 9.58e-01
REGULATION OF POSTSYNAPTIC DENSITY ASSEMBLY 11 7.69e-01 5.11e-02 9.63e-01
G PROTEIN COUPLED PURINERGIC RECEPTOR SIGNALING PATHWAY 12 7.59e-01 -5.11e-02 9.61e-01
PARKIN MEDIATED STIMULATION OF MITOPHAGY IN RESPONSE TO MITOCHONDRIAL DEPOLARIZATION 6 8.29e-01 -5.11e-02 9.71e-01
MAINTENANCE OF SYNAPSE STRUCTURE 26 6.52e-01 -5.11e-02 9.41e-01
SKELETAL SYSTEM MORPHOGENESIS 227 1.85e-01 -5.10e-02 7.07e-01
CELLULAR RESPONSE TO DSRNA 23 6.72e-01 5.10e-02 9.46e-01
LUNG ALVEOLUS DEVELOPMENT 49 5.37e-01 -5.10e-02 9.13e-01
CENTROSOME DUPLICATION 76 4.42e-01 -5.09e-02 8.78e-01
GOLGI LUMEN ACIDIFICATION 13 7.51e-01 -5.09e-02 9.59e-01
SYNAPTONEMAL COMPLEX ORGANIZATION 26 6.53e-01 -5.09e-02 9.41e-01
ANTIGEN PROCESSING AND PRESENTATION OF EXOGENOUS PEPTIDE ANTIGEN VIA MHC CLASS I 8 8.03e-01 -5.09e-02 9.68e-01
ESTABLISHMENT OF PROTEIN LOCALIZATION 1669 5.27e-04 -5.09e-02 3.95e-02
POSITIVE REGULATION OF RESPONSE TO CYTOKINE STIMULUS 66 4.75e-01 -5.08e-02 8.91e-01
REGULATION OF SYNAPTIC VESICLE CYCLE 13 7.51e-01 -5.08e-02 9.59e-01
POSITIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL PROLIFERATION 10 7.81e-01 -5.08e-02 9.65e-01
ENERGY RESERVE METABOLIC PROCESS 88 4.10e-01 -5.08e-02 8.64e-01
POSITIVE REGULATION OF PROTEOLYSIS INVOLVED IN PROTEIN CATABOLIC PROCESS 140 3.00e-01 -5.08e-02 8.06e-01
NEGATIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE 41 5.74e-01 -5.07e-02 9.24e-01
PROTEIN O LINKED MANNOSYLATION 17 7.17e-01 -5.07e-02 9.55e-01
POSITIVE REGULATION OF BIOMINERAL TISSUE DEVELOPMENT 54 5.19e-01 5.07e-02 9.09e-01
DENDRITIC CELL DIFFERENTIATION 46 5.52e-01 -5.07e-02 9.18e-01
POSITIVE REGULATION OF FC RECEPTOR MEDIATED STIMULATORY SIGNALING PATHWAY 5 8.45e-01 5.06e-02 9.72e-01
EPITHELIAL TO MESENCHYMAL TRANSITION INVOLVED IN ENDOCARDIAL CUSHION FORMATION 18 7.10e-01 5.06e-02 9.54e-01
CENTRAL NERVOUS SYSTEM MYELIN FORMATION 8 8.04e-01 -5.05e-02 9.68e-01
MICROVILLUS ORGANIZATION 30 6.32e-01 -5.05e-02 9.36e-01
CELLULAR RESPONSE TO X RAY 11 7.72e-01 -5.05e-02 9.63e-01
FUNGIFORM PAPILLA DEVELOPMENT 6 8.30e-01 5.05e-02 9.71e-01
PROTEIN IMPORT INTO PEROXISOME MATRIX 15 7.35e-01 5.05e-02 9.58e-01
NEGATIVE REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION 53 5.25e-01 5.05e-02 9.10e-01
G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY INVOLVED IN HEART PROCESS 18 7.11e-01 -5.05e-02 9.54e-01
PHOSPHATIDYLINOSITOL METABOLIC PROCESS 154 2.80e-01 -5.05e-02 7.87e-01
HISTONE H3 ACETYLATION 6 8.31e-01 -5.05e-02 9.71e-01
CENTRAL NERVOUS SYSTEM NEURON DIFFERENTIATION 181 2.42e-01 5.04e-02 7.61e-01
PTERIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS 12 7.62e-01 5.04e-02 9.61e-01
ESTABLISHMENT OF ENDOTHELIAL BARRIER 54 5.22e-01 -5.04e-02 9.10e-01
BILE ACID METABOLIC PROCESS 50 5.38e-01 5.04e-02 9.13e-01
NEGATIVE REGULATION OF DEVELOPMENTAL GROWTH 114 3.54e-01 -5.03e-02 8.43e-01
ORGANELLE ASSEMBLY 998 7.12e-03 -5.03e-02 1.97e-01
NEUROMUSCULAR PROCESS 161 2.71e-01 -5.02e-02 7.79e-01
TRACHEA DEVELOPMENT 19 7.05e-01 -5.02e-02 9.52e-01
PYRIMIDINE RIBONUCLEOTIDE CATABOLIC PROCESS 8 8.06e-01 5.02e-02 9.68e-01
REGULATION OF OLIGODENDROCYTE DIFFERENTIATION 45 5.60e-01 5.02e-02 9.20e-01
POSITIVE REGULATION OF MITOCHONDRIAL CALCIUM ION CONCENTRATION 11 7.73e-01 -5.02e-02 9.63e-01
POSITIVE REGULATION OF BLOOD PRESSURE BY EPINEPHRINE NOREPINEPHRINE 6 8.32e-01 -5.02e-02 9.71e-01
POSITIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT 290 1.42e-01 -5.01e-02 6.69e-01
CELLULAR RESPONSE TO OXYGEN GLUCOSE DEPRIVATION 8 8.06e-01 5.01e-02 9.68e-01
REGULATION OF NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS NONSENSE MEDIATED DECAY 13 7.54e-01 -5.01e-02 9.60e-01
PEPTIDE BIOSYNTHETIC PROCESS 832 1.40e-02 -5.01e-02 2.78e-01
UNSATURATED FATTY ACID METABOLIC PROCESS 114 3.56e-01 5.01e-02 8.44e-01
POSITIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE I 33 6.19e-01 -5.01e-02 9.32e-01
ER OVERLOAD RESPONSE 11 7.74e-01 5.00e-02 9.63e-01
GROWTH 918 1.01e-02 -5.00e-02 2.34e-01
POSITIVE REGULATION OF ATP DEPENDENT ACTIVITY 40 5.84e-01 5.00e-02 9.24e-01
MITOCHONDRIAL RESPIRATORY CHAIN COMPLEX ASSEMBLY 95 4.00e-01 5.00e-02 8.62e-01
RESPONSE TO PEPTIDE 517 5.20e-02 -4.99e-02 4.74e-01
METANEPHRIC S SHAPED BODY MORPHOGENESIS 5 8.47e-01 4.99e-02 9.72e-01
EPITHELIAL CELL FATE COMMITMENT 15 7.38e-01 -4.99e-02 9.58e-01
NEGATIVE REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT 21 6.93e-01 -4.98e-02 9.50e-01
NEGATIVE REGULATION OF DNA REPLICATION 25 6.66e-01 4.98e-02 9.45e-01
SYNAPTIC TRANSMISSION CHOLINERGIC 31 6.31e-01 4.98e-02 9.36e-01
NEGATIVE REGULATION OF GLIOGENESIS 45 5.63e-01 -4.98e-02 9.21e-01
ORGANONITROGEN COMPOUND CATABOLIC PROCESS 1320 2.37e-03 -4.97e-02 1.08e-01
EMBRYONIC APPENDAGE MORPHOGENESIS 120 3.47e-01 4.97e-02 8.37e-01
DETECTION OF TEMPERATURE STIMULUS INVOLVED IN THERMOCEPTION 5 8.47e-01 -4.97e-02 9.72e-01
ENDOTHELIAL CELL PROLIFERATION 209 2.16e-01 -4.97e-02 7.33e-01
NEGATIVE REGULATION OF GROWTH 245 1.81e-01 -4.97e-02 7.01e-01
PRIMARY MIRNA PROCESSING 20 7.01e-01 4.96e-02 9.52e-01
NEPHRIC DUCT DEVELOPMENT 15 7.39e-01 -4.96e-02 9.58e-01
CARDIAC MUSCLE TISSUE REGENERATION 8 8.08e-01 -4.96e-02 9.69e-01
POSITIVE REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS 115 3.59e-01 -4.95e-02 8.46e-01
POSITIVE REGULATION OF INTERLEUKIN 1 BETA PRODUCTION 62 5.00e-01 -4.95e-02 9.00e-01
REGULATION OF ESTABLISHMENT OF T CELL POLARITY 6 8.34e-01 -4.95e-02 9.71e-01
PROTEIN MODIFICATION BY SMALL PROTEIN REMOVAL 117 3.55e-01 -4.95e-02 8.44e-01
REGULATION OF CELL GROWTH INVOLVED IN CARDIAC MUSCLE CELL DEVELOPMENT 20 7.02e-01 -4.95e-02 9.52e-01
RESPONSE TO UV C 14 7.49e-01 -4.95e-02 9.59e-01
POSITIVE REGULATION OF AUTOPHAGOSOME MATURATION 7 8.21e-01 -4.95e-02 9.71e-01
LIPOPHAGY 7 8.21e-01 -4.94e-02 9.71e-01
POSITIVE REGULATION OF CELL CYCLE 329 1.23e-01 -4.94e-02 6.43e-01
POSTREPLICATION REPAIR 34 6.18e-01 4.94e-02 9.32e-01
ESTABLISHMENT OF PLANAR POLARITY OF EMBRYONIC EPITHELIUM 16 7.32e-01 -4.94e-02 9.58e-01
AMINO ACID NEUROTRANSMITTER REUPTAKE 10 7.87e-01 4.94e-02 9.65e-01
CELLULAR RESPONSE TO CADMIUM ION 37 6.03e-01 -4.94e-02 9.29e-01
ATP SYNTHESIS COUPLED ELECTRON TRANSPORT 87 4.26e-01 4.94e-02 8.73e-01
MOLTING CYCLE PROCESS 96 4.03e-01 -4.94e-02 8.63e-01
REGULATION OF DIGESTIVE SYSTEM PROCESS 37 6.04e-01 -4.93e-02 9.29e-01
RECEPTOR SIGNALING PATHWAY VIA STAT 180 2.54e-01 -4.93e-02 7.69e-01
POSITIVE REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY 14 7.49e-01 -4.93e-02 9.59e-01
KETONE CATABOLIC PROCESS 14 7.49e-01 4.93e-02 9.59e-01
NK T CELL DIFFERENTIATION 11 7.77e-01 4.92e-02 9.64e-01
IMMUNE RESPONSE REGULATING SIGNALING PATHWAY 474 6.63e-02 -4.92e-02 5.26e-01
MESENCHYMAL CELL DIFFERENTIATION 263 1.70e-01 -4.92e-02 6.87e-01
MYELOID CELL DEVELOPMENT 85 4.34e-01 -4.91e-02 8.74e-01
KERATINOCYTE APOPTOTIC PROCESS 7 8.22e-01 -4.91e-02 9.71e-01
MESONEPHROS DEVELOPMENT 103 3.89e-01 4.91e-02 8.56e-01
POSITIVE REGULATION OF PHOSPHORYLATION 652 3.23e-02 -4.91e-02 3.93e-01
REGULATION OF MRNA SPLICING VIA SPLICEOSOME 99 3.98e-01 -4.91e-02 8.60e-01
AMIDE METABOLIC PROCESS 1262 3.32e-03 -4.91e-02 1.31e-01
NEGATIVE REGULATION OF REPRODUCTIVE PROCESS 76 4.59e-01 -4.91e-02 8.87e-01
POSITIVE REGULATION OF TRANSFERASE ACTIVITY 412 8.75e-02 -4.90e-02 5.79e-01
INDUCTION OF POSITIVE CHEMOTAXIS 14 7.51e-01 -4.90e-02 9.59e-01
REGULATION OF TERMINATION OF DNA TEMPLATED TRANSCRIPTION 5 8.49e-01 4.90e-02 9.73e-01
AMINE TRANSPORT 108 3.79e-01 4.90e-02 8.51e-01
NATURAL KILLER CELL MEDIATED IMMUNE RESPONSE TO TUMOR CELL 11 7.78e-01 -4.90e-02 9.64e-01
NEGATIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION 34 6.21e-01 4.90e-02 9.32e-01
GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR PRODUCTION 18 7.19e-01 4.90e-02 9.55e-01
NEGATIVE REGULATION OF CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS 19 7.12e-01 4.89e-02 9.54e-01
RESPONSE TO AMINE 47 5.62e-01 4.89e-02 9.20e-01
NUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS 117 3.62e-01 -4.88e-02 8.46e-01
UBIQUITIN RECYCLING 13 7.61e-01 4.88e-02 9.61e-01
SYNAPTIC VESICLE CLUSTERING 16 7.36e-01 -4.88e-02 9.58e-01
PEPTIDE METABOLIC PROCESS 960 1.04e-02 -4.88e-02 2.40e-01
SPERM FLAGELLUM ASSEMBLY 41 5.89e-01 4.87e-02 9.25e-01
REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS 60 5.14e-01 -4.87e-02 9.07e-01
ADENYLATE CYCLASE INHIBITING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY 80 4.52e-01 4.86e-02 8.81e-01
POSITIVE REGULATION OF PROTEIN DEACETYLATION 12 7.71e-01 4.86e-02 9.63e-01
DNA MODIFICATION 102 3.96e-01 -4.86e-02 8.59e-01
NEUTRAL AMINO ACID TRANSPORT 58 5.22e-01 -4.85e-02 9.10e-01
POSITIVE REGULATION OF ALPHA BETA T CELL DIFFERENTIATION 52 5.45e-01 4.85e-02 9.13e-01
REGULATION OF TOLL LIKE RECEPTOR 7 SIGNALING PATHWAY 7 8.24e-01 4.85e-02 9.71e-01
REGULATION OF CHONDROCYTE DIFFERENTIATION 52 5.45e-01 4.85e-02 9.13e-01
RIBOSOMAL LARGE SUBUNIT ASSEMBLY 25 6.75e-01 -4.84e-02 9.48e-01
KERATINOCYTE DIFFERENTIATION 172 2.73e-01 4.84e-02 7.80e-01
POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE 21 7.01e-01 -4.84e-02 9.52e-01
PYRAMIDAL NEURON DIFFERENTIATION 14 7.54e-01 -4.84e-02 9.60e-01
REGULATION OF GAMMA DELTA T CELL DIFFERENTIATION 9 8.02e-01 -4.84e-02 9.68e-01
HIPPOCAMPUS DEVELOPMENT 94 4.18e-01 4.84e-02 8.68e-01
PROTEIN HEXAMERIZATION 9 8.02e-01 4.84e-02 9.68e-01
COLLAGEN ACTIVATED TYROSINE KINASE RECEPTOR SIGNALING PATHWAY 10 7.91e-01 -4.83e-02 9.67e-01
REGULATION OF ANTIMICROBIAL HUMORAL RESPONSE 12 7.72e-01 4.83e-02 9.63e-01
POSITIVE REGULATION OF DEPHOSPHORYLATION 52 5.47e-01 4.83e-02 9.14e-01
NEGATIVE REGULATION OF POST TRANSLATIONAL PROTEIN MODIFICATION 95 4.16e-01 -4.82e-02 8.67e-01
VENTRICULAR CARDIAC MUSCLE CELL DEVELOPMENT 10 7.92e-01 -4.82e-02 9.67e-01
REGULATION OF RENAL SYSTEM PROCESS 21 7.02e-01 -4.82e-02 9.52e-01
ENSHEATHMENT OF NEURONS 147 3.13e-01 -4.82e-02 8.15e-01
POSITIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR SIGNALING PATHWAY 9 8.02e-01 -4.82e-02 9.68e-01
NUCLEOSIDE PHOSPHATE BIOSYNTHETIC PROCESS 284 1.62e-01 -4.82e-02 6.81e-01
POLY A PLUS MRNA EXPORT FROM NUCLEUS 22 6.96e-01 4.82e-02 9.51e-01
CARDIAC NEURAL CREST CELL DEVELOPMENT INVOLVED IN OUTFLOW TRACT MORPHOGENESIS 13 7.64e-01 -4.82e-02 9.61e-01
PERK MEDIATED UNFOLDED PROTEIN RESPONSE 18 7.24e-01 -4.82e-02 9.56e-01
RESPIRATORY BURST INVOLVED IN DEFENSE RESPONSE 16 7.39e-01 4.81e-02 9.58e-01
NEURON MIGRATION 176 2.71e-01 4.81e-02 7.79e-01
TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY 233 2.06e-01 -4.81e-02 7.29e-01
GERM LINE STEM CELL POPULATION MAINTENANCE 5 8.52e-01 -4.80e-02 9.74e-01
POSITIVE REGULATION OF HEMOPOIESIS 186 2.58e-01 -4.80e-02 7.72e-01
CARDIAC VENTRICLE MORPHOGENESIS 72 4.81e-01 4.80e-02 8.94e-01
GLYCOPROTEIN BIOSYNTHETIC PROCESS 301 1.52e-01 -4.80e-02 6.79e-01
INOSINE METABOLIC PROCESS 5 8.52e-01 -4.80e-02 9.74e-01
POSITIVE REGULATION OF DNA BIOSYNTHETIC PROCESS 69 4.90e-01 4.80e-02 8.95e-01
REGULATION OF BRANCHING INVOLVED IN LUNG MORPHOGENESIS 6 8.39e-01 -4.80e-02 9.72e-01
POSITIVE REGULATION OF PEPTIDYL LYSINE ACETYLATION 16 7.40e-01 4.80e-02 9.58e-01
POSITIVE REGULATION OF HOMOTYPIC CELL CELL ADHESION 16 7.40e-01 -4.79e-02 9.58e-01
CEREBELLAR PURKINJE CELL LAYER MORPHOGENESIS 19 7.18e-01 4.79e-02 9.55e-01
RESPONSE TO MAGNESIUM ION 20 7.11e-01 -4.79e-02 9.54e-01
DIOL BIOSYNTHETIC PROCESS 21 7.04e-01 -4.79e-02 9.52e-01
RENAL VESICLE FORMATION 8 8.15e-01 4.79e-02 9.70e-01
POSITIVE REGULATION OF B CELL MEDIATED IMMUNITY 42 5.91e-01 -4.79e-02 9.26e-01
REGULATION OF CELL FATE COMMITMENT 43 5.87e-01 -4.79e-02 9.24e-01
EPIGENETIC REGULATION OF GENE EXPRESSION 222 2.19e-01 -4.79e-02 7.37e-01
LEARNING 150 3.12e-01 4.79e-02 8.14e-01
SKELETAL MUSCLE ORGAN DEVELOPMENT 174 2.76e-01 4.78e-02 7.83e-01
MIDBRAIN HINDBRAIN BOUNDARY DEVELOPMENT 7 8.27e-01 4.78e-02 9.71e-01
MICROTUBULE CYTOSKELETON ORGANIZATION INVOLVED IN MITOSIS 164 2.91e-01 -4.78e-02 7.99e-01
REGULATION OF RECEPTOR RECYCLING 25 6.79e-01 -4.78e-02 9.49e-01
REGULATION OF DOSAGE COMPENSATION BY INACTIVATION OF X CHROMOSOME 13 7.66e-01 -4.78e-02 9.62e-01
CELL DIFFERENTIATION INVOLVED IN METANEPHROS DEVELOPMENT 23 6.92e-01 4.78e-02 9.50e-01
MESENCHYMAL CELL MIGRATION 62 5.15e-01 -4.78e-02 9.07e-01
NEGATIVE REGULATION OF RECEPTOR INTERNALIZATION 17 7.33e-01 -4.78e-02 9.58e-01
WOUND HEALING INVOLVED IN INFLAMMATORY RESPONSE 9 8.04e-01 -4.77e-02 9.68e-01
CITRATE TRANSPORT 5 8.53e-01 -4.77e-02 9.74e-01
REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION 72 4.84e-01 4.77e-02 8.94e-01
INTERLEUKIN 12 PRODUCTION 64 5.09e-01 4.77e-02 9.05e-01
POSITIVE REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNE RESPONSE TO TUMOR CELL 7 8.27e-01 -4.77e-02 9.71e-01
POSITIVE REGULATION OF LYMPHOCYTE DIFFERENTIATION 129 3.50e-01 -4.77e-02 8.41e-01
DENDRITIC TRANSPORT OF RIBONUCLEOPROTEIN COMPLEX 5 8.54e-01 -4.76e-02 9.74e-01
REGULATION OF GERMINAL CENTER FORMATION 8 8.16e-01 -4.76e-02 9.70e-01
RESPONSE TO HYPEROXIA 19 7.19e-01 -4.76e-02 9.55e-01
PROTEIN MATURATION BY IRON SULFUR CLUSTER TRANSFER 15 7.50e-01 4.76e-02 9.59e-01
PROTEIN DE ADP RIBOSYLATION 5 8.54e-01 4.76e-02 9.74e-01
STARTLE RESPONSE 27 6.69e-01 -4.76e-02 9.46e-01
NEGATIVE REGULATION OF GTPASE ACTIVITY 23 6.93e-01 -4.76e-02 9.50e-01
REGULATION OF BILE ACID BIOSYNTHETIC PROCESS 12 7.75e-01 4.75e-02 9.64e-01
NEGATIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY 33 6.36e-01 -4.75e-02 9.38e-01
REGULATION OF CILIUM BEAT FREQUENCY 17 7.34e-01 -4.75e-02 9.58e-01
POSITIVE REGULATION OF PROTEIN LOCALIZATION TO EARLY ENDOSOME 9 8.05e-01 4.75e-02 9.68e-01
RESPONSE TO IRON II ION 6 8.40e-01 4.75e-02 9.72e-01
NOREPINEPHRINE TRANSPORT 22 7.00e-01 -4.75e-02 9.52e-01
REGULATION OF CALCINEURIN MEDIATED SIGNALING 41 5.99e-01 -4.75e-02 9.28e-01
POSITIVE REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION 28 6.64e-01 -4.74e-02 9.44e-01
REGULATION OF FILOPODIUM ASSEMBLY 51 5.59e-01 -4.73e-02 9.19e-01
REGULATION OF RESPONSE TO DRUG 14 7.59e-01 -4.73e-02 9.61e-01
REGULATION OF MACROPHAGE CHEMOTAXIS 28 6.65e-01 -4.73e-02 9.45e-01
ARACHIDONIC ACID SECRETION 31 6.49e-01 4.73e-02 9.41e-01
NEGATIVE REGULATION OF INTERLEUKIN 18 PRODUCTION 5 8.55e-01 -4.73e-02 9.74e-01
REGULATION OF MUSCLE ORGAN DEVELOPMENT 23 6.95e-01 4.72e-02 9.51e-01
MITOCHONDRIAL RESPIRASOME ASSEMBLY 10 7.96e-01 -4.72e-02 9.67e-01
HORMONE METABOLIC PROCESS 238 2.09e-01 4.72e-02 7.30e-01
PIGMENT CELL DIFFERENTIATION 36 6.24e-01 4.72e-02 9.33e-01
REGULATION OF INNATE IMMUNE RESPONSE 421 9.64e-02 -4.72e-02 5.96e-01
ATP METABOLIC PROCESS 127 3.59e-01 -4.71e-02 8.46e-01
HEPATOCYTE DIFFERENTIATION 15 7.52e-01 4.71e-02 9.60e-01
REGULATION OF HYALURONAN BIOSYNTHETIC PROCESS 8 8.18e-01 -4.71e-02 9.70e-01
ARGININE BIOSYNTHETIC PROCESS 5 8.55e-01 4.71e-02 9.74e-01
REGULATION OF SMOOTHENED SIGNALING PATHWAY INVOLVED IN DORSAL VENTRAL NEURAL TUBE PATTERNING 11 7.87e-01 4.71e-02 9.65e-01
ERK1 AND ERK2 CASCADE 342 1.34e-01 -4.71e-02 6.59e-01
POSITIVE REGULATION OF CHONDROCYTE PROLIFERATION 8 8.18e-01 4.71e-02 9.70e-01
NEGATIVE REGULATION OF MACROPHAGE CHEMOTAXIS 7 8.29e-01 -4.71e-02 9.71e-01
NUCLEOSIDE BISPHOSPHATE CATABOLIC PROCESS 12 7.78e-01 4.71e-02 9.64e-01
PYRIMIDINE CONTAINING COMPOUND CATABOLIC PROCESS 42 5.98e-01 4.71e-02 9.28e-01
PULMONARY ARTERY MORPHOGENESIS 6 8.42e-01 -4.71e-02 9.72e-01
CELLULAR RESPONSE TO STEROID HORMONE STIMULUS 206 2.44e-01 -4.70e-02 7.63e-01
REGULATION OF ESTABLISHMENT OR MAINTENANCE OF CELL POLARITY 27 6.72e-01 4.70e-02 9.46e-01
CATECHOLAMINE UPTAKE INVOLVED IN SYNAPTIC TRANSMISSION 12 7.78e-01 -4.70e-02 9.64e-01
REGULATION OF MITOCHONDRIAL MEMBRANE POTENTIAL 73 4.88e-01 -4.69e-02 8.94e-01
TENDON DEVELOPMENT 5 8.56e-01 4.69e-02 9.74e-01
RIBOSOMAL SUBUNIT EXPORT FROM NUCLEUS 14 7.61e-01 4.69e-02 9.61e-01
NEGATIVE REGULATION OF CYCLASE ACTIVITY 15 7.53e-01 4.69e-02 9.60e-01
POSITIVE REGULATION OF CELLULAR SENESCENCE 18 7.31e-01 -4.68e-02 9.58e-01
CARDIAC CELL DEVELOPMENT 93 4.36e-01 -4.68e-02 8.74e-01
POSITIVE REGULATION OF PROSTAGLANDIN BIOSYNTHETIC PROCESS 7 8.31e-01 4.67e-02 9.71e-01
ADAPTATION OF SIGNALING PATHWAY 24 6.92e-01 4.67e-02 9.50e-01
RIBOSOMAL SMALL SUBUNIT BIOGENESIS 103 4.13e-01 4.67e-02 8.66e-01
NEGATIVE REGULATION OF SEQUESTERING OF TRIGLYCERIDE 6 8.43e-01 4.67e-02 9.72e-01
POSITIVE REGULATION OF EPITHELIAL CELL DIFFERENTIATION 72 4.94e-01 -4.67e-02 8.97e-01
REGULATION OF GLUCOSE IMPORT 60 5.32e-01 -4.66e-02 9.11e-01
MITOCHONDRIAL FUSION 33 6.43e-01 -4.66e-02 9.41e-01
POSITIVE REGULATION OF IMMUNE RESPONSE 718 3.34e-02 -4.66e-02 4.00e-01
DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION RESULTING IN TRANSCRIPTION 19 7.25e-01 4.66e-02 9.57e-01
SMAD PROTEIN SIGNAL TRANSDUCTION 84 4.61e-01 -4.66e-02 8.88e-01
CELLULAR RESPONSE TO STRESS 1943 6.77e-04 -4.65e-02 4.73e-02
GLAND DEVELOPMENT 441 9.42e-02 -4.65e-02 5.92e-01
MAST CELL ACTIVATION 69 5.05e-01 4.65e-02 9.02e-01
PROTEIN LOCALIZATION TO ENDOPLASMIC RETICULUM EXIT SITE 7 8.32e-01 -4.64e-02 9.71e-01
POSTSYNAPTIC DENSITY ASSEMBLY 21 7.13e-01 4.64e-02 9.55e-01
REGULATION OF CALCIUM MEDIATED SIGNALING 83 4.65e-01 4.64e-02 8.90e-01
REGULATION OF STEROID BIOSYNTHETIC PROCESS 82 4.68e-01 -4.64e-02 8.90e-01
POST GOLGI VESICLE MEDIATED TRANSPORT 103 4.16e-01 -4.63e-02 8.67e-01
MODULATION OF PROCESS OF ANOTHER ORGANISM 19 7.27e-01 -4.63e-02 9.57e-01
CELL JUNCTION ORGANIZATION 754 3.02e-02 -4.63e-02 3.83e-01
POSITIVE REGULATION OF HAIR FOLLICLE MATURATION 5 8.58e-01 -4.63e-02 9.74e-01
MANNOSYLATION 23 7.01e-01 4.63e-02 9.52e-01
REGULATION OF CELL PROJECTION SIZE 13 7.73e-01 -4.63e-02 9.63e-01
UDP GLUCOSE METABOLIC PROCESS 6 8.44e-01 -4.63e-02 9.72e-01
UROGENITAL SYSTEM DEVELOPMENT 67 5.13e-01 4.62e-02 9.07e-01
ENGULFMENT OF APOPTOTIC CELL 15 7.57e-01 -4.62e-02 9.61e-01
TETRAHYDROFOLATE INTERCONVERSION 9 8.10e-01 4.62e-02 9.69e-01
PHOSPHOLIPASE C ACTIVATING G PROTEIN COUPLED ACETYLCHOLINE RECEPTOR SIGNALING PATHWAY 8 8.21e-01 -4.62e-02 9.71e-01
POSITIVE REGULATION OF MYOBLAST DIFFERENTIATION 43 6.00e-01 4.62e-02 9.28e-01
PHOTORECEPTOR CELL DEVELOPMENT 49 5.76e-01 -4.61e-02 9.24e-01
REGULATION OF MEMBRANE TUBULATION 5 8.58e-01 4.61e-02 9.74e-01
PROTEIN LOCALIZATION TO NUCLEOLUS 18 7.35e-01 4.61e-02 9.58e-01
TRANSCRIPTION INITIATION AT RNA POLYMERASE II PROMOTER 99 4.28e-01 4.61e-02 8.74e-01
POST TRANSLATIONAL PROTEIN MODIFICATION 1051 1.15e-02 -4.61e-02 2.50e-01
NEGATIVE REGULATION OF ALPHA BETA T CELL PROLIFERATION 14 7.65e-01 -4.60e-02 9.62e-01
CORONARY VASCULATURE DEVELOPMENT 50 5.73e-01 -4.60e-02 9.24e-01
INDOLE CONTAINING COMPOUND METABOLIC PROCESS 23 7.02e-01 4.60e-02 9.52e-01
MITOTIC DNA REPLICATION 16 7.50e-01 4.60e-02 9.59e-01
REGULATION OF NEURON PROJECTION DEVELOPMENT 453 9.33e-02 -4.60e-02 5.90e-01
PROTEIN DEPHOSPHORYLATION 201 2.61e-01 -4.60e-02 7.72e-01
NEGATIVE REGULATION OF WOUND HEALING 74 4.95e-01 -4.59e-02 8.98e-01
REGULATION OF POST TRANSLATIONAL PROTEIN MODIFICATION 280 1.86e-01 -4.59e-02 7.08e-01
SPINDLE ASSEMBLY 133 3.61e-01 -4.59e-02 8.46e-01
REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL 18 7.36e-01 4.59e-02 9.58e-01
NEUROTRANSMITTER UPTAKE 45 5.95e-01 -4.58e-02 9.26e-01
POSITIVE REGULATION OF PROTEIN MODIFICATION PROCESS 801 2.73e-02 -4.58e-02 3.69e-01
BOX C D SNORNP ASSEMBLY 10 8.02e-01 4.58e-02 9.68e-01
RESPONSE TO NITRIC OXIDE 20 7.23e-01 4.58e-02 9.56e-01
RENAL SYSTEM VASCULATURE MORPHOGENESIS 8 8.23e-01 4.58e-02 9.71e-01
RNA SECONDARY STRUCTURE UNWINDING 9 8.12e-01 -4.58e-02 9.70e-01
PHOSPHATIDYLINOSITOL ACYL CHAIN REMODELING 6 8.46e-01 4.58e-02 9.72e-01
MITOCHONDRIAL TRANSLATION 130 3.68e-01 4.57e-02 8.48e-01
RESPONSE TO IONIZING RADIATION 139 3.52e-01 -4.57e-02 8.41e-01
EPITHELIAL CELL DEVELOPMENT 219 2.43e-01 -4.57e-02 7.63e-01
CELLULAR RESPONSE TO HORMONE STIMULUS 606 5.47e-02 -4.57e-02 4.84e-01
MEMBRANE INVAGINATION 63 5.31e-01 -4.56e-02 9.11e-01
NEGATIVE REGULATION OF PHOSPHORYLATION 324 1.58e-01 -4.56e-02 6.79e-01
PURINE NUCLEOSIDE MONOPHOSPHATE CATABOLIC PROCESS 11 7.93e-01 -4.56e-02 9.67e-01
SUBSTRATE DEPENDENT CELL MIGRATION 26 6.87e-01 4.56e-02 9.50e-01
RENAL VESICLE DEVELOPMENT 18 7.38e-01 -4.56e-02 9.58e-01
PLASMA MEMBRANE RAFT ASSEMBLY 7 8.35e-01 -4.56e-02 9.71e-01
METHIONINE METABOLIC PROCESS 16 7.52e-01 -4.56e-02 9.60e-01
REGULATION OF PROTEIN MATURATION 70 5.10e-01 -4.56e-02 9.05e-01
POSITIVE REGULATION OF EMBRYONIC DEVELOPMENT 22 7.11e-01 -4.56e-02 9.54e-01
CAMERA TYPE EYE MORPHOGENESIS 133 3.64e-01 -4.55e-02 8.48e-01
REGULATION OF PRIMARY MIRNA PROCESSING 6 8.47e-01 4.55e-02 9.72e-01
REGULATION OF MICROTUBULE BASED PROCESS 257 2.09e-01 -4.55e-02 7.29e-01
ODONTOGENESIS OF DENTIN CONTAINING TOOTH 92 4.51e-01 -4.55e-02 8.81e-01
ACID SECRETION 43 6.06e-01 4.55e-02 9.29e-01
NEGATIVE REGULATION OF IMMATURE T CELL PROLIFERATION 5 8.60e-01 4.55e-02 9.74e-01
BRAIN MORPHOGENESIS 37 6.32e-01 4.54e-02 9.36e-01
REGULATION OF DOUBLE STRAND BREAK REPAIR 132 3.67e-01 -4.54e-02 8.48e-01
REGULATION OF LYMPHOCYTE DIFFERENTIATION 211 2.55e-01 -4.54e-02 7.70e-01
BUNDLE OF HIS CELL TO PURKINJE MYOCYTE COMMUNICATION 15 7.61e-01 4.54e-02 9.61e-01
POSITIVE REGULATION OF GROWTH 253 2.14e-01 -4.54e-02 7.33e-01
REGULATION OF CELL CYCLE PROCESS 736 3.59e-02 -4.54e-02 4.04e-01
DENDRITE MORPHOGENESIS 139 3.56e-01 4.54e-02 8.44e-01
CARDIAC MUSCLE CELL DIFFERENTIATION 131 3.70e-01 -4.54e-02 8.48e-01
VIRAL GENE EXPRESSION 101 4.31e-01 -4.53e-02 8.74e-01
IMMATURE B CELL DIFFERENTIATION 12 7.86e-01 -4.53e-02 9.65e-01
REGULATION OF ANATOMICAL STRUCTURE SIZE 508 8.01e-02 -4.53e-02 5.60e-01
REGULATION OF RUFFLE ASSEMBLY 32 6.57e-01 -4.53e-02 9.43e-01
PYRIDINE CONTAINING COMPOUND CATABOLIC PROCESS 8 8.24e-01 -4.53e-02 9.71e-01
POSITIVE REGULATION OF NUCLEAR DIVISION 60 5.44e-01 -4.53e-02 9.13e-01
MICROTUBULE BASED PROTEIN TRANSPORT 14 7.70e-01 -4.52e-02 9.63e-01
INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY 54 5.65e-01 -4.52e-02 9.21e-01
RESPONSE TO VIRUS 430 1.08e-01 -4.52e-02 6.13e-01
POSITIVE REGULATION OF AMPA RECEPTOR ACTIVITY 5 8.61e-01 4.52e-02 9.74e-01
BIOLOGICAL PHASE 11 7.95e-01 4.52e-02 9.67e-01
CELLULAR RESPONSE TO THYROID HORMONE STIMULUS 17 7.47e-01 -4.52e-02 9.59e-01
PROTEIN K63 LINKED DEUBIQUITINATION 31 6.64e-01 4.51e-02 9.44e-01
REGULATION OF APOPTOTIC SIGNALING PATHWAY 393 1.24e-01 -4.51e-02 6.46e-01
NEUROMUSCULAR PROCESS CONTROLLING POSTURE 19 7.34e-01 -4.51e-02 9.58e-01
REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT 78 4.91e-01 -4.51e-02 8.95e-01
ETHANOL METABOLIC PROCESS 19 7.34e-01 4.50e-02 9.58e-01
ELASTIC FIBER ASSEMBLY 10 8.06e-01 -4.50e-02 9.68e-01
DTTP METABOLIC PROCESS 5 8.62e-01 4.49e-02 9.74e-01
RENAL SYSTEM PROCESS 122 3.91e-01 -4.49e-02 8.57e-01
MITOCHONDRIAL DEPOLARIZATION 23 7.09e-01 -4.49e-02 9.53e-01
POSITIVE REGULATION OF MONOCYTE EXTRAVASATION 5 8.62e-01 4.49e-02 9.74e-01
CENTRIOLE ASSEMBLY 49 5.88e-01 -4.48e-02 9.24e-01
PHOSPHATIDYLINOSITOL BIOSYNTHETIC PROCESS 130 3.78e-01 -4.48e-02 8.51e-01
POSITIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS 717 4.14e-02 -4.47e-02 4.30e-01
REGULATION OF FIBROBLAST APOPTOTIC PROCESS 19 7.36e-01 -4.47e-02 9.58e-01
INTRACELLULAR GLUCOSE HOMEOSTASIS 157 3.34e-01 -4.47e-02 8.31e-01
PEPTIDYL HISTIDINE MODIFICATION 8 8.27e-01 4.47e-02 9.71e-01
CELLULAR RESPONSE TO ALDEHYDE 17 7.50e-01 -4.46e-02 9.59e-01
PROTEIN DNA COMPLEX ORGANIZATION 834 2.85e-02 -4.46e-02 3.73e-01
REGULATION OF MAP KINASE ACTIVITY 145 3.54e-01 -4.46e-02 8.43e-01
CARBOHYDRATE HOMEOSTASIS 252 2.23e-01 -4.46e-02 7.41e-01
POSITIVE REGULATION OF MACROPHAGE ACTIVATION 30 6.73e-01 4.46e-02 9.46e-01
ATTACHMENT OF MITOTIC SPINDLE MICROTUBULES TO KINETOCHORE 21 7.24e-01 -4.46e-02 9.56e-01
REGULATION OF PEPTIDE TRANSPORT 199 2.78e-01 -4.46e-02 7.85e-01
POSITIVE REGULATION OF TRANSLATION IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS 5 8.63e-01 -4.46e-02 9.74e-01
POSITIVE REGULATION OF INSULIN SECRETION INVOLVED IN CELLULAR RESPONSE TO GLUCOSE STIMULUS 30 6.73e-01 4.45e-02 9.47e-01
POSITIVE REGULATION OF NITRIC OXIDE SYNTHASE ACTIVITY 17 7.51e-01 -4.45e-02 9.59e-01
OPTIC NERVE DEVELOPMENT 21 7.24e-01 -4.45e-02 9.56e-01
NEURONAL STEM CELL POPULATION MAINTENANCE 23 7.12e-01 4.45e-02 9.54e-01
EMBRYO DEVELOPMENT 1119 1.19e-02 -4.45e-02 2.53e-01
MISMATCH REPAIR 34 6.54e-01 4.45e-02 9.41e-01
REGULATION OF MESENCHYMAL CELL PROLIFERATION 32 6.64e-01 4.44e-02 9.44e-01
POSITIVE REGULATION OF PROTEIN BINDING 61 5.48e-01 4.44e-02 9.15e-01
CELL PROLIFERATION INVOLVED IN METANEPHROS DEVELOPMENT 10 8.08e-01 4.44e-02 9.69e-01
CELLULAR RESPONSE TO INCREASED OXYGEN LEVELS 12 7.90e-01 4.44e-02 9.66e-01
RESPONSE TO BACTERIAL LIPOPROTEIN 11 7.99e-01 -4.44e-02 9.67e-01
RESPONSE TO ALKALOID 91 4.65e-01 -4.43e-02 8.90e-01
RESPONSE TO RETINOIC ACID 106 4.30e-01 -4.43e-02 8.74e-01
SOMATIC STEM CELL POPULATION MAINTENANCE 69 5.24e-01 4.43e-02 9.10e-01
SINOATRIAL NODE CELL DIFFERENTIATION 6 8.51e-01 4.43e-02 9.74e-01
RESPONSE TO RADIATION 423 1.18e-01 -4.43e-02 6.30e-01
REGULATION OF LIPASE ACTIVITY 78 4.99e-01 4.43e-02 8.99e-01
NEGATIVE REGULATION OF OXIDATIVE STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY 34 6.55e-01 -4.43e-02 9.42e-01
ANIMAL ORGAN MORPHOGENESIS 1037 1.59e-02 -4.43e-02 2.95e-01
LIVER MORPHOGENESIS 25 7.02e-01 -4.42e-02 9.52e-01
SMOOTHENED SIGNALING PATHWAY 146 3.56e-01 -4.42e-02 8.44e-01
REGULATION OF MEMBRANE REPOLARIZATION 38 6.37e-01 -4.42e-02 9.38e-01
OSTEOCLAST DIFFERENTIATION 106 4.32e-01 4.42e-02 8.74e-01
N ACETYLGLUCOSAMINE METABOLIC PROCESS 18 7.46e-01 -4.42e-02 9.59e-01
NEGATIVE REGULATION OF DNA TEMPLATED DNA REPLICATION 9 8.18e-01 4.42e-02 9.70e-01
PROTEIN NEDDYLATION 28 6.86e-01 -4.41e-02 9.50e-01
ATRIOVENTRICULAR NODE DEVELOPMENT 9 8.19e-01 -4.41e-02 9.70e-01
COMPLEMENT DEPENDENT CYTOTOXICITY 13 7.83e-01 -4.41e-02 9.65e-01
MUSCLE HYPERTROPHY IN RESPONSE TO STRESS 31 6.71e-01 -4.41e-02 9.46e-01
NEGATIVE REGULATION OF NATURAL KILLER CELL ACTIVATION 10 8.09e-01 4.41e-02 9.69e-01
PROTEIN LOCALIZATION TO CILIUM 71 5.21e-01 -4.41e-02 9.09e-01
RESPONSE TO PEPTIDE HORMONE 429 1.17e-01 -4.41e-02 6.30e-01
RESPONSE TO MECHANICAL STIMULUS 212 2.69e-01 -4.40e-02 7.78e-01
NCRNA PROCESSING 434 1.16e-01 4.40e-02 6.30e-01
TYPE I INTERFERON PRODUCTION 123 3.99e-01 -4.40e-02 8.61e-01
LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY 58 5.62e-01 -4.40e-02 9.20e-01
REGULATION OF KERATINOCYTE MIGRATION 14 7.76e-01 -4.40e-02 9.64e-01
REGULATION OF BILE ACID METABOLIC PROCESS 15 7.68e-01 4.39e-02 9.63e-01
REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE 42 6.22e-01 -4.39e-02 9.32e-01
CILIUM ORGANIZATION 425 1.20e-01 -4.39e-02 6.34e-01
REGULATION OF FAT CELL DIFFERENTIATION 146 3.60e-01 4.39e-02 8.46e-01
REGULATION OF STEROID HORMONE SECRETION 22 7.22e-01 -4.38e-02 9.56e-01
NUCLEAR EXPORT 163 3.35e-01 -4.38e-02 8.31e-01
REGULATION OF B CELL PROLIFERATION 64 5.45e-01 -4.38e-02 9.13e-01
TRNA THIO MODIFICATION 5 8.65e-01 4.38e-02 9.74e-01
TUBULIN COMPLEX ASSEMBLY 9 8.20e-01 4.38e-02 9.71e-01
ADAPTIVE IMMUNE RESPONSE 454 1.10e-01 4.37e-02 6.17e-01
MULTICELLULAR ORGANISMAL LEVEL CHEMICAL HOMEOSTASIS 73 5.19e-01 -4.37e-02 9.09e-01
POSTSYNAPSE ASSEMBLY 39 6.37e-01 4.36e-02 9.38e-01
REGULATION OF WNT SIGNALING PATHWAY 336 1.69e-01 -4.36e-02 6.87e-01
POSITIVE REGULATION OF PEPTIDASE ACTIVITY 170 3.26e-01 -4.36e-02 8.27e-01
CELLULAR RESPONSE TO VITAMIN D 22 7.23e-01 4.36e-02 9.56e-01
FOAM CELL DIFFERENTIATION 41 6.29e-01 4.36e-02 9.35e-01
IMMUNOGLOBULIN PRODUCTION INVOLVED IN IMMUNOGLOBULIN MEDIATED IMMUNE RESPONSE 59 5.62e-01 4.36e-02 9.20e-01
POSITIVE REGULATION OF PROTEIN METABOLIC PROCESS 1288 8.50e-03 -4.36e-02 2.17e-01
BILE ACID SECRETION 12 7.94e-01 -4.36e-02 9.67e-01
DNA CYTOSINE DEAMINATION 9 8.21e-01 -4.35e-02 9.71e-01
POSITIVE REGULATION OF TRANSLATIONAL INITIATION 26 7.01e-01 -4.35e-02 9.52e-01
REGULATION OF EPITHELIAL CELL PROLIFERATION 416 1.28e-01 -4.35e-02 6.48e-01
POSITIVE REGULATION OF PROTEIN SECRETION 144 3.68e-01 -4.35e-02 8.48e-01
MUSCLE ORGAN MORPHOGENESIS 82 4.97e-01 4.34e-02 8.99e-01
REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION 45 6.15e-01 -4.34e-02 9.32e-01
MEIOTIC TELOMERE CLUSTERING 10 8.12e-01 -4.33e-02 9.70e-01
ZINC ION TRANSPORT 28 6.91e-01 4.33e-02 9.50e-01
TELENCEPHALON DEVELOPMENT 276 2.16e-01 4.33e-02 7.33e-01
REGULATION OF MUSCLE TISSUE DEVELOPMENT 46 6.12e-01 4.33e-02 9.31e-01
PULMONARY VALVE MORPHOGENESIS 19 7.44e-01 -4.32e-02 9.59e-01
SNRNA TRANSCRIPTION BY RNA POLYMERASE II 16 7.65e-01 -4.32e-02 9.61e-01
MECHANOSENSORY BEHAVIOR 14 7.80e-01 4.32e-02 9.65e-01
MALATE METABOLIC PROCESS 9 8.23e-01 -4.31e-02 9.71e-01
BILE ACID BIOSYNTHETIC PROCESS 37 6.50e-01 4.31e-02 9.41e-01
POSITIVE REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORT 37 6.50e-01 -4.31e-02 9.41e-01
SUCCINYL COA CATABOLIC PROCESS 6 8.55e-01 4.31e-02 9.74e-01
POSITIVE REGULATION OF SYNAPSE ASSEMBLY 63 5.54e-01 4.31e-02 9.18e-01
MITOTIC SPINDLE ORGANIZATION 131 3.95e-01 -4.30e-02 8.59e-01
LUNG CELL DIFFERENTIATION 28 6.93e-01 -4.30e-02 9.50e-01
POSITIVE REGULATION OF MIRNA METABOLIC PROCESS 63 5.55e-01 -4.30e-02 9.18e-01
CHROMOSOME LOCALIZATION 117 4.21e-01 -4.30e-02 8.72e-01
CYTOKINESIS 183 3.15e-01 -4.30e-02 8.18e-01
MAINTENANCE OF PROTEIN LOCALIZATION IN ENDOPLASMIC RETICULUM 12 7.97e-01 -4.30e-02 9.67e-01
SCHWANN CELL MIGRATION 7 8.44e-01 -4.30e-02 9.72e-01
THIAMINE CONTAINING COMPOUND METABOLIC PROCESS 7 8.44e-01 4.30e-02 9.72e-01
POSITIVE REGULATION OF CELL DEVELOPMENT 445 1.20e-01 -4.29e-02 6.34e-01
POSITIVE REGULATION OF MEMBRANE POTENTIAL 15 7.74e-01 4.29e-02 9.63e-01
NEURON INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO OXIDATIVE STRESS 21 7.34e-01 -4.29e-02 9.58e-01
RESPONSE TO LEPTIN 21 7.34e-01 4.29e-02 9.58e-01
NEGATIVE REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE 46 6.15e-01 -4.29e-02 9.32e-01
VIRAL TRANSCRIPTION 51 5.96e-01 -4.29e-02 9.27e-01
POSITIVE REGULATION OF NEUROTRANSMITTER SECRETION 17 7.60e-01 -4.29e-02 9.61e-01
COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE 24 7.16e-01 4.29e-02 9.55e-01
CYTOPLASM ORGANIZATION 15 7.74e-01 -4.29e-02 9.63e-01
CD4 POSITIVE ALPHA BETA T CELL CYTOKINE PRODUCTION 19 7.46e-01 -4.29e-02 9.59e-01
REGULATION OF PROTEIN MODIFICATION PROCESS 1292 9.54e-03 -4.29e-02 2.29e-01
AXIS ELONGATION 29 6.90e-01 4.28e-02 9.50e-01
PROTEIN STABILIZATION 212 2.83e-01 -4.28e-02 7.90e-01
AMIDE BIOSYNTHETIC PROCESS 969 2.39e-02 -4.28e-02 3.60e-01
NUCLEOTIDE TRANSMEMBRANE TRANSPORT 28 6.95e-01 -4.28e-02 9.51e-01
SEROTONIN UPTAKE 13 7.89e-01 4.28e-02 9.66e-01
T CELL DIFFERENTIATION 306 1.98e-01 -4.28e-02 7.24e-01
MAINTENANCE OF LENS TRANSPARENCY 7 8.45e-01 -4.27e-02 9.72e-01
REGULATION OF RESPONSE TO BIOTIC STIMULUS 507 9.96e-02 -4.27e-02 6.02e-01
MOTOR LEARNING 7 8.45e-01 4.27e-02 9.72e-01
POSITIVE REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS 54 5.88e-01 -4.26e-02 9.24e-01
REGULATION OF PHOSPHORUS METABOLIC PROCESS 1168 1.41e-02 -4.26e-02 2.79e-01
SODIUM DEPENDENT PHOSPHATE TRANSPORT 12 7.99e-01 4.25e-02 9.67e-01
NEGATIVE REGULATION OF CHROMOSOME ORGANIZATION 92 4.81e-01 4.25e-02 8.94e-01
SPINDLE MIDZONE ASSEMBLY 14 7.83e-01 4.25e-02 9.65e-01
POSITIVE REGULATION OF P38MAPK CASCADE 31 6.83e-01 -4.24e-02 9.50e-01
SOMITOGENESIS 66 5.51e-01 4.24e-02 9.17e-01
EPITHELIAL TUBE BRANCHING INVOLVED IN LUNG MORPHOGENESIS 30 6.88e-01 -4.24e-02 9.50e-01
REGULATION OF CELL CYCLE 1108 1.71e-02 -4.24e-02 3.00e-01
MATURATION OF SSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA 35 6.64e-01 4.24e-02 9.44e-01
HIS PURKINJE SYSTEM DEVELOPMENT 7 8.46e-01 -4.23e-02 9.72e-01
INTRACILIARY ANTEROGRADE TRANSPORT 17 7.62e-01 -4.23e-02 9.61e-01
FATTY ACID METABOLIC PROCESS 398 1.47e-01 -4.23e-02 6.75e-01
NEGATIVE REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS 53 5.94e-01 -4.23e-02 9.26e-01
REGULATION OF SNARE COMPLEX ASSEMBLY 14 7.84e-01 -4.23e-02 9.65e-01
POSITIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR PRODUCTION 30 6.89e-01 4.23e-02 9.50e-01
ADENINE TRANSPORT 6 8.58e-01 4.23e-02 9.74e-01
NEGATIVE REGULATION OF TELOMERE MAINTENANCE 33 6.75e-01 -4.22e-02 9.47e-01
NEGATIVE REGULATION OF CARDIAC MUSCLE TISSUE GROWTH 27 7.04e-01 -4.22e-02 9.52e-01
REGULATION OF PHOSPHATE TRANSPORT 6 8.58e-01 -4.22e-02 9.74e-01
RNA MODIFICATION 174 3.38e-01 4.21e-02 8.33e-01
POSITIVE REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION 31 6.85e-01 -4.21e-02 9.50e-01
REPLACEMENT OSSIFICATION 30 6.90e-01 4.21e-02 9.50e-01
RESPIRATORY SYSTEM DEVELOPMENT 214 2.89e-01 -4.21e-02 7.98e-01
REGULATION OF EPIDERMIS DEVELOPMENT 66 5.55e-01 -4.21e-02 9.18e-01
RETINA DEVELOPMENT IN CAMERA TYPE EYE 159 3.60e-01 -4.20e-02 8.46e-01
PROTEIN CONTAINING COMPLEX REMODELING 36 6.63e-01 -4.20e-02 9.44e-01
NEGATIVE REGULATION OF TRANSMEMBRANE TRANSPORT 142 3.88e-01 -4.20e-02 8.56e-01
COLLAGEN BIOSYNTHETIC PROCESS 47 6.19e-01 -4.20e-02 9.32e-01
REGULATION OF PHOSPHORYLATION 1036 2.22e-02 -4.20e-02 3.49e-01
CORTISOL BIOSYNTHETIC PROCESS 10 8.18e-01 4.19e-02 9.70e-01
POSITIVE REGULATION OF EXTRACELLULAR MATRIX ASSEMBLY 12 8.02e-01 -4.19e-02 9.68e-01
REGULATION OF TRIGLYCERIDE CATABOLIC PROCESS 13 7.94e-01 -4.19e-02 9.67e-01
NEURON PROJECTION ARBORIZATION 32 6.82e-01 4.19e-02 9.50e-01
POSITIVE REGULATION OF VIRAL GENOME REPLICATION 31 6.87e-01 4.18e-02 9.50e-01
PEPTIDYL TYROSINE DEPHOSPHORYLATION 31 6.87e-01 4.18e-02 9.50e-01
ADULT FEEDING BEHAVIOR 10 8.19e-01 -4.18e-02 9.70e-01
PENILE ERECTION 7 8.48e-01 4.18e-02 9.72e-01
NEGATIVE REGULATION OF NEUROTRANSMITTER SECRETION 6 8.59e-01 4.18e-02 9.74e-01
ASSOCIATIVE LEARNING 85 5.06e-01 4.17e-02 9.02e-01
WATER SOLUBLE VITAMIN METABOLIC PROCESS 60 5.77e-01 -4.17e-02 9.24e-01
POSITIVE REGULATION OF ADAPTIVE IMMUNE RESPONSE 128 4.15e-01 -4.17e-02 8.67e-01
ACTIVATION OF PROTEIN KINASE B ACTIVITY 25 7.19e-01 -4.16e-02 9.55e-01
RESPONSE TO INTERLEUKIN 1 138 3.99e-01 4.16e-02 8.60e-01
MONOCYTE EXTRAVASATION 10 8.20e-01 4.16e-02 9.71e-01
REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY BARORECEPTOR FEEDBACK 5 8.72e-01 4.16e-02 9.77e-01
SKELETAL MUSCLE SATELLITE CELL ACTIVATION 8 8.39e-01 4.16e-02 9.72e-01
REGULATION OF CARDIOCYTE DIFFERENTIATION 33 6.79e-01 -4.16e-02 9.49e-01
ONE CARBON COMPOUND TRANSPORT 60 5.77e-01 -4.16e-02 9.24e-01
ESTABLISHMENT OF PIGMENT GRANULE LOCALIZATION 23 7.30e-01 4.16e-02 9.58e-01
LEUKOTRIENE BIOSYNTHETIC PROCESS 17 7.67e-01 4.16e-02 9.63e-01
NEGATIVE REGULATION OF AXONOGENESIS 66 5.59e-01 -4.15e-02 9.20e-01
NUCLEUS ORGANIZATION 146 3.87e-01 -4.15e-02 8.55e-01
RESPONSE TO FOLIC ACID 10 8.20e-01 -4.15e-02 9.71e-01
NEGATIVE REGULATION OF VASCULAR WOUND HEALING 7 8.49e-01 -4.15e-02 9.73e-01
SRP DEPENDENT COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE 19 7.55e-01 4.14e-02 9.60e-01
REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY NOREPINEPHRINE EPINEPHRINE 8 8.39e-01 -4.14e-02 9.72e-01
POSITIVE REGULATION OF TRANSCRIPTION ELONGATION BY RNA POLYMERASE II 49 6.16e-01 -4.14e-02 9.32e-01
REGULATION OF NITRIC OXIDE METABOLIC PROCESS 60 5.79e-01 -4.14e-02 9.24e-01
MESENCHYMAL EPITHELIAL CELL SIGNALING 7 8.50e-01 4.14e-02 9.73e-01
REGULATION OF HEART GROWTH 70 5.50e-01 4.13e-02 9.16e-01
MALE MEIOTIC NUCLEAR DIVISION 55 5.96e-01 4.13e-02 9.27e-01
NEGATIVE REGULATION OF HEART RATE 12 8.04e-01 -4.13e-02 9.68e-01
REGULATION OF CENTROMERIC SISTER CHROMATID COHESION 5 8.73e-01 4.12e-02 9.77e-01
REGULATION OF COLLAGEN METABOLIC PROCESS 42 6.44e-01 4.12e-02 9.41e-01
MAPK CASCADE 771 5.15e-02 -4.12e-02 4.71e-01
ATRIAL SEPTUM MORPHOGENESIS 15 7.82e-01 -4.12e-02 9.65e-01
PLANAR CELL POLARITY PATHWAY INVOLVED IN AXIS ELONGATION 6 8.61e-01 4.12e-02 9.74e-01
MITOCHONDRIAL GENE EXPRESSION 163 3.64e-01 4.12e-02 8.48e-01
MICROTUBULE ORGANIZING CENTER LOCALIZATION 32 6.87e-01 -4.12e-02 9.50e-01
REGULATION OF PROTEIN DEPHOSPHORYLATION 77 5.33e-01 -4.11e-02 9.11e-01
NOTOCHORD DEVELOPMENT 19 7.57e-01 -4.10e-02 9.61e-01
ACYLGLYCEROL TRANSPORT 8 8.41e-01 4.10e-02 9.72e-01
CELL CHEMOTAXIS 316 2.10e-01 4.10e-02 7.30e-01
PURINE DEOXYRIBONUCLEOSIDE MONOPHOSPHATE CATABOLIC PROCESS 6 8.62e-01 -4.10e-02 9.74e-01
REGULATION OF T CELL APOPTOTIC PROCESS 40 6.54e-01 4.10e-02 9.41e-01
ALCOHOL METABOLIC PROCESS 370 1.76e-01 -4.10e-02 6.94e-01
CO TRANSCRIPTIONAL RNA 3 END PROCESSING CLEAVAGE AND POLYADENYLATION PATHWAY 6 8.62e-01 -4.10e-02 9.74e-01
MODULATION BY SYMBIONT OF ENTRY INTO HOST 56 5.96e-01 -4.09e-02 9.27e-01
INTRINSIC APOPTOTIC SIGNALING PATHWAY 316 2.11e-01 -4.09e-02 7.32e-01
REGULATION OF POTASSIUM ION TRANSPORT 102 4.75e-01 4.09e-02 8.91e-01
NEGATIVE REGULATION OF ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION 7 8.51e-01 -4.09e-02 9.74e-01
CHEMOSENSORY BEHAVIOR 18 7.64e-01 -4.09e-02 9.61e-01
CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION 93 4.96e-01 -4.08e-02 8.99e-01
AMINOPHOSPHOLIPID TRANSPORT 9 8.32e-01 4.08e-02 9.71e-01
REGULATION OF NITRIC OXIDE SYNTHASE ACTIVITY 30 6.99e-01 -4.08e-02 9.52e-01
ORGANIC ACID BIOSYNTHETIC PROCESS 329 2.03e-01 -4.08e-02 7.29e-01
RESPONSE TO FOLLICLE STIMULATING HORMONE 16 7.78e-01 -4.08e-02 9.64e-01
REGULATION OF NEUROTRANSMITTER TRANSPORT 98 4.86e-01 4.08e-02 8.94e-01
POSITIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY 129 4.24e-01 -4.07e-02 8.73e-01
CARTILAGE DEVELOPMENT 203 3.18e-01 -4.07e-02 8.21e-01
NEGATIVE REGULATION OF LIPOPROTEIN LIPASE ACTIVITY 8 8.42e-01 4.07e-02 9.72e-01
NEGATIVE REGULATION OF AUTOPHAGOSOME MATURATION 5 8.75e-01 4.06e-02 9.77e-01
REGULATION OF NAD P H OXIDASE ACTIVITY 7 8.52e-01 4.06e-02 9.74e-01
PROTEIN LOCALIZATION TO ORGANELLE 941 3.47e-02 -4.06e-02 4.03e-01
POST EMBRYONIC ANIMAL MORPHOGENESIS 17 7.72e-01 -4.06e-02 9.63e-01
POSITIVE REGULATION OF ANTIMICROBIAL HUMORAL RESPONSE 8 8.42e-01 4.06e-02 9.72e-01
S SHAPED BODY MORPHOGENESIS 7 8.53e-01 -4.06e-02 9.74e-01
CELL REDOX HOMEOSTASIS 39 6.61e-01 -4.06e-02 9.44e-01
MESENCHYME DEVELOPMENT 321 2.12e-01 -4.05e-02 7.32e-01
TORC1 SIGNALING 98 4.88e-01 -4.05e-02 8.94e-01
NEGATIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY 138 4.11e-01 -4.05e-02 8.65e-01
REGULATION OF LIPOPHAGY 5 8.75e-01 -4.05e-02 9.77e-01
CELLULAR RESPONSE TO NITROGEN COMPOUND 687 7.07e-02 -4.04e-02 5.37e-01
ALTERNATIVE MRNA SPLICING VIA SPLICEOSOME 69 5.62e-01 4.04e-02 9.20e-01
PERIPHERAL NERVOUS SYSTEM DEVELOPMENT 81 5.30e-01 -4.04e-02 9.11e-01
ANIMAL ORGAN FORMATION 67 5.68e-01 4.04e-02 9.21e-01
CELLULAR GLUCURONIDATION 19 7.61e-01 4.03e-02 9.61e-01
REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY 57 5.99e-01 -4.03e-02 9.28e-01
SYNAPTIC VESICLE RECYCLING VIA ENDOSOME 5 8.76e-01 4.03e-02 9.77e-01
B CELL HOMEOSTASIS 34 6.84e-01 -4.03e-02 9.50e-01
METANEPHRIC GLOMERULUS DEVELOPMENT 17 7.74e-01 4.02e-02 9.63e-01
MICROTUBULE CYTOSKELETON ORGANIZATION 650 8.00e-02 -4.02e-02 5.60e-01
REGULATION OF TYPE 2 IMMUNE RESPONSE 34 6.85e-01 -4.02e-02 9.50e-01
NUCLEOBASE CONTAINING SMALL MOLECULE CATABOLIC PROCESS 30 7.03e-01 -4.02e-02 9.52e-01
RESPIRATORY SYSTEM PROCESS 39 6.64e-01 -4.01e-02 9.44e-01
NEGATIVE REGULATION OF CELL GROWTH 188 3.43e-01 -4.01e-02 8.36e-01
REGULATION OF HETEROTYPIC CELL CELL ADHESION 25 7.29e-01 4.01e-02 9.58e-01
REGULATION OF LOCOMOTION INVOLVED IN LOCOMOTORY BEHAVIOR 6 8.65e-01 -4.00e-02 9.74e-01
CELLULAR RESPONSE TO LAMINAR FLUID SHEAR STRESS 8 8.45e-01 -4.00e-02 9.72e-01
NEURON APOPTOTIC PROCESS 277 2.52e-01 -3.99e-02 7.68e-01
NEGATIVE REGULATION OF RESPONSE TO STIMULUS 1732 5.67e-03 -3.99e-02 1.74e-01
DNA DEAMINATION 13 8.03e-01 3.99e-02 9.68e-01
SECOND MESSENGER MEDIATED SIGNALING 308 2.29e-01 3.99e-02 7.45e-01
MITOTIC DNA REPLICATION CHECKPOINT SIGNALING 10 8.27e-01 3.99e-02 9.71e-01
N TERMINAL PROTEIN AMINO ACID MODIFICATION 28 7.15e-01 -3.98e-02 9.55e-01
NEGATIVE REGULATION OF MITOCHONDRIAL FUSION 8 8.45e-01 -3.98e-02 9.72e-01
NEGATIVE REGULATION OF MAPK CASCADE 173 3.66e-01 -3.98e-02 8.48e-01
SPERM CAPACITATION 30 7.06e-01 3.98e-02 9.52e-01
REGULATION OF GLUCAGON SECRETION 8 8.45e-01 -3.98e-02 9.72e-01
BLOOD VESSEL MATURATION 8 8.46e-01 -3.97e-02 9.72e-01
PROTEIN PHOSPHORYLATION 1314 1.54e-02 -3.97e-02 2.94e-01
GLYCOSIDE CATABOLIC PROCESS 9 8.37e-01 -3.97e-02 9.72e-01
BONE GROWTH 32 6.98e-01 -3.96e-02 9.52e-01
NEGATIVE REGULATION OF PROTEIN MODIFICATION PROCESS 433 1.57e-01 -3.96e-02 6.79e-01
POSITIVE REGULATION OF CHEMOTAXIS 143 4.13e-01 3.96e-02 8.66e-01
REGULATION OF CARTILAGE DEVELOPMENT 70 5.66e-01 3.96e-02 9.21e-01
CALCIUM MEDIATED SIGNALING 210 3.22e-01 3.96e-02 8.23e-01
CENTRIOLE ELONGATION 8 8.46e-01 -3.96e-02 9.72e-01
RENAL SYSTEM VASCULATURE DEVELOPMENT 32 6.98e-01 -3.96e-02 9.52e-01
REGULATION OF VESICLE MEDIATED TRANSPORT 526 1.20e-01 -3.96e-02 6.34e-01
REGULATION OF TAU PROTEIN KINASE ACTIVITY 13 8.05e-01 -3.96e-02 9.68e-01
POSITIVE REGULATION OF AUTOPHAGY 149 4.05e-01 -3.96e-02 8.63e-01
RESPONSE TO ACETYLCHOLINE 36 6.81e-01 -3.95e-02 9.50e-01
MITOTIC G1 S TRANSITION CHECKPOINT SIGNALING 29 7.12e-01 3.95e-02 9.55e-01
INOSITOL PHOSPHATE METABOLIC PROCESS 45 6.46e-01 3.95e-02 9.41e-01
NEGATIVE REGULATION OF DEFENSE RESPONSE 317 2.26e-01 -3.95e-02 7.44e-01
PROTEIN MONOUBIQUITINATION 43 6.54e-01 -3.95e-02 9.42e-01
PROTEIN FOLDING IN ENDOPLASMIC RETICULUM 12 8.13e-01 3.95e-02 9.70e-01
RESPONSE TO HORMONE 867 4.83e-02 -3.95e-02 4.58e-01
VASCULAR PROCESS IN CIRCULATORY SYSTEM 268 2.66e-01 -3.94e-02 7.76e-01
NEGATIVE REGULATION OF COAGULATION 52 6.23e-01 -3.94e-02 9.32e-01
SOMATIC DIVERSIFICATION OF IMMUNE RECEPTORS 79 5.45e-01 3.94e-02 9.13e-01
POSITIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION 1007 3.44e-02 -3.94e-02 4.03e-01
CELLULAR RESPONSE TO GONADOTROPIN STIMULUS 18 7.73e-01 -3.93e-02 9.63e-01
ACTIVATION OF PROTEIN KINASE ACTIVITY 87 5.26e-01 -3.93e-02 9.10e-01
POSITIVE REGULATION OF MITOCHONDRIAL FISSION 21 7.55e-01 -3.93e-02 9.60e-01
POSITIVE REGULATION OF IMMUNE EFFECTOR PROCESS 266 2.70e-01 -3.93e-02 7.79e-01
TRABECULA MORPHOGENESIS 47 6.42e-01 -3.93e-02 9.40e-01
FLAVONOID GLUCURONIDATION 5 8.79e-01 -3.92e-02 9.77e-01
XENOBIOTIC GLUCURONIDATION 5 8.79e-01 -3.92e-02 9.77e-01
NEGATIVE REGULATION OF PROTEIN MATURATION 29 7.15e-01 3.92e-02 9.55e-01
CARBOHYDRATE MEDIATED SIGNALING 11 8.22e-01 3.92e-02 9.71e-01
INTRACELLULAR SODIUM ION HOMEOSTASIS 22 7.50e-01 -3.92e-02 9.59e-01
RNA SPLICING 441 1.58e-01 -3.92e-02 6.79e-01
CORTICOSTERONE SECRETION 5 8.79e-01 -3.92e-02 9.77e-01
KETONE BIOSYNTHETIC PROCESS 48 6.39e-01 -3.92e-02 9.39e-01
PLACENTA DEVELOPMENT 152 4.05e-01 -3.92e-02 8.63e-01
DEVELOPMENTAL GROWTH 654 8.74e-02 -3.91e-02 5.79e-01
MITOTIC NUCLEAR DIVISION 276 2.63e-01 -3.91e-02 7.74e-01
REGULATION OF VIRAL PROCESS 167 3.83e-01 -3.91e-02 8.54e-01
VALINE METABOLIC PROCESS 7 8.58e-01 3.91e-02 9.74e-01
DEOXYRIBONUCLEOSIDE MONOPHOSPHATE CATABOLIC PROCESS 14 8.00e-01 3.91e-02 9.68e-01
REGULATION OF PROTEIN STABILITY 320 2.29e-01 -3.91e-02 7.46e-01
REGULATION OF LEUKOCYTE APOPTOTIC PROCESS 92 5.17e-01 -3.90e-02 9.08e-01
NEUTROPHIL MEDIATED IMMUNITY 36 6.85e-01 -3.90e-02 9.50e-01
DETECTION OF LIGHT STIMULUS INVOLVED IN SENSORY PERCEPTION 22 7.51e-01 3.90e-02 9.59e-01
NEURON CELLULAR HOMEOSTASIS 63 5.92e-01 3.90e-02 9.26e-01
RETROGRADE TRANS SYNAPTIC SIGNALING BY LIPID 5 8.80e-01 3.90e-02 9.77e-01
REGULATION OF ORGANIC ACID TRANSPORT 77 5.54e-01 -3.90e-02 9.18e-01
LONG TERM SYNAPTIC POTENTIATION 106 4.88e-01 -3.90e-02 8.94e-01
POSTSYNAPTIC SPECIALIZATION ASSEMBLY 27 7.26e-01 3.89e-02 9.57e-01
REGULATION OF OSTEOCLAST PROLIFERATION 6 8.69e-01 -3.89e-02 9.76e-01
SENSORY PERCEPTION OF SOUR TASTE 9 8.40e-01 -3.89e-02 9.72e-01
DE NOVO CENTRIOLE ASSEMBLY 6 8.69e-01 3.89e-02 9.76e-01
ACTIVIN RECEPTOR SIGNALING PATHWAY 45 6.52e-01 -3.89e-02 9.41e-01
REGULATION OF PROTEIN BINDING 142 4.24e-01 -3.89e-02 8.73e-01
POSITIVE REGULATION OF CAMP MEDIATED SIGNALING 15 7.95e-01 3.88e-02 9.67e-01
BLOOD VESSEL ENDOTHELIAL CELL DIFFERENTIATION 14 8.01e-01 -3.88e-02 9.68e-01
REGULATION OF GLUTAMATE RECEPTOR SIGNALING PATHWAY 6 8.69e-01 -3.88e-02 9.76e-01
NEGATIVE REGULATION OF RESPONSE TO BIOTIC STIMULUS 149 4.14e-01 -3.88e-02 8.66e-01
RESPONSE TO FUNGICIDE 7 8.59e-01 -3.88e-02 9.74e-01
POSITIVE REGULATION OF INFLAMMASOME MEDIATED SIGNALING PATHWAY 21 7.59e-01 -3.87e-02 9.61e-01
CALCIUM ION TRANSMEMBRANE IMPORT INTO CYTOSOL 204 3.40e-01 3.87e-02 8.35e-01
PURINE CONTAINING COMPOUND CATABOLIC PROCESS 61 6.01e-01 3.87e-02 9.28e-01
NEGATIVE REGULATION OF CIRCADIAN RHYTHM 12 8.16e-01 -3.87e-02 9.70e-01
COPPER ION IMPORT 7 8.59e-01 -3.87e-02 9.74e-01
DNA REPLICATION CHECKPOINT SIGNALING 18 7.76e-01 -3.87e-02 9.64e-01
MITOCHONDRION LOCALIZATION 50 6.36e-01 3.86e-02 9.38e-01
REGULATION OF PROTEOLYSIS INVOLVED IN PROTEIN CATABOLIC PROCESS 233 3.10e-01 -3.86e-02 8.13e-01
REGULATION OF HORMONE SECRETION 252 2.91e-01 -3.86e-02 7.99e-01
NEGATIVE REGULATION OF LEUKOCYTE MIGRATION 54 6.24e-01 3.86e-02 9.33e-01
XMP METABOLIC PROCESS 7 8.60e-01 3.85e-02 9.74e-01
NUCLEOTIDE SUGAR METABOLIC PROCESS 37 6.85e-01 -3.85e-02 9.50e-01
CD40 SIGNALING PATHWAY 16 7.90e-01 3.85e-02 9.66e-01
CELL ADHESION INVOLVED IN HEART MORPHOGENESIS 6 8.70e-01 3.85e-02 9.76e-01
CELL FATE SPECIFICATION 110 4.86e-01 3.84e-02 8.94e-01
OOGENESIS 110 4.88e-01 -3.83e-02 8.94e-01
ACUTE INFLAMMATORY RESPONSE 105 4.98e-01 3.83e-02 8.99e-01
TRANSFORMING GROWTH FACTOR BETA1 PRODUCTION 17 7.85e-01 -3.83e-02 9.65e-01
REGULATION OF GUANYL NUCLEOTIDE EXCHANGE FACTOR ACTIVITY 7 8.61e-01 -3.83e-02 9.74e-01
SURFACTANT HOMEOSTASIS 17 7.85e-01 3.83e-02 9.65e-01
ASPARTATE FAMILY AMINO ACID METABOLIC PROCESS 48 6.47e-01 3.82e-02 9.41e-01
TOLERANCE INDUCTION TO SELF ANTIGEN 5 8.82e-01 3.82e-02 9.78e-01
REGULATION OF NEUROGENESIS 390 1.96e-01 -3.82e-02 7.19e-01
NEGATIVE REGULATION OF LEUKOCYTE CELL CELL ADHESION 149 4.21e-01 -3.82e-02 8.72e-01
REGULATION OF GROWTH 614 1.06e-01 -3.82e-02 6.11e-01
BEHAVIORAL RESPONSE TO COCAINE 14 8.05e-01 -3.82e-02 9.68e-01
CARDIAC MUSCLE CELL CONTRACTION 76 5.65e-01 -3.81e-02 9.21e-01
PYRIMIDINE NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS 21 7.62e-01 -3.81e-02 9.61e-01
NEGATIVE REGULATION OF TRANSPORT 466 1.58e-01 -3.81e-02 6.79e-01
REGULATION OF CILIUM DEPENDENT CELL MOTILITY 29 7.23e-01 3.81e-02 9.56e-01
POSITIVE REGULATION OF STEROL TRANSPORT 38 6.85e-01 -3.81e-02 9.50e-01
REGULATION OF SECONDARY METABOLIC PROCESS 16 7.92e-01 3.81e-02 9.67e-01
NEGATIVE REGULATION OF LEUKOCYTE MEDIATED IMMUNITY 68 5.87e-01 3.81e-02 9.24e-01
SULFUR AMINO ACID BIOSYNTHETIC PROCESS 16 7.92e-01 -3.81e-02 9.67e-01
TERMINATION OF RNA POLYMERASE II TRANSCRIPTION 10 8.35e-01 -3.81e-02 9.71e-01
MIRNA PROCESSING 47 6.52e-01 -3.80e-02 9.41e-01
PROTEIN LINEAR POLYUBIQUITINATION 5 8.83e-01 -3.80e-02 9.78e-01
DENDRITIC SPINE DEVELOPMENT 95 5.23e-01 -3.79e-02 9.10e-01
REGULATION OF ALTERNATIVE MRNA SPLICING VIA SPLICEOSOME 52 6.36e-01 3.79e-02 9.38e-01
REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS 44 6.63e-01 -3.79e-02 9.44e-01
INTESTINE SMOOTH MUSCLE CONTRACTION 8 8.53e-01 -3.79e-02 9.74e-01
GOLGI TO PLASMA MEMBRANE TRANSPORT 58 6.18e-01 -3.79e-02 9.32e-01
PROTEOLYSIS INVOLVED IN PROTEIN CATABOLIC PROCESS 740 7.93e-02 -3.79e-02 5.59e-01
REGULATION OF P38MAPK CASCADE 47 6.54e-01 -3.78e-02 9.41e-01
SYNAPTIC VESICLE RECYCLING 82 5.54e-01 -3.78e-02 9.18e-01
REGULATION OF TELOMERASE ACTIVITY 49 6.47e-01 -3.78e-02 9.41e-01
OLIGOSACCHARIDE METABOLIC PROCESS 66 5.95e-01 -3.78e-02 9.27e-01
POSITIVE REGULATION OF ALPHA BETA T CELL ACTIVATION 71 5.82e-01 3.78e-02 9.24e-01
ANTIGEN PROCESSING AND PRESENTATION OF EXOGENOUS PEPTIDE ANTIGEN VIA MHC CLASS II 28 7.29e-01 3.78e-02 9.58e-01
REGULATION OF MONOATOMIC ION TRANSMEMBRANE TRANSPORT 449 1.70e-01 3.77e-02 6.87e-01
REGULATION OF PROTEIN CATABOLIC PROCESS 361 2.18e-01 -3.77e-02 7.36e-01
POSITIVE REGULATION OF GLIAL CELL PROLIFERATION 23 7.54e-01 -3.77e-02 9.60e-01
MONOAMINE TRANSPORT 89 5.39e-01 3.77e-02 9.13e-01
DETECTION OF MECHANICAL STIMULUS 53 6.35e-01 3.77e-02 9.38e-01
POSITIVE REGULATION OF PROTEIN GLYCOSYLATION 8 8.54e-01 -3.77e-02 9.74e-01
ARTERY DEVELOPMENT 111 4.93e-01 -3.77e-02 8.96e-01
REGULATION OF MUSCLE CELL DIFFERENTIATION 162 4.08e-01 -3.76e-02 8.64e-01
INTRACILIARY TRANSPORT 46 6.59e-01 -3.76e-02 9.43e-01
HEART DEVELOPMENT 608 1.13e-01 -3.76e-02 6.25e-01
EMBRYONIC HEMOPOIESIS 24 7.50e-01 -3.76e-02 9.59e-01
CARDIAC MUSCLE CONTRACTION 138 4.46e-01 -3.75e-02 8.79e-01
REGULATION OF RESPONSE TO OXIDATIVE STRESS 34 7.05e-01 -3.75e-02 9.52e-01
REGULATION OF CELL CHEMOTAXIS TO FIBROBLAST GROWTH FACTOR 11 8.30e-01 -3.75e-02 9.71e-01
POSITIVE REGULATION OF DNA REPAIR 128 4.64e-01 -3.75e-02 8.89e-01
DEFENSE RESPONSE TO SYMBIONT 329 2.43e-01 -3.74e-02 7.63e-01
REGULATION OF PEPTIDYL CYSTEINE S NITROSYLATION 11 8.30e-01 -3.74e-02 9.71e-01
NEGATIVE REGULATION OF CELLULAR EXTRAVASATION 9 8.46e-01 3.74e-02 9.72e-01
REGULATION OF BRANCHING INVOLVED IN SALIVARY GLAND MORPHOGENESIS 8 8.55e-01 -3.74e-02 9.74e-01
POSITIVE REGULATION OF CGMP MEDIATED SIGNALING 5 8.85e-01 -3.74e-02 9.78e-01
POSTSYNAPTIC MODULATION OF CHEMICAL SYNAPTIC TRANSMISSION 27 7.37e-01 3.73e-02 9.58e-01
POSITIVE REGULATION OF CARDIOCYTE DIFFERENTIATION 18 7.84e-01 3.73e-02 9.65e-01
POSITIVE REGULATION OF MEIOTIC NUCLEAR DIVISION 17 7.90e-01 -3.73e-02 9.66e-01
MYOTUBE DIFFERENTIATION INVOLVED IN SKELETAL MUSCLE REGENERATION 8 8.55e-01 3.73e-02 9.74e-01
POSITIVE REGULATION OF CELL ADHESION 478 1.63e-01 -3.73e-02 6.81e-01
MONOCARBOXYLIC ACID TRANSPORT 178 3.91e-01 -3.73e-02 8.57e-01
REGULATION OF MYOBLAST FUSION 21 7.68e-01 3.72e-02 9.63e-01
APOPTOTIC PROCESS 1917 6.87e-03 -3.72e-02 1.95e-01
MRNA EXPORT FROM NUCLEUS 67 5.98e-01 -3.72e-02 9.28e-01
POSITIVE REGULATION OF NATURAL KILLER CELL ACTIVATION 24 7.52e-01 -3.72e-02 9.60e-01
NUCLEOSIDE TRIPHOSPHATE CATABOLIC PROCESS 12 8.24e-01 3.72e-02 9.71e-01
LYMPHOCYTE AGGREGATION 5 8.86e-01 -3.72e-02 9.78e-01
NEGATIVE REGULATION OF CELL CYCLE G1 S PHASE TRANSITION 94 5.33e-01 3.72e-02 9.11e-01
PROTEIN LOCALIZATION TO NON MOTILE CILIUM 13 8.17e-01 -3.71e-02 9.70e-01
POSITIVE REGULATION OF MEIOTIC CELL CYCLE 27 7.38e-01 -3.71e-02 9.58e-01
CARBOHYDRATE DERIVATIVE BIOSYNTHETIC PROCESS 639 1.09e-01 -3.71e-02 6.17e-01
STRIATED MUSCLE ATROPHY 7 8.65e-01 -3.71e-02 9.74e-01
SPERMIDINE METABOLIC PROCESS 9 8.47e-01 3.71e-02 9.72e-01
RESPONSE TO NUTRIENT 152 4.30e-01 -3.71e-02 8.74e-01
POSITIVE REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT 44 6.71e-01 -3.70e-02 9.46e-01
INTRACELLULAR PH ELEVATION 8 8.56e-01 3.70e-02 9.74e-01
NEGATIVE REGULATION OF CELL SIZE 9 8.48e-01 -3.70e-02 9.72e-01
REGULATION OF TYPE B PANCREATIC CELL PROLIFERATION 14 8.11e-01 -3.70e-02 9.69e-01
GALACTOLIPID METABOLIC PROCESS 9 8.48e-01 -3.69e-02 9.72e-01
PEPTIDYL LYSINE MONOMETHYLATION 9 8.48e-01 -3.69e-02 9.72e-01
POSITIVE REGULATION OF VIRAL PROCESS 64 6.10e-01 -3.69e-02 9.31e-01
SENSORY PERCEPTION OF TEMPERATURE STIMULUS 27 7.40e-01 -3.68e-02 9.58e-01
REGULATION OF BIOLOGICAL PROCESS INVOLVED IN SYMBIOTIC INTERACTION 65 6.08e-01 -3.68e-02 9.30e-01
SMOOTH MUSCLE CELL APOPTOTIC PROCESS 33 7.15e-01 -3.68e-02 9.55e-01
NEGATIVE REGULATION OF OXIDOREDUCTASE ACTIVITY 29 7.32e-01 -3.67e-02 9.58e-01
POSITIVE REGULATION OF MHC CLASS I BIOSYNTHETIC PROCESS 6 8.76e-01 3.67e-02 9.77e-01
LYMPHANGIOGENESIS 18 7.87e-01 3.67e-02 9.65e-01
POSITIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE ACTIVITY 21 7.71e-01 -3.67e-02 9.63e-01
NEUROMUSCULAR JUNCTION DEVELOPMENT 52 6.47e-01 3.67e-02 9.41e-01
ALPHA AMINO ACID CATABOLIC PROCESS 92 5.43e-01 -3.67e-02 9.13e-01
POSITIVE REGULATION OF INTERLEUKIN 1 PRODUCTION 72 5.91e-01 -3.67e-02 9.26e-01
POSITIVE REGULATION OF RNA BINDING 6 8.77e-01 3.66e-02 9.77e-01
IMMUNOGLOBULIN PRODUCTION 108 5.11e-01 -3.66e-02 9.06e-01
REGULATION OF IMMUNOGLOBULIN PRODUCTION 76 5.82e-01 -3.66e-02 9.24e-01
REGULATION OF T CELL MEDIATED IMMUNITY 97 5.34e-01 3.65e-02 9.12e-01
GLYCINE TRANSPORT 15 8.07e-01 -3.65e-02 9.68e-01
POSITIVE REGULATION OF LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL 26 7.48e-01 3.65e-02 9.59e-01
ERAD PATHWAY 110 5.09e-01 -3.64e-02 9.05e-01
LOCOMOTION 1314 2.68e-02 -3.63e-02 3.67e-01
REGULATION OF ISOTYPE SWITCHING 38 6.99e-01 3.63e-02 9.52e-01
REGULATION OF LONG TERM NEURONAL SYNAPTIC PLASTICITY 22 7.68e-01 -3.63e-02 9.63e-01
OLIGOSACCHARIDE CATABOLIC PROCESS 17 7.96e-01 -3.63e-02 9.67e-01
CEREBRAL CORTEX DEVELOPMENT 125 4.84e-01 3.63e-02 8.94e-01
NEGATIVE REGULATION OF MATRIX METALLOPEPTIDASE SECRETION 7 8.68e-01 -3.63e-02 9.76e-01
PROTEIN CONTAINING COMPLEX ASSEMBLY 1581 1.60e-02 -3.62e-02 2.96e-01
REGULATION OF DNA REPAIR 213 3.62e-01 -3.62e-02 8.46e-01
FOREBRAIN NEURON FATE COMMITMENT 7 8.69e-01 -3.61e-02 9.76e-01
NEGATIVE REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY 32 7.24e-01 3.61e-02 9.56e-01
NON MOTILE CILIUM ASSEMBLY 65 6.15e-01 -3.61e-02 9.32e-01
INTRACELLULAR TRANSPORT OF VIRUS 11 8.36e-01 3.61e-02 9.72e-01
CYCLIC NUCLEOTIDE MEDIATED SIGNALING 82 5.73e-01 3.60e-02 9.24e-01
FORMATION OF CYTOPLASMIC TRANSLATION INITIATION COMPLEX 14 8.16e-01 -3.59e-02 9.70e-01
REGULATION OF CHROMOSOME CONDENSATION 13 8.23e-01 3.59e-02 9.71e-01
PALLIUM DEVELOPMENT 189 3.95e-01 3.59e-02 8.59e-01
MULTICELLULAR ORGANISMAL LEVEL HOMEOSTASIS 805 8.31e-02 -3.59e-02 5.70e-01
NEUTROPHIL ACTIVATION INVOLVED IN IMMUNE RESPONSE 20 7.81e-01 -3.59e-02 9.65e-01
CELLULAR RESPONSE TO RETINOIC ACID 67 6.12e-01 -3.59e-02 9.31e-01
ESTABLISHMENT OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE 63 6.23e-01 -3.59e-02 9.32e-01
CELLULAR RESPONSE TO LEUCINE STARVATION 13 8.23e-01 3.58e-02 9.71e-01
NEGATIVE REGULATION OF TRANSFORMING GROWTH FACTOR BETA PRODUCTION 12 8.30e-01 -3.58e-02 9.71e-01
REGULATION OF LYASE ACTIVITY 58 6.38e-01 3.58e-02 9.38e-01
REGULATION OF SYNAPTIC PLASTICITY 213 3.69e-01 -3.57e-02 8.48e-01
RIBOSOME BIOGENESIS 318 2.74e-01 3.56e-02 7.81e-01
REGULATION OF RESPONSE TO STRESS 1485 2.15e-02 -3.56e-02 3.43e-01
INTRACELLULAR PROTEIN TRANSPORT 863 7.61e-02 -3.55e-02 5.52e-01
CIRCULATORY SYSTEM PROCESS 597 1.38e-01 -3.55e-02 6.63e-01
PYRIMIDINE CONTAINING COMPOUND TRANSMEMBRANE TRANSPORT 16 8.06e-01 -3.54e-02 9.68e-01
REGULATION OF ATP BIOSYNTHETIC PROCESS 18 7.95e-01 -3.54e-02 9.67e-01
POSITIVE REGULATION OF RNA METABOLIC PROCESS 1868 1.10e-02 -3.54e-02 2.45e-01
HYPOTHALAMUS DEVELOPMENT 27 7.50e-01 3.54e-02 9.59e-01
RESPIRATORY GASEOUS EXCHANGE BY RESPIRATORY SYSTEM 74 5.98e-01 -3.54e-02 9.28e-01
MESENDODERM DEVELOPMENT 9 8.54e-01 3.54e-02 9.74e-01
MITOCHONDRIAL RNA CATABOLIC PROCESS 6 8.81e-01 3.54e-02 9.78e-01
ESTABLISHMENT OF CENTROSOME LOCALIZATION 10 8.46e-01 -3.54e-02 9.72e-01
POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY IN ABSENCE OF LIGAND 11 8.39e-01 3.53e-02 9.72e-01
RESPONSE TO TRANSFORMING GROWTH FACTOR BETA 296 2.96e-01 -3.53e-02 8.04e-01
REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS 146 4.62e-01 -3.53e-02 8.88e-01
REGULATION OF INTRACELLULAR PROTEIN TRANSPORT 222 3.65e-01 -3.53e-02 8.48e-01
REGULATION OF ENAMEL MINERALIZATION 7 8.72e-01 3.53e-02 9.77e-01
CELLULAR SENESCENCE 108 5.27e-01 -3.52e-02 9.10e-01
ECTOPIC GERM CELL PROGRAMMED CELL DEATH 18 7.96e-01 -3.52e-02 9.67e-01
REGULATION OF THYROID HORMONE GENERATION 7 8.72e-01 -3.52e-02 9.77e-01
FREE UBIQUITIN CHAIN POLYMERIZATION 9 8.55e-01 3.52e-02 9.74e-01
REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY 184 4.11e-01 3.51e-02 8.64e-01
REGULATION OF MULTICELLULAR ORGANISMAL DEVELOPMENT 1472 2.40e-02 -3.51e-02 3.60e-01
REGULATION OF BIOMINERAL TISSUE DEVELOPMENT 100 5.44e-01 3.51e-02 9.13e-01
ARTERY MORPHOGENESIS 81 5.85e-01 -3.51e-02 9.24e-01
HEART PROCESS 255 3.35e-01 -3.51e-02 8.31e-01
PROTEIN LOCALIZATION TO CELL LEADING EDGE 5 8.92e-01 -3.50e-02 9.79e-01
POSITIVE REGULATION OF NK T CELL ACTIVATION 9 8.56e-01 3.50e-02 9.74e-01
POSITIVE REGULATION OF TISSUE REMODELING 23 7.71e-01 -3.50e-02 9.63e-01
PROTECTION FROM NON HOMOLOGOUS END JOINING AT TELOMERE 8 8.64e-01 3.50e-02 9.74e-01
POTASSIUM ION EXPORT ACROSS PLASMA MEMBRANE 20 7.87e-01 3.49e-02 9.65e-01
REGULATION OF CELL CELL ADHESION MEDIATED BY CADHERIN 21 7.82e-01 3.49e-02 9.65e-01
VASCULAR ENDOTHELIAL GROWTH FACTOR SIGNALING PATHWAY 50 6.69e-01 3.49e-02 9.46e-01
REGULATION OF HEAT GENERATION 12 8.34e-01 3.49e-02 9.71e-01
REGULATION OF ATPASE COUPLED CALCIUM TRANSMEMBRANE TRANSPORTER ACTIVITY 6 8.82e-01 -3.49e-02 9.78e-01
POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA NONHOMOLOGOUS END JOINING 14 8.21e-01 3.49e-02 9.71e-01
GLYCOSYL COMPOUND METABOLIC PROCESS 81 5.87e-01 -3.49e-02 9.24e-01
DE NOVO PROTEIN FOLDING 41 6.99e-01 3.49e-02 9.52e-01
NEGATIVE REGULATION OF ALPHA BETA T CELL ACTIVATION 45 6.86e-01 3.48e-02 9.50e-01
CELL MOTILITY 1784 1.44e-02 -3.48e-02 2.82e-01
CALCIUM ION HOMEOSTASIS 331 2.77e-01 3.48e-02 7.83e-01
EXCRETION 29 7.46e-01 3.48e-02 9.59e-01
REGULATION OF APOPTOTIC PROCESS INVOLVED IN DEVELOPMENT 13 8.28e-01 -3.47e-02 9.71e-01
INNER MITOCHONDRIAL MEMBRANE ORGANIZATION 39 7.08e-01 3.47e-02 9.53e-01
MITOTIC G2 M TRANSITION CHECKPOINT 53 6.63e-01 -3.46e-02 9.44e-01
REGULATION OF GENE SILENCING BY REGULATORY NCRNA 31 7.39e-01 -3.46e-02 9.58e-01
CHAPERONE MEDIATED AUTOPHAGY 15 8.17e-01 -3.46e-02 9.70e-01
CELL CYCLE 1805 1.46e-02 -3.46e-02 2.85e-01
REGULATION OF NODAL SIGNALING PATHWAY INVOLVED IN DETERMINATION OF LEFT RIGHT ASYMMETRY 5 8.94e-01 3.45e-02 9.79e-01
DNA RECOMBINATION 331 2.80e-01 3.45e-02 7.87e-01
ANAGEN 5 8.94e-01 3.45e-02 9.79e-01
SENSORY ORGAN DEVELOPMENT 587 1.53e-01 3.45e-02 6.79e-01
NEGATIVE REGULATION OF INNATE IMMUNE RESPONSE 91 5.70e-01 -3.45e-02 9.22e-01
TAXIS 461 2.04e-01 3.45e-02 7.29e-01
DNA REPLICATION 278 3.23e-01 3.45e-02 8.23e-01
NEGATIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION 78 5.99e-01 -3.44e-02 9.28e-01
REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS 193 4.10e-01 -3.44e-02 8.64e-01
REGULATION OF PROTEIN ACETYLATION 40 7.07e-01 3.44e-02 9.53e-01
RIBOSOMAL LARGE SUBUNIT EXPORT FROM NUCLEUS 7 8.75e-01 3.43e-02 9.77e-01
NEGATIVE REGULATION OF ORGAN GROWTH 36 7.22e-01 -3.43e-02 9.56e-01
RESPONSE TO ENDOGENOUS STIMULUS 1758 1.67e-02 -3.43e-02 2.98e-01
POSITIVE REGULATION OF MONOATOMIC ION TRANSMEMBRANE TRANSPORT 158 4.58e-01 3.42e-02 8.84e-01
MESENCHYMAL TO EPITHELIAL TRANSITION INVOLVED IN METANEPHROS MORPHOGENESIS 11 8.44e-01 3.42e-02 9.72e-01
DNA DEALKYLATION INVOLVED IN DNA REPAIR 9 8.59e-01 -3.41e-02 9.74e-01
CELL FATE SPECIFICATION INVOLVED IN PATTERN SPECIFICATION 7 8.76e-01 3.41e-02 9.77e-01
REGULATION OF GAMMA DELTA T CELL ACTIVATION 11 8.45e-01 -3.41e-02 9.72e-01
POSITIVE REGULATION OF NON MOTILE CILIUM ASSEMBLY 8 8.67e-01 -3.41e-02 9.76e-01
NUCLEOTIDE SUGAR BIOSYNTHETIC PROCESS 19 7.97e-01 -3.40e-02 9.67e-01
REACTIVE OXYGEN SPECIES METABOLIC PROCESS 230 3.74e-01 -3.40e-02 8.50e-01
THYMUS DEVELOPMENT 49 6.80e-01 -3.40e-02 9.50e-01
VENTRICULAR CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION 28 7.56e-01 3.40e-02 9.60e-01
POSITIVE REGULATION OF CREB TRANSCRIPTION FACTOR ACTIVITY 15 8.20e-01 -3.40e-02 9.71e-01
T CELL DIFFERENTIATION IN THYMUS 87 5.84e-01 3.39e-02 9.24e-01
ORGANELLE LOCALIZATION 602 1.55e-01 -3.39e-02 6.79e-01
ICOSANOID BIOSYNTHETIC PROCESS 57 6.58e-01 3.39e-02 9.43e-01
SENSORY ORGAN MORPHOGENESIS 277 3.32e-01 3.38e-02 8.31e-01
RRNA METHYLATION 25 7.70e-01 3.38e-02 9.63e-01
GLUTAMINE METABOLIC PROCESS 27 7.61e-01 3.38e-02 9.61e-01
GDP MANNOSE METABOLIC PROCESS 7 8.77e-01 -3.38e-02 9.77e-01
REGULATION OF CELLULAR RESPONSE TO HYPOXIA 20 7.93e-01 3.38e-02 9.67e-01
VASCULAR ENDOTHELIAL GROWTH FACTOR PRODUCTION 61 6.48e-01 -3.38e-02 9.41e-01
POSITIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS 1671 2.13e-02 -3.38e-02 3.42e-01
DETOXIFICATION 155 4.68e-01 -3.37e-02 8.90e-01
TRANSLATIONAL INITIATION 116 5.31e-01 -3.37e-02 9.11e-01
POSITIVE REGULATION OF MUSCLE CELL APOPTOTIC PROCESS 34 7.34e-01 3.36e-02 9.58e-01
CARBOHYDRATE DERIVATIVE METABOLIC PROCESS 1020 6.93e-02 -3.36e-02 5.33e-01
BIOLOGICAL PROCESS INVOLVED IN INTRASPECIES INTERACTION BETWEEN ORGANISMS 54 6.69e-01 -3.36e-02 9.46e-01
ANTIGEN PROCESSING AND PRESENTATION OF EXOGENOUS PEPTIDE ANTIGEN 37 7.24e-01 -3.36e-02 9.56e-01
REGULATION OF L GLUTAMATE IMPORT ACROSS PLASMA MEMBRANE 8 8.70e-01 -3.35e-02 9.76e-01
MYELOID LEUKOCYTE ACTIVATION 239 3.72e-01 -3.35e-02 8.49e-01
GLUTAMATE CATABOLIC PROCESS 8 8.70e-01 -3.35e-02 9.76e-01
REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN 49 6.85e-01 -3.35e-02 9.50e-01
SCF DEPENDENT PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS 47 6.91e-01 -3.35e-02 9.50e-01
REGULATION OF RESPONSE TO EXTERNAL STIMULUS 1121 5.86e-02 -3.34e-02 4.97e-01
TISSUE REGENERATION 73 6.21e-01 -3.34e-02 9.32e-01
FACULTATIVE HETEROCHROMATIN FORMATION 42 7.08e-01 -3.34e-02 9.53e-01
RESPONSE TO NICOTINE 49 6.86e-01 3.34e-02 9.50e-01
SEMINIFEROUS TUBULE DEVELOPMENT 16 8.17e-01 3.34e-02 9.70e-01
MEMBRANE REPOLARIZATION DURING VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL 16 8.17e-01 -3.33e-02 9.70e-01
CELLULAR RESPONSE TO INTERFERON BETA 26 7.69e-01 -3.33e-02 9.63e-01
ORGANIC HYDROXY COMPOUND BIOSYNTHETIC PROCESS 250 3.64e-01 -3.33e-02 8.48e-01
REGULATION OF CELL DIFFERENTIATION 1603 2.60e-02 -3.33e-02 3.65e-01
POSITIVE REGULATION OF REPRODUCTIVE PROCESS 85 5.96e-01 3.33e-02 9.27e-01
NUCLEOBASE CONTAINING SMALL MOLECULE METABOLIC PROCESS 587 1.68e-01 -3.33e-02 6.87e-01
HEMOSTASIS 230 3.85e-01 -3.32e-02 8.55e-01
SPLICEOSOMAL COMPLEX ASSEMBLY 79 6.10e-01 -3.32e-02 9.31e-01
REGULATION OF MRNA PROCESSING 121 5.28e-01 -3.32e-02 9.10e-01
REGULATION OF CALCIUM ION TRANSPORT 249 3.68e-01 -3.31e-02 8.48e-01
REGULATION OF LEUKOCYTE MIGRATION 225 3.92e-01 -3.31e-02 8.57e-01
NEGATIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION 23 7.83e-01 3.31e-02 9.65e-01
RNA SPLICING VIA TRANSESTERIFICATION REACTIONS 300 3.24e-01 -3.31e-02 8.25e-01
POSITIVE REGULATION OF RETINOIC ACID RECEPTOR SIGNALING PATHWAY 5 8.98e-01 -3.31e-02 9.80e-01
POSITIVE REGULATION OF CELL POPULATION PROLIFERATION 1261 4.82e-02 -3.30e-02 4.58e-01
POSITIVE REGULATION OF PROTEIN IMPORT INTO NUCLEUS 40 7.18e-01 -3.30e-02 9.55e-01
REGULATION OF GRANULOCYTE DIFFERENTIATION 16 8.19e-01 3.30e-02 9.70e-01
NEGATIVE REGULATION OF GENE EXPRESSION EPIGENETIC 113 5.44e-01 -3.30e-02 9.13e-01
NEGATIVE REGULATION OF EPIDERMIS DEVELOPMENT 14 8.31e-01 3.30e-02 9.71e-01
NEGATIVE REGULATION OF RYANODINE SENSITIVE CALCIUM RELEASE CHANNEL ACTIVITY 12 8.44e-01 3.29e-02 9.72e-01
POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS 68 6.40e-01 -3.28e-02 9.39e-01
RESPONSE TO STEROID HORMONE 328 3.07e-01 -3.28e-02 8.11e-01
REGULATION OF ANOIKIS 24 7.81e-01 3.28e-02 9.65e-01
REGULATION OF CHROMOSOME SEGREGATION 130 5.18e-01 -3.28e-02 9.09e-01
NEGATIVE REGULATION OF TRANSPORTER ACTIVITY 96 5.79e-01 -3.28e-02 9.24e-01
L GLUTAMATE IMPORT 39 7.23e-01 -3.28e-02 9.56e-01
NEGATIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY 177 4.52e-01 -3.27e-02 8.81e-01
GLUTAMINE FAMILY AMINO ACID METABOLIC PROCESS 79 6.15e-01 -3.27e-02 9.32e-01
REGULATION OF MEMBRANE LIPID DISTRIBUTION 62 6.56e-01 3.27e-02 9.42e-01
DICARBOXYLIC ACID TRANSPORT 99 5.74e-01 -3.27e-02 9.24e-01
EPITHELIUM DEVELOPMENT 1236 5.31e-02 -3.26e-02 4.77e-01
MRNA METHYLATION 17 8.16e-01 3.26e-02 9.70e-01
NEGATIVE REGULATION OF DNA BINDING 35 7.39e-01 3.26e-02 9.58e-01
MEMBRANE HYPERPOLARIZATION 11 8.51e-01 3.26e-02 9.74e-01
CD8 POSITIVE ALPHA BETA T CELL DIFFERENTIATION 15 8.27e-01 -3.26e-02 9.71e-01
NEGATIVE REGULATION OF CALCIUM ION DEPENDENT EXOCYTOSIS 8 8.73e-01 -3.26e-02 9.77e-01
IODIDE TRANSPORT 9 8.66e-01 -3.26e-02 9.74e-01
CHAPERONE COFACTOR DEPENDENT PROTEIN REFOLDING 32 7.50e-01 3.26e-02 9.59e-01
CHEMICAL SYNAPTIC TRANSMISSION POSTSYNAPTIC 115 5.47e-01 3.25e-02 9.14e-01
URETER DEVELOPMENT 18 8.11e-01 3.25e-02 9.69e-01
REGULATION OF MITOTIC CELL CYCLE 522 2.04e-01 -3.25e-02 7.29e-01
REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS 58 6.69e-01 3.24e-02 9.46e-01
REGULATION OF POSTSYNAPTIC DENSITY ORGANIZATION 14 8.34e-01 3.24e-02 9.71e-01
PROTEIN LOCALIZATION TO ENDOPLASMIC RETICULUM 70 6.39e-01 3.24e-02 9.39e-01
EYE PHOTORECEPTOR CELL DEVELOPMENT 34 7.44e-01 -3.24e-02 9.59e-01
MULTICELLULAR ORGANISM GROWTH 147 4.98e-01 -3.24e-02 8.99e-01
OSMOSENSORY SIGNALING PATHWAY 6 8.91e-01 3.24e-02 9.79e-01
OSTEOCLAST PROLIFERATION 11 8.53e-01 -3.23e-02 9.74e-01
CELL CELL ADHESION MEDIATED BY INTEGRIN 17 8.18e-01 3.23e-02 9.70e-01
PROTEIN RETENTION IN ER LUMEN 8 8.74e-01 -3.23e-02 9.77e-01
TERPENOID CATABOLIC PROCESS 8 8.74e-01 -3.23e-02 9.77e-01
POSITIVE REGULATION OF AMINO ACID TRANSPORT 24 7.84e-01 -3.23e-02 9.65e-01
CONVERGENT EXTENSION INVOLVED IN AXIS ELONGATION 6 8.91e-01 -3.23e-02 9.79e-01
CELLULAR RESPONSE TO CAMP 50 6.93e-01 -3.23e-02 9.50e-01
POSITIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS 614 1.72e-01 -3.22e-02 6.90e-01
LEUKOCYTE CHEMOTAXIS 236 3.93e-01 3.22e-02 8.58e-01
POSITIVE REGULATION OF BLOOD PRESSURE 33 7.49e-01 3.22e-02 9.59e-01
POSITIVE REGULATION OF DEVELOPMENTAL PROCESS 1362 4.58e-02 -3.22e-02 4.48e-01
NEGATIVE REGULATION OF FAT CELL DIFFERENTIATION 61 6.64e-01 3.22e-02 9.44e-01
MRNA TRANSCRIPTION 50 6.95e-01 -3.21e-02 9.51e-01
T HELPER 1 CELL CYTOKINE PRODUCTION 8 8.75e-01 3.21e-02 9.77e-01
POSITIVE REGULATION OF SECONDARY METABOLITE BIOSYNTHETIC PROCESS 10 8.61e-01 3.20e-02 9.74e-01
REGULATION OF HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION 40 7.26e-01 3.20e-02 9.57e-01
REGULATION OF RESTING MEMBRANE POTENTIAL 10 8.61e-01 -3.20e-02 9.74e-01
NEGATIVE REGULATION OF NEURON MIGRATION 11 8.54e-01 -3.20e-02 9.74e-01
REGULATION OF VOLTAGE GATED SODIUM CHANNEL ACTIVITY 10 8.61e-01 3.19e-02 9.74e-01
REGULATION OF NEURON APOPTOTIC PROCESS 231 4.03e-01 -3.19e-02 8.63e-01
NATURAL KILLER CELL DIFFERENTIATION 24 7.87e-01 3.19e-02 9.65e-01
RESPONSE TO RAPAMYCIN 5 9.02e-01 3.19e-02 9.82e-01
NEGATIVE REGULATION OF ERAD PATHWAY 6 8.93e-01 -3.19e-02 9.79e-01
PYRIMIDINE NUCLEOBASE BIOSYNTHETIC PROCESS 8 8.76e-01 3.18e-02 9.77e-01
EXTRACELLULAR EXOSOME ASSEMBLY 7 8.84e-01 3.18e-02 9.78e-01
PEPTIDOGLYCAN METABOLIC PROCESS 6 8.93e-01 3.18e-02 9.79e-01
REGULATION OF GTPASE ACTIVITY 295 3.48e-01 -3.17e-02 8.39e-01
REGULATION OF PROGRAMMED CELL DEATH 1518 3.84e-02 -3.17e-02 4.15e-01
PROTON MOTIVE FORCE DRIVEN ATP SYNTHESIS 67 6.53e-01 3.17e-02 9.41e-01
ACTIN CROSSLINK FORMATION 13 8.43e-01 -3.17e-02 9.72e-01
MODULATION BY HOST OF VIRAL PROCESS 49 7.01e-01 3.17e-02 9.52e-01
REGULATION OF NITRIC OXIDE MEDIATED SIGNAL TRANSDUCTION 11 8.56e-01 -3.17e-02 9.74e-01
SPHINGOMYELIN BIOSYNTHETIC PROCESS 11 8.56e-01 3.17e-02 9.74e-01
HEMATOPOIETIC OR LYMPHOID ORGAN DEVELOPMENT 98 5.88e-01 -3.16e-02 9.24e-01
FATTY ACID HOMEOSTASIS 17 8.21e-01 -3.16e-02 9.71e-01
REGULATION OF CELL DEVELOPMENT 838 1.20e-01 -3.16e-02 6.33e-01
REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT 111 5.65e-01 3.16e-02 9.21e-01
N TERMINAL PEPTIDYL METHIONINE ACETYLATION 6 8.93e-01 3.16e-02 9.79e-01
EXOCYTIC PROCESS 83 6.19e-01 3.16e-02 9.32e-01
CHORION DEVELOPMENT 10 8.63e-01 -3.15e-02 9.74e-01
ADRENAL GLAND DEVELOPMENT 28 7.73e-01 -3.15e-02 9.63e-01
REGULATION OF THE FORCE OF HEART CONTRACTION 26 7.81e-01 3.15e-02 9.65e-01
PYRIMIDINE NUCLEOTIDE CATABOLIC PROCESS 21 8.03e-01 3.15e-02 9.68e-01
CARDIAC ATRIUM DEVELOPMENT 37 7.40e-01 3.15e-02 9.58e-01
CELL CYCLE PROCESS 1293 5.73e-02 -3.14e-02 4.95e-01
RECEPTOR DIFFUSION TRAPPING 10 8.63e-01 3.14e-02 9.74e-01
REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY 49 7.04e-01 -3.14e-02 9.52e-01
CELL PROJECTION ORGANIZATION 1608 3.54e-02 -3.14e-02 4.03e-01
GANGLIOSIDE CATABOLIC PROCESS 7 8.86e-01 -3.14e-02 9.78e-01
REGULATION OF LONG TERM SYNAPTIC DEPRESSION 14 8.39e-01 3.13e-02 9.72e-01
CALCIUM ION TRANSPORT INTO CYTOSOL 28 7.74e-01 3.13e-02 9.63e-01
GLYCOSPHINGOLIPID CATABOLIC PROCESS 14 8.39e-01 3.13e-02 9.72e-01
POSITIVE REGULATION OF DEFENSE RESPONSE 477 2.42e-01 -3.13e-02 7.61e-01
DEFINITIVE HEMOPOIESIS 20 8.09e-01 3.12e-02 9.69e-01
NEGATIVE REGULATION OF PROTEIN BINDING 77 6.36e-01 -3.12e-02 9.38e-01
ENDOSOMAL LUMEN ACIDIFICATION 14 8.40e-01 -3.12e-02 9.72e-01
PROTEIN LOCALIZATION TO MEMBRANE RAFT 10 8.64e-01 -3.12e-02 9.74e-01
OLIGODENDROCYTE DEVELOPMENT 48 7.09e-01 3.12e-02 9.53e-01
POSITIVE REGULATION OF MIRNA TRANSCRIPTION 52 6.98e-01 -3.11e-02 9.52e-01
ORNITHINE METABOLIC PROCESS 10 8.65e-01 3.11e-02 9.74e-01
NADH DEHYDROGENASE COMPLEX ASSEMBLY 54 6.92e-01 3.11e-02 9.50e-01
MAINTENANCE OF BLOOD BRAIN BARRIER 38 7.40e-01 3.11e-02 9.58e-01
REGULATION OF KINASE ACTIVITY 578 2.01e-01 -3.11e-02 7.27e-01
VESICLE DOCKING INVOLVED IN EXOCYTOSIS 42 7.27e-01 3.11e-02 9.57e-01
PRIMARY ALCOHOL METABOLIC PROCESS 104 5.84e-01 3.11e-02 9.24e-01
SERINE FAMILY AMINO ACID METABOLIC PROCESS 38 7.40e-01 3.11e-02 9.58e-01
POSITIVE REGULATION OF PROTEIN DEPHOSPHORYLATION 42 7.28e-01 -3.10e-02 9.58e-01
T CELL SELECTION 53 6.97e-01 -3.09e-02 9.52e-01
CELLULAR RESPONSE TO ATP 18 8.20e-01 -3.09e-02 9.71e-01
NEGATIVE REGULATION OF HEMOPOIESIS 117 5.63e-01 3.09e-02 9.21e-01
NEGATIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY 100 5.94e-01 3.08e-02 9.26e-01
MULTICELLULAR ORGANISMAL LEVEL WATER HOMEOSTASIS 33 7.59e-01 -3.08e-02 9.61e-01
NEGATIVE REGULATION OF CALCIUM ION TRANSPORT 69 6.58e-01 -3.08e-02 9.43e-01
CORONARY VASCULATURE MORPHOGENESIS 19 8.16e-01 3.08e-02 9.70e-01
POSITIVE REGULATION OF CELL CYCLE PHASE TRANSITION 117 5.66e-01 3.07e-02 9.21e-01
ENDODERM FORMATION 58 6.86e-01 3.07e-02 9.50e-01
URETER MORPHOGENESIS 7 8.88e-01 3.07e-02 9.79e-01
SYNAPTIC ASSEMBLY AT NEUROMUSCULAR JUNCTION 10 8.67e-01 3.07e-02 9.75e-01
INTERLEUKIN 1 ALPHA PRODUCTION 11 8.60e-01 -3.06e-02 9.74e-01
T FOLLICULAR HELPER CELL DIFFERENTIATION 7 8.88e-01 -3.06e-02 9.79e-01
SENSORY PERCEPTION OF LIGHT STIMULUS 219 4.35e-01 -3.06e-02 8.74e-01
RESPONSE TO MISFOLDED PROTEIN 25 7.91e-01 -3.06e-02 9.67e-01
PURINE DEOXYRIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS 6 8.97e-01 -3.06e-02 9.80e-01
VERY LONG CHAIN FATTY ACID CATABOLIC PROCESS 7 8.89e-01 3.05e-02 9.79e-01
TRANSPOSITION 38 7.45e-01 3.05e-02 9.59e-01
PROTEOLYSIS 1609 4.12e-02 -3.05e-02 4.29e-01
POSITIVE REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL 41 7.36e-01 -3.05e-02 9.58e-01
METAPHASE CHROMOSOME ALIGNMENT 97 6.05e-01 -3.04e-02 9.29e-01
INNER CELL MASS CELL PROLIFERATION 14 8.44e-01 3.04e-02 9.72e-01
TRIF DEPENDENT TOLL LIKE RECEPTOR SIGNALING PATHWAY 11 8.62e-01 -3.03e-02 9.74e-01
REGULATION OF CELLULAR RESPONSE TO OXIDATIVE STRESS 25 7.93e-01 -3.03e-02 9.67e-01
TNFSF11 MEDIATED SIGNALING PATHWAY 5 9.07e-01 3.03e-02 9.82e-01
GLANDULAR EPITHELIAL CELL DIFFERENTIATION 72 6.56e-01 -3.03e-02 9.42e-01
POSITIVE REGULATION OF MUSCLE CELL DIFFERENTIATION 83 6.33e-01 3.03e-02 9.37e-01
REGULATION OF AMYLOID FIBRIL FORMATION 17 8.29e-01 -3.03e-02 9.71e-01
REGULATION OF HEMATOPOIETIC STEM CELL DIFFERENTIATION 17 8.29e-01 3.02e-02 9.71e-01
VACUOLAR LOCALIZATION 87 6.26e-01 -3.02e-02 9.34e-01
RENAL SYSTEM DEVELOPMENT 324 3.50e-01 3.02e-02 8.41e-01
POSITIVE REGULATION OF MUSCLE HYPERTROPHY 36 7.54e-01 -3.02e-02 9.60e-01
INOSITOL PHOSPHATE BIOSYNTHETIC PROCESS 29 7.79e-01 3.02e-02 9.64e-01
REGULATION OF DEFENSE RESPONSE TO VIRUS BY HOST 44 7.30e-01 -3.01e-02 9.58e-01
NEGATIVE REGULATION OF MESENCHYMAL CELL PROLIFERATION 7 8.90e-01 -3.01e-02 9.79e-01
DUCTUS ARTERIOSUS CLOSURE 5 9.07e-01 3.01e-02 9.82e-01
VESICLE DOCKING 64 6.77e-01 3.01e-02 9.48e-01
ACTIVATED T CELL PROLIFERATION 49 7.16e-01 -3.01e-02 9.55e-01
REGULATION OF BONE MINERALIZATION INVOLVED IN BONE MATURATION 7 8.90e-01 -3.01e-02 9.79e-01
NEGATIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS 476 2.61e-01 -3.00e-02 7.72e-01
REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY 187 4.79e-01 -3.00e-02 8.93e-01
AMINO ACID METABOLIC PROCESS 287 3.81e-01 -3.00e-02 8.52e-01
HEAD DEVELOPMENT 757 1.60e-01 2.99e-02 6.81e-01
VERY LONG CHAIN FATTY ACID METABOLIC PROCESS 35 7.59e-01 -2.99e-02 9.61e-01
CELL PROLIFERATION INVOLVED IN KIDNEY DEVELOPMENT 23 8.04e-01 -2.99e-02 9.68e-01
REGULATION OF GLIAL CELL DIFFERENTIATION 79 6.46e-01 -2.99e-02 9.41e-01
DIAPHRAGM DEVELOPMENT 8 8.84e-01 -2.98e-02 9.78e-01
CELLULAR RESPONSE TO CORTICOSTEROID STIMULUS 59 6.92e-01 -2.98e-02 9.50e-01
REGULATION OF EPINEPHRINE SECRETION 7 8.91e-01 2.98e-02 9.79e-01
REGULATION OF CALCIUM ION EXPORT ACROSS PLASMA MEMBRANE 5 9.08e-01 2.98e-02 9.82e-01
DNA CONFORMATION CHANGE 90 6.25e-01 2.98e-02 9.34e-01
NEGATIVE REGULATION OF CELL FATE COMMITMENT 11 8.64e-01 2.98e-02 9.74e-01
RESPONSE TO X RAY 29 7.82e-01 -2.97e-02 9.65e-01
POSITIVE REGULATION OF DEFENSE RESPONSE TO VIRUS BY HOST 32 7.71e-01 -2.97e-02 9.63e-01
REGULATION OF RECEPTOR CLUSTERING 14 8.47e-01 -2.97e-02 9.72e-01
RESPONSE TO UV A 14 8.47e-01 -2.97e-02 9.72e-01
NEPHRON DEVELOPMENT 157 5.21e-01 2.97e-02 9.09e-01
OVULATION CYCLE 72 6.63e-01 2.97e-02 9.44e-01
MONOATOMIC ION HOMEOSTASIS 606 2.13e-01 2.96e-02 7.32e-01
ADENYLATE CYCLASE ACTIVATING ADRENERGIC RECEPTOR SIGNALING PATHWAY INVOLVED IN HEART PROCESS 9 8.78e-01 -2.96e-02 9.77e-01
REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION 124 5.69e-01 2.96e-02 9.22e-01
NEGATIVE REGULATION OF DEPHOSPHORYLATION 35 7.62e-01 -2.96e-02 9.61e-01
NODAL SIGNALING PATHWAY 16 8.38e-01 2.96e-02 9.72e-01
CELLULAR RESPONSE TO ANTIBIOTIC 12 8.59e-01 2.96e-02 9.74e-01
RETINAL CONE CELL DEVELOPMENT 11 8.65e-01 -2.96e-02 9.74e-01
RESPONSE TO MONOSACCHARIDE 206 4.64e-01 -2.96e-02 8.89e-01
TROPHECTODERMAL CELL DIFFERENTIATION 19 8.23e-01 -2.96e-02 9.71e-01
MEIOTIC CELL CYCLE 283 3.92e-01 2.95e-02 8.57e-01
NEGATIVE REGULATION OF AUTOPHAGOSOME ASSEMBLY 13 8.54e-01 -2.94e-02 9.74e-01
PHAGOCYTOSIS RECOGNITION 29 7.84e-01 -2.94e-02 9.65e-01
MULTICELLULAR ORGANISMAL RESPONSE TO STRESS 92 6.26e-01 2.94e-02 9.34e-01
SNORNA LOCALIZATION 6 9.01e-01 -2.94e-02 9.81e-01
POSITIVE REGULATION OF GTPASE ACTIVITY 228 4.44e-01 -2.94e-02 8.78e-01
EXPORT FROM CELL 893 1.36e-01 -2.94e-02 6.60e-01
DEOXYRIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS 23 8.07e-01 -2.94e-02 9.69e-01
IMPORT INTO NUCLEUS 164 5.17e-01 -2.93e-02 9.08e-01
INORGANIC ION HOMEOSTASIS 534 2.46e-01 2.93e-02 7.64e-01
MAINTENANCE OF APICAL BASAL CELL POLARITY 11 8.66e-01 -2.93e-02 9.75e-01
ORGAN OR TISSUE SPECIFIC IMMUNE RESPONSE 42 7.43e-01 2.93e-02 9.59e-01
POSITIVE REGULATION OF NUCLEOTIDE BIOSYNTHETIC PROCESS 14 8.50e-01 2.93e-02 9.73e-01
RESPONSE TO EPIDERMAL GROWTH FACTOR 45 7.34e-01 -2.93e-02 9.58e-01
REGULATION OF IMMUNE EFFECTOR PROCESS 384 3.25e-01 -2.92e-02 8.25e-01
PROTEASOMAL PROTEIN CATABOLIC PROCESS 525 2.52e-01 -2.92e-02 7.68e-01
REGULATION OF HISTONE ACETYLATION 18 8.30e-01 -2.92e-02 9.71e-01
POSITIVE REGULATION OF INTERLEUKIN 4 PRODUCTION 27 7.93e-01 2.92e-02 9.67e-01
PTERIDINE CONTAINING COMPOUND METABOLIC PROCESS 32 7.75e-01 2.91e-02 9.64e-01
FAT CELL DIFFERENTIATION 249 4.28e-01 2.91e-02 8.74e-01
RESPONSE TO CARBOHYDRATE 230 4.47e-01 -2.91e-02 8.79e-01
CORTICOSPINAL TRACT MORPHOGENESIS 8 8.87e-01 -2.91e-02 9.78e-01
POLYOL METABOLIC PROCESS 108 6.01e-01 -2.91e-02 9.28e-01
CEREBRAL CORTEX CELL MIGRATION 48 7.27e-01 2.91e-02 9.58e-01
REGULATION OF NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION DEPENDENT DECAY 26 7.98e-01 2.91e-02 9.67e-01
BEHAVIOR 649 2.07e-01 2.90e-02 7.29e-01
POSITIVE REGULATION OF NERVOUS SYSTEM PROCESS 31 7.80e-01 -2.90e-02 9.65e-01
TYPE II INTERFERON PRODUCTION 117 5.88e-01 2.90e-02 9.24e-01
POSITIVE REGULATION OF MITOTIC NUCLEAR DIVISION 44 7.40e-01 -2.89e-02 9.58e-01
POSITIVE REGULATION OF BICELLULAR TIGHT JUNCTION ASSEMBLY 7 8.95e-01 -2.89e-02 9.79e-01
ENDOPLASMIC RETICULUM TUBULAR NETWORK ORGANIZATION 20 8.23e-01 2.89e-02 9.71e-01
REGULATION OF BLOOD CIRCULATION 259 4.24e-01 -2.89e-02 8.73e-01
ACETYL COA METABOLIC PROCESS 33 7.74e-01 -2.89e-02 9.63e-01
AMYLOID BETA CLEARANCE 39 7.55e-01 -2.89e-02 9.60e-01
REGULATION OF ODONTOGENESIS 18 8.32e-01 2.88e-02 9.71e-01
STEROID METABOLIC PROCESS 322 3.74e-01 -2.88e-02 8.50e-01
NEGATIVE REGULATION OF ADAPTIVE IMMUNE RESPONSE 62 6.95e-01 2.88e-02 9.51e-01
ENDODERMAL CELL FATE COMMITMENT 15 8.47e-01 -2.87e-02 9.72e-01
RESPONSE TO GROWTH FACTOR 757 1.79e-01 -2.87e-02 6.99e-01
BLOOD COAGULATION FIBRIN CLOT FORMATION 16 8.43e-01 -2.87e-02 9.72e-01
SPLEEN DEVELOPMENT 38 7.60e-01 -2.87e-02 9.61e-01
ALPHA AMINO ACID METABOLIC PROCESS 205 4.79e-01 -2.86e-02 8.94e-01
APICAL PROTEIN LOCALIZATION 15 8.48e-01 -2.86e-02 9.72e-01
REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS 50 7.26e-01 -2.86e-02 9.57e-01
CELLULAR RESPONSE TO FATTY ACID 34 7.73e-01 -2.86e-02 9.63e-01
GENOMIC IMPRINTING 18 8.34e-01 2.85e-02 9.71e-01
CELL CELL ADHESION 954 1.35e-01 -2.85e-02 6.59e-01
PROSTANOID METABOLIC PROCESS 51 7.25e-01 2.85e-02 9.57e-01
POSITIVE REGULATION OF NATURAL KILLER CELL PROLIFERATION 10 8.76e-01 -2.84e-02 9.77e-01
NEGATIVE REGULATION OF MITOTIC CELL CYCLE PHASE TRANSITION 196 4.93e-01 2.84e-02 8.96e-01
LYMPH VESSEL MORPHOGENESIS 23 8.14e-01 -2.84e-02 9.70e-01
EPITHELIAL CELL DIFFERENTIATION INVOLVED IN PROSTATE GLAND DEVELOPMENT 11 8.71e-01 -2.84e-02 9.76e-01
NEGATIVE REGULATION OF SECRETION 169 5.25e-01 -2.84e-02 9.10e-01
MONOATOMIC ION TRANSMEMBRANE TRANSPORT 1022 1.25e-01 2.84e-02 6.46e-01
RENAL TUBULAR SECRETION 19 8.31e-01 -2.84e-02 9.71e-01
MYOBLAST FATE COMMITMENT 6 9.04e-01 2.83e-02 9.82e-01
REGULATION OF HEART RATE BY CARDIAC CONDUCTION 38 7.62e-01 2.83e-02 9.61e-01
MATURATION OF LSU RRNA 28 7.95e-01 2.83e-02 9.67e-01
PROTEIN HOMOTETRAMERIZATION 59 7.07e-01 2.83e-02 9.53e-01
POSITIVE REGULATION OF AMIDE METABOLIC PROCESS 163 5.33e-01 -2.83e-02 9.11e-01
PURINE CONTAINING COMPOUND METABOLIC PROCESS 477 2.90e-01 -2.83e-02 7.99e-01
POSTSYNAPTIC SIGNAL TRANSDUCTION 38 7.63e-01 -2.83e-02 9.61e-01
RESPONSE TO L PHENYLALANINE DERIVATIVE 6 9.05e-01 2.83e-02 9.82e-01
VISUAL BEHAVIOR 56 7.15e-01 -2.82e-02 9.55e-01
POSITIVE REGULATION OF NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION DEPENDENT DECAY 15 8.50e-01 2.82e-02 9.73e-01
PROTEIN KINASE C SIGNALING 35 7.73e-01 -2.82e-02 9.63e-01
REGULATION OF LYMPHOID PROGENITOR CELL DIFFERENTIATION 12 8.66e-01 -2.82e-02 9.74e-01
LEUKOCYTE DEGRANULATION 79 6.66e-01 2.81e-02 9.45e-01
NEGATIVE REGULATION OF NON CANONICAL NF KAPPAB SIGNAL TRANSDUCTION 42 7.53e-01 2.81e-02 9.60e-01
LYMPH VESSEL DEVELOPMENT 31 7.87e-01 -2.80e-02 9.65e-01
DEPYRIMIDINATION 8 8.91e-01 2.79e-02 9.79e-01
GLYCOSYL COMPOUND CATABOLIC PROCESS 35 7.75e-01 -2.79e-02 9.64e-01
REGULATION OF ORGANELLE TRANSPORT ALONG MICROTUBULE 10 8.79e-01 -2.79e-02 9.77e-01
NEGATIVE REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION 15 8.52e-01 -2.79e-02 9.74e-01
AMIDE TRANSPORT 354 3.67e-01 -2.79e-02 8.48e-01
NEGATIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS 1238 9.84e-02 -2.79e-02 6.00e-01
LONG CHAIN FATTY ACYL COA METABOLIC PROCESS 25 8.10e-01 2.78e-02 9.69e-01
SODIUM ION EXPORT ACROSS PLASMA MEMBRANE 15 8.52e-01 -2.78e-02 9.74e-01
PARALLEL ACTIN FILAMENT BUNDLE ASSEMBLY 7 8.99e-01 2.77e-02 9.81e-01
CYTOSKELETON DEPENDENT INTRACELLULAR TRANSPORT 207 4.92e-01 -2.77e-02 8.96e-01
POSITIVE REGULATION OF CELL CYCLE PROCESS 257 4.44e-01 -2.77e-02 8.78e-01
RADIAL GLIA GUIDED PYRAMIDAL NEURON MIGRATION 6 9.06e-01 2.77e-02 9.82e-01
REGULATION OF BONE MINERALIZATION 80 6.69e-01 2.77e-02 9.46e-01
MAINTENANCE OF CENTROSOME LOCATION 6 9.07e-01 2.77e-02 9.82e-01
TYPE I PNEUMOCYTE DIFFERENTIATION 8 8.92e-01 2.77e-02 9.79e-01
LEUKOCYTE PROLIFERATION 341 3.80e-01 2.77e-02 8.51e-01
ATTACHMENT OF SPINDLE MICROTUBULES TO KINETOCHORE 49 7.38e-01 2.76e-02 9.58e-01
GAMMA AMINOBUTYRIC ACID SECRETION 12 8.69e-01 2.76e-02 9.76e-01
VENTRICULAR CARDIAC MUSCLE TISSUE DEVELOPMENT 58 7.16e-01 2.76e-02 9.55e-01
CELLULAR RESPONSE TO EXOGENOUS DSRNA 17 8.44e-01 2.76e-02 9.72e-01
NEGATIVE REGULATION OF TOLL LIKE RECEPTOR 2 SIGNALING PATHWAY 7 8.99e-01 -2.76e-02 9.81e-01
REGULATION OF TRANSCRIPTION BY RNA POLYMERASE III 30 7.94e-01 2.75e-02 9.67e-01
REGULATION OF SYNAPTIC VESICLE RECYCLING 26 8.08e-01 2.75e-02 9.69e-01
AUTOPHAGOSOME MATURATION 62 7.08e-01 -2.75e-02 9.53e-01
POSITIVE REGULATION OF LIPID LOCALIZATION 111 6.17e-01 -2.75e-02 9.32e-01
ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY 183 5.22e-01 -2.75e-02 9.10e-01
PYRIMIDINE CONTAINING COMPOUND METABOLIC PROCESS 89 6.55e-01 -2.74e-02 9.42e-01
LEUKOCYTE MIGRATION INVOLVED IN INFLAMMATORY RESPONSE 19 8.36e-01 -2.74e-02 9.72e-01
CILIUM MOVEMENT 200 5.05e-01 2.73e-02 9.02e-01
AXONEMAL CENTRAL APPARATUS ASSEMBLY 6 9.08e-01 2.73e-02 9.82e-01
CHAPERONE MEDIATED PROTEIN FOLDING 75 6.83e-01 2.73e-02 9.50e-01
POSITIVE REGULATION OF MONOATOMIC ION TRANSPORT 213 4.92e-01 2.73e-02 8.96e-01
HEART GROWTH 96 6.44e-01 -2.73e-02 9.41e-01
REGULATION OF ERYTHROCYTE DIFFERENTIATION 47 7.46e-01 -2.73e-02 9.59e-01
REGULATION OF ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION 29 8.00e-01 2.72e-02 9.67e-01
VESICLE TARGETING 66 7.02e-01 -2.72e-02 9.52e-01
NEUROMUSCULAR SYNAPTIC TRANSMISSION 28 8.03e-01 2.72e-02 9.68e-01
KYNURENINE METABOLIC PROCESS 11 8.76e-01 -2.71e-02 9.77e-01
ENDOCRINE PANCREAS DEVELOPMENT 46 7.51e-01 2.71e-02 9.59e-01
TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY 406 3.49e-01 -2.71e-02 8.40e-01
MITOTIC CELL CYCLE 928 1.62e-01 -2.71e-02 6.81e-01
NEGATIVE REGULATION OF PROTEIN CATABOLIC PROCESS 110 6.24e-01 -2.71e-02 9.33e-01
KERATINOCYTE PROLIFERATION 60 7.17e-01 -2.71e-02 9.55e-01
VESICLE CARGO LOADING 29 8.01e-01 -2.70e-02 9.68e-01
PROGRAMMED CELL DEATH INVOLVED IN CELL DEVELOPMENT 25 8.15e-01 -2.70e-02 9.70e-01
NEGATIVE REGULATION OF MHC CLASS II BIOSYNTHETIC PROCESS 6 9.09e-01 -2.70e-02 9.82e-01
POLAR BODY EXTRUSION AFTER MEIOTIC DIVISIONS 5 9.17e-01 -2.70e-02 9.87e-01
SEXUAL REPRODUCTION 1032 1.43e-01 2.70e-02 6.69e-01
NEGATIVE REGULATION OF B CELL PROLIFERATION 16 8.52e-01 -2.69e-02 9.74e-01
BILE ACID AND BILE SALT TRANSPORT 29 8.02e-01 2.69e-02 9.68e-01
ALPHA BETA T CELL DIFFERENTIATION 124 6.06e-01 -2.68e-02 9.29e-01
POSITIVE REGULATION OF LEUKOCYTE MIGRATION 145 5.78e-01 -2.68e-02 9.24e-01
GLYCOLIPID BIOSYNTHETIC PROCESS 73 6.92e-01 -2.68e-02 9.50e-01
NUCLEAR TRANSPORT 323 4.08e-01 -2.68e-02 8.64e-01
RESPONSE TO ALDOSTERONE 18 8.44e-01 -2.68e-02 9.72e-01
REGULATION OF TETRAPYRROLE METABOLIC PROCESS 9 8.89e-01 2.68e-02 9.79e-01
FORMATION OF PRIMARY GERM LAYER 127 6.02e-01 -2.68e-02 9.29e-01
REGULATION OF BINDING 260 4.57e-01 -2.68e-02 8.84e-01
AEROBIC RESPIRATION 179 5.37e-01 2.68e-02 9.13e-01
MYD88 DEPENDENT TOLL LIKE RECEPTOR SIGNALING PATHWAY 20 8.36e-01 -2.67e-02 9.72e-01
CELLULAR RESPONSE TO BIOTIC STIMULUS 263 4.56e-01 -2.67e-02 8.84e-01
REGULATION OF CENTRIOLE REPLICATION 23 8.25e-01 2.67e-02 9.71e-01
NOTCH SIGNALING INVOLVED IN HEART DEVELOPMENT 11 8.78e-01 -2.66e-02 9.77e-01
NEGATIVE REGULATION OF GLIAL CELL DIFFERENTIATION 28 8.07e-01 -2.66e-02 9.69e-01
POSITIVE REGULATION OF FATTY ACID TRANSPORT 23 8.25e-01 -2.66e-02 9.71e-01
REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT 59 7.24e-01 2.66e-02 9.56e-01
PROTEIN LOCALIZATION TO MITOCHONDRION 131 6.00e-01 -2.65e-02 9.28e-01
REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORT 86 6.70e-01 2.65e-02 9.46e-01
NEGATIVE REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY 57 7.29e-01 2.65e-02 9.58e-01
MICROTUBULE BASED PROCESS 931 1.70e-01 -2.65e-02 6.87e-01
COGNITION 317 4.18e-01 2.65e-02 8.68e-01
TRANSPORT OF VIRUS 23 8.26e-01 2.65e-02 9.71e-01
MEMBRANE DOCKING 92 6.61e-01 2.65e-02 9.44e-01
HOMEOSTATIC PROCESS 1717 6.79e-02 -2.64e-02 5.32e-01
REGULATION OF TRANSLATIONAL INITIATION BY EIF2 ALPHA PHOSPHORYLATION 10 8.85e-01 -2.64e-02 9.78e-01
MEIOSIS I CELL CYCLE PROCESS 133 5.99e-01 2.64e-02 9.28e-01
CRANIAL SUTURE MORPHOGENESIS 8 8.97e-01 -2.64e-02 9.80e-01
REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY 65 7.13e-01 -2.64e-02 9.55e-01
CELL COMMUNICATION BY ELECTRICAL COUPLING INVOLVED IN CARDIAC CONDUCTION 27 8.12e-01 2.64e-02 9.70e-01
RESPONSE TO UV 152 5.75e-01 -2.64e-02 9.24e-01
TUBULIN DEACETYLATION 22 8.30e-01 -2.64e-02 9.71e-01
REGULATION OF DNA TEMPLATED TRANSCRIPTION IN RESPONSE TO STRESS 39 7.76e-01 2.63e-02 9.64e-01
NEGATIVE REGULATION OF LEUKOCYTE CHEMOTAXIS 22 8.31e-01 2.63e-02 9.71e-01
MITOCHONDRIAL DNA METABOLIC PROCESS 23 8.27e-01 -2.63e-02 9.71e-01
T HELPER 1 TYPE IMMUNE RESPONSE 48 7.53e-01 2.63e-02 9.60e-01
RECEPTOR LOCALIZATION TO SYNAPSE 62 7.21e-01 2.63e-02 9.56e-01
REPRODUCTIVE SYSTEM DEVELOPMENT 301 4.34e-01 2.62e-02 8.74e-01
SPERM MOTILITY 132 6.03e-01 2.62e-02 9.29e-01
SECRETION 950 1.71e-01 -2.62e-02 6.87e-01
NEGATIVE REGULATION OF LIPID BIOSYNTHETIC PROCESS 68 7.09e-01 2.62e-02 9.53e-01
XENOBIOTIC TRANSMEMBRANE TRANSPORT 16 8.56e-01 -2.62e-02 9.74e-01
PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION 812 2.04e-01 -2.62e-02 7.29e-01
NEGATIVE REGULATION OF DENDRITE MORPHOGENESIS 8 8.98e-01 -2.61e-02 9.80e-01
LENS FIBER CELL DEVELOPMENT 14 8.66e-01 2.61e-02 9.74e-01
REGULATION OF LONG TERM SYNAPTIC POTENTIATION 46 7.59e-01 2.61e-02 9.61e-01
REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS 180 5.45e-01 -2.61e-02 9.13e-01
POSITIVE REGULATION OF FOCAL ADHESION ASSEMBLY 26 8.18e-01 -2.61e-02 9.70e-01
THIOESTER METABOLIC PROCESS 94 6.62e-01 2.61e-02 9.44e-01
POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS 11 8.81e-01 2.60e-02 9.78e-01
REGULATION OF STRIATED MUSCLE TISSUE DEVELOPMENT 18 8.48e-01 2.60e-02 9.72e-01
RELAXATION OF MUSCLE 33 7.96e-01 2.60e-02 9.67e-01
NEGATIVE REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY 25 8.22e-01 -2.60e-02 9.71e-01
POSITIVE REGULATION OF MITOTIC CELL CYCLE PHASE TRANSITION 97 6.58e-01 2.60e-02 9.43e-01
SYNAPTIC VESICLE LUMEN ACIDIFICATION 16 8.57e-01 2.60e-02 9.74e-01
POSITIVE REGULATION OF MYOBLAST FUSION 16 8.57e-01 -2.59e-02 9.74e-01
POSITIVE REGULATION OF IMMUNE SYSTEM PROCESS 1042 1.57e-01 -2.59e-02 6.79e-01
INTERLEUKIN 17 MEDIATED SIGNALING PATHWAY 11 8.82e-01 2.59e-02 9.78e-01
METENCEPHALON DEVELOPMENT 110 6.39e-01 2.59e-02 9.39e-01
POSITIVE REGULATION OF CALCIUM ION IMPORT 15 8.62e-01 2.58e-02 9.74e-01
NEGATIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY 5 9.20e-01 -2.58e-02 9.87e-01
REGULATION OF NERVOUS SYSTEM DEVELOPMENT 466 3.40e-01 -2.58e-02 8.35e-01
SNRNA TRANSCRIPTION 19 8.46e-01 -2.58e-02 9.72e-01
PRENYLATION 12 8.77e-01 -2.58e-02 9.77e-01
POSITIVE REGULATION OF AXON EXTENSION INVOLVED IN AXON GUIDANCE 7 9.06e-01 2.57e-02 9.82e-01
NEGATIVE REGULATION OF PROGRAMMED CELL DEATH 914 1.87e-01 -2.57e-02 7.08e-01
OPTIC NERVE MORPHOGENESIS 6 9.13e-01 -2.57e-02 9.85e-01
ACTIVATION OF JANUS KINASE ACTIVITY 13 8.73e-01 -2.57e-02 9.77e-01
EMBRYONIC CAMERA TYPE EYE DEVELOPMENT 37 7.87e-01 2.57e-02 9.65e-01
POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CELL CORTEX 6 9.13e-01 2.57e-02 9.85e-01
REGULATION OF ADIPOSE TISSUE DEVELOPMENT 16 8.59e-01 -2.56e-02 9.74e-01
HOMEOSTASIS OF NUMBER OF CELLS 315 4.34e-01 -2.56e-02 8.74e-01
REGULATION OF T CELL MEDIATED CYTOTOXICITY 49 7.56e-01 -2.56e-02 9.61e-01
ACTIN NUCLEATION 55 7.43e-01 2.56e-02 9.59e-01
POSITIVE REGULATION OF TRANSPORT 887 1.96e-01 -2.56e-02 7.20e-01
POSITIVE REGULATION OF SUPEROXIDE ANION GENERATION 16 8.59e-01 2.56e-02 9.74e-01
ER ASSOCIATED MISFOLDED PROTEIN CATABOLIC PROCESS 12 8.78e-01 -2.56e-02 9.77e-01
B CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE 88 6.79e-01 2.55e-02 9.49e-01
CGMP BIOSYNTHETIC PROCESS 11 8.83e-01 2.55e-02 9.78e-01
POSITIVE REGULATION OF TORC2 SIGNALING 5 9.21e-01 -2.55e-02 9.87e-01
NEGATIVE REGULATION OF DNA BIOSYNTHETIC PROCESS 38 7.86e-01 -2.54e-02 9.65e-01
INSULIN SECRETION INVOLVED IN CELLULAR RESPONSE TO GLUCOSE STIMULUS 64 7.25e-01 2.54e-02 9.57e-01
POSITIVE REGULATION OF NITRIC OXIDE METABOLIC PROCESS 39 7.83e-01 -2.54e-02 9.65e-01
POSITIVE REGULATION OF WNT SIGNALING PATHWAY PLANAR CELL POLARITY PATHWAY 9 8.95e-01 -2.54e-02 9.80e-01
NEGATIVE REGULATION OF SMOOTHENED SIGNALING PATHWAY INVOLVED IN DORSAL VENTRAL NEURAL TUBE PATTERNING 7 9.07e-01 -2.54e-02 9.82e-01
AMMONIUM HOMEOSTASIS 6 9.14e-01 2.54e-02 9.85e-01
DNA INTEGRITY CHECKPOINT SIGNALING 135 6.11e-01 -2.53e-02 9.31e-01
NEGATIVE REGULATION OF INTERLEUKIN 13 PRODUCTION 7 9.08e-01 2.53e-02 9.82e-01
TERPENOID METABOLIC PROCESS 98 6.65e-01 2.53e-02 9.45e-01
ORGANELLE INHERITANCE 15 8.65e-01 -2.53e-02 9.74e-01
MESODERM DEVELOPMENT 130 6.18e-01 -2.53e-02 9.32e-01
NEGATIVE REGULATION OF CATALYTIC ACTIVITY 474 3.46e-01 2.52e-02 8.37e-01
TOR SIGNALING 164 5.78e-01 -2.52e-02 9.24e-01
MICROVILLUS ASSEMBLY 22 8.38e-01 2.52e-02 9.72e-01
GOLGI TO ENDOSOME TRANSPORT 17 8.57e-01 -2.52e-02 9.74e-01
GDP METABOLIC PROCESS 11 8.85e-01 2.52e-02 9.78e-01
CD4 POSITIVE ALPHA BETA T CELL ACTIVATION 117 6.39e-01 -2.51e-02 9.39e-01
POSITIVE REGULATION OF PLASMINOGEN ACTIVATION 8 9.02e-01 -2.50e-02 9.82e-01
SUBSTANTIA NIGRA DEVELOPMENT 43 7.76e-01 -2.50e-02 9.64e-01
CELL FATE COMMITMENT 286 4.66e-01 2.50e-02 8.90e-01
NEGATIVE REGULATION OF CELL DIFFERENTIATION 703 2.59e-01 -2.50e-02 7.72e-01
RESPONSE TO NERVE GROWTH FACTOR 48 7.65e-01 -2.50e-02 9.61e-01
GRANULOCYTE ACTIVATION 48 7.65e-01 2.49e-02 9.61e-01
POSITIVE REGULATION OF TRANSPORTER ACTIVITY 94 6.76e-01 2.49e-02 9.48e-01
MITOTIC CELL CYCLE PROCESS 773 2.38e-01 -2.49e-02 7.57e-01
NUCLEOBASE CONTAINING COMPOUND TRANSPORT 219 5.26e-01 -2.49e-02 9.10e-01
REGULATION OF HUMORAL IMMUNE RESPONSE 47 7.68e-01 -2.49e-02 9.63e-01
PHAGOCYTOSIS ENGULFMENT 47 7.68e-01 2.49e-02 9.63e-01
NEGATIVE REGULATION OF AMYLOID BETA CLEARANCE 11 8.87e-01 2.49e-02 9.78e-01
REGULATION OF PROTEIN NEDDYLATION 19 8.52e-01 -2.48e-02 9.74e-01
REGULATORY T CELL DIFFERENTIATION 41 7.84e-01 -2.48e-02 9.65e-01
SKIN DEVELOPMENT 312 4.52e-01 -2.48e-02 8.81e-01
NEPHRON EPITHELIUM DEVELOPMENT 120 6.40e-01 2.47e-02 9.39e-01
POSITIVE REGULATION OF PLATELET AGGREGATION 11 8.87e-01 -2.47e-02 9.79e-01
RESPONSE TO INORGANIC SUBSTANCE 524 3.33e-01 -2.47e-02 8.31e-01
VENTRICULAR CARDIAC MUSCLE TISSUE MORPHOGENESIS 47 7.69e-01 2.47e-02 9.63e-01
REGULATION OF MACROPHAGE ACTIVATION 61 7.39e-01 2.47e-02 9.58e-01
ESTABLISHMENT OF ORGANELLE LOCALIZATION 465 3.62e-01 -2.46e-02 8.46e-01
REGULATION OF LIPOPROTEIN METABOLIC PROCESS 17 8.60e-01 2.46e-02 9.74e-01
THREONINE METABOLIC PROCESS 5 9.24e-01 -2.46e-02 9.88e-01
REGULATION OF GLIOGENESIS 110 6.56e-01 -2.46e-02 9.42e-01
CYTIDINE METABOLIC PROCESS 12 8.83e-01 2.46e-02 9.78e-01
SPINAL CORD MOTOR NEURON CELL FATE SPECIFICATION 10 8.93e-01 -2.46e-02 9.79e-01
PROTEIN LOCALIZATION TO LYSOSOME 60 7.42e-01 -2.46e-02 9.59e-01
REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT 172 5.79e-01 -2.45e-02 9.24e-01
VITAMIN D RECEPTOR SIGNALING PATHWAY 12 8.83e-01 2.45e-02 9.78e-01
CELLULAR RESPONSE TO IONIZING RADIATION 70 7.23e-01 -2.45e-02 9.56e-01
SNARE COMPLEX ASSEMBLY 23 8.39e-01 2.45e-02 9.72e-01
REGULATION OF CHROMATIN BINDING 11 8.88e-01 2.45e-02 9.79e-01
ELECTRON TRANSPORT CHAIN 161 5.92e-01 -2.44e-02 9.26e-01
SYNAPTIC VESICLE DOCKING 10 8.94e-01 2.44e-02 9.79e-01
TERPENOID BIOSYNTHETIC PROCESS 16 8.66e-01 2.44e-02 9.74e-01
MALE SEX DETERMINATION 13 8.79e-01 2.44e-02 9.77e-01
CARTILAGE CONDENSATION 19 8.54e-01 2.43e-02 9.74e-01
SINGLE STRANDED VIRAL RNA REPLICATION VIA DOUBLE STRANDED DNA INTERMEDIATE 20 8.51e-01 2.43e-02 9.73e-01
ALPHA KETOGLUTARATE TRANSPORT 7 9.12e-01 2.42e-02 9.84e-01
RIBONUCLEOPROTEIN COMPLEX LOCALIZATION 9 9.00e-01 2.42e-02 9.81e-01
GLYCOLIPID CATABOLIC PROCESS 17 8.63e-01 2.42e-02 9.74e-01
POSITIVE REGULATION OF BLOOD CIRCULATION 40 7.91e-01 2.42e-02 9.67e-01
REGULATION OF HEPATIC STELLATE CELL ACTIVATION 7 9.12e-01 -2.41e-02 9.84e-01
POSITIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT 61 7.44e-01 -2.41e-02 9.59e-01
CALCIUM IMPORT INTO THE MITOCHONDRION 12 8.85e-01 -2.41e-02 9.78e-01
PROTEIN ACYLATION 142 6.20e-01 -2.41e-02 9.32e-01
POSITIVE REGULATION OF STEM CELL PROLIFERATION 55 7.58e-01 -2.41e-02 9.61e-01
VESICLE ORGANIZATION 361 4.32e-01 -2.41e-02 8.74e-01
TELOMERE ORGANIZATION 181 5.77e-01 -2.40e-02 9.24e-01
CILIUM OR FLAGELLUM DEPENDENT CELL MOTILITY 160 6.00e-01 2.40e-02 9.28e-01
DEFENSE RESPONSE TO OTHER ORGANISM 1171 1.66e-01 2.40e-02 6.84e-01
DETECTION OF BIOTIC STIMULUS 38 7.98e-01 -2.40e-02 9.67e-01
PROTOPORPHYRINOGEN IX BIOSYNTHETIC PROCESS 9 9.01e-01 -2.40e-02 9.81e-01
RISC COMPLEX ASSEMBLY 10 8.96e-01 -2.40e-02 9.80e-01
EPIDERMIS MORPHOGENESIS 37 8.01e-01 -2.39e-02 9.68e-01
EPITHELIAL FLUID TRANSPORT 11 8.91e-01 -2.39e-02 9.79e-01
POSITIVE REGULATION OF CATALYTIC ACTIVITY 922 2.18e-01 -2.39e-02 7.37e-01
POSITIVE REGULATION OF GLIOGENESIS 72 7.26e-01 -2.39e-02 9.57e-01
NEGATIVE REGULATION OF TYPE II INTERFERON PRODUCTION 42 7.89e-01 -2.39e-02 9.66e-01
REGULATION OF HEPATOCYTE PROLIFERATION 16 8.69e-01 -2.38e-02 9.76e-01
NEGATIVE REGULATION OF PHOSPHOPROTEIN PHOSPHATASE ACTIVITY 20 8.54e-01 2.38e-02 9.74e-01
POSITIVE REGULATION OF NEUROBLAST PROLIFERATION 37 8.02e-01 2.38e-02 9.68e-01
REGULATION OF LEUKOCYTE DIFFERENTIATION 321 4.64e-01 -2.38e-02 8.89e-01
REGULATION OF PROTEIN POLYUBIQUITINATION 28 8.28e-01 2.38e-02 9.71e-01
REGULATION OF INSULIN SECRETION INVOLVED IN CELLULAR RESPONSE TO GLUCOSE STIMULUS 54 7.63e-01 2.37e-02 9.61e-01
PULMONARY VALVE DEVELOPMENT 23 8.44e-01 -2.37e-02 9.72e-01
POSITIVE T CELL SELECTION 40 7.95e-01 -2.37e-02 9.67e-01
POSITIVE REGULATION OF CELL MIGRATION BY VASCULAR ENDOTHELIAL GROWTH FACTOR SIGNALING PATHWAY 8 9.08e-01 -2.37e-02 9.82e-01
EMBRYONIC BRAIN DEVELOPMENT 18 8.62e-01 -2.37e-02 9.74e-01
RESPONSE TO ZINC ION 51 7.70e-01 2.37e-02 9.63e-01
REGULATION OF STEM CELL PROLIFERATION 95 6.91e-01 -2.36e-02 9.50e-01
IMMUNE RESPONSE REGULATING CELL SURFACE RECEPTOR SIGNALING PATHWAY 321 4.67e-01 -2.36e-02 8.90e-01
POINTED END ACTIN FILAMENT CAPPING 7 9.14e-01 -2.36e-02 9.85e-01
MONOATOMIC ION TRANSPORT 1251 1.60e-01 2.36e-02 6.80e-01
POSITIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION 68 7.37e-01 2.36e-02 9.58e-01
RIBOSE PHOSPHATE BIOSYNTHETIC PROCESS 224 5.43e-01 -2.36e-02 9.13e-01
EPIDERMIS DEVELOPMENT 379 4.30e-01 -2.36e-02 8.74e-01
REGULATION OF DEFENSE RESPONSE 811 2.53e-01 -2.36e-02 7.69e-01
REGULATION OF MONOATOMIC ION TRANSPORT 567 3.37e-01 2.36e-02 8.33e-01
RESPONSE TO PROTOZOAN 31 8.21e-01 2.35e-02 9.71e-01
BASE EXCISION REPAIR 44 7.87e-01 2.35e-02 9.65e-01
POSITIVE REGULATION OF CELL CELL ADHESION 319 4.70e-01 2.35e-02 8.90e-01
NEGATIVE REGULATION OF GLUCONEOGENESIS 18 8.63e-01 -2.35e-02 9.74e-01
NEGATIVE REGULATION OF PROTEOLYSIS INVOLVED IN PROTEIN CATABOLIC PROCESS 65 7.43e-01 -2.35e-02 9.59e-01
MALE MEIOSIS I 27 8.33e-01 -2.35e-02 9.71e-01
FACE DEVELOPMENT 51 7.72e-01 -2.35e-02 9.63e-01
REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS 357 4.47e-01 -2.34e-02 8.79e-01
POSITIVE REGULATION OF CHOLESTEROL EFFLUX 27 8.33e-01 -2.34e-02 9.71e-01
RNA PROCESSING 1301 1.55e-01 -2.34e-02 6.79e-01
DOUBLE STRAND BREAK REPAIR INVOLVED IN MEIOTIC RECOMBINATION 11 8.93e-01 2.34e-02 9.79e-01
PROTEIN K48 LINKED DEUBIQUITINATION 27 8.34e-01 -2.34e-02 9.71e-01
CILIARY BODY MORPHOGENESIS 5 9.28e-01 2.34e-02 9.88e-01
REGULATION OF CLATHRIN DEPENDENT ENDOCYTOSIS 19 8.60e-01 2.34e-02 9.74e-01
DENDRITE DEVELOPMENT 233 5.39e-01 -2.33e-02 9.13e-01
POSITIVE REGULATION OF CYTOPLASMIC TRANSPORT 15 8.76e-01 2.33e-02 9.77e-01
DEOXYRIBONUCLEOSIDE CATABOLIC PROCESS 6 9.21e-01 -2.33e-02 9.87e-01
RESPONSE TO CELL CYCLE CHECKPOINT SIGNALING 8 9.09e-01 -2.33e-02 9.82e-01
RIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS 60 7.56e-01 2.32e-02 9.60e-01
NEUROPEPTIDE SIGNALING PATHWAY 109 6.75e-01 2.32e-02 9.48e-01
B CELL ACTIVATION 269 5.13e-01 2.32e-02 9.07e-01
CELL CELL ADHESION MEDIATED BY CADHERIN 48 7.81e-01 2.32e-02 9.65e-01
PEPTIDYL SERINE MODIFICATION 300 4.90e-01 -2.32e-02 8.95e-01
NEGATIVE REGULATION OF MONOATOMIC ION TRANSPORT 133 6.45e-01 2.32e-02 9.41e-01
VESICLE LOCALIZATION 214 5.60e-01 -2.31e-02 9.20e-01
DENTATE GYRUS DEVELOPMENT 23 8.48e-01 -2.31e-02 9.72e-01
CHEMOKINE C X C MOTIF LIGAND 1 PRODUCTION 6 9.22e-01 -2.31e-02 9.87e-01
BRANCHING MORPHOGENESIS OF AN EPITHELIAL TUBE 156 6.19e-01 2.31e-02 9.32e-01
T CELL CYTOKINE PRODUCTION 38 8.06e-01 2.30e-02 9.68e-01
POSITIVE REGULATION OF LEUKOCYTE CELL CELL ADHESION 272 5.13e-01 2.30e-02 9.07e-01
REGULATION OF PROTEIN KINASE A SIGNALING 20 8.59e-01 2.30e-02 9.74e-01
HEAD MORPHOGENESIS 36 8.11e-01 -2.30e-02 9.69e-01
ADAPTIVE IMMUNE RESPONSE BASED ON SOMATIC RECOMBINATION OF IMMUNE RECEPTORS BUILT FROM IMMUNOGLOBULIN SUPERFAMILY DOMAINS 304 4.91e-01 -2.30e-02 8.95e-01
NEGATIVE REGULATION OF LIPID METABOLIC PROCESS 111 6.76e-01 -2.30e-02 9.48e-01
MITOTIC CYTOKINESIS 87 7.11e-01 -2.29e-02 9.54e-01
SIGNAL TRANSDUCTION IN RESPONSE TO DNA DAMAGE 189 5.87e-01 2.29e-02 9.24e-01
ELASTIN CATABOLIC PROCESS 5 9.29e-01 -2.29e-02 9.88e-01
NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS 77 7.28e-01 -2.29e-02 9.58e-01
PROTEIN PEPTIDYL PROLYL ISOMERIZATION 19 8.63e-01 2.29e-02 9.74e-01
REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION INVOLVED IN ENDOCARDIAL CUSHION FORMATION 6 9.23e-01 -2.29e-02 9.88e-01
POSITIVE REGULATION OF MYOTUBE DIFFERENTIATION 17 8.70e-01 -2.29e-02 9.76e-01
REGULATION OF CARDIAC MUSCLE CONTRACTION 78 7.27e-01 2.29e-02 9.57e-01
LONG CHAIN FATTY ACID METABOLIC PROCESS 109 6.80e-01 2.29e-02 9.50e-01
MONOATOMIC CATION TRANSMEMBRANE TRANSPORT 849 2.58e-01 2.28e-02 7.71e-01
RNA EXPORT FROM NUCLEUS 88 7.13e-01 -2.27e-02 9.55e-01
T CELL PROLIFERATION 212 5.69e-01 2.27e-02 9.22e-01
ISOPRENOID METABOLIC PROCESS 133 6.51e-01 2.27e-02 9.41e-01
RESPONSE TO FOOD 36 8.14e-01 2.26e-02 9.70e-01
REGULATION OF RESPONSE TO TYPE II INTERFERON 14 8.84e-01 2.26e-02 9.78e-01
LUNG SACCULE DEVELOPMENT 10 9.02e-01 2.26e-02 9.82e-01
ANTEROGRADE NEURONAL DENSE CORE VESICLE TRANSPORT 7 9.18e-01 -2.26e-02 9.87e-01
HORMONE TRANSPORT 320 4.88e-01 -2.26e-02 8.94e-01
HAIR FOLLICLE MATURATION 15 8.80e-01 2.25e-02 9.77e-01
PROTEIN LOCALIZATION TO CHROMOSOME 115 6.76e-01 2.25e-02 9.48e-01
NUCLEOSIDE PHOSPHATE CATABOLIC PROCESS 87 7.17e-01 2.25e-02 9.55e-01
NATURAL KILLER CELL CYTOKINE PRODUCTION 9 9.07e-01 -2.25e-02 9.82e-01
RECOMBINATIONAL REPAIR 176 6.08e-01 2.24e-02 9.30e-01
REGULATION OF AMINO ACID TRANSPORT 43 7.99e-01 2.24e-02 9.67e-01
NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS 130 6.59e-01 -2.24e-02 9.43e-01
NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE 37 8.14e-01 -2.24e-02 9.70e-01
FATTY ACID DERIVATIVE METABOLIC PROCESS 73 7.41e-01 -2.23e-02 9.59e-01
MEMBRANE DEPOLARIZATION 80 7.30e-01 2.23e-02 9.58e-01
METHIONINE BIOSYNTHETIC PROCESS 12 8.94e-01 -2.23e-02 9.79e-01
INTERKINETIC NUCLEAR MIGRATION 5 9.31e-01 2.23e-02 9.89e-01
NUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS 42 8.03e-01 2.22e-02 9.68e-01
REGULATION OF TRANSCRIPTION INVOLVED IN G1 S TRANSITION OF MITOTIC CELL CYCLE 22 8.57e-01 -2.22e-02 9.74e-01
PROTEIN LOCALIZATION TO CHROMOSOME CENTROMERIC REGION 37 8.16e-01 -2.21e-02 9.70e-01
FACE MORPHOGENESIS 30 8.34e-01 2.21e-02 9.71e-01
POSITIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION 62 7.64e-01 -2.20e-02 9.61e-01
REGULATION OF PROTEIN LOCALIZATION TO SYNAPSE 22 8.58e-01 -2.20e-02 9.74e-01
NEGATIVE REGULATION OF BMP SIGNALING PATHWAY 70 7.50e-01 -2.20e-02 9.59e-01
EMBRYONIC HEART TUBE MORPHOGENESIS 71 7.49e-01 2.20e-02 9.59e-01
DNA STRAND ELONGATION INVOLVED IN DNA REPLICATION 15 8.83e-01 2.19e-02 9.78e-01
REGULATION OF KERATINOCYTE DIFFERENTIATION 40 8.10e-01 2.19e-02 9.69e-01
REGULATION OF MAST CELL ACTIVATION 40 8.11e-01 -2.18e-02 9.69e-01
LOCOMOTORY BEHAVIOR 202 5.93e-01 2.18e-02 9.26e-01
POSITIVE REGULATION OF APOPTOTIC CELL CLEARANCE 8 9.15e-01 2.18e-02 9.85e-01
REGULATION OF MATRIX METALLOPEPTIDASE SECRETION 11 9.00e-01 2.18e-02 9.81e-01
CARDIAC ATRIUM MORPHOGENESIS 29 8.39e-01 2.18e-02 9.72e-01
T CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE 116 6.86e-01 -2.18e-02 9.50e-01
INNER DYNEIN ARM ASSEMBLY 17 8.77e-01 2.17e-02 9.77e-01
POSITIVE REGULATION OF SYNAPTIC VESICLE ENDOCYTOSIS 6 9.27e-01 -2.17e-02 9.88e-01
REGULATION OF HEART CONTRACTION 209 5.89e-01 -2.17e-02 9.25e-01
CELL MORPHOGENESIS 958 2.56e-01 -2.17e-02 7.70e-01
CELLULAR RESPONSE TO VITAMIN 29 8.40e-01 -2.16e-02 9.72e-01
LYMPHOCYTE MIGRATION INTO LYMPHOID ORGANS 9 9.11e-01 2.16e-02 9.83e-01
UBIQUITIN DEPENDENT ERAD PATHWAY 84 7.32e-01 -2.16e-02 9.58e-01
ORGANELLE FUSION 158 6.39e-01 -2.16e-02 9.39e-01
NEGATIVE REGULATION OF PROTEIN LOCALIZATION 216 5.84e-01 -2.16e-02 9.24e-01
NEGATIVE REGULATION OF CELL DEVELOPMENT 285 5.31e-01 -2.16e-02 9.11e-01
T CELL LINEAGE COMMITMENT 32 8.33e-01 2.16e-02 9.71e-01
PIGMENT GRANULE ORGANIZATION 40 8.14e-01 2.15e-02 9.70e-01
NEGATIVE REGULATION OF T HELPER CELL DIFFERENTIATION 19 8.71e-01 2.15e-02 9.77e-01
RESPONSE TO STEROL 35 8.26e-01 2.15e-02 9.71e-01
CEREBRAL CORTEX RADIALLY ORIENTED CELL MIGRATION 36 8.24e-01 -2.15e-02 9.71e-01
AMINOGLYCAN CATABOLIC PROCESS 34 8.28e-01 2.15e-02 9.71e-01
PHAGOSOME LYSOSOME FUSION 13 8.94e-01 -2.14e-02 9.79e-01
CARBOHYDRATE DERIVATIVE CATABOLIC PROCESS 178 6.22e-01 -2.14e-02 9.32e-01
SERTOLI CELL DIFFERENTIATION 21 8.65e-01 -2.14e-02 9.74e-01
NEGATIVE REGULATION OF HEPATOCYTE APOPTOTIC PROCESS 7 9.22e-01 -2.14e-02 9.87e-01
RESPONSE TO NITROGEN COMPOUND 1118 2.27e-01 -2.14e-02 7.44e-01
DOUBLE STRAND BREAK REPAIR VIA NONHOMOLOGOUS END JOINING 68 7.61e-01 2.14e-02 9.61e-01
REGULATION OF HEMOPOIESIS 414 4.56e-01 -2.14e-02 8.84e-01
RIBOSOME ASSEMBLY 62 7.71e-01 -2.13e-02 9.63e-01
CELLULAR COMPONENT MORPHOGENESIS 784 3.10e-01 -2.13e-02 8.13e-01
NUCLEAR MRNA SURVEILLANCE 10 9.07e-01 2.13e-02 9.82e-01
ORGANIC HYDROXY COMPOUND METABOLIC PROCESS 564 3.88e-01 -2.12e-02 8.56e-01
SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR 174 6.29e-01 2.12e-02 9.35e-01
EMBRYONIC DIGIT MORPHOGENESIS 57 7.82e-01 2.12e-02 9.65e-01
DEOXYRIBONUCLEOTIDE METABOLIC PROCESS 42 8.12e-01 -2.12e-02 9.70e-01
CHROMOSOME SEPARATION 81 7.42e-01 2.12e-02 9.59e-01
REGULATION OF POSTSYNAPTIC MEMBRANE NEUROTRANSMITTER RECEPTOR LEVELS 88 7.31e-01 -2.12e-02 9.58e-01
TELOMERE MAINTENANCE VIA RECOMBINATION 14 8.91e-01 2.12e-02 9.79e-01
CELL JUNCTION DISASSEMBLY 27 8.49e-01 2.12e-02 9.73e-01
EMBRYONIC MORPHOGENESIS 613 3.72e-01 -2.11e-02 8.49e-01
MONONUCLEAR CELL DIFFERENTIATION 473 4.33e-01 -2.10e-02 8.74e-01
REGULATION OF TRANSPORT 1765 1.42e-01 -2.10e-02 6.69e-01
MICROTUBULE DEPOLYMERIZATION 46 8.06e-01 -2.10e-02 9.68e-01
POSITIVE REGULATION OF PROGRAMMED CELL DEATH 560 3.96e-01 -2.10e-02 8.59e-01
TISSUE HOMEOSTASIS 271 5.53e-01 -2.09e-02 9.18e-01
POSITIVE REGULATION OF ENDOTHELIAL CELL DIFFERENTIATION 19 8.75e-01 -2.09e-02 9.77e-01
PROTON TRANSPORTING TWO SECTOR ATPASE COMPLEX ASSEMBLY 16 8.85e-01 -2.09e-02 9.78e-01
NEGATIVE REGULATION OF CYTOKINESIS 7 9.24e-01 -2.09e-02 9.88e-01
CANONICAL WNT SIGNALING PATHWAY 313 5.25e-01 -2.09e-02 9.10e-01
POSITIVE REGULATION OF PHAGOCYTOSIS 70 7.63e-01 -2.08e-02 9.61e-01
AXIS SPECIFICATION 97 7.23e-01 2.08e-02 9.56e-01
REGULATION OF MEIOTIC CELL CYCLE 66 7.71e-01 2.08e-02 9.63e-01
NEGATIVE REGULATION OF DEVELOPMENTAL PROCESS 978 2.71e-01 -2.08e-02 7.79e-01
REGULATION OF VITAMIN D RECEPTOR SIGNALING PATHWAY 10 9.10e-01 -2.07e-02 9.83e-01
REGULATION OF SHORT TERM NEURONAL SYNAPTIC PLASTICITY 15 8.90e-01 2.07e-02 9.79e-01
MITOTIC DNA INTEGRITY CHECKPOINT SIGNALING 87 7.39e-01 -2.07e-02 9.58e-01
NEGATIVE REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY 21 8.70e-01 2.06e-02 9.76e-01
POSITIVE REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS 35 8.33e-01 2.06e-02 9.71e-01
INTERFERON ALPHA PRODUCTION 30 8.46e-01 -2.05e-02 9.72e-01
FOREBRAIN NEURON DIFFERENTIATION 44 8.14e-01 -2.05e-02 9.70e-01
CELLULAR OXIDANT DETOXIFICATION 98 7.27e-01 -2.04e-02 9.57e-01
REGULATION OF NK T CELL ACTIVATION 11 9.07e-01 -2.04e-02 9.82e-01
INTRACELLULAR IRON ION HOMEOSTASIS 70 7.68e-01 2.04e-02 9.63e-01
POSITIVE REGULATION OF ACTIN NUCLEATION 14 8.95e-01 2.04e-02 9.80e-01
CYTOKINE MEDIATED SIGNALING PATHWAY 498 4.37e-01 -2.03e-02 8.75e-01
POSITIVE REGULATION OF EPITHELIAL CELL PROLIFERATION 218 6.05e-01 -2.03e-02 9.29e-01
POSITIVE REGULATION OF GENE EXPRESSION 1176 2.40e-01 -2.03e-02 7.59e-01
REGULATION OF FEEDING BEHAVIOR 27 8.55e-01 2.03e-02 9.74e-01
VACUOLAR ACIDIFICATION 34 8.38e-01 -2.02e-02 9.72e-01
PHOSPHOLIPASE C ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY 110 7.14e-01 2.02e-02 9.55e-01
POSITIVE REGULATION OF FILOPODIUM ASSEMBLY 31 8.45e-01 -2.02e-02 9.72e-01
REGULATION OF COMPLEMENT ACTIVATION 23 8.67e-01 -2.02e-02 9.75e-01
POSITIVE REGULATION OF LIPASE ACTIVITY 60 7.86e-01 2.02e-02 9.65e-01
DOUBLE STRAND BREAK REPAIR 304 5.45e-01 -2.02e-02 9.13e-01
OSTEOBLAST DIFFERENTIATION 256 5.79e-01 2.01e-02 9.24e-01
REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION 56 7.95e-01 -2.01e-02 9.67e-01
NEGATIVE REGULATION OF CARDIAC MUSCLE CELL DIFFERENTIATION 11 9.08e-01 -2.01e-02 9.82e-01
RESOLUTION OF MEIOTIC RECOMBINATION INTERMEDIATES 16 8.89e-01 -2.01e-02 9.79e-01
REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY 192 6.31e-01 -2.01e-02 9.36e-01
NEGATIVE REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS 19 8.80e-01 2.00e-02 9.77e-01
PEPTIDE ANTIGEN ASSEMBLY WITH MHC PROTEIN COMPLEX 18 8.83e-01 2.00e-02 9.78e-01
TRNA METABOLIC PROCESS 194 6.30e-01 2.00e-02 9.36e-01
NEGATIVE REGULATION OF DNA METABOLIC PROCESS 143 6.79e-01 2.00e-02 9.49e-01
NEGATIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY 240 5.93e-01 -2.00e-02 9.26e-01
REGULATION BY VIRUS OF VIRAL PROTEIN LEVELS IN HOST CELL 7 9.27e-01 -1.99e-02 9.88e-01
REGULATION OF VENTRICULAR CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION 23 8.69e-01 -1.99e-02 9.76e-01
ENERGY DERIVATION BY OXIDATION OF ORGANIC COMPOUNDS 318 5.41e-01 -1.99e-02 9.13e-01
NEGATIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE 48 8.11e-01 1.99e-02 9.69e-01
PROTEIN MATURATION 532 4.32e-01 -1.99e-02 8.74e-01
POSITIVE REGULATION OF GLUCOSE IMPORT 37 8.34e-01 -1.99e-02 9.71e-01
NEGATIVE REGULATION OF CELL KILLING 28 8.55e-01 1.99e-02 9.74e-01
POSITIVE REGULATION OF INTERFERON BETA PRODUCTION 40 8.28e-01 -1.99e-02 9.71e-01
PEPTIDYL GLUTAMIC ACID MODIFICATION 26 8.61e-01 -1.99e-02 9.74e-01
CELLULAR RESPONSE TO CARBOHYDRATE STIMULUS 151 6.74e-01 -1.99e-02 9.47e-01
VENTRICULAR SYSTEM DEVELOPMENT 33 8.44e-01 -1.98e-02 9.72e-01
REGULATION OF PROTEIN DEACETYLATION 34 8.42e-01 -1.98e-02 9.72e-01
GERM CELL DEVELOPMENT 352 5.24e-01 -1.98e-02 9.10e-01
REGULATION OF METAL ION TRANSPORT 395 5.00e-01 -1.98e-02 9.00e-01
MEMORY 123 7.05e-01 1.98e-02 9.52e-01
NEGATIVE REGULATION OF INTERLEUKIN 6 PRODUCTION 67 7.80e-01 -1.97e-02 9.65e-01
NEGATIVE REGULATION OF CELL CYCLE 404 4.97e-01 -1.97e-02 8.99e-01
TRANSPORT ALONG MICROTUBULE 170 6.58e-01 -1.97e-02 9.43e-01
POSITIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION 65 7.84e-01 -1.97e-02 9.65e-01
MAINTENANCE OF LOCATION IN CELL 233 6.06e-01 -1.96e-02 9.29e-01
TRABECULA FORMATION 26 8.63e-01 -1.96e-02 9.74e-01
REGULATION OF EXIT FROM MITOSIS 18 8.85e-01 -1.96e-02 9.78e-01
INTERLEUKIN 17 PRODUCTION 48 8.14e-01 -1.96e-02 9.70e-01
GERM CELL PROLIFERATION 11 9.10e-01 1.96e-02 9.83e-01
VIRAL TRANSLATION 21 8.77e-01 -1.95e-02 9.77e-01
POSITIVE REGULATION OF TROPHOBLAST CELL MIGRATION 7 9.29e-01 1.95e-02 9.88e-01
SEX DIFFERENTIATION 280 5.75e-01 1.95e-02 9.24e-01
POSITIVE REGULATION OF STEM CELL POPULATION MAINTENANCE 48 8.15e-01 1.95e-02 9.70e-01
POSITIVE REGULATION OF DNA RECOMBINATION 70 7.78e-01 -1.95e-02 9.64e-01
DEVELOPMENT OF PRIMARY SEXUAL CHARACTERISTICS 230 6.11e-01 1.95e-02 9.31e-01
REGULATION OF TRANSMEMBRANE TRANSPORT 582 4.22e-01 1.95e-02 8.72e-01
REGULATION OF MODIFICATION OF POSTSYNAPTIC STRUCTURE 9 9.20e-01 1.94e-02 9.87e-01
DETECTION OF OTHER ORGANISM 19 8.84e-01 1.94e-02 9.78e-01
POSITIVE REGULATION OF MYELOID CELL DIFFERENTIATION 103 7.34e-01 -1.94e-02 9.58e-01
AMINO SUGAR METABOLIC PROCESS 42 8.28e-01 1.94e-02 9.71e-01
DNA TOPOLOGICAL CHANGE 9 9.20e-01 1.94e-02 9.87e-01
MATERNAL PROCESS INVOLVED IN FEMALE PREGNANCY 58 7.99e-01 -1.93e-02 9.67e-01
REGULATION OF HYDROGEN PEROXIDE METABOLIC PROCESS 18 8.87e-01 -1.93e-02 9.79e-01
ALPHA BETA T CELL PROLIFERATION 45 8.23e-01 1.93e-02 9.71e-01
REGULATION OF DNA DAMAGE CHECKPOINT 24 8.70e-01 1.92e-02 9.76e-01
MUSCLE ORGAN DEVELOPMENT 350 5.36e-01 1.92e-02 9.13e-01
NEGATIVE REGULATION OF PEPTIDYL LYSINE ACETYLATION 6 9.35e-01 1.92e-02 9.91e-01
NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS 38 8.38e-01 -1.92e-02 9.72e-01
REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT 108 7.30e-01 -1.92e-02 9.58e-01
INFLAMMATORY RESPONSE 877 3.35e-01 -1.92e-02 8.31e-01
ESTABLISHMENT OF RNA LOCALIZATION 155 6.81e-01 1.92e-02 9.50e-01
REGULATION OF MYELOID CELL DIFFERENTIATION 210 6.33e-01 1.91e-02 9.36e-01
POSITIVE REGULATION OF CALCIUM ION TRANSPORT 117 7.21e-01 1.91e-02 9.56e-01
CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT 57 8.03e-01 1.91e-02 9.68e-01
GLANDULAR EPITHELIAL CELL DEVELOPMENT 36 8.44e-01 -1.90e-02 9.72e-01
POSITIVE REGULATION OF MOLECULAR FUNCTION 1262 2.56e-01 -1.90e-02 7.70e-01
INTRACELLULAR WATER HOMEOSTASIS 6 9.36e-01 -1.90e-02 9.91e-01
NEGATIVE REGULATION OF SPHINGOLIPID BIOSYNTHETIC PROCESS 6 9.36e-01 -1.90e-02 9.91e-01
N ACETYLNEURAMINATE METABOLIC PROCESS 12 9.09e-01 -1.90e-02 9.83e-01
NEPHRON MORPHOGENESIS 81 7.68e-01 1.89e-02 9.63e-01
MITOCHONDRIAL ELECTRON TRANSPORT NADH TO UBIQUINONE 44 8.28e-01 -1.89e-02 9.71e-01
MONOATOMIC CATION TRANSPORT 1038 3.03e-01 1.89e-02 8.07e-01
REGULATION OF INFLAMMATORY RESPONSE 421 5.07e-01 -1.89e-02 9.02e-01
RESPONSE TO TUMOR CELL 42 8.33e-01 -1.88e-02 9.71e-01
CELL CYCLE CHECKPOINT SIGNALING 192 6.53e-01 -1.88e-02 9.41e-01
NEGATIVE REGULATION OF MYELOID CELL DIFFERENTIATION 92 7.55e-01 1.88e-02 9.60e-01
PROSTAGLANDIN SECRETION 17 8.93e-01 1.88e-02 9.79e-01
ORGANELLE FISSION 486 4.78e-01 -1.88e-02 8.93e-01
T HELPER CELL LINEAGE COMMITMENT 20 8.85e-01 1.88e-02 9.78e-01
PROTEIN PALMITOYLATION 31 8.57e-01 -1.88e-02 9.74e-01
REGULATION OF SIGNALING RECEPTOR ACTIVITY 107 7.38e-01 -1.87e-02 9.58e-01
REGULATION OF NEUROINFLAMMATORY RESPONSE 41 8.36e-01 -1.87e-02 9.72e-01
REGULATION OF NATURAL KILLER CELL ACTIVATION 41 8.36e-01 1.87e-02 9.72e-01
REGULATION OF NEURONAL SYNAPTIC PLASTICITY 55 8.11e-01 -1.87e-02 9.69e-01
PROTEIN LOCALIZATION TO PRESYNAPSE 11 9.15e-01 1.87e-02 9.85e-01
REGULATION OF PROTEIN LOCALIZATION TO CHROMATIN 10 9.19e-01 -1.86e-02 9.87e-01
TRANSCRIPTION DEPENDENT TETHERING OF RNA POLYMERASE II GENE DNA AT NUCLEAR PERIPHERY 7 9.32e-01 1.86e-02 9.89e-01
REGULATION OF TRANSFERASE ACTIVITY 690 4.05e-01 -1.86e-02 8.63e-01
VAGINA DEVELOPMENT 10 9.19e-01 -1.85e-02 9.87e-01
CELLULAR RESPONSE TO LIPID 609 4.35e-01 -1.85e-02 8.74e-01
DEVELOPMENT OF PRIMARY FEMALE SEXUAL CHARACTERISTICS 105 7.43e-01 1.85e-02 9.59e-01
REGULATION OF ALPHA BETA T CELL ACTIVATION 113 7.34e-01 1.85e-02 9.58e-01
NEGATIVE REGULATION OF NF KAPPAB TRANSCRIPTION FACTOR ACTIVITY 86 7.67e-01 -1.84e-02 9.63e-01
POSITIVE REGULATION OF RESPONSE TO TUMOR CELL 15 9.02e-01 1.84e-02 9.82e-01
MEMBRANE REPOLARIZATION 54 8.15e-01 1.84e-02 9.70e-01
RESPONSE TO OXYGEN CONTAINING COMPOUND 1794 1.95e-01 -1.84e-02 7.19e-01
EMBRYONIC ORGAN MORPHOGENESIS 295 5.87e-01 1.84e-02 9.24e-01
VESTIBULOCOCHLEAR NERVE MORPHOGENESIS 7 9.33e-01 1.84e-02 9.90e-01
FEMALE MEIOSIS I 13 9.09e-01 1.84e-02 9.82e-01
CELLULAR RESPONSE TO XENOBIOTIC STIMULUS 186 6.66e-01 1.84e-02 9.45e-01
NEGATIVE REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION 13 9.09e-01 1.84e-02 9.82e-01
RRNA METABOLIC PROCESS 261 6.10e-01 1.84e-02 9.31e-01
CRANIAL NERVE STRUCTURAL ORGANIZATION 10 9.20e-01 -1.83e-02 9.87e-01
POTASSIUM ION HOMEOSTASIS 34 8.54e-01 1.83e-02 9.74e-01
FIBROBLAST APOPTOTIC PROCESS 25 8.74e-01 -1.83e-02 9.77e-01
NEGATIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION 132 7.17e-01 -1.83e-02 9.55e-01
REGULATION OF MITOCHONDRIAL DNA METABOLIC PROCESS 8 9.29e-01 -1.82e-02 9.88e-01
POSITIVE REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL 129 7.21e-01 1.82e-02 9.56e-01
RESPONSE TO L GLUTAMATE 15 9.03e-01 1.82e-02 9.82e-01
NEGATIVE REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY 54 8.17e-01 -1.82e-02 9.70e-01
PROTON TRANSMEMBRANE TRANSPORT 149 7.03e-01 1.81e-02 9.52e-01
NEGATIVE REGULATION OF KINASE ACTIVITY 191 6.67e-01 -1.81e-02 9.46e-01
NEGATIVE REGULATION OF CELL CYCLE PROCESS 318 5.80e-01 -1.80e-02 9.24e-01
PROTEIN LOCALIZATION TO CHROMATIN 55 8.17e-01 1.80e-02 9.70e-01
REGULATION OF PROTON TRANSPORT 17 8.98e-01 1.80e-02 9.80e-01
REGULATION OF RESPIRATORY GASEOUS EXCHANGE BY NERVOUS SYSTEM PROCESS 12 9.14e-01 -1.80e-02 9.85e-01
POSITIVE REGULATION OF RNA EXPORT FROM NUCLEUS 5 9.44e-01 -1.80e-02 9.92e-01
SRP DEPENDENT COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE SIGNAL SEQUENCE RECOGNITION 6 9.39e-01 1.80e-02 9.91e-01
INNER EAR AUDITORY RECEPTOR CELL DIFFERENTIATION 45 8.35e-01 -1.80e-02 9.71e-01
URONIC ACID METABOLIC PROCESS 24 8.79e-01 1.79e-02 9.77e-01
PROTEIN LOCALIZATION TO CELL JUNCTION 108 7.47e-01 1.79e-02 9.59e-01
RESPONSE TO SALT 361 5.58e-01 1.79e-02 9.19e-01
ESTABLISHMENT OF PROTEIN LOCALIZATION TO ORGANELLE 449 5.15e-01 -1.79e-02 9.07e-01
POSITIVE REGULATION OF TYPE I INTERFERON PRODUCTION 72 7.93e-01 -1.79e-02 9.67e-01
REGULATION OF IMMUNE RESPONSE 897 3.63e-01 -1.79e-02 8.47e-01
POLYAMINE METABOLIC PROCESS 19 8.93e-01 -1.78e-02 9.79e-01
PROTEIN ACTIVATION CASCADE 19 8.93e-01 -1.78e-02 9.79e-01
PROSTANOID BIOSYNTHETIC PROCESS 32 8.62e-01 1.78e-02 9.74e-01
L GLUTAMATE IMPORT ACROSS PLASMA MEMBRANE 17 8.99e-01 1.77e-02 9.81e-01
NEGATIVE REGULATION OF EPITHELIAL CELL DIFFERENTIATION 56 8.18e-01 1.77e-02 9.70e-01
IMMUNE SYSTEM DEVELOPMENT 200 6.66e-01 1.77e-02 9.45e-01
REGULATION OF CHROMATIN ORGANIZATION 49 8.31e-01 1.76e-02 9.71e-01
MRNA PROCESSING 471 5.12e-01 -1.76e-02 9.07e-01
PROTEIN EXIT FROM ENDOPLASMIC RETICULUM 49 8.31e-01 1.76e-02 9.71e-01
INTESTINAL EPITHELIAL CELL DEVELOPMENT 18 8.98e-01 -1.75e-02 9.80e-01
REGULATION OF PHAGOCYTOSIS 98 7.65e-01 -1.75e-02 9.61e-01
REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION 80 7.87e-01 1.75e-02 9.65e-01
PROTEIN DESUMOYLATION 8 9.32e-01 1.75e-02 9.89e-01
EPITHELIAL CELL MATURATION 24 8.83e-01 1.74e-02 9.78e-01
LIVER REGENERATION 29 8.71e-01 1.74e-02 9.77e-01
POSITIVE REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS 13 9.14e-01 -1.74e-02 9.85e-01
CELLULAR RESPONSE TO ORGANIC CYCLIC COMPOUND 545 4.88e-01 -1.74e-02 8.94e-01
FC RECEPTOR SIGNALING PATHWAY 54 8.25e-01 1.74e-02 9.71e-01
MELANIN METABOLIC PROCESS 26 8.78e-01 1.73e-02 9.77e-01
POSITIVE REGULATION OF BINDING 125 7.38e-01 1.73e-02 9.58e-01
OOCYTE MATURATION 33 8.63e-01 1.73e-02 9.74e-01
GPI ANCHOR METABOLIC PROCESS 32 8.66e-01 1.73e-02 9.74e-01
EPIDERMAL CELL DIFFERENTIATION 240 6.46e-01 1.72e-02 9.41e-01
POLYOL BIOSYNTHETIC PROCESS 62 8.15e-01 -1.72e-02 9.70e-01
LIMB BUD FORMATION 9 9.29e-01 1.72e-02 9.88e-01
NCRNA CATABOLIC PROCESS 55 8.26e-01 -1.72e-02 9.71e-01
REGULATION OF LEUKOCYTE PROLIFERATION 263 6.32e-01 1.72e-02 9.36e-01
PLASMA MEMBRANE RAFT ORGANIZATION 11 9.22e-01 -1.71e-02 9.87e-01
POSITIVE REGULATION OF ISOTYPE SWITCHING 28 8.76e-01 1.71e-02 9.77e-01
REGULATION OF CYCLASE ACTIVITY 54 8.28e-01 1.70e-02 9.71e-01
FACIAL NERVE MORPHOGENESIS 10 9.26e-01 -1.70e-02 9.88e-01
CHROMATIN LOOPING 11 9.22e-01 -1.70e-02 9.87e-01
NEGATIVE REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS 32 8.68e-01 -1.70e-02 9.76e-01
ANTIGEN PROCESSING AND PRESENTATION OF EXOGENOUS ANTIGEN 46 8.42e-01 -1.69e-02 9.72e-01
PHOSPHATE ION HOMEOSTASIS 20 8.96e-01 1.69e-02 9.80e-01
REGULATION OF ACTIN NUCLEATION 38 8.57e-01 -1.69e-02 9.74e-01
REGULATION OF IMMUNE SYSTEM PROCESS 1502 2.74e-01 -1.69e-02 7.80e-01
INTERLEUKIN 8 PRODUCTION 103 7.68e-01 -1.69e-02 9.63e-01
PROTEIN DESTABILIZATION 47 8.42e-01 1.68e-02 9.72e-01
POSITIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT 84 7.90e-01 1.68e-02 9.66e-01
CELLULAR RESPONSE TO UV 91 7.82e-01 -1.68e-02 9.65e-01
NUCLEOSIDE TRANSPORT 10 9.27e-01 1.68e-02 9.88e-01
MITOTIC G2 DNA DAMAGE CHECKPOINT SIGNALING 37 8.60e-01 -1.68e-02 9.74e-01
REGULATION OF NATURAL KILLER CELL PROLIFERATION 12 9.20e-01 -1.68e-02 9.87e-01
RNA TEMPLATED DNA BIOSYNTHETIC PROCESS 70 8.09e-01 -1.67e-02 9.69e-01
T CELL MEDIATED CYTOTOXICITY 59 8.25e-01 -1.67e-02 9.71e-01
LACTATE TRANSMEMBRANE TRANSPORT 7 9.39e-01 -1.67e-02 9.91e-01
MAMMARY GLAND EPITHELIAL CELL DIFFERENTIATION 17 9.05e-01 1.67e-02 9.82e-01
REGULATION OF CELL CYCLE G2 M PHASE TRANSITION 116 7.57e-01 -1.67e-02 9.61e-01
TRANSDIFFERENTIATION 7 9.39e-01 1.66e-02 9.91e-01
CEREBELLAR PURKINJE CELL LAYER DEVELOPMENT 28 8.79e-01 1.66e-02 9.77e-01
CELLULAR RESPONSE TO DECREASED OXYGEN LEVELS 157 7.19e-01 -1.66e-02 9.55e-01
RESPONSE TO GLYCOPROTEIN 11 9.24e-01 1.66e-02 9.88e-01
DEOXYRIBONUCLEOTIDE CATABOLIC PROCESS 28 8.79e-01 -1.66e-02 9.77e-01
RESPONSE TO ETHER 12 9.21e-01 1.66e-02 9.87e-01
L SERINE BIOSYNTHETIC PROCESS 5 9.49e-01 1.65e-02 9.93e-01
ANATOMICAL STRUCTURE MATURATION 259 6.47e-01 -1.65e-02 9.41e-01
POSITIVE REGULATION OF CELL DIFFERENTIATION 888 4.03e-01 -1.65e-02 8.63e-01
ENDOCARDIAL CELL DIFFERENTIATION 6 9.44e-01 1.65e-02 9.92e-01
RNA LOCALIZATION 192 6.93e-01 1.65e-02 9.50e-01
REGULATION OF TRANSLATION IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS 12 9.21e-01 1.65e-02 9.87e-01
GASTRIC ACID SECRETION 13 9.18e-01 1.65e-02 9.87e-01
REGULATION OF MONOOXYGENASE ACTIVITY 45 8.49e-01 -1.64e-02 9.72e-01
NEUROTRANSMITTER RECEPTOR TRANSPORT POSTSYNAPTIC ENDOSOME TO LYSOSOME 7 9.40e-01 1.64e-02 9.91e-01
CARDIAC MUSCLE CELL ACTION POTENTIAL 76 8.05e-01 -1.64e-02 9.68e-01
CELLULAR RESPONSE TO TYPE II INTERFERON 115 7.61e-01 1.64e-02 9.61e-01
BRUSH BORDER ASSEMBLY 7 9.40e-01 1.64e-02 9.91e-01
REGULATION OF TRANSLATION IN RESPONSE TO STRESS 21 8.97e-01 -1.64e-02 9.80e-01
NEGATIVE REGULATION OF TRANSFERASE ACTIVITY 224 6.74e-01 -1.63e-02 9.47e-01
RIBOSOMAL LARGE SUBUNIT BIOGENESIS 72 8.11e-01 -1.63e-02 9.69e-01
POSITIVE REGULATION OF LEUKOCYTE CHEMOTAXIS 94 7.85e-01 -1.63e-02 9.65e-01
COLLATERAL SPROUTING IN ABSENCE OF INJURY 5 9.50e-01 1.63e-02 9.93e-01
REGULATION OF DNA BIOSYNTHETIC PROCESS 121 7.57e-01 -1.63e-02 9.61e-01
CYTOPLASMIC TRANSLATIONAL INITIATION 37 8.64e-01 -1.63e-02 9.74e-01
POSITIVE REGULATION OF ERK1 AND ERK2 CASCADE 221 6.77e-01 -1.63e-02 9.48e-01
GLUTAMINE TRANSPORT 10 9.29e-01 -1.62e-02 9.88e-01
NEUROGENESIS 1707 2.66e-01 -1.62e-02 7.76e-01
ION CHANNEL MODULATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY 8 9.37e-01 -1.61e-02 9.91e-01
REGULATION OF ADAPTIVE IMMUNE RESPONSE 204 6.91e-01 -1.61e-02 9.50e-01
NEGATIVE REGULATION OF CELL JUNCTION ASSEMBLY 32 8.75e-01 -1.61e-02 9.77e-01
PONS DEVELOPMENT 11 9.27e-01 1.61e-02 9.88e-01
ORGANELLE TRANSPORT ALONG MICROTUBULE 88 7.96e-01 1.60e-02 9.67e-01
LENS DEVELOPMENT IN CAMERA TYPE EYE 88 7.96e-01 1.60e-02 9.67e-01
POSITIVE REGULATION OF TRANSMEMBRANE TRANSPORT 217 6.86e-01 1.59e-02 9.50e-01
CYTOPLASMIC TRANSLATIONAL ELONGATION 5 9.51e-01 1.59e-02 9.94e-01
NEGATIVE CHEMOTAXIS 47 8.50e-01 1.59e-02 9.73e-01
NEGATIVE REGULATION OF TYROSINE PHOSPHORYLATION OF STAT PROTEIN 12 9.24e-01 -1.59e-02 9.88e-01
TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY 68 8.21e-01 -1.59e-02 9.71e-01
NEURON PROJECTION MAINTENANCE 12 9.24e-01 1.58e-02 9.88e-01
POSITIVE REGULATION OF PROTEIN KINASE A SIGNALING 12 9.24e-01 -1.58e-02 9.88e-01
MALE GAMETE GENERATION 601 5.09e-01 1.58e-02 9.05e-01
RESPONSE TO CYTOKINE 930 4.15e-01 -1.57e-02 8.67e-01
POSITIVE REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS 15 9.16e-01 1.57e-02 9.86e-01
REGULATION OF RESPONSE TO EXTRACELLULAR STIMULUS 28 8.86e-01 -1.57e-02 9.78e-01
REGULATION OF PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS 144 7.45e-01 -1.57e-02 9.59e-01
NEGATIVE REGULATION OF INFLAMMATORY RESPONSE 199 7.03e-01 -1.57e-02 9.52e-01
ZINC ION IMPORT ACROSS PLASMA MEMBRANE 9 9.35e-01 1.57e-02 9.91e-01
NEGATIVE REGULATION OF CHONDROCYTE DIFFERENTIATION 24 8.95e-01 -1.56e-02 9.79e-01
SNO S RNA METABOLIC PROCESS 17 9.11e-01 -1.56e-02 9.83e-01
DNA DAMAGE RESPONSE 870 4.35e-01 -1.56e-02 8.74e-01
PEPTIDYL PROLINE MODIFICATION 33 8.77e-01 -1.56e-02 9.77e-01
POSITIVE REGULATION OF MITOTIC CELL CYCLE 127 7.62e-01 -1.55e-02 9.61e-01
MEIOTIC CELL CYCLE PROCESS 211 6.97e-01 1.55e-02 9.52e-01
GAMETE GENERATION 763 4.67e-01 1.55e-02 8.90e-01
NEGATIVE REGULATION OF PROTEIN DEPHOSPHORYLATION 28 8.87e-01 1.55e-02 9.79e-01
REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS 164 7.32e-01 -1.55e-02 9.58e-01
REGULATION OF DENDRITE EXTENSION 26 8.91e-01 -1.55e-02 9.79e-01
NEGATIVE REGULATION OF CHEMOTAXIS 69 8.24e-01 -1.54e-02 9.71e-01
REGULATION OF PROTEOLYSIS 612 5.14e-01 -1.54e-02 9.07e-01
SECRETORY GRANULE ORGANIZATION 64 8.31e-01 -1.54e-02 9.71e-01
ADENYLATE CYCLASE ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY 156 7.40e-01 1.54e-02 9.58e-01
NEGATIVE REGULATION OF NUCLEOBASE CONTAINING COMPOUND METABOLIC PROCESS 1518 3.16e-01 -1.54e-02 8.19e-01
ICOSANOID METABOLIC PROCESS 121 7.70e-01 1.54e-02 9.63e-01
NEGATIVE REGULATION OF RNA BIOSYNTHETIC PROCESS 1289 3.53e-01 -1.54e-02 8.43e-01
REGULATION OF CELL CELL ADHESION MEDIATED BY INTEGRIN 11 9.30e-01 1.54e-02 9.89e-01
REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY 403 5.97e-01 -1.54e-02 9.27e-01
NUCLEOSIDE MONOPHOSPHATE CATABOLIC PROCESS 19 9.08e-01 1.53e-02 9.82e-01
RECEPTOR INTERNALIZATION 128 7.64e-01 -1.53e-02 9.61e-01
VASCULOGENESIS INVOLVED IN CORONARY VASCULAR MORPHOGENESIS 5 9.53e-01 1.53e-02 9.94e-01
REGULATION OF BEHAVIOR 75 8.18e-01 1.53e-02 9.70e-01
ANTERIOR POSTERIOR PATTERN SPECIFICATION 215 6.99e-01 -1.53e-02 9.52e-01
TYPE B PANCREATIC CELL DIFFERENTIATION 30 8.85e-01 1.53e-02 9.78e-01
REGULATION OF PHOSPHOPROTEIN PHOSPHATASE ACTIVITY 47 8.56e-01 1.53e-02 9.74e-01
PHOSPHATIDYLINOSITOL PHOSPHATE BIOSYNTHETIC PROCESS 65 8.31e-01 -1.53e-02 9.71e-01
REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION 76 8.18e-01 1.52e-02 9.70e-01
INHIBITION OF NEUROEPITHELIAL CELL DIFFERENTIATION 5 9.53e-01 -1.52e-02 9.94e-01
ENUCLEATE ERYTHROCYTE DIFFERENTIATION 10 9.34e-01 -1.52e-02 9.90e-01
GANGLIOSIDE BIOSYNTHETIC PROCESS 17 9.14e-01 -1.52e-02 9.85e-01
REGULATION OF PROTEIN IMPORT INTO NUCLEUS 58 8.41e-01 1.52e-02 9.72e-01
REGULATION OF FAT CELL PROLIFERATION 10 9.34e-01 -1.52e-02 9.90e-01
MALE SEX DIFFERENTIATION 171 7.33e-01 -1.51e-02 9.58e-01
REGULATION OF EPITHELIAL CELL DIFFERENTIATION 172 7.33e-01 -1.51e-02 9.58e-01
REGULATION OF RESPONSE TO TUMOR CELL 22 9.03e-01 1.51e-02 9.82e-01
AMINE BIOSYNTHETIC PROCESS 39 8.71e-01 -1.51e-02 9.76e-01
NEGATIVE REGULATION OF LYMPHOCYTE DIFFERENTIATION 60 8.40e-01 1.50e-02 9.72e-01
POSITIVE REGULATION OF RESPONSE TO TYPE II INTERFERON 6 9.49e-01 1.50e-02 9.93e-01
VITAMIN METABOLIC PROCESS 109 7.87e-01 1.50e-02 9.65e-01
POSITIVE REGULATION OF EPITHELIAL CELL PROLIFERATION INVOLVED IN LUNG MORPHOGENESIS 5 9.54e-01 -1.50e-02 9.94e-01
CELLULAR RESPONSE TO ETHANOL 13 9.25e-01 -1.50e-02 9.88e-01
TRIGLYCERIDE CATABOLIC PROCESS 28 8.91e-01 1.50e-02 9.79e-01
MOTILE CILIUM ASSEMBLY 66 8.33e-01 1.50e-02 9.71e-01
POSITIVE REGULATION OF STEROID HORMONE SECRETION 11 9.31e-01 -1.50e-02 9.89e-01
RESPONSE TO MOLECULE OF BACTERIAL ORIGIN 367 6.22e-01 -1.50e-02 9.32e-01
NEGATIVE REGULATION OF MONOCYTE DIFFERENTIATION 8 9.42e-01 -1.49e-02 9.92e-01
HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION 132 7.67e-01 -1.49e-02 9.63e-01
FEMALE SEX DIFFERENTIATION 120 7.78e-01 1.49e-02 9.64e-01
MYELOID CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE 98 7.99e-01 -1.49e-02 9.67e-01
MYELOID PROGENITOR CELL DIFFERENTIATION 9 9.38e-01 1.49e-02 9.91e-01
POSITIVE REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION 60 8.42e-01 -1.49e-02 9.72e-01
REGULATION OF RECEPTOR INTERNALIZATION 64 8.37e-01 -1.48e-02 9.72e-01
CYTOSKELETON DEPENDENT CYTOKINESIS 115 7.83e-01 -1.48e-02 9.65e-01
RESPONSE TO ALCOHOL 254 6.84e-01 -1.48e-02 9.50e-01
MYELOID CELL APOPTOTIC PROCESS 39 8.73e-01 -1.48e-02 9.77e-01
POSITIVE REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY 126 7.74e-01 1.48e-02 9.63e-01
REGULATION OF ERAD PATHWAY 21 9.07e-01 -1.48e-02 9.82e-01
NEGATIVE REGULATION OF PROTEIN UBIQUITINATION 77 8.23e-01 -1.48e-02 9.71e-01
SYNAPSE ORGANIZATION 479 5.80e-01 1.48e-02 9.24e-01
APPENDAGE DEVELOPMENT 180 7.33e-01 1.48e-02 9.58e-01
POSITIVE REGULATION OF DNA METABOLIC PROCESS 294 6.64e-01 -1.47e-02 9.44e-01
SMOOTH MUSCLE TISSUE DEVELOPMENT 27 8.95e-01 1.47e-02 9.79e-01
VENTRICULAR CARDIAC MUSCLE CELL DIFFERENTIATION 14 9.24e-01 1.47e-02 9.88e-01
ALPHA LINOLENIC ACID METABOLIC PROCESS 10 9.36e-01 1.47e-02 9.91e-01
POSITIVE REGULATION BY HOST OF VIRAL PROCESS 21 9.07e-01 1.47e-02 9.82e-01
ADENYLATE CYCLASE MODULATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY 246 6.92e-01 1.47e-02 9.50e-01
REGULATION OF PEPTIDASE ACTIVITY 308 6.58e-01 1.46e-02 9.43e-01
REGULATION OF CANONICAL WNT SIGNALING PATHWAY 259 6.85e-01 -1.46e-02 9.50e-01
HOMOLOGOUS RECOMBINATION 66 8.37e-01 1.46e-02 9.72e-01
PROTEIN DNA COMPLEX ASSEMBLY 212 7.14e-01 -1.46e-02 9.55e-01
BIOGENIC AMINE METABOLIC PROCESS 97 8.05e-01 1.45e-02 9.68e-01
REGULATION OF TRANS SYNAPTIC SIGNALING 488 5.83e-01 1.45e-02 9.24e-01
NEPHRIC DUCT MORPHOGENESIS 11 9.34e-01 -1.45e-02 9.90e-01
SEQUESTERING OF CALCIUM ION 142 7.65e-01 -1.45e-02 9.61e-01
NEURON PROJECTION ORGANIZATION 90 8.12e-01 1.45e-02 9.70e-01
PROXIMAL DISTAL PATTERN FORMATION 34 8.84e-01 1.44e-02 9.78e-01
POSITIVE REGULATION OF NITRIC OXIDE SYNTHASE BIOSYNTHETIC PROCESS 16 9.21e-01 1.44e-02 9.87e-01
PROTEIN PROCESSING 242 7.01e-01 -1.43e-02 9.52e-01
HAIR CELL DIFFERENTIATION 53 8.57e-01 -1.43e-02 9.74e-01
NEGATIVE REGULATION OF BINDING 121 7.86e-01 -1.43e-02 9.65e-01
REGULATION OF RNA EXPORT FROM NUCLEUS 13 9.29e-01 1.43e-02 9.88e-01
DORSAL ROOT GANGLION DEVELOPMENT 7 9.48e-01 1.43e-02 9.93e-01
REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION 97 8.08e-01 1.43e-02 9.69e-01
NEGATIVE REGULATION OF NEURON DIFFERENTIATION 73 8.33e-01 -1.43e-02 9.71e-01
NEURAL CREST CELL DIFFERENTIATION 95 8.10e-01 1.43e-02 9.69e-01
LONG TERM MEMORY 38 8.79e-01 1.42e-02 9.77e-01
SYNAPTIC VESICLE MEMBRANE ORGANIZATION 28 8.97e-01 1.42e-02 9.80e-01
REGULATION OF PEPTIDYL LYSINE ACETYLATION 28 8.97e-01 -1.41e-02 9.80e-01
CIRCADIAN RHYTHM 203 7.29e-01 -1.41e-02 9.58e-01
REGULATION OF SECRETION 616 5.51e-01 -1.41e-02 9.17e-01
ROUNDABOUT SIGNALING PATHWAY 5 9.57e-01 1.41e-02 9.95e-01
MOTOR NEURON AXON GUIDANCE 24 9.05e-01 1.40e-02 9.82e-01
SYNAPTIC TRANSMISSION DOPAMINERGIC 28 8.98e-01 -1.40e-02 9.80e-01
REGULATION OF DEPHOSPHORYLATION 105 8.05e-01 -1.40e-02 9.68e-01
POSITIVE REGULATION OF CYTOKINE PRODUCTION 496 5.95e-01 -1.39e-02 9.27e-01
CENTRAL NERVOUS SYSTEM DEVELOPMENT 1015 4.53e-01 1.39e-02 8.81e-01
CELLULAR RESPONSE TO ACID CHEMICAL 94 8.16e-01 -1.39e-02 9.70e-01
POSITIVE REGULATION OF EARLY ENDOSOME TO LATE ENDOSOME TRANSPORT 9 9.43e-01 1.39e-02 9.92e-01
METANEPHRIC NEPHRON DEVELOPMENT 41 8.78e-01 1.38e-02 9.77e-01
CELLULAR RESPONSE TO MURAMYL DIPEPTIDE 9 9.43e-01 1.38e-02 9.92e-01
ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE OR POLYSACCHARIDE ANTIGEN VIA MHC CLASS II 34 8.89e-01 -1.38e-02 9.79e-01
AMPA GLUTAMATE RECEPTOR CLUSTERING 11 9.37e-01 1.38e-02 9.91e-01
NEUROTRANSMITTER TRANSPORT 207 7.33e-01 1.38e-02 9.58e-01
REGULATION OF RESPONSE TO FOOD 14 9.29e-01 1.38e-02 9.88e-01
NEGATIVE REGULATION OF MULTICELLULAR ORGANISM GROWTH 12 9.35e-01 -1.37e-02 9.90e-01
POST TRANSLATIONAL PROTEIN TARGETING TO ENDOPLASMIC RETICULUM MEMBRANE 16 9.24e-01 -1.37e-02 9.88e-01
MULTICELLULAR ORGANISM REPRODUCTION 921 4.81e-01 1.37e-02 8.94e-01
PHOTORECEPTOR CELL MAINTENANCE 43 8.77e-01 1.37e-02 9.77e-01
CELLULAR RESPONSE TO OXYGEN CONTAINING COMPOUND 1285 4.10e-01 -1.37e-02 8.64e-01
ESTABLISHMENT OF PROTEIN LOCALIZATION TO CHROMOSOME 28 9.01e-01 1.36e-02 9.81e-01
GAMMA DELTA T CELL DIFFERENTIATION 13 9.32e-01 1.36e-02 9.89e-01
PROTEIN DENEDDYLATION 11 9.38e-01 1.36e-02 9.91e-01
PREPULSE INHIBITION 13 9.33e-01 1.36e-02 9.89e-01
FOLIC ACID CONTAINING COMPOUND METABOLIC PROCESS 26 9.06e-01 1.34e-02 9.82e-01
REGULATION OF RNA BINDING 8 9.48e-01 -1.34e-02 9.93e-01
PLATELET AGGREGATION 73 8.43e-01 1.34e-02 9.72e-01
REGULATION OF NEURON DIFFERENTIATION 197 7.46e-01 1.34e-02 9.59e-01
CELLULAR RESPONSE TO STEROL 25 9.08e-01 -1.34e-02 9.82e-01
RESPONSE TO ESTRADIOL 113 8.07e-01 -1.33e-02 9.68e-01
POSITIVE REGULATION OF COLLAGEN METABOLIC PROCESS 26 9.06e-01 1.33e-02 9.82e-01
EMBRYONIC ORGAN DEVELOPMENT 454 6.27e-01 -1.33e-02 9.34e-01
DEFENSE RESPONSE 1784 3.50e-01 1.33e-02 8.41e-01
NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION DEPENDENT DECAY 69 8.48e-01 -1.33e-02 9.72e-01
REGULATION OF STEM CELL POPULATION MAINTENANCE 73 8.44e-01 -1.33e-02 9.72e-01
ANATOMICAL STRUCTURE ARRANGEMENT 16 9.27e-01 1.33e-02 9.88e-01
OTOLITH DEVELOPMENT 10 9.42e-01 1.33e-02 9.92e-01
TELOMERE CAPPING 39 8.86e-01 -1.32e-02 9.78e-01
STEM CELL FATE SPECIFICATION 6 9.55e-01 1.32e-02 9.95e-01
REGULATION OF BLOOD PRESSURE 185 7.58e-01 1.31e-02 9.61e-01
REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS 47 8.76e-01 -1.31e-02 9.77e-01
STRIATED MUSCLE TISSUE DEVELOPMENT 263 7.15e-01 -1.31e-02 9.55e-01
DNA CATABOLIC PROCESS 32 8.98e-01 1.30e-02 9.80e-01
NEGATIVE REGULATION OF CELL ACTIVATION 220 7.39e-01 -1.30e-02 9.58e-01
PSYCHOMOTOR BEHAVIOR 5 9.60e-01 1.29e-02 9.96e-01
REGULATION OF MYELOID CELL APOPTOTIC PROCESS 32 9.00e-01 -1.29e-02 9.81e-01
POSITIVE REGULATION OF GLIAL CELL DIFFERENTIATION 45 8.81e-01 1.29e-02 9.78e-01
DETECTION OF BACTERIUM 16 9.29e-01 1.29e-02 9.88e-01
LEUKOCYTE DIFFERENTIATION 611 5.88e-01 -1.28e-02 9.24e-01
REGULATION OF TUBE SIZE 146 7.89e-01 1.28e-02 9.66e-01
PROTEIN POLY ADP RIBOSYLATION 10 9.44e-01 -1.28e-02 9.92e-01
POSITIVE REGULATION OF CELL CELL ADHESION MEDIATED BY INTEGRIN 6 9.57e-01 1.28e-02 9.95e-01
TRANSLOCATION OF MOLECULES INTO HOST 8 9.50e-01 1.28e-02 9.94e-01
ACIDIC AMINO ACID TRANSPORT 66 8.57e-01 1.28e-02 9.74e-01
POSITIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY 110 8.17e-01 1.28e-02 9.70e-01
POSITIVE REGULATION OF NECROPTOTIC PROCESS 8 9.50e-01 1.27e-02 9.94e-01
B CELL CHEMOTAXIS 7 9.54e-01 -1.27e-02 9.94e-01
NEGATIVE REGULATION OF LEUKOCYTE PROLIFERATION 93 8.33e-01 1.27e-02 9.71e-01
POSITIVE REGULATION OF LEUKOCYTE PROLIFERATION 165 7.79e-01 1.27e-02 9.64e-01
INORGANIC ANION TRANSMEMBRANE TRANSPORT 133 8.01e-01 -1.27e-02 9.68e-01
CELL CYCLE G2 M PHASE TRANSITION 155 7.86e-01 1.27e-02 9.65e-01
REGULATION OF OSSIFICATION 120 8.11e-01 1.26e-02 9.69e-01
REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE 38 8.93e-01 1.26e-02 9.79e-01
RESPONSE TO DOPAMINE 72 8.53e-01 1.26e-02 9.74e-01
POSITIVE REGULATION OF CHROMATIN BINDING 9 9.48e-01 1.26e-02 9.93e-01
ENDOCRINE SYSTEM DEVELOPMENT 139 7.98e-01 1.26e-02 9.67e-01
CITRULLINE BIOSYNTHETIC PROCESS 5 9.61e-01 1.26e-02 9.96e-01
INTERLEUKIN 2 PRODUCTION 63 8.64e-01 1.25e-02 9.74e-01
REGULATION OF CHROMOSOME ORGANIZATION 244 7.37e-01 -1.25e-02 9.58e-01
CELL CYCLE PHASE TRANSITION 571 6.10e-01 -1.25e-02 9.31e-01
NEGATIVE REGULATION OF PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS 39 8.93e-01 -1.25e-02 9.79e-01
RESPONSE TO FORSKOLIN 14 9.36e-01 1.25e-02 9.91e-01
AMINO ACID IMPORT ACROSS PLASMA MEMBRANE 50 8.79e-01 -1.24e-02 9.77e-01
NEGATIVE REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR 34 9.00e-01 1.24e-02 9.81e-01
NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY 30 9.06e-01 -1.24e-02 9.82e-01
POSITIVE REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY 21 9.22e-01 -1.24e-02 9.87e-01
MYELOID LEUKOCYTE MEDIATED IMMUNITY 109 8.23e-01 1.24e-02 9.71e-01
HEME TRANSPORT 10 9.46e-01 1.24e-02 9.93e-01
POSITIVE REGULATION OF TELOMERASE ACTIVITY 34 9.01e-01 1.24e-02 9.81e-01
REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE 94 8.36e-01 -1.23e-02 9.72e-01
INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR 83 8.46e-01 1.23e-02 9.72e-01
REGULATION OF FOREBRAIN NEURON DIFFERENTIATION 5 9.62e-01 1.23e-02 9.96e-01
NAD TRANSPORT 6 9.58e-01 -1.23e-02 9.96e-01
MYELOID LEUKOCYTE MIGRATION 238 7.43e-01 1.23e-02 9.59e-01
MIDBRAIN DOPAMINERGIC NEURON DIFFERENTIATION 17 9.30e-01 -1.23e-02 9.89e-01
MESENCHYMAL STEM CELL MAINTENANCE INVOLVED IN NEPHRON MORPHOGENESIS 6 9.58e-01 1.23e-02 9.96e-01
NEGATIVE REGULATION OF AMINO ACID TRANSPORT 16 9.32e-01 1.23e-02 9.89e-01
T CELL APOPTOTIC PROCESS 58 8.72e-01 -1.23e-02 9.77e-01
SOMATIC DIVERSIFICATION OF IMMUNOGLOBULINS 67 8.62e-01 1.23e-02 9.74e-01
SISTER CHROMATID SEGREGATION 227 7.51e-01 -1.22e-02 9.59e-01
STEM CELL DIFFERENTIATION 245 7.43e-01 -1.22e-02 9.59e-01
RESPONSE TO CORTICOSTEROID 148 7.99e-01 1.21e-02 9.67e-01
MITOTIC CELL CYCLE CHECKPOINT SIGNALING 142 8.03e-01 -1.21e-02 9.68e-01
REGULATION OF CELL CYCLE CHECKPOINT 46 8.87e-01 -1.21e-02 9.79e-01
MIRNA CATABOLIC PROCESS 19 9.27e-01 1.21e-02 9.88e-01
MITOCHONDRIAL TRANSCRIPTION 19 9.27e-01 -1.21e-02 9.88e-01
RESPONSE TO BMP 177 7.82e-01 -1.21e-02 9.65e-01
CELLULAR RESPONSE TO INORGANIC SUBSTANCE 226 7.55e-01 -1.21e-02 9.60e-01
REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY 296 7.22e-01 -1.20e-02 9.56e-01
L SERINE CATABOLIC PROCESS 5 9.63e-01 1.18e-02 9.96e-01
POSITIVE REGULATION OF TRANSLATION 135 8.12e-01 -1.18e-02 9.70e-01
PROTEIN TARGETING TO LYSOSOME 33 9.06e-01 -1.18e-02 9.82e-01
REGULATION OF LYSOSOMAL LUMEN PH 30 9.11e-01 -1.18e-02 9.83e-01
SPERMATID DIFFERENTIATION 207 7.71e-01 1.17e-02 9.63e-01
EPITHELIAL CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT 47 8.90e-01 1.17e-02 9.79e-01
MAGNESIUM ION HOMEOSTASIS 11 9.47e-01 1.16e-02 9.93e-01
REGULATION OF EXOCYTOSIS 186 7.85e-01 1.16e-02 9.65e-01
REGULATION OF NUCLEAR DIVISION 146 8.09e-01 -1.16e-02 9.69e-01
CELLULAR RESPONSE TO NITROSATIVE STRESS 6 9.61e-01 -1.16e-02 9.96e-01
RESPONSE TO LIPID 921 5.50e-01 -1.16e-02 9.17e-01
HEART MORPHOGENESIS 264 7.46e-01 1.16e-02 9.59e-01
EMBRYONIC CRANIAL SKELETON MORPHOGENESIS 45 8.93e-01 1.16e-02 9.79e-01
MAINTENANCE OF CELL NUMBER 186 7.86e-01 1.15e-02 9.65e-01
NEGATIVE REGULATION OF T HELPER 17 TYPE IMMUNE RESPONSE 13 9.43e-01 1.15e-02 9.92e-01
RESPIRATORY BURST 36 9.05e-01 -1.15e-02 9.82e-01
EMBRYONIC HEART TUBE DEVELOPMENT 84 8.55e-01 1.15e-02 9.74e-01
PIGMENTATION 115 8.32e-01 1.14e-02 9.71e-01
REGULATION OF AUTOPHAGY OF MITOCHONDRION IN RESPONSE TO MITOCHONDRIAL DEPOLARIZATION 15 9.39e-01 1.14e-02 9.91e-01
REGULATION OF REGULATED SECRETORY PATHWAY 122 8.28e-01 -1.14e-02 9.71e-01
INNATE IMMUNE RESPONSE 928 5.56e-01 1.14e-02 9.18e-01
RETINA MORPHOGENESIS IN CAMERA TYPE EYE 65 8.74e-01 1.14e-02 9.77e-01
COMPLEMENT ACTIVATION 59 8.80e-01 -1.14e-02 9.77e-01
RESPONSE TO ETHANOL 121 8.29e-01 -1.14e-02 9.71e-01
PLATELET DENSE GRANULE ORGANIZATION 25 9.22e-01 1.13e-02 9.87e-01
NEGATIVE REGULATION OF PROTEIN ACETYLATION 10 9.51e-01 1.13e-02 9.94e-01
REGULATION OF MICROVILLUS ASSEMBLY 6 9.62e-01 -1.13e-02 9.96e-01
SODIUM ION TRANSMEMBRANE TRANSPORT 179 7.94e-01 1.13e-02 9.67e-01
LIPID EXPORT FROM CELL 47 8.94e-01 1.13e-02 9.79e-01
POSITIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION 59 8.81e-01 -1.12e-02 9.78e-01
POSITIVE REGULATION OF DNA REPLICATION 38 9.05e-01 -1.12e-02 9.82e-01
RESPIRATORY ELECTRON TRANSPORT CHAIN 109 8.40e-01 -1.12e-02 9.72e-01
REGULATION OF CELL MATURATION 20 9.31e-01 1.12e-02 9.89e-01
PROTEIN ACETYLATION 102 8.47e-01 -1.10e-02 9.72e-01
POSITIVE REGULATION OF NEURON PROJECTION DEVELOPMENT 158 8.11e-01 1.10e-02 9.69e-01
REGULATION OF HEART RATE 102 8.48e-01 1.10e-02 9.72e-01
REGULATION OF MITOCHONDRIAL FISSION 30 9.17e-01 -1.10e-02 9.87e-01
PHOSPHOLIPID TRANSLOCATION 52 8.92e-01 1.09e-02 9.79e-01
POSITIVE REGULATION OF ORGANIC ACID TRANSPORT 46 8.98e-01 -1.09e-02 9.80e-01
CELL COMMUNICATION INVOLVED IN CARDIAC CONDUCTION 60 8.84e-01 1.09e-02 9.78e-01
REGULATION OF NUCLEOTIDE BIOSYNTHETIC PROCESS 30 9.18e-01 1.09e-02 9.87e-01
MITOTIC SISTER CHROMATID SEGREGATION 186 7.98e-01 1.09e-02 9.67e-01
POSITIVE REGULATION OF TRANSCRIPTION OF NOTCH RECEPTOR TARGET 7 9.60e-01 -1.09e-02 9.96e-01
BIOMINERAL TISSUE DEVELOPMENT 172 8.06e-01 1.09e-02 9.68e-01
REGULATION OF MITOTIC NUCLEAR DIVISION 118 8.38e-01 -1.09e-02 9.72e-01
B CELL RECEPTOR SIGNALING PATHWAY 62 8.82e-01 -1.09e-02 9.78e-01
NEGATIVE REGULATION OF INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY 9 9.55e-01 1.08e-02 9.95e-01
MATURATION OF LSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA 16 9.40e-01 -1.08e-02 9.91e-01
MICROTUBULE BUNDLE FORMATION 125 8.35e-01 1.08e-02 9.71e-01
ANTERIOR POSTERIOR AXIS SPECIFICATION 58 8.87e-01 1.08e-02 9.79e-01
NEGATIVE REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS 49 8.96e-01 1.08e-02 9.80e-01
NEUROTRANSMITTER RECEPTOR LOCALIZATION TO POSTSYNAPTIC SPECIALIZATION MEMBRANE 25 9.26e-01 -1.08e-02 9.88e-01
NUCLEOTIDE SUGAR TRANSMEMBRANE TRANSPORT 12 9.49e-01 -1.08e-02 9.93e-01
REGULATION OF LEUKOCYTE CHEMOTAXIS 123 8.37e-01 -1.07e-02 9.72e-01
NEGATIVE REGULATION OF RUFFLE ASSEMBLY 7 9.61e-01 1.07e-02 9.96e-01
NEGATIVE REGULATION OF TROPHOBLAST CELL MIGRATION 8 9.58e-01 -1.07e-02 9.96e-01
VESICLE TRANSPORT ALONG MICROTUBULE 46 9.00e-01 1.07e-02 9.81e-01
REGULATION OF MEGAKARYOCYTE DIFFERENTIATION 34 9.14e-01 -1.07e-02 9.85e-01
DIGESTIVE SYSTEM DEVELOPMENT 145 8.25e-01 -1.07e-02 9.71e-01
REGULATION OF DENDRITE MORPHOGENESIS 64 8.83e-01 -1.07e-02 9.78e-01
MESONEPHRIC TUBULE FORMATION 10 9.54e-01 -1.06e-02 9.94e-01
DIGESTION 131 8.34e-01 -1.06e-02 9.71e-01
REGULATION OF KERATINOCYTE PROLIFERATION 48 8.99e-01 1.06e-02 9.81e-01
BONE MINERALIZATION 122 8.40e-01 1.06e-02 9.72e-01
ACROSOME ASSEMBLY 27 9.25e-01 1.05e-02 9.88e-01
AXON DEVELOPMENT 508 6.85e-01 -1.05e-02 9.50e-01
NEGATIVE REGULATION OF IMMUNE RESPONSE 203 7.97e-01 1.05e-02 9.67e-01
LYMPHOCYTE ACTIVATION INVOLVED IN IMMUNE RESPONSE 204 7.98e-01 1.04e-02 9.67e-01
REGULATION OF STEROID HORMONE BIOSYNTHETIC PROCESS 15 9.44e-01 -1.04e-02 9.92e-01
CELLULAR RESPONSE TO MINERALOCORTICOID STIMULUS 12 9.50e-01 1.04e-02 9.94e-01
T HELPER 1 CELL DIFFERENTIATION 23 9.32e-01 1.03e-02 9.89e-01
NEGATIVE REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING 13 9.49e-01 1.03e-02 9.93e-01
RESPONSE TO ORGANOPHOSPHORUS 127 8.41e-01 -1.03e-02 9.72e-01
ORGANELLE MEMBRANE FUSION 119 8.46e-01 -1.03e-02 9.72e-01
REGULATION OF EOSINOPHIL MIGRATION 6 9.65e-01 -1.03e-02 9.97e-01
POSTSYNAPTIC SPECIALIZATION ORGANIZATION 43 9.07e-01 1.03e-02 9.82e-01
NEGATIVE REGULATION OF ACTIVATED T CELL PROLIFERATION 15 9.45e-01 -1.03e-02 9.93e-01
NEGATIVE REGULATION OF MYELINATION 9 9.57e-01 1.03e-02 9.96e-01
NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS 31 9.21e-01 1.03e-02 9.87e-01
THYMOCYTE APOPTOTIC PROCESS 20 9.37e-01 1.02e-02 9.91e-01
VIRAL RNA GENOME REPLICATION 30 9.23e-01 1.02e-02 9.88e-01
POSITIVE REGULATION OF NF KAPPAB TRANSCRIPTION FACTOR ACTIVITY 150 8.29e-01 -1.02e-02 9.71e-01
MODULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL 49 9.02e-01 -1.02e-02 9.82e-01
REGULATION OF B CELL ACTIVATION 128 8.42e-01 -1.02e-02 9.72e-01
RESPONSE TO XENOBIOTIC STIMULUS 424 7.19e-01 -1.02e-02 9.55e-01
MICROTUBULE BASED TRANSPORT 211 7.99e-01 1.02e-02 9.67e-01
IMMUNE EFFECTOR PROCESS 622 6.64e-01 -1.02e-02 9.44e-01
IMPORT ACROSS PLASMA MEMBRANE 213 7.98e-01 1.02e-02 9.67e-01
MYELOID LEUKOCYTE DIFFERENTIATION 236 7.89e-01 -1.01e-02 9.66e-01
POSITIVE REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR RESULTING IN TRANSCRIPTION OF P21 CLASS MEDIATOR 5 9.69e-01 -1.01e-02 9.97e-01
NEGATIVE REGULATION OF JNK CASCADE 37 9.15e-01 1.01e-02 9.85e-01
REGULATION OF TRANSLATIONAL INITIATION IN RESPONSE TO STRESS 14 9.48e-01 1.01e-02 9.93e-01
REGULATION OF CYTOPLASMIC TRANSLATIONAL INITIATION 8 9.61e-01 -1.01e-02 9.96e-01
GLOMERULUS VASCULATURE MORPHOGENESIS 6 9.66e-01 1.01e-02 9.97e-01
PROTEIN FOLDING 212 8.00e-01 -1.01e-02 9.68e-01
ERYTHROCYTE MATURATION 18 9.41e-01 -1.00e-02 9.92e-01
SYNAPTIC SIGNALING 779 6.37e-01 9.94e-03 9.38e-01
REGULATION OF NEURON MIGRATION 48 9.05e-01 -9.91e-03 9.82e-01
REGULATION OF DELAYED RECTIFIER POTASSIUM CHANNEL ACTIVITY 19 9.41e-01 9.88e-03 9.91e-01
POSITIVE REGULATION OF TORC1 SIGNALING 52 9.02e-01 9.86e-03 9.82e-01
RESPONSE TO METAL ION 355 7.50e-01 -9.86e-03 9.59e-01
NEGATIVE REGULATION OF INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY 15 9.47e-01 9.85e-03 9.93e-01
CHROMOSOME ORGANIZATION 619 6.76e-01 -9.84e-03 9.48e-01
POSITIVE REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY 242 7.93e-01 -9.81e-03 9.67e-01
REGULATION OF CELL CYCLE G1 S PHASE TRANSITION 206 8.09e-01 -9.79e-03 9.69e-01
POSITIVE REGULATION OF LEUKOCYTE MEDIATED IMMUNITY 149 8.37e-01 9.78e-03 9.72e-01
NEGATIVE REGULATION OF MUSCLE CONTRACTION 23 9.35e-01 9.77e-03 9.91e-01
DNA REPAIR DEPENDENT CHROMATIN REMODELING 20 9.40e-01 9.75e-03 9.91e-01
CELL PROLIFERATION IN BONE MARROW 11 9.55e-01 9.73e-03 9.95e-01
REGULATION OF CATALYTIC ACTIVITY 1471 5.32e-01 -9.71e-03 9.11e-01
CRANIAL NERVE DEVELOPMENT 63 8.94e-01 9.67e-03 9.79e-01
EMBRYONIC CAMERA TYPE EYE MORPHOGENESIS 26 9.32e-01 -9.66e-03 9.89e-01
LYMPHOCYTE MEDIATED IMMUNITY 289 7.78e-01 9.65e-03 9.64e-01
RESPONSE TO CATECHOLAMINE 88 8.77e-01 9.57e-03 9.77e-01
POSITIVE REGULATION OF GAMMA DELTA T CELL ACTIVATION 9 9.60e-01 9.56e-03 9.96e-01
GLYCOSYL COMPOUND BIOSYNTHETIC PROCESS 22 9.38e-01 -9.55e-03 9.91e-01
REGULATED EXOCYTOSIS 223 8.06e-01 9.53e-03 9.68e-01
POSITIVE REGULATION OF ISOTYPE SWITCHING TO IGA ISOTYPES 6 9.68e-01 9.53e-03 9.97e-01
RENAL SODIUM EXCRETION 11 9.56e-01 -9.51e-03 9.95e-01
POSITIVE REGULATION OF DEVELOPMENTAL GROWTH 166 8.33e-01 -9.47e-03 9.71e-01
REGULATION OF TELOMERE MAINTENANCE 102 8.69e-01 -9.46e-03 9.76e-01
NAD TRANSMEMBRANE TRANSPORT 5 9.71e-01 9.46e-03 9.97e-01
REGULATION OF DOUBLE STRAND BREAK REPAIR VIA NONHOMOLOGOUS END JOINING 28 9.31e-01 -9.41e-03 9.89e-01
HETEROCHROMATIN ORGANIZATION 94 8.75e-01 9.37e-03 9.77e-01
ORGAN GROWTH 175 8.31e-01 9.37e-03 9.71e-01
PHOSPHOLIPID HOMEOSTASIS 16 9.48e-01 -9.36e-03 9.93e-01
HOMOCYSTEINE METABOLIC PROCESS 13 9.53e-01 -9.35e-03 9.94e-01
REGULATION OF HYDROLASE ACTIVITY 760 6.62e-01 9.32e-03 9.44e-01
PROTEIN HYDROXYLATION 23 9.38e-01 -9.31e-03 9.91e-01
NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY 113 8.64e-01 -9.31e-03 9.74e-01
HOMOLOGOUS CHROMOSOME PAIRING AT MEIOSIS 53 9.07e-01 -9.29e-03 9.82e-01
NEGATIVE REGULATION OF MYOBLAST PROLIFERATION 9 9.62e-01 9.29e-03 9.96e-01
RESPONSE TO ANTIBIOTIC 37 9.22e-01 9.25e-03 9.88e-01
OOCYTE DIFFERENTIATION 65 8.98e-01 9.23e-03 9.80e-01
PRIMARY ALCOHOL BIOSYNTHETIC PROCESS 14 9.53e-01 -9.19e-03 9.94e-01
POSITIVE REGULATION OF G1 S TRANSITION OF MITOTIC CELL CYCLE 51 9.10e-01 -9.18e-03 9.83e-01
NEGATIVE REGULATION OF PHOSPHATASE ACTIVITY 24 9.38e-01 9.15e-03 9.91e-01
POST EMBRYONIC EYE MORPHOGENESIS 7 9.67e-01 9.14e-03 9.97e-01
REGULATION OF CELL CYCLE PHASE TRANSITION 453 7.39e-01 -9.14e-03 9.58e-01
REGULATION OF CELL CELL ADHESION 490 7.30e-01 -9.10e-03 9.58e-01
CELL PART MORPHOGENESIS 675 6.88e-01 -9.06e-03 9.50e-01
PROTEIN MATURATION BY PROTEIN FOLDING 8 9.65e-01 -9.01e-03 9.97e-01
NEGATIVE REGULATION OF NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS NONSENSE MEDIATED DECAY 8 9.65e-01 -9.00e-03 9.97e-01
NEGATIVE REGULATION OF CARTILAGE DEVELOPMENT 31 9.31e-01 -8.98e-03 9.89e-01
MEDIUM CHAIN FATTY ACID METABOLIC PROCESS 15 9.52e-01 8.95e-03 9.94e-01
POSTSYNAPTIC MEMBRANE ORGANIZATION 39 9.23e-01 -8.93e-03 9.88e-01
PATTERN SPECIFICATION PROCESS 469 7.41e-01 8.92e-03 9.58e-01
UNSATURATED FATTY ACID BIOSYNTHETIC PROCESS 51 9.12e-01 -8.91e-03 9.84e-01
CYTOKINE PRODUCTION 870 6.55e-01 -8.90e-03 9.42e-01
MYELOID CELL HOMEOSTASIS 174 8.40e-01 -8.86e-03 9.72e-01
PROTEIN AUTOUBIQUITINATION 68 9.00e-01 -8.85e-03 9.81e-01
REGULATION OF SODIUM ION TRANSPORT 84 8.89e-01 8.84e-03 9.79e-01
PROTEIN DELIPIDATION 5 9.73e-01 -8.82e-03 9.97e-01
REGULATION OF RESPIRATORY BURST 16 9.51e-01 -8.81e-03 9.94e-01
POSITIVE REGULATION OF CHROMOSOME SEPARATION 29 9.35e-01 -8.81e-03 9.90e-01
CARDIAC MUSCLE CELL CARDIAC MUSCLE CELL ADHESION 7 9.68e-01 8.78e-03 9.97e-01
RESPONSE TO MUSCLE STRETCH 25 9.40e-01 8.76e-03 9.91e-01
NEGATIVE REGULATION OF MEMBRANE POTENTIAL 12 9.58e-01 -8.68e-03 9.96e-01
REGULATION OF HORMONE BIOSYNTHETIC PROCESS 24 9.41e-01 8.68e-03 9.92e-01
POSITIVE REGULATION OF CELL CYCLE G1 S PHASE TRANSITION 63 9.05e-01 8.67e-03 9.82e-01
REGULATION OF SUPEROXIDE ANION GENERATION 19 9.48e-01 -8.66e-03 9.93e-01
CELLULAR RESPONSE TO CGMP 7 9.68e-01 8.66e-03 9.97e-01
ENDOCYTOSIS INVOLVED IN VIRAL ENTRY INTO HOST CELL 13 9.57e-01 -8.65e-03 9.95e-01
REGULATION OF CARDIAC MUSCLE CELL ACTION POTENTIAL 29 9.36e-01 8.63e-03 9.91e-01
RECEPTOR TRANSACTIVATION 5 9.73e-01 8.63e-03 9.97e-01
AUDITORY RECEPTOR CELL MORPHOGENESIS 20 9.47e-01 -8.59e-03 9.93e-01
CARDIAC CONDUCTION SYSTEM DEVELOPMENT 37 9.28e-01 8.58e-03 9.88e-01
ORGANISM EMERGENCE FROM PROTECTIVE STRUCTURE 26 9.40e-01 8.58e-03 9.91e-01
FATTY ACYL COA BIOSYNTHETIC PROCESS 26 9.40e-01 8.57e-03 9.91e-01
SKELETAL MUSCLE TISSUE GROWTH 10 9.63e-01 8.49e-03 9.96e-01
REGULATION OF BARBED END ACTIN FILAMENT CAPPING 5 9.74e-01 8.44e-03 9.97e-01
EPITHELIAL CELL DIFFERENTIATION 740 6.96e-01 8.44e-03 9.51e-01
POSITIVE REGULATION OF CELL CELL ADHESION MEDIATED BY CADHERIN 11 9.61e-01 8.42e-03 9.96e-01
RIBONUCLEOPROTEIN COMPLEX BIOGENESIS 469 7.56e-01 8.38e-03 9.60e-01
REGULATION OF LYMPHOCYTE ACTIVATION 499 7.49e-01 8.38e-03 9.59e-01
POSITIVE REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY 22 9.46e-01 -8.27e-03 9.93e-01
AUDITORY RECEPTOR CELL DEVELOPMENT 24 9.44e-01 8.26e-03 9.92e-01
ENDOCRINE HORMONE SECRETION 56 9.15e-01 -8.23e-03 9.85e-01
DNA BIOSYNTHETIC PROCESS 193 8.44e-01 -8.21e-03 9.72e-01
REGULATION OF RESPIRATORY BURST INVOLVED IN INFLAMMATORY RESPONSE 7 9.70e-01 8.18e-03 9.97e-01
INTESTINAL EPITHELIAL CELL MATURATION 6 9.72e-01 -8.18e-03 9.97e-01
REGULATION OF SMAD PROTEIN SIGNAL TRANSDUCTION 52 9.20e-01 -8.09e-03 9.87e-01
RESPONSE TO VITAMIN 84 8.98e-01 -8.09e-03 9.80e-01
NEGATIVE REGULATION OF T CELL PROLIFERATION 70 9.08e-01 8.03e-03 9.82e-01
MODULATION BY HOST OF SYMBIONT PROCESS 85 8.98e-01 -8.02e-03 9.80e-01
NEGATIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT 155 8.63e-01 -8.01e-03 9.74e-01
REGULATION OF DNA METABOLIC PROCESS 525 7.54e-01 -8.00e-03 9.60e-01
TOLL LIKE RECEPTOR 2 SIGNALING PATHWAY 18 9.53e-01 -8.00e-03 9.94e-01
SEGMENTATION 102 8.89e-01 7.99e-03 9.79e-01
REGULATION OF REPRODUCTIVE PROCESS 207 8.43e-01 7.97e-03 9.72e-01
REGULATION OF NEUROTRANSMITTER RECEPTOR ACTIVITY 46 9.25e-01 -7.97e-03 9.88e-01
POSITIVE REGULATION OF PEPTIDE SECRETION 111 8.85e-01 -7.96e-03 9.78e-01
REGULATION OF DENDRITE DEVELOPMENT 99 8.91e-01 7.94e-03 9.79e-01
NUCLEAR CHROMOSOME SEGREGATION 313 8.10e-01 -7.91e-03 9.69e-01
RESPONSE TO COLD 44 9.28e-01 -7.86e-03 9.88e-01
FOREBRAIN NEURON DEVELOPMENT 25 9.46e-01 -7.85e-03 9.93e-01
MITOCHONDRIAL FISSION 40 9.32e-01 7.83e-03 9.89e-01
REGULATION OF IRON ION TRANSPORT 8 9.69e-01 7.82e-03 9.97e-01
TRANSMEMBRANE TRANSPORT 1545 6.08e-01 7.80e-03 9.30e-01
PROTEIN DEUBIQUITINATION INVOLVED IN UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS 6 9.74e-01 7.79e-03 9.97e-01
PEROXISOME ORGANIZATION 36 9.36e-01 -7.77e-03 9.91e-01
RESPONSE TO COCAINE 48 9.26e-01 -7.77e-03 9.88e-01
CELLULAR RESPONSE TO ALDOSTERONE 8 9.70e-01 7.74e-03 9.97e-01
PROTEIN TARGETING TO MITOCHONDRION 106 8.90e-01 7.74e-03 9.79e-01
MRNA TRANSPORT 121 8.84e-01 7.71e-03 9.78e-01
HOMEOSTASIS OF NUMBER OF CELLS WITHIN A TISSUE 35 9.37e-01 -7.69e-03 9.91e-01
POSITIVE REGULATION OF ADENYLATE CYCLASE ACTIVITY 32 9.40e-01 -7.65e-03 9.91e-01
REGULATION OF AMINE METABOLIC PROCESS 33 9.40e-01 -7.63e-03 9.91e-01
LINOLEIC ACID METABOLIC PROCESS 21 9.52e-01 -7.58e-03 9.94e-01
RESPONSE TO IMMOBILIZATION STRESS 24 9.49e-01 -7.55e-03 9.93e-01
RESPONSE TO PHORBOL 13 ACETATE 12 MYRISTATE 10 9.67e-01 -7.51e-03 9.97e-01
RNA IMPORT INTO MITOCHONDRION 5 9.77e-01 7.50e-03 9.97e-01
RESPONSE TO ACID CHEMICAL 141 8.78e-01 -7.49e-03 9.77e-01
P38MAPK CASCADE 58 9.21e-01 7.49e-03 9.87e-01
POSITIVE REGULATION OF DNA BINDING 41 9.34e-01 -7.42e-03 9.90e-01
NOREPINEPHRINE BIOSYNTHETIC PROCESS 8 9.71e-01 7.42e-03 9.97e-01
REGULATION OF NATURAL KILLER CELL DIFFERENTIATION 12 9.65e-01 7.32e-03 9.97e-01
REGULATION OF ALPHA BETA T CELL DIFFERENTIATION 74 9.13e-01 -7.32e-03 9.85e-01
POSITIVE REGULATION OF NEUROTRANSMITTER TRANSPORT 23 9.52e-01 -7.30e-03 9.94e-01
ATP BIOSYNTHETIC PROCESS 92 9.04e-01 -7.29e-03 9.82e-01
CELLULAR PIGMENTATION 63 9.20e-01 7.29e-03 9.87e-01
POSITIVE REGULATION OF CELL GROWTH INVOLVED IN CARDIAC MUSCLE CELL DEVELOPMENT 8 9.72e-01 -7.24e-03 9.97e-01
EMBRYONIC SKELETAL SYSTEM MORPHOGENESIS 94 9.03e-01 -7.24e-03 9.82e-01
RESPIRATORY CHAIN COMPLEX IV ASSEMBLY 29 9.46e-01 7.22e-03 9.93e-01
NEGATIVE REGULATION OF LYMPHOCYTE ACTIVATION 166 8.72e-01 7.22e-03 9.77e-01
REGULATION OF CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS 31 9.45e-01 7.14e-03 9.93e-01
POSITIVE REGULATION OF ENDOTHELIAL CELL APOPTOTIC PROCESS 24 9.52e-01 -7.14e-03 9.94e-01
DNA TEMPLATED TRANSCRIPTION INITIATION 139 8.85e-01 -7.12e-03 9.78e-01
RIBONUCLEOSIDE CATABOLIC PROCESS 20 9.56e-01 -7.12e-03 9.95e-01
MYOBLAST DIFFERENTIATION 110 8.97e-01 -7.11e-03 9.80e-01
INSEMINATION 12 9.66e-01 7.11e-03 9.97e-01
NEGATIVE REGULATION OF NEURON APOPTOTIC PROCESS 163 8.76e-01 7.11e-03 9.77e-01
POSITIVE REGULATION OF LYMPHOCYTE ACTIVATION 324 8.26e-01 7.10e-03 9.71e-01
POSITIVE REGULATION OF HYDROLASE ACTIVITY 492 7.87e-01 -7.10e-03 9.65e-01
VESICLE CYTOSKELETAL TRAFFICKING 69 9.19e-01 -7.06e-03 9.87e-01
CELLULAR RESPONSE TO INTERLEUKIN 1 109 8.99e-01 7.04e-03 9.81e-01
REGULATION OF MYOBLAST DIFFERENTIATION 73 9.17e-01 7.04e-03 9.87e-01
NEGATIVE REGULATION OF PEPTIDYL CYSTEINE S NITROSYLATION 8 9.73e-01 7.00e-03 9.97e-01
EXCITATORY SYNAPSE ASSEMBLY 32 9.45e-01 -7.00e-03 9.93e-01
INFLAMMATORY CELL APOPTOTIC PROCESS 24 9.53e-01 6.99e-03 9.94e-01
SERTOLI CELL PROLIFERATION 5 9.78e-01 -6.98e-03 9.97e-01
NEURON DEVELOPMENT 1137 6.92e-01 -6.95e-03 9.50e-01
RESPONSE TO ISCHEMIA 63 9.24e-01 -6.94e-03 9.88e-01
POSITIVE REGULATION OF SECRETION 308 8.34e-01 -6.93e-03 9.71e-01
FEMALE GAMETE GENERATION 162 8.79e-01 6.91e-03 9.77e-01
REGULATION OF OSTEOBLAST PROLIFERATION 31 9.47e-01 6.91e-03 9.93e-01
ADULT BEHAVIOR 145 8.86e-01 6.90e-03 9.78e-01
ENDOCHONDRAL BONE MORPHOGENESIS 59 9.27e-01 6.87e-03 9.88e-01
DNA METABOLIC PROCESS 1023 7.10e-01 -6.87e-03 9.54e-01
REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY HORMONE 38 9.42e-01 -6.86e-03 9.92e-01
NATURAL KILLER CELL PROLIFERATION 15 9.63e-01 6.84e-03 9.96e-01
THYROID STIMULATING HORMONE SECRETING CELL DIFFERENTIATION 6 9.77e-01 -6.83e-03 9.97e-01
POSITIVE REGULATION OF CELL JUNCTION ASSEMBLY 106 9.04e-01 6.77e-03 9.82e-01
PROTEIN REFOLDING 27 9.52e-01 6.75e-03 9.94e-01
POSITIVE REGULATION OF POTASSIUM ION TRANSPORT 44 9.38e-01 -6.73e-03 9.91e-01
HORMONE CATABOLIC PROCESS 11 9.69e-01 -6.69e-03 9.97e-01
GENERATION OF NEURONS 1477 6.68e-01 -6.67e-03 9.46e-01
REGULATION OF NUCLEOBASE CONTAINING COMPOUND TRANSPORT 16 9.63e-01 6.65e-03 9.96e-01
MORPHOGENESIS OF A BRANCHING STRUCTURE 202 8.71e-01 -6.63e-03 9.77e-01
DNA REPAIR 587 7.85e-01 -6.58e-03 9.65e-01
POSITIVE REGULATION OF CELLULAR RESPIRATION 13 9.68e-01 6.43e-03 9.97e-01
NEGATIVE REGULATION OF SMOOTH MUSCLE CELL MIGRATION 37 9.46e-01 6.42e-03 9.93e-01
WNT SIGNALING PATHWAY INVOLVED IN MIDBRAIN DOPAMINERGIC NEURON DIFFERENTIATION 12 9.70e-01 6.34e-03 9.97e-01
V D J RECOMBINATION 19 9.62e-01 6.33e-03 9.96e-01
OLEFINIC COMPOUND BIOSYNTHETIC PROCESS 28 9.54e-01 6.32e-03 9.94e-01
MEMBRANE FUSION 179 8.84e-01 6.31e-03 9.78e-01
REGULATION OF ATP DEPENDENT ACTIVITY 63 9.31e-01 -6.29e-03 9.89e-01
REGULATION OF TYPE B PANCREATIC CELL DEVELOPMENT 9 9.74e-01 -6.27e-03 9.97e-01
NEGATIVE REGULATION OF JUN KINASE ACTIVITY 14 9.68e-01 6.27e-03 9.97e-01
TORC2 SIGNALING 15 9.66e-01 -6.27e-03 9.97e-01
ALDEHYDE BIOSYNTHETIC PROCESS 16 9.66e-01 6.22e-03 9.97e-01
POSITIVE REGULATION OF WNT SIGNALING PATHWAY 146 8.97e-01 -6.21e-03 9.80e-01
NUCLEOSIDE BISPHOSPHATE METABOLIC PROCESS 120 9.08e-01 6.12e-03 9.82e-01
LYSOSOMAL LUMEN ACIDIFICATION 22 9.60e-01 -6.11e-03 9.96e-01
ENDOPLASMIC RETICULUM TO GOLGI VESICLE MEDIATED TRANSPORT 131 9.04e-01 6.09e-03 9.82e-01
REGULATION OF ADENYLATE CYCLASE ACTIVITY 45 9.44e-01 6.09e-03 9.92e-01
REPRODUCTIVE BEHAVIOR 43 9.45e-01 6.07e-03 9.93e-01
REGULATION OF CHEMOTAXIS 229 8.75e-01 6.06e-03 9.77e-01
POSITIVE REGULATION OF PLATELET ACTIVATION 10 9.74e-01 -6.04e-03 9.97e-01
CELL CELL SIGNALING 1700 6.79e-01 -6.03e-03 9.49e-01
REGULATION OF MITOTIC CELL CYCLE PHASE TRANSITION 354 8.46e-01 6.02e-03 9.72e-01
CELLULAR HOMEOSTASIS 813 7.70e-01 -6.02e-03 9.63e-01
CELLULAR RESPONSE TO OXYGEN LEVELS 173 8.92e-01 -6.00e-03 9.79e-01
RESPONSE TO FATTY ACID 56 9.39e-01 -5.95e-03 9.91e-01
NEGATIVE REGULATION OF VASCULAR ENDOTHELIAL CELL PROLIFERATION 25 9.59e-01 5.93e-03 9.96e-01
NEGATIVE REGULATION OF MORPHOGENESIS OF AN EPITHELIUM 9 9.75e-01 -5.91e-03 9.97e-01
CENTRAL NERVOUS SYSTEM NEURON DEVELOPMENT 89 9.24e-01 -5.86e-03 9.88e-01
OLIGODENDROCYTE DIFFERENTIATION 106 9.17e-01 5.86e-03 9.87e-01
RIBONUCLEOSIDE MONOPHOSPHATE CATABOLIC PROCESS 15 9.69e-01 5.82e-03 9.97e-01
ACROSOMAL VESICLE EXOCYTOSIS 9 9.76e-01 5.79e-03 9.97e-01
CHLORIDE TRANSPORT 126 9.11e-01 -5.78e-03 9.83e-01
LEPTIN MEDIATED SIGNALING PATHWAY 10 9.75e-01 5.78e-03 9.97e-01
REGULATION OF NERVOUS SYSTEM PROCESS 118 9.14e-01 -5.78e-03 9.85e-01
MIDBRAIN DEVELOPMENT 90 9.25e-01 5.77e-03 9.88e-01
REGULATION OF TRANSPORTER ACTIVITY 264 8.72e-01 5.76e-03 9.77e-01
MINERALOCORTICOID SECRETION 7 9.79e-01 5.75e-03 9.97e-01
NEGATIVE REGULATION OF OSTEOBLAST PROLIFERATION 15 9.69e-01 5.72e-03 9.97e-01
POSITIVE REGULATION OF ASTROCYTE DIFFERENTIATION 13 9.72e-01 -5.71e-03 9.97e-01
REGULATION OF EXTRACELLULAR MATRIX ASSEMBLY 21 9.64e-01 -5.70e-03 9.96e-01
LONG TERM SYNAPTIC DEPRESSION 32 9.56e-01 -5.70e-03 9.95e-01
REPRODUCTION 1478 7.14e-01 5.69e-03 9.55e-01
CELL RECOGNITION 155 9.03e-01 5.68e-03 9.82e-01
NEGATIVE REGULATION OF PROTEIN AUTOPHOSPHORYLATION 11 9.74e-01 5.64e-03 9.97e-01
REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN EXECUTION PHASE OF APOPTOSIS 5 9.83e-01 5.64e-03 9.99e-01
SPERM EGG RECOGNITION 51 9.45e-01 5.58e-03 9.93e-01
NEGATIVE REGULATION OF GONADOTROPIN SECRETION 7 9.80e-01 5.57e-03 9.97e-01
CALCIUM ION REGULATED EXOCYTOSIS 65 9.38e-01 5.53e-03 9.91e-01
COLLAGEN ACTIVATED SIGNALING PATHWAY 15 9.71e-01 5.48e-03 9.97e-01
CHROMOSOME SEGREGATION 421 8.47e-01 -5.48e-03 9.72e-01
EPHRIN RECEPTOR SIGNALING PATHWAY 51 9.46e-01 5.47e-03 9.93e-01
GAMMA AMINOBUTYRIC ACID TRANSPORT 20 9.66e-01 5.47e-03 9.97e-01
SYNAPTIC MEMBRANE ADHESION 27 9.61e-01 5.45e-03 9.96e-01
MYELOID CELL DIFFERENTIATION 428 8.47e-01 -5.42e-03 9.72e-01
PARENTAL BEHAVIOR 11 9.75e-01 5.40e-03 9.97e-01
PLACENTA BLOOD VESSEL DEVELOPMENT 31 9.59e-01 5.35e-03 9.96e-01
REGULATORY NCRNA PROCESSING 87 9.31e-01 5.35e-03 9.89e-01
INTERLEUKIN 10 PRODUCTION 64 9.41e-01 5.32e-03 9.92e-01
CHONDROCYTE DIFFERENTIATION 114 9.22e-01 -5.32e-03 9.87e-01
COLUMNAR CUBOIDAL EPITHELIAL CELL DEVELOPMENT 52 9.47e-01 -5.29e-03 9.93e-01
ACETYL COA BIOSYNTHETIC PROCESS 18 9.69e-01 -5.29e-03 9.97e-01
POSTSYNAPTIC MEMBRANE ASSEMBLY 10 9.77e-01 5.28e-03 9.97e-01
NEGATIVE REGULATION OF OSSIFICATION 39 9.55e-01 -5.27e-03 9.95e-01
SKELETAL MYOFIBRIL ASSEMBLY 10 9.77e-01 -5.27e-03 9.97e-01
REGULATION OF SYNAPTIC VESICLE ENDOCYTOSIS 19 9.69e-01 -5.23e-03 9.97e-01
LATERAL VENTRICLE DEVELOPMENT 12 9.75e-01 -5.22e-03 9.97e-01
POLY N ACETYLLACTOSAMINE METABOLIC PROCESS 7 9.81e-01 -5.14e-03 9.98e-01
MYOBLAST PROLIFERATION 34 9.59e-01 -5.13e-03 9.96e-01
VESTIBULOCOCHLEAR NERVE FORMATION 5 9.84e-01 -5.10e-03 9.99e-01
CELLULAR RESPONSE TO POTASSIUM ION 13 9.75e-01 5.04e-03 9.97e-01
RESPONSE TO LEUKEMIA INHIBITORY FACTOR 106 9.29e-01 -5.04e-03 9.88e-01
POSITIVE REGULATION OF SYNCYTIUM FORMATION BY PLASMA MEMBRANE FUSION 24 9.66e-01 5.02e-03 9.97e-01
RESPONSE TO ZINC ION STARVATION 9 9.79e-01 -5.01e-03 9.97e-01
POSITIVE REGULATION OF REGULATORY T CELL DIFFERENTIATION 23 9.67e-01 -4.99e-03 9.97e-01
SIGNAL RELEASE 483 8.51e-01 4.99e-03 9.74e-01
DOPAMINE TRANSPORT 55 9.49e-01 4.98e-03 9.93e-01
P BODY ASSEMBLY 21 9.69e-01 -4.96e-03 9.97e-01
NEGATIVE REGULATION OF TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY 111 9.28e-01 4.93e-03 9.88e-01
POSITIVE REGULATION OF AMINE TRANSPORT 41 9.56e-01 -4.93e-03 9.95e-01
CGMP MEDIATED SIGNALING 32 9.62e-01 -4.93e-03 9.96e-01
NEGATIVE REGULATION OF IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE 5 9.85e-01 -4.93e-03 9.99e-01
SODIUM ION TRANSPORT 247 8.94e-01 4.92e-03 9.79e-01
UV DAMAGE EXCISION REPAIR 14 9.75e-01 -4.92e-03 9.97e-01
PROTEIN HETEROTETRAMERIZATION 15 9.74e-01 4.92e-03 9.97e-01
HAIR CYCLE PHASE 9 9.80e-01 -4.88e-03 9.97e-01
REGULATION OF OSTEOBLAST DIFFERENTIATION 149 9.18e-01 4.88e-03 9.87e-01
POSITIVE REGULATION OF LYASE ACTIVITY 40 9.58e-01 -4.82e-03 9.96e-01
HEPATICOBILIARY SYSTEM DEVELOPMENT 145 9.20e-01 -4.80e-03 9.87e-01
T CELL MEDIATED IMMUNITY 126 9.26e-01 4.80e-03 9.88e-01
INTERLEUKIN 5 MEDIATED SIGNALING PATHWAY 6 9.84e-01 -4.79e-03 9.99e-01
SOMATOTROPIN SECRETING CELL DIFFERENTIATION 5 9.85e-01 -4.79e-03 9.99e-01
CHEMICAL HOMEOSTASIS 1030 7.95e-01 -4.77e-03 9.67e-01
EXONUCLEOLYTIC CATABOLISM OF DEADENYLATED MRNA 13 9.76e-01 4.74e-03 9.97e-01
CORTISOL METABOLIC PROCESS 12 9.78e-01 -4.62e-03 9.97e-01
PHARYNGEAL SYSTEM DEVELOPMENT 30 9.65e-01 4.62e-03 9.97e-01
RIBOSE PHOSPHATE METABOLIC PROCESS 379 8.78e-01 -4.61e-03 9.77e-01
INTRACELLULAR ZINC ION HOMEOSTASIS 36 9.62e-01 -4.61e-03 9.96e-01
DNA DEALKYLATION 38 9.61e-01 4.60e-03 9.96e-01
ERYTHROCYTE HOMEOSTASIS 141 9.25e-01 4.59e-03 9.88e-01
CHOLINE METABOLIC PROCESS 6 9.85e-01 4.57e-03 9.99e-01
REGULATION OF CD8 POSITIVE ALPHA BETA T CELL DIFFERENTIATION 8 9.82e-01 4.57e-03 9.99e-01
CELL CELL SIGNALING INVOLVED IN CARDIAC CONDUCTION 34 9.63e-01 -4.55e-03 9.96e-01
POSITIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION 34 9.64e-01 4.52e-03 9.96e-01
REGULATION OF TOOTH MINERALIZATION 12 9.78e-01 4.52e-03 9.97e-01
TRNA METHYLATION 43 9.59e-01 4.52e-03 9.96e-01
RESPONSE TO POTASSIUM ION 18 9.74e-01 -4.51e-03 9.97e-01
MITOTIC NUCLEAR MEMBRANE DISASSEMBLY 7 9.84e-01 4.51e-03 9.99e-01
POSITIVE REGULATION OF CELL ACTIVATION 388 8.79e-01 4.51e-03 9.77e-01
NEGATIVE REGULATION OF MOLECULAR FUNCTION 780 8.32e-01 -4.46e-03 9.71e-01
PROTEIN TARGETING TO VACUOLE INVOLVED IN AUTOPHAGY 6 9.85e-01 -4.44e-03 9.99e-01
STEROID HORMONE SECRETION 27 9.68e-01 4.44e-03 9.97e-01
ENDODERM DEVELOPMENT 83 9.44e-01 4.43e-03 9.92e-01
PEPTIDYL THREONINE DEPHOSPHORYLATION 18 9.74e-01 -4.40e-03 9.97e-01
LYMPHOCYTE ACTIVATION 773 8.35e-01 4.39e-03 9.72e-01
REGULATION OF T CELL ACTIVATION 376 8.84e-01 4.39e-03 9.78e-01
REGULATION OF EMBRYONIC DEVELOPMENT 91 9.42e-01 -4.39e-03 9.92e-01
REGULATION OF APOPTOTIC CELL CLEARANCE 10 9.81e-01 -4.35e-03 9.98e-01
HEMOPOIESIS 935 8.22e-01 -4.34e-03 9.71e-01
REGULATION OF MELANOCYTE DIFFERENTIATION 6 9.85e-01 4.31e-03 9.99e-01
RNA METHYLATION 89 9.44e-01 -4.29e-03 9.92e-01
THYROID HORMONE GENERATION 23 9.72e-01 4.28e-03 9.97e-01
REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING 59 9.55e-01 -4.27e-03 9.95e-01
REGULATION OF DEVELOPMENTAL GROWTH 326 8.95e-01 -4.27e-03 9.79e-01
POSITIVE REGULATION OF VOLTAGE GATED POTASSIUM CHANNEL ACTIVITY 12 9.80e-01 4.24e-03 9.97e-01
DIGESTIVE TRACT MORPHOGENESIS 48 9.60e-01 4.19e-03 9.96e-01
REGULATION OF CATION CHANNEL ACTIVITY 122 9.36e-01 -4.19e-03 9.91e-01
MONOATOMIC ANION HOMEOSTASIS 21 9.74e-01 4.17e-03 9.97e-01
RESPONSE TO ACTINOMYCIN D 5 9.87e-01 -4.16e-03 9.99e-01
TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING 79 9.49e-01 4.15e-03 9.93e-01
REGULATION OF TRANSLATION AT SYNAPSE 6 9.86e-01 -4.14e-03 9.99e-01
LEUKOCYTE MIGRATION 390 8.89e-01 4.13e-03 9.79e-01
REGULATION OF ANIMAL ORGAN MORPHOGENESIS 126 9.36e-01 4.11e-03 9.91e-01
CELLULAR RESPIRATION 225 9.15e-01 -4.11e-03 9.85e-01
POSITIVE REGULATION OF SYNAPTIC TRANSMISSION 174 9.26e-01 4.11e-03 9.88e-01
NEGATIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE II 956 8.30e-01 -4.09e-03 9.71e-01
NEGATIVE REGULATION OF IMMUNE SYSTEM PROCESS 513 8.74e-01 -4.08e-03 9.77e-01
POSITIVE REGULATION OF MULTICELLULAR ORGANISM GROWTH 31 9.69e-01 -4.04e-03 9.97e-01
POSITIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION 43 9.64e-01 -4.03e-03 9.96e-01
PHASIC SMOOTH MUSCLE CONTRACTION 24 9.73e-01 -4.03e-03 9.97e-01
HOMOLOGOUS CHROMOSOME SEGREGATION 64 9.56e-01 4.03e-03 9.95e-01
CELL ACTIVATION 1084 8.23e-01 -4.03e-03 9.71e-01
REGULATION OF AUTOPHAGOSOME MATURATION 17 9.77e-01 -4.02e-03 9.97e-01
NEGATIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT 23 9.73e-01 4.01e-03 9.97e-01
CELL MATURATION 194 9.24e-01 -3.98e-03 9.88e-01
NCRNA METABOLIC PROCESS 625 8.65e-01 3.97e-03 9.74e-01
MAST CELL MEDIATED IMMUNITY 58 9.58e-01 3.96e-03 9.96e-01
ARGININE METABOLIC PROCESS 20 9.76e-01 -3.94e-03 9.97e-01
REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR RESULTING IN TRANSCRIPTION OF P21 CLASS MEDIATOR 6 9.87e-01 3.88e-03 9.99e-01
REGULATION OF ICOSANOID SECRETION 20 9.76e-01 -3.86e-03 9.97e-01
REGULATION OF CARDIAC CONDUCTION 28 9.72e-01 -3.86e-03 9.97e-01
REGULATION OF CELL JUNCTION ASSEMBLY 213 9.24e-01 -3.81e-03 9.88e-01
NEURAL NUCLEUS DEVELOPMENT 66 9.57e-01 3.80e-03 9.96e-01
REGULATION OF BILE ACID SECRETION 6 9.87e-01 3.79e-03 9.99e-01
COLLATERAL SPROUTING 28 9.72e-01 3.79e-03 9.97e-01
POSITIVE REGULATION OF ERYTHROCYTE DIFFERENTIATION 34 9.70e-01 3.79e-03 9.97e-01
RENAL TUBULE DEVELOPMENT 104 9.47e-01 -3.78e-03 9.93e-01
RESPONSE TO TOXIC SUBSTANCE 255 9.18e-01 -3.76e-03 9.87e-01
B CELL DIFFERENTIATION 146 9.38e-01 -3.71e-03 9.91e-01
ENDOTHELIAL CELL ACTIVATION 11 9.83e-01 3.69e-03 9.99e-01
MITOCHONDRIAL CYTOCHROME C OXIDASE ASSEMBLY 25 9.75e-01 -3.68e-03 9.97e-01
REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION 33 9.71e-01 3.68e-03 9.97e-01
NEUROMUSCULAR PROCESS CONTROLLING BALANCE 51 9.64e-01 3.67e-03 9.96e-01
CELLULAR RESPONSE TO BRAIN DERIVED NEUROTROPHIC FACTOR STIMULUS 8 9.86e-01 3.65e-03 9.99e-01
POSITIVE REGULATION OF GAMMA DELTA T CELL DIFFERENTIATION 7 9.87e-01 3.63e-03 9.99e-01
CALCIUM ION TRANSMEMBRANE TRANSPORT 349 9.08e-01 -3.60e-03 9.82e-01
NEGATIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT 33 9.72e-01 3.56e-03 9.97e-01
FOREBRAIN GENERATION OF NEURONS 53 9.65e-01 -3.51e-03 9.97e-01
POSTSYNAPSE ORGANIZATION 192 9.33e-01 3.51e-03 9.90e-01
ENDODERMAL CELL DIFFERENTIATION 49 9.66e-01 -3.47e-03 9.97e-01
REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL 82 9.57e-01 3.47e-03 9.95e-01
CELL DIVISION 631 8.82e-01 -3.46e-03 9.78e-01
PHAGOLYSOSOME ASSEMBLY 18 9.80e-01 3.46e-03 9.97e-01
CARDIAC CELL FATE COMMITMENT 16 9.81e-01 3.45e-03 9.98e-01
LEUKOCYTE MEDIATED IMMUNITY 388 9.07e-01 3.45e-03 9.82e-01
RESPONSE TO INTERLEUKIN 17 17 9.81e-01 -3.37e-03 9.98e-01
EYE MORPHOGENESIS 162 9.42e-01 -3.32e-03 9.92e-01
PHENOL CONTAINING COMPOUND CATABOLIC PROCESS 9 9.86e-01 3.30e-03 9.99e-01
LUNG ASSOCIATED MESENCHYME DEVELOPMENT 8 9.87e-01 3.28e-03 9.99e-01
NEGATIVE REGULATION OF MONOATOMIC ION TRANSMEMBRANE TRANSPORT 100 9.55e-01 3.26e-03 9.95e-01
NEUROTRANSMITTER REUPTAKE 35 9.74e-01 -3.24e-03 9.97e-01
EXOCYTOSIS 343 9.18e-01 3.24e-03 9.87e-01
NEGATIVE REGULATION OF CELL GROWTH INVOLVED IN CARDIAC MUSCLE CELL DEVELOPMENT 13 9.84e-01 3.23e-03 9.99e-01
REGULATION OF DNA TOPOISOMERASE ATP HYDROLYZING ACTIVITY 5 9.90e-01 -3.22e-03 1.00e+00
PROTEIN HOMOOLIGOMERIZATION 194 9.39e-01 -3.19e-03 9.91e-01
AMINE METABOLIC PROCESS 117 9.53e-01 -3.17e-03 9.94e-01
NEGATIVE REGULATION OF DNA REPAIR 37 9.73e-01 -3.17e-03 9.97e-01
MITOTIC CELL CYCLE PHASE TRANSITION 469 9.07e-01 3.14e-03 9.82e-01
REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE MEDIATED BY A CHEMICAL SIGNAL 47 9.70e-01 -3.13e-03 9.97e-01
N TERMINAL PROTEIN LIPIDATION 6 9.90e-01 3.08e-03 1.00e+00
HOMOTYPIC CELL CELL ADHESION 96 9.59e-01 3.06e-03 9.96e-01
PURINE NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS 43 9.72e-01 -3.05e-03 9.97e-01
MONOATOMIC ANION TRANSPORT 171 9.46e-01 3.01e-03 9.93e-01
AXON GUIDANCE 232 9.37e-01 -2.99e-03 9.91e-01
POST EMBRYONIC ANIMAL ORGAN DEVELOPMENT 18 9.82e-01 -2.99e-03 9.99e-01
RESPONSE TO ORGANIC CYCLIC COMPOUND 899 8.79e-01 -2.98e-03 9.77e-01
GLIAL CELL FATE COMMITMENT 13 9.85e-01 2.92e-03 9.99e-01
POSITIVE REGULATION OF TRANSLATION IN RESPONSE TO STRESS 7 9.89e-01 2.92e-03 1.00e+00
MITOCHONDRIAL TRANSMEMBRANE TRANSPORT 60 9.69e-01 -2.90e-03 9.97e-01
VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL 35 9.76e-01 2.90e-03 9.97e-01
REGULATION OF DNA BINDING 85 9.63e-01 -2.89e-03 9.96e-01
POSITIVE REGULATION OF UBIQUITIN PROTEIN LIGASE ACTIVITY 9 9.88e-01 -2.88e-03 1.00e+00
ENDOCRINE PROCESS 92 9.62e-01 -2.86e-03 9.96e-01
CHROMOSOME ORGANIZATION INVOLVED IN MEIOTIC CELL CYCLE 65 9.68e-01 2.86e-03 9.97e-01
MITOCHONDRIAL GENOME MAINTENANCE 31 9.78e-01 2.85e-03 9.97e-01
DEVELOPMENTAL MATURATION 328 9.29e-01 2.85e-03 9.88e-01
MUSCLE TISSUE DEVELOPMENT 430 9.20e-01 2.84e-03 9.87e-01
REGULATION OF SISTER CHROMATID SEGREGATION 104 9.61e-01 2.79e-03 9.96e-01
POSITIVE REGULATION OF BMP SIGNALING PATHWAY 41 9.76e-01 2.77e-03 9.97e-01
REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY 288 9.37e-01 2.73e-03 9.91e-01
POSITIVE REGULATION OF SYNAPTIC TRANSMISSION CHOLINERGIC 6 9.91e-01 2.65e-03 1.00e+00
VASCULOGENESIS 83 9.67e-01 -2.65e-03 9.97e-01
NEGATIVE REGULATION OF IMMUNE EFFECTOR PROCESS 124 9.60e-01 2.60e-03 9.96e-01
EMBRYONIC SKELETAL SYSTEM DEVELOPMENT 127 9.60e-01 -2.60e-03 9.96e-01
POSITIVE REGULATION OF MIRNA PROCESSING 5 9.92e-01 2.58e-03 1.00e+00
PROTEIN QUALITY CONTROL FOR MISFOLDED OR INCOMPLETELY SYNTHESIZED PROTEINS 31 9.81e-01 2.53e-03 9.98e-01
NEGATIVE REGULATION OF CATION CHANNEL ACTIVITY 50 9.76e-01 2.50e-03 9.97e-01
PEPTIDYL CYSTEINE MODIFICATION 44 9.78e-01 2.43e-03 9.97e-01
POSITIVE REGULATION OF HORMONE SECRETION 140 9.61e-01 2.42e-03 9.96e-01
CELLULAR RESPONSE TO VIRUS 81 9.71e-01 -2.37e-03 9.97e-01
LIPID PHOSPHORYLATION 11 9.89e-01 -2.36e-03 1.00e+00
PROTEIN COMPLEX OLIGOMERIZATION 255 9.49e-01 -2.35e-03 9.93e-01
ACTIVATION OF ADENYLATE CYCLASE ACTIVITY 26 9.84e-01 -2.34e-03 9.99e-01
LEUKOCYTE CHEMOTAXIS INVOLVED IN INFLAMMATORY RESPONSE 8 9.91e-01 -2.31e-03 1.00e+00
ISOPRENOID CATABOLIC PROCESS 10 9.90e-01 2.29e-03 1.00e+00
NEGATIVE REGULATION OF MITOTIC CELL CYCLE 248 9.52e-01 2.24e-03 9.94e-01
INORGANIC ANION TRANSPORT 172 9.60e-01 -2.21e-03 9.96e-01
TRICARBOXYLIC ACID CYCLE 32 9.83e-01 -2.19e-03 9.99e-01
ALPHA BETA T CELL ACTIVATION 175 9.60e-01 2.19e-03 9.96e-01
DEVELOPMENTAL PROCESS INVOLVED IN REPRODUCTION 957 9.10e-01 2.16e-03 9.83e-01
REGULATION OF MONOATOMIC CATION TRANSMEMBRANE TRANSPORT 312 9.48e-01 -2.15e-03 9.93e-01
INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS 78 9.75e-01 2.08e-03 9.97e-01
REGULATION OF STEM CELL DIFFERENTIATION 79 9.75e-01 2.07e-03 9.97e-01
REGULATION OF MORPHOGENESIS OF AN EPITHELIUM 65 9.77e-01 -2.06e-03 9.97e-01
REGULATION OF B CELL RECEPTOR SIGNALING PATHWAY 22 9.87e-01 2.03e-03 9.99e-01
POSITIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE II 1233 9.04e-01 -2.03e-03 9.82e-01
POSITIVE REGULATION OF LIPID TRANSPORT 86 9.74e-01 -2.03e-03 9.97e-01
POSITIVE REGULATION OF INTERFERON ALPHA PRODUCTION 24 9.86e-01 2.02e-03 9.99e-01
MICROTUBULE BASED MOVEMENT 415 9.44e-01 -2.00e-03 9.92e-01
OSTEOBLAST DEVELOPMENT 17 9.89e-01 -2.00e-03 1.00e+00
TESTOSTERONE BIOSYNTHETIC PROCESS 11 9.91e-01 -1.99e-03 1.00e+00
HINDBRAIN TANGENTIAL CELL MIGRATION 5 9.94e-01 -1.99e-03 1.00e+00
LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL 58 9.79e-01 -1.97e-03 9.97e-01
CONNECTIVE TISSUE REPLACEMENT INVOLVED IN INFLAMMATORY RESPONSE WOUND HEALING 7 9.93e-01 -1.94e-03 1.00e+00
DENSE CORE GRANULE LOCALIZATION 11 9.91e-01 -1.94e-03 1.00e+00
COLUMNAR CUBOIDAL EPITHELIAL CELL MATURATION 13 9.90e-01 -1.94e-03 1.00e+00
NEGATIVE REGULATION OF TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY 14 9.90e-01 1.92e-03 1.00e+00
RESPONSE TO CGMP 9 9.92e-01 -1.90e-03 1.00e+00
BONE MINERALIZATION INVOLVED IN BONE MATURATION 13 9.91e-01 -1.89e-03 1.00e+00
COMMISSURAL NEURON AXON GUIDANCE 12 9.91e-01 -1.88e-03 1.00e+00
CARDIAC CONDUCTION 98 9.74e-01 -1.88e-03 9.97e-01
PURKINJE MYOCYTE TO VENTRICULAR CARDIAC MUSCLE CELL COMMUNICATION 6 9.94e-01 1.87e-03 1.00e+00
SPECIFICATION OF SYMMETRY 138 9.70e-01 1.86e-03 9.97e-01
NITRIC OXIDE SYNTHASE BIOSYNTHETIC PROCESS 20 9.89e-01 -1.77e-03 1.00e+00
FEMALE MEIOTIC NUCLEAR DIVISION 38 9.85e-01 -1.75e-03 9.99e-01
LENS MORPHOGENESIS IN CAMERA TYPE EYE 22 9.89e-01 -1.73e-03 1.00e+00
PRESYNAPTIC MEMBRANE ORGANIZATION 10 9.92e-01 1.73e-03 1.00e+00
REGULATION OF CAMP DEPENDENT PROTEIN KINASE ACTIVITY 15 9.91e-01 1.71e-03 1.00e+00
CALCIUM ION TRANSPORT 442 9.52e-01 -1.67e-03 9.94e-01
NEGATIVE REGULATION OF REGULATED SECRETORY PATHWAY 23 9.89e-01 1.65e-03 1.00e+00
LONG CHAIN FATTY ACID BIOSYNTHETIC PROCESS 27 9.88e-01 -1.61e-03 1.00e+00
REGULATION OF MEMBRANE DEPOLARIZATION 47 9.85e-01 -1.56e-03 9.99e-01
NCRNA EXPORT FROM NUCLEUS 9 9.94e-01 1.54e-03 1.00e+00
N TERMINAL PROTEIN AMINO ACID ACETYLATION 16 9.92e-01 1.54e-03 1.00e+00
OSSIFICATION 440 9.56e-01 1.53e-03 9.95e-01
PROTEIN POLYGLUTAMYLATION 12 9.93e-01 1.53e-03 1.00e+00
POSITIVE REGULATION OF POST TRANSLATIONAL PROTEIN MODIFICATION 156 9.74e-01 1.50e-03 9.97e-01
GEPHYRIN CLUSTERING INVOLVED IN POSTSYNAPTIC DENSITY ASSEMBLY 5 9.95e-01 -1.49e-03 1.00e+00
PROTEIN INSERTION INTO MEMBRANE 76 9.82e-01 1.46e-03 9.99e-01
PHOSPHATE ION TRANSPORT 28 9.89e-01 -1.45e-03 1.00e+00
CELLULAR RESPONSE TO TOXIC SUBSTANCE 127 9.78e-01 -1.44e-03 9.97e-01
VASOCONSTRICTION 83 9.82e-01 1.42e-03 9.99e-01
NEGATIVE REGULATION OF ION TRANSMEMBRANE TRANSPORTER ACTIVITY 73 9.83e-01 -1.42e-03 9.99e-01
TELOMERE MAINTENANCE 153 9.76e-01 1.41e-03 9.97e-01
PLATELET ACTIVATION 134 9.78e-01 1.40e-03 9.97e-01
HYALURONAN CATABOLIC PROCESS 16 9.92e-01 -1.36e-03 1.00e+00
FATTY ACID ALPHA OXIDATION 8 9.95e-01 1.35e-03 1.00e+00
MITOCHONDRIAL RIBOSOME ASSEMBLY 10 9.94e-01 1.34e-03 1.00e+00
RHYTHMIC PROCESS 296 9.69e-01 1.31e-03 9.97e-01
POSITIVE REGULATION OF HEPATIC STELLATE CELL ACTIVATION 5 9.96e-01 -1.31e-03 1.00e+00
POSITIVE REGULATION OF HORMONE BIOSYNTHETIC PROCESS 9 9.95e-01 -1.30e-03 1.00e+00
BIOLOGICAL PROCESS INVOLVED IN INTERSPECIES INTERACTION BETWEEN ORGANISMS 1669 9.32e-01 1.25e-03 9.89e-01
REGULATION OF BMP SIGNALING PATHWAY 120 9.81e-01 -1.24e-03 9.98e-01
POSITIVE REGULATION OF INFLAMMATORY RESPONSE 151 9.79e-01 1.22e-03 9.97e-01
REGULATION OF MITOTIC CENTROSOME SEPARATION 9 9.95e-01 1.21e-03 1.00e+00
MITOTIC SPINDLE ELONGATION 12 9.94e-01 1.19e-03 1.00e+00
NEGATIVE REGULATION OF MOTOR NEURON APOPTOTIC PROCESS 11 9.95e-01 1.18e-03 1.00e+00
INHIBITORY SYNAPSE ASSEMBLY 20 9.93e-01 -1.13e-03 1.00e+00
STEM CELL DEVELOPMENT 88 9.86e-01 1.11e-03 9.99e-01
NEGATIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY 62 9.88e-01 -1.10e-03 1.00e+00
REGULATION OF OXIDATIVE STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY 46 9.90e-01 1.09e-03 1.00e+00
POSITIVE REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION 29 9.92e-01 -1.08e-03 1.00e+00
PROTEIN HISTIDYL MODIFICATION TO DIPHTHAMIDE 6 9.96e-01 -1.07e-03 1.00e+00
NEGATIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL MIGRATION 25 9.93e-01 1.06e-03 1.00e+00
RESPONSE TO ISOQUINOLINE ALKALOID 12 9.95e-01 1.06e-03 1.00e+00
RESPONSE TO TYPE II INTERFERON 138 9.83e-01 -1.03e-03 9.99e-01
FOLIC ACID METABOLIC PROCESS 15 9.95e-01 -1.01e-03 1.00e+00
RETINAL PIGMENT EPITHELIUM DEVELOPMENT 7 9.96e-01 -9.99e-04 1.00e+00
POSITIVE REGULATION OF ERAD PATHWAY 15 9.95e-01 -9.59e-04 1.00e+00
SENSORY SYSTEM DEVELOPMENT 400 9.74e-01 -9.53e-04 9.97e-01
SERTOLI CELL DEVELOPMENT 15 9.95e-01 -9.07e-04 1.00e+00
POSITIVE REGULATION OF CATION CHANNEL ACTIVITY 49 9.91e-01 9.03e-04 1.00e+00
REGULATION OF SARCOMERE ORGANIZATION 9 9.96e-01 -8.74e-04 1.00e+00
NEGATIVE REGULATION OF SINGLE STRANDED VIRAL RNA REPLICATION VIA DOUBLE STRANDED DNA INTERMEDIATE 16 9.95e-01 8.36e-04 1.00e+00
REGULATION OF DEFENSE RESPONSE TO FUNGUS 6 9.97e-01 -8.11e-04 1.00e+00
GLYCOSYLATION 219 9.85e-01 -7.58e-04 9.99e-01
REGULATION OF MULTICELLULAR ORGANISM GROWTH 63 9.92e-01 -7.40e-04 1.00e+00
CRANIAL SKELETAL SYSTEM DEVELOPMENT 72 9.91e-01 7.28e-04 1.00e+00
REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO OXIDATIVE STRESS 7 9.97e-01 -7.26e-04 1.00e+00
MITOCHONDRIAL CALCIUM ION HOMEOSTASIS 26 9.95e-01 -7.09e-04 1.00e+00
ESTROUS CYCLE 16 9.96e-01 6.52e-04 1.00e+00
CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE 296 9.85e-01 -6.40e-04 9.99e-01
REGULATION OF CELL ACTIVATION 642 9.78e-01 -6.35e-04 9.97e-01
POSITIVE REGULATION OF HUMORAL IMMUNE RESPONSE 23 9.96e-01 -6.26e-04 1.00e+00
NEGATIVE REGULATION OF OXIDATIVE STRESS INDUCED NEURON INTRINSIC APOPTOTIC SIGNALING PATHWAY 13 9.97e-01 5.92e-04 1.00e+00
REGULATION OF HORMONE LEVELS 535 9.82e-01 5.73e-04 9.99e-01
CALCIUM ACTIVATED PHOSPHOLIPID SCRAMBLING 5 9.98e-01 -5.65e-04 1.00e+00
EXPLORATION BEHAVIOR 30 9.96e-01 -5.51e-04 1.00e+00
COLUMNAR CUBOIDAL EPITHELIAL CELL DIFFERENTIATION 122 9.92e-01 -5.35e-04 1.00e+00
HYALOID VASCULAR PLEXUS REGRESSION 7 9.98e-01 -5.15e-04 1.00e+00
T CELL ACTIVATION 550 9.84e-01 -4.84e-04 9.99e-01
PROTEIN TARGETING 329 9.89e-01 -4.58e-04 1.00e+00
CELLULAR RESPONSE TO SALT 195 9.92e-01 -3.96e-04 1.00e+00
CELL MORPHOGENESIS INVOLVED IN NEURON DIFFERENTIATION 571 9.87e-01 -3.96e-04 9.99e-01
LEUKOCYTE CELL CELL ADHESION 414 9.89e-01 -3.95e-04 1.00e+00
NEGATIVE REGULATION OF T HELPER 1 TYPE IMMUNE RESPONSE 8 9.99e-01 3.58e-04 1.00e+00
REGULATION OF GLUCOCORTICOID BIOSYNTHETIC PROCESS 9 9.99e-01 -3.52e-04 1.00e+00
THIOESTER BIOSYNTHETIC PROCESS 46 9.97e-01 3.08e-04 1.00e+00
TRANSCRIPTION BY RNA POLYMERASE III 61 9.97e-01 -2.80e-04 1.00e+00
POSITIVE REGULATION OF PROTEIN K63 LINKED UBIQUITINATION 8 9.99e-01 -2.61e-04 1.00e+00
CELLULAR RESPONSE TO GONADOTROPIN RELEASING HORMONE 6 9.99e-01 -2.61e-04 1.00e+00
CLATHRIN COAT ASSEMBLY 17 9.99e-01 -2.22e-04 1.00e+00
U4 SNRNA 3 END PROCESSING 8 9.99e-01 -2.17e-04 1.00e+00
CELL CYCLE G1 S PHASE TRANSITION 276 9.95e-01 2.13e-04 1.00e+00
NEGATIVE REGULATION OF COLD INDUCED THERMOGENESIS 47 9.98e-01 -2.05e-04 1.00e+00
POSITIVE REGULATION OF ASPARTIC TYPE PEPTIDASE ACTIVITY 8 9.99e-01 1.95e-04 1.00e+00
CELLULAR PROCESS INVOLVED IN REPRODUCTION IN MULTICELLULAR ORGANISM 463 9.94e-01 1.93e-04 1.00e+00
POSITIVE REGULATION OF CYCLASE ACTIVITY 39 9.98e-01 -1.80e-04 1.00e+00
DEOXYRIBONUCLEOTIDE BIOSYNTHETIC PROCESS 14 9.99e-01 1.37e-04 1.00e+00
RESPONSE TO PURINE CONTAINING COMPOUND 143 9.98e-01 1.33e-04 1.00e+00
MATING BEHAVIOR 36 9.99e-01 9.18e-05 1.00e+00
KIDNEY EPITHELIUM DEVELOPMENT 150 9.99e-01 8.04e-05 1.00e+00
REGULATION OF LEUKOCYTE MEDIATED IMMUNITY 244 9.98e-01 7.77e-05 1.00e+00
VESICLE MEDIATED TRANSPORT IN SYNAPSE 220 9.99e-01 6.38e-05 1.00e+00
REGULATION OF PROTEIN UBIQUITINATION 195 9.99e-01 -3.71e-05 1.00e+00
L ASPARTATE TRANSMEMBRANE TRANSPORT 11 1.00e+00 1.18e-05 1.00e+00
ACTION POTENTIAL 146 1.00e+00 9.58e-06 1.00e+00


Detailed Gene set reports



DISRUPTION OF PLASMA MEMBRANE INTEGRITY IN ANOTHER ORGANISM

DISRUPTION OF PLASMA MEMBRANE INTEGRITY IN ANOTHER ORGANISM
1165
set DISRUPTION OF PLASMA MEMBRANE INTEGRITY IN ANOTHER ORGANISM
setSize 6
pANOVA 0.000101
s.dist 0.917
p.adjustANOVA 0.0137



Top enriched genes

Top 20 genes
GeneID Gene Rank
DEFA4 11146
DEFA5 10992
DEFA1 10974
DEFA1B 10974
DEFA3 10974
DEFA6 10402

Click HERE to show all gene set members

All member genes
GeneID Gene Rank
DEFA4 11146
DEFA5 10992
DEFA1 10974
DEFA1B 10974
DEFA3 10974
DEFA6 10402


DISRUPTION OF CELLULAR ANATOMICAL STRUCTURE IN ANOTHER ORGANISM

DISRUPTION OF CELLULAR ANATOMICAL STRUCTURE IN ANOTHER ORGANISM
1164
set DISRUPTION OF CELLULAR ANATOMICAL STRUCTURE IN ANOTHER ORGANISM
setSize 10
pANOVA 3.66e-06
s.dist 0.845
p.adjustANOVA 0.00101



Top enriched genes

Top 20 genes
GeneID Gene Rank
REG3G 11240
REG1B 11153
DEFA4 11146
DEFA5 10992
DEFA1 10974
DEFA1B 10974
DEFA3 10974
DEFA6 10402
REG3A 10292
REG1A 2732

Click HERE to show all gene set members

All member genes
GeneID Gene Rank
REG3G 11240
REG1B 11153
DEFA4 11146
DEFA5 10992
DEFA1 10974
DEFA1B 10974
DEFA3 10974
DEFA6 10402
REG3A 10292
REG1A 2732


LOBAR BRONCHUS EPITHELIUM DEVELOPMENT

LOBAR BRONCHUS EPITHELIUM DEVELOPMENT
2212
set LOBAR BRONCHUS EPITHELIUM DEVELOPMENT
setSize 5
pANOVA 0.00236
s.dist -0.785
p.adjustANOVA 0.108



Top enriched genes

Top 20 genes
GeneID Gene Rank
HOXA5 -11090
SPDEF -10936
AGR2 -10635
ADAMTSL2 -6534
IL13 -4214

Click HERE to show all gene set members

All member genes
GeneID Gene Rank
HOXA5 -11090
SPDEF -10936
AGR2 -10635
ADAMTSL2 -6534
IL13 -4214


NEGATIVE REGULATION OF SEROTONIN SECRETION

NEGATIVE REGULATION OF SEROTONIN SECRETION
3370
set NEGATIVE REGULATION OF SEROTONIN SECRETION
setSize 5
pANOVA 0.00308
s.dist 0.764
p.adjustANOVA 0.13



Top enriched genes

Top 20 genes
GeneID Gene Rank
HRH3 10875
LILRB1 10822
CNR1 9925
MAOB 8880
HTR1B 5287

Click HERE to show all gene set members

All member genes
GeneID Gene Rank
HRH3 10875
LILRB1 10822
CNR1 9925
MAOB 8880
HTR1B 5287


MODULATION OF MICROTUBULE CYTOSKELETON INVOLVED IN CEREBRAL CORTEX RADIAL GLIA GUIDED MIGRATION

MODULATION OF MICROTUBULE CYTOSKELETON INVOLVED IN CEREBRAL CORTEX RADIAL GLIA GUIDED MIGRATION
2624
set MODULATION OF MICROTUBULE CYTOSKELETON INVOLVED IN CEREBRAL CORTEX RADIAL GLIA GUIDED MIGRATION
setSize 5
pANOVA 0.00386
s.dist -0.746
p.adjustANOVA 0.145



Top enriched genes

Top 20 genes
GeneID Gene Rank
SRGAP2C -11025
SUN1 -9666
SRGAP2 -9110
SYNE2 -5822
SUN2 -5532

Click HERE to show all gene set members

All member genes
GeneID Gene Rank
SRGAP2C -11025
SUN1 -9666
SRGAP2 -9110
SYNE2 -5822
SUN2 -5532


REGULATION OF T CELL EXTRAVASATION

REGULATION OF T CELL EXTRAVASATION
6478
set REGULATION OF T CELL EXTRAVASATION
setSize 5
pANOVA 0.00736
s.dist 0.692
p.adjustANOVA 0.2



Top enriched genes

Top 20 genes
GeneID Gene Rank
CCR2 11662
IL27RA 9871
RIPK3 9460
FADD 6892
CD99L2 3744

Click HERE to show all gene set members

All member genes
GeneID Gene Rank
CCR2 11662
IL27RA 9871
RIPK3 9460
FADD 6892
CD99L2 3744


GALACTOSE CATABOLIC PROCESS

GALACTOSE CATABOLIC PROCESS
1607
set GALACTOSE CATABOLIC PROCESS
setSize 5
pANOVA 0.00845
s.dist -0.68
p.adjustANOVA 0.216



Top enriched genes

Top 20 genes
GeneID Gene Rank
GALK1 -9276
GALT -8228
GALE -7476
GALM -7234
GLB1 -5137

Click HERE to show all gene set members

All member genes
GeneID Gene Rank
GALK1 -9276
GALT -8228
GALE -7476
GALM -7234
GLB1 -5137


INDUCTION OF BACTERIAL AGGLUTINATION

INDUCTION OF BACTERIAL AGGLUTINATION
1939
set INDUCTION OF BACTERIAL AGGLUTINATION
setSize 6
pANOVA 0.00409
s.dist 0.677
p.adjustANOVA 0.151



Top enriched genes

Top 20 genes
GeneID Gene Rank
FGB 11323
FGA 11156
RNASE3 10988
DMBT1 7667
RNASE2 7344
SPON2 420

Click HERE to show all gene set members

All member genes
GeneID Gene Rank
FGB 11323
FGA 11156
RNASE3 10988
DMBT1 7667
RNASE2 7344
SPON2 420


REGULATION OF SUPEROXIDE DISMUTASE ACTIVITY

REGULATION OF SUPEROXIDE DISMUTASE ACTIVITY
6377
set REGULATION OF SUPEROXIDE DISMUTASE ACTIVITY
setSize 7
pANOVA 0.00212
s.dist -0.671
p.adjustANOVA 0.104



Top enriched genes

Top 20 genes
GeneID Gene Rank
MIR21 -10557
MIR675 -10540
H19 -9418
PARK7 -8702
SZT2 -6849
TNF -6188
SIRT3 715

Click HERE to show all gene set members

All member genes
GeneID Gene Rank
MIR21 -10557
MIR675 -10540
H19 -9418
PARK7 -8702
SZT2 -6849
TNF -6188
SIRT3 715


CELLULAR RESPONSE TO SODIUM ARSENITE

CELLULAR RESPONSE TO SODIUM ARSENITE
689
set CELLULAR RESPONSE TO SODIUM ARSENITE
setSize 5
pANOVA 0.00942
s.dist -0.67
p.adjustANOVA 0.228



Top enriched genes

Top 20 genes
GeneID Gene Rank
MAPK13 -10123
HSF1 -10037
DAXX -8422
ZC3H12A -6832
HNRNPA1 -1388

Click HERE to show all gene set members

All member genes
GeneID Gene Rank
MAPK13 -10123
HSF1 -10037
DAXX -8422
ZC3H12A -6832
HNRNPA1 -1388


POSITIVE REGULATION OF RAC PROTEIN SIGNAL TRANSDUCTION

POSITIVE REGULATION OF RAC PROTEIN SIGNAL TRANSDUCTION
4678
set POSITIVE REGULATION OF RAC PROTEIN SIGNAL TRANSDUCTION
setSize 5
pANOVA 0.0109
s.dist 0.658
p.adjustANOVA 0.244



Top enriched genes

Top 20 genes
GeneID Gene Rank
PIK3CG 11346
PIK3CB 9795
ALS2 7783
KRAS 5975
AUTS2 4743

Click HERE to show all gene set members

All member genes
GeneID Gene Rank
PIK3CG 11346
PIK3CB 9795
ALS2 7783
KRAS 5975
AUTS2 4743


LOBAR BRONCHUS DEVELOPMENT

LOBAR BRONCHUS DEVELOPMENT
2211
set LOBAR BRONCHUS DEVELOPMENT
setSize 6
pANOVA 0.0056
s.dist -0.653
p.adjustANOVA 0.174



Top enriched genes

Top 20 genes
GeneID Gene Rank
HOXA5 -11090
SPDEF -10936
AGR2 -10635
ADAMTSL2 -6534
IL13 -4214
WNT7B 451

Click HERE to show all gene set members

All member genes
GeneID Gene Rank
HOXA5 -11090
SPDEF -10936
AGR2 -10635
ADAMTSL2 -6534
IL13 -4214
WNT7B 451


PROXIMAL DISTAL PATTERN FORMATION INVOLVED IN NEPHRON DEVELOPMENT

PROXIMAL DISTAL PATTERN FORMATION INVOLVED IN NEPHRON DEVELOPMENT
5145
set PROXIMAL DISTAL PATTERN FORMATION INVOLVED IN NEPHRON DEVELOPMENT
setSize 5
pANOVA 0.0115
s.dist -0.653
p.adjustANOVA 0.25



Top enriched genes

Top 20 genes
GeneID Gene Rank
OSR1 -10453
HES5 -9986
IRX3 -9881
IRX1 -8332
IRX2 2877

Click HERE to show all gene set members

All member genes
GeneID Gene Rank
OSR1 -10453
HES5 -9986
IRX3 -9881
IRX1 -8332
IRX2 2877


REGULATION OF LONG CHAIN FATTY ACID IMPORT ACROSS PLASMA MEMBRANE

REGULATION OF LONG CHAIN FATTY ACID IMPORT ACROSS PLASMA MEMBRANE
5872
set REGULATION OF LONG CHAIN FATTY ACID IMPORT ACROSS PLASMA MEMBRANE
setSize 6
pANOVA 0.00572
s.dist -0.651
p.adjustANOVA 0.174



Top enriched genes

Top 20 genes
GeneID Gene Rank
THBS1 -10367
AKT1 -10318
AKT2 -9845
ACSL1 -8996
IRS2 -5797
ACSL5 2476

Click HERE to show all gene set members

All member genes
GeneID Gene Rank
THBS1 -10367
AKT1 -10318
AKT2 -9845
ACSL1 -8996
IRS2 -5797
ACSL5 2476


POSITIVE REGULATION OF PROTEOGLYCAN BIOSYNTHETIC PROCESS

POSITIVE REGULATION OF PROTEOGLYCAN BIOSYNTHETIC PROCESS
4673
set POSITIVE REGULATION OF PROTEOGLYCAN BIOSYNTHETIC PROCESS
setSize 5
pANOVA 0.0117
s.dist -0.651
p.adjustANOVA 0.251



Top enriched genes

Top 20 genes
GeneID Gene Rank
MUSTN1 -10685
TCF7L2 -8588
SLC2A10 -8568
PXYLP1 -7509
CTNNB1 -333

Click HERE to show all gene set members

All member genes
GeneID Gene Rank
MUSTN1 -10685
TCF7L2 -8588
SLC2A10 -8568
PXYLP1 -7509
CTNNB1 -333


DNA METHYLATION ON CYTOSINE

DNA METHYLATION ON CYTOSINE
1188
set DNA METHYLATION ON CYTOSINE
setSize 6
pANOVA 0.00587
s.dist -0.649
p.adjustANOVA 0.177



Top enriched genes

Top 20 genes
GeneID Gene Rank
DNMT1 -9676
EHMT2 -8752
STPG4 -7860
DNMT3A -6773
DNMT3L -5525
DNMT3B -4118

Click HERE to show all gene set members

All member genes
GeneID Gene Rank
DNMT1 -9676
EHMT2 -8752
STPG4 -7860
DNMT3A -6773
DNMT3L -5525
DNMT3B -4118


MODULATION BY VIRUS OF HOST PROCESS

MODULATION BY VIRUS OF HOST PROCESS
2621
set MODULATION BY VIRUS OF HOST PROCESS
setSize 7
pANOVA 0.00321
s.dist -0.643
p.adjustANOVA 0.13



Top enriched genes

Top 20 genes
GeneID Gene Rank
MIR141 -11154
AKT1 -10318
MIR130A -9238
BCL2L1 -7957
PPARA -4890
MIR30C1 -4463
BECN1 -1300

Click HERE to show all gene set members

All member genes
GeneID Gene Rank
MIR141 -11154
AKT1 -10318
MIR130A -9238
BCL2L1 -7957
PPARA -4890
MIR30C1 -4463
BECN1 -1300


FC RECEPTOR MEDIATED INHIBITORY SIGNALING PATHWAY

FC RECEPTOR MEDIATED INHIBITORY SIGNALING PATHWAY
1531
set FC RECEPTOR MEDIATED INHIBITORY SIGNALING PATHWAY
setSize 5
pANOVA 0.0131
s.dist 0.641
p.adjustANOVA 0.269



Top enriched genes

Top 20 genes
GeneID Gene Rank
LILRB1 10822
LYN 10397
LILRB4 8886
PSG9 8149
LILRB2 430

Click HERE to show all gene set members

All member genes
GeneID Gene Rank
LILRB1 10822
LYN 10397
LILRB4 8886
PSG9 8149
LILRB2 430


NEGATIVE REGULATION OF PHOSPHOLIPID METABOLIC PROCESS

NEGATIVE REGULATION OF PHOSPHOLIPID METABOLIC PROCESS
3276
set NEGATIVE REGULATION OF PHOSPHOLIPID METABOLIC PROCESS
setSize 7
pANOVA 0.00342
s.dist -0.639
p.adjustANOVA 0.134



Top enriched genes

Top 20 genes
GeneID Gene Rank
SLC27A1 -9293
ABCA2 -9017
PDGFA -8837
APOC1 -8763
LPCAT1 -8338
MIR30C1 -4463
PDGFB -264

Click HERE to show all gene set members

All member genes
GeneID Gene Rank
SLC27A1 -9293
ABCA2 -9017
PDGFA -8837
APOC1 -8763
LPCAT1 -8338
MIR30C1 -4463
PDGFB -264


REGULATION OF MIDBRAIN DOPAMINERGIC NEURON DIFFERENTIATION

REGULATION OF MIDBRAIN DOPAMINERGIC NEURON DIFFERENTIATION
5954
set REGULATION OF MIDBRAIN DOPAMINERGIC NEURON DIFFERENTIATION
setSize 5
pANOVA 0.0149
s.dist -0.629
p.adjustANOVA 0.287



Top enriched genes

Top 20 genes
GeneID Gene Rank
CSNK1D -10134
CSNK1E -9836
SFRP1 -9555
DKK1 -3657
SFRP2 -1233

Click HERE to show all gene set members

All member genes
GeneID Gene Rank
CSNK1D -10134
CSNK1E -9836
SFRP1 -9555
DKK1 -3657
SFRP2 -1233


LEUKOTRIENE B4 METABOLIC PROCESS

LEUKOTRIENE B4 METABOLIC PROCESS
2166
set LEUKOTRIENE B4 METABOLIC PROCESS
setSize 5
pANOVA 0.0157
s.dist 0.624
p.adjustANOVA 0.295



Top enriched genes

Top 20 genes
GeneID Gene Rank
CYP4F2 11778
CYP4F12 10773
CYP4F3 10723
CYP4A11 8201
PTGR1 -3774

Click HERE to show all gene set members

All member genes
GeneID Gene Rank
CYP4F2 11778
CYP4F12 10773
CYP4F3 10723
CYP4A11 8201
PTGR1 -3774


C 5 METHYLATION OF CYTOSINE

C 5 METHYLATION OF CYTOSINE
1028
set C 5 METHYLATION OF CYTOSINE
setSize 5
pANOVA 0.0162
s.dist -0.621
p.adjustANOVA 0.297



Top enriched genes

Top 20 genes
GeneID Gene Rank
DNMT1 -9676
STPG4 -7860
DNMT3A -6773
DNMT3L -5525
DNMT3B -4118

Click HERE to show all gene set members

All member genes
GeneID Gene Rank
DNMT1 -9676
STPG4 -7860
DNMT3A -6773
DNMT3L -5525
DNMT3B -4118


GLOSSOPHARYNGEAL NERVE DEVELOPMENT

GLOSSOPHARYNGEAL NERVE DEVELOPMENT
1673
set GLOSSOPHARYNGEAL NERVE DEVELOPMENT
setSize 5
pANOVA 0.0171
s.dist -0.616
p.adjustANOVA 0.3



Top enriched genes

Top 20 genes
GeneID Gene Rank
HOXD3 -10801
HOXA3 -10142
HOXB3 -9780
NAV2 -4839
PLXNA4 1923

Click HERE to show all gene set members

All member genes
GeneID Gene Rank
HOXD3 -10801
HOXA3 -10142
HOXB3 -9780
NAV2 -4839
PLXNA4 1923


PYRIMIDINE NUCLEOSIDE BIOSYNTHETIC PROCESS

PYRIMIDINE NUCLEOSIDE BIOSYNTHETIC PROCESS
5211
set PYRIMIDINE NUCLEOSIDE BIOSYNTHETIC PROCESS
setSize 5
pANOVA 0.0173
s.dist -0.615
p.adjustANOVA 0.301



Top enriched genes

Top 20 genes
GeneID Gene Rank
UCKL1 -10560
TK1 -8881
TK2 -7424
DTYMK -5993
DHFR2 -739

Click HERE to show all gene set members

All member genes
GeneID Gene Rank
UCKL1 -10560
TK1 -8881
TK2 -7424
DTYMK -5993
DHFR2 -739


CELL MOTILITY INVOLVED IN CEREBRAL CORTEX RADIAL GLIA GUIDED MIGRATION

CELL MOTILITY INVOLVED IN CEREBRAL CORTEX RADIAL GLIA GUIDED MIGRATION
777
set CELL MOTILITY INVOLVED IN CEREBRAL CORTEX RADIAL GLIA GUIDED MIGRATION
setSize 8
pANOVA 0.00271
s.dist -0.612
p.adjustANOVA 0.12



Top enriched genes

Top 20 genes
GeneID Gene Rank
SRGAP2C -11025
DAB2IP -9700
SUN1 -9666
SRGAP2 -9110
BMERB1 -8611
SYNE2 -5822
SUN2 -5532
P2RY12 5964

Click HERE to show all gene set members

All member genes
GeneID Gene Rank
SRGAP2C -11025
DAB2IP -9700
SUN1 -9666
SRGAP2 -9110
BMERB1 -8611
SYNE2 -5822
SUN2 -5532
P2RY12 5964


NEGATIVE REGULATION OF ATP METABOLIC PROCESS

NEGATIVE REGULATION OF ATP METABOLIC PROCESS
2821
set NEGATIVE REGULATION OF ATP METABOLIC PROCESS
setSize 7
pANOVA 0.00513
s.dist -0.611
p.adjustANOVA 0.168



Top enriched genes

Top 20 genes
GeneID Gene Rank
MIR675 -10540
H19 -9418
FLCN -8893
FIS1 -8027
TSPO -7964
PARP1 -1262
PID1 -605

Click HERE to show all gene set members

All member genes
GeneID Gene Rank
MIR675 -10540
H19 -9418
FLCN -8893
FIS1 -8027
TSPO -7964
PARP1 -1262
PID1 -605


RETINAL CELL APOPTOTIC PROCESS

RETINAL CELL APOPTOTIC PROCESS
6814
set RETINAL CELL APOPTOTIC PROCESS
setSize 7
pANOVA 0.00514
s.dist -0.611
p.adjustANOVA 0.168



Top enriched genes

Top 20 genes
GeneID Gene Rank
MIR21 -10557
AKT2 -9845
PDE6B -9103
CLN8 -5814
DIO3 -4209
THRB -3725
GDF6 -3447

Click HERE to show all gene set members

All member genes
GeneID Gene Rank
MIR21 -10557
AKT2 -9845
PDE6B -9103
CLN8 -5814
DIO3 -4209
THRB -3725
GDF6 -3447


POSITIVE REGULATION OF PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY

POSITIVE REGULATION OF PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY
4615
set POSITIVE REGULATION OF PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY
setSize 6
pANOVA 0.00988
s.dist -0.608
p.adjustANOVA 0.232



Top enriched genes

Top 20 genes
GeneID Gene Rank
MIR296 -10391
SRC -9773
HIP1R -9537
HIP1 -6253
F7 -2512
F3 -1393

Click HERE to show all gene set members

All member genes
GeneID Gene Rank
MIR296 -10391
SRC -9773
HIP1R -9537
HIP1 -6253
F7 -2512
F3 -1393


EXOCYST LOCALIZATION

EXOCYST LOCALIZATION
1473
set EXOCYST LOCALIZATION
setSize 5
pANOVA 0.0194
s.dist -0.603
p.adjustANOVA 0.323



Top enriched genes

Top 20 genes
GeneID Gene Rank
TNFAIP2 -9922
EXOC3 -8811
EXOC3L1 -8114
EXOC3L4 -6290
RALB 195

Click HERE to show all gene set members

All member genes
GeneID Gene Rank
TNFAIP2 -9922
EXOC3 -8811
EXOC3L1 -8114
EXOC3L4 -6290
RALB 195


CARDIOLIPIN BIOSYNTHETIC PROCESS

CARDIOLIPIN BIOSYNTHETIC PROCESS
522
set CARDIOLIPIN BIOSYNTHETIC PROCESS
setSize 7
pANOVA 0.00575
s.dist -0.603
p.adjustANOVA 0.174



Top enriched genes

Top 20 genes
GeneID Gene Rank
SLC27A1 -9293
PGS1 -9019
PLA2G6 -8849
TAMM41 -7512
CRLS1 -4752
PLSCR3 -3735
PTPMT1 -2897

Click HERE to show all gene set members

All member genes
GeneID Gene Rank
SLC27A1 -9293
PGS1 -9019
PLA2G6 -8849
TAMM41 -7512
CRLS1 -4752
PLSCR3 -3735
PTPMT1 -2897


REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY ENDOTHELIN

REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY ENDOTHELIN
6403
set REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY ENDOTHELIN
setSize 6
pANOVA 0.0109
s.dist -0.6
p.adjustANOVA 0.244



Top enriched genes

Top 20 genes
GeneID Gene Rank
EDN1 -10748
ECE1 -10005
EDN2 -9048
RHOA -4849
NOS3 -2592
EDN3 -2050

Click HERE to show all gene set members

All member genes
GeneID Gene Rank
EDN1 -10748
ECE1 -10005
EDN2 -9048
RHOA -4849
NOS3 -2592
EDN3 -2050


REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS INVOLVED IN CHOLESTEROL TRANSPORT

REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS INVOLVED IN CHOLESTEROL TRANSPORT
6261
set REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS INVOLVED IN CHOLESTEROL TRANSPORT
setSize 6
pANOVA 0.011
s.dist -0.599
p.adjustANOVA 0.245



Top enriched genes

Top 20 genes
GeneID Gene Rank
MIR27B -10858
MIR17 -9214
ABCA2 -9017
LDLRAP1 -8195
ANXA2 -2076
PCSK9 117

Click HERE to show all gene set members

All member genes
GeneID Gene Rank
MIR27B -10858
MIR17 -9214
ABCA2 -9017
LDLRAP1 -8195
ANXA2 -2076
PCSK9 117


NEGATIVE REGULATION OF T CELL MIGRATION

NEGATIVE REGULATION OF T CELL MIGRATION
3460
set NEGATIVE REGULATION OF T CELL MIGRATION
setSize 6
pANOVA 0.012
s.dist 0.592
p.adjustANOVA 0.253



Top enriched genes

Top 20 genes
GeneID Gene Rank
CD200R1 10232
IL27RA 9871
APOD 9813
RIPOR2 9189
LRCH1 7328
CD200 -3361

Click HERE to show all gene set members

All member genes
GeneID Gene Rank
CD200R1 10232
IL27RA 9871
APOD 9813
RIPOR2 9189
LRCH1 7328
CD200 -3361


REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE ACTIVITY

REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE ACTIVITY
6132
set REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE ACTIVITY
setSize 8
pANOVA 0.00373
s.dist -0.592
p.adjustANOVA 0.141



Top enriched genes

Top 20 genes
GeneID Gene Rank
PIK3R1 -10856
WDR81 -8680
PIK3R2 -8347
AGAP2 -8017
PIK3IP1 -7160
WDR91 -7028
PIK3R3 -1029
RUBCN -544

Click HERE to show all gene set members

All member genes
GeneID Gene Rank
PIK3R1 -10856
WDR81 -8680
PIK3R2 -8347
AGAP2 -8017
PIK3IP1 -7160
WDR91 -7028
PIK3R3 -1029
RUBCN -544


KETONE BODY BIOSYNTHETIC PROCESS

KETONE BODY BIOSYNTHETIC PROCESS
2108
set KETONE BODY BIOSYNTHETIC PROCESS
setSize 6
pANOVA 0.013
s.dist -0.585
p.adjustANOVA 0.268



Top enriched genes

Top 20 genes
GeneID Gene Rank
SLC27A5 -10044
HMGCS2 -9396
HMGCL -7839
AACS -7611
HMGCLL1 -2867
ACSS3 -533

Click HERE to show all gene set members

All member genes
GeneID Gene Rank
SLC27A5 -10044
HMGCS2 -9396
HMGCL -7839
AACS -7611
HMGCLL1 -2867
ACSS3 -533


AMELOBLAST DIFFERENTIATION

AMELOBLAST DIFFERENTIATION
127
set AMELOBLAST DIFFERENTIATION
setSize 5
pANOVA 0.0234
s.dist 0.585
p.adjustANOVA 0.358



Top enriched genes

Top 20 genes
GeneID Gene Rank
ENAM 11254
BMP2 10340
BMP7 8932
BMP4 6751
FST -1786

Click HERE to show all gene set members

All member genes
GeneID Gene Rank
ENAM 11254
BMP2 10340
BMP7 8932
BMP4 6751
FST -1786


NADH OXIDATION

NADH OXIDATION
2755
set NADH OXIDATION
setSize 6
pANOVA 0.0132
s.dist -0.584
p.adjustANOVA 0.271



Top enriched genes

Top 20 genes
GeneID Gene Rank
GPD1 -10774
NQO1 -10362
PCK2 -9776
GPD2 -5403
GPD1L -3975
ALDOB 2090

Click HERE to show all gene set members

All member genes
GeneID Gene Rank
GPD1 -10774
NQO1 -10362
PCK2 -9776
GPD2 -5403
GPD1L -3975
ALDOB 2090


REGULATION OF SEROTONIN SECRETION

REGULATION OF SEROTONIN SECRETION
6320
set REGULATION OF SEROTONIN SECRETION
setSize 7
pANOVA 0.00747
s.dist 0.584
p.adjustANOVA 0.2



Top enriched genes

Top 20 genes
GeneID Gene Rank
HRH3 10875
LILRB1 10822
CNR1 9925
MAOB 8880
HTR1B 5287
HTR1A 4181
SLC6A4 -416

Click HERE to show all gene set members

All member genes
GeneID Gene Rank
HRH3 10875
LILRB1 10822
CNR1 9925
MAOB 8880
HTR1B 5287
HTR1A 4181
SLC6A4 -416


POSITIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION OF STAT PROTEIN

POSITIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION OF STAT PROTEIN
4594
set POSITIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION OF STAT PROTEIN
setSize 14
pANOVA 0.000161
s.dist 0.582
p.adjustANOVA 0.018



Top enriched genes

Top 20 genes
GeneID Gene Rank
IFNA14 11826
IFNA13 11677
IFNA21 11621
IFNA1 11119
IFNA2 10695
IFNG 10626
IFNA7 10311
IFNA5 10081
IFNA8 7438
IFNB1 6068
IFNW1 2482
IFNK 580
RET 263
LIF -5946

Click HERE to show all gene set members

All member genes
GeneID Gene Rank
IFNA14 11826
IFNA13 11677
IFNA21 11621
IFNA1 11119
IFNA2 10695
IFNG 10626
IFNA7 10311
IFNA5 10081
IFNA8 7438
IFNB1 6068
IFNW1 2482
IFNK 580
RET 263
LIF -5946


MAINTENANCE OF PROTEIN LOCATION IN MITOCHONDRION

MAINTENANCE OF PROTEIN LOCATION IN MITOCHONDRION
2333
set MAINTENANCE OF PROTEIN LOCATION IN MITOCHONDRION
setSize 5
pANOVA 0.0258
s.dist -0.576
p.adjustANOVA 0.365



Top enriched genes

Top 20 genes
GeneID Gene Rank
AKT1 -10318
HK1 -9246
TSPO -7964
HK2 -6448
PINK1 2624

Click HERE to show all gene set members

All member genes
GeneID Gene Rank
AKT1 -10318
HK1 -9246
TSPO -7964
HK2 -6448
PINK1 2624


REGULATION OF PHOSPHATIDYLCHOLINE BIOSYNTHETIC PROCESS

REGULATION OF PHOSPHATIDYLCHOLINE BIOSYNTHETIC PROCESS
6130
set REGULATION OF PHOSPHATIDYLCHOLINE BIOSYNTHETIC PROCESS
setSize 5
pANOVA 0.0263
s.dist -0.574
p.adjustANOVA 0.365



Top enriched genes

Top 20 genes
GeneID Gene Rank
LPCAT1 -8338
ACSL3 -7755
CAPN2 -6411
RAB38 -6140
FABP3 -2585

Click HERE to show all gene set members

All member genes
GeneID Gene Rank
LPCAT1 -8338
ACSL3 -7755
CAPN2 -6411
RAB38 -6140
FABP3 -2585


5 PHOSPHORIBOSE 1 DIPHOSPHATE METABOLIC PROCESS

5 PHOSPHORIBOSE 1 DIPHOSPHATE METABOLIC PROCESS
9
set 5 PHOSPHORIBOSE 1 DIPHOSPHATE METABOLIC PROCESS
setSize 6
pANOVA 0.0151
s.dist 0.573
p.adjustANOVA 0.29



Top enriched genes

Top 20 genes
GeneID Gene Rank
PRPS1L1 10367
PYGL 9664
PRPS2 8489
PRPS1 6842
PRPSAP2 4904
PRPSAP1 1440

Click HERE to show all gene set members

All member genes
GeneID Gene Rank
PRPS1L1 10367
PYGL 9664
PRPS2 8489
PRPS1 6842
PRPSAP2 4904
PRPSAP1 1440


LIPID HYDROXYLATION

LIPID HYDROXYLATION
2190
set LIPID HYDROXYLATION
setSize 7
pANOVA 0.00876
s.dist 0.572
p.adjustANOVA 0.22



Top enriched genes

Top 20 genes
GeneID Gene Rank
CYP2C8 11395
CYP3A7 11109
CYP3A5 11043
CYP3A4 9179
CYP2E1 2280
CYP1A1 2206
CYP4A22 1397

Click HERE to show all gene set members

All member genes
GeneID Gene Rank
CYP2C8 11395
CYP3A7 11109
CYP3A5 11043
CYP3A4 9179
CYP2E1 2280
CYP1A1 2206
CYP4A22 1397


REGULATION OF PHOSPHOLIPID CATABOLIC PROCESS

REGULATION OF PHOSPHOLIPID CATABOLIC PROCESS
6140
set REGULATION OF PHOSPHOLIPID CATABOLIC PROCESS
setSize 7
pANOVA 0.00898
s.dist -0.57
p.adjustANOVA 0.222



Top enriched genes

Top 20 genes
GeneID Gene Rank
APOC1 -8763
APOC2 -8594
LDLR -6975
PRKCD -6414
SCARB1 -6392
ENPP7 -6176
IDH1 -124

Click HERE to show all gene set members

All member genes
GeneID Gene Rank
APOC1 -8763
APOC2 -8594
LDLR -6975
PRKCD -6414
SCARB1 -6392
ENPP7 -6176
IDH1 -124


RESPONSE TO OZONE

RESPONSE TO OZONE
6745
set RESPONSE TO OZONE
setSize 5
pANOVA 0.0287
s.dist -0.565
p.adjustANOVA 0.373



Top enriched genes

Top 20 genes
GeneID Gene Rank
EDN1 -10748
IL1A -10189
SCGB1A1 -9959
CAT -824
TACR1 986

Click HERE to show all gene set members

All member genes
GeneID Gene Rank
EDN1 -10748
IL1A -10189
SCGB1A1 -9959
CAT -824
TACR1 986


NEGATIVE REGULATION OF ATP BIOSYNTHETIC PROCESS

NEGATIVE REGULATION OF ATP BIOSYNTHETIC PROCESS
2819
set NEGATIVE REGULATION OF ATP BIOSYNTHETIC PROCESS
setSize 5
pANOVA 0.0287
s.dist -0.565
p.adjustANOVA 0.373



Top enriched genes

Top 20 genes
GeneID Gene Rank
MIR675 -10540
H19 -9418
FLCN -8893
PARP1 -1262
PID1 -605

Click HERE to show all gene set members

All member genes
GeneID Gene Rank
MIR675 -10540
H19 -9418
FLCN -8893
PARP1 -1262
PID1 -605


LONG CHAIN FATTY ACID IMPORT ACROSS PLASMA MEMBRANE

LONG CHAIN FATTY ACID IMPORT ACROSS PLASMA MEMBRANE
2221
set LONG CHAIN FATTY ACID IMPORT ACROSS PLASMA MEMBRANE
setSize 10
pANOVA 0.002
s.dist -0.564
p.adjustANOVA 0.102



Top enriched genes

Top 20 genes
GeneID Gene Rank
THBS1 -10367
AKT1 -10318
SLC27A5 -10044
AKT2 -9845
SLC27A1 -9293
ACSL1 -8996
IRS2 -5797
SLC2A1 -3860
ACSL5 2476
CD36 4683

Click HERE to show all gene set members

All member genes
GeneID Gene Rank
THBS1 -10367
AKT1 -10318
SLC27A5 -10044
AKT2 -9845
SLC27A1 -9293
ACSL1 -8996
IRS2 -5797
SLC2A1 -3860
ACSL5 2476
CD36 4683


ENDOCANNABINOID SIGNALING PATHWAY

ENDOCANNABINOID SIGNALING PATHWAY
1291
set ENDOCANNABINOID SIGNALING PATHWAY
setSize 5
pANOVA 0.0305
s.dist -0.559
p.adjustANOVA 0.385



Top enriched genes

Top 20 genes
GeneID Gene Rank
ALOX15B -10310
DAGLA -9279
CAMK2A -5593
MGLL -3948
ABHD6 -1237

Click HERE to show all gene set members

All member genes
GeneID Gene Rank
ALOX15B -10310
DAGLA -9279
CAMK2A -5593
MGLL -3948
ABHD6 -1237


REGULATION OF FAS SIGNALING PATHWAY

REGULATION OF FAS SIGNALING PATHWAY
5661
set REGULATION OF FAS SIGNALING PATHWAY
setSize 6
pANOVA 0.0179
s.dist -0.558
p.adjustANOVA 0.308



Top enriched genes

Top 20 genes
GeneID Gene Rank
TMBIM1 -8784
ZDHHC7 -8107
SP100 -7031
MIR23A -6196
MIR27A -5141
SMAD5 -1152

Click HERE to show all gene set members

All member genes
GeneID Gene Rank
TMBIM1 -8784
ZDHHC7 -8107
SP100 -7031
MIR23A -6196
MIR27A -5141
SMAD5 -1152


FATTY ACID OMEGA OXIDATION

FATTY ACID OMEGA OXIDATION
1517
set FATTY ACID OMEGA OXIDATION
setSize 5
pANOVA 0.0331
s.dist 0.55
p.adjustANOVA 0.399



Top enriched genes

Top 20 genes
GeneID Gene Rank
CYP4F2 11778
CYP4V2 10498
ADH7 10070
ADH5 3431
ADH4 -2309

Click HERE to show all gene set members

All member genes
GeneID Gene Rank
CYP4F2 11778
CYP4V2 10498
ADH7 10070
ADH5 3431
ADH4 -2309


Here is the session info with all the versions of packages used.

sessionInfo()
## R version 4.3.2 (2023-10-31)
## Platform: x86_64-pc-linux-gnu (64-bit)
## Running under: Ubuntu 22.04.3 LTS
## 
## Matrix products: default
## BLAS:   /usr/lib/x86_64-linux-gnu/openblas-pthread/libblas.so.3 
## LAPACK: /usr/lib/x86_64-linux-gnu/openblas-pthread/libopenblasp-r0.3.20.so;  LAPACK version 3.10.0
## 
## locale:
##  [1] LC_CTYPE=en_US.UTF-8       LC_NUMERIC=C              
##  [3] LC_TIME=en_US.UTF-8        LC_COLLATE=en_US.UTF-8    
##  [5] LC_MONETARY=en_US.UTF-8    LC_MESSAGES=en_US.UTF-8   
##  [7] LC_PAPER=en_US.UTF-8       LC_NAME=C                 
##  [9] LC_ADDRESS=C               LC_TELEPHONE=C            
## [11] LC_MEASUREMENT=en_US.UTF-8 LC_IDENTIFICATION=C       
## 
## time zone: Etc/UTC
## tzcode source: system (glibc)
## 
## attached base packages:
## [1] parallel  stats4    stats     graphics  grDevices utils     datasets 
## [8] methods   base     
## 
## other attached packages:
##  [1] pkgload_1.3.3                                      
##  [2] GGally_2.2.0                                       
##  [3] ggplot2_3.4.4                                      
##  [4] reshape2_1.4.4                                     
##  [5] gplots_3.1.3                                       
##  [6] gtools_3.9.5                                       
##  [7] tibble_3.2.1                                       
##  [8] dplyr_1.1.4                                        
##  [9] echarts4r_0.4.5                                    
## [10] png_0.1-8                                          
## [11] gridExtra_2.3                                      
## [12] missMethyl_1.36.0                                  
## [13] beeswarm_0.4.0                                     
## [14] kableExtra_1.3.4                                   
## [15] tictoc_1.2                                         
## [16] HGNChelper_0.8.1                                   
## [17] IlluminaHumanMethylationEPICanno.ilm10b4.hg19_0.6.0
## [18] IlluminaHumanMethylation450kanno.ilmn12.hg19_0.6.1 
## [19] minfi_1.48.0                                       
## [20] bumphunter_1.44.0                                  
## [21] locfit_1.5-9.8                                     
## [22] iterators_1.0.14                                   
## [23] foreach_1.5.2                                      
## [24] Biostrings_2.70.1                                  
## [25] XVector_0.42.0                                     
## [26] SummarizedExperiment_1.32.0                        
## [27] Biobase_2.62.0                                     
## [28] MatrixGenerics_1.14.0                              
## [29] matrixStats_1.2.0                                  
## [30] GenomicRanges_1.54.1                               
## [31] GenomeInfoDb_1.38.2                                
## [32] IRanges_2.36.0                                     
## [33] S4Vectors_0.40.2                                   
## [34] BiocGenerics_0.48.1                                
## [35] eulerr_7.0.0                                       
## [36] limma_3.58.1                                       
## [37] mitch_1.15.2                                       
## 
## loaded via a namespace (and not attached):
##   [1] splines_4.3.2             later_1.3.2              
##   [3] BiocIO_1.12.0             bitops_1.0-7             
##   [5] filelock_1.0.3            preprocessCore_1.64.0    
##   [7] XML_3.99-0.16             lifecycle_1.0.4          
##   [9] lattice_0.22-5            MASS_7.3-60              
##  [11] base64_2.0.1              scrime_1.3.5             
##  [13] magrittr_2.0.3            sass_0.4.8               
##  [15] rmarkdown_2.25            jquerylib_0.1.4          
##  [17] yaml_2.3.8                httpuv_1.6.13            
##  [19] askpass_1.2.0             doRNG_1.8.6              
##  [21] DBI_1.1.3                 RColorBrewer_1.1-3       
##  [23] abind_1.4-5               zlibbioc_1.48.0          
##  [25] quadprog_1.5-8            rvest_1.0.3              
##  [27] purrr_1.0.2               RCurl_1.98-1.13          
##  [29] rappdirs_0.3.3            GenomeInfoDbData_1.2.11  
##  [31] genefilter_1.84.0         annotate_1.80.0          
##  [33] svglite_2.1.3             DelayedMatrixStats_1.24.0
##  [35] codetools_0.2-19          DelayedArray_0.28.0      
##  [37] xml2_1.3.6                tidyselect_1.2.0         
##  [39] beanplot_1.3.1            BiocFileCache_2.10.1     
##  [41] illuminaio_0.44.0         webshot_0.5.5            
##  [43] GenomicAlignments_1.38.0  jsonlite_1.8.8           
##  [45] multtest_2.58.0           ellipsis_0.3.2           
##  [47] survival_3.5-7            systemfonts_1.0.5        
##  [49] tools_4.3.2               progress_1.2.3           
##  [51] Rcpp_1.0.11               glue_1.6.2               
##  [53] SparseArray_1.2.2         xfun_0.41                
##  [55] HDF5Array_1.30.0          withr_2.5.2              
##  [57] fastmap_1.1.1             rhdf5filters_1.14.1      
##  [59] fansi_1.0.6               openssl_2.1.1            
##  [61] caTools_1.18.2            digest_0.6.33            
##  [63] R6_2.5.1                  mime_0.12                
##  [65] colorspace_2.1-0          biomaRt_2.58.0           
##  [67] RSQLite_2.3.4             utf8_1.2.4               
##  [69] tidyr_1.3.0               generics_0.1.3           
##  [71] data.table_1.14.10        rtracklayer_1.62.0       
##  [73] prettyunits_1.2.0         httr_1.4.7               
##  [75] htmlwidgets_1.6.4         S4Arrays_1.2.0           
##  [77] ggstats_0.5.1             pkgconfig_2.0.3          
##  [79] gtable_0.3.4              blob_1.2.4               
##  [81] siggenes_1.76.0           htmltools_0.5.7          
##  [83] scales_1.3.0              knitr_1.45               
##  [85] rstudioapi_0.15.0         tzdb_0.4.0               
##  [87] rjson_0.2.21              nlme_3.1-163             
##  [89] curl_5.2.0                org.Hs.eg.db_3.18.0      
##  [91] cachem_1.0.8              rhdf5_2.46.1             
##  [93] stringr_1.5.1             KernSmooth_2.23-22       
##  [95] AnnotationDbi_1.64.1      restfulr_0.0.15          
##  [97] GEOquery_2.70.0           pillar_1.9.0             
##  [99] grid_4.3.2                reshape_0.8.9            
## [101] vctrs_0.6.5               promises_1.2.1           
## [103] dbplyr_2.4.0              xtable_1.8-4             
## [105] evaluate_0.23             readr_2.1.4              
## [107] GenomicFeatures_1.54.1    cli_3.6.2                
## [109] compiler_4.3.2            Rsamtools_2.18.0         
## [111] rlang_1.1.2               crayon_1.5.2             
## [113] rngtools_1.5.2            nor1mix_1.3-2            
## [115] mclust_6.0.1              plyr_1.8.9               
## [117] stringi_1.8.3             viridisLite_0.4.2        
## [119] BiocParallel_1.36.0       munsell_0.5.0            
## [121] Matrix_1.6-1.1            hms_1.1.3                
## [123] sparseMatrixStats_1.14.0  bit64_4.0.5              
## [125] Rhdf5lib_1.24.1           KEGGREST_1.42.0          
## [127] statmod_1.5.0             shiny_1.8.0              
## [129] highr_0.10                memoise_2.0.1            
## [131] bslib_0.6.1               bit_4.0.5

END of report